0000875045-16-000065.txt : 20160721 0000875045-16-000065.hdr.sgml : 20160721 20160721173012 ACCESSION NUMBER: 0000875045-16-000065 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 120 CONFORMED PERIOD OF REPORT: 20160630 FILED AS OF DATE: 20160721 DATE AS OF CHANGE: 20160721 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOGEN INC. CENTRAL INDEX KEY: 0000875045 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330112644 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-19311 FILM NUMBER: 161778025 BUSINESS ADDRESS: STREET 1: 225 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 7814642000 MAIL ADDRESS: STREET 1: 225 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC. DATE OF NAME CHANGE: 20070427 FORMER COMPANY: FORMER CONFORMED NAME: BIOGEN IDEC INC DATE OF NAME CHANGE: 20031112 FORMER COMPANY: FORMER CONFORMED NAME: IDEC PHARMACEUTICALS CORP / DE DATE OF NAME CHANGE: 19970530 10-Q 1 biib-2016630x10q.htm 10-Q Document


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
 
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2016
OR
 
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number 0-19311
BIOGEN INC.
(Exact name of registrant as specified in its charter)
Delaware
 
33-0112644
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
225 Binney Street, Cambridge, MA 02142
(617) 679-2000
(Address, including zip code, and telephone number, including
area code, of registrant’s principal executive offices)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:    Yes  x    No  o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files):    Yes  x    No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (Check One):
Large accelerated filer x
 
Accelerated filer  o
Non-accelerated filer o
 
Smaller reporting company  o
(Do not check if a smaller reporting company)
 
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act):    Yes  o    No  x
The number of shares of the issuer’s Common Stock, $0.0005 par value, outstanding as of July 15, 2016, was 219,120,762 shares.
 


BIOGEN INC.
FORM 10-Q — Quarterly Report
For the Quarterly Period Ended June 30, 2016
TABLE OF CONTENTS
 
 
 
Page
 
 
 
Item 1.
Financial Statements (unaudited)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Certain totals may not sum due to rounding.
 
 
 
 
Item 2.
 
 
 
Item 3.
 
 
 
Item 4.
 
PART II — OTHER INFORMATION
 
 
 
Item 1.
 
 
 
Item 1A.
 
 
 
Item 2.
 
 
 
Item 6.
 
 


2

NOTE REGARDING FORWARD-LOOKING STATEMENTS
This report contains forward-looking statements that are being made pursuant to the provisions of the Private Securities Litigation Reform Act of 1995 (the Act) with the intention of obtaining the benefits of the “Safe Harbor” provisions of the Act. These forward-looking statements may be accompanied by such words as “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “potential,” “project,” “target,” “will” and other words and terms of similar meaning. Reference is made in particular to forward-looking statements regarding:
•
the anticipated amount, timing and accounting of revenues, contingent payments, milestone, royalty and other payments under licensing, collaboration or acquisition agreements, tax positions and contingencies, collectability of receivables, pre-approval inventory, cost of sales, research and development costs, compensation and other selling, general and administrative expenses, amortization of intangible assets, foreign currency exchange risk, estimated fair value of assets and liabilities and impairment assessments;
•
expectations, plans and prospects relating to sales, pricing, growth and launch of our marketed and pipeline products;
•
the potential impact of increased product competition in the markets in which we compete;
•
the proposed spin off of our hemophilia business, including the completion and timing of the spin off and its anticipated benefits, costs and tax treatment;
•
the costs and timing of potential clinical trials, filing and approvals, and the potential therapeutic scope of the development and commercialization of our and our collaborators’ pipeline products;
•
the drivers for growing our business, including our plans and intent to commit resources relating to research and development programs;
•
our manufacturing capacity, use of third-party contract manufacturing organizations and plans and timing relating to the expansion of our manufacturing capabilities, including investments and activities in new manufacturing facilities;
•
the expected financial impact of ceasing manufacturing activities and fully or partially vacating our biologics manufacturing facility in Cambridge, MA and warehouse space in Somerville, MA;
•
the impact of the continued uncertainty of the credit and economic conditions in certain countries in Europe and our collection of accounts receivable in such countries;
•
the potential impact on our results of operations and liquidity of the United Kingdom's (U.K.'s) intent to voluntarily depart from the European Union (E.U.);
•
the potential impact of healthcare reform in the United States (U.S.) and measures being taken worldwide designed to reduce healthcare costs to constrain the overall level of government expenditures, including the impact of pricing actions and reduced reimbursement for our products;
•
the timing, outcome and impact of administrative, regulatory, legal and other proceedings related to patents and other proprietary and intellectual property rights, tax audits, assessments and settlements, pricing matters, sales and promotional practices, product liability and other matters;
•
lease commitments, purchase obligations and the timing and satisfaction of other contractual obligations;
•
potential costs and expenses incurred to execute business transformation and optimization initiatives;
•
our ability to finance our operations and business initiatives and obtain funding for such activities; and
•
the impact of new laws and accounting standards.
These forward-looking statements involve risks and uncertainties, including those that are described in the “Risk Factors” section of this report, and elsewhere in this report that could cause actual results to differ materially from those reflected in such statements. You should not place undue reliance on these statements. Forward-looking statements speak only as of the date of this report. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

3

NOTE REGARDING COMPANY AND PRODUCT REFERENCES
Throughout this report, “Biogen,” the “Company,” “we,” “us” and “our” refer to Biogen Inc. and its consolidated subsidiaries. References to “RITUXAN” refer to both RITUXAN (the trade name for rituximab in the U.S., Canada and Japan) and MabThera (the trade name for rituximab outside the U.S., Canada and Japan). References to "ELOCTATE" refer to both ELOCTATE (the trade name for Antihemophilic Factor (Recombinant), Fc Fusion Protein in the U.S., Canada and Japan) and ELOCTA (the trade name for Antihemophilic Factor (Recombinant), Fc Fusion Protein in the E.U.).
NOTE REGARDING TRADEMARKS
ALPROLIX®, AVONEX®, BENEPALI®, ELOCTATE®, FLIXABI®, PLEGRIDY®, RITUXAN®, TECFIDERA® and TYSABRI® are registered trademarks of Biogen. FUMADERMTM and ZINBRYTATM are trademarks of Biogen. ENBREL®, GAZYVA®, HUMIRA®, REMICADE® and other trademarks referenced in this report are the property of their respective owners.

4

PART I FINANCIAL INFORMATION

BIOGEN INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(unaudited, in millions, except per share amounts)
 
 
For the Three Months
Ended June 30,
 
For the Six Months
Ended June 30,
 
2016
 
2015
 
2016
 
2015
Revenues:
 
 
 
 
 
 
 
Product, net
$
2,466.0

 
$
2,198.6

 
$
4,775.4

 
$
4,370.9

Revenues from anti-CD20 therapeutic programs
349.2

 
337.5

 
678.7

 
668.1

Other
79.0

 
55.6

 
166.9

 
107.6

Total revenues
2,894.2

 
2,591.6

 
5,621.0

 
5,146.6

Cost and expenses:
 
 
 
 
 
 
 
Cost of sales, excluding amortization of acquired intangible assets
370.3

 
286.1

 
683.3

 
598.6

Research and development
473.1

 
490.7

 
910.4

 
951.3

Selling, general and administrative
492.4

 
491.9

 
989.7

 
1,052.3

Amortization of acquired intangible assets
92.9

 
92.0

 
181.7

 
187.9

(Gain) loss on fair value remeasurement of contingent consideration
10.6

 
(2.2
)
 
12.9

 
5.6

Restructuring charges
—

 
—

 
9.7

 
—

Collaboration profit (loss) sharing
(5.6
)
 
—

 
(5.6
)
 
—

Total cost and expenses
1,433.7

 
1,358.5

 
2,782.1

 
2,795.6

Income from operations
1,460.5

 
1,233.1

 
2,838.9

 
2,351.0

Other income (expense), net
(58.5
)
 
(10.9
)
 
(111.3
)
 
(25.9
)
Income before income tax expense and equity in loss of investee, net of tax
1,402.0

 
1,222.2

 
2,727.6

 
2,325.1

Income tax expense
353.6

 
292.5

 
710.0

 
574.4

Equity in loss of investee, net of tax
—

 
4.9

 
—

 
5.7

Net income
1,048.4

 
924.8

 
2,017.6

 
1,745.0

Net income (loss) attributable to noncontrolling interests, net of tax
(1.4
)
 
(2.5
)
 
(3.1
)
 
(4.8
)
Net income attributable to Biogen Inc.
$
1,049.8

 
$
927.3

 
$
2,020.7

 
$
1,749.8

Net income per share:
 
 
 
 
 
 
 
Basic earnings per share attributable to Biogen Inc.
$
4.79

 
$
3.94

 
$
9.23

 
$
7.44

Diluted earnings per share attributable to Biogen Inc.
$
4.79

 
$
3.93

 
$
9.21

 
$
7.42

Weighted-average shares used in calculating:
 
 
 
 
 
 
 
Basic earnings per share attributable to Biogen Inc.
219.1

 
235.3

 
219.0

 
235.1

Diluted earnings per share attributable to Biogen Inc.
219.4

 
235.7

 
219.3

 
235.7








See accompanying notes to these unaudited condensed consolidated financial statements.

5

BIOGEN INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(unaudited, in millions)
 
 
For the Three Months
Ended June 30,
 
For the Six Months
Ended June 30,
 
2016
 
2015
 
2016
 
2015
Net income attributable to Biogen Inc.
$
1,049.8

 
$
927.3

 
$
2,020.7

 
$
1,749.8

Other comprehensive income:
 
 
 
 
 
 
 
Unrealized gains (losses) on securities available for sale, net of tax
4.5

 
(0.2
)
 
7.0

 
1.1

Unrealized gains (losses) on cash flow hedges, net of tax
29.3

 
(96.2
)
 
(18.3
)
 
(8.9
)
Unrealized gains (losses) on pension benefit obligation
0.7

 
2.9

 
0.9

 
4.1

Currency translation adjustment
(58.0
)
 
63.0

 
(48.4
)
 
(37.8
)
Total other comprehensive income (loss), net of tax
(23.5
)
 
(30.5
)
 
(58.8
)
 
(41.5
)
Comprehensive income attributable to Biogen Inc.
1,026.3

 
896.8

 
1,961.9

 
1,708.3

Comprehensive income (loss) attributable to noncontrolling interests, net of tax
(1.4
)
 
(2.3
)
 
(3.1
)
 
(4.5
)
Comprehensive income
$
1,024.9

 
$
894.5

 
$
1,958.8

 
$
1,703.7




































See accompanying notes to these unaudited condensed consolidated financial statements.

6

BIOGEN INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited, in millions, except per share amounts)
 
 
As of June 30,
2016
 
As of December 31,
2015
ASSETS
Current assets:
 
 
 
Cash and cash equivalents
$
1,362.0

 
$
1,308.0

Marketable securities
2,434.8

 
2,120.5

Accounts receivable, net
1,293.0

 
1,227.0

Due from anti-CD20 therapeutic programs
334.1

 
314.5

Inventory
996.4

 
893.4

Other current assets
1,027.4

 
836.9

Total current assets
7,447.7

 
6,700.3

Marketable securities
3,477.6

 
2,760.4

Property, plant and equipment, net
2,301.8

 
2,187.6

Intangible assets, net
3,967.6

 
4,085.1

Goodwill
3,167.1

 
2,663.8

Investments and other assets
1,153.0

 
1,107.6

Total assets
$
21,514.8

 
$
19,504.8

LIABILITIES AND EQUITY
Current liabilities:
 
 
 
Current portion of notes payable and other financing arrangements
$
4.8

 
$
4.8

Taxes payable
212.8

 
208.7

Accounts payable
225.9

 
267.4

Accrued expenses and other
2,072.7

 
2,096.8

Total current liabilities
2,516.2

 
2,577.7

Notes payable and other financing arrangements
6,538.3

 
6,521.5

Long-term deferred tax liability
105.6

 
124.9

Other long-term liabilities
951.0

 
905.8

Total liabilities
10,111.1

 
10,129.9

Commitments and contingencies


 


Equity:
 
 
 
Biogen Inc. shareholders’ equity
 
 
 
Preferred stock, par value $0.001 per share
—

 
—

Common stock, par value $0.0005 per share
0.1

 
0.1

Additional paid-in capital
69.1

 
—

Accumulated other comprehensive loss
(282.8
)
 
(224.0
)
Retained earnings
14,229.1

 
12,208.4

Treasury stock, at cost
(2,611.7
)
 
(2,611.7
)
Total Biogen Inc. shareholders’ equity
11,403.8

 
9,372.8

Noncontrolling interests
(0.1
)
 
2.1

Total equity
11,403.7

 
9,374.9

Total liabilities and equity
$
21,514.8

 
$
19,504.8



See accompanying notes to these unaudited condensed consolidated financial statements.

7

BIOGEN INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited, in millions)
 
 
For the Six Months
Ended June 30,
 
2016
 
2015
Cash flows from operating activities:
 
 
 
Net income
$
2,017.6

 
$
1,745.0

Adjustments to reconcile net income to net cash flows from operating activities:
 
 
 
Depreciation and amortization
325.1

 
292.5

Share-based compensation
84.1

 
93.7

Deferred income taxes
(30.2
)
 
(90.6
)
Other
19.8

 
(5.8
)
Changes in operating assets and liabilities, net:
 
 
 
Accounts receivable
(65.0
)
 
(38.9
)
Inventory
(128.3
)
 
(81.3
)
Accrued expenses and other current liabilities
(162.3
)
 
(169.9
)
Current taxes payable
(151.7
)
 
102.0

Other changes in operating assets and liabilities, net
50.1

 
(66.4
)
Net cash flows provided by operating activities
1,959.2

 
1,780.3

Cash flows from investing activities:
 
 
 
Proceeds from sales and maturities of marketable securities
2,823.6

 
975.5

Purchases of marketable securities
(3,833.3
)
 
(2,045.0
)
Acquisitions of business, net of cash acquired
—

 
(198.8
)
Purchases of property, plant and equipment
(263.7
)
 
(227.7
)
Contingent consideration related to Fumapharm AG acquisition
(600.0
)
 
(250.0
)
Other
(65.9
)
 
(10.1
)
Net cash flows used in investing activities
(1,939.3
)
 
(1,756.1
)
Cash flows from financing activities:
 
 
 
Purchase of treasury stock
—

 
(42.2
)
Proceeds from issuance of stock for share-based compensation arrangements
23.9

 
34.7

Excess tax benefit from share-based awards
9.0

 
69.7

Other
1.1

 
15.0

Net cash flows provided by financing activities
34.0

 
77.2

Net increase in cash and cash equivalents
53.9

 
101.4

Effect of exchange rate changes on cash and cash equivalents
0.1

 
(24.2
)
Cash and cash equivalents, beginning of the period
1,308.0

 
1,204.9

Cash and cash equivalents, end of the period
$
1,362.0

 
$
1,282.1













See accompanying notes to these unaudited condensed consolidated financial statements.

8
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)


1.    Summary of Significant Accounting Policies
Business Overview
Biogen is a global biopharmaceutical company focused on discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological diseases, autoimmune disorders and rare diseases.
Our marketed products include TECFIDERA, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for multiple sclerosis (MS), ELOCTATE for hemophilia A and ALPROLIX for hemophilia B and FUMADERM for the treatment of severe plaque psoriasis. We also have a collaboration agreement with Genentech, Inc. (Genentech), a wholly-owned member of the Roche Group, which entitles us to certain business and financial rights with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other potential anti-CD20 therapies.
In addition to our innovative drug development efforts, we aim to leverage our manufacturing capabilities and scientific expertise through Samsung Bioepis, our joint venture with Samsung BioLogics Co. Ltd. (Samsung Biologics) that develops, manufactures and markets biosimilars as well as through other strategic contract manufacturing partners. Under our commercial agreement with Samsung Bioepis, we market and sell BENEPALI, an etanercept biosimilar referencing ENBREL, and FLIXABI, an infliximab biosimilar referencing REMICADE, in the European Union (E.U.).
In May 2016, we announced our intention to spin off our hemophilia business as an independent, publicly traded company. The new company will focus on the discovery and development of therapies for the treatment of hemophilia and other blood disorders, with existing marketed products ELOCTATE and ALPROLIX. The transaction is expected to be completed in early 2017, subject to the satisfaction of certain conditions, including, among others, final approval of our Board of Directors, receipt of a favorable opinion with respect to the tax-free nature of the transaction and the effectiveness of a Form 10 registration statement that will be filed with the Securities and Exchange Commission. The results of our hemophilia business will be included in our condensed consolidated financial statements until the transaction is completed.
Basis of Presentation
In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring accruals, necessary for a fair statement of our financial statements for interim periods in accordance with accounting principles generally accepted in the United States (U.S. GAAP). The information included in this quarterly report on Form 10-Q should be read in conjunction with our consolidated financial statements and the accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2015 (2015 Form 10-K). Our accounting policies are described in the “Notes to Consolidated Financial Statements” in our 2015 Form 10-K and updated, as necessary, in this Form 10-Q. The year-end condensed consolidated balance sheet data presented for comparative purposes was derived from our audited financial statements, but does not include all disclosures required by U.S. GAAP. The results of operations for the three and six months ended June 30, 2016, are not necessarily indicative of the operating results for the full year or for any other subsequent interim period.
We operate as one operating segment, which is discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological diseases, autoimmune disorders and rare diseases.
Consolidation
Our condensed consolidated financial statements reflect our financial statements, those of our wholly-owned subsidiaries and those of certain variable interest entities where we are the primary beneficiary. For consolidated entities where we own or are exposed to less than 100% of the economics, we record net income (loss) attributable to noncontrolling interests in our condensed consolidated statements of income equal to the percentage of the economic or ownership interest retained in such entities by the respective noncontrolling parties. Intercompany balances and transactions are eliminated in consolidation.

9
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

In determining whether we are the primary beneficiary of an entity, we apply a qualitative approach that determines whether we have both (1) the power to direct the economically significant activities of the entity and (2) the obligation to absorb losses of, or the right to receive benefits from, the entity that could potentially be significant to that entity. These considerations impact the way we account for our existing collaborative relationships and other arrangements. We continuously assess whether we are the primary beneficiary of a variable interest entity as changes to existing relationships or future transactions may result in us consolidating or deconsolidating one or more of our collaborators or partners.
 Use of Estimates
The preparation of our condensed consolidated financial statements requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosure of contingent assets and liabilities. On an on-going basis we evaluate our estimates, judgments and methodologies. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity and the amount of revenues and expenses. Actual results may differ from these estimates under different assumptions or conditions.
New Accounting Pronouncements
From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (FASB) or other standard setting bodies that we adopt as of the specified effective date. Unless otherwise discussed, we do not believe that the impact of recently issued standards that are not yet effective will have a material impact on our financial position or results of operations upon adoption.
In May 2014, the FASB issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes all existing revenue recognition requirements, including most industry-specific guidance. The new standard requires a company to recognize revenue when it transfers goods or services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, which delayed the effective date of the new standard from January 1, 2017 to January 1, 2018. The FASB also agreed to allow entities to choose to adopt the standard as of the original effective date. In March 2016, the FASB issued ASU No. 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations, which clarifies the implementation guidance on principal versus agent considerations. In April 2016, the FASB issued ASU No. 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing, which clarifies certain aspects of identifying performance obligations and licensing implementation guidance. In May 2016, the FASB issued ASU No. 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients related to disclosures of remaining performance obligations, as well as other amendments to guidance on collectibility, non-cash consideration and the presentation of sales and other similar taxes collected from customers. These standards have the same effective date and transition date of January 1, 2018. We are currently evaluating the method of adoption and the potential impact that these standards may have on our financial position and results of operations.
During 2015, the FASB issued the following new standards, which we adopted on January 1, 2016:
•
ASU No. 2015-05, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Fees Paid in a Cloud Computing Arrangement.
•
ASU No. 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory.
•
ASU No. 2015-16, Business Combinations (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments.
The adoption of these standards did not have an impact on our financial position or results of operations. For additional information related to these standards, please read Note 1, Summary of Significant Accounting Policies: New Accounting Pronouncements to our consolidated financial statements included in our 2015 Form 10-K.

10
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

In January 2016, the FASB issued ASU No. 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The new standard amends certain aspects of accounting and disclosure requirements of financial instruments, including the requirement that equity investments with readily determinable fair values be measured at fair value with changes in fair value recognized in our results of operations. The new standard does not apply to investments accounted for under the equity method of accounting or those that result in consolidation of the investee. Equity investments that do not have readily determinable fair values may be measured at fair value or at cost minus impairment adjusted for changes in observable prices. A financial liability that is measured at fair value in accordance with the fair value option is required to be presented separately in other comprehensive income for the portion of the total change in the fair value resulting from change in the instrument-specific credit risk. In addition, a valuation allowance should be evaluated on deferred tax assets related to available-for-sale debt securities in combination with other deferred tax assets. The new standard will be effective for us on January 1, 2018. The adoption of this standard is not expected to have a material impact on our financial position or results of operations.
In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). The new standard requires that all lessees recognize the assets and liabilities that arise from leases on the balance sheet and disclose qualitative and quantitative information about its leasing arrangements. The new standard will be effective for us on January 1, 2019. The adoption of this standard is not expected to have a material impact on our net financial position, but will impact our assets and liabilities. We are currently evaluating the potential impact that this standard may have on our results of operations.
In March 2016, the FASB issued ASU No. 2016-06, Derivatives and Hedging (Topic 815): Contingent Put and Call Options in Debt Instruments. The new standard simplifies the embedded derivative analysis for debt instruments containing contingent call or put options by removing the requirement to assess whether a contingent event is related to interest rates or credit risks. The new standard will be effective for us on January 1, 2017. The adoption of this standard is not expected to have an impact on our financial position or results of operations.
In March 2016, the FASB issued ASU No. 2016-07, Investments - Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting. The new standard eliminates the requirement that when an investment qualifies for use of the equity method as a result of an increase in the level of ownership interest or degree of influence, an adjustment must be made to the investment, results of operations and retained earnings retroactively on a step-by-step basis as if the equity method had been in effect during all previous periods that the investment had been held. The new standard will be effective for us on January 1, 2017. The adoption of this standard is not expected to have a material impact on our financial position or results of operations.
In March 2016, the FASB issued ASU No. 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The new standard requires recognition of the income tax effects of vested or settled awards in the income statement and involves several other aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. The new standard will be effective for us on January 1, 2017. This standard is not expected to have a material impact on our financial position, results of operations or statements of cash flows upon adoption.
In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The new standard changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investment in leases that are not accounted for at fair value through net income to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. The new standard will be effective for us on January 1, 2020. The adoption of this standard is not expected to have a material impact on our financial position or results of operations.

11
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

2.    Restructuring
On October 21, 2015, we announced a corporate restructuring, which included the termination of certain pipeline programs and an 11% reduction in workforce. Under this restructuring, cash payments will total approximately $120 million, of which $15.9 million were related to previously accrued 2015 incentive compensation, resulting in net expected restructuring charges totaling approximately $105 million. These amounts will be substantially paid by the end of 2016.
For the three and six months ended June 30, 2016, we recognized restructuring charges totaling $0.0 million and $9.7 million, respectively. We previously recognized $93.4 million of restructuring charges in our consolidated statements of income during the fourth quarter of 2015. Our restructuring reserve is included in accrued expenses and other in our condensed consolidated balance sheets.
The following table summarizes the charges and spending related to our restructuring efforts during the six months ended June 30, 2016:
(In millions)
Workforce
Reduction
 
Pipeline
Programs
 
Total
Restructuring reserve as of December 31, 2015
$
33.7

 
$
3.6

 
$
37.3

Expense
4.9

 
5.4

 
10.3

Payments
(28.7
)
 
(6.0
)
 
(34.7
)
Adjustments to previous estimates, net
(3.5
)
 
2.9

 
(0.6
)
Restructuring reserve as of June 30, 2016
$
6.4

 
$
5.9

 
$
12.3

3.    Reserves for Discounts and Allowances
An analysis of the change in reserves for discounts and allowances is summarized as follows:
(In millions)
Discounts
 
Contractual
Adjustments
 
Returns
 
Total
Balance, as of December 31, 2015
$
56.1

 
$
548.7

 
$
57.9

 
$
662.7

Current provisions relating to sales in current year
266.8

 
973.8

 
17.6

 
1,258.2

Adjustments relating to prior years
(2.4
)
 
1.6

 
(5.5
)
 
(6.3
)
Payments/credits relating to sales in current year
(210.2
)
 
(605.1
)
 
(0.7
)
 
(816.0
)
Payments/credits relating to sales in prior years
(51.5
)
 
(384.9
)
 
(10.4
)
 
(446.8
)
Balance, as of June 30, 2016
$
58.8

 
$
534.1

 
$
58.9

 
$
651.8

The total reserves above, included in our condensed consolidated balance sheets, are summarized as follows:
(In millions)
As of
June 30,
2016
 
As of
December 31,
2015
Reduction of accounts receivable
$
161.3

 
$
144.6

Component of accrued expenses and other
490.5

 
518.1

Total reserves
$
651.8

 
$
662.7


12
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

4.    Inventory
The components of inventory are summarized as follows:
(In millions)
As of
June 30,
2016
 
As of
December 31,
2015
Raw materials
$
235.0

 
$
213.0

Work in process
654.6

 
577.6

Finished goods
139.1

 
143.0

Total inventory
$
1,028.7

 
$
933.6

 
 
 
 
Balance Sheet Classification:
 
 
 
Inventory
$
996.4

 
$
893.4

Investments and other assets
32.3

 
40.2

Total inventory
$
1,028.7

 
$
933.6

Inventory included in investments and other assets in our condensed consolidated balance sheets primarily consisted of work in process.
As of December 31, 2015, our inventory included $24.7 million associated with our ZINBRYTA program, $24.2 million associated with the FLIXABI program and $18.4 million associated with the BENEPALI program, which had been capitalized in advance of regulatory approval. The European Commission (EC) approved the marketing authorization applications for BENEPALI and FLIXABI, two anti-tumor necrosis factor (TNF) biosimilars, for marketing in the E.U. in January 2016 and May 2016, respectively, and the U.S. Food and Drug Administration (FDA) approved ZINBRYTA for the treatment of relapsing forms of MS in the U.S. in May 2016.
5.    Intangible Assets and Goodwill
Intangible Assets
Intangible assets, net of accumulated amortization, impairment charges and adjustments, are summarized as follows:
 
 
 
As of June 30, 2016
 
As of December 31, 2015
(In millions)
Estimated
Life
 
Cost
 
Accumulated
Amortization
 
Net
 
Cost
 
Accumulated
Amortization
 
Net
Out-licensed patents
13-23 years
 
$
543.3

 
$
(514.9
)
 
$
28.4

 
$
543.3

 
$
(506.0
)
 
$
37.3

Developed 
technology
15-23 years
 
3,005.3

 
(2,604.5
)
 
400.8

 
3,005.3

 
(2,552.9
)
 
452.4

In-process research and development
Indefinite until commercialization
 
692.3

 
—

 
692.3

 
730.5

 
—

 
730.5

Trademarks and 
tradenames
Indefinite
 
64.0

 
—

 
64.0

 
64.0

 
—

 
64.0

Acquired and in-licensed rights 
and patents
6-18 years
 
3,405.4

 
(623.3
)
 
2,782.1

 
3,303.2

 
(502.3
)
 
2,800.9

Total intangible assets
 
 
$
7,710.3

 
$
(3,742.7
)
 
$
3,967.6

 
$
7,646.3

 
$
(3,561.2
)
 
$
4,085.1

For the three and six months ended June 30, 2016, amortization of acquired intangible assets totaled $92.9 million and $181.7 million, respectively, as compared to $92.0 million and $187.9 million, respectively, in the prior year comparative periods. In-process research and development amounts include adjustments for foreign exchange rate fluctuations.

13
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

Developed Technology
Developed technology primarily relates to our AVONEX product, which was recorded in connection with the merger of Biogen, Inc. and IDEC Pharmaceuticals Corporation in 2003. The net book value of this asset as of June 30, 2016 was $392.8 million.
Acquired and In-licensed Rights and Patents
Acquired and in-licensed rights and patents primarily relate to our acquisition of all remaining rights to TYSABRI from Elan Corporation plc (Elan). The net book value of this asset as of June 30, 2016 was $2,633.4 million.
The increase in acquired and in-licensed rights and patents during the six months ended June 30, 2016, primarily reflects:
•
$50.0 million in total milestone payments due to Samsung Bioepis, which became payable upon the approval of BENEPALI and FLIXABI in the E.U. in January 2016 and May 2016, respectively;
•
$20.0 million milestone payment due to AbbVie Biotherapeutics, Inc. (AbbVie), which became payable upon the regulatory approval of ZINBRYTA in the U.S. in May 2016; and
•
$26.5 million upon the approval of ALPROLIX in the E.U. in May 2016, which is comprised of a $20.0 million contingent payment due to the former owners of Syntonix Pharmaceuticals, Inc. (Syntonix) and $6.5 million related to the establishment of a corresponding deferred tax liability.
For additional information on our relationship with Samsung Bioepis, please read Note 17, Collaborative and Other Relationships to these condensed consolidated financial statements. For additional information on our relationship with Syntonix, please read Note 21, Commitments and Contingencies to our consolidated financial statements included in our 2015 Form 10-K. For additional information on our relationship with AbbVie, please read Note 19, Collaborative and Other Relationships to our consolidated financial statements included in our 2015 Form 10-K.
Estimated Future Amortization of Intangible Assets
Our amortization expense is based on the economic consumption of intangible assets. Our most significant intangible assets are related to our AVONEX and TYSABRI products. Annually, during our long-range planning cycle, we perform an analysis of anticipated lifetime revenues of AVONEX and TYSABRI. This analysis is also updated whenever events or changes in circumstances would significantly affect the anticipated lifetime revenues of either product.
Our most recent long range planning cycle was completed in the third quarter of 2015. Based upon this analysis, the estimated future amortization of acquired intangible assets for the next five years is expected to be as follows:
(In millions)
As of
June 30,
2016
2016 (remaining six months)
$
181.6

2017
325.1

2018
298.2

2019
282.7

2020
277.1

2021
265.0


14
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

Goodwill
The following table provides a roll forward of the changes in our goodwill balance:
(In millions)
As of
June 30,
2016
Goodwill, beginning of period
$
2,663.8

Increase to goodwill
515.0

Other
(11.7
)
Goodwill, end of period
$
3,167.1

The increase in goodwill during the six months ended June 30, 2016 was related to $600.0 million in contingent milestones achieved (exclusive of $85.0 million in tax benefits) and payable to the former shareholders of Fumapharm AG or holders of their rights. Other includes changes in foreign exchange rates. For additional information related to future contingent payments to the former shareholders of Fumapharm AG or holders of their rights, please read Note 19, Commitments and Contingencies to these condensed consolidated financial statements.
As of June 30, 2016, we had no accumulated impairment losses related to goodwill.
6.    Fair Value Measurements
The tables below present information about our assets and liabilities that are regularly measured and carried at fair value and indicate the level within the fair value hierarchy of the valuation techniques we utilized to determine such fair value:
As of June 30, 2016 (In millions)
Total
 
Quoted Prices
in Active
Markets
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
874.6

 
$
—

 
$
874.6

 
$
—

Marketable debt securities:
 
 
 
 
 
 
 
Corporate debt securities
2,290.3

 
—

 
2,290.3

 
—

Government securities
2,973.4

 
—

 
2,973.4

 
—

Mortgage and other asset backed securities
648.7

 
—

 
648.7

 
—

Marketable equity securities
32.4

 
32.4

 
—

 
—

Derivative contracts
30.1

 
—

 
30.1

 
—

Plan assets for deferred compensation
35.6

 
—

 
35.6

 
—

Total
$
6,885.1

 
$
32.4

 
$
6,852.7

 
$
—

Liabilities:
 
 
 
 
 
 
 
Derivative contracts
$
24.8

 
$
—

 
$
24.8

 
$
—

Contingent consideration obligations
515.7

 
—

 
—

 
515.7

Total
$
540.5

 
$
—

 
$
24.8

 
$
515.7


15
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

As of December 31, 2015 (In millions)
Total
 
Quoted Prices
in Active
Markets
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
Assets:
 
 
 
 
 
 
 
Cash equivalents
$
909.5

 
$
—

 
$
909.5

 
$
—

Marketable debt securities:
 
 
 
 
 
 
 
Corporate debt securities
1,510.9

 
—

 
1,510.9

 
—

Government securities
2,875.9

 
—

 
2,875.9

 
—

Mortgage and other asset backed securities
494.1

 
—

 
494.1

 
—

Marketable equity securities
37.5

 
37.5

 
—

 
—

Derivative contracts
27.2

 
—

 
27.2

 
—

Plan assets for deferred compensation
40.1

 
—

 
40.1

 
—

Total
$
5,895.2

 
$
37.5

 
$
5,857.7

 
$
—

Liabilities:
 
 
 
 
 
 
 
Derivative contracts
$
14.7

 
$
—

 
$
14.7

 
$
—

Contingent consideration obligations
506.0

 
—

 
—

 
506.0

Total
$
520.7

 
$
—

 
$
14.7

 
$
506.0

There have been no material impairments of our assets measured and carried at fair value during the three and six months ended June 30, 2016. In addition, there were no changes in valuation techniques or inputs utilized or transfers between fair value measurement levels during the three and six months ended June 30, 2016. The fair values of Level 2 instruments classified as cash equivalents and marketable debt securities were determined through third party pricing services. For a description of our validation procedures related to prices provided by third party pricing services, refer to Note 1, Summary of Significant Accounting Policies: Fair Value Measurements, to our consolidated financial statements included in our 2015 Form 10-K.
Debt Instruments
The fair and carrying values of our debt instruments, which are Level 2 liabilities, are summarized as follows:
 
As of June 30, 2016
 
As of December 31, 2015
(In millions)
Fair
Value
 
Carrying
Value
 
Fair
Value
 
Carrying
Value
Notes payable to Fumedica
$
6.4

 
$
6.1

 
$
9.4

 
$
9.0

6.875% Senior Notes due March 1, 2018
598.2

 
561.9

 
602.6

 
565.3

2.900% Senior Notes due September 15, 2020
1,561.7

 
1,507.9

 
1,497.5

 
1,485.5

3.625% Senior Notes due September 15, 2022
1,061.0

 
992.7

 
1,014.2

 
992.2

4.050% Senior Notes due September 15, 2025
1,887.3

 
1,734.1

 
1,764.6

 
1,733.4

5.200% Senior Notes due September 15, 2045
1,996.3

 
1,721.3

 
1,757.6

 
1,721.1

Total
$
7,110.9

 
$
6,524.0

 
$
6,645.9

 
$
6,506.5

The fair value of our notes payable to Fumedica was estimated using market observable inputs, including current interest and foreign currency exchange rates. The fair values of each of our series of Senior Notes were determined through market, observable and corroborated sources. For additional information related to our debt instruments, please read Note 11, Indebtedness to our consolidated financial statements included in our 2015 Form 10-K.

16
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

Contingent Consideration Obligations
The following table provides a roll forward of the fair values of our contingent consideration obligations which includes Level 3 measurements:
 
For the Three Months
Ended June 30,
 
For the Six Months
Ended June 30,
(In millions)
2016
 
2015
 
2016
 
2015
Fair value, beginning of period
$
508.3

 
$
461.8

 
$
506.0

 
$
215.5

Additions
—

 
36.0

 
—

 
274.5

Changes in fair value
10.6

 
(2.2
)
 
12.9

 
5.6

Payments
(3.2
)
 
—

 
(3.2
)
 
—

Fair value, end of period
$
515.7

 
$
495.6

 
$
515.7

 
$
495.6

As of June 30, 2016 and December 31, 2015, approximately $304.0 million and $301.3 million, respectively, of our contingent consideration obligations valued using Level 3 measurements were reflected as components of other long-term liabilities in our condensed consolidated balance sheets with the remaining balances reflected as a component of accrued expenses and other.
7.    Financial Instruments
The following table summarizes our financial assets with maturities of less than 90 days from the date of purchase included in cash and cash equivalents on the accompanying condensed consolidated balance sheet:
(In millions)
As of
June 30,
2016
 
As of
December 31,
2015
Commercial paper
$
56.9

 
$
21.9

Overnight reverse repurchase agreements
66.3

 
134.7

Money market funds
531.5

 
673.8

Short-term debt securities
219.9

 
79.1

Total
$
874.6

 
$
909.5

The carrying values of our commercial paper, including accrued interest, overnight reverse repurchase agreements, money market funds and our short-term debt securities approximate fair value due to their short-term maturities. Our overnight reverse repurchase agreements are collateralized with agency-guaranteed mortgage-backed securities and represent approximately 0.3% and 0.7% of total assets as of June 30, 2016 and December 31, 2015, respectively.
The following tables summarize our marketable debt and equity securities, classified as available-for-sale:
As of June 30, 2016 (In millions)
Fair
Value
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Amortized
Cost
Corporate debt securities
 
 
 
 
 
 
 
Current
$
913.4

 
$
0.3

 
$
(0.2
)
 
$
913.3

Non-current
1,376.9

 
7.8

 
(0.4
)
 
1,369.5

Government securities
 
 
 
 
 
 
 
Current
1,521.3

 
0.6

 
—

 
1,520.7

Non-current
1,452.1

 
3.1

 
(0.6
)
 
1,449.6

Mortgage and other asset backed securities
 
 
 
 
 
 
 
Current
0.1

 
—

 
—

 
0.1

Non-current
648.6

 
1.4

 
(0.9
)
 
648.1

Total marketable debt securities
$
5,912.4

 
$
13.2

 
$
(2.1
)
 
$
5,901.3

Marketable equity securities, non-current
$
32.4

 
$
0.9

 
$
(2.1
)
 
$
33.6


17
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

As of December 31, 2015 (In millions)
Fair
Value
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Amortized
Cost
Corporate debt securities
 
 
 
 
 
 
 
Current
$
394.3

 
$
—

 
$
(0.5
)
 
$
394.8

Non-current
1,116.6

 
0.1

 
(4.1
)
 
1,120.6

Government securities
 
 
 
 
 
 
 
Current
1,723.4

 
0.1

 
(1.1
)
 
1,724.4

Non-current
1,152.5

 
—

 
(3.1
)
 
1,155.6

Mortgage and other asset backed securities
 
 
 
 
 
 
 
Current
2.8

 
—

 
—

 
2.8

Non-current
491.3

 
0.1

 
(1.8
)
 
493.0

Total marketable debt securities
$
4,880.9

 
$
0.3

 
$
(10.6
)
 
$
4,891.2

Marketable equity securities, non-current
$
37.5

 
$
9.2

 
$
—

 
$
28.3

Summary of Contractual Maturities: Available-for-Sale Securities
The estimated fair value and amortized cost of our marketable debt securities available-for-sale by contractual maturity are summarized as follows:
 
As of June 30, 2016
 
As of December 31, 2015
(In millions)
Estimated
Fair Value
 
Amortized
Cost
 
Estimated
Fair Value
 
Amortized
Cost
Due in one year or less
$
2,434.8

 
$
2,434.1

 
$
2,120.5

 
$
2,122.0

Due after one year through five years
3,255.9

 
3,245.4

 
2,575.9

 
2,583.9

Due after five years
221.7

 
221.8

 
184.5

 
185.3

Total available-for-sale securities
$
5,912.4

 
$
5,901.3

 
$
4,880.9

 
$
4,891.2

The average maturity of our marketable debt securities available-for-sale as of June 30, 2016 and December 31, 2015 was approximately 13 months and 16 months, respectively.
Proceeds from Marketable Debt Securities
The proceeds from maturities and sales of marketable debt securities and resulting realized gains and losses are summarized as follows:
 
For the Three Months
Ended June 30,
 
For the Six Months
Ended June 30,
(In millions)
2016
 
2015
 
2016
 
2015
Proceeds from maturities and sales
$
1,642.5

 
$
601.9

 
$
2,823.6

 
$
975.5

Realized gains
$
0.6

 
$
0.3

 
$
1.0

 
$
0.5

Realized losses
$
(1.2
)
 
$
(0.5
)
 
$
(1.6
)
 
$
(0.8
)
Strategic Investments
As of June 30, 2016 and December 31, 2015, our strategic investment portfolio was comprised of investments totaling $98.3 million and $96.0 million, respectively, which are included in investments and other assets in our condensed consolidated balance sheets. Our strategic investment portfolio includes investments in equity securities of certain biotechnology companies and investments in venture capital funds where the underlying investments are in equity securities of biotechnology companies.

18
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

8.    Derivative Instruments
Foreign Currency Forward Contracts - Hedging Instruments
Due to the global nature of our operations, portions of our revenues and operating expenses are recorded in currencies other than the U.S. dollar. The value of revenues and operating expenses measured in U.S. dollars is therefore subject to changes in foreign currency exchange rates. In order to mitigate these changes we use foreign currency forward contracts to lock in exchange rates associated with a portion of our forecasted international revenues and operating expenses.
Foreign currency forward contracts in effect as of June 30, 2016 and December 31, 2015 had durations of 1 to 18 months. These contracts have been designated as cash flow hedges and accordingly, to the extent effective, any unrealized gains or losses on these foreign currency forward contracts are reported in accumulated other comprehensive income (loss) (referred to as AOCI in the tables below). Realized gains and losses for the effective portion of such contracts are recognized in revenue when the sale of product in the currency being hedged is recognized and, beginning in the fourth quarter 2015, in operating expenses when the expense in the currency being hedged is recorded. To the extent ineffective, hedge transaction gains and losses are reported in other income (expense), net.
The notional value of foreign currency forward contracts that were entered into to hedge forecasted revenues and operating expenses is summarized as follows:
 
Notional Amount
Foreign Currency: (In millions)
As of
June 30,
2016
 
As of
December 31,
2015
Euro
$
1,126.5

 
$
945.5

Swiss francs
43.5

 
80.8

Canadian dollar
39.9

 
76.7

Total foreign currency forward contracts
$
1,209.9

 
$
1,103.0

The portion of the fair value of these foreign currency forward contracts that was included in accumulated other comprehensive income (loss) in total equity reflected net losses of $16.4 million and net gains of $1.8 million as of June 30, 2016 and December 31, 2015, respectively. We expect all contracts to be settled over the next 18 months and any amounts in accumulated other comprehensive income (loss) to be reported as an adjustment to revenue or operating expense. We consider the impact of our and our counterparties’ credit risk on the fair value of the contracts as well as the ability of each party to execute its contractual obligations. As of June 30, 2016 and December 31, 2015, credit risk did not change the fair value of our foreign currency forward contracts.
The following tables summarize the effect of foreign currency forward contracts designated as hedging instruments on our condensed consolidated statements of income:
For the Three Months Ended June 30,
Net Gains/(Losses)
Reclassified from AOCI into Operating Income
(Effective Portion)
 
Net Gains/(Losses)
Recognized into Net Income
(Ineffective Portion)
Location
 
2016
 
2015
 
Location
 
2016
 
2015
Revenue
 
$
(4.3
)
 
$
40.4

 
Other income (expense)
 
$
2.1

 
$
1.2

Operating expenses
 
$
(0.1
)
 
$
—

 
Other income (expense)
 
$
—

 
$
—


19
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

For the Six Months Ended June 30,
Net Gains/(Losses)
Reclassified from AOCI into Operating Income
(Effective Portion)
 
Net Gains/(Losses)
Recognized into Net Income
(Ineffective Portion)
Location
 
2016
 
2015
 
Location
 
2016
 
2015
Revenue
 
$
4.5

 
$
75.4

 
Other income (expense)
 
$
4.0

 
$
3.4

Operating expenses
 
$
(0.2
)
 
$
—

 
Other income (expense)
 
$
(0.3
)
 
$
—

Interest Rate Contracts - Hedging Instruments
We have entered into interest rate swap contracts on certain borrowing transactions to manage our exposure to interest rate changes.
In connection with the issuance of our 2.90% Senior Notes, we entered into interest rate swaps with an aggregate notional amount of $675.0 million, which expire on September 15, 2020. The interest rate swap contracts are designated as hedges of the fair value changes in the 2.90% Senior Notes attributable to changes in interest rates. Since the specific terms and notional amount of the swaps match the debt being hedged, it is assumed to be a highly effective hedge and all changes in the fair value of the swaps are recorded as a component of the 2.90% Senior Notes with no net impact recorded in income. Any net interest payments made or received on the interest rate swap contracts are recognized as a component of interest expense in our condensed consolidated statements of income.
Foreign Currency Forward Contracts - Other Derivatives
We also enter into other foreign currency forward contracts, usually with durations of one month or less, to mitigate the foreign currency risk related to certain balance sheet positions. We have not elected hedge accounting for these transactions.
The aggregate notional amount of these outstanding foreign currency contracts was $557.2 million and $721.0 million as of June 30, 2016 and December 31, 2015, respectively. Net losses of $18.6 million and $16.2 million related to these contracts were recognized as a component of other income (expense), net, for three and six months ended June 30, 2016, respectively, as compared to net gains of $13.6 million and $3.9 million, respectively, in the prior year comparative periods.

20
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

Summary of Derivatives
While certain of our derivatives are subject to netting arrangements with our counterparties, we do not offset derivative assets and liabilities in our condensed consolidated balance sheets.
The following table summarizes the fair value and presentation in our condensed consolidated balance sheets of our outstanding derivatives including those designated as hedging instruments:
 
 
Fair Value
(In millions)
Balance Sheet Location
As of June 30, 2016
Hedging Instruments:
 
 
Asset derivatives
Other current assets
$
2.0

 
Investments and other assets
$
23.6

Liability derivatives
Accrued expenses and other
$
14.8

 
Other long-term liabilities
$
—

Other Derivatives:
 
 
Asset derivatives
Other current assets
$
4.5

Liability derivatives
Accrued expenses and other
$
10.0

 
 
 
 
 
Fair Value
(In millions)
Balance Sheet Location
As of December 31, 2015
Hedging Instruments:
 
 
Asset derivatives
Other current assets
$
16.6

 
Investments and other assets
$
0.3

Liability derivatives
Accrued expenses and other
$
10.2

 
Other long-term liabilities
$
2.5

Other Derivatives:
 
 
Asset derivatives
Other current assets
$
10.3

Liability derivatives
Accrued expenses and other
$
2.0

9.    Property, Plant and Equipment
Property, plant and equipment are recorded at historical cost, net of accumulated depreciation. Accumulated depreciation on property, plant and equipment was $1,471.0 million and $1,330.1 million as of June 30, 2016 and December 31, 2015, respectively.
Solothurn, Switzerland Facility
On December 1, 2015, we purchased land in Solothurn, Switzerland for 64.4 million Swiss Francs (approximately $62.5 million). We are building a biologics manufacturing facility on this land in the Commune of Luterbach over the next several years. As of June 30, 2016 and December 31, 2015, we had approximately $247.8 million and $99.0 million, respectively, capitalized as construction in progress related to the construction of this facility.
Cambridge, MA Manufacturing Facility
In June 2016, as a result of an evaluation of our manufacturing capabilities and capacity needs based on current and expected future demand, we determined that we intend to cease manufacturing in Cambridge, MA and vacate our 67,000 square foot small-scale biologics manufacturing facility in Cambridge, MA and 46,000 square foot warehouse space in Somerville, MA by the end of 2016.
We are currently considering alternatives for the facility, which may include a sale of our rights to the facility and related assets. In the event we are unsuccessful with a sale, we will close the facility by December 31, 2016.
As of June 30, 2016, the carrying value of associated assets totaled approximately $43.0 million and our remaining lease obligation related to these facilities totaled $26.3 million.

21
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

An impairment assessment as of June 30, 2016 was performed related to the assets, which resulted in no impairments.
The anticipated departure from these facilities has shortened the expected useful lives of certain leasehold improvements and other assets at these facilities. As a result, we recorded additional depreciation expense to reflect the assets' new shorter useful lives. As of June 30, 2016, we recognized approximately $15.8 million of this additional depreciation, which was recorded as cost of sales in our condensed consolidated statements of income.
10.    Equity
Total equity as of June 30, 2016 increased $2,028.8 million compared to December 31, 2015. This increase was primarily driven by net income attributable to Biogen Inc. of $2,020.7 million and an increase in additional paid in capital related to our share-based compensation arrangements, partially offset by other comprehensive losses.
Share Repurchases
In July 2016, our Board of Directors authorized a program to repurchase up to $5.0 billion of our common stock (2016 Share Repurchase Program). This authorization does not have an expiration date. Repurchased shares will be retired. The 2016 Share Repurchase Program is in addition to the approximately 1.3 million shares remaining under our February 2011 Share Repurchase Program (2011 Share Repurchase Program), which has been used principally to offset common stock issuances under our share-based compensation plans. During the six months ended June 30, 2016 and 2015, we did not repurchase any shares of common stock under our 2011 Share Repurchase Program.
In May 2015, our Board of Directors authorized a program to repurchase up to $5.0 billion of our common stock, which was completed as of December 31, 2015. During the six months ended June 30, 2015, we repurchased and retired 0.1 million shares of common stock at a cost of $42.2 million.
Noncontrolling Interests
The following table reconciles equity (deficit) attributable to noncontrolling interests (NCI):
 
For the Three Months
Ended June 30,
 
For the Six Months
Ended June 30,
(In millions)
2016
 
2015
 
2016
 
2015
NCI, beginning of period
$
1.3

 
$
2.7

 
$
2.1

 
$
5.0

Net income (loss) attributable to NCI, net of tax
(1.4
)
 
(2.5
)
 
(3.1
)
 
(4.8
)
Fair value of net assets and liabilities acquired and assigned to NCI
—

 
—

 
0.9

 
—

Translation adjustment and other
—

 
0.2

 
—

 
0.2

NCI, end of period
$
(0.1
)
 
$
0.4

 
$
(0.1
)
 
$
0.4


22
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

11.    Accumulated Other Comprehensive Income (Loss)
The following table summarizes the changes in accumulated other comprehensive income (loss), net of tax by component:
(In millions)
Unrealized Gains (Losses) on Securities Available for Sale
 
Unrealized Gains (Losses) on Cash Flow Hedges
 
Unfunded Status of Postretirement Benefit Plans
 
Translation Adjustments
 
Total
Balance, as of December 31, 2015
$
(0.8
)
 
$
10.2

 
$
(37.8
)
 
$
(195.6
)
 
$
(224.0
)
Other comprehensive income (loss) before reclassifications
6.6

 
(13.9
)
 
0.9

 
(48.4
)
 
(54.8
)
Amounts reclassified from accumulated other comprehensive income (loss)
0.4

 
(4.4
)
 
—

 
—

 
(4.0
)
Net current period other comprehensive income (loss)
7.0

 
(18.3
)
 
0.9

 
(48.4
)
 
(58.8
)
Balance, as of June 30, 2016
$
6.2

 
$
(8.1
)
 
$
(36.9
)
 
$
(244.0
)
 
$
(282.8
)
(In millions)
Unrealized Gains (Losses) on Securities Available for Sale
 
Unrealized Gains (Losses) on Cash Flow Hedges
 
Unfunded Status of Postretirement Benefit Plans
 
Translation Adjustments
 
Total
Balance, as of December 31, 2014
$
(0.4
)
 
$
71.7

 
$
(31.6
)
 
$
(99.2
)
 
$
(59.5
)
Other comprehensive income (loss) before reclassifications
0.9

 
66.1

 
4.1

 
(37.8
)
 
33.3

Amounts reclassified from accumulated other comprehensive income (loss)
0.2

 
(75.0
)
 
—

 
—

 
(74.8
)
Net current period other comprehensive income (loss)
1.1

 
(8.9
)
 
4.1

 
(37.8
)
 
(41.5
)
Balance, as of June 30, 2015
$
0.7

 
$
62.8

 
$
(27.5
)
 
$
(137.0
)
 
$
(101.0
)
The following table summarizes the amounts reclassified from accumulated other comprehensive income:
(In millions)
Income Statement Location
Amounts Reclassified from Accumulated Other Comprehensive Income
For the Three Months
Ended June 30,
 
For the Six Months
Ended June 30,
2016
 
2015
 
2016
 
2015
Gains (losses) on securities available for sale
Other income (expense)
$
(0.6
)
 
$
(0.2
)
 
$
(0.6
)
 
$
(0.3
)
 
Income tax benefit (expense)
0.2

 
0.1

 
0.2

 
0.1

 
 
 
 
 
 
 
 
 
Gains (losses) on cash flow hedges
Revenues
(4.3
)
 
40.4

 
4.5

 
75.4

 
Operating expenses
(0.1
)
 
—

 
(0.2
)
 
—

 
Other income (expense)
—

 
—

 
0.1

 
—

 
Income tax benefit (expense)
0.1

 
(0.2
)
 
—

 
(0.4
)
 
 
 
 
 
 
 
 
 
Total reclassifications, net of tax
 
$
(4.7
)
 
$
40.1

 
$
4.0

 
$
74.8


23
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

12.    Earnings per Share
Basic and diluted earnings per share are calculated as follows:
 
For the Three Months
Ended June 30,
 
For the Six Months
Ended June 30,
(In millions)
2016
 
2015
 
2016
 
2015
Numerator:
 
 
 
 
 
 
 
Net income attributable to Biogen Inc.
$
1,049.8

 
$
927.3

 
$
2,020.7

 
$
1,749.8

Denominator:
 
 
 
 
 
 
 
Weighted average number of common shares outstanding
219.1

 
235.3

 
219.0

 
235.1

Effect of dilutive securities:
 
 
 
 
 
 
 
Stock options and employee stock purchase plan
0.1

 
0.1

 
0.1

 
0.1

Time-vested restricted stock units
0.1

 
0.2

 
0.1

 
0.3

Market stock units
0.1

 
0.1

 
0.1

 
0.2

Dilutive potential common shares
0.3

 
0.4

 
0.3

 
0.6

Shares used in calculating diluted earnings per share
219.4

 
235.7

 
219.3

 
235.7

Amounts excluded from the calculation of net income per diluted share because their effects were anti-dilutive were insignificant.
13.     Share-based Payments
Share-based Compensation Expense
The following table summarizes share-based compensation expense included in our condensed consolidated statements of income:
 
For the Three Months
Ended June 30,
 
For the Six Months
Ended June 30,
(In millions)
2016
 
2015
 
2016
 
2015
Research and development
$
21.5

 
$
22.1

 
$
42.9

 
$
57.5

Selling, general and administrative
28.7

 
26.2

 
63.4

 
81.8

Restructuring charges
—

 
—

 
(1.8
)
 
—

Subtotal
50.2

 
48.3

 
104.5

 
139.3

Capitalized share-based compensation costs
(4.4
)
 
(2.2
)
 
(7.5
)
 
(5.6
)
Share-based compensation expense included in total cost and expenses
45.8

 
46.1

 
97.0

 
133.7

Income tax effect
(12.7
)
 
(12.9
)
 
(27.9
)
 
(39.6
)
Share-based compensation expense included in net income attributable to Biogen Inc.
$
33.1

 
$
33.2

 
$
69.1

 
$
94.1


24
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

The following table summarizes share-based compensation expense associated with each of our share-based compensation programs:
 
For the Three Months
Ended June 30,
 
For the Six Months
Ended June 30,
(In millions)
2016
 
2015
 
2016
 
2015
Market stock units
$
7.9

 
$
9.1

 
$
21.3

 
26.1

Time-vested restricted stock units
33.9

 
31.8

 
64.0

 
63.7

Cash settled performance units
4.6

 
3.2

 
4.8

 
27.0

Performance units
1.3

 
1.2

 
8.2

 
14.4

Employee stock purchase plan
2.5

 
3.0

 
6.2

 
8.1

Subtotal
50.2

 
48.3

 
104.5

 
139.3

Capitalized share-based compensation costs
(4.4
)
 
(2.2
)
 
(7.5
)
 
(5.6
)
Share-based compensation expense included in total cost and expenses
$
45.8

 
$
46.1

 
$
97.0

 
$
133.7

We estimate the fair value of our obligations associated with our performance units and cash settled performance units at the end of each reporting period through expected settlement. Cumulative adjustments to these obligations are recorded each quarter to reflect changes in the stock price and estimated outcome of the performance-related conditions. 
Grants Under Share-based Compensation Plans
The following table summarizes our equity grants to employees, officers and directors under our current stock plans:
 
For the Six Months
Ended June 30,
 
2016
 
2015
Market stock units
166,000

 
179,000

Cash settled performance shares
86,000

 
115,000

Performance units
56,000

 
89,000

Time-vested restricted stock units
594,000

 
375,000

Employee Stock Purchase Plan (ESPP)
In June 2015, our stockholders approved the Biogen Inc. 2015 ESPP (2015 ESPP). The 2015 ESPP, which became effective on July 1, 2015, replaced the Biogen Idec Inc. 1995 ESPP (1995 ESPP), which expired on June 30, 2015. The maximum aggregate number of shares of our common stock that may be purchased under the 2015 ESPP is 6,200,000.
For the six months ended June 30, 2016, approximately 109,000 shares were issued under our 2015 ESPP, compared to approximately 98,000 shares issued under our 1995 ESPP in the prior year comparative period.

25
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

14.    Income Taxes
A reconciliation between the U.S. federal statutory tax rate and our effective tax rate is summarized as follows:
 
For the Three Months
Ended June 30,
 
For the Six Months
Ended June 30,
 
2016
 
2015
 
2016
 
2015
Statutory rate
35.0
 %
 
35.0
 %
 
35.0
 %
 
35.0
 %
State taxes
1.0

 
0.4

 
1.0

 
—

Taxes on foreign earnings
(10.0
)
 
(11.1
)
 
(9.0
)
 
(9.8
)
Credits and net operating loss utilization
(1.2
)
 
(0.7
)
 
(1.2
)
 
(0.7
)
Purchased intangible assets
1.1

 
1.1

 
1.1

 
1.0

Manufacturing deduction
(1.6
)
 
(2.1
)
 
(1.7
)
 
(1.8
)
Other permanent items
0.6

 
0.9

 
0.6

 
0.7

Other
0.3

 
0.4

 
0.2

 
0.3

Effective tax rate
25.2
 %
 
23.9
 %
 
26.0
 %
 
24.7
 %
For the three and six months ended June 30, 2016, compared to the same period in 2015, our effective tax rate increased primarily due to a state tax benefit in 2015 resulting from the remeasurement of one of our uncertain positions, described below, and a higher relative percentage of our earnings being attributed to the U.S., a higher tax jurisdiction.
Accounting for Uncertainty in Income Taxes
We and our subsidiaries are routinely examined by various taxing authorities. We file income tax returns in the U.S. federal jurisdiction, various U.S. states and foreign jurisdictions. With few exceptions, including the proposed disallowance we discuss below, we are no longer subject to U.S. federal tax examination for years before 2013 or state, local or non-U.S. income tax examinations for years before 2004.
In March 2015, we received a final assessment from the Danish Tax Authority (SKAT) for 2009 regarding withholding taxes and the treatment of certain intercompany transactions involving a Danish affiliate and another of our affiliates. In April 2016, we received final assessments for 2011 and 2013 regarding withholding taxes for similar intercompany transactions. The total amount assessed for 2009, 2011 and 2013 is estimated to be $66.9 million, including interest. For the assessments related to 2011 and 2013, we have made payments to SKAT totaling $13.0 million. We continue to dispute the assessments for all of these periods and believe that the positions we have taken in our historical filings are valid.
During the six months ended June 30, 2015, the net effect of adjustments to our uncertain tax positions was a net benefit of approximately $24.0 million primarily related to the state impact of a federal uncertain tax item.
It is reasonably possible that we will adjust the value of our uncertain tax positions related to our revenues from anti-CD20 therapeutic programs and certain transfer pricing issues as we receive additional information from various taxing authorities, including reaching settlements with the tax authorities. In addition, the Internal Revenue Service (IRS) and other national tax authorities routinely examine our intercompany transfer pricing with respect to intellectual property related transactions and it is possible that they may disagree with one or more positions we have taken with respect to such valuations.
In October 2011, in conjunction with an examination by the IRS, the IRS proposed a disallowance of approximately $130.0 million in deductions for tax years 2007, 2008 and 2009 related to payments for services provided by our wholly owned Danish subsidiary located in Hillerød, Denmark. We initiated a mutual agreement procedure between the IRS and SKAT for the years 2001 through 2009, to reach agreement on the issue. Over the past year, we have reached agreement with the IRS and SKAT regarding the tax treatment of these items for the years up to and including 2009. We have recorded the results of these agreements, which were not significant to our results. In addition, we applied for a bilateral advance pricing agreement for the years 2010 through 2014 to resolve similar issues for those years. In June 2016, we withdrew from the bilateral advance pricing agreement process. We believe that the positions we have taken in our historical filings are valid and supportable and potential changes in these positions are not expected to have a significant impact on our financial position or results of operations.

26
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

15.    Other Consolidated Financial Statement Detail
Other Income (Expense), Net
Components of other income (expense), net, are summarized as follows:
 
For the Three Months
Ended June 30,
 
For the Six Months
Ended June 30,
(In millions)
2016
 
2015
 
2016
 
2015
Interest income
$
15.4

 
$
4.3

 
$
26.6

 
$
7.6

Interest expense
(65.9
)
 
(5.8
)
 
(129.2
)
 
(12.5
)
Gain (loss) on investments, net
(2.7
)
 
0.3

 
(1.1
)
 
(1.4
)
Foreign exchange gains (losses), net
0.2

 
(1.5
)
 
2.3

 
(14.5
)
Other, net
(5.5
)
 
(8.2
)
 
(9.9
)
 
(5.1
)
Total other income (expense), net
$
(58.5
)
 
$
(10.9
)
 
$
(111.3
)
 
$
(25.9
)
Other Current Assets
Other current assets includes prepaid taxes totaling approximately $704.1 million and $550.6 million as of June 30, 2016 and December 31, 2015, respectively.
Accrued Expenses and Other
Accrued expenses and other consists of the following:
(In millions)
As of
June 30,
2016
 
As of
December 31,
2015
Current portion of contingent consideration obligations and milestones
$
556.7

 
$
504.7

Revenue-related reserves for discounts and allowances
490.5

 
518.1

Employee compensation and benefits
228.4

 
270.8

Royalties and licensing fees
183.7

 
167.9

Other
613.4

 
635.3

Total accrued expenses and other
$
2,072.7

 
$
2,096.8

Pricing of TYSABRI in Italy - AIFA
In the fourth quarter of 2011, Biogen Italia SRL, our Italian subsidiary, received a notice from the Italian National Medicines Agency (Agenzia Italiana del Farmaco or AIFA) that sales of TYSABRI after mid-February 2009 exceeded a reimbursement limit established pursuant to a Price Determination Resolution (Price Resolution) granted by AIFA in December 2006. In January 2012, we filed an appeal in the Regional Administrative Tribunal of Lazio (Il Tribunale Amministrativo Regionale per il Lazio) in Rome, Italy seeking a ruling that the reimbursement limit in the Price Resolution should apply as written to only "the first 24 months" of TYSABRI sales, which ended in mid-February 2009. That appeal is still pending.
In June 2014, AIFA approved a resolution affirming that there is no reimbursement limit from and after February 2013. As a result, we recognized $53.5 million of TYSABRI revenues related to the periods beginning February 2013 that were previously deferred. AIFA and Biogen Italia SRL are still discussing a possible resolution for the period from February 2009 through January 2013. We have approximately EUR75 million recorded as accrued expenses and deferred revenue both included in our long-term liabilities in our condensed consolidated balance sheet for this matter as of June 30, 2016 and December 31, 2015.
For additional information relating to our agreement with AIFA relating to sales of TYSABRI in Italy, please read Note 17, Other Consolidated Financial Statement Detail to our consolidated financial statements included in our 2015 Form 10-K.

27
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

16.    Investments in Variable Interest Entities
Consolidated Variable Interest Entities
Our condensed consolidated financial statements include the financial results of variable interest entities in which we are the primary beneficiary.
Neurimmune SubOne AG
In 2007, we entered into a collaboration agreement with Neurimmune SubOne AG (Neurimmune), a subsidiary of Neurimmune AG, for the development and commercialization of antibodies for the treatment of Alzheimer’s disease. Neurimmune conducts research to identify potential therapeutic antibodies and we are responsible for the development, manufacturing and commercialization of all products. Our anti-amyloid beta antibody, aducanumab, for the treatment of Alzheimer’s disease resulted from this collaboration. Based upon our current development plans for aducanumab, we may pay Neurimmune up to $275.0 million in remaining milestone payments. We may also pay royalties in the low-to-mid-teens on sales of any resulting commercial products.
We determined that we are the primary beneficiary of Neurimmune because we have the power through the collaboration to direct the activities that most significantly impact the entity’s economic performance and are required to fund 100% of the research and development costs incurred in support of the collaboration agreement. Accordingly, we consolidate the results of Neurimmune.
We are required to reimburse Neurimmune for amounts that are incurred by Neurimmune for research and development expenses in support of the collaboration. Amounts reimbursed are reflected in research and development expense in our condensed consolidated statements of income. For the three and six months ended June 30, 2016 and 2015, these amounts were immaterial. Future milestone payments and royalties, if any, will be reflected in our condensed consolidated statements of income as a charge to noncontrolling interest, net of tax, when such milestones are achieved.
The assets and liabilities of Neurimmune are not significant to our financial position or results of operations as it is a research and development organization. We have provided no financing to Neurimmune other than previously contractually required amounts.
Other Variable Interest Entities
We also consolidate the financial results of our other variable interest entities where we are the primary beneficiary. We may pay these variable interest entities up to approximately $8.0 million in remaining milestone payments. We have provided no financing to these entities other than amounts provided for in the contract.
Unconsolidated Variable Interest Entities
We have relationships with other variable interest entities that we do not consolidate as we lack the power to direct the activities that significantly impact the economic success of these entities. These relationships include investments in certain biotechnology companies and research collaboration agreements. As of June 30, 2016 and December 31, 2015, the total carrying value of our investments in biotechnology companies totaled $38.0 million and $29.2 million, respectively. Our maximum exposure to loss related to these variable interest entities is limited to the carrying value of our investments.
We have also entered into research collaboration agreements with certain variable interest entities where we are required to fund certain development activities. These development activities are included in research and development expense in our condensed consolidated statements of income, as they are incurred. We have provided no financing to these variable interest entities other than previously contractually required amounts.
For additional information related to our investments in variable interest entities, please read Note 18, Investments in Variable Interest Entities to our consolidated financial statements included in our 2015 Form 10-K.

28
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

17.    Collaborative and Other Relationships
University of Pennsylvania
In May 2016, we entered into a collaboration and alliance with the University of Pennsylvania (Penn) to advance gene therapy and gene editing technologies. The collaboration will primarily focus on the development of therapeutic approaches that target the eye, skeletal muscle and the central nervous system. The alliance is also expected to focus on the research and validation of next-generation gene transfer technology using adeno-associated virus gene delivery vectors and exploring the expanded use of genome editing technology as a potential therapeutic platform.
During the second quarter of 2016, we paid Penn an upfront amount of $20.0 million, which was recorded as research and development expense in our condensed consolidated statements of income, and prepaid research and development expenditures of $15.0 million, which was recorded in investments and other assets in our condensed consolidated balance sheets. We also expect to fund an additional $47.5 million in the aggregate in research and development costs extending over the next three to five years in seven preclinical research and development programs, as well as the exploration of genome-editing technology.
If all of the collaboration programs are successful and we exercise all of our options under the Penn collaboration and alliance, we may be required to make future payments of over $2.0 billion in research funding, options and milestone payments, in addition to royalties payable on net sales of products.
Swedish Orphan Biovitrum AB
In January 2007, we acquired 100% of the stock of Syntonix. Syntonix had previously entered into a collaboration agreement with Swedish Orphan Biovitrum AB (publ) (Sobi) to jointly develop and commercialize Factor VIII and Factor IX hemophilia products, including ELOCTATE and ALPROLIX. Under an amended and restated collaboration agreement, we have commercial rights for North America (the Biogen North America Territory) and for rest of the world markets outside of the Sobi Territory, as defined below (the Biogen Direct Territory). Following its exercise of an option right, Sobi has assumed commercialization rights for ELOCTA, the trade name for ELOCTATE, and ALPROLIX, in substantially all of Europe, Northern Africa, Russia and certain countries in the Middle East (the Sobi Territory). For additional information on our collaboration agreement with Sobi, please read Note 19, Collaborative and Other Relationships to our consolidated financial statements included in our 2015 Form 10-K.
Sobi had its first commercial sale of ELOCTA in January 2016. In March 2016, the EC approved the transfer of the marketing authorization for ELOCTA from Biogen to Sobi, making Sobi the marketing authorization holder of ELOCTA in the E.U. As the marketing authorization holder, Sobi assumes full legal responsibility for ELOCTA, from a regulatory perspective, during its entire life cycle in the E.U. As of June 30, 2016, approximately $157.0 million in expenditures for ELOCTA, net of an escrow payment and other royalty adjustments as described in the table and its footnote (3) below, are reimbursable to us by Sobi under our collaboration agreement due to Sobi's election to assume final development and commercialization of ELOCTA in the Sobi Territory, which is the Opt-In Consideration for ELOCTA. This reimbursement will be recognized by us as royalty revenue in proportion to collaboration revenues, over a ten year period, consistent with the initial patent term of the product.
ALPROLIX was approved in the E.U. by the EC in May 2016 and Sobi had its first commercial sale in June 2016. As of June 30, 2016, approximately $130.0 million in expenditures for ALPROLIX, net of an escrow payment and other royalty adjustments as described in the table and its footnote (3) below, are reimbursable to us by Sobi under our collaboration agreement due to Sobi's election to assume final development and commercialization of ALPROLIX in the Sobi Territory, which is the Opt-In Consideration for ALPROLIX. This reimbursement will be recognized by us as royalty revenue in proportion to collaboration revenues, over a ten year period, consistent with the initial patent term of the product.

29
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

We expect to recognize the effect of the cash reimbursement as an adjustment to the Base Rate in the table below over a ten year period, consistent with the initial patent term of the products. Under the collaboration agreement, cash payments are as follows:
 
 
 
Rates post Sobi Opt-In(3)
Royalty and Net Revenue Share Rates:
Method
 
Base Rate following
1st commercial sale in
the Sobi Territory:
 
Rate during the
Reimbursement
Period:
Sobi rate to Biogen on net sales in the Sobi Territory
Royalty
 
12%
 
Base Rate
plus 5%
Biogen rate to Sobi on net sales in the Biogen North America Territory
Royalty
 
12%
 
Base Rate
less 5%
Biogen rate to Sobi on net sales in the Biogen Direct Territory
Royalty
 
17%
 
Base Rate
less 5%
Biogen rate to Sobi on net revenue(1) 
from the Biogen Distributor Territory(2)
Net
Revenue
Share
 
50%
 
Base Rate
less 15%
(1)
Net revenue represents Biogen’s pre-tax receipts from third-party distributors, less expenses incurred by Biogen in the conduct of commercialization activities supporting the distributor activities.
(2)
The Biogen Distributor Territory represents Biogen territories where sales are derived utilizing a third-party distributor.
(3)
A credit will be issued to Sobi against its reimbursement of the Opt-in Consideration in an amount equal to the difference in the rate paid by Biogen to Sobi on sales in the Biogen territories for certain periods prior to the first commercial sale in the Sobi Territory versus the rate that otherwise would have been payable on such sales.
If the reimbursement of the Opt-in Consideration has not been achieved within six years of the first commercial sale of such product, we maintain the right to require Sobi to pay any remaining balances due to us within 90 days of the six year anniversary date of the first commercial sale.
Samsung Bioepis
Joint Venture Agreement
In February 2012, we entered into a joint venture agreement with Samsung BioLogics Co. Ltd. (Samsung Biologics), establishing an entity, Samsung Bioepis, to develop, manufacture and market biosimilar pharmaceuticals. Samsung Biologics contributed 280.5 billion South Korean won (approximately $250.0 million) for an 85% stake in Samsung Bioepis and we contributed approximately 49.5 billion South Korean won (approximately $45.0 million) for the remaining 15% ownership interest. Under the joint venture agreement, we have no obligation to provide any additional funding and our ownership interest may be diluted due to financings in which we do not participate. As of June 30, 2016, our ownership interest is approximately 9%, which reflects the effect of additional equity financings in which we did not participate. We maintain an option to purchase additional stock in Samsung Bioepis that would allow us to increase our ownership percentage up to 49.9%. The exercise of this option is within our control and is based on paying for 49.9% of the total investment made by Samsung Biologics into Samsung Bioepis in excess of what we have already contributed under the agreement plus a rate that will represent their return on capital.
Based on our level of influence over Samsung Bioepis, we account for this investment under the equity method of accounting and we recognize our share of the results of operations related to our investment in Samsung Bioepis one quarter in arrears when the results of the entity become available, which is reflected as equity in loss of investee, net of tax in our condensed consolidated statements of income. During the three and six months ended June 30, 2015, we recognized a loss on our investment of $4.9 million and $5.7 million, respectively. During 2015, as our share of losses exceeded the carrying value of our investment, we suspended recognizing additional losses and will continue to do so unless we commit to providing additional funding.

30
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

Commercial Agreement
In December 2013, pursuant to our rights under the joint venture agreement with Samsung Biologics, we entered into an agreement with Samsung Bioepis to commercialize, over a 10-year term, three anti-TNF biosimilar product candidates in Europe and in the case of one anti-TNF biosimilar, Japan. Under the terms of this agreement, we have made total upfront and milestone payments of $46.0 million, which have been recorded as a research and development expense in our condensed consolidated statements of income as the programs they relate to had not achieved regulatory approval. We also agreed to make an additional milestone payment of $25.0 million upon regulatory approval in the E.U. for each of the three anti-TNF biosimilar product candidates. During the six months ended June 30, 2016, we made a $25.0 million milestone payment and accrued another $25.0 million, which have been capitalized in intangible assets, net in our condensed consolidated balance sheet as BENEPALI received regulatory approval in the E.U. in January 2016 and FLIXABI received regulatory approval in the E.U. in May 2016.
We began to recognize revenue on sales of BENEPALI in the E.U. in the first quarter of 2016. We reflect revenues on sales of BENEPALI to third parties in product revenues, net in our condensed consolidated statements of income and record the related cost of revenues and sales and marketing expenses in our condensed consolidated statements of income to their respective line items when these costs are incurred. We share 50% of the profit or loss related to our commercial agreement with Samsung Bioepis. This profit share with Samsung Bioepis is recognized in collaboration profit (loss) sharing in our condensed consolidated statements of income.
Other Services
Simultaneous with the formation of Samsung Bioepis, we also entered into a license agreement, a technical development services agreement and a manufacturing agreement with Samsung Bioepis. For the three and six months ended June 30, 2016, we recognized $14.2 million and $16.9 million, respectively, in relation to these services as other revenues in our condensed consolidated statements of income, as compared to $17.2 million and $36.1 million, respectively, in the prior year comparative periods.
For additional information related to our other significant collaboration arrangements, please read Note 19, Collaborative and Other Relationships to our consolidated financial statements included in our 2015 Form 10-K.
18.    Litigation
We are currently involved in various claims and legal proceedings, including the matters described below. For information as to our accounting policies relating to claims and legal proceedings, including use of estimates and contingencies, please read Note 1, Summary of Significant Accounting Policies to our consolidated financial statements included in our 2015 Form 10-K.
With respect to some loss contingencies, an estimate of the possible loss or range of loss cannot be made until management has further information, including, for example, (i) which claims, if any, will survive dispositive motion practice; (ii) information to be obtained through discovery; (iii) information as to the parties' damages claims and supporting evidence; (iv) the parties’ legal theories; and (v) the parties' settlement positions.
The claims and legal proceedings in which we are involved also include challenges to the scope, validity or enforceability of the patents relating to our products, pipeline or processes, and challenges to the scope, validity or enforceability of the patents held by others. These include claims by third parties that we infringe their patents. An adverse outcome in any of these proceedings could result in one or more of the following and have a material impact on our business or consolidated results of operations and financial position: (i) loss of patent protection; (ii) inability to continue to engage in certain activities; and (iii) payment of significant damages, royalties, penalties and/or license fees to third parties.

31
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

Loss Contingencies
Forward Pharma German Patent Litigation
On November 18, 2014, Forward Pharma A/S (Forward Pharma) filed suit against us in the Regional Court of Dusseldorf, Germany alleging that TECFIDERA infringes German Utility Model DE 20 2005 022 112 U1 (the utility model), which was issued in April 2014 and expired in October 2015. Forward Pharma subsequently extended its allegations to assert that TECFIDERA infringes Forward Pharma's European Patent No. 2 801 355, which was issued in May 2015 and expires in October 2025 (the '355 patent). Forward Pharma seeks declarations of infringement and damages for our sales of TECFIDERA in Germany. Under German law, disgorgement of profits on infringing sales is a measure of damages. With respect to the '355 patent, the hearing has been stayed pending the outcome of opposition proceedings that we and others have filed in the European Patent Office, and with respect to the utility model the hearing has been stayed pending the outcome of those proceedings and proceedings in the German Patent Office.
ALPROLIX Patent Licensing Matter
We are in discussions with Pfizer regarding its proposal that we take a license to its U.S. Patent No. 8,603,777 (Expression of Factor VII and IX Activities in Mammalian Cells) and pay royalties on sales of ALPROLIX. An estimate of the possible loss or range of loss cannot be made at this time.
Italian National Medicines Agency
In the fourth quarter of 2011, Biogen Italia SRL received notice from the Italian National Medicines Agency (Agenzia Italiana del Farmaco or AIFA) that sales of TYSABRI after mid-February 2009 exceeded a reimbursement limit established pursuant to a Price Determination Resolution (Price Resolution) granted by AIFA in December 2006. On January 12, 2012, we filed an appeal in the Regional Administrative Tribunal of Lazio (Il Tribunale Amministrativo Regionale per il Lazio) in Rome, Italy seeking a ruling that the reimbursement limit in the Price Resolution should apply as written to only “the first 24 months” of TYSABRI sales, which ended in mid-February 2009. The appeal is still pending. In June 2014, AIFA approved a resolution affirming that there is no reimbursement limit from and after February 2013. AIFA and Biogen Italia SRL are discussing a possible resolution for the period from February 2009 through January 2013.
For additional information regarding this matter, please read Note 15, Other Consolidated Financial Statement Detail to these condensed consolidated financial statements.
Qui Tam Litigation
On July 6, 2015, four qui tam actions filed against us by relators suing on behalf of the United States and certain states were unsealed by the U.S. District Court for the District of Massachusetts. All but one of the actions has been voluntarily dismissed. The pending action alleges sales and promotional activities in violation of the federal False Claims Act and state law counterparts, and seeks single and treble damages, civil penalties, interest, attorneys’ fees and costs. The complaint was recently amended, and we intend to move to dismiss. The United States has not made an intervention decision. An estimate of the possible loss or range of loss cannot be made at this time.
Securities Litigation
We and certain current and former officers are defendants in In re Biogen Inc. Securities Litigation, filed by a shareholder on August 18, 2015 in the U.S. District Court for the District of Massachusetts. The amended complaint alleges violations of federal securities laws under 15 U.S.C. §78j(b) and §78t(a) and 17 C.F.R. §240.10b-5. The lead plaintiff sought a declaration of the action as a class action, certification as a representative of the class and its counsel as class counsel, and an award of damages, interest and attorneys' fees. On July 1, 2016 the U.S. District Court dismissed the case. An estimate of the possible loss or range of loss cannot be made at this time.

32
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

Other Matters
Interference Proceeding with Forward Pharma
In April 2015, the U.S. Patent and Trademark Office (USPTO) declared an interference between Forward Pharma’s pending U.S. Patent Application No. 11/576,871 and our U.S. Patent No. 8,399,514 (the '514 patent). The '514 patent includes claims covering the treatment of multiple sclerosis with 480 mg of dimethyl fumarate as provided for in our TECFIDERA label. A hearing has been scheduled for late 2016.
Inter Partes Review Petitions and Proceeding
On March 22, 2016, the USPTO instituted inter partes review of the '514 patent on the petition of the Coalition for Affordable Drugs V LLC, an entity associated with a hedge fund. A hearing has been scheduled for late 2016.
On April 18, 2016, Swiss Pharma International AG filed petitions in the USPTO for inter partes review of U.S. Patent Nos. 8,349,321 and, 8,900,577, relating to specific formulations of natalizumab (TYSABRI), and U.S. Patent No. 8,815,236, relating to methods for treating multiple sclerosis and Crohn’s disease using specific formulations of natalizumab (TYSABRI). The USPTO has not yet decided whether to institute review.
European Patent Office Oppositions
On March 10, 2016, the European Patent Office verbally revoked our European patent number 2 137 537 (the '537 patent), which includes claims covering the treatment of multiple sclerosis with 480 mg of dimethyl fumarate as provided for in our TECFIDERA label. In June 2016 the European Patent Office issued a written decision confirming its position from which we intend to appeal.
Patent Revocation Matter
In December 2015, Swiss Pharma International AG brought an action in the Patents Court of the United Kingdom to revoke the UK counterpart of our European Patent Number 1 485 127 (“Administration of agents to treat inflammation”) (the '127 patent), which was issued in June 2011 and concerns administration of natalizumab (TYSABRI) to treat multiple sclerosis. The patent expires in February 2023. Subsequently, the same entity brought actions in the District Court of The Hague (on January 11, 2016) and the German Patents Court (on March 3, 2016) to invalidate the Dutch and German counterparts of the '127 patent. A hearing has been scheduled in the UK action for late 2016 and in the Dutch action for early 2017. No hearing has yet been scheduled in the German action.
'755 Patent Litigation
On May 28, 2010, Biogen MA Inc. (formerly Biogen Idec MA Inc.) filed a complaint in the U.S. District Court for the District of New Jersey alleging infringement by Bayer Healthcare Pharmaceuticals Inc. (Bayer) (manufacturer, marketer and seller of BETASERON and manufacturer of EXTAVIA), EMD Serono, Inc. (manufacturer, marketer and seller of REBIF), Pfizer Inc. (co-marketer of REBIF) and Novartis Pharmaceuticals Corp. (marketer and seller of EXTAVIA) of our U.S. Patent No. 7,588,755 ('755 Patent), which claims the use of interferon beta for immunomodulation or treating a viral condition, viral disease, cancers or tumors. The complaint seeks monetary damages, including lost profits and royalties. Bayer had previously filed a complaint against us in the same court, on May 27, 2010, seeking a declaratory judgment that it does not infringe the '755 Patent and that the patent is invalid, and seeking monetary relief in the form of attorneys' fees, costs and expenses. The court has consolidated the two lawsuits, and we refer to the two actions as the “Consolidated '755 Patent Actions.”
Bayer, Pfizer, Novartis and EMD Serono have all filed counterclaims in the Consolidated '755 Patent Actions seeking declaratory judgments of patent invalidity and non-infringement, and seeking monetary relief in the form of costs and attorneys' fees, and EMD Serono and Bayer have each filed a counterclaim seeking a declaratory judgment that the '755 Patent is unenforceable based on alleged inequitable conduct. Bayer has also amended its complaint to seek such a declaration. Trial has been set for September 2017.

33
BIOGEN INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, continued)

Government Matters
We have learned that state and federal governmental authorities are investigating our sales and promotional practices and have received related subpoenas. We are cooperating with the government.
On March 4, 2016 we received a subpoena from the federal government for documents relating to our relationship with non-profit organizations that provide assistance to patients taking drugs sold by Biogen. We are cooperating with the government.
On July 1, 2016, we received civil investigative demands from the federal government for documents and information relating to our treatment of certain service agreements with wholesalers when calculating and reporting Average Manufacturer Prices in connection with the Medicaid Drug Rebate Program. We are in the process of responding to the government.
Product Liability and Other Legal Proceedings
We are also involved in product liability claims and other legal proceedings generally incidental to our normal business activities. While the outcome of any of these proceedings cannot be accurately predicted, we do not believe the ultimate resolution of any of these existing matters would have a material adverse effect on our business or financial condition.
19.    Commitments and Contingencies
Fumapharm AG
In 2006, we acquired Fumapharm AG. As part of this acquisition we acquired FUMADERM and TECFIDERA (together, Fumapharm Products). We paid $220.0 million upon closing of the transaction and agreed to pay an additional $15.0 million if a Fumapharm Product was approved for MS in the U.S. or E.U. In the second quarter of 2013, we paid this $15.0 million contingent payment as TECFIDERA was approved in the U.S. for MS by the FDA. We are also required to make additional contingent payments to former shareholders of Fumapharm AG or holders of their rights based on the attainment of certain cumulative sales levels of Fumapharm Products and the level of total net sales of Fumapharm Products in the prior twelve month period.
During the six months ended June 30, 2016, we paid $600.0 million in contingent payments as we reached the $7.0 billion and $8.0 billion cumulative sales levels related to the Fumapharm Products in the fourth quarter of 2015 and first quarter of 2016, respectively, and accrued $300.0 million upon reaching $9.0 billion in total cumulative sales of Fumapharm Products in the second quarter of 2016.
We will owe an additional $300.0 million contingent payment for every additional $1.0 billion in cumulative sales level of Fumapharm Products reached if the prior 12 months sales of the Fumapharm Products exceed $3.0 billion, until such time as the cumulative sales level reaches $20.0 billion, at which time no further contingent payments shall be due. These payments will be accounted for as an increase to goodwill as incurred, in accordance with the accounting standard applicable to business combinations when we acquired Fumapharm. Any portion of the payment which is tax deductible will be recorded as a reduction to goodwill. Payments are due within 60 days following the end of the quarter in which the applicable cumulative sales level has been reached.
Solothurn, Switzerland Facility
On December 1, 2015, we purchased land in Solothurn, Switzerland where we are building a biologics manufacturing facility over the next several years. As of June 30, 2016, we had contractual commitments of approximately $226.0 million for the construction of this facility.
20.    Subsequent Events
On July 21, 2016, we announced that George A. Scangos, Ph.D. will step down as our Chief Executive Officer after a successor has been identified. Dr. Scangos will remain on our Board of Directors until he steps down from his executive position. Our Board of Directors will begin a search for Dr. Scangos’ successor immediately.

34

Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion should be read in conjunction with our condensed consolidated financial statements and accompanying notes beginning on page 5 of this quarterly report on Form 10-Q and our audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2015 (2015 Form 10-K). Certain totals may not sum due to rounding.
Executive Summary
Introduction
Biogen is a global biopharmaceutical company focused on discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological diseases, autoimmune disorders and rare diseases.
Our marketed products include TECFIDERA, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for multiple sclerosis (MS), ELOCTATE for hemophilia A and ALPROLIX for hemophilia B and FUMADERM for the treatment of severe plaque psoriasis. We also have a collaboration agreement with Genentech, Inc. (Genentech), a wholly-owned member of the Roche Group, which entitles us to certain business and financial rights with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other potential anti-CD20 therapies.
In May 2016, we announced our intention to spin off our hemophilia business as an independent, publicly traded company. The new company will focus on the discovery and development of therapies for the treatment of hemophilia and other blood disorders, with existing marketed products ELOCTATE and ALPROLIX. The transaction is expected to be completed in early 2017, subject to the satisfaction of certain conditions, including, among others, final approval of our Board of Directors, receipt of a favorable opinion with respect to the tax-free nature of the transaction and the effectiveness of a Form 10 registration statement that will be filed with the Securities and Exchange Commission. The results of our hemophilia business will be included in our condensed consolidated financial statements until the transaction is completed.
 
Our current revenues depend upon continued sales of our principal products, and unless we develop or acquire rights to new products and technologies, we may be substantially dependent on sales from our principal products for many years. Further, if the proposed spin off of our hemophilia business is completed, our revenues will be further reliant and concentrated on sales of our MS products in an increasingly competitive market.
In the longer term, our revenue growth will be dependent upon the successful clinical development, regulatory approval and launch of new commercial products as well as additional indications for our existing products, our ability to obtain and maintain patents and other rights related to our marketed products, assets originating from our research and development efforts, and successful execution of external business development opportunities. As part of our ongoing research and development efforts, we have devoted significant resources to conducting clinical studies to advance the development of new pharmaceutical products in disease areas for which there are inadequate treatments and to explore the utility of our existing products in treating disorders beyond those currently approved in their labels.
In addition to our innovative drug development efforts, we aim to leverage our manufacturing capabilities and scientific expertise through Samsung Bioepis, our joint venture with Samsung BioLogics Co. Ltd. (Samsung Biologics) that develops, manufactures and markets biosimilars as well as through other strategic contract manufacturing partners. Under our commercial agreement with Samsung Bioepis, we market and sell BENEPALI, an etanercept biosimilar referencing ENBREL, and FLIXABI, an infliximab biosimilar referencing REMICADE, in the European Union (E.U.).


35

Financial Highlights
Diluted earnings per share attributable to Biogen Inc. were $4.79 for the three months ended June 30, 2016, representing an increase of 21.9% over the same period in 2015.
Our income from operations for the three months ended June 30, 2016 reflects the following:
•
Total revenues were $2,894.2 million for the second quarter of 2016, representing an increase of 11.7% over the same period in 2015.
•
Product revenues, net totaled $2,466.0 million for the second quarter of 2016, representing an increase of 12.2% over the same period in 2015. This increase was driven by an 11.7% increase in worldwide TECFIDERA revenues, a 7.4% increase in worldwide TYSABRI revenues, a 5.6% increase in worldwide Interferon revenues and revenues from ELOCTATE, ALPROLIX and BENEPALI. Product revenues, net for the second quarter of 2016, compared to the same period in 2015, were also negatively impacted by a $44.7 million change in hedge results under our hedging program in the comparative period.
 
•
Revenues from anti-CD20 therapeutic programs totaled $349.2 million for the second quarter of 2016, representing an increase of 3.5% over the same period in 2015.
•
Other revenues totaled $79.0 million for the second quarter of 2016, representing an increase of 42.1% from the same period in 2015. This increase was primarily driven by an increase in other corporate revenue.
•
Total cost and expenses totaled $1,433.7 million for the second quarter of 2016, representing an increase of 5.5% compared to the same period in 2015. This increase was driven by a 29.4% increase in cost of sales and the recognition of a loss on fair value remeasurement of contingent consideration, partially offset by a 3.6% decrease in research and development expense.
We generated $1,959.2 million of net cash flows from operations for the six months ended June 30, 2016, which were primarily driven by earnings. Cash, cash equivalents and marketable securities totaled approximately $7,274.4 million as of June 30, 2016.
Business Environment
The biopharmaceutical industry and the markets in which we operate are intensely competitive. Many of our competitors are working to develop or have commercialized products similar to those we market or are developing. In addition, the commercialization of certain of our own approved MS products, products of our collaborators and pipeline product candidates may negatively impact future sales of our existing MS products. Our products may also face increased competitive pressures from the introduction of generic versions, prodrugs of existing therapeutics or biosimilars of existing products and other technologies, such as gene therapies and bispecific antibodies.
In addition, sales of our products are dependent, in large part, on the availability and extent of coverage, pricing and reimbursement from government health administration authorities, private health insurers and other organizations. Drug prices are under significant scrutiny in the markets in which our products are prescribed. Drug pricing and other health care costs continue to be subject to intense political and societal pressures. 
For additional information related to our competition and pricing risks that could negatively impact our products, please read the “Risk Factors” section of this report.


36

Key Pipeline and Product Developments
TYSABRI
In June 2016, the European Commission (EC) approved a variation to the marketing authorization of TYSABRI, which extended its indication to include relapsing-remitting MS patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy. TYSABRI was previously only indicated for patients who had failed to respond to beta-interferon or glatiramer acetate in the E.U.
ZINBRYTA
In May 2016, the U.S. Food and Drug Administration (FDA) approved ZINBRYTA for the treatment of relapsing forms of MS and in July 2016, the EC approved ZINBRYTA for the treatment of relapsing forms of MS. Under our collaboration agreement with AbbVie, we and AbbVie will conduct co-promotion activities in the E.U., U.S. and Canada Territories, where development and commercialization costs and profits are shared equally. Shipments of ZINBRYTA are expected to commence in the third quarter of 2016.
For additional information related to our relationship with AbbVie, please read Note 19, Collaborative and Other Relationships to our consolidated financial statements included in our 2015 Form 10-K.
Hemophilia
In March 2016, the EC approved the transfer of the marketing authorization for ELOCTA to Swedish Orphan Biovitrum AB (publ) (Sobi). As the marketing authorization holder, Sobi assumes full legal responsibility for ELOCTA, from a regulatory perspective, during its entire life cycle in the E.U.
In May 2016, the EC approved ALPROLIX in the E.U. for the treatment of hemophilia B. Under our collaboration agreement with Sobi, Sobi has assumed responsibility for final development and commercialization of ALPROLIX in their territory, which includes substantially all of Europe, Northern Africa, Russia, and certain markets in the Middle East (Sobi Territory).
 
Biosimilars
The EC approved Samsung Bioepis' marketing authorisation applications (MAAs) for BENEPALI and FLIXABI, two anti-tumor necrosis factor (TNF) biosimilars, for marketing in the E.U. in January 2016 and May 2016, respectively. Under our agreement with Samsung Bioepis, we manufacture and commercialize BENEPALI and FLIXABI in specified E.U. countries.
In July 2016, the European Medicine Agency (EMA) accepted Samsung Bioepis' MAA for SB5, an adalimumab biosimilar candidate referencing HUMIRA.
GAZYVA
In February 2016, the Roche Group announced that the FDA approved GAZYVA plus bendamustine chemotherapy followed by GAZYVA alone as a new treatment for people with follicular lymphoma who did not respond to a RITUXAN-containing regimen, or whose follicular lymphoma returned after such treatment. Follicular lymphoma is the most common type of indolent non-Hodgkin’s lymphoma.
In May 2016, the Roche Group announced positive results from the Phase 3 GALLIUM study, which investigated the efficacy and safety of GAZYVA in combination with chemotherapy followed by maintenance with GAZYVA alone, compared to RITUXAN in combination with chemotherapy followed by maintenance with RITUXAN alone in previously untreated patients with follicular lymphoma, the most common type of indolent non-Hodgkin's lymphoma. Results from a pre-planned interim analysis showed that GAZYVA-based treatment significantly reduced the risk of disease worsening or death compared to RITUXAN-based treatment.
In July 2016, the Roche Group announced that the Phase 3 GOYA study evaluating GAZYVA plus CHOP chemotherapy in people with previously untreated diffuse large B-cell lymphoma did not meet its primary endpoint of significantly reducing the risk of disease worsening or death compared to RITUXAN plus CHOP chemotherapy. Adverse events with GAZYVA and RITUXAN were consistent with those seen in previous clinical trials when each was combined with various chemotherapies.
For additional information related to our relationship with Genentech (Roche Group), please read Note 19, Collaborative and Other Relationships to our consolidated financial statements included in our 2015 Form 10-K.


37

OCREVUS (Ocrelizumab)
In June 2016, the Roche Group announced that the EMA validated its MAA of OCREVUS for the treatment of relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS) in the E.U. Validation signifies the MAA is under review by the Committee for Medicinal Products for Human Use (CHMP). The FDA has also accepted for review its Biologics License Application for OCREVUS for the treatment of RMS and PPMS, and has granted the application Priority Review Designation with a targeted action date of December 28, 2016.
Under our agreement with Genentech, if OCREVUS is approved, we will receive tiered royalty payments on sales of OCREVUS. For additional information related to our relationship with Genentech, please read Note 19, Collaborative and Other Relationships to our consolidated financial statements included in our 2015 Form 10-K.
While we have a financial interest in OCREVUS, future sales of our MS products may be adversely affected by the commercialization of OCREVUS.
 
Aducanumab
In June 2016, we announced that aducanumab, our investigational treatment for early Alzheimer’s disease, was accepted into the EMA's Priority Medicines (PRIME) program. PRIME aims to bring treatments to patients faster by enhancing the EMA’s support for the development of investigational medicines for diseases without available treatment or in need of better treatment options. Aducanumab was accepted into PRIME based on results from the Phase 1b placebo-controlled study of aducanumab in patients with prodromal or mild Alzheimer’s disease. Through the PRIME program, we will have access to enhanced support from EMA, including advice at key development milestones and the potential for accelerated assessment of a MAA.
Anti-LINGO
In June 2016, we reported top-line results from SYNERGY our Phase 2 trial evaluating anti-LINGO in people with relapsing forms of MS. Anti-LINGO missed the primary endpoint of the SYNERGY trial as well as its secondary efficacy endpoint in the trial. We continue to analyze the results to determine the appropriate next steps.

Results of Operations
Revenues
Revenues are summarized as follows:
 
For the Three Months
Ended June 30,
 
For the Six Months
Ended June 30,
(In millions, except percentages)
2016
 
2015
 
2016
 
2015
Product revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
United States
$
1,777.5

 
61.4
%
 
$
1,565.4

 
60.4
%
 
$
3,440.8

 
61.2
%
 
$
3,099.1

 
60.2
%
Rest of world
688.5

 
23.8
%
 
633.2

 
24.4
%
 
1,334.6

 
23.7
%
 
1,271.8

 
24.7
%
Total product revenues
2,466.0

 
85.2
%
 
2,198.6

 
84.8
%
 
4,775.4

 
85.0
%
 
4,370.9

 
84.9
%
Revenues from anti-CD20 therapeutic programs
349.2

 
12.1
%
 
337.5

 
13.0
%
 
678.7

 
12.1
%
 
668.1

 
13.0
%
Other revenues
79.0

 
2.7
%
 
55.6

 
2.1
%
 
166.9

 
3.0
%
 
107.6

 
2.1
%
Total revenues
$
2,894.2

 
100.0
%
 
$
2,591.6

 
100.0
%
 
$
5,621.0

 
100.0
%
 
$
5,146.6

 
100.0
%

38

Product Revenues
Product revenues are summarized as follows:
 
For the Three Months
Ended June 30,
 
For the Six Months
Ended June 30,
(In millions, except percentages)
2016
 
2015
 
2016
 
2015
Multiple Sclerosis:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TECFIDERA
$
986.5

 
40.0
%
 
$
883.3

 
40.2
%
 
$
1,932.4

 
40.5
%
 
$
1,708.2

 
39.1
%
Interferon*
728.3

 
29.5
%
 
689.7

 
31.4
%
 
1,398.7

 
29.3
%
 
1,444.2

 
33.0
%
TYSABRI
497.4

 
20.1
%
 
463.1

 
21.1
%
 
974.4

 
20.4
%
 
925.7

 
21.2
%
FAMPYRA
21.6

 
0.9
%
 
21.1

 
1.0
%
 
41.8

 
0.9
%
 
41.1

 
0.9
%
Hemophilia:
 
 

 
 
 

 
 
 

 
 
 

ELOCTATE
124.7

 
5.1
%
 
74.3

 
3.4
%
 
232.4

 
4.9
%
 
127.9

 
2.9
%
ALPROLIX
80.3

 
3.3
%
 
54.4

 
2.5
%
 
155.3

 
3.2
%
 
97.5

 
2.2
%
Other product revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FUMADERM
11.8

 
0.5
%
 
12.7

 
0.6
%
 
23.2

 
0.5
%
 
26.3

 
0.6
%
BENEPALI
15.4

 
0.6
%
 
—

 
—
%
 
17.2

 
0.4
%
 
—

 
—
%
Total product revenues
$
2,466.0

 
100.0
%
 
$
2,198.6

 
100.0
%
 
$
4,775.4

 
100.0
%
 
$
4,370.9

 
100.0
%
*Interferon includes AVONEX and PLEGRIDY.
Multiple Sclerosis (MS)
TECFIDERA
For the three and six months ended June 30, 2016, compared to the same periods in 2015, the increase in U.S. TECFIDERA revenues was primarily due to price increases, partially offset by higher discounts and allowances.
 
For the three and six months ended June 30, 2016, compared to the same periods in 2015, the increase in rest of world TECFIDERA revenues was primarily due to increases in unit sales volume of 39% and 45%, respectively, including sales in existing markets and new markets where we continue to launch the product and expand our presence around the world. Rest of world TECFIDERA revenues for the three and six months ended June 30, 2016, compared to the same periods in 2015, were negatively impacted by a $12.7 million and $19.9 million change in hedge results under our hedging program in the comparative periods, respectively.


39

Interferon
AVONEX and PLEGRIDY
For the three months ended June 30, 2016, compared to the same period in 2015, the increase in U.S. Interferon revenues was primarily due to price increases and an overall increase in Interferon unit sales volume, which was mainly attributable to an increase in PLEGRIDY unit sales volume, partially offset by higher discounts and allowances.
For the six months ended June 30, 2016, compared to the same period in 2015, the increase in U.S. Interferon revenues was primarily due to gross price increases, partially offset by an overall decrease in Interferon unit sales volume attributable to a decrease in AVONEX unit sales volume and higher discounts and allowances.
For the three and six months ended June 30, 2016, U.S. AVONEX revenues totaled $442.2 million and $842.2 million, respectively, as compared to $404.7 million and $883.4 million, respectively, in the prior year comparative periods.  
For the three and six months ended June 30, 2016, U.S. PLEGRIDY revenues totaled $76.8 million and $144.3 million, respectively, as compared to $50.4 million and $89.9 million, respectively, in the prior year comparative periods.
 
For the three and six months ended June 30, 2016, compared to the same periods in 2015, the decrease in rest of world Interferon revenues was primarily due to pricing reductions in certain European countries, partially offset by an overall increase in Interferon unit sales volume attributable to an increase in PLEGRIDY unit sales volume, partially offset by a decrease in AVONEX unit sales volume. Rest of world Interferon revenues for the three and six months ended June 30, 2016, compared to the same periods in 2015, were also negatively impacted by a $18.0 million and $29.3 million change in hedge results under our hedging program in the comparative periods, respectively.
For the three and six months ended June 30, 2016, rest of world AVONEX revenues totaled $163.4 million and $327.5 million, respectively, as compared to $210.5 million and $424.5 million, respectively, in the prior year comparative periods.
For the three and six months ended June 30, 2016, rest of world PLEGRIDY revenues totaled $45.9 million and $84.7 million, respectively, as compared to $24.1 million and $46.4 million, respectively, in the prior year comparative periods.
We expect that overall Interferon revenues will continue to decline as a result of competition from our other products, including TECFIDERA, as well as other MS therapies.


40

TYSABRI
For the three and six months ended June 30, 2016, compared to the same periods in 2015, the increase in U.S. TYSABRI revenues was primarily due to increases in unit sales volume of 6% and 3%, respectively, and increases in gross selling prices partially offset by higher discounts and allowances.
For the three and six months ended June 30, 2016, compared to the same periods in 2015, the decrease in rest of world TYSABRI revenues was due to pricing reductions in certain European countries, partially offset by an increase in unit sales volume of 13% and 10%, respectively, primarily in Europe. Rest of world TYSABRI revenues for the three and six months ended June 30, 2016, compared to the same periods in 2015, were also negatively impacted by a $12.7 million and $19.3 million change in hedge results under our hedging program in the comparative periods, respectively.
In the fourth quarter of 2011, Biogen Italia SRL, our Italian subsidiary, received a notice from the Italian National Medicines Agency (Agenzia Italiana del Farmaco or AIFA) that sales of TYSABRI after mid-February 2009 exceeded a reimbursement limit established pursuant to a Price Determination Resolution (Price Resolution) granted by AIFA in December 2006. AIFA and Biogen Italia SRL are still discussing a possible resolution for the period from February 2009 through January 2013. If our most recent settlement offer is accepted, we could recognize approximately EUR40 million in revenue upon resolution of this matter. For information regarding our agreement with AIFA relating to sales of TYSABRI in Italy, please read Note 17, Other Consolidated Financial Statement Detail to our consolidated financial statements included in our 2015 Form 10-K.
 
We expect that TYSABRI revenues will continue to face competition from additional treatments for MS, including ZINBRYTA, and other MS product candidates, including OCREVUS.
Hemophilia
ELOCTATE
For the three and six months ended June 30, 2016, compared to the same periods in 2015, the increase in U.S. ELOCTATE revenues was primarily due to an increase in unit sales volume of 53% and 70%, respectively.
For the three and six months ended June 30, 2016, compared to the same periods in 2015, the increase in rest of world ELOCTATE revenues was primarily due to an increase in unit sales volume primarily in Japan.


41

ALPROLIX
For the three and six months ended June 30, 2016, compared to the same periods in 2015, the increase in U.S. ALPROLIX revenues was primarily due to an increase in unit sales volume of 33% and 43%, respectively.
For the three and six months ended June 30, 2016, compared to the same periods in 2015, the increase in rest of world ALPROLIX revenues was primarily due to an increase in unit sales volume primarily in Japan.
We expect continued growth of ELOCTATE as there remains a significant portion of the patient population that we believe can benefit from long-acting therapies. We also expect continued growth for ELOCTATE and ALPROLIX as we and Sobi expand into additional markets.
 
BENEPALI
Under the terms of our commercial agreement with Samsung Bioepis, we began to recognize revenues on sales of BENEPALI to third parties in the E.U. in the first quarter of 2016.
For additional information on our relationship with Samsung Bioepis, please read Note 17, Collaborative and Other Relationships to our condensed consolidated financial statements included in this report.


42

Revenues from Anti-CD20 Therapeutic Programs
Genentech (Roche Group)
Our share of RITUXAN and GAZYVA operating profits are summarized as follows:
Biogen’s Share of Pre-tax Profits in the U.S. for RITUXAN and GAZYVA
The following tables provide a summary of amounts comprising our share of pre-tax profits on RITUXAN and GAZYVA in the U.S.:
 
For the Three Months
Ended June 30,
(In millions)
2016
 
2015
Product revenues, net
$
1,032.8

 
$
985.8

Cost and expenses
178.1

 
181.4

Pre-tax profits in the U.S.
854.7

 
804.4

Biogen's share of pre-tax profits
$
333.9

 
$
323.2

 
For the Six Months
Ended June 30,
(In millions)
2016
 
2015
Product revenues, net
$
2,007.5

 
$
1,942.0

Cost and expenses
353.2

 
355.3

Pre-tax profits in the U.S.
1,654.3

 
1,586.7

Biogen's share of pre-tax profits
$
646.7

 
$
632.8

 
For the three and six months ended June 30, 2016, compared to the same periods in 2015, the increase in U.S. product revenues was primarily due to price increases and increases in RITUXAN unit sales volume of 3% and 2%, respectively, partially offset by higher discounts and allowances.
Collaboration costs and expenses for the three and six months ended June 30, 2016, compared to the same periods in 2015, were relatively consistent.
Our share of RITUXAN pre-tax profits in the U.S. decreased to 39% from 40% as GAZYVA was approved by the FDA in follicular lymphoma in February 2016.
For additional information related to our collaboration with Genentech, including information regarding the pre-tax profit sharing formula and its impact on future revenues from anti-CD20 therapeutic programs, please read Note 19, Collaborative and Other Relationships to our consolidated financial statements included in our 2015 Form 10-K.
Revenue on Sales in the Rest of World for RITUXAN
Revenue on sales in the rest of world for RITUXAN consists of our share of pre-tax co-promotion profits on RITUXAN in Canada and royalty revenue on sales outside the U.S. and Canada. For the three months ended June 30, 2016, compared to the same period in 2015, revenue on sales in the rest of world for RITUXAN increased as a result of higher pre-tax co-promotion profits on RITUXAN in Canada.
For the six months ended June 30, 2016, compared to the same period in 2015, revenue on sales in the rest of world for RITUXAN decreased as a result of lower pre-tax co-promotion profits on RITUXAN in Canada and patent expirations.


43

Other Revenues
Other revenues are summarized as follows:
 
For the Three Months
Ended June 30,
 
For the Six Months
Ended June 30,
(In millions, except percentages)
2016
 
2015
 
2016
 
2015
Revenues from collaborative and other relationships
$
19.6

 
24.8
%
 
$
17.2

 
30.9
%
 
$
31.1

 
18.6
%
 
$
36.1

 
33.6
%
Other royalty and corporate revenues
59.4

 
75.2
%
 
38.4

 
69.1
%
 
135.8

 
81.4
%
 
71.5

 
66.4
%
Total other revenues
$
79.0

 
100.0
%
 
$
55.6

 
100.0
%
 
$
166.9

 
100.0
%
 
$
107.6

 
100.0
%
Revenues from Collaborative and Other Relationships
Revenues from collaborative and other relationships include revenues earned under our manufacturing services agreement with Sobi on shipments of ELOCTA to Sobi, royalties from Sobi on sales of ELOCTA in the Sobi Territory, and revenues from our license, technical development and manufacturing services agreements with Samsung Bioepis.
For the three months ended June 30, 2016, compared to the same period in 2015, the increase in revenues from collaborative and other relationships is primarily due to an increase in ELOCTA shipments made under our manufacturing services agreement with Sobi.
For the six months ended June 30, 2016, compared to the same period in 2015, the decrease in revenues from collaborative and other relationships is primarily due to lower revenues earned under our manufacturing services agreement with Samsung Bioepis, partially offset by an increase in ELOCTA shipments made under our manufacturing services agreement with Sobi.
For additional information on our collaborative and other relationships, please read Note 17, Collaborative and Other Relationships to our condensed consolidated financial statements included in this report.
 
Other Royalty and Corporate Revenues
Royalty Revenues
We receive royalties from net sales on products related to patents that we have out-licensed.
For the three and six months ended June 30, 2016, compared to the same periods in 2015, royalty revenues were relatively consistent.
Other Corporate Revenues
Our other corporate revenues include amounts earned under contract manufacturing agreements.
For the three and six months ended June 30, 2016, compared to the same periods in 2015, the increase in other corporate revenues was primarily due to higher contract manufacturing revenues related to services provided to a strategic partner.


44

Reserves for Discounts and Allowances
Revenues from product sales are recorded net of applicable discounts and allowances, including those associated with the implementation of pricing actions in certain international markets where we operate.
Reserves established for these discounts and allowances are classified as reductions of accounts receivable (if the amount is payable to our customer) or a liability (if the amount is payable to a party other than our customer). These reserves are based on estimates of the amounts earned or to be claimed on the related sales. Our estimates take into consideration our historical experience, current contractual and statutory requirements, specific known market events and trends and forecasted customer buying and payment patterns. Actual amounts may ultimately differ from our estimates. If actual results vary, we adjust these estimates, which will have an effect on earnings in same the period. To date, such adjustments have not been significant.
Reserves for discounts, contractual adjustments and returns that reduced gross product revenues are summarized as follows:
 
Discounts
Discounts include trade term discounts and wholesaler incentives.
For the three and six months ended June 30, 2016, compared to the same periods in 2015, the increase in discounts was primarily driven by increases in gross selling price and contractual discount rates.
Contractual Adjustments
Contractual adjustments relate to Medicaid and managed care rebates, co-payment assistance, Veterans Administration, Public Health Service discounts, specialty pharmacy program fees and other government rebates or applicable allowances.
For the three and six months ended June 30, 2016, compared to the same periods in 2015, the increase in contractual adjustments was primarily due to higher Medicaid and other governmental rebates and allowances in the U.S., and managed care rebates as a result of an increase in gross selling prices and contractual rates.
Returns
Product return reserves are established for returns made by wholesalers. In accordance with contractual terms, wholesalers are permitted to return product for reasons such as damaged or expired product. The majority of wholesaler returns are due to product expiration. Provisions for product returns are recorded in the period the related revenue is recognized, resulting in a reduction to product sales.
For the three months ended June 30, 2016, compared to the same period in 2015, return provisions decreased primarily due to a reduction in return rates based on recent experiences of returned products.
For the six months ended June 30, 2016, compared to the same period in 2015, return provisions increased primarily due to higher unit sales volume, partially offset by a reduction in return rates based on recent experiences of returned products.
For additional information related to our reserves, please read Note 3, Reserves for Discounts and Allowances to our condensed consolidated financial statements included in this report.


45

Cost and Expenses
A summary of total cost and expenses is as follows:
 
For the Three Months
Ended June 30,
 
For the Six Months
Ended June 30,
(In millions, except percentages)
2016
 
2015
 
Change %
 
2016
 
2015
 
Change %
Cost of sales, excluding amortization of acquired intangible assets
$
370.3

 
$
286.1

 
29.4
 %
 
$
683.3

 
$
598.6

 
14.1
 %
Research and development
473.1

 
490.7

 
(3.6
)%
 
910.4

 
951.3

 
(4.3
)%
Selling, general and administrative
492.4

 
491.9

 
0.1
 %
 
989.7

 
1,052.3

 
(5.9
)%
Amortization of acquired intangible assets
92.9

 
92.0

 
1.0
 %
 
181.7

 
187.9

 
(3.3
)%
(Gain) loss on fair value remeasurement of contingent consideration
10.6

 
(2.2
)
 
(581.8
)%
 
12.9

 
5.6

 
130.4
 %
Restructuring charges
—

 
—

 
**

 
9.7

 
—

 
**

Collaboration profit (loss) sharing
(5.6
)
 
—

 
**

 
(5.6
)
 
—

 
**

Total cost and expenses
$
1,433.7

 
$
1,358.5

 
5.5
 %
 
$
2,782.1

 
$
2,795.6

 
(0.5
)%
** Percentage not meaningful.
Cost of Sales, Excluding Amortization of Acquired Intangible Assets
Product Cost of Sales
For the three and six months ended June 30, 2016 compared to the same periods in 2015, the increase in product cost of sales was primarily driven by an increase in amounts written down as a result of excess, obsolete or unsaleable inventory, higher unit sales volume related to PLEGRIDY, ELOCTATE and ALPROLIX and increased contract manufacturing production, partially offset by favorable production costs and mix of products.
 
Product cost of sales for the three and six months ended June 30, 2016 also reflects the recognition of $15.8 million of accelerated depreciation as a result of the determination that we intend to cease manufacturing in Cambridge, MA and vacate our biologics manufacturing facility in Cambridge, MA and warehouse space in Somerville, MA by the end of 2016.
Royalty Cost of Sales
For the three and six months ended June 30, 2016, compared to the same periods in 2015, the increase in royalty cost of sales was primarily driven by the increase in royalty rates payable to Sobi and increased sales of TYSABRI and our hemophilia products.
For additional information on our relationship with Sobi, please read Note 17, Collaborative and Other Relationships to our condensed consolidated financial statements included in this report.
On June 28, 2016, the U.S. Patent and Trademark Office issued to the Japanese Foundation for Cancer Research (JFCR) a patent related to recombinant interferon-beta protein. This patent, US Patent No. 9,376,478, expires in June 2033. This patent was issued following an interference proceeding among JFCR and us. This patent is relevant to AVONEX and PLEGRIDY, and we will pay royalties in the mid single digits in relation to this patent during the life of the patent. The royalty payment is expected to be approximately $50 million for the remainder of 2016.



46

Research and Development
 
Research and development expense incurred in support of our marketed products includes costs associated with product lifecycle management activities including, if applicable, costs associated with the development of new indications for existing products. Late stage programs are programs in Phase 3 development or in registration stage. Early stage programs are programs in Phase 1 or Phase 2 development. Research and discovery represents costs incurred to support our discovery research and translational science efforts. Other research and development costs consist of indirect costs incurred in support of overall research and development activities and non-specific programs, including activities that benefit multiple programs, such as management costs as well as depreciation and other facility-based expenses. Costs are reflected in the development stage based upon the program status when incurred. Therefore, the same program could be reflected in different development stages in the same year. For several of our programs, the research and development activities are part of our collaborative and other relationships. Our costs reflect our share of the total costs incurred.


47

For the three months ended June 30, 2016 compared to the same period in 2015, the decrease in research and development expense was primarily related to decreases in costs incurred in connection with our early stage programs and marketed products, partially offset by increased costs incurred in connection with our late stage programs.
For the six months ended June 30, 2016 compared to the same period in 2015, the decrease in research and development expense was primarily related to a decrease in milestone and upfront expenses and decreases in costs incurred in connection with our early stage programs and marketed products, partially offset by increased costs incurred in connection with our late stage programs.
The decrease in spending associated with our early stage programs for the three and six months ended June 30, 2016, compared to the same periods in 2015 was primarily due to the advancement of our aducanumab program for Alzheimer's disease to a late stage program in the third quarter of 2015 and the discontinuance of development of anti-TWEAK in lupus nephritis and Neublastin in neuropathic pain, partially offset by increased costs of BIIB074 (formerly known as Raxatrigine) in trigeminal neuralgia (TGN).
The decrease in spending associated with our marketed products for the three and six months ended June 30, 2016, compared to the same periods in 2015 was primarily due to the discontinuance of development of TYSABRI in secondary-progressive MS in the third quarter of 2015.
The increase in spending associated with our late stage programs for the three and six months ended June 30, 2016, compared to the same periods in 2015 was primarily driven by costs incurred to advance our aducanumab program for Alzheimer's disease and the nusinersen program for the treatment of spinal muscular atrophy.
The decrease in spending associated with milestone and upfront expenses for the six months ended June 30, 2016, compared to the same period in 2015 was primarily due to lower milestones recorded in relation to our collaboration agreements with Ionis Pharmaceuticals (Ionis) and prior year milestones paid to AbbVie for the development of ZINBRYTA as a result of filing with the FDA and EMA in 2015, partially offset by the upfront milestone paid to the University of Pennsylvania upon entering into a collaboration and alliance.
We intend to continue committing significant resources to targeted research and development opportunities where there is a significant unmet need and where the drug candidate has the potential to be
 
highly differentiated. Specifically, we intend to continue to invest in our MS pipeline, our aducanumab program, the BAN2401 and E2609 programs, the nusinersen program, the amiselimod program and our BIIB074 program.
Selling, General and Administrative
For the three months ended June 30, 2016, compared to the same period in 2015, selling, general and administrative expenses remained relatively unchanged. Cost savings in connection with our corporate restructuring, which is described below under the heading "Restructuring Charges", were offset by costs associated with developing commercial capabilities for the product launches of BENEPALI and FLIXABI and the potential product launch of ZINBRYTA.
For the six months ended June 30, 2016, compared to the same period in 2015, the decrease in selling, general and administrative expenses reflects cost savings in connection with our corporate restructuring, an $18.0 million benefit to reflect the reimbursement of Samsung Bioepis' share of historical pre-launch costs pursuant to our commercial agreement with Samsung Bioepis, partially offset by an increase in corporate giving and costs associated with developing commercial capabilities for the product launches of BENEPALI and FLIXABI and the anticipated product launch of ZINBRYTA.
For additional information related to our commercial agreement with Samsung Bioepis, please read Note 17, Collaborative and Other Relationships to our condensed consolidated financial statements included in this report.


48

Amortization of Acquired Intangible Assets
Our amortization expense is based on the economic consumption of intangible assets. Our most significant intangible assets are related to our AVONEX and TYSABRI products. Annually, during our long-range planning cycle, we perform an analysis of anticipated lifetime revenues of AVONEX and TYSABRI. This analysis is also updated whenever events or changes in circumstances would significantly affect the anticipated lifetime revenues of either product.
Our most recent long range planning cycle was updated in the third quarter of 2015. Based upon this analysis, there was not a significant change in our expected rate of amortization for acquired intangible assets.
We monitor events and expectations regarding product performance. If new information indicates that the assumptions underlying our most recent analysis are substantially different than those utilized in our current estimates, our analysis would be updated and may result in a significant change in the anticipated lifetime revenues of the relevant process. The occurrence of an adverse event could substantially increase the amount of amortization expense associated with our acquired intangible assets as compared to previous periods or our current expectations, which may result in a significant negative impact on our future results of operations.
For additional information related to the amortization of acquired intangible assets, please read Note 5, Intangible Assets and Goodwill to our condensed consolidated financial statements included in this report.
 
In Process Research & Development (IPR&D)
Overall, the value of our acquired IPR&D assets is dependent upon a number of variables, including estimates of future revenues and the effects of competition, the level of anticipated development costs and the probability and timing of successfully advancing a particular research program from a clinical trial phase to the next. We are continually reevaluating our estimates concerning these and other variables and evaluating industry and market data regarding the productivity of clinical research and the development process and the estimated economics of our product candidates and those of our expected competitors. Changes in our estimates of items may result in a significant change to our valuation of these assets.
The field of developing treatments for idiopathic pulmonary fibrosis (IPF) and forms of neuropathic pain, such as TGN, are highly competitive and can be affected by rapid changes to expected market candidates. There can be no assurance that we will be able to successfully develop STX-100 for the treatment of IPF or BIIB074 for the treatment of TGN or other indications or that a successfully developed therapy will be able to secure sufficient pricing in a competitive market. Changes to clinical development plans or life cycle management strategies are evaluated regularly. We review amounts capitalized as acquired IPR&D for impairment at least annually, as of October 31, and whenever events or changes in circumstances indicate that the carrying value of the assets might not be recoverable. Our most recent impairment assessment as of October 31, 2015 resulted in no impairments.


49

(Gain) Loss on Fair Value Remeasurement of Contingent Consideration
The consideration for certain of our business combinations includes future payments that are contingent upon the occurrence of a particular factor or factors. We record an obligation for such contingent consideration payments at fair value on the acquisition date. We then revalue our contingent consideration obligations each reporting period. Changes in the fair value of our contingent consideration obligations, other than changes due to payments, are recognized as a (gain) loss on fair value remeasurement of contingent consideration in our condensed consolidated statements of income.
The change in fair value remeasurement of contingent consideration for the three and six months ended June 30, 2016, compared to the same periods in 2015, was primarily due to changes in the probabilities of success related to the achievement of certain developmental milestones and the discount rate.
 
Restructuring Charges
On October 21, 2015, we announced a corporate restructuring, which included the termination of certain pipeline programs and an 11% reduction in workforce. As a result of these initiatives, we reduced our annual run rate of operating expenses by $250 million and reinvested these savings to support the advancement of our high potential pipeline candidates and key commercial activities.
Under this restructuring, cash payments will total approximately $120 million, of which $15.9 million were related to previously accrued 2015 incentive compensation, resulting in net expected restructuring charges totaling approximately $105 million. These amounts will be substantially paid by the end of 2016.
For the three and six months ended June 30, 2016, we recognized restructuring charges totaling $0.0 million and $9.7 million, respectively. We previously recognized $93.4 million of restructuring charges in our consolidated statements of income during the fourth quarter of 2015.
We may continue to execute business transformation and optimization initiatives to streamline operations in the future, including achieving targeted cost reductions, rationalizing manufacturing facilities and other cost savings associated with resource realignments in connection with changes in business strategies and other business conditions.


50

The following table summarizes the charges and spending related to our restructuring efforts during the six months ended June 30, 2016:
(In millions)
Workforce
Reduction
 
Pipeline
Programs
 
Total
Restructuring reserve as of December 31, 2015
$
33.7

 
$
3.6

 
$
37.3

Expense
4.9

 
5.4

 
10.3

Payments
(28.7
)
 
(6.0
)
 
(34.7
)
Adjustments to previous estimates, net
(3.5
)
 
2.9

 
(0.6
)
Restructuring reserve as of June 30, 2016
$
6.4

 
$
5.9

 
$
12.3

Collaboration Profit (Loss) Sharing
In December 2013, pursuant to our rights under the joint venture agreement with Samsung Biologics, we entered into an agreement with Samsung Bioepis to commercialize, over a 10-year term, three anti-TNF biosimilar product candidates in Europe, and in the case of one anti-TNF biosimilar, Japan. We reflect revenues on sales of biosimilars to third parties in product revenues, net in our condensed consolidated statements of income and record the related cost of revenues and sales and marketing expenses in our condensed consolidated statements of income to their respective line items when these costs are incurred. We share 50% of the profit or loss related to our commercial agreement with Samsung Bioepis. The profit share with Samsung Bioepis is recognized in collaboration profit (loss) sharing in our condensed consolidated statements of income.
For additional information related to this transaction, please read Note 17, Collaborative and Other Relationships to our condensed consolidated financial statements included in this report.
 
Other Income (Expense), Net
For the three months ended June 30, 2016 compared to the same period in 2015, the change in other income (expense), net was primarily due to an increase in interest expense as a result of our issuance of our senior unsecured notes in the third quarter of 2015, partially offset by an increase in interest income due to higher cash, cash equivalents and marketable securities balances.
For the six months ended June 30, 2016 compared to the same period in 2015, the change in other income (expense), net was primarily due to an increase in interest expense as a result of our issuance of our senior unsecured notes in the third quarter of 2015, partially offset by an increase in interest income due to higher cash, cash equivalents and marketable securities balances and the impact of foreign exchange gains recorded during the six months ended June 30, 2016 compared to losses recorded in the prior year comparative period.


51

Income Tax Provision
Our effective tax rate fluctuates from year to year due to the global nature of our operations. The factors that most significantly impact our effective tax rate include variability in the allocation of our taxable earnings among multiple jurisdictions, changes in tax laws, the amount and characterization of our research and development expenses, the levels of certain deductions and credits, acquisitions and licensing transactions.
For the three and six months ended June 30, 2016, compared to the same period in 2015, our effective tax rate increased primarily due to a state tax benefit in 2015 resulting from the remeasurement of one of our uncertain positions and a higher relative percentage of our earnings being attributed to the U.S., a higher tax jurisdiction.
For more information on our uncertain tax positions and income tax rate reconciliation for the three and six months ended June 30, 2016 and 2015, please read Note 14, Income Taxes to our condensed consolidated financial statements included in this report.
 
Share in Equity in Loss of Investee, Net of Tax
In February 2012, we entered into an agreement with Samsung Biologics, establishing an entity, Samsung Bioepis, to develop, manufacture and market biosimilar pharmaceuticals. We account for this investment under the equity method of accounting. We recognize our share of the results of operations related to our investment in Samsung Bioepis one quarter in arrears.
During 2015, our share of losses exceeded the carrying value of our investment. We therefore suspended recognizing additional losses and will continue to do so unless we commit to providing additional funding.
For additional information related to this transaction, please read Note 17, Collaborative and Other Relationships to our condensed consolidated financial statements included in this report.


52

Cambridge, MA Manufacturing Facility
In June 2016, as a result of an evaluation of our manufacturing capabilities and capacity needs based on current and expected future demand, we determined that we intend to cease manufacturing in Cambridge, MA and vacate our 67,000 square foot small-scale biologics manufacturing facility in Cambridge, MA and 46,000 square foot warehouse space in Somerville, MA by the end of 2016.
We are currently considering alternatives for the facility, which may include a sale of our rights to the facility and related assets. In the event we are unsuccessful with a sale, we will close the facility by December 31, 2016.
As of June 30, 2016, the carrying value of associated assets totaled approximately $43.0 million and our remaining lease obligation related to these facilities totaled $26.3 million.
 
As a result of these actions, we may incur significant costs, including employee separation and retention expenses, facility lease termination fees, rent expense in excess of sublease income and facility closing costs. An impairment assessment as of June 30, 2016 was performed related to the assets, which resulted in no impairments.
The anticipated departure from these facilities has shortened the expected useful lives of certain leasehold improvements and other assets at these facilities. As a result, we recorded additional depreciation expense to reflect the assets' new shorter useful lives. As of June 30, 2016, we recognized approximately $15.8 million of this additional depreciation, which was recorded as cost of sales in our condensed consolidated statements of income.

Financial Condition, Liquidity and Capital Resources
Our financial condition is summarized as follows:
(In millions, except percentages)
As of
June 30,
2016
 
As of
December 31,
2015
 
Change %
Financial assets:
 
 
 
 
 
Cash and cash equivalents
$
1,362.0

 
$
1,308.0

 
4.1
 %
Marketable securities — current
2,434.8

 
2,120.5

 
14.8
 %
Marketable securities — non-current
3,477.6

 
2,760.4

 
26.0
 %
Total cash, cash equivalents and marketable securities
$
7,274.4

 
$
6,188.9

 
17.5
 %
Borrowings:
 
 
 
 
 
Current portion of notes payable and other financing arrangements
$
4.8

 
$
4.8

 
—
 %
Notes payable and other financing arrangements
6,538.3

 
6,521.5

 
0.3
 %
Total borrowings
$
6,543.1

 
$
6,526.3

 
0.3
 %
Working capital:
 
 
 
 
 
Current assets
$
7,447.7

 
$
6,700.3

 
11.2
 %
Current liabilities
(2,516.2
)
 
(2,577.7
)
 
(2.4
)%
Total working capital
$
4,931.5

 
$
4,122.6

 
19.6
 %
For the six months ended June 30, 2016, certain significant cash flows were as follows:
•
$1,959.2 million in net cash flows provided by operating activities;
•
$840.8 million in total payments for income taxes;
•
$600.0 million in contingent payments made to former shareholders of Fumapharm AG and holders of their rights; and
•
$263.7 million used for purchases of property, plant and equipment.
 
For the six months ended June 30, 2015, certain significant cash flows were as follows:
•
$1,780.3 million in net cash flows provided by operating activities;
•
$520.9 million in total payments for income taxes;
•
$250.0 million in contingent payments made to former shareholders of Fumapharm AG and holders of their rights;
•
$227.7 million used for purchases of property, plant and equipment;


53

•
$198.8 million net cash paid for the acquisition of Convergence Pharmaceuticals (Convergence); and
•
$42.2 million used for share repurchases.
Overview
We have historically financed our operating and capital expenditures primarily through cash flows earned through our operations. During 2015, we issued senior unsecured notes for an aggregate principal amount of $6.0 billion. We expect to continue funding our current and planned operating requirements principally through our cash flows from operations, as well as our existing cash resources. We believe that our existing funds, when combined with cash generated from operations and our access to additional financing resources, if needed, are sufficient to satisfy our operating, working capital, strategic alliance, milestone payment, capital expenditure and debt service requirements for the foreseeable future. In addition, we may choose to opportunistically return cash to shareholders and pursue other business initiatives, including acquisition and licensing activities. We may, from time to time, also seek additional funding through a combination of new collaborative agreements, strategic alliances and additional equity and debt financings or from other sources should we identify a significant new opportunity.
The undistributed cumulative foreign earnings of certain of our foreign subsidiaries, exclusive of earnings that would result in little or no net income tax expense under current U.S. tax law or which has already been subject to tax under U.S. tax law, are invested indefinitely outside the U.S.
Of the total cash, cash equivalents and marketable securities at June 30, 2016, approximately $4.2 billion was generated in foreign jurisdictions and is primarily intended for use in our foreign operations or in connection with business development transactions outside of the U.S. In managing our day-to-day liquidity in the U.S., we do not rely on the unrepatriated earnings as a source of funds and we have not provided for U.S. federal or state income taxes on these undistributed foreign earnings.
For additional information related to certain risks that could negatively impact our financial position or future results of operations, please read the “Risk Factors” and “Quantitative and Qualitative Disclosures About Market Risk” sections of this report.
 
Share Repurchase Programs
In July 2016, our Board of Directors authorized a program to repurchase up to $5.0 billion of our common stock (2016 Share Repurchase Program). This authorization does not have an expiration date. Repurchased shares will be retired. The 2016 Share Repurchase Program is in addition to the approximately 1.3 million shares remaining under our February 2011 Share Repurchase Program (2011 Share Repurchase Program), which has been used principally to offset common stock issuances under our share-based compensation plans. During the six months ended June 30, 2016 and 2015, we did not repurchase any shares of common stock under our 2011 Share Repurchase Program.
In May 2015, our Board of Directors authorized a program to repurchase up to $5.0 billion of our common stock, which was completed as of December 31, 2015. During the six months ended June 30, 2015, we repurchased and retired 0.1 million shares of common stock at a cost of $42.2 million.
Cash, Cash Equivalents and Marketable Securities
Until required for another use in our business, we typically invest our cash reserves in bank deposits, certificates of deposit, commercial paper, corporate notes, U.S. and foreign government instruments and other interest bearing marketable debt instruments in accordance with our investment policy. It is our policy to mitigate credit risk in our cash reserves and marketable securities by maintaining a well-diversified portfolio that limits the amount of exposure as to institution, maturity and investment type.
The net increase in cash, cash equivalents and marketable securities at June 30, 2016 from December 31, 2015, is primarily due to net cash flows provided by operating activities, partially offset by contingent payments made to former shareholders of Fumapharm AG and holders of their rights and net purchases of property, plant and equipment.
Borrowings
The following is a summary of our principal indebtedness:
•
$550.0 million aggregate principal amount of 6.875% Senior Notes due March 1, 2018;
•
$1.5 billion aggregate principal amount of 2.90% Senior Notes due September 15, 2020;
•
$1.0 billion aggregate principal amount of 3.625% Senior Notes due September 15, 2022;
•
$1.75 billion aggregate principal amount of 4.05% Senior Notes due September 15, 2025; and


54

•
$1.75 billion aggregate principal amount of 5.20% Senior Notes due September 15, 2045.
These senior unsecured notes were issued at a discount and are amortized as additional interest expense over the period from issuance through maturity.
During the third quarter of 2015, we entered into a $1.0 billion, 5-year senior unsecured revolving credit facility under which we are permitted to draw funds for working capital and general corporate purposes. The terms of the revolving credit facility include a financial covenant that requires us not to exceed a maximum consolidated leverage ratio. As of June 30, 2016, we had no outstanding borrowings and were in compliance with all covenants under this facility.
 
For a summary of the fair and carrying values of our outstanding borrowings as of June 30, 2016 and December 31, 2015, please read Note 6, Fair Value Measurements to our condensed consolidated financial statements included in this report.
Working Capital
We define working capital as current assets less current liabilities. The increase in working capital at June 30, 2016 from December 31, 2015 reflects an increase in total current assets of $747.4 million as well as a decrease in current liabilities of $61.5 million. The increase in total current assets was primarily driven by an increase in marketable securities, prepaid taxes and inventory. The decrease in total current liabilities primarily resulted from a decrease in accounts payable and accrued expenses and other.

Cash Flows
The following table summarizes our cash flow activity:
 
 
For the Six Months
Ended June 30,
(In millions, except percentages)
 
2016
 
2015
 
% Change
Net cash flows provided by operating activities
 
$
1,959.2

 
$
1,780.3

 
10.0
 %
Net cash flows used in investing activities
 
$
(1,939.3
)
 
$
(1,756.1
)
 
10.4
 %
Net cash flows provided by financing activities
 
$
34.0

 
$
77.2

 
(56.0
)%
Operating Activities
Cash flows from operating activities represent the cash receipts and disbursements related to all of our activities other than investing and financing activities. We expect cash provided from operating activities will continue to be our primary source of funds to finance operating needs and capital expenditures for the foreseeable future.
Operating cash flow is derived by adjusting our net income for:
•
Non-cash operating items such as depreciation and amortization, impairment charges and share-based compensation charges;
•
Changes in operating assets and liabilities which reflect timing differences between the receipt and payment of cash associated with transactions and when they are recognized in results of operations; and
•
Changes associated with the fair value of contingent payments associated with our acquisitions of businesses and payments related to collaborations.
 
For the six months ended June 30, 2016, compared to the same period in 2015, the increase in net cash flows provided by operating activities is primarily driven by higher net income, partially offset by a decrease in income taxes payable.
Investing Activities
For the six months ended June 30, 2016, compared to the same period in 2015, the increase in net cash flows used in investing activities is primarily due to an increase in the contingent consideration related to the Fumapharm AG acquisition, partially offset by cash paid for the acquisition of Convergence in February 2015.
Financing Activities
For the six months ended June 30, 2016, compared to the same period in 2015, the decrease in net cash flows provided by financing activities is primarily due to a decrease in tax benefit from share-based awards.


55

Contractual Obligations and Off-Balance Sheet Arrangements
Contractual Obligations
Our contractual obligations primarily consist of our obligations under non-cancellable operating leases, capital leases, long-term debt obligations and defined benefit and other purchase obligations, excluding amounts related to uncertain tax positions, funding commitments, contingent development, regulatory and commercial milestone payments, TYSABRI contingent payments and contingent consideration related to our business combinations, as described below.
On December 1, 2015, we purchased land in Solothurn, Switzerland where we are building a biologics manufacturing facility over the next several years. As of June 30, 2016, we had contractual commitments of approximately $226.0 million for the construction of this facility.
There have been no other material changes in our contractual obligations since December 31, 2015.
Tax Related Obligations
We exclude liabilities pertaining to uncertain tax positions from our summary of contractual obligations as we cannot make a reliable estimate of the period of cash settlement with the respective taxing authorities. As of June 30, 2016, we have approximately $70.0 million of liabilities associated with uncertain tax positions.
Other Funding Commitments
As of June 30, 2016, we have several on-going clinical studies in various clinical trial stages. Our most significant clinical trial expenditures are to contract research organizations (CROs). The contracts with CROs are generally cancellable, with notice, at our option. We have recorded accrued expenses of approximately $36.0 million on our condensed consolidated balance sheet for expenditures incurred by CROs as of June 30, 2016. We have approximately $490.0 million in cancellable future commitments based on existing CRO contracts as of June 30, 2016.
As of June 30, 2016, we have planned clinical trials for our nusinersen program which is managed by Ionis. We have agreed to pay up to approximately $72.5 million to Ionis as the trials for this program proceed. If these trials advance, and we continue with our Ionis program, it is possible that we could make a significant amount of additional development payments in the future.
 
Contingent Development, Regulatory and Commercial Milestone Payments
Based on our development plans as of June 30, 2016, we could make potential future milestone payments to third parties of up to approximately $3.4 billion as part of our various collaborations, including licensing and development programs. Payments under these agreements generally become due and payable upon achievement of certain development, regulatory or commercial milestones. Because the achievement of these milestones had not occurred as of June 30, 2016, such contingencies have not been recorded in our financial statements. Amounts related to contingent milestone payments are not considered contractual obligations as they are contingent on the successful achievement of certain development, regulatory approval and commercial milestones.
We anticipate that we may pay approximately $40.0 million of milestone payments during the remainder of 2016, provided various development, regulatory or commercial milestones are achieved.
TYSABRI Contingent Payments
In 2013, we acquired from Elan Corporation plc (Elan) full ownership of all remaining rights to TYSABRI that we did not already own or control. Under the terms of the acquisition agreement, we are obligated to make contingent payments to Elan of 18% on annual worldwide net sales up to $2.0 billion and 25% on annual worldwide net sales that exceed $2.0 billion. Royalty payments to Elan and other third parties are recognized as cost of sales in our condensed consolidated statements of income. Elan was acquired by Perrigo in December 2013. Following that acquisition, we began making these royalty payments to Perrigo.
Contingent Consideration related to Business Combinations
In connection with our acquisitions of Convergence, Stromedix, Inc. (Stromedix) and Biogen International Neuroscience GmbH (BIN), we agreed to make additional payments based upon the achievement of certain milestone events.
As the acquisitions of Convergence, Stromedix and BIN, formerly Panima Pharmaceuticals AG, occurred after January 1, 2009, we record contingent consideration liabilities at their fair value on the acquisition date and revalue these obligations each reporting period.
We may pay up to approximately $1.3 billion in remaining milestones related to these acquisitions.


56

Fumapharm AG
In 2006, we acquired Fumapharm AG. As part of this acquisition we acquired FUMADERM and TECFIDERA (together, Fumapharm Products). We are required to make contingent payments to former shareholders of Fumapharm AG or holders of their rights based on the attainment of certain cumulative sales levels of Fumapharm Products and the level of total net sales of Fumapharm Products in the prior twelve month period.
During the six months ended June 30, 2016, we paid $600.0 million in contingent payments as we reached the $7.0 billion and $8.0 billion cumulative sales levels related to the Fumapharm Products in the fourth quarter of 2015 and first quarter of 2016, respectively, and accrued $300.0 million upon reaching $9.0 billion in total cumulative sales of Fumapharm Products in the second quarter of 2016.
We will owe an additional $300.0 million contingent payment for every additional $1.0 billion in cumulative sales level of Fumapharm Products reached if the prior 12 months sales of the Fumapharm Products exceed $3.0 billion, until such time as the cumulative sales level reaches $20.0 billion, at which time no further contingent payments shall be due. These payments will be accounted for as an increase to goodwill as incurred, in accordance with the accounting standard applicable to business combinations when we acquired Fumapharm. Any portion of the payment which is tax deductible will be recorded as a reduction to goodwill. Payments are due within 60 days following the end of the quarter in which the applicable cumulative sales level has been reached.
Other Off-Balance Sheet Arrangements
We do not have any relationships with entities often referred to as structured finance or special purpose entities that were established for the purpose of facilitating off-balance sheet arrangements. As such, we are not exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships. We consolidate variable interest entities if we are the primary beneficiary.

 
New Accounting Standards
For a discussion of new accounting standards please read Note 1, Summary of Significant Accounting Policies - New Accounting Pronouncements to our condensed consolidated financial statements included in this report.
Critical Accounting Estimates
The preparation of our condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the U.S. (U.S. GAAP), requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosure of contingent assets and liabilities. On an on-going basis we evaluate our estimates, judgments and methodologies. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity and the amount of revenues and expenses. Actual results may differ from these estimates under different assumptions or conditions.
For a discussion of our critical accounting estimates, please read Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our 2015 Form 10-K. There have been no material changes to these critical accounting estimates since our 2015 Form 10-K.


57

Item 3.    Quantitative and Qualitative Disclosures About Market Risk
Market Risk
We are subject to certain risks which may affect our results of operations, cash flows and fair values of assets and liabilities, including volatility in foreign currency exchange rates, interest rate movements, pricing pressures worldwide and weak economic conditions in the foreign markets in which we operate. We manage the impact of foreign currency exchange rates and interest rates through various financial instruments, including derivative instruments such as foreign currency forward contracts, interest rate lock contracts and interest rate swap contracts. We do not enter into financial instruments for trading or speculative purposes. The counter-parties to these contracts are major financial institutions and there is no significant concentration of exposure with any one counter-party.
Foreign Currency Exchange Risk
Our results of operations are subject to foreign currency exchange rate fluctuations due to the global nature of our operations. We have operations or maintain distribution relationships in the U.S., Europe, Canada, Asia and Central and South America. In addition, we recognize our share of pre-tax co-promotion profits on RITUXAN in Canada. As a result, our financial position, results of operations and cash flows can be affected by market fluctuations in foreign exchange rates, primarily with respect to the Euro, British pound sterling, Canadian dollar, Swiss franc, Danish krone and Japanese yen.
While the financial results of our global activities are reported in U.S. dollars, the functional currency for most of our foreign subsidiaries is their respective local currency. Fluctuations in the foreign currency exchange rates of the countries in which we do business will affect our operating results, often in ways that are difficult to predict. In particular, as the U.S. dollar strengthens versus other currencies, the value of the non-U.S. revenue will decline when reported in U.S. dollars. The impact to net income as a result of a strengthening U.S. dollar will be partially mitigated by the value of non-U.S. expense which will also decline when reported in U.S. dollars. As the U.S. dollar weakens versus other currencies, the value of the non-U.S. revenue and expenses will increase when reported in U.S. dollars.
We have established revenue and operating expense hedging and balance sheet risk management programs to protect against volatility of future foreign currency cash flows and changes in fair value caused by volatility in foreign exchange rates.
 
In June 2016, the U.K. voted in a referendum to voluntarily depart from the E.U., known as Brexit. The macroeconomic impact on our results of operations from this vote remains unknown. To date, the foreign exchange impact has been negligible since we hedged the balance sheet foreign currency exchange risk.
Revenue and Operating Expense Hedging Program
Our foreign currency hedging program is designed to mitigate, over time, a portion of the impact resulting from volatility in exchange rate changes on revenues and operating expenses. We use foreign currency forward contracts to manage foreign currency risk, with the majority of our forward contracts used to hedge certain forecasted revenue and operating expense transactions denominated in foreign currencies in the next 18 months. We do not engage in currency speculation. For a more detailed disclosure of our revenue and operating expense hedging program, please read Note 8, Derivative Instruments to our condensed consolidated financial statements included in this report.
Our ability to mitigate the impact of exchange rate changes on revenues and net income diminishes as significant exchange rate fluctuations are sustained over extended periods of time. In particular, devaluation or significant deterioration of foreign currency exchange rates are difficult to mitigate and likely to negatively impact earnings. The cash flows from these contracts are reported as operating activities in our condensed consolidated statements of cash flows.
Balance Sheet Risk Management Hedging Program
We also use forward contracts to mitigate the foreign currency exposure related to certain balance sheet items. The primary objective of our balance sheet risk management program is to mitigate the exposure of foreign currency denominated net monetary assets of foreign affiliates. In these instances, we principally utilize currency forward contracts. We have not elected hedge accounting for the balance sheet related items. The cash flows from these contracts are reported as operating activities in our condensed consolidated statement of cash flows.


58

The following quantitative information includes the impact of currency movements on forward contracts used in our revenue, operating expense and balance sheet hedging programs. As of June 30, 2016 and December 31, 2015, a hypothetical adverse 10% movement in foreign currency rates compared to the U.S. dollar across all maturities would result in a hypothetical decrease in the fair value of forward contracts of approximately $178.0 million and $185.0 million, respectively. The estimated fair value change was determined by measuring the impact of the hypothetical exchange rate movement on outstanding forward contracts. Our use of this methodology to quantify the market risk of such instruments is subject to assumptions and actual impact could be significantly different. The quantitative information about market risk is limited because it does not take into account all foreign currency operating transactions.
Interest Rate Risk
Our investment portfolio includes cash equivalents and short-term investments. The fair value of our marketable securities is subject to change as a result of potential changes in market interest rates. The potential change in fair value for interest rate sensitive instruments has been assessed on a hypothetical 100 basis point adverse movement across all maturities. As of June 30, 2016 and December 31, 2015, we estimate that such hypothetical 100 basis point adverse movement would result in a hypothetical loss in fair value of approximately $50.0 million and $43.0 million, respectively, to our interest rate sensitive instruments. The fair values of our investments were determined using third-party pricing services or other market observable data.
To achieve a desired mix of fixed and floating interest rate debt, we entered into interest rate swap contracts during 2015 for certain of our fixed-rate debt. These derivative contracts effectively converted a fixed-rate interest coupon to a floating-rate LIBOR-based coupon over the life of the respective note. As of June 30, 2016 and December 31, 2015, a 100 basis-point adverse movement (increase in LIBOR) would increase annual interest expense by approximately $6.8 million, respectively.
Pricing Pressure
Governments in some international markets in which we operate have implemented measures aimed at reducing healthcare costs to constrain the overall level of government expenditures. These implemented measures vary by country and include, among other things, mandatory rebates and discounts, prospective and possible retroactive price reductions and suspensions on price increases of pharmaceuticals.
 
In addition, certain countries set prices by reference to the prices in other countries where our products are marketed. Thus, our inability to secure favorable prices in a particular country may impair our ability to obtain acceptable prices in existing and potential new markets and limit market growth. The continued implementation of pricing actions throughout Europe may also lead to higher levels of parallel trade.
In the U.S., federal and state legislatures, health agencies and third-party payors continue to focus on containing the cost of health care. Legislative and regulatory proposals, enactments to reform health care insurance programs and increasing pressure from social sources could significantly influence the manner in which our products are prescribed and purchased. It is possible that additional federal health care reform measures will be adopted in the future, which could result in increased pricing pressure and reduced reimbursement for our products and otherwise have an adverse impact on our financial position or results of operations.
There is also significant economic pressure on state budgets that may result in states increasingly seeking to achieve budget savings through mechanisms that limit coverage or payment for our drugs. Managed care organizations are also continuing to seek price discounts and, in some cases, to impose restrictions on the coverage of particular drugs.
Credit Risk
We are subject to credit risk from our accounts receivable related to our product sales. The majority of our accounts receivable arise from product sales in the U.S. and Europe with concentrations of credit risk limited due to the wide variety of customers and markets using our products, as well as their dispersion across many different geographic areas. Our accounts receivable are primarily due from wholesale distributors, public hospitals and other government entities. We monitor the financial performance and creditworthiness of our customers so that we can properly assess and respond to changes in their credit profile. We operate in certain countries where weakness in economic conditions can result in extended collection periods. We continue to monitor these conditions, including the volatility associated with international economies and the relevant financial markets, and assess their possible impact on our business. To date, we have not experienced any significant losses with respect to the collection of our accounts receivable.


59

Credit and economic conditions in the E.U. continue to remain uncertain, which has, from time to time, led to long collection periods for our accounts receivable and greater collection risk in certain countries.
We believe that our allowance for doubtful accounts was adequate as of June 30, 2016 and December 31, 2015. However, if significant changes occur in the availability of government funding or the reimbursement practices of these or other governments, we may not be able to collect on amounts due to us from customers in such countries and our results of operations could be adversely affected.
 
Item 4.    Controls and Procedures
Disclosure Controls and Procedures and Internal Control over Financial Reporting
Controls and Procedures
We have carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended), as of June 30, 2016. Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures are effective in ensuring that (a) the information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities Exchange Commission’s rules and forms, and (b) such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, our management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting during the quarter ended June 30, 2016, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.


60

Part II — OTHER INFORMATION
Item 1.    Legal Proceedings
Please refer to Note 18, Litigation to our condensed consolidated financial statements included in this report, which is incorporated into this item by reference.
Item 1A.    Risk Factors
We are substantially dependent on revenues from our principal products.
Our current revenues depend upon continued sales of our principal products, and, unless we develop or acquire rights to new products and technologies, we are substantially dependent on sales from our principal products for many years. Further, if the proposed spin off of our hemophilia business is completed, our revenues will be further reliant and concentrated on sales of our MS products in an increasingly competitive market. Any of the following negative developments relating to any of our principal products may adversely affect our revenues and results of operations or could cause a decline in our stock price:
•
safety or efficacy issues;
•
the introduction or greater acceptance of competing products;
•
constraints and additional pressures on product pricing or price increases, due to a number of factors, including governmental or regulatory requirements, increased competition or changes in, or, implementation of, reimbursement policies and practices of payors and other third parties; or
•
adverse legal, administrative, regulatory or legislative developments.
If we fail to compete effectively, our business and market position would suffer.
The biopharmaceutical industry and the markets in which we operate are intensely competitive. We compete in the marketing and sale of our products, the development of new products and processes, the acquisition of rights to new products with commercial potential and the hiring and retention of personnel. We compete with biotechnology and pharmaceutical companies that have a greater number of products on the market and in the product pipeline, greater financial and other resources and other technological or competitive advantages. One or more of our competitors may benefit from significantly greater sales and marketing capabilities, may develop products that are accepted more widely than ours or may receive patent protection that dominates, blocks or adversely affects our product development or business.
Our products are also susceptible to competition from generics and biosimilars in many markets. Generic versions of drugs and biosimilars are likely to be sold at substantially lower prices than branded products. Accordingly, the introduction of generic or biosimilar versions of our marketed products likely would significantly reduce both the price that we receive for such marketed products and the volume of products that we sell, which may have an adverse impact on our results of operations.
In the MS market, we face intense competition as the number of products and competitors continues to expand. Due to our significant reliance on sales of our MS products, our business may be harmed if we are unable to successfully compete in the MS market. More specifically, our ability to compete, maintain and grow our share in the MS market may be adversely affected due to a number of factors, including:
•
the introduction of more efficacious, safer, less expensive or more convenient alternatives to our MS products, including our own products and products of our collaborators;
•
the introduction of lower-cost biosimilars, follow-on products or generic versions of branded MS products sold by our competitors, and the possibility of future competition from generic versions or prodrugs of existing therapeutics or from off-label use by physicians of therapies indicated for other conditions to treat MS patients;
•
patient dynamics, including the size of the patient population and our ability to attract new patients to our therapies;
•
damage to physician and patient confidence in any of our MS products or to our sales and reputation as a result of label changes or adverse experiences or events that occur with patients treated with our MS products;

61

•
inability to obtain appropriate pricing and reimbursement for our MS products compared to our competitors in key international markets; or
•
our ability to obtain and maintain patent, data or market exclusivity for our MS products.
Similarly, the hemophilia treatment market is a highly competitive market, with current treatments marketed by companies that have substantially greater financial resources and marketing expertise. Our ability to successfully compete in the hemophilia market and gain share in this market may be adversely affected due to a number of reasons, including:
•
difficulty in further penetrating this market if our therapies are not regarded by patients, healthcare providers or payers as offering significant benefits and value over current treatments;
•
changes in technology, including the introduction by other companies of new technologies, such as gene therapies and bispecific antibody technology that have the potential to transform the standard of care in hemophilia, or longer-lasting or more efficacious, safer, less expensive or more convenient treatments than our therapies; or
•
our limited marketing experience within the hemophilia treatment market relative to certain of our competitors, which may impact our ability to develop relationships with the associated medical and scientific community.
Sales of our products depend, to a significant extent, on adequate coverage, pricing and reimbursement from third-party payors, which are subject to increasing and intense pressure from political, social, competitive and other sources. Our inability to maintain adequate coverage, or a reduction in pricing or reimbursement, could have an adverse effect on our business, revenues and results of operations, and could cause a decline in our stock price.
Sales of our products are dependent, in large part, on the availability and extent of coverage, pricing and reimbursement from government health administration authorities, private health insurers and other organizations. When a new pharmaceutical product is approved, the availability of government and private reimbursement for that product may be uncertain, as is the pricing and amount for which that product will be reimbursed.
Pricing and reimbursement for our products may be adversely affected by a number of factors, including:
•
changes in, and implementation of, federal, state or foreign government regulations or private third-party payors' reimbursement policies;
•
pressure by employers on private health insurance plans to reduce costs; and
•
consolidation and increasing assertiveness of payors, including managed care organizations, health insurers, pharmacy benefit managers, government health administration authorities, private health insurers and other organizations, seeking price discounts or rebates in connection with the placement of our products on their formularies and, in some cases, the imposition of restrictions on access or coverage of particular drugs or pricing determined based on perceived value. 
Our ability to set the price for our products can vary significantly from country to country and as a result so can the price of our products. Certain countries set prices by reference to the prices in other countries where our products are marketed. Thus, our inability to secure adequate prices in a particular country may not only limit the revenue from our products within that country, but may also adversely affect our ability to obtain acceptable prices in other markets. This may create the opportunity for third-party cross-border trade or influence our decision to sell or not to sell a product, thus adversely affecting our geographic expansion plans and revenues.
Our failure to maintain adequate coverage, pricing or reimbursement for our products would have an adverse effect on our business, revenues and results of operation, could curtail or eliminate our ability to adequately fund research and development programs for the discovery and commercialization of new products, and could cause a decline in our stock price.
Drug prices are under significant scrutiny in the markets in which our products are prescribed. Drug pricing and other health care costs continue to be subject to intense political and societal pressures which we anticipate will continue and escalate on a global basis. As a result, our business and reputation may be harmed, our stock price may be adversely impacted and experience periods of volatility and our results of operations may be adversely impacted. 

62

Our results of operations may be adversely affected by current and potential future healthcare reforms.
In the U.S., federal and state legislatures, health agencies and third-party payors continue to focus on containing the cost of health care. Legislative and regulatory proposals and enactments to reform health care insurance programs could significantly influence the manner in which our products are prescribed and purchased. For example, provisions of the Patient Protection and Affordable Care Act (PPACA) have resulted in changes in the way health care is paid for by both governmental and private insurers, including increased rebates owed by manufacturers under the Medicaid Drug Rebate Program, annual fees and taxes on manufacturers of certain branded prescription drugs, the requirement that manufacturers participate in a discount program for certain outpatient drugs under Medicare Part D and the expansion of the number of hospitals eligible for discounts under Section 340B of the Public Health Service Act. These changes have had and are expected to continue to have a significant impact on our business.
There is also significant economic pressure on state budgets that may result in states increasingly seeking to achieve budget savings through mechanisms that limit coverage or payment for our drugs. In recent years, some states have considered legislation and ballot initiatives that would control the prices of drugs, including laws to allow importation of pharmaceutical products from lower cost jurisdictions outside the U.S. and laws intended to impose price controls on state drug purchases. State Medicaid programs are increasingly requesting manufacturers to pay supplemental rebates and requiring prior authorization by the state program for use of any drug for which supplemental rebates are not being paid. Government efforts to reduce Medicaid expenses may lead to increased use of managed care organizations by Medicaid programs. This may result in managed care organizations influencing prescription decisions for a larger segment of the population and a corresponding constraint on prices and reimbursement for our products. In addition, under the PPACA, as states implement their health care marketplaces or operate under the federal exchange, the impact on drug manufacturers, including us, will depend in part on the formulary and benefit design decisions made by insurance sponsors or plans participating in these programs. It is possible that we may need to provide discounts or rebates to such plans in order to maintain favorable formulary access for our products for this patient population, which could have an adverse impact on our sales and results of operations.
In the E.U. and some other international markets, the government provides health care at low cost to consumers and regulates pharmaceutical prices, patient eligibility or reimbursement levels to control costs for the government-sponsored health care system. Many countries have announced or implemented measures to reduce health care costs to constrain their overall level of government expenditures. These measures vary by country and may include, among other things, patient access restrictions, suspensions on price increases, prospective and possibly retroactive price reductions and other recoupments and increased mandatory discounts or rebates, recoveries of past price increases and greater importation of drugs from lower-cost countries to higher-cost countries. These measures have negatively impacted our revenues, and may continue to adversely affect our revenues and results of operations in the future.
Adverse safety events or restrictions on use and safety warnings for our products can negatively affect our business, product sales and stock price.
Adverse safety events involving our marketed products have a negative impact on our business. Discovery of safety issues with our products could create product liability and could cause additional regulatory scrutiny and requirements for additional labeling or safety monitoring, withdrawal of products from the market and the imposition of fines or criminal penalties. Adverse safety events may also damage physician and patient confidence in our products and our reputation. Any of these could result in liabilities, loss of revenue, material write-offs of inventory, material impairments of intangible assets, goodwill and fixed assets, material restructuring charges and other adverse impacts on our results of operations.
Regulatory authorities are making greater amounts of stand-alone safety information directly available to the public through periodic safety update reports, patient registries and other reporting requirements. The reporting of adverse safety events involving our products or products similar to ours and public rumors about such events may increase claims against us and may also cause our product sales or stock price to decline or experience periods of volatility.
Restrictions on use or significant safety warnings that may be required to be included in the label of our products, such as the risk of developing progressive multifocal leukoencephalopathy (PML), a serious brain infection, in the label for certain of our products, may significantly reduce expected revenues for those products and require significant expense and management time.

63

If we are unable to obtain and maintain adequate protection for our data, intellectual property and other proprietary rights, our business may be harmed.
Our success depends in part on our ability to obtain and defend patent and other intellectual property rights that are important to the commercialization of our products and product candidates. The degree of patent protection that will be afforded to our products and processes in the U.S. and in other important markets remains uncertain and is dependent upon the scope of protection decided upon by the patent offices, courts and lawmakers in these countries. We can provide no assurance that we will successfully obtain or preserve patent protection for the technologies incorporated into our products and processes, or that the protection obtained will be of sufficient breadth and degree to protect our commercial interests in all countries where we conduct business. If we cannot prevent others from exploiting our inventions, we will not derive the benefit from them that we currently expect. Furthermore, we can provide no assurance that our products will not infringe patents or other intellectual property rights held by third parties.
We also rely on regulatory exclusivity for protection of our products. Implementation and enforcement of regulatory exclusivity, which may consist of regulatory data protection and market protection, varies widely from country to country. Failure to qualify for regulatory exclusivity, or failure to obtain or maintain the extent or duration of such protections that we expect in each of the markets for our products due to challenges, changes or interpretations in the law or otherwise, could affect our revenue for our products or our decision on whether to market our products in a particular country or countries or could otherwise have an adverse impact on our results of operations.
Litigation, interferences, oppositions, inter partes reviews or other proceedings are, have been and may in the future be necessary in some instances to determine the validity and scope of certain of our proprietary rights, and in other instances to determine the validity, scope or non-infringement of certain patent rights claimed by third parties to be pertinent to the manufacture, use or sale of our products. We may also face challenges to our patent and regulatory protections covering our products by manufacturers of generics and biosimilars that may choose to launch or attempt to launch their products before the expiration of our patent or regulatory exclusivity. Litigation, interference, oppositions, inter partes reviews or other similar types of proceedings are unpredictable and may be protracted, expensive and distracting to management. The outcome of such proceedings could adversely affect the validity and scope of our patent or other proprietary rights, hinder our ability to manufacture and market our products, require us to seek a license for the infringed product or technology or result in the assessment of significant monetary damages against us that may exceed amounts, if any, accrued in our financial statements. An adverse determination in a judicial or administrative proceeding or a failure to obtain necessary licenses could prevent us from manufacturing or selling our products. Furthermore, payments under any licenses that we are able to obtain would reduce our profits derived from the covered products and services.
Our long-term success depends upon the successful development of new products and additional indications for existing products.
Our long-term viability and growth will depend upon successful development of additional indications for our existing products as well as successful development of new products and technologies from our research and development activities, our biosimilars joint venture with Samsung Biologics or licenses or acquisitions from third parties.
Product development is very expensive and involves a high degree of risk. Only a small number of research and development programs result in the commercialization of a product. Clinical trials may indicate that our product candidates lack efficacy, have harmful side effects, result in unexpected adverse events or raise other concerns that may significantly reduce the likelihood of regulatory approval. This may result in terminated programs, significant restrictions on use and safety warnings in an approved label, adverse placement within the treatment paradigm or significant reduction in the commercial potential of the product candidate.

64

Clinical trials and the development of biopharmaceutical products is a lengthy and complex process. If we fail to adequately manage our clinical activities, our clinical trials or potential regulatory approvals may be delayed or denied.
Conducting clinical trials is a complex, time-consuming and expensive process. Our ability to complete clinical trials in a timely fashion depends in large part on a number of key factors. These factors include protocol design, regulatory and institutional review board approval, patient enrollment rates and compliance with extensive current Good Clinical Practices. If we or our third-party clinical trial providers or third-party contract research organizations, or CROs, do not successfully carry out these clinical activities, our clinical trials or the potential regulatory approval of a product candidate may be delayed or be unsuccessful.
We have opened clinical sites and are enrolling patients in a number of countries where our experience is more limited. In most cases, we use the services of third parties to carry out our clinical trial related activities and rely on such parties to accurately report their results. Our reliance on third parties for these activities may impact our ability to control the timing, conduct, expense and quality of our clinical trials. One CRO has responsibility for a substantial portion of our clinical trial related activities and reporting. If this CRO does not adequately perform, many of our trials may be affected. We may need to replace our CROs. Although we believe there are a number of other CROs we could engage to continue these activities, the replacement of an existing CRO may result in the delay of the affected trials or otherwise adversely affect our efforts to obtain regulatory approvals and commercialize our product candidates.
Successful preclinical work or early stage clinical trials does not ensure success in later stage trials, regulatory approval or commercial viability of a product.
Positive results in a trial may not be replicated in subsequent or confirmatory trials. Additionally, success in preclinical work or early stage clinical trials does not ensure that later stage or larger scale clinical trials will be successful or that regulatory approval will be obtained. In addition, even if later stage clinical trials are successful, regulatory authorities may delay or decline approval of our product candidates. Regulatory authorities may disagree with our view of the data, require additional studies or disagree with our trial design or endpoints. Regulatory authorities may also fail to approve the facilities or the processes used to manufacture a product candidate, our dosing or delivery methods or companion devices. Regulatory authorities may grant marketing approval that is more restricted than anticipated. These restrictions may include limiting indications to narrow patient populations and the imposition of safety monitoring, educational requirements and risk evaluation and mitigation strategies. The occurrence of any of these events could result in significant costs and expenses, have an adverse effect on our business, financial condition and results of operations and cause our stock price to decline or experience periods of volatility.
Even if we are able to successfully develop new products or indications, sales of new products or products with additional indications may not meet investor expectations. We may also make a strategic decision to discontinue development of a product or indication if, for example, we believe commercialization will be difficult relative to the standard of care or other opportunities in our pipeline.
Management and key personnel changes may disrupt our operations, and we may have difficulty retaining key personnel or attracting and retaining qualified replacements on a timely basis for management and other key personnel who may leave the Company.
We have experienced changes in management and other key personnel in critical functions across our organization. In July 2016, we announced that our chief executive officer will be leaving our company after his successor is identified. It is possible that we may experience other personnel changes in connection with our business operations and the proposed spin off of our hemophilia business. Changes in management and other key personnel have the potential to disrupt our business, and any such disruption could adversely affect our operations, programs, growth, financial condition and results of operations. Further, new members of management may have different perspectives on programs and opportunities for our business, which may cause us to focus on new business opportunities or reduce or change emphasis on our existing business programs.
Our success is dependent upon our ability to attract and retain qualified management and key personnel in a highly competitive environment. Qualified individuals are in high demand, and we may incur significant costs to attract them, particularly at the executive level. We may face difficulty in attracting and retaining key talent for a number of reasons, such as management changes, the underperformance or discontinuation of one or more late stage programs or recruitment by competitors. We cannot assure that we will be able to hire or retain the personnel necessary for our operations or that the loss of any such personnel will not have a material impact on our financial condition and results of operations.

65

Manufacturing issues could substantially increase our costs, limit supply of our products and reduce our revenues.
The process of manufacturing our products is complex, highly regulated and subject to numerous risks, including:
•
Risk of Product Loss. The manufacturing process for our products is extremely susceptible to product loss due to contamination, oxidation, equipment failure or improper installation or operation of equipment or vendor or operator error. Even minor deviations from normal manufacturing processes result in reduced production yields, product defects and other supply disruptions. If microbial, viral or other contaminations are discovered in our products or manufacturing facilities, we may need to close our manufacturing facilities for an extended period of time to investigate and remediate the contaminant.
•
Risks of Reliance on Third Parties and Single Source Providers. We rely on third-party suppliers and manufacturers for many aspects of our manufacturing process for our products and product candidates. In some cases, due to the unique manner in which our products are manufactured, we rely on single source providers of several raw materials and manufacturing supplies. These third parties are independent entities subject to their own unique operational and financial risks that are outside of our control. These third parties may not perform their obligations in a timely and cost-effective manner or in compliance with applicable regulations, and they may be unable or unwilling to increase production capacity commensurate with demand for our existing or future products. Finding alternative providers could take a significant amount of time and involve significant expense due to the specialized nature of the services and the need to obtain regulatory approval of any significant changes to our suppliers or manufacturing methods. We cannot be certain that we could reach agreement with alternative providers or that the FDA or other regulatory authorities would approve our use of such alternatives.
•
Global Bulk Supply Risks. We rely on our manufacturing facilities in Cambridge, MA, RTP, NC and Hillerød, Denmark for the production of drug substance for our large molecule products and product candidates. Our global bulk supply of these products and product candidates depends on the uninterrupted and efficient operation of these facilities, which could be adversely affected by equipment failures, labor shortages, natural disasters, power failures and numerous other factors.
•
Risks Relating to Compliance with cGMP. We and our third-party providers are generally required to maintain compliance with cGMP and other stringent requirements and are subject to inspections by the FDA and comparable agencies in other jurisdictions to confirm such compliance. Any delay, interruption or other issues that arise in the manufacture, fill-finish, packaging or storage of our products as a result of a failure of our facilities or the facilities or operations of third parties to pass any regulatory agency inspection could significantly impair our ability to develop and commercialize our products. Significant noncompliance could also result in the imposition of monetary penalties or other civil or criminal sanctions and damage our reputation.
Any adverse developments affecting our manufacturing operations or the operations of our third-party suppliers and manufacturers may result in shipment delays, inventory shortages, lot failures, product withdrawals or recalls or other interruptions in the commercial supply of our products. We may also have to take inventory write-offs and incur other charges and expenses for products that fail to meet specifications, undertake costly remediation efforts or seek more costly manufacturing alternatives. Such developments could increase our manufacturing costs, cause us to lose revenue or market share as patients and physicians turn to competing therapeutics, diminish our profitability or damage our reputation.
We depend on relationships with collaborators and other third parties for revenue, and the development, regulatory approval, commercialization and marketing of certain products, which are outside of our full control.
We rely on a number of significant collaborative relationships for revenue, and the development, regulatory approval, commercialization and marketing of certain of our products and product candidates. We also outsource to third parties certain aspects of our regulatory affairs and clinical development relating to our products and product candidates. Reliance on collaborative and other third-party relationships subjects us to a number of risks, including:
•
we may be unable to control the resources our collaborator or third party devotes to our programs or products;
•
disputes may arise with respect to ownership of rights to technology developed with our collaborator or other third party, and the underlying contract with our collaborator or other third party may fail to provide significant protection or may fail to be effectively enforced if the collaborator or third party fails to perform;

66

•
the interests of our collaborator or third party may not always be aligned with our interests and such party may not pursue regulatory approvals or market a product in the same manner or to the same extent that we would, which could adversely affect our revenues;
•
third-party relationships and collaborations often require the parties to cooperate, and failure to do so effectively could adversely affect product sales, or the clinical development or regulatory approvals of products under joint control or could result in termination of the research, development or commercialization of product candidates or result in litigation or arbitration; and
•
any failure on the part of our collaborator or other third party to comply with applicable laws and regulatory requirements in the marketing, sale and maintenance of the market authorization of our products or to fulfill any responsibilities our collaborator may have to protect and enforce any intellectual property rights underlying our products could have an adverse effect on our revenues as well as involve us in possible legal proceedings.
Given these risks, there is considerable uncertainty regarding the success of our current and future collaborative efforts. If these efforts fail, our product development or commercialization of new products could be delayed or revenues from products could decline.
Our business may be adversely affected if we do not successfully execute our growth initiatives.
We are experiencing a period of slower revenue growth compared to recent years. We anticipate growth through internal development projects, commercial initiatives and external opportunities, which may include the acquisition, partnering and in-licensing of products, technologies and companies or the entry into strategic alliances and collaborations. While we believe we have a number of promising programs in our pipeline, failure of internal development projects to advance or difficulties in executing on our commercial initiatives could impact our current and future growth, resulting in additional reliance on external development opportunities for growth. The availability of high quality cost-effective development opportunities is limited and competitive, and we are not certain that we will be able to identify candidates that we and our shareholders consider suitable or complete transactions on terms that are acceptable to us and our shareholders. We may fail to complete transactions for other reasons, including if we are unable to obtain desired financing on favorable terms, if at all. Even if we are able to successfully identify and complete acquisitions and other strategic alliances and collaborations, we may face unanticipated costs or liabilities in connection with the transaction, or we may not be able to integrate them or take full advantage of them or otherwise realize the benefits that we expect.
Supporting our growth initiatives and the further development of our existing products and potential new products in our pipeline requires significant capital expenditures and management resources, including investments in research and development, sales and marketing, manufacturing capabilities and other areas of our business. If we do not successfully execute our growth initiatives, then our business and financial results may be adversely affected and we may incur asset impairment or restructuring charges.
The proposed spin off of our hemophilia business is subject to various risks and uncertainties and may not be completed on the terms or timeline currently contemplated, if at all, and will involve significant time and expense, which could harm our business, results of operations and financial condition.
In May 2016, we announced plans to separate our hemophilia business as an independent, publicly-traded company. The transaction is expected to be completed in early 2017, subject to satisfaction of certain conditions. Unanticipated developments could delay, prevent or otherwise adversely affect this proposed spin off, including but not limited to disruptions in general market conditions or potential problems, delays or difficulties in satisfying conditions and obtaining approvals and clearances or litigation or other legal proceedings that may arise as a result of the proposed spin off. In addition, consummation of the spin off will require final approval from our Board of Directors. Therefore, we cannot assure that we will be able to complete the spin off on the terms or on the timeline that we announced, if at all.
We will incur significant expenses in connection with the spin off, and such costs and expenses may be greater than we anticipate. In addition, completion of the spin off will require a significant amount of management time and effort which may disrupt our business or otherwise divert management’s attention from other aspects of our business operations. Any such difficulties could adversely affect our business, results of operations and financial condition.

67

The proposed spin off may not achieve some or all of the anticipated benefits.
If the spin off is completed, there is uncertainty as to whether the anticipated operational, financial and strategic benefits of the spin off will be achieved. There can be no assurance that the combined value of the common stock of the two publicly-traded companies will be equal to or greater than what the value of our common stock would have been had the proposed separation not occurred. The combined value of the common stock of the two companies could be lower than anticipated for a variety of reasons, including, but not limited to, the inability of the new spin off company to operate and compete effectively as an independent company, and the stock price of the common stock of each of the two companies could experience periods of volatility. If we fail to achieve the anticipated benefits of the spin off, our stock price could decline.
If the spin off does not qualify as a transaction that is generally tax-free for U.S. federal income tax purposes, we and our stockholders could be subject to significant tax liabilities.
We intend to obtain an opinion of outside counsel regarding the qualification of the distribution in the spin off, together with certain related transactions, as a transaction that is generally tax-free for U.S. federal income tax purposes. The opinion will be based on and rely on, among other things, certain facts and assumptions, as well as certain representations, statements and undertakings of Biogen and the new spin off company, including those relating to the past and future conduct of Biogen and the new spin off company. If any of these facts, assumptions, representations, statements or undertakings are, or become, inaccurate or incomplete, or if we or the new spin off company breach any of their respective covenants in the separation documents, the opinion of counsel may be invalid and the conclusions reached therein could be jeopardized. It is also possible that the U.S. Internal Revenue Service, or the IRS, could determine that the distribution in the spin off, together with certain related transactions, is taxable for U.S. federal income tax purposes if it determines that any of these facts, assumptions, representations, statements or undertakings are incorrect or have been violated or if it disagrees with the conclusions in the opinion of counsel. An opinion of counsel is not binding on the IRS or any court and there can be no assurance that the IRS will not challenge the conclusions reached in the opinion. If the distribution in the spin off, together with certain related transactions, is ultimately determined to be taxable, we and our stockholders that are subject to U.S. federal income tax could incur significant tax liabilities.
A breakdown or breach of our technology systems could subject us to liability or interrupt the operation of our business.
We are increasingly dependent upon technology systems and data. Our computer systems continue to increase in multitude and complexity due to the growth in our business, making them potentially vulnerable to breakdown, malicious intrusion and random attack. Likewise, data privacy or security breaches by individuals authorized to access our technology systems or others may pose a risk that sensitive data, including intellectual property, trade secrets or personal information belonging to us, our patients, customers or other business partners, may be exposed to unauthorized persons or to the public. Cyber-attacks are increasing in their frequency, sophistication and intensity, and are becoming increasingly difficult to detect. They are often carried out by motivated, well-resourced, skilled and persistent actors including nation states, organized crime groups and “hacktivists.” Cyber-attacks could include the deployment of harmful malware and key loggers, a denial-of-service attack, a malicious website, the use of social engineering and other means to affect the confidentiality, integrity and availability of our technology systems and data. Our key business partners face similar risks and any security breach of their systems could adversely affect our security posture. While we continue to build and improve our systems and infrastructure and believe we have taken appropriate security measures to reduce these risks to our data and information technology systems, there can be no assurance that our efforts will prevent breakdowns or breaches in our systems that could adversely affect our business and operations and/or result in the loss of critical or sensitive information, which could result in financial, legal, business or reputational harm to us. In addition, our liability insurance may not be sufficient in type or amount to cover us against claims related to security breaches, cyber-attacks and other related breaches.
If we fail to comply with the extensive legal and regulatory requirements affecting the health care industry, we could face increased costs, penalties and a loss of business.
Our activities, and the activities of our collaborators, distributors and other third-party providers, are subject to extensive government regulation and oversight both in the U.S. and in foreign jurisdictions. The FDA and comparable agencies in other jurisdictions directly regulate many of our most critical business activities, including the conduct of preclinical and clinical studies, product manufacturing, advertising and promotion, product distribution, adverse event reporting and product risk management. Our interactions in the U.S. or abroad with physicians and other health care providers that prescribe or purchase our products are also subject to government regulation designed to prevent fraud and abuse in the sale and use of the products and place significant restrictions on the marketing practices of health care companies. Health care companies such as ours are facing heightened scrutiny of their relationships

68

with health care providers from anti-corruption enforcement officials. In addition, health care companies such as ours have been the target of lawsuits and investigations alleging violations of government regulation, including claims asserting submission of incorrect pricing information, impermissible off-label promotion of pharmaceutical products, payments intended to influence the referral of health care business, submission of false claims for government reimbursement, antitrust violations or violations related to environmental matters. There is also enhanced scrutiny of company-sponsored patient assistance programs, including insurance premium and co-pay assistance programs and donations to third party charities that provide such assistance. If we, or our vendors or donation recipients, are deemed to fail to comply with relevant laws, regulations or government guidance in the operation of these programs, we could be subject to significant fines or penalties. Risks relating to compliance with laws and regulations may be heightened as we continue to expand our global operations and enter new therapeutic areas with different patient populations, which may have different product distribution methods, marketing programs or patient assistance programs from those we currently utilize or support.
Regulations governing the health care industry are subject to change, with possibly retroactive effect, including:
•
new laws, regulations or judicial decisions, or new interpretations of existing laws, regulations or decisions, related to health care availability, pricing or marketing practices, compliance with wage and hour laws and other employment practices, method of delivery, payment for health care products and services, compliance with health information and data privacy and security laws and regulations, tracking and reporting payments and other transfers of value made to physicians and teaching hospitals, extensive anti-bribery and anti-corruption prohibitions, product serialization and labeling requirements and used product take-back requirements;
•
changes in the FDA and foreign regulatory approval processes that may delay or prevent the approval of new products and result in lost market opportunity;
•
requirements that provide for increased transparency of clinical trial results and quality data, such as the EMA’s clinical transparency policy, which could impact our ability to protect trade secrets and competitively-sensitive information contained in approval applications or could be misinterpreted leading to reputational damage, misperception or legal action which could harm our business; and
•
changes in FDA and foreign regulations that may require additional safety monitoring, labeling changes, restrictions on product distribution or use or other measures after the introduction of our products to market, which could increase our costs of doing business, adversely affect the future permitted uses of approved products or otherwise adversely affect the market for our products.
Violations of governmental regulation may be punishable by criminal and civil sanctions against us, including fines and civil monetary penalties and exclusion from participation in government programs, including Medicare and Medicaid, as well as against executives overseeing our business. In addition to penalties for violation of laws and regulations, we could be required to repay amounts we received from government payors or pay additional rebates and interest if we are found to have miscalculated the pricing information we have submitted to the government. We cannot ensure that our compliance controls, policies and procedures will in every instance protect us from acts committed by our employees, collaborators, partners or third-party providers that would violate the laws or regulations of the jurisdictions in which we operate. Whether or not we have complied with the law, an investigation into alleged unlawful conduct could increase our expenses, damage our reputation, divert management time and attention and adversely affect our business.
Our indebtedness could adversely affect our business and limit our ability to plan for or respond to changes in our business.
Our indebtedness, together with our significant contingent liabilities, including milestone and royalty payment obligations, could have important consequences to our business; for example, such obligations could:
•
increase our vulnerability to general adverse economic and industry conditions;
•
limit our ability to access capital markets and incur additional debt in the future;
•
require us to dedicate a substantial portion of our cash flow from operations to payments on our indebtedness, thereby reducing the availability of our cash flow for other purposes, including business development efforts, research and development and mergers and acquisitions; and
•
limit our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate, thereby placing us at a competitive disadvantage compared to our competitors that have less debt.

69

Our sales and operations are subject to the risks of doing business internationally.
We are increasing our presence in international markets, particularly emerging markets, subjecting us to many risks that could adversely affect our business and revenues, such as:
•
the inability to obtain necessary foreign regulatory or pricing approvals of products in a timely manner;
•
collectability of accounts receivable;
•
fluctuations in foreign currency exchange rates, in particular the recent strength of the U.S. dollar versus foreign currencies which has adversely impacted our revenues and net income;
•
difficulties in staffing and managing international operations;
•
the imposition of governmental controls;
•
less favorable intellectual property or other applicable laws;
•
increasingly complex standards for complying with foreign laws and regulations that may differ substantially from country to country and may conflict with corresponding U.S. laws and regulations;
•
the far-reaching anti-bribery and anti-corruption legislation in the U.K., including the U.K. Bribery Act 2010, and elsewhere and escalation of investigations and prosecutions pursuant to such laws;
•
compliance with complex import and export control laws;
•
restrictions on direct investments by foreign entities and trade restrictions;
•
greater political or economic instability; and
•
changes in tax laws and tariffs.
In addition, our international operations are subject to regulation under U.S. law. For example, the Foreign Corrupt Practices Act prohibits U.S. companies and their representatives from offering, promising, authorizing or making payments to foreign officials for the purpose of obtaining or retaining business abroad. In many countries, the health care professionals we regularly interact with may meet the definition of a foreign government official for purposes of the Foreign Corrupt Practices Act. Failure to comply with domestic or foreign laws could result in various adverse consequences, including: possible delay in approval or refusal to approve a product; recalls, seizures or withdrawal of an approved product from the market; disruption in the supply or availability of our products or suspension of export or import privileges; the imposition of civil or criminal sanctions; the prosecution of executives overseeing our international operations; and damage to our reputation. Any significant impairment of our ability to sell products outside of the U.S. could adversely impact our business and financial results.
Our effective tax rate may fluctuate and we may incur obligations in tax jurisdictions in excess of accrued amounts.
As a global biopharmaceutical company, we are subject to taxation in numerous countries, states and other jurisdictions. As a result, our effective tax rate is derived from a combination of applicable tax rates in the various places that we operate. In preparing our financial statements, we estimate the amount of tax that will become payable in each of such places. Our effective tax rate, however, may be different than experienced in the past due to numerous factors, including changes in the mix of our profitability from country to country, the results of examinations and audits of our tax filings, adjustments to the value of our uncertain tax positions, changes in accounting for income taxes and changes in tax laws. Any of these factors could cause us to experience an effective tax rate significantly different from previous periods or our current expectations.
In addition, our inability to secure or sustain acceptable arrangements with tax authorities and future changes in the tax laws, among other things, may result in tax obligations in excess of amounts accrued in our financial statements.
In the U.S., there are several proposals under consideration to reform tax law, including proposals that may reduce or eliminate the deferral of U.S. income tax on our unrepatriated earnings, penalize certain transfer pricing structures and reduce or eliminate certain foreign or domestic tax credits or deductions. Our future reported financial results may be adversely affected by tax law changes which restrict or eliminate certain foreign tax credits or our ability to deduct expenses attributable to foreign earnings, or otherwise affect the treatment of our unrepatriated earnings.

70

In addition to U.S. tax reform proposals, the adoption of some or all of the recommendations set forth in the Organization for Economic Co-operation and Development’s project on “Base Erosion and Profit Shifting” (BEPS) by tax authorities in the countries in which we operate, could negatively impact our effective tax rate. These recommendations focus on payments from affiliates in high tax jurisdictions to affiliates in lower tax jurisdictions and the activities that give rise to a taxable presence in a particular country.
Our operating results are subject to significant fluctuations.
Our quarterly revenues, expenses and net income (loss) have fluctuated in the past and are likely to fluctuate significantly in the future due to the risks described in these “Risk Factors” as well as the timing of charges and expenses that we may take. We have recorded, or may be required to record, charges that include:
•
the cost of restructurings;
•
impairments with respect to investments, fixed assets and long-lived assets, including in-process R&D and other intangible assets;
•
inventory write-downs for failed quality specifications, charges for excess or obsolete inventory and charges for inventory write downs relating to product suspensions, expirations or recalls;
•
changes in the fair value of contingent consideration;
•
bad debt expenses and increased bad debt reserves;
•
outcomes of litigation and other legal or administrative proceedings, regulatory matters and tax matters;
•
milestone payments under license and collaboration agreements; and
•
payments in connection with acquisitions and other business development activities.
Our revenues are also subject to foreign exchange rate fluctuations due to the global nature of our operations. Although we have foreign currency forward contracts to hedge specific forecasted transactions denominated in foreign currencies, our efforts to mitigate the impact of fluctuating currency exchange rates may not be successful. As a result, currency fluctuations among our reporting currency, the U.S. dollar and the currencies in which we do business will affect our operating results, often in unpredictable ways. Our net income may also fluctuate due to the impact of charges we may be required to take with respect to foreign currency hedge transactions. In particular, we may incur higher than expected charges from hedge ineffectiveness or from the termination of a hedge relationship.
Our operating results during any one period do not necessarily suggest the anticipated results of future periods.
We are pursuing opportunities to expand our manufacturing capacity for future clinical and commercial requirements for product candidates, which will result in the incurrence of significant investment with no assurance that such investment will be recouped.
While we believe we currently have sufficient manufacturing capacity to meet our near-term manufacturing requirements, it is probable that we would need additional manufacturing capacity to support future clinical and commercial manufacturing requirements for product candidates in our pipeline, if such candidates are successful and approved. We are building a biologics manufacturing facility in Solothurn, Switzerland and acquired an additional manufacturing facility in RTP, NC. Due to the long lead times necessary for the expansion of manufacturing capacity, we expect to incur significant investment to build or expand our facilities or obtain third-party contract manufacturers with no assurance that such investment will be recouped. If we are unable to adequately and timely manufacture and supply our products and product candidates or if we do not fully utilize our manufacturing facilities, our business may be harmed.
Our investment in Samsung Bioepis, and our success in commercializing biosimilars developed by Samsung Bioepis, are subject to risks and uncertainties inherent in the development, manufacture and commercialization of biosimilars.
Our investment in Samsung Bioepis, and our success in commercializing biosimilars developed by Samsung Bioepis, are subject to a number of risks, including:
•
Reliance on Third Parties. We are dependent on the efforts of Samsung Bioepis and other third parties over whom we have limited or no control in the development and manufacturing of biosimilars products. If Samsung Bioepis or such other third parties fail to perform successfully, we may not realize the anticipated benefits of our investment in Samsung Bioepis;

71

•
Regulatory Compliance. Biosimilar products may face regulatory hurdles or delays due to the evolving and uncertain regulatory and commercial pathway of biosimilars products in certain jurisdictions;
•
Intellectual Property and Regulatory Challenges. Biosimilar products may face extensive patent clearances, patent infringement litigation, injunctions or regulatory challenges, which could prevent the commercial launch of a product or delay it for many years;
•
Failure to Gain Market and Patient Acceptance. Market success of biosimilar products will be adversely affected if patients, physicians and payers do not accept biosimilar products as safe and efficacious products offering a more competitive price or other benefit over existing therapies; and
•
Competitive Challenges. Biosimilar products face significant competition, including from innovator products and from biosimilar products offered by other companies. In some jurisdictions, local tendering processes may restrict biosimilar products from being marketed and sold in those jurisdictions. The number of competitors in a jurisdiction, the timing of approval and the ability to market biosimilar products successfully in a timely and cost-effective matter are additional factors that may impact our success and/or the success of Samsung Bioepis in this business area.
Our investments in properties may not be fully realized.
We own or lease real estate primarily consisting of buildings that contain research laboratories, office space and manufacturing operations. For strategic or other operational reasons, we may decide to further consolidate or co-locate certain aspects of our business operations or dispose of one or more of our properties, some of which may be located in markets that are experiencing high vacancy rates and decreasing property values. If we determine that the fair value of any of our owned properties is lower than their book value we may not realize the full investment in these properties and incur significant impairment charges or additional depreciation when the expected useful life of certain assets have been shortened due to the anticipated closing of facilities. If we decide to fully or partially vacate a leased property, we may incur significant cost, including facility closing costs, employee separation and retention expenses, lease termination fees, rent expense in excess of sublease income and impairment of leasehold improvements and accelerated depreciation of assets. Any of these events may have an adverse impact on our results of operations.
Our portfolio of marketable securities is subject to market, interest and credit risk that may reduce its value.
We maintain a portfolio of marketable securities for investment of our cash. Changes in the value of our portfolio of marketable securities could adversely affect our earnings. In particular, the value of our investments may decline due to increases in interest rates, downgrades of the bonds and other securities included in our portfolio, instability in the global financial markets that reduces the liquidity of securities included in our portfolio, declines in the value of collateral underlying the securities included in our portfolio and other factors. Each of these events may cause us to record charges to reduce the carrying value of our investment portfolio or sell investments for less than our acquisition cost. Although we attempt to mitigate these risks through diversification of our investments and continuous monitoring of our portfolio's overall risk profile, the value of our investments may nevertheless decline.
There can be no assurance that we will continue to repurchase stock or that we will repurchase stock at favorable prices.
Our Board of Directors has approved stock repurchase programs and may approve additional repurchase programs in the future. The amount and timing of stock repurchases are subject to capital availability and our determination that stock repurchases are in the best interest of our stockholders and are in compliance with all respective laws and our agreements applicable to the repurchase of stock. Our ability to repurchase stock will depend upon, among other factors, our cash balances and potential future capital requirements for strategic transactions, results of operations, financial condition, and other factors beyond our control that we may deem relevant. A reduction in, or the completion or expiration of, our stock repurchase programs could have a negative effect on our stock price. We can provide no assurance that we will repurchase stock at favorable prices, if at all.

72

We may not be able to access the capital and credit markets on terms that are favorable to us.
We may seek access to the capital markets to supplement our existing funds and cash generated from operations for working capital, capital expenditure and debt service requirements and other business initiatives. The capital and credit markets have experienced extreme volatility and disruption which leads to uncertainty and liquidity issues for both borrowers and investors. In the event of adverse capital and credit market conditions, we may be unable to obtain capital market financing on favorable terms. Changes in credit ratings issued by nationally recognized credit rating agencies could also adversely affect our cost of financing and the market price of our securities.
Our business involves environmental risks, which include the cost of compliance and the risk of contamination or injury.
Our business and the business of several of our strategic partners involve the controlled use of hazardous materials, chemicals, biologics and radioactive compounds. Although we believe that our safety procedures for handling and disposing of such materials comply with state, federal and foreign standards, there will always be the risk of accidental contamination or injury. If we were to become liable for an accident, or if we were to suffer an extended facility shutdown, we could incur significant costs, damages and penalties that could harm our business. Manufacturing of our products and product candidates also requires permits from government agencies for water supply and wastewater discharge. If we do not obtain appropriate permits, including permits for sufficient quantities of water and wastewater, we could incur significant costs and limits on our manufacturing volumes that could harm our business.
The illegal distribution and sale by third parties of counterfeit versions of our products or stolen products could have a negative impact on our reputation and business.
Third parties might illegally distribute and sell counterfeit or unfit versions of our products, which do not meet our rigorous manufacturing, distribution and testing standards. A patient who receives a counterfeit or unfit drug may be at risk for a number of dangerous health consequences. Our reputation and business could suffer harm as a result of counterfeit or unfit drugs sold under our brand name. Stolen inventory that is not properly stored or sold through unauthorized channels could adversely impact patient safety, our reputation and our business. In addition, thefts of inventory at warehouses, plants or while in-transit, which are not properly stored and which are sold through unauthorized channels, could adversely impact patient safety, our reputation and our business.
The increasing use of social media platforms presents new risks and challenges.
Social media is increasingly being used to communicate about our products and the diseases our therapies are designed to treat. Social media practices in the biopharmaceutical industry continue to evolve and regulations relating to such use are not always clear. This evolution creates uncertainty and risk of noncompliance with regulations applicable to our business. For example, patients may use social media channels to comment on the effectiveness of a product or to report an alleged adverse event. When such disclosures occur, there is a risk that we fail to monitor and comply with applicable adverse event reporting obligations or we may not be able to defend the company or the public's legitimate interests in the face of the political and market pressures generated by social media due to restrictions on what we may say about our products. There is also a risk of inappropriate disclosure of sensitive information or negative or inaccurate posts or comments about us on any social networking website. If any of these events were to occur or we otherwise fail to comply with applicable regulations, we could incur liability, face overly restrictive regulatory actions or incur other harm to our business.
Some of our collaboration agreements contain change in control provisions that may discourage a third party from attempting to acquire us.
Some of our collaboration agreements include change in control provisions that could reduce the potential acquisition price an acquirer is willing to pay or discourage a takeover attempt that could be viewed as beneficial to shareholders.  Upon a change in control, some of these provisions could trigger reduced milestone, profit or royalty payments to us or give our collaboration partner rights to terminate our collaboration agreement, acquire operational control or force the purchase or sale of the programs that are the subject of the collaboration. 

73

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
In July 2016, our Board of Directors authorized a program to repurchase up to $5.0 billion of our common stock (2016 Share Repurchase Program). This authorization does not have an expiration date. Repurchased shares will be retired. The 2016 Share Repurchase Program is in addition to the approximately 1.3 million shares remaining under our February 2011 Share Repurchase Program (2011 Share Repurchase Program), which has been used principally to offset common stock issuances under our share-based compensation plans. During the six months ended June 30, 2016 and 2015, we did not repurchase any shares of common stock under our 2011 Share Repurchase Program.
In May 2015, our Board of Directors authorized a program to repurchase up to $5.0 billion of our common stock, which was completed as of December 31, 2015. During the six months ended June 30, 2015, we repurchased and retired 0.1 million shares of common stock at a cost of $42.2 million.
Item 6.    Exhibits
The exhibits listed on the Exhibit Index immediately preceding such exhibits, which is incorporated herein by reference, are filed or furnished as part of this Quarterly Report on Form 10-Q.

74

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
BIOGEN INC.
 
/s/    Paul J. Clancy
Paul J. Clancy
Executive Vice President and
Chief Financial Officer
(principal financial officer)
July 21, 2016

75

EXHIBIT INDEX 
Exhibit
Number
  
Description of Exhibit
 
 
 
10.1*+
 
Letter regarding employment arrangement of John Cox dated May 19, 2016.
 
 
 
31.1+
  
Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
 
31.2+
  
Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
 
32.1++
  
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
 
101++
  
The following materials from Biogen Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2016, formatted in XBRL (Extensible Business Reporting Language): (i) the Condensed Consolidated Statements of Income, (ii) the Condensed Consolidated Statements of Comprehensive Income, (iii) the Condensed Consolidated Balance Sheets, (iv) the Condensed Consolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements.

*    Management contract or compensatory plan or arrangement
+    Filed herewith
++    Furnished herewith

76
 EX-10.1 2 biib-2016630xex101.htm EXHIBIT 10.1 Exhibit


Exhibit 10.1

May 19, 2016

John Cox
559 Concord Road
Sudbury, MA 01776

Re: Conditional Offer of SpinCo Employment

Dear John,

This letter agreement (“Agreement”) sets forth the terms and conditions of our conditional offer of employment with the new legal entity expected to be spun out from Biogen Inc. to focus on the research, development, and commercialization of hemophilia therapies. For purposes of this letter agreement, the new legal entity will be referred to as “SpinCo” and the date of the separation and distribution of SpinCo shares to SpinCo shareholders (i.e., the date the spin out occurs) will be referred to as the “Date of Distribution.” Provided SpinCo has been legally formed, the spin-off occurs, and you have met all of the terms and conditions for employment with SpinCo as set forth below, if you accept this offer your new full-time position with SpinCo will be as its Chief Executive Officer.

1.
Compensation and Benefits:

If the contingencies set forth below are met, and you become employed by SpinCo under this Agreement, your employment shall be at-will, and your compensation and benefits package will be as follows:

The SpinCo Offer

Salary: This is a full-time, exempt position and your starting annual salary at SpinCo will be $800,000.00, and will be paid in accordance with SpinCo’s standard payroll practices and policies in effect from time to time.

Annual Cash Bonus: You will be eligible to receive an annual cash target bonus equal to 100% of your annual base salary. Based upon your start date, your annual target bonus amount for the 2016 performance year may be pro-rated for the time served as EVP, PO&T for Biogen and the time spent as the CEO under the SpinCo bonus plan based on the compensation that was effective at such time. At this time final details with respect to the SpinCo annual bonus plan have not been finalized. The annual cash bonus shall be payable in a single lump sum as soon as reasonably practicable following the close of the year with respect to which the bonus is paid, but in all events prior to March 15 of the year following the year with respect to which the bonus is paid.

Founders’ Stock Option Grant: In connection with the commencement of your employment with SpinCo, on or near your commencement date you will be provided a one-time grant of SpinCo stock options with an exercise price equal to the fair market value of SpinCo stock on the date of grant (“Founders’ Grant”). The approximate grant date expected value of your SpinCo stock options will be $6,500,000.00. These stock options will be subject to a three-year cliff vesting (i.e., they will all vest three years after the date of grant) and will be granted on or shortly after the Date of Distribution, following your start date.

The actual terms of your Founders’ Grant stock options will be communicated to you following the grant date. Your Founders’ Grant will be awarded under a SpinCo Omnibus Equity Plan, which plan has not yet been finalized.

Each year, typically in the first quarter of the year, you will be eligible to receive a SpinCo annual Long Term Incentive (LTI) award, which will be based on the planning range in effect at the time of grant. The current estimated planning reference point is $6,500,000.00 and the delivery vehicle is expected to be 50% SpinCo restricted stock units and 50% SpinCo stock options. Final determination of the SpinCo annual LTI award amounts and delivery vehicles will be made by the SpinCo compensation committee of the Board of Directors of SpinCo once it is formed.





Enhanced Severance Benefit: If, (1) during the time period beginning with the date of this letter through the Date of Distribution, you are involuntarily terminated by Biogen other than “For Cause” (as defined in Biogen’s Amended and Restated 2008 Omnibus Equity Plan)  or (2) on or after the Date of Distribution through the first anniversary of the Date of Distribution, you are involuntarily terminated by SpinCo other than “For Cause” (as defined in Biogen’s Amended and Restated 2008 Omnibus Equity Plan)  or you experience an “Involuntary Employment Action” following a “Corporate Change in Control”  (each as defined in Biogen’s Amended and Restated 2008 Omnibus Equity Plan) , you will be entitled to receive (i) a lump sum severance payment equal to 24 months of salary and target bonus, (ii) up to 12 months of executive level outplacement services from a recognized provider of such services for C-level executives selected by the employer company, and (iii) continued subsidized health benefits for 21 months provided you timely complete and submit your COBRA election form and continue to pay timely the employee portion of the premiums. In addition, payment and provision of these severance benefits are conditioned upon your signing an irrevocable general release in favor of the employer company, in form and substance acceptable to the employer company, with respect to any and all claims relating to your employment and the termination of your employment with the employer company.

In addition, if between July 1, 2016 and the expected Date of Distribution (expected to be Q4 2016 or Q1 2017) (1) an acquirer is identified for the hemophilia business and/or the SpinCo spin out is not expected to occur or does not occur, and (2) your current Biogen position is no longer available for you to return to, then, in addition to the benefits described in the above paragraph, you shall be entitled to acceleration of all (100%) of your outstanding Biogen LTI awards that are unvested as of your termination date in accordance with the terms of the award agreements, including the requirements of Section 409A of the Internal Revenue Code.

The enhanced severance benefits described in the above paragraphs will be provided to you in lieu of and not in addition to any severance benefits you would have been eligible for under the Severance Plan for U.S. Executive Vice Presidents effective January 1, 2014; provided, however, that if, after the first anniversary of the Date of Distribution, your Spinco employment terminates, then you will be eligible for severance benefits under the SpinCo severance plan for executives in effect at the time of termination.

Change in Control: It is expected that the Spinco omnibus equity plan and executive severance plan will contain standard change in control provisions similar to those contained in the comparable Biogen plans.
Benefits: You may participate in all SpinCo qualified employee benefit plans, welfare benefit plans and programs for which you are eligible, in accordance with the terms and conditions of such plans and programs as in effect and as they may be amended from time to time. Your participation in some or all of these plans may be contingent upon your execution of, and the acceptance by the plan’s administrator of, a participation agreement, and upon your satisfaction of other terms and conditions. Except as specifically set forth herein, the benefits provided under this Agreement shall in no way alter or affect the terms and conditions of any SpinCo sponsored or maintained qualified employee benefit plans, non-qualified employee benefits plans, programs, and welfare benefit plans in which you may otherwise be eligible to participate, and your eligibility to participate in any such plans or programs will be determined in accordance with the terms and conditions of such plans or programs, as they may be amended from time to time.

At this time, the compensation and benefit plans, programs and arrangements to be offered to employees of SpinCo have not been finalized. However, SpinCo will offer its employees market competitive benefits plans (and comparable to Biogen’s plans), with the 401k and the non-qualified retirement plans generally comparable to the current Biogen plans. All such benefit plans will be in place by your start date.

2.
Other Matters:
  
Share Ownership Requirement: It will be important for SpinCo to ensure strong alignment between the interests of its senior executives and those of SpinCo stockholders. It is expected that through your SpinCo annual long-term incentive grants, you will accumulate and retain SpinCo shares in an amount equivalent to a specified multiple of your salary within a reasonable period of time that is yet to be determined.

Signed Proprietary Agreement: As a condition of employment, you will be required to sign SpinCo’s form of “Employee Proprietary Information and Inventions and Dispute Resolution Agreement”’ as a condition of employment. This agreement has not been finalized but it is expected to be substantially similar to the Biogen agreement currently used with its employees.





Treatment of Unvested Biogen LTI Awards: The unvested and outstanding Biogen LTI Awards will be converted to SpinCo shares as follows: (a) Restricted Stock Units (RSUs) - all unvested Biogen RSUs will convert into an equivalent value of SpinCo RSUs at or near the Date of Distribution and continue their regular vesting schedule; (b) Market Stock Units (MSUs) - at or near Date of Distribution we will determine the performance multiplier based on the then 30-day average of Biogen closing stock price and derive the number of Biogen shares earned; we will convert the shares earned to an equivalent value of SpinCo RSUs and continue their regular vesting schedule and (c) Cash Settled Performance Units (CSPUs) - at or near the Date of Distribution we will apply a projected performance multiplier to calculate the shares earned, then use the 30-day average of Biogen’s closing stock price at or near the Date of Distribution to derive the CSPU value. This value will be converted into an equivalent value of SpinCo RSUs and continue their regular vesting schedule.

Indemnification: You will be indemnified pursuant to an indemnification agreement that you will enter into with SpinCo that is expected to contain provisions similar to the indemnification agreement you currently have with Biogen.

3.
Contingencies:

This SpinCo offer of employment is contingent upon: (1) the actual legal formation of SpinCo; (2) the spin-off occurring on terms approved by the board of directors of Biogen Inc.; (3) your formal acceptance of this offer within the time frame set forth below; and (4) you remaining employed by Biogen, continuing to perform your central duties of transitioning your current role to a successor and assisting with the establishment of SpinCo, until you become employed by SpinCo. The Distribution Date (i.e., the date on which SpinCo is spun off from Biogen Inc.) shall be your date of hire with SpinCo unless you are notified otherwise in writing (“SpinCo Hire Date”). Until the SpinCo Hire Date, the terms and conditions of your current at-will Biogen employment will remain in effect (except as noted in the “Enhanced Severance Benefit” section), although you will be expected to work on matters associated with SpinCo in the interim.

Following your SpinCo Hire Date, as a condition of maintaining your employment with SpinCo, you agree that you must: comply with any and all SpinCo hiring and employment policies, practices and procedures, including but not limited to, the execution of any forms provided by SpinCo in connection with your employment and if required, presenting suitable documentation for I-9 INS certification.

4.
Additional Terms:

(a)
At-Will Employment. Your employment with SpinCo will be at-will at all times, as it is currently with Biogen. This means that both you and SpinCo shall always have the right to terminate your employment with SpinCo at any time for any reason, with or without notice or cause. Nothing in this Agreement shall be construed as a contract or guarantee of continued employment with either Biogen or SpinCo for any length of time.

(b)
Employment Files. In connection with your employment at SpinCo, you agree to, and hereby authorize the disclosure and transfer of copies or originals of all of your personnel, medical, benefits and other employment-related files and information from Biogen to SpinCo upon your SpinCo Hire Date. Among other things, such transfer of your files or information may be necessary to ensure you receive appropriate service credits or meet other benefit eligibility requirements. You agree to execute any lawful and reasonable authorizations requested by SpinCo or Biogen to effectuate such transfers.

(c)
Integration; Amendment. This Agreement supersedes any and all prior oral and/or written agreements or understandings with respect to your contemplated employment by SpinCo and sets forth the entire agreement between Biogen and you with respect to your contemplated employment by SpinCo. No provision of this Agreement may be modified, amended or waived except in a writing signed by both parties.

(d)
Applicable Law. The validity, interpretation and performance of this Agreement, shall be governed by, and construed in accordance with, the internal laws of Massachusetts, without giving effect to conflict of law principles.





(e)
Severability and Execution. The provisions of this Agreement are severable, and if for any reason any part hereof shall be found to be unenforceable, the remaining provisions shall be enforced in full. This Agreement may be executed in counterparts, each of which shall be an original, but all of which together shall constitute one agreement. Execution of a facsimile copy of this Agreement shall have the same force and effect as execution of an original, and a facsimile signature shall be deemed an original and valid signature.

(f)
Acknowledgement. By signing the Agreement in the space provided below, you are acknowledging that you have read and understand all of the terms of this Agreement and are entering into this Agreement voluntarily.

(g)
Rule 409A and Rule 280G. Please see Exhibit A.


If you have any questions, please feel free to contact me.

Best regards,


/s/ Robert Pangia
Robert Pangia
Compensation and Management Development Committee, Chairman
Biogen Inc. Board of Directors

I accept this conditional offer of employment and acknowledge the contingencies of employment described above, including the at-will nature of my employment.

ACCEPTED:


/s/ John Cox                    John Cox            May 19, 2016
Signature     Name (Print) Date






Exhibit A

Rule 409A: The parties intend that any amounts payable hereunder comply with or are exempt from Section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”), and this Agreement shall be administered accordingly. Notwithstanding the foregoing, the Company does not guarantee any particular tax effect, and you shall be solely responsible and liable for the satisfaction of all taxes, penalties and interest that may be imposed on you or for your account in connection with the Agreement (including any taxes, penalties and interest under Section 409A), and neither the Company nor any of its affiliates shall have any obligation to indemnify or otherwise hold you (or any beneficiary) harmless from any or all of such taxes, penalties or interest. 

For purposes of Section 409A, each of the payments that may be made under this Agreement shall be deemed to be a separate payment for purposes of Section 409A and the right, if any, to a series of installment payments under this Agreement is to be treated as a right to a series of separate payments.

With respect to the time of payments of any amounts under the Agreement that are “deferred compensation” subject to Section 409A, references in the Agreement to “termination of employment” (and substantially similar phrases) shall mean “separation from service” within the meaning of Section 409A. (after giving effect to the presumptions contained therein). Notwithstanding anything to the contrary in this Agreement, if at the time of your termination of employment, you are a “specified employee,” as defined below, any and all amounts payable under this Agreement on account of such separation from service that constitute deferred compensation and would (but for this provision) be payable within six (6) months following the date of termination, shall instead be paid on the next business day following the expiration of such six (6) month period or, if earlier, upon your death; except (A) to the extent of amounts that do not constitute a deferral of compensation within the meaning of Treasury regulation Section 1.409A-1(b) (including without limitation by reason of the safe harbor set forth in Section 1.409A-1(b)(9)(iii), as determined by the Company in its reasonable good faith discretion); (B) benefits that qualify as excepted welfare benefits pursuant to Treasury regulation Section 1.409A-1(a)(5); or (C) other amounts or benefits that are not subject to the requirements of Section 409A. The term “specified employee” means an individual determined by the Company to be a specified employee under Treasury regulation Section 1.409A-1(i).
For the avoidance of doubt, it is intended that any expense reimbursement made to you hereunder shall be exempt from Section 409A. Notwithstanding the foregoing, if any expense reimbursement made hereunder shall be determined to be “deferred compensation” within the meaning of Section 409A, then (i) the amount of the indemnification payment or expense reimbursement during one taxable year shall not affect the amount of the expense reimbursement during any other taxable year, (ii) the expense reimbursement shall be made on or before the last day of your taxable year following the year in which the expense was incurred and (iii) the right to expense reimbursement hereunder shall not be subject to liquidation or exchange for another benefit.

Section 280G: Notwithstanding anything to the contrary contained in the this Agreement or any other agreement or arrangement between you and SpinCo, to the extent that any of the payments and benefits provided for under this Agreement or such other agreement or arrangement (collectively, the “Payments”) would constitute an “excess parachute payment” within the meaning of section 280G of the Internal Revenue Code of 1986, as amended (the “Code”), the amount of such Payments shall be reduced to the amount that would result in no portion of the Payments being subject to the excise tax imposed pursuant to section 4999 of the Code.


EX-31.1 3 biib-2016630xex311.htm EXHIBIT 31.1 Exhibit


Exhibit 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, George A. Scangos, certify that:

1.
I have reviewed this quarterly report of Biogen Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: July 21, 2016
 
/s/ George A. Scangos
 
 
George A. Scangos
 
 
Chief Executive Officer


 EX-31.2 4 biib-2016630xex312.htm EXHIBIT 31.2 Exhibit


Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Paul J. Clancy, certify that:

1.
I have reviewed this quarterly report of Biogen Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: July 21, 2016
 
/s/ Paul J. Clancy
 
 
Paul J. Clancy
 
 
Executive Vice President and
 
 
Chief Financial Officer


 EX-32.1 5 biib-2016630xex321.htm EXHIBIT 32.1 Exhibit


Exhibit 32.1
CERTIFICATION
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Biogen Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report on Form 10-Q for the quarter ended June 30, 2016 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Dated: July 21, 2016
 
/s/ George A. Scangos
 
 
George A. Scangos
 
 
Chief Executive Officer
 
 
[principal executive officer]
 
Dated: July 21, 2016
 
/s/ Paul J. Clancy
 
 
Paul J. Clancy
 
 
Executive Vice President and
 
 
Chief Financial Officer
 
 
[principal financial officer]
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.


 EX-101.INS 6 biib-20160630.xml XBRL INSTANCE DOCUMENT 0000875045 2016-01-01 2016-06-30 0000875045 2016-07-15 0000875045 2015-01-01 2015-06-30 0000875045 2015-04-01 2015-06-30 0000875045 2016-04-01 2016-06-30 0000875045 2015-12-31 0000875045 2016-06-30 0000875045 2014-12-31 0000875045 2015-06-30 0000875045 us-gaap:EmployeeSeveranceMember 2015-10-01 2015-12-31 0000875045 2015-10-01 2015-12-31 0000875045 us-gaap:ContractTerminationMember 2016-01-01 2016-06-30 0000875045 us-gaap:ContractTerminationMember 2016-06-30 0000875045 us-gaap:EmployeeSeveranceMember 2015-12-31 0000875045 us-gaap:ContractTerminationMember 2015-12-31 0000875045 us-gaap:EmployeeSeveranceMember 2016-06-30 0000875045 us-gaap:EmployeeSeveranceMember 2016-01-01 2016-06-30 0000875045 us-gaap:ReserveForCashDiscountMember 2016-01-01 2016-06-30 0000875045 biib:ContractualAdjustmentsMember 2016-01-01 2016-06-30 0000875045 us-gaap:SalesReturnsAndAllowancesMember 2015-12-31 0000875045 us-gaap:SalesReturnsAndAllowancesMember 2016-01-01 2016-06-30 0000875045 biib:ContractualAdjustmentsMember 2015-12-31 0000875045 us-gaap:ReserveForCashDiscountMember 2016-06-30 0000875045 biib:ContractualAdjustmentsMember 2016-06-30 0000875045 us-gaap:ReserveForCashDiscountMember 2015-12-31 0000875045 us-gaap:SalesReturnsAndAllowancesMember 2016-06-30 0000875045 us-gaap:AccountsReceivableMember 2016-06-30 0000875045 us-gaap:OtherCurrentLiabilitiesMember 2015-12-31 0000875045 us-gaap:AccountsReceivableMember 2015-12-31 0000875045 us-gaap:OtherCurrentLiabilitiesMember 2016-06-30 0000875045 biib:FLIXABIMember 2015-12-31 0000875045 biib:BENEPALIMember 2015-12-31 0000875045 biib:ZINBRYTAMember 2015-12-31 0000875045 us-gaap:DevelopedTechnologyRightsMember biib:AVONEXMember 2016-06-30 0000875045 biib:InLicensedPatentsMember biib:ALPROLIXMember 2016-01-01 2016-06-30 0000875045 biib:TysabriProductMember biib:InLicensedPatentsMember 2016-06-30 0000875045 biib:InLicensedPatentsMember biib:BiosimilarsMember 2016-01-01 2016-06-30 0000875045 biib:InLicensedPatentsMember biib:ZINBRYTAMember 2016-01-01 2016-06-30 0000875045 biib:FumapharmAgMember biib:TecfideraMember 2016-01-01 2016-06-30 0000875045 biib:InLicensedPatentsMember biib:ALPROLIXMember 2016-06-30 0000875045 biib:OutLicensedPatentsMember 2016-06-30 0000875045 biib:InLicensedPatentsMember 2015-12-31 0000875045 biib:InLicensedPatentsMember 2016-06-30 0000875045 us-gaap:DevelopedTechnologyRightsMember 2015-12-31 0000875045 us-gaap:InProcessResearchAndDevelopmentMember 2015-12-31 0000875045 biib:OutLicensedPatentsMember 2015-12-31 0000875045 us-gaap:TrademarksAndTradeNamesMember 2015-12-31 0000875045 us-gaap:TrademarksAndTradeNamesMember 2016-06-30 0000875045 us-gaap:DevelopedTechnologyRightsMember 2016-06-30 0000875045 us-gaap:InProcessResearchAndDevelopmentMember 2016-06-30 0000875045 biib:InLicensedPatentsMember us-gaap:MinimumMember 2016-01-01 2016-06-30 0000875045 us-gaap:DevelopedTechnologyRightsMember us-gaap:MinimumMember 2016-01-01 2016-06-30 0000875045 biib:InLicensedPatentsMember us-gaap:MaximumMember 2016-01-01 2016-06-30 0000875045 us-gaap:InProcessResearchAndDevelopmentMember 2016-01-01 2016-06-30 0000875045 us-gaap:TrademarksAndTradeNamesMember 2016-01-01 2016-06-30 0000875045 biib:OutLicensedPatentsMember us-gaap:MaximumMember 2016-01-01 2016-06-30 0000875045 biib:OutLicensedPatentsMember us-gaap:MinimumMember 2016-01-01 2016-06-30 0000875045 us-gaap:DevelopedTechnologyRightsMember us-gaap:MaximumMember 2016-01-01 2016-06-30 0000875045 us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0000875045 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0000875045 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0000875045 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0000875045 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0000875045 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0000875045 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0000875045 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0000875045 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0000875045 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0000875045 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0000875045 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0000875045 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0000875045 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0000875045 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0000875045 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2016-06-30 0000875045 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0000875045 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0000875045 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0000875045 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0000875045 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0000875045 us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0000875045 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0000875045 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0000875045 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0000875045 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0000875045 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0000875045 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0000875045 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0000875045 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0000875045 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0000875045 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueMeasurementsRecurringMember 2015-12-31 0000875045 biib:SeniorNotesFourPointZeroFivePercentDueTwentyTwentyFiveMember 2016-06-30 0000875045 biib:SeniorNotesThreePointSixTwoFivePercentDueTwentyTwentyTwoMember 2015-12-31 0000875045 biib:SeniorNotesFivePointTwoPercentDueTwentyFortyFiveMember 2015-12-31 0000875045 biib:SeniorNotesThreePointSixTwoFivePercentDueTwentyTwentyTwoMember 2016-06-30 0000875045 biib:NotesPayableToFumedicaMember 2015-12-31 0000875045 biib:SeniorNotesTwoPointNinePercentDueTwentyTwentyMember 2015-12-31 0000875045 biib:SeniorNotesTwoPointNinePercentDueTwentyTwentyMember 2016-06-30 0000875045 biib:SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember 2015-12-31 0000875045 biib:SeniorNotesFourPointZeroFivePercentDueTwentyTwentyFiveMember 2015-12-31 0000875045 biib:SeniorNotesSixPointEightSevenFivePercentDueTwentyEighteenMember 2016-06-30 0000875045 biib:NotesPayableToFumedicaMember 2016-06-30 0000875045 biib:SeniorNotesFivePointTwoPercentDueTwentyFortyFiveMember 2016-06-30 0000875045 us-gaap:FairValueMeasurementsRecurringMember 2016-03-31 0000875045 us-gaap:FairValueMeasurementsRecurringMember 2015-06-30 0000875045 us-gaap:FairValueMeasurementsRecurringMember 2014-12-31 0000875045 us-gaap:FairValueMeasurementsRecurringMember 2015-03-31 0000875045 us-gaap:MoneyMarketFundsMember 2016-06-30 0000875045 us-gaap:CommercialPaperMember 2015-12-31 0000875045 us-gaap:CommercialPaperMember 2016-06-30 0000875045 us-gaap:RepurchaseAgreementsMember 2016-06-30 0000875045 us-gaap:RepurchaseAgreementsMember 2015-12-31 0000875045 us-gaap:DebtSecuritiesMember 2016-06-30 0000875045 us-gaap:MoneyMarketFundsMember 2015-12-31 0000875045 us-gaap:DebtSecuritiesMember 2015-12-31 0000875045 biib:MortgageAndOtherAssetBackedSecuritiesNonCurrentMember 2015-12-31 0000875045 us-gaap:EquitySecuritiesMember 2015-12-31 0000875045 biib:GovernmentSecuritiesNonCurrentMember 2015-12-31 0000875045 biib:CorporateDebtSecuritiesCurrentMember 2015-12-31 0000875045 biib:CorporateDebtSecuritiesNonCurrentMember 2015-12-31 0000875045 biib:MortgageAndOtherAssetBackedSecuritiesCurrentMember 2015-12-31 0000875045 biib:GovernmentSecuritiesCurrentMember 2015-12-31 0000875045 biib:GovernmentSecuritiesCurrentMember 2016-06-30 0000875045 biib:CorporateDebtSecuritiesNonCurrentMember 2016-06-30 0000875045 biib:GovernmentSecuritiesNonCurrentMember 2016-06-30 0000875045 biib:MortgageAndOtherAssetBackedSecuritiesCurrentMember 2016-06-30 0000875045 us-gaap:EquitySecuritiesMember 2016-06-30 0000875045 biib:MortgageAndOtherAssetBackedSecuritiesNonCurrentMember 2016-06-30 0000875045 biib:CorporateDebtSecuritiesCurrentMember 2016-06-30 0000875045 biib:StrategicInvestmentsMember 2015-12-31 0000875045 biib:StrategicInvestmentsMember 2016-06-30 0000875045 2015-01-01 2015-12-31 0000875045 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2016-06-30 0000875045 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2015-12-31 0000875045 us-gaap:OtherInvestmentsMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-06-30 0000875045 us-gaap:OtherInvestmentsMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-12-31 0000875045 us-gaap:AccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2015-12-31 0000875045 us-gaap:AccruedLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-12-31 0000875045 us-gaap:OtherCurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-06-30 0000875045 us-gaap:OtherCurrentAssetsMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-12-31 0000875045 us-gaap:AccruedLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-06-30 0000875045 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-12-31 0000875045 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2016-06-30 0000875045 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-06-30 0000875045 us-gaap:ForeignExchangeContractMember us-gaap:OperatingExpenseMember 2015-04-01 2015-06-30 0000875045 us-gaap:ForeignExchangeContractMember biib:CashflowsrevenueMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-04-01 2016-06-30 0000875045 us-gaap:ForeignExchangeContractMember us-gaap:OperatingExpenseMember 2016-04-01 2016-06-30 0000875045 us-gaap:ForeignExchangeContractMember biib:CashflowsoperatingexpensesMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-04-01 2016-06-30 0000875045 us-gaap:ForeignExchangeContractMember us-gaap:SalesMember 2016-04-01 2016-06-30 0000875045 us-gaap:ForeignExchangeContractMember biib:CashflowsrevenueMember us-gaap:OtherNonoperatingIncomeExpenseMember 2015-04-01 2015-06-30 0000875045 us-gaap:ForeignExchangeContractMember us-gaap:SalesMember 2015-04-01 2015-06-30 0000875045 us-gaap:ForeignExchangeContractMember biib:CashflowsoperatingexpensesMember us-gaap:OtherNonoperatingIncomeExpenseMember 2015-04-01 2015-06-30 0000875045 us-gaap:ForeignExchangeContractMember biib:CashflowsrevenueMember us-gaap:OtherNonoperatingIncomeExpenseMember 2015-01-01 2015-06-30 0000875045 us-gaap:ForeignExchangeContractMember biib:CashflowsoperatingexpensesMember us-gaap:OtherNonoperatingIncomeExpenseMember 2015-01-01 2015-06-30 0000875045 us-gaap:ForeignExchangeContractMember biib:CashflowsoperatingexpensesMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-06-30 0000875045 us-gaap:ForeignExchangeContractMember us-gaap:SalesMember 2015-01-01 2015-06-30 0000875045 us-gaap:ForeignExchangeContractMember us-gaap:OperatingExpenseMember 2015-01-01 2015-06-30 0000875045 us-gaap:ForeignExchangeContractMember us-gaap:SalesMember 2016-01-01 2016-06-30 0000875045 us-gaap:ForeignExchangeContractMember biib:CashflowsrevenueMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-06-30 0000875045 us-gaap:ForeignExchangeContractMember us-gaap:OperatingExpenseMember 2016-01-01 2016-06-30 0000875045 us-gaap:MaximumMember 2016-01-01 2016-06-30 0000875045 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-06-30 0000875045 us-gaap:MinimumMember 2016-01-01 2016-06-30 0000875045 us-gaap:NondesignatedMember 2016-06-30 0000875045 us-gaap:NondesignatedMember 2015-12-31 0000875045 currency:EUR us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-06-30 0000875045 currency:CHF us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-12-31 0000875045 currency:EUR us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-12-31 0000875045 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-12-31 0000875045 currency:CAD us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-06-30 0000875045 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-06-30 0000875045 currency:CAD us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2015-12-31 0000875045 currency:CHF us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-06-30 0000875045 us-gaap:MinimumMember 2015-01-01 2015-12-31 0000875045 us-gaap:MaximumMember 2015-01-01 2015-12-31 0000875045 biib:CambridgeMAMember 2016-06-30 0000875045 biib:SolothurnSwitzerlandMember us-gaap:LandMember 2015-10-01 2015-12-31 0000875045 biib:SolothurnSwitzerlandMember 2016-06-30 0000875045 biib:SolothurnSwitzerlandMember 2015-12-31 0000875045 biib:CambridgeMAMember 2016-04-01 2016-06-30 0000875045 2015-03-31 0000875045 2016-03-31 0000875045 us-gaap:SubsequentEventMember 2016-07-18 0000875045 2015-05-31 0000875045 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2015-01-01 2015-06-30 0000875045 us-gaap:AccumulatedTranslationAdjustmentMember 2015-01-01 2015-06-30 0000875045 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2015-01-01 2015-06-30 0000875045 us-gaap:AccumulatedTranslationAdjustmentMember 2014-12-31 0000875045 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2015-06-30 0000875045 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2014-12-31 0000875045 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2014-12-31 0000875045 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2015-01-01 2015-06-30 0000875045 us-gaap:AccumulatedTranslationAdjustmentMember 2015-06-30 0000875045 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2015-06-30 0000875045 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2014-12-31 0000875045 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2015-06-30 0000875045 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2015-01-01 2015-06-30 0000875045 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-01-01 2016-06-30 0000875045 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2015-04-01 2015-06-30 0000875045 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-04-01 2016-06-30 0000875045 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-04-01 2016-06-30 0000875045 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2015-01-01 2015-06-30 0000875045 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2015-04-01 2015-06-30 0000875045 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-06-30 0000875045 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-04-01 2016-06-30 0000875045 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-01-01 2016-06-30 0000875045 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2015-04-01 2015-06-30 0000875045 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2015-01-01 2015-06-30 0000875045 us-gaap:AccumulatedTranslationAdjustmentMember 2016-01-01 2016-06-30 0000875045 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-06-30 0000875045 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2016-01-01 2016-06-30 0000875045 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-01-01 2016-06-30 0000875045 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2015-12-31 0000875045 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-01-01 2016-06-30 0000875045 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2015-12-31 0000875045 us-gaap:AccumulatedTranslationAdjustmentMember 2015-12-31 0000875045 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-06-30 0000875045 us-gaap:AccumulatedTranslationAdjustmentMember 2016-06-30 0000875045 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2015-12-31 0000875045 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2016-06-30 0000875045 biib:StockOptionsAndEmployeeStockPurchasePlanMember 2015-01-01 2015-06-30 0000875045 biib:StockOptionsAndEmployeeStockPurchasePlanMember 2015-04-01 2015-06-30 0000875045 biib:TimeVestedRestrictedStockUnitsMember 2016-04-01 2016-06-30 0000875045 biib:TimeVestedRestrictedStockUnitsMember 2015-01-01 2015-06-30 0000875045 biib:MarketStockUnitsMember 2016-04-01 2016-06-30 0000875045 biib:MarketStockUnitsMember 2016-01-01 2016-06-30 0000875045 biib:StockOptionsAndEmployeeStockPurchasePlanMember 2016-01-01 2016-06-30 0000875045 biib:MarketStockUnitsMember 2015-01-01 2015-06-30 0000875045 biib:TimeVestedRestrictedStockUnitsMember 2016-01-01 2016-06-30 0000875045 biib:TimeVestedRestrictedStockUnitsMember 2015-04-01 2015-06-30 0000875045 biib:StockOptionsAndEmployeeStockPurchasePlanMember 2016-04-01 2016-06-30 0000875045 biib:MarketStockUnitsMember 2015-04-01 2015-06-30 0000875045 biib:TimeVestedRestrictedStockUnitsMember 2015-01-01 2015-06-30 0000875045 us-gaap:PerformanceSharesMember 2015-01-01 2015-06-30 0000875045 biib:MarketStockUnitsMember 2016-01-01 2016-06-30 0000875045 us-gaap:PerformanceSharesMember 2016-01-01 2016-06-30 0000875045 biib:MarketStockUnitsMember 2015-01-01 2015-06-30 0000875045 biib:TimeVestedRestrictedStockUnitsMember 2016-01-01 2016-06-30 0000875045 biib:CashSettledPerformanceSharesMember 2015-01-01 2015-06-30 0000875045 biib:CashSettledPerformanceSharesMember 2016-01-01 2016-06-30 0000875045 us-gaap:PerformanceSharesMember 2016-04-01 2016-06-30 0000875045 biib:MarketStockUnitsMember 2015-04-01 2015-06-30 0000875045 biib:CashSettledPerformanceSharesMember 2016-04-01 2016-06-30 0000875045 biib:EmployeeStockPurchasePlanMember 2015-04-01 2015-06-30 0000875045 biib:TimeVestedRestrictedStockUnitsMember 2016-04-01 2016-06-30 0000875045 biib:EmployeeStockPurchasePlanMember 2015-01-01 2015-06-30 0000875045 biib:MarketStockUnitsMember 2016-04-01 2016-06-30 0000875045 biib:TimeVestedRestrictedStockUnitsMember 2015-04-01 2015-06-30 0000875045 us-gaap:PerformanceSharesMember 2015-04-01 2015-06-30 0000875045 biib:EmployeeStockPurchasePlanMember 2016-01-01 2016-06-30 0000875045 biib:EmployeeStockPurchasePlanMember 2016-04-01 2016-06-30 0000875045 biib:CashSettledPerformanceSharesMember 2015-04-01 2015-06-30 0000875045 biib:A1995ESPPMember 2015-01-01 2015-06-30 0000875045 biib:A2015ESPPMember 2016-01-01 2016-06-30 0000875045 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2015-01-01 2015-06-30 0000875045 us-gaap:RestructuringChargesMember 2015-04-01 2015-06-30 0000875045 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-04-01 2016-06-30 0000875045 us-gaap:ParentMember 2016-01-01 2016-06-30 0000875045 us-gaap:ResearchAndDevelopmentExpenseMember 2015-04-01 2015-06-30 0000875045 us-gaap:RestructuringChargesMember 2016-04-01 2016-06-30 0000875045 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2015-04-01 2015-06-30 0000875045 us-gaap:RestructuringChargesMember 2016-01-01 2016-06-30 0000875045 us-gaap:ParentMember 2015-04-01 2015-06-30 0000875045 us-gaap:ParentMember 2016-04-01 2016-06-30 0000875045 us-gaap:ResearchAndDevelopmentExpenseMember 2016-04-01 2016-06-30 0000875045 us-gaap:ResearchAndDevelopmentExpenseMember 2015-01-01 2015-06-30 0000875045 us-gaap:ParentMember 2015-01-01 2015-06-30 0000875045 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-01-01 2016-06-30 0000875045 us-gaap:ResearchAndDevelopmentExpenseMember 2016-01-01 2016-06-30 0000875045 us-gaap:RestructuringChargesMember 2015-01-01 2015-06-30 0000875045 us-gaap:ForeignCountryMember 2016-06-30 0000875045 us-gaap:TaxYear2009Member 2011-10-01 2011-10-31 0000875045 us-gaap:ForeignCountryMember 2016-01-01 2016-06-30 0000875045 us-gaap:TaxYear2007Member 2011-10-01 2011-10-31 0000875045 us-gaap:TaxYear2008Member 2011-10-01 2011-10-31 0000875045 country:IT 2016-06-30 0000875045 country:IT 2014-04-01 2014-06-30 0000875045 biib:NeurimmuneMember 2016-01-01 2016-06-30 0000875045 biib:OtherVariableInterestEntitiesMember 2016-06-30 0000875045 biib:BiogenRateToSobiOnNetSalesInBiogenNorthAmericaTerritoryMember 2016-01-01 2016-06-30 0000875045 biib:BiogenRateToSobiOnNetSalesInBiogenDirectTerritoryMember 2016-01-01 2016-06-30 0000875045 biib:BiogenRateToSobiOnNetRevenueFromBiogenDistributorTerritoryMember 2016-01-01 2016-06-30 0000875045 biib:BiogenRateToSobiOnNetSalesInBiogenNorthAmericaTerritoryMember biib:SobiTerritoryMember 2016-01-01 2016-06-30 0000875045 biib:SobiRateToBiogenOnNetSalesInSobiTerritoryMember 2016-01-01 2016-06-30 0000875045 biib:BiogenRateToSobiOnNetSalesInBiogenDirectTerritoryMember biib:SobiTerritoryMember 2016-01-01 2016-06-30 0000875045 biib:BiogenRateToSobiOnNetRevenueFromBiogenDistributorTerritoryMember biib:SobiTerritoryMember 2016-01-01 2016-06-30 0000875045 biib:SamsungBiosimilarAgreementMember 2013-10-01 2013-12-31 0000875045 biib:SamsungBiosimilarAgreementMember 2012-02-29 0000875045 biib:SamsungBiosimilarAgreementMember 2015-01-01 2015-06-30 0000875045 biib:SamsungBiosimilarAgreementMember 2016-01-01 2016-06-30 0000875045 biib:SwedishOrphanBiovitrumMember 2016-01-01 2016-06-30 0000875045 biib:SamsungBiosimilarAgreementMember 2012-02-01 2012-02-29 0000875045 biib:SamsungBiosimilarAgreementMember 2015-04-01 2015-06-30 0000875045 biib:ALPROLIXMember biib:SwedishOrphanBiovitrumMember 2016-01-01 2016-06-30 0000875045 biib:SamsungBiosimilarAgreementMember 2016-04-01 2016-06-30 0000875045 biib:InLicensedPatentsMember biib:BiosimilarsMember 2016-04-01 2016-06-30 0000875045 biib:UniversityofPennsylvaniaMember 2016-04-01 2016-06-30 0000875045 biib:BiogenIdecHemophiliaMember 2007-01-31 0000875045 biib:UniversityofPennsylvaniaMember 2016-06-30 0000875045 biib:SamsungBiosimilarAgreementMember 2016-06-30 0000875045 biib:ELOCTATEMember biib:SwedishOrphanBiovitrumMember 2016-01-01 2016-06-30 0000875045 biib:SevenbillionMember biib:FumapharmAgMember 2016-06-30 0000875045 country:CH 2016-06-30 0000875045 biib:ThreeBillionMember biib:FumapharmAgMember 2016-06-30 0000875045 biib:EachAdditionalOneBillionUpToTwentyBillionMember biib:FumapharmAgMember 2016-06-30 0000875045 biib:FumapharmAgMember 2016-01-01 2016-06-30 0000875045 biib:FumapharmAgMember biib:TecfideraMember 2013-06-30 0000875045 biib:EightbillionMember biib:FumapharmAgMember 2016-06-30 0000875045 biib:NinebillionMember biib:FumapharmAgMember 2016-06-30 0000875045 biib:NinebillionMember biib:FumapharmAgMember 2016-01-01 2016-06-30 0000875045 biib:FumapharmAgMember 2006-01-01 2006-12-31 0000875045 biib:OneBillionMember biib:FumapharmAgMember 2016-06-30 biib:segment iso4217:CHF iso4217:USD xbrli:pure xbrli:shares iso4217:USD xbrli:shares iso4217:EUR iso4217:KRW 6300000 -1600000 2400000 5500000 185300000 221800000 184500000 221700000 P16M P13M 0.5 0.17 0.12 0.12 0 0 -5600000 -5600000 20000000000 8000000000 9000000000 1000000000 7000000000 3000000000 1258200000 973800000 266800000 17600000 314500000 334100000 -0.021 -0.018 -0.016 -0.017 6200000 0.499 0.5 47500000 Indefinite until commercialization Indefinite 1.00 933600000 1028700000 29200000 38000000 280500000000 250000000 0.85 20000000 200000 200000 0 0 0.007 0.003 816000000 605100000 210200000 700000 446800000 384900000 51500000 10400000 0 40100000 0 40100000 0 35600000 0 35600000 2000000000 18400000 24200000 24700000 130000000 130000000 130000000 Base Rate less 15% Base Rate less 5% Base Rate less 5% Base Rate plus 5% P6Y P24M Net Revenue Share Royalty Royalty Royalty P10Y 275000000 1 120000000 0.11 337500000 668100000 349200000 678700000 46100000 133700000 45800000 97000000 96000000 98300000 P90D 1800000 16400000 false --12-31 Q2 2016 2016-06-30 10-Q 0000875045 219120762 Large Accelerated Filer BIOGEN INC. 76700000 80800000 945500000 1103000000 721000000 39900000 43500000 1126500000 1209900000 675000000 557200000 267400000 225900000 1227000000 1293000000 167900000 183700000 1330100000 1471000000 -59500000 -31600000 71700000 -400000 -99200000 -101000000 -27500000 62800000 700000 -137000000 -224000000 -37800000 10200000 -800000 -195600000 -282800000 -36900000 -8100000 6200000 -244000000 0 69100000 3200000 3000000 9100000 31800000 1200000 33200000 22100000 0 26200000 27000000 8100000 26100000 63700000 14400000 94100000 57500000 0 81800000 4600000 2500000 7900000 33900000 1300000 33100000 21500000 0 28700000 4800000 6200000 21300000 64000000 8200000 69100000 42900000 1800000 63400000 48300000 139300000 50200000 104500000 92000000 187900000 92900000 181700000 0 19504800000 21514800000 6700300000 7447700000 37500000 5857700000 0 5895200000 32400000 6852700000 0 6885100000 4891200000 5901300000 4880900000 0 494100000 0 494100000 0 1510900000 0 1510900000 0 2875900000 0 2875900000 394300000 1116600000 1723400000 1152500000 2800000 491300000 37500000 5912400000 0 648700000 0 648700000 0 2290300000 0 2290300000 0 2973400000 0 2973400000 913400000 1376900000 1521300000 1452100000 100000 648600000 32400000 300000 0 100000 100000 0 0 100000 9200000 13200000 300000 7800000 600000 3100000 0 1400000 900000 10600000 500000 4100000 1100000 3100000 0 1800000 0 2100000 200000 400000 0 600000 0 900000 2100000 4891200000 394800000 1120600000 1724400000 1155600000 2800000 493000000 28300000 5901300000 913300000 1369500000 1520700000 1449600000 100000 648100000 33600000 2120500000 2434800000 2583900000 3245400000 2575900000 3255900000 2122000000 2434100000 2120500000 2434800000 300000 500000 600000 1000000 500000 800000 1200000 1600000 2760400000 3477600000 1 15000000 215500000 461800000 495600000 0 0 506000000 506000000 508300000 0 0 515700000 515700000 504700000 556700000 301300000 304000000 1204900000 1282100000 1308000000 1362000000 0 909500000 0 909500000 0 874600000 0 874600000 101400000 53900000 909500000 21900000 79100000 673800000 134700000 874600000 56900000 219900000 531500000 66300000 0.0005 0.0005 100000 100000 896800000 1708300000 1026300000 1961900000 2300000 4500000 1400000 3100000 894500000 1703700000 1024900000 1958800000 99000000 247800000 26300000 286100000 598600000 370300000 683300000 1358500000 2795600000 1433700000 2782100000 4800000 4800000 6645900000 7110900000 0.052 0.0405 0.06875 0.03625 0.029 75000000 -90600000 -30200000 6500000 124900000 105600000 292500000 325100000 10300000 16600000 300000 4500000 2000000 23600000 2000000 10200000 2500000 10000000 14800000 0 0 40400000 0 75400000 -100000 -4300000 -200000 4500000 0 1200000 0 3400000 0 2100000 -300000 4000000 P18M P1M P18M P1M 3.94 7.44 4.79 9.23 3.93 7.42 4.79 9.21 -24200000 100000 0.239 0.247 0.252 0.260 0.35 0.350 0.35 0.350 -0.111 -0.098 -0.100 -0.090 0.011 0.010 0.011 0.011 0.009 0.007 0.006 0.006 0.004 0.003 0.003 0.002 0.004 0.000 0.010 0.010 0.007 0.007 0.012 0.012 270800000 228400000 2200000 5600000 4400000 7500000 12900000 39600000 12700000 27900000 0.09 0.15 49500000000 45000000 69700000 9000000 2200000 -5600000 -10600000 -12900000 36000000 274500000 0 0 0 0 3200000 3200000 0 P18Y P6Y P23Y P13Y P23Y P15Y 3561200000 502300000 506000000 2552900000 0 0 3742700000 623300000 514900000 2604500000 0 0 325100000 181600000 265000000 277100000 282700000 298200000 3303200000 543300000 3005300000 3405400000 543300000 3005300000 2800900000 37300000 452400000 2633400000 2782100000 28400000 400800000 392800000 25000000 26500000 50000000 20000000 0 27200000 0 27200000 0 30100000 0 30100000 0 14700000 0 14700000 0 24800000 0 24800000 -1500000 -14500000 200000 2300000 13600000 3900000 18600000 16200000 300000 -1400000 -2700000 -1100000 2663800000 3167100000 515000000 600000000 0 -11700000 1222200000 2325100000 1402000000 2727600000 -4900000 -4900000 -5700000 -5700000 0 0 66900000 292500000 -200000 100000 574400000 -400000 100000 353600000 100000 200000 710000000 85000000 0 200000 38900000 65000000 102000000 -151700000 -169900000 -162300000 81300000 128300000 66400000 -50100000 100000 100000 200000 200000 100000 300000 100000 100000 100000 100000 100000 100000 730500000 64000000 692300000 64000000 7646300000 7710300000 4085100000 3967600000 5800000 12500000 65900000 129200000 143000000 139100000 893400000 996400000 40200000 32300000 213000000 235000000 577600000 654600000 4300000 7600000 15400000 26600000 37500000 0 0 37500000 32400000 0 0 32400000 10129900000 10111100000 19504800000 21514800000 2577700000 2516200000 0 14700000 506000000 520700000 0 24800000 515700000 540500000 6521500000 6538300000 P18M 5000000 2700000 400000 2100000 1300000 -100000 77200000 34000000 -1756100000 -1939300000 1780300000 1959200000 927300000 40100000 1749800000 74800000 1049800000 -4700000 2020700000 4000000 -2500000 -4800000 -1400000 -3100000 0 0 0 900000 -10900000 0 -200000 -25900000 0 -300000 -58500000 0 -600000 -111300000 100000 -600000 6506500000 9000000 1721100000 1733400000 565300000 992200000 1485500000 6524000000 6100000 1721300000 1734100000 561900000 992700000 1507900000 9400000 1757600000 1764600000 602600000 1014200000 1497500000 6400000 1996300000 1887300000 598200000 1061000000 1561700000 1 0 0 100000 200000 1233100000 2351000000 1460500000 2838900000 635300000 613400000 836900000 1027400000 1107600000 1153000000 15000000 226000000 8000000 -200000 1100000 4500000 7000000 33300000 4100000 66100000 900000 -37800000 -54800000 900000 -13900000 6600000 -48400000 -96200000 -8900000 29300000 -18300000 63000000 -37800000 -58000000 -48400000 -30500000 -41500000 4100000 -8900000 1100000 -37800000 -23500000 -58800000 900000 -18300000 7000000 -48400000 -2900000 -4100000 -700000 -900000 2096800000 2072700000 905800000 951000000 5800000 -19800000 -8200000 -5100000 -5500000 -9900000 55600000 17200000 107600000 36100000 79000000 14200000 166900000 16900000 13000000 10100000 65900000 42200000 0 34700000 6000000 28700000 2045000000 3833300000 220000000 300000000 600000000 198800000 0 250000000 600000000 227700000 263700000 0.001 0.001 0 0 550600000 704100000 34700000 23900000 15000000 1100000 601900000 975500000 1642500000 2823600000 924800000 1745000000 1048400000 2017600000 64400000 62500000 2187600000 2301800000 43000000 -74800000 0 -75000000 200000 0 -4000000 0 -4400000 400000 0 46000000 490700000 951300000 473100000 20000000 910400000 130000000 157000000 105000000 0 0 93400000 0 9700000 10300000 5400000 4900000 37300000 3600000 33700000 12300000 5900000 6400000 15800000 15900000 -600000 2900000 -3500000 12208400000 14229100000 2591600000 5146600000 2894200000 5621000000 53500000 2198600000 40400000 4370900000 75400000 2466000000 4300000 4775400000 4500000 491900000 1052300000 492400000 989700000 93700000 84100000 115000 179000 375000 89000 86000 166000 594000 56000 98000 109000 5000000000 5000000000 1300000 9372800000 11403800000 9374900000 11403700000 2028800000 208700000 212800000 100000 2611700000 2611700000 24000000 662700000 144600000 518100000 548700000 56100000 57900000 651800000 161300000 490500000 534100000 58800000 58900000 400000 600000 300000 300000 235700000 235700000 219400000 219300000 235300000 235100000 219100000 219000000 <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">An analysis of the change in reserves for discounts and allowances is summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Discounts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Contractual</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Returns</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">56.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">548.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">57.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">662.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current provisions relating to sales in current year</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">266.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">973.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">17.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,258.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Adjustments relating to prior years</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(5.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(6.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Payments/credits relating to sales in current year</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(210.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(605.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(816.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Payments/credits relating to sales in prior years</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(51.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(384.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(10.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(446.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of June 30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">58.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">534.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">58.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">651.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Biogen is a global biopharmaceutical company focused on discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological diseases, autoimmune disorders and rare diseases.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our marketed products include TECFIDERA, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for multiple sclerosis (MS), ELOCTATE for hemophilia A and ALPROLIX for hemophilia B and FUMADERM for the treatment of severe plaque psoriasis. We also have a collaboration agreement with Genentech, Inc. (Genentech), a wholly-owned member of the Roche Group, which entitles us to certain business and financial rights with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other potential anti-CD20 therapies.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In addition to our innovative drug development efforts, we aim to leverage our manufacturing capabilities and scientific expertise through Samsung Bioepis, our joint venture with Samsung BioLogics Co. Ltd. (Samsung Biologics) that develops, manufactures and markets biosimilars as well as through other strategic contract manufacturing partners. Under our commercial agreement with Samsung Bioepis, we market and sell BENEPALI, an etanercept biosimilar referencing ENBREL, and FLIXABI, an infliximab biosimilar referencing REMICADE, in the European Union (E.U.).</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In May 2016, we announced our intention to spin off our hemophilia business as an independent, publicly traded company. The new company will focus on the discovery and development of therapies for the treatment of hemophilia and other blood disorders, with existing marketed products ELOCTATE and ALPROLIX.&#160;The transaction is expected to be completed in early 2017, subject to the satisfaction of certain conditions, including, among others, final approval of our Board of Directors, receipt of a favorable opinion with respect to the tax-free nature of the transaction and the effectiveness of a Form 10 registration statement that will be filed with the Securities and Exchange Commission. The results of our hemophilia business will be included in our condensed consolidated financial statements until the transaction is completed.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Intangible assets, net of accumulated amortization, impairment charges and adjustments, are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="26" rowspan="1"></td></tr><tr><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of June 30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Estimated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Life</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Out-licensed patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">13-23 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">543.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(514.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">28.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">543.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(506.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">37.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Developed&#160;</font></div><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">15-23&#160;years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,005.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2,604.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">400.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3,005.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2,552.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">452.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In-process research and development</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Indefinite until commercialization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">692.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">692.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">730.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">730.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Trademarks&#160;and&#160;</font></div><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">tradenames</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Indefinite</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">64.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">64.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">64.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">64.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired and in-licensed&#160;rights&#160;</font></div><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">and&#160;patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6-18 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,405.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(623.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,782.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3,303.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(502.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,800.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7,710.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(3,742.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,967.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">7,646.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3,561.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4,085.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table reconciles equity (deficit) attributable to noncontrolling interests (NCI):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">NCI, beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss) attributable to NCI, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(3.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(4.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of net assets and liabilities acquired and assigned to NCI</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Translation adjustment and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">NCI, end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We expect to recognize the effect of the cash reimbursement as an adjustment to the Base Rate in the table below over a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">ten</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> year period, consistent with the initial patent term of the products. Under the collaboration agreement, cash payments are as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Rates post Sobi Opt-In</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(3)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Royalty and Net Revenue Share Rates:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Method</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Base Rate following</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">1st&#160;commercial&#160;sale&#160;in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">the Sobi Territory:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Rate during the</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Reimbursement</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Period:</font></div></td></tr><tr><td style="vertical-align:top;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Sobi rate to Biogen on net sales in the Sobi Territory</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Royalty</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">12%</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Base&#160;Rate<br clear="none"/>plus 5%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Biogen rate to Sobi on net sales in the Biogen North America Territory</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Royalty</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">12%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Base Rate<br clear="none"/>less 5%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Biogen rate to Sobi on net sales in the Biogen Direct Territory</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Royalty</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">17%</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Base Rate<br clear="none"/>less 5%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Biogen rate to Sobi on net revenue</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">&#160;</font></div><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">from the Biogen Distributor Territory</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Net<br clear="none"/>Revenue<br clear="none"/>Share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">50%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Base Rate<br clear="none"/>less 15%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes our equity grants to employees, officers and directors under our current stock plans:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Market stock units</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">166,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">179,000</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash settled performance shares</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">86,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">115,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Performance units</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">56,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">89,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Time-vested restricted stock units</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">594,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">375,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The total reserves above, included in our condensed consolidated balance sheets, are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Reduction of accounts receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">161.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">144.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Component of accrued expenses and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">490.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">518.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total reserves</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">651.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">662.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Other Consolidated Financial Statement Detail</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Other Income (Expense), Net</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Components of other income (expense), net, are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">15.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">26.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">7.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(65.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(129.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(12.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gain (loss) on investments, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Foreign exchange gains (losses), net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(14.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(5.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(8.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(9.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total other income (expense), net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(58.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(10.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(111.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(25.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Other Current Assets</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets includes prepaid taxes totaling approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$704.1 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$550.6 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Accrued Expenses and Other</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other consists of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current portion of contingent consideration obligations and milestones</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">556.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">504.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue-related reserves for discounts and allowances</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">490.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">518.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee compensation and benefits</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">228.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">270.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Royalties and licensing fees</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">183.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">167.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">613.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">635.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total accrued expenses and other</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,072.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,096.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#538235;font-style:italic;">Pricing of TYSABRI in Italy - AIFA</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In the fourth quarter of 2011, Biogen Italia SRL, our Italian subsidiary,&#160;received a notice from the Italian National Medicines Agency (Agenzia Italiana del Farmaco or AIFA) that sales of TYSABRI after mid-February 2009 exceeded a reimbursement limit established pursuant to a Price Determination Resolution (Price Resolution) granted by AIFA in December 2006. In January 2012, we filed an appeal in the Regional Administrative Tribunal of Lazio (Il Tribunale Amministrativo Regionale per il Lazio) in Rome, Italy seeking a ruling that the reimbursement limit in the Price Resolution should apply as written to only "the first </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">24</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months" of TYSABRI sales, which ended in mid-February 2009. That appeal is still pending. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In June 2014, AIFA approved a resolution affirming that there is no reimbursement limit from and after February 2013. As a result, we recognized </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$53.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> of TYSABRI revenues related to the periods beginning February 2013 that were previously deferred. AIFA and Biogen Italia SRL are still discussing a possible resolution for the period from February 2009 through January 2013. We have approximately EUR</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">75 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> recorded as accrued expenses and deferred revenue both included in our long-term liabilities in our condensed consolidated balance sheet for this matter as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For additional information relating to our agreement with AIFA relating to sales of TYSABRI in Italy, please read Note 17, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Other Consolidated Financial Statement Detail</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to our consolidated financial statements included in our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form 10-K.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following tables summarize our marketable debt and equity securities, classified as available-for-sale:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of June 30, 2016 (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">913.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">913.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,376.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,369.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Government securities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,521.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,520.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,452.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,449.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Mortgage and other asset backed securities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">648.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">648.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total marketable debt securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5,912.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">13.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5,901.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable equity securities, non-current</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">32.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">33.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2015 (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">394.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">394.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,116.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(4.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,120.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Government securities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,723.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,724.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,152.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,155.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Mortgage and other asset backed securities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">491.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">493.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total marketable debt securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4,880.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(10.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4,891.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable equity securities, non-current</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">37.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">28.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring accruals, necessary for a fair statement of our financial statements for interim periods in accordance with accounting principles generally accepted in the United States (U.S.&#160;GAAP). The information included in this quarterly report on Form&#160;10-Q should be read in conjunction with our consolidated financial statements and the accompanying notes included in our Annual Report on Form&#160;10-K for the year ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> (</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form&#160;10-K). Our accounting policies are described in the &#8220;</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Notes to Consolidated Financial Statements</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8221; in our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form&#160;10-K and updated, as necessary, in this Form&#160;10-Q. The year-end condensed consolidated balance sheet data presented for comparative purposes was derived from our audited financial statements, but does not include all disclosures required by U.S.&#160;GAAP. The results of operations for the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, are not necessarily indicative of the operating results for the full year or for any other subsequent interim period. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We operate as </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">one</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> operating segment, which is discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological diseases, autoimmune disorders and rare diseases.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Financial Instruments</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes our financial assets with maturities of less than 90&#160;days from the date of purchase included in cash and cash equivalents on the accompanying condensed consolidated balance sheet:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Commercial paper</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">56.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">21.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Overnight reverse repurchase agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">66.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">134.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Money market funds</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">531.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">673.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Short-term debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">219.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">79.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">874.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">909.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The carrying values of our commercial paper, including accrued interest, overnight reverse repurchase agreements, money market funds and our short-term debt securities approximate fair value due to their short-term maturities. Our overnight reverse repurchase agreements are collateralized with agency-guaranteed mortgage-backed securities and represent approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.7%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> of total assets as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following tables summarize our marketable debt and equity securities, classified as available-for-sale:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of June 30, 2016 (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">913.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">913.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,376.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,369.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Government securities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,521.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,520.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,452.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,449.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Mortgage and other asset backed securities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">648.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">648.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total marketable debt securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5,912.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">13.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5,901.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable equity securities, non-current</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">32.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">33.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2015 (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">394.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">394.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,116.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(4.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,120.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Government securities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,723.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,724.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,152.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,155.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Mortgage and other asset backed securities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Non-current</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">491.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">493.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total marketable debt securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4,880.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(10.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4,891.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable equity securities, non-current</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">37.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">28.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Summary of Contractual Maturities: Available-for-Sale Securities</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The estimated fair value and amortized cost of our marketable debt securities available-for-sale by contractual maturity are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of June 30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Estimated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Estimated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Due in one year or less</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,434.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,434.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,120.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,122.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Due after one year through five years</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,255.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,245.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,575.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,583.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Due after five years</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">221.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">221.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">184.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">185.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total available-for-sale securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5,912.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5,901.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4,880.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4,891.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The average maturity of our marketable debt securities available-for-sale as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> was approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">13 months</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">16 months</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Proceeds from Marketable Debt Securities</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The proceeds from maturities and sales of marketable debt securities and resulting realized gains and losses are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Proceeds from maturities and sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,642.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">601.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,823.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">975.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Realized gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Realized losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Strategic Investments</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, our strategic investment portfolio was comprised of investments totaling </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$98.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$96.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, which are included in investments and other assets in our condensed consolidated balance sheets. Our strategic investment portfolio includes investments in equity securities of certain biotechnology companies and investments in venture capital funds where the underlying investments are in equity securities of biotechnology companies.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Collaborative and Other Relationships</font></div><div style="line-height:120%;padding-top:6px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">University of Pennsylvania</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In May 2016, we entered into a&#160;collaboration&#160;and alliance&#160;with the&#160;University&#160;of Pennsylvania (Penn) to advance gene therapy and gene editing technologies. The collaboration will primarily focus on the development of therapeutic approaches that target the eye, skeletal muscle and the central nervous system. The alliance is also expected to focus on the research and validation of next-generation gene transfer technology using adeno-associated virus gene delivery vectors and exploring the expanded use of genome editing technology as a potential therapeutic platform.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">During the second quarter of 2016, we paid Penn an upfront amount of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$20.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, which was recorded as research and development expense in our condensed consolidated statements of income, and prepaid research and development expenditures of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$15.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, which was recorded in investments and other assets in our condensed consolidated balance sheets. We also expect to fund an additional </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$47.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> in the aggregate in research and development costs extending over the next three to five years in seven preclinical research and development programs, as well as the exploration of genome-editing technology. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">If all of the collaboration programs are successful and we exercise all of our options under the Penn collaboration and alliance, we may be required to make future payments of over </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$2.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> in research funding, options and milestone payments, in addition to royalties payable on net sales of products.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Swedish Orphan Biovitrum AB</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In January 2007, we acquired </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">100%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> of the stock of Syntonix. Syntonix had previously entered into a collaboration agreement with Swedish Orphan Biovitrum AB (publ) (Sobi) to jointly develop and commercialize Factor VIII and Factor IX hemophilia products, including ELOCTATE and ALPROLIX. Under an amended and restated collaboration agreement, we have commercial rights for North America (the Biogen North America Territory) and for rest of the world markets outside of the Sobi Territory, as defined below (the Biogen Direct Territory).&#160;Following its exercise of an option right, Sobi has assumed commercialization rights for ELOCTA, the trade name for ELOCTATE, and ALPROLIX, in substantially all of Europe, Northern Africa, Russia and certain countries in the Middle East (the Sobi Territory). For additional information on our collaboration agreement with Sobi, please read Note&#160;19, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Collaborative and Other Relationships</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to our consolidated financial statements included in our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form 10-K.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Sobi had its first commercial sale of ELOCTA in January 2016. In March 2016, the EC approved the transfer of the marketing authorization for ELOCTA from Biogen to Sobi, making Sobi the marketing authorization holder of ELOCTA in the E.U. As the marketing authorization holder, Sobi assumes full legal responsibility for ELOCTA, from a regulatory perspective, during its entire life cycle in the E.U. As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$157.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> in expenditures for ELOCTA, net of an escrow payment and other royalty adjustments as described in the table and its footnote (3) below, are reimbursable to us by Sobi under our collaboration agreement due to Sobi's election to assume final development and commercialization of ELOCTA in the Sobi Territory, which is the Opt-In Consideration for ELOCTA. This reimbursement will be recognized by us as royalty revenue in proportion to collaboration revenues, over a ten year period, consistent with the initial patent term of the product.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">ALPROLIX was approved in the E.U. by the EC in May 2016 and Sobi had its first commercial sale in June 2016. As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$130.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> in expenditures for ALPROLIX, net of an escrow payment and other royalty adjustments as described in the table and its footnote (3) below, are reimbursable to us by Sobi under our collaboration agreement due to Sobi's election to assume final development and commercialization of ALPROLIX in the Sobi Territory, which is the Opt-In Consideration for ALPROLIX. This reimbursement will be recognized by us as royalty revenue in proportion to collaboration revenues, over a ten year period, consistent with the initial patent term of the product. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We expect to recognize the effect of the cash reimbursement as an adjustment to the Base Rate in the table below over a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">ten</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> year period, consistent with the initial patent term of the products. Under the collaboration agreement, cash payments are as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Rates post Sobi Opt-In</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(3)</sup></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Royalty and Net Revenue Share Rates:</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Method</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Base Rate following</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">1st&#160;commercial&#160;sale&#160;in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">the Sobi Territory:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Rate during the</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Reimbursement</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Period:</font></div></td></tr><tr><td style="vertical-align:top;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Sobi rate to Biogen on net sales in the Sobi Territory</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Royalty</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">12%</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Base&#160;Rate<br clear="none"/>plus 5%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Biogen rate to Sobi on net sales in the Biogen North America Territory</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Royalty</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">12%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Base Rate<br clear="none"/>less 5%</font></div></td></tr><tr><td style="vertical-align:top;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Biogen rate to Sobi on net sales in the Biogen Direct Territory</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Royalty</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">17%</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Base Rate<br clear="none"/>less 5%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Biogen rate to Sobi on net revenue</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">&#160;</font></div><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">from the Biogen Distributor Territory</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Net<br clear="none"/>Revenue<br clear="none"/>Share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">50%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">Base Rate<br clear="none"/>less 15%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:9pt;">Net revenue represents Biogen&#8217;s pre-tax receipts from third-party distributors, less expenses incurred by Biogen in the conduct of commercialization activities supporting the distributor activities.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:9pt;">The Biogen Distributor Territory represents Biogen territories where sales are derived utilizing a third-party distributor.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3)</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:9pt;">A credit will be issued to Sobi against its reimbursement of the Opt-in Consideration in an amount equal to the difference in the rate paid by Biogen to Sobi on sales in the Biogen territories for certain periods prior to the first commercial sale in the Sobi Territory versus the rate that otherwise would have been payable on such sales.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">If the reimbursement of the Opt-in Consideration has not been achieved within </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> years of the first commercial sale of such product, we maintain the right to require Sobi to pay any remaining balances due to us within </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">90</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> days of the six year anniversary date of the first commercial sale.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Samsung Bioepis</font></div><div style="line-height:120%;padding-top:6px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#538235;font-style:italic;">Joint Venture Agreement</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In February 2012, we entered into a joint venture agreement with Samsung BioLogics Co. Ltd. (Samsung Biologics), establishing an entity, Samsung Bioepis, to develop, manufacture and market biosimilar pharmaceuticals.&#160;Samsung Biologics contributed </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">280.5 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> South Korean won (approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$250.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">) for an </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">85%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> stake in Samsung Bioepis and we contributed approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">49.5 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> South Korean won (approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$45.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">) for the remaining </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">15%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> ownership interest.&#160;Under the joint venture agreement, we have no obligation to provide any additional funding and our ownership interest may be diluted due to financings in which we do not participate. As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, our ownership interest is approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, which reflects the effect of additional equity financings in which we did not participate. We maintain an option to purchase additional stock in Samsung Bioepis that would allow us to increase our ownership percentage up to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">49.9%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">.&#160;The exercise of this option is within our control and is based on paying for </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">49.9%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> of the total investment made by Samsung Biologics into Samsung Bioepis in excess of what we have already contributed under the agreement plus a rate that will represent their return on capital.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Based on our level of influence over Samsung Bioepis, we account for this investment under the equity method of accounting and we recognize our share of the results of operations related to our investment in Samsung Bioepis one quarter in arrears when the results of the entity become available, which is reflected as equity in loss of investee, net of tax in our condensed consolidated statements of income. During the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we recognized a loss on our investment of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$4.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$5.7 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively. During 2015, as our share of losses exceeded the carrying value of our investment, we suspended recognizing additional losses and will continue to do so unless we commit to providing additional funding. </font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#538235;font-style:italic;">Commercial Agreement</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In December 2013, pursuant to our rights under the joint venture agreement with Samsung Biologics, we entered into an agreement with Samsung Bioepis to commercialize, over a 10-year term, three anti-TNF biosimilar product candidates in Europe and in the case of one anti-TNF biosimilar, Japan.&#160;Under the terms of this agreement, we have made total upfront and milestone payments of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$46.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, which have been recorded as a research and development expense in our condensed consolidated statements of income as the programs they relate to had not achieved regulatory approval. We also agreed to make an additional milestone payment of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$25.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> upon regulatory approval in the E.U. for each of the three anti-TNF biosimilar product candidates. During the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we made a </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$25.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> milestone payment and accrued another </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$25.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, which have been capitalized in intangible assets, net in our condensed consolidated balance sheet as BENEPALI received regulatory approval in the E.U. in January 2016 and FLIXABI received regulatory approval in the E.U. in May 2016. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We began to recognize revenue on sales of BENEPALI in the E.U. in the first quarter of 2016. We reflect revenues on sales of BENEPALI to third parties in product revenues, net in our condensed consolidated statements of income and record the related cost of revenues and sales and marketing expenses in our condensed consolidated statements of income to their respective line items when these costs are incurred. We share </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">50%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> of the profit or loss related to our commercial agreement with Samsung Bioepis. This profit share with Samsung Bioepis is recognized in collaboration profit (loss) sharing in our condensed consolidated statements of income. </font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#538235;font-style:italic;">Other Services</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Simultaneous with the formation of Samsung Bioepis, we also entered into a license agreement, a technical development services agreement and a manufacturing agreement with Samsung Bioepis. For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we recognized </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$14.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$16.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, in relation to these services as other revenues in our condensed consolidated statements of income, as compared to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$17.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$36.1 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, in the prior year comparative periods. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For additional information related to our other significant collaboration arrangements, please read Note 19, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Collaborative and Other Relationships</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to our consolidated financial statements included in our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form 10-K.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Commitments and Contingencies</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Fumapharm AG</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In 2006, we acquired Fumapharm AG. As part of this acquisition we acquired FUMADERM and TECFIDERA (together, Fumapharm Products). We paid </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$220.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> upon closing of the transaction and agreed to pay an additional </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$15.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> if a Fumapharm Product was approved for MS in the U.S.&#160;or E.U. In the second quarter of 2013, we paid this </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$15.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> contingent payment as TECFIDERA was approved in the U.S. for MS by the FDA. We are also required to make additional contingent payments to former shareholders of Fumapharm AG or holders of their rights based on the attainment of certain cumulative sales levels of Fumapharm Products and the level of total net sales of Fumapharm Products in the prior twelve month period. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">During the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we paid </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$600.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> in contingent payments as we reached the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$7.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$8.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> cumulative sales levels related to the Fumapharm Products in the fourth quarter of 2015 and first quarter of 2016, respectively, and accrued </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$300.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> upon reaching </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$9.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> in total cumulative sales of Fumapharm Products in the second quarter of 2016.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We will owe an additional </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$300.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> contingent payment for every additional </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$1.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> in cumulative sales level of Fumapharm Products reached if the prior 12 months sales of the Fumapharm Products exceed </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$3.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, until such time as the cumulative sales level reaches </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$20.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, at which time no further contingent payments shall be due. These payments will be accounted for as an increase to goodwill as incurred, in accordance with the accounting standard applicable to business combinations when we acquired Fumapharm. Any portion of the payment which is tax deductible will be recorded as a reduction to goodwill. Payments are due within 60&#160;days following the end of the quarter in which the applicable cumulative sales level has been reached. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Solothurn, Switzerland Facility</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On December 1, 2015, we purchased land in Solothurn, Switzerland where we are building a biologics manufacturing facility over the next several years. As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we had contractual commitments of approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$226.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> for the construction of this facility.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Accumulated Other Comprehensive Income (Loss)</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the changes in accumulated other comprehensive income (loss), net of tax by component:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:31%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized Gains (Losses) on Securities Available for Sale</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized Gains (Losses) on Cash Flow Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unfunded Status of Postretirement Benefit Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Translation Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">10.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(37.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(195.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(224.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other comprehensive income (loss) before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(13.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(48.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(54.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amounts reclassified from accumulated other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(4.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(4.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net current period other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(18.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(48.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(58.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of June 30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(8.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(36.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(244.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(282.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:31%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized Gains (Losses) on Securities Available for Sale</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized Gains (Losses) on Cash Flow Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unfunded Status of Postretirement Benefit Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Translation Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">71.7</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(31.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(99.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(59.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other comprehensive income (loss) before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">66.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(37.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">33.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amounts reclassified from accumulated other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(75.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(74.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net current period other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(8.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(37.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(41.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of June 30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">62.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(27.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(137.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(101.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the amounts reclassified from accumulated other comprehensive income:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Income Statement Location</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amounts Reclassified from Accumulated Other Comprehensive Income</font></div></td></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gains (losses) on securities available for sale</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income tax benefit (expense)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gains (losses) on cash flow hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenues</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(4.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">40.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">75.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income tax benefit (expense)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total reclassifications, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(4.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">40.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">74.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our condensed consolidated financial statements reflect our financial statements, those of our wholly-owned subsidiaries and those of certain variable interest entities where we are the primary beneficiary. For consolidated entities where we own or are exposed to less than </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">100%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> of the economics, we record net income (loss) attributable to noncontrolling interests in our condensed consolidated statements of income equal to the percentage of the economic or ownership interest retained in such entities by the respective noncontrolling parties. Intercompany balances and transactions are eliminated in consolidation. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In determining whether we are the primary beneficiary of an entity, we apply a qualitative approach that determines whether we have both (1) the power to direct the economically significant activities of the entity and (2) the obligation to absorb losses of, or the right to receive benefits from, the entity that could potentially be significant to that entity. These considerations impact the way we account for our existing collaborative relationships and other arrangements. We continuously assess whether we are the primary beneficiary of a variable interest entity as changes to existing relationships or future transactions may result in us consolidating or deconsolidating one or more of our collaborators or partners.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Derivative Instruments</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Foreign Currency Forward Contracts - Hedging Instruments</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Due to the global nature of our operations, portions of our revenues and operating expenses are recorded in currencies other than the U.S.&#160;dollar. The value of revenues and operating expenses measured in U.S.&#160;dollars is therefore subject to changes in foreign currency exchange rates. In order to mitigate these changes we use foreign currency forward contracts to lock in exchange rates associated with a portion of our forecasted international revenues and operating expenses.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Foreign currency forward contracts in effect as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> had durations of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">18 months</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. These contracts have been designated as cash flow hedges and accordingly, to the extent effective, any unrealized gains or losses on these foreign currency forward contracts are reported in accumulated other comprehensive income (loss) (referred to as AOCI in the tables below). Realized gains and losses for the effective portion of such contracts are recognized in revenue when the sale of product in the currency being hedged is recognized and, beginning in the fourth quarter 2015, in operating expenses when the expense in the currency being hedged is recorded. To the extent ineffective, hedge transaction gains and losses are reported in other income (expense), net.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The notional value of foreign currency forward contracts that were entered into to hedge forecasted revenues and operating expenses is summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.02534113060429%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Notional Amount</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Foreign Currency: (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Euro</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,126.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">945.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Swiss francs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">43.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">80.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Canadian dollar</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">39.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">76.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,209.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,103.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The portion of the fair value of these foreign currency forward contracts that was included in accumulated other comprehensive income (loss) in total equity reflected net losses of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$16.4 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and net gains of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$1.8 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively. We expect all contracts to be settled over the next </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">18</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months and any amounts in accumulated other comprehensive income (loss) to be reported as an adjustment to revenue or operating expense. We consider the impact of our and our counterparties&#8217; credit risk on the fair value of the contracts as well as the ability of each party to execute its contractual obligations. As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, credit risk did not change the fair value of our foreign currency forward contracts.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following tables summarize the effect of foreign currency forward contracts designated as hedging instruments on our condensed consolidated statements of income:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months Ended June 30,</font></div></td></tr><tr><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net Gains/(Losses)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Reclassified from AOCI into Operating Income</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net Gains/(Losses)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Recognized into Net Income</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;">(Ineffective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(4.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">40.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months Ended June 30,</font></div></td></tr><tr><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net Gains/(Losses)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Reclassified from AOCI into Operating Income</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net Gains/(Losses)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Recognized into Net Income</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;">(Ineffective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">75.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Interest Rate Contracts - Hedging Instruments</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We have entered into interest rate swap contracts on certain borrowing transactions to manage our exposure to interest rate changes. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In connection with the issuance of our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.90%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Senior Notes, we entered into interest rate swaps with an aggregate notional amount of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$675.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, which expire on September 15, 2020. The interest rate swap contracts are designated as hedges of the fair value changes in the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.90%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Senior Notes attributable to changes in interest rates. Since the specific terms and notional amount of the swaps match the debt being hedged, it is assumed to be a highly effective hedge and all changes in the fair value of the swaps are recorded as a component of the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.90%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Senior Notes with no net impact recorded in income. Any net interest payments made or received on the interest rate swap contracts are recognized as a component of interest expense in our condensed consolidated statements of income.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Foreign Currency Forward Contracts - Other Derivatives</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We also enter into other foreign currency forward contracts, usually with durations of one month or less, to mitigate the foreign currency risk related to certain balance sheet positions. We have not elected hedge accounting for these transactions.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The aggregate notional amount of these outstanding foreign currency contracts was </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$557.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$721.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively. Net losses of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$18.6 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$16.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> related to these contracts were recognized as a component of other income (expense), net, for </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, as compared to net gains of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$13.6 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$3.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, in the prior year comparative periods.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Summary of Derivatives</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">While certain of our derivatives are subject to netting arrangements with our counterparties, we do not offset derivative assets and liabilities in our condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the fair value and presentation in our condensed consolidated balance sheets of our outstanding derivatives including those designated as hedging instruments:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Balance Sheet Location</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of June 30, 2016</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Hedging Instruments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Asset derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Investments and other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">23.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Liability derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">14.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Other Derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Asset derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Liability derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">10.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Balance Sheet Location</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Hedging Instruments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Asset derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">16.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Investments and other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Liability derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Other Derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Asset derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Liability derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Share-based Payments</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Share-based Compensation Expense</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes share-based compensation expense included in our condensed consolidated statements of income:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Research and development </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">21.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">22.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">42.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">57.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Selling, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">28.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">26.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">63.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">81.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Restructuring charges</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Subtotal</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">50.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">48.3</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">104.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">139.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Capitalized share-based compensation costs </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(4.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(7.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Share-based compensation expense included in total cost and expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">45.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">46.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">97.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">133.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income tax effect</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(12.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(12.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(27.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(39.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Share-based compensation expense included in net income attributable to Biogen Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">33.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">33.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">69.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">94.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes share-based compensation expense associated with each of our share-based compensation programs:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Market stock units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">21.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">26.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Time-vested restricted stock units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">33.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">31.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">64.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">63.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash settled performance units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">27.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Performance units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">8.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">14.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee stock purchase plan</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">8.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Subtotal</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">50.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">48.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">104.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">139.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Capitalized share-based compensation costs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(4.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(7.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Share-based compensation expense included in total cost and expenses</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">45.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">46.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">97.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">133.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We estimate the fair value of our obligations associated with our performance units and cash settled performance units at the end of each reporting period through expected settlement.&#160;Cumulative adjustments to these obligations are recorded each quarter to reflect changes in the stock price and estimated outcome of the performance-related conditions.&#160;</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Grants Under Share-based Compensation Plans</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes our equity grants to employees, officers and directors under our current stock plans:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Market stock units</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">166,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">179,000</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash settled performance shares</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">86,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">115,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Performance units</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">56,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">89,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Time-vested restricted stock units</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">594,000</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">375,000</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Employee Stock Purchase Plan (ESPP)</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In June 2015, our stockholders approved the Biogen Inc. 2015 ESPP (2015 ESPP). The 2015 ESPP, which became effective on July 1, 2015, replaced the Biogen Idec Inc. 1995 ESPP (1995 ESPP), which expired on June&#160;30, 2015. The maximum aggregate number of shares of our common stock that may be purchased under the 2015 ESPP is </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6,200,000</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">109,000</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> shares were issued under our 2015 ESPP, compared to approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">98,000</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;shares issued under our 1995 ESPP in the prior year comparative period.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Earnings&#160;per Share</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Basic and diluted earnings per share are calculated as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income attributable to Biogen Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,049.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">927.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,020.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,749.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted average number of common shares outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">219.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">235.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">219.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">235.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Effect of dilutive securities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Stock options and employee stock purchase plan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Time-vested restricted stock units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Market stock units</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Dilutive potential common shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Shares used in calculating diluted earnings per share</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">219.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">235.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">219.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">235.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amounts excluded from the calculation of net income per diluted share because their effects were anti-dilutive were insignificant.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Fair Value Measurements</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The tables below present information about our assets and liabilities that are regularly measured and carried at fair value and indicate the level within the fair value hierarchy of the valuation techniques we utilized to determine such fair value:</font></div><div style="line-height:120%;padding-top:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of June 30, 2016 (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Quoted&#160;Prices</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">in Active</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Significant&#160;Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Observable&#160;Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">874.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">874.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable debt securities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,290.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,290.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Government securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,973.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,973.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Mortgage and other asset backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">648.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">648.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">32.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">32.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Derivative contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">30.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">30.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Plan assets for deferred compensation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">35.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">35.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6,885.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">32.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6,852.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Derivative contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">24.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">24.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration obligations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">515.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">515.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">540.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">24.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">515.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2015 (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Quoted&#160;Prices</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">in Active</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Significant&#160;Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Observable&#160;Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">909.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">909.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable debt securities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,510.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,510.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Government securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,875.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,875.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Mortgage and other asset backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">494.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">494.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">37.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">37.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Derivative contracts</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">27.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">27.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Plan assets for deferred compensation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">40.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">40.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5,895.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">37.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5,857.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Derivative contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">14.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">14.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration obligations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">506.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">506.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">520.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">14.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">506.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">There have been </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">no</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> material impairments of our assets measured and carried at fair value during the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. In addition, there were </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">no</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> changes in valuation techniques or inputs utilized or transfers between fair value measurement levels during the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. The fair values of Level 2 instruments classified as cash equivalents and marketable debt securities were determined through third party pricing services. For a description of our validation procedures related to prices provided by third party pricing services, refer to Note 1, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Summary of Significant Accounting Policies: Fair Value Measurements</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, to our consolidated financial statements included in our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form 10-K. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Debt Instruments</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The fair and carrying values of our debt instruments, which are Level&#160;2 liabilities, are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.02534113060429%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of June 30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Notes payable to Fumedica</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.875% Senior Notes due March&#160;1, 2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">598.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">561.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">602.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">565.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.900% Senior Notes due September 15, 2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,561.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,507.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,497.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,485.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.625% Senior Notes due September 15, 2022</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,061.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">992.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,014.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">992.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.050% Senior Notes due September 15, 2025</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,887.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,734.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,764.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,733.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.200% Senior Notes due September 15, 2045</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,996.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,721.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,757.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,721.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7,110.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6,524.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6,645.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6,506.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The fair value of our notes payable to Fumedica was estimated using market observable inputs, including current interest and foreign currency exchange rates. The fair values of each of our series of Senior Notes were determined through market, observable and corroborated sources. For additional information related to our debt instruments, please read Note 11, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Indebtedness</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to our consolidated financial statements included in our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form 10-K.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Contingent Consideration Obligations</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table provides a roll forward of the fair values of our contingent consideration obligations which includes Level 3 measurements:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value, beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">508.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">461.8</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">506.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">215.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Additions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">36.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">274.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Changes in fair value</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">10.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">12.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(3.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(3.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value, end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">515.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">495.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">515.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">495.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$304.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$301.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, of our contingent consideration obligations valued using Level 3 measurements were reflected as components of other long-term liabilities in our condensed consolidated balance sheets with the remaining balances reflected as a component of accrued expenses and other.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table provides a roll forward of the fair values of our contingent consideration obligations which includes Level 3 measurements:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value, beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">508.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">461.8</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">506.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">215.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Additions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">36.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">274.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Changes in fair value</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">10.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">12.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(3.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(3.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value, end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">515.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">495.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">515.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">495.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Intangible Assets and Goodwill</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Intangible Assets</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Intangible assets, net of accumulated amortization, impairment charges and adjustments, are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="26" rowspan="1"></td></tr><tr><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:7%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of June 30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Estimated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Life</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Out-licensed patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">13-23 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">543.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(514.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">28.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">543.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(506.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">37.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Developed&#160;</font></div><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">15-23&#160;years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,005.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2,604.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">400.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3,005.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2,552.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">452.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In-process research and development</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Indefinite until commercialization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">692.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">692.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">730.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">730.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Trademarks&#160;and&#160;</font></div><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">tradenames</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Indefinite</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">64.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">64.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">64.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">64.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired and in-licensed&#160;rights&#160;</font></div><div style="font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">and&#160;patents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6-18 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,405.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(623.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,782.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3,303.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(502.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,800.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7,710.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(3,742.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,967.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">7,646.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(3,561.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4,085.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, amortization of acquired intangible assets totaled </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$92.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$181.7 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, as compared to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$92.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$187.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, in the prior year comparative periods. In-process research and development amounts include adjustments for foreign exchange rate fluctuations.</font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#538235;font-style:italic;">Developed Technology</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Developed technology primarily relates to our AVONEX product, which was recorded in connection with the merger of Biogen, Inc. and IDEC Pharmaceuticals Corporation in 2003. The net book value of this asset as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> was </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$392.8 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#538235;font-style:italic;">Acquired and In-licensed Rights and Patents</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Acquired and in-licensed rights and patents primarily relate to our acquisition of all remaining rights to TYSABRI from Elan Corporation plc (Elan). The net book value of this asset as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> was </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$2,633.4 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The increase in acquired and in-licensed rights and patents during the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, primarily reflects:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book;font-size:10pt;">$50.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> in total milestone payments due to Samsung Bioepis, which became payable upon the approval of BENEPALI and FLIXABI in the E.U. in January 2016 and May 2016, respectively;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book;font-size:10pt;">$20.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> milestone payment due to AbbVie Biotherapeutics, Inc. (AbbVie), which became payable upon the regulatory approval of ZINBRYTA in the U.S. in May 2016; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Franklin Gothic Book;font-size:10pt;">$26.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;upon the approval of ALPROLIX in the E.U. in May 2016, which is comprised of a </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">$20.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> contingent payment due to the former owners of Syntonix Pharmaceuticals, Inc. (Syntonix) and </font><font style="font-family:Franklin Gothic Book;font-size:10pt;">$6.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;related to the establishment of a corresponding deferred tax liability.</font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For additional information on our relationship with Samsung Bioepis, please read Note 17, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Collaborative and Other Relationships</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to these condensed consolidated financial statements. For additional information on our relationship with Syntonix, please read Note 21, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Commitments and Contingencies</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to our consolidated financial statements included in our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form 10-K. For additional information on our relationship with AbbVie, please read Note 19, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Collaborative and Other Relationships</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to our consolidated financial statements included in our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form 10-K.</font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#538235;font-style:italic;">Estimated Future Amortization of Intangible Assets</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#679acb;font-style:italic;"> </font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our amortization expense is based on the economic consumption of intangible assets. Our most significant intangible assets are related to our AVONEX and TYSABRI products. Annually, during our long-range planning cycle, we perform an analysis of anticipated lifetime revenues of AVONEX and TYSABRI. This analysis is also updated whenever events or changes in circumstances would significantly affect the anticipated lifetime revenues of either product.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our most recent long range planning cycle was completed in the third quarter of 2015. Based upon this analysis, the estimated future amortization of acquired intangible assets for the next five years is expected to be as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:87%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2016 (remaining six months)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">181.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">325.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">298.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">282.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">277.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">265.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Goodwill</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table provides a roll forward of the changes in our goodwill balance:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:87%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Goodwill, beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,663.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increase to goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">515.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(11.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Goodwill, end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,167.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The increase in goodwill during the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> was related to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$600.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> in contingent milestones achieved (exclusive of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$85.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> in tax benefits) and payable to the former shareholders of Fumapharm AG or holders of their rights. Other includes changes in foreign exchange rates. For additional information related to future contingent payments to the former shareholders of Fumapharm AG or holders of their rights, please read Note 19, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Commitments and Contingencies</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to these condensed consolidated financial statements. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we had </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">no</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> accumulated impairment losses related to goodwill.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">A reconciliation between the U.S.&#160;federal statutory tax rate and our effective tax rate is summarized as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Statutory rate</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">State taxes</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Taxes on foreign earnings</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(10.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(11.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(9.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(9.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Credits and net operating loss utilization</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Purchased intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Manufacturing deduction</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other permanent items</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Effective tax rate</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">25.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">23.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">26.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">24.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, compared to the same period in </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, our effective tax rate increased primarily due to a state tax benefit in 2015 resulting from the remeasurement of one of our uncertain positions, described below, and a higher relative percentage of our earnings being attributed to the U.S., a higher tax jurisdiction. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Accounting for Uncertainty in Income Taxes</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We and our subsidiaries are routinely examined by various taxing authorities. We file income tax returns in the U.S.&#160;federal jurisdiction, various U.S. states and foreign jurisdictions. With few exceptions, including the proposed disallowance we discuss below, we are no longer subject to U.S.&#160;federal tax examination for years before 2013 or state, local or non-U.S.&#160;income tax examinations for years before 2004. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In March 2015, we received a final assessment from the Danish Tax Authority (SKAT) for 2009 regarding withholding taxes and the treatment of certain intercompany transactions involving a Danish affiliate and another of our affiliates.&#160;In April 2016, we received final assessments for 2011 and 2013 regarding withholding taxes for similar intercompany transactions. The total amount assessed for 2009, 2011 and 2013 is estimated to be </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$66.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, including interest.&#160;For the assessments related to 2011 and 2013, we have made payments to SKAT totaling </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$13.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. We continue to dispute the assessments for all of these periods and believe that the positions we have taken in our historical filings are valid. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">During the six months ended June&#160;30, 2015, the net effect of adjustments to our uncertain tax positions was a net benefit of approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$24.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> primarily related to the state impact of a federal uncertain tax item.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">It is reasonably possible that we will adjust the value of our uncertain tax positions related to our revenues from anti-CD20 therapeutic programs and certain transfer pricing issues as we receive additional information from various taxing authorities, including reaching settlements with the tax authorities. In addition, the Internal Revenue Service (IRS) and other national tax authorities routinely examine our intercompany transfer pricing with respect to intellectual property related transactions and it is possible that they may disagree with one or more positions we have taken with respect to such valuations.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In October 2011, in conjunction with an examination by the IRS, the IRS proposed a disallowance of approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$130.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> in deductions for tax years 2007, 2008 and 2009 related to payments for services provided by our wholly owned Danish subsidiary located in Hiller&#248;d, Denmark. We initiated a mutual agreement procedure between the IRS and SKAT for the years 2001 through 2009, to reach agreement on the issue. Over the past year, we have reached agreement with the IRS and SKAT regarding the tax treatment of these items for the years up to and including 2009. We have recorded the results of these agreements, which were not significant to our results. In addition, we applied for a bilateral advance pricing agreement for the years 2010 through 2014 to resolve similar issues for those years. In June 2016, we withdrew from the bilateral advance pricing agreement process. We believe that the positions we have taken in our historical filings are valid and supportable and potential changes in these positions are not expected to have a significant impact on our financial position or results of operations.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Inventory</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The components of inventory are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">235.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">213.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">654.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">577.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">139.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">143.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total inventory</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,028.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">933.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Balance Sheet Classification:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">996.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">893.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Investments and other assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">32.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">40.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total inventory</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,028.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">933.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory included in investments and other assets in our condensed consolidated balance sheets primarily consisted of work in process.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, our inventory included </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$24.7 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> associated with our ZINBRYTA program, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$24.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> associated with the FLIXABI program and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$18.4 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> associated with the BENEPALI program, which had been capitalized in advance of regulatory approval. The European Commission (EC) approved the marketing authorization applications for BENEPALI and FLIXABI, two anti-tumor necrosis factor (TNF) biosimilars, for marketing in the E.U. in January 2016 and May 2016, respectively, and the U.S. Food and Drug Administration (FDA) approved ZINBRYTA for the treatment of relapsing forms of MS in the U.S. in May 2016.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The estimated fair value and amortized cost of our marketable debt securities available-for-sale by contractual maturity are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of June 30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Estimated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Estimated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Cost</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Due in one year or less</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,434.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,434.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,120.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,122.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Due after one year through five years</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,255.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,245.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,575.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,583.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Due after five years</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">221.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">221.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">184.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">185.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total available-for-sale securities</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5,912.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">5,901.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4,880.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4,891.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Litigation</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We are currently involved in various claims and legal proceedings, including the matters described below. For information as to our accounting policies relating to claims and legal proceedings, including use of estimates and contingencies, please read Note 1,</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;"> Summary of Significant Accounting Policies</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to our consolidated financial statements included in our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form 10-K.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">With respect to some loss contingencies, an estimate of the possible loss or range of loss cannot be made until management has further information, including, for example, (i) which claims, if any, will survive dispositive motion practice; (ii) information to be obtained through discovery; (iii) information as to the parties' damages claims and supporting evidence; (iv) the parties&#8217; legal theories; and (v) the parties' settlement positions. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The claims and legal proceedings in which we are involved also include challenges to the scope, validity or enforceability of the patents relating to our products, pipeline or processes, and challenges to the scope, validity or enforceability of the patents held by others. These include claims by third parties that we infringe their patents. An adverse outcome in any of these proceedings could result in one or more of the following and have a material impact on our business or consolidated results of operations and financial position: (i) loss of patent protection; (ii) inability to continue to engage in certain activities; and (iii) payment of significant damages, royalties, penalties and/or license fees to third parties. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Loss Contingencies </font></div><div style="line-height:120%;padding-top:6px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#538235;font-style:italic;">Forward Pharma German Patent Litigation</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On November 18, 2014, Forward Pharma A/S (Forward Pharma) filed suit against us in the Regional Court of Dusseldorf, Germany alleging that TECFIDERA infringes German Utility Model DE&#160;20 2005 022 112&#160;U1 (the utility model), which was issued in April 2014 and expired in October 2015. Forward Pharma subsequently&#160;extended its allegations&#160;to assert that TECFIDERA infringes Forward Pharma's European Patent No. 2 801 355, which was issued in May 2015 and expires in October 2025 (the '355 patent). Forward Pharma seeks declarations of infringement and damages for our sales of TECFIDERA in Germany. Under German law, disgorgement of profits on infringing sales is a measure of damages. With respect to the '355 patent, the hearing has been stayed pending the outcome of opposition proceedings that we and others have filed in the European Patent Office, and with respect to the utility model the hearing has been stayed pending the outcome of those proceedings and proceedings in the German Patent Office. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#538235;font-style:italic;">ALPROLIX Patent Licensing Matter </font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We are in discussions with Pfizer regarding its proposal that we take a license to its U.S. Patent No. 8,603,777&#160;(Expression of Factor VII and IX Activities in Mammalian Cells) and pay&#160;royalties on sales of ALPROLIX. </font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">An estimate of the possible loss or range of loss cannot be made at this time.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#538235;font-style:italic;">Italian National Medicines Agency</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In the fourth quarter of 2011, Biogen Italia SRL&#160;received notice from the Italian National Medicines Agency (Agenzia Italiana del Farmaco or AIFA) that sales of TYSABRI after mid-February 2009 exceeded a reimbursement limit established pursuant to a Price Determination Resolution (Price Resolution) granted by AIFA in December 2006. On January&#160;12, 2012, we filed an appeal in the Regional Administrative Tribunal of Lazio (Il Tribunale Amministrativo Regionale per il Lazio) in Rome, Italy seeking a ruling that the reimbursement limit in the Price Resolution should apply as written to only &#8220;the first </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">24</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months&#8221; of TYSABRI sales, which ended in mid-February 2009. The appeal is still pending. In June 2014, AIFA approved a resolution affirming that there is no reimbursement limit from and after February 2013. AIFA and Biogen Italia SRL are discussing a possible resolution for the period from February 2009 through January 2013.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For additional information regarding this matter, please read Note 15, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Other Consolidated Financial Statement Detail</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to these condensed consolidated financial statements.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#538235;font-style:italic;">Qui Tam Litigation</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On July 6, 2015, four qui tam actions filed against us by relators suing on behalf of the United States and certain states were unsealed by the U.S. District Court for the District of Massachusetts. All but one of the actions has been voluntarily dismissed. The pending action alleges sales and promotional activities in violation of the federal False Claims Act and state law counterparts, and seeks single and treble damages, civil penalties, interest, attorneys&#8217; fees and costs. The complaint was recently amended, and we intend to move to dismiss. The United States has not made an intervention decision. An estimate of the possible loss or range of loss cannot be made at this time.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#538235;font-style:italic;">Securities Litigation</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We and certain current and former officers are defendants in In re Biogen Inc. Securities Litigation, filed by a shareholder on August 18, 2015 in the U.S. District Court for the District of Massachusetts. The amended complaint alleges violations of federal securities laws under 15 U.S.C. &#167;78j(b) and &#167;78t(a) and 17 C.F.R. &#167;240.10b-5. The lead plaintiff sought a declaration of the action as a class action, certification as a representative of the class and its counsel as class counsel, and an award of damages, interest and attorneys' fees. On July 1, 2016 the U.S. District Court dismissed the case. An estimate of the possible loss or range of loss cannot be made at this time.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Other Matters</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#538235;font-style:italic;">Interference Proceeding with Forward Pharma</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In April 2015, the U.S. Patent and Trademark Office (USPTO) declared an interference between Forward Pharma&#8217;s pending U.S. Patent Application No. 11/576,871 and our U.S. Patent No. 8,399,514 (the '514 patent). The '514 patent includes claims covering the treatment of multiple sclerosis with 480 mg of dimethyl fumarate as provided for in our TECFIDERA label. A hearing has been scheduled for late 2016. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#538235;font-style:italic;">Inter Partes Review Petitions and Proceeding</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On March 22, 2016, the USPTO instituted </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">inter partes</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> review of the '514 patent on the petition of the Coalition for Affordable Drugs V LLC, an entity associated with a hedge fund. A hearing has been scheduled for late 2016. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On April 18, 2016, Swiss Pharma International AG filed petitions in the USPTO for </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">inter partes</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> review of U.S. Patent Nos. 8,349,321 and, 8,900,577, relating to specific formulations of natalizumab (TYSABRI), and U.S. Patent No. 8,815,236, relating to methods for treating multiple sclerosis and Crohn&#8217;s disease using specific formulations of natalizumab (TYSABRI). The USPTO has not yet decided whether to institute review.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#538235;font-style:italic;">European Patent Office Oppositions</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On March 10, 2016, the European Patent Office verbally revoked our European patent number 2 137 537 (the '537 patent), which includes claims covering the treatment of multiple sclerosis with 480 mg of dimethyl fumarate as provided for in our TECFIDERA label. In June 2016 the European Patent Office issued a written decision confirming its position from which we intend to appeal.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#538235;font-style:italic;">Patent Revocation Matter</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In December 2015, Swiss Pharma International AG brought an action in the Patents Court of the United Kingdom to revoke the UK counterpart of our European Patent Number 1 485 127&#160;(&#8220;Administration of agents to treat inflammation&#8221;) (the '127 patent), which was issued in June 2011 and concerns administration of natalizumab (TYSABRI) to treat multiple sclerosis. The patent expires in February 2023.&#160;Subsequently, the same entity brought actions in the District Court of The Hague (on January 11, 2016) and the German Patents Court (on March 3, 2016) to invalidate the Dutch and German counterparts of the '127 patent. A hearing has been scheduled in the UK action for late 2016 and in the Dutch action for early 2017. No hearing has yet been scheduled in the German action.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#538235;font-style:italic;">'755 Patent Litigation</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On May&#160;28, 2010, Biogen MA Inc. (formerly Biogen Idec MA Inc.) filed a complaint in the U.S.&#160;District Court for the District of New Jersey alleging infringement by Bayer Healthcare Pharmaceuticals Inc. (Bayer) (manufacturer, marketer and seller of BETASERON and manufacturer of EXTAVIA), EMD Serono, Inc. (manufacturer, marketer and seller of REBIF), Pfizer Inc. (co-marketer of REBIF) and Novartis Pharmaceuticals Corp. (marketer and seller of EXTAVIA) of our U.S. Patent No. 7,588,755 ('755 Patent), which claims the use of interferon beta for immunomodulation or treating a viral condition, viral disease, cancers or tumors. The complaint seeks monetary damages, including lost profits and royalties. Bayer had previously filed a complaint against us in the same court, on May 27, 2010, seeking a declaratory judgment that it does not infringe the '755 Patent and that the patent is invalid, and seeking monetary relief in the form of attorneys' fees, costs and expenses. The court has consolidated the two lawsuits, and we refer to the two actions as the &#8220;Consolidated '755 Patent Actions.&#8221;</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Bayer, Pfizer, Novartis and EMD Serono have all filed counterclaims in the Consolidated '755 Patent Actions seeking declaratory judgments of patent invalidity and non-infringement, and seeking monetary relief in the form of costs and attorneys' fees, and EMD Serono and Bayer have each filed a counterclaim seeking a declaratory judgment that the '755 Patent is unenforceable based on alleged inequitable conduct. Bayer has also amended its complaint to seek such a declaration. Trial has been set for September 2017.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#538235;font-style:italic;">Government Matters</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We have learned that state and federal governmental authorities are investigating our sales and promotional practices and have received related subpoenas. We are cooperating with the government. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On March 4, 2016 we received a subpoena from the federal government for documents relating to our relationship with non-profit organizations that provide assistance to patients taking drugs sold by Biogen. We are cooperating with the government.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On July 1, 2016, we received civil investigative demands from the federal government for documents and information relating to our treatment of certain service agreements with wholesalers when calculating and reporting Average Manufacturer Prices in connection with the Medicaid Drug Rebate Program.&#160;We are in the process of responding to the government.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Product Liability and Other Legal Proceedings</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We are also involved in product liability claims and other legal proceedings generally incidental to our normal business activities. While the outcome of any of these proceedings cannot be accurately predicted, we do not believe the ultimate resolution of any of these existing matters would have a material adverse effect on our business or financial condition.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (FASB) or other standard setting bodies that we adopt as of the specified effective date. Unless otherwise discussed, we do not believe that the impact of recently issued standards that are not yet effective will have a material impact on our financial position or results of operations upon adoption.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In May 2014, the FASB issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes all existing revenue recognition requirements, including most industry-specific guidance. The new standard requires a company to recognize revenue when it transfers goods or services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, which delayed the effective date of the new standard from January 1, 2017 to January 1, 2018. The FASB also agreed to allow entities to choose to adopt the standard as of the original effective date. In March 2016, the FASB issued ASU No. 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations, which clarifies the implementation guidance on principal versus agent considerations. In April 2016, the FASB issued ASU No. 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing, which clarifies certain aspects of identifying performance obligations and licensing implementation guidance. In May 2016, the FASB issued ASU No. 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients related to disclosures of remaining performance obligations, as well as other amendments to guidance on collectibility, non-cash consideration and the presentation of sales and other similar taxes collected from customers. These standards have the same effective date and transition date of January 1, 2018. We are currently evaluating the method of adoption and the potential impact that these standards may have on our financial position and results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">During 2015, the FASB issued the following new standards, which we adopted on January 1, 2016:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">ASU No. 2015-05, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Fees Paid in a Cloud Computing Arrangement. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">ASU No. 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">ASU No. 2015-16, Business Combinations (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments. </font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The adoption of these standards did not have an impact on our financial position or results of operations. For additional information related to these standards, please read Note 1, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Summary of Significant Accounting Policies: New Accounting Pronouncements</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to our consolidated financial statements included in our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form 10-K.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In January 2016, the FASB issued ASU No. 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The new standard amends certain aspects of accounting and disclosure requirements of financial instruments, including the requirement that equity investments with readily determinable fair values be measured at fair value with changes in fair value recognized in our results of operations. The new standard does not apply to investments accounted for under the equity method of accounting or those that result in consolidation of the investee. Equity investments that do not have readily determinable fair values may be measured at fair value or at cost minus impairment adjusted for changes in observable prices. A financial liability that is measured at fair value in accordance with the fair value option is required to be presented separately in other comprehensive income for the portion of the total change in the fair value resulting from change in the instrument-specific credit risk. In addition, a valuation allowance should be evaluated on deferred tax assets related to available-for-sale debt securities in combination with other deferred tax assets. The new standard will be effective for us on January 1, 2018. The adoption of this standard is not expected to have a material impact on our financial position or results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). The new standard requires that all lessees recognize the assets and liabilities that arise from leases on the balance sheet and disclose qualitative and quantitative information about its leasing arrangements. The new standard will be effective for us on January 1, 2019. The adoption of this standard is not expected to have a material impact on our net financial position, but will impact our assets and liabilities. We are currently evaluating the potential impact that this standard may have on our results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In March 2016, the FASB issued ASU No. 2016-06, Derivatives and Hedging (Topic 815): Contingent Put and Call Options in Debt Instruments. The new standard simplifies the embedded derivative analysis for debt instruments containing contingent call or put options by removing the requirement to assess whether a contingent event is related to interest rates or credit risks. The new standard will be effective for us on January 1, 2017. The adoption of this standard is not expected to have an impact on our financial position or results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In March 2016, the FASB issued ASU No. 2016-07, Investments - Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting. The new standard eliminates the requirement that when an investment qualifies for use of the equity method as a result of an increase in the level of ownership interest or degree of influence, an adjustment must be made to the investment, results of operations and retained earnings retroactively on a step-by-step basis as if the equity method had been in effect during all previous periods that the investment had been held. The new standard will be effective for us on January 1, 2017. The adoption of this standard is not expected to have a material impact on our financial position or results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In March 2016, the FASB issued ASU No. 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The new standard requires recognition of the income tax effects of vested or settled awards in the income statement and involves several other aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. The new standard will be effective for us on January 1, 2017. This standard is not expected to have a material impact on our financial position, results of operations or statements of cash flows upon adoption.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The new standard changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investment in leases that are not accounted for at fair value through net income to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. The new standard will be effective for us on January 1, 2020. The adoption of this standard is not expected to have a material impact on our financial position or results of operations.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Property, Plant and Equipment</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Property, plant and equipment are recorded at historical cost, net of accumulated depreciation. Accumulated depreciation on property, plant and equipment was </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$1,471.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$1,330.1 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Solothurn, Switzerland Facility</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On December 1, 2015, we purchased land in Solothurn, Switzerland for </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">64.4 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Swiss Francs (approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$62.5 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">). We are building a biologics manufacturing facility on this land in the Commune of Luterbach over the next several years. As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we had approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$247.8 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$99.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively, capitalized as construction in progress related to the construction of this facility. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Cambridge, MA Manufacturing Facility</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In June 2016, as a result of an evaluation of our manufacturing capabilities and capacity needs based on current and expected future demand, we determined that we intend to cease manufacturing in Cambridge, MA and vacate our 67,000 square foot small-scale biologics manufacturing facility in Cambridge, MA and 46,000 square foot warehouse space in Somerville, MA by the end of 2016. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We are currently considering alternatives for the facility, which may include a sale of our rights to the facility and related assets. In the event we are unsuccessful with a sale, we will close the facility by December 31, 2016. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the carrying value of associated assets totaled approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$43.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and our remaining lease obligation related to these facilities totaled </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$26.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">An impairment assessment as of June&#160;30, 2016 was performed related to the assets, which resulted in no impairments. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The anticipated departure from these facilities has shortened the expected useful lives of certain leasehold improvements and other assets at these facilities. As a result, we recorded additional depreciation expense to reflect the assets' new shorter useful lives. As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we recognized approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$15.8 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> of this additional depreciation, which was recorded as cost of sales in our condensed consolidated statements of income.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The proceeds from maturities and sales of marketable debt securities and resulting realized gains and losses are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Proceeds from maturities and sales</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,642.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">601.9</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,823.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">975.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Realized gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Realized losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the amounts reclassified from accumulated other comprehensive income:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:24%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Income Statement Location</font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Amounts Reclassified from Accumulated Other Comprehensive Income</font></div></td></tr><tr><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gains (losses) on securities available for sale</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income tax benefit (expense)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gains (losses) on cash flow hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenues</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(4.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">40.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">75.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income tax benefit (expense)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total reclassifications, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(4.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">40.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">74.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Restructuring</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On October 21, 2015, we announced a corporate restructuring, which included the termination of certain pipeline programs and an </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">11%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> reduction in workforce. Under this restructuring, cash payments will total approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$120 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, of which </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$15.9 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> were related to previously accrued 2015 incentive compensation, resulting in net expected restructuring charges totaling approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$105 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. These amounts will be substantially paid by the end of 2016.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we recognized restructuring charges totaling </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$0.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$9.7 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively.&#160;We previously recognized </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$93.4 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> of restructuring charges in our consolidated statements of income during the fourth quarter of 2015. Our restructuring reserve is included in accrued expenses and other in our condensed consolidated balance sheets.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the charges and spending related to our restructuring efforts during the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Workforce</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Reduction</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Pipeline</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Programs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Restructuring reserve as of December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">33.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">3.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">37.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">4.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">5.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">10.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">(28.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">(6.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">(34.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Adjustments to previous estimates, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">(3.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">2.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Restructuring reserve as of June 30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">6.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">5.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">12.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other consists of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current portion of contingent consideration obligations and milestones</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">556.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">504.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue-related reserves for discounts and allowances</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">490.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">518.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee compensation and benefits</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">228.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">270.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Royalties and licensing fees</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">183.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">167.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">613.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">635.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total accrued expenses and other</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,072.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,096.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the changes in accumulated other comprehensive income (loss), net of tax by component:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:31%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized Gains (Losses) on Securities Available for Sale</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized Gains (Losses) on Cash Flow Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unfunded Status of Postretirement Benefit Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Translation Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">10.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(37.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(195.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(224.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other comprehensive income (loss) before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(13.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(48.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(54.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amounts reclassified from accumulated other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(4.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(4.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net current period other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(18.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(48.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(58.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of June 30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(8.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(36.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(244.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(282.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:31%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized Gains (Losses) on Securities Available for Sale</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unrealized Gains (Losses) on Cash Flow Hedges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unfunded Status of Postretirement Benefit Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Translation Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">71.7</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(31.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(99.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(59.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other comprehensive income (loss) before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">66.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(37.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">33.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Amounts reclassified from accumulated other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(75.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(74.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net current period other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(8.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(37.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(41.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of June 30, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">62.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(27.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(137.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(101.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The fair and carrying values of our debt instruments, which are Level&#160;2 liabilities, are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.02534113060429%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of June 30, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2015</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Notes payable to Fumedica</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6.875% Senior Notes due March&#160;1, 2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">598.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">561.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">602.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">565.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.900% Senior Notes due September 15, 2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,561.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,507.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,497.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,485.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.625% Senior Notes due September 15, 2022</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,061.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">992.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,014.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">992.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.050% Senior Notes due September 15, 2025</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,887.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,734.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,764.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,733.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.200% Senior Notes due September 15, 2045</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,996.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,721.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,757.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,721.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7,110.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6,524.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6,645.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">6,506.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes our financial assets with maturities of less than 90&#160;days from the date of purchase included in cash and cash equivalents on the accompanying condensed consolidated balance sheet:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Commercial paper</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">56.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">21.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Overnight reverse repurchase agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">66.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">134.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Money market funds</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">531.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">673.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Short-term debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">219.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">79.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">874.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">909.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes share-based compensation expense associated with each of our share-based compensation programs:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Market stock units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">7.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">9.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">21.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">26.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Time-vested restricted stock units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">33.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">31.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">64.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">63.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash settled performance units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">27.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Performance units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">8.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">14.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Employee stock purchase plan</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">8.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Subtotal</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">50.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">48.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">104.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">139.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Capitalized share-based compensation costs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(4.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(7.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Share-based compensation expense included in total cost and expenses</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">45.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">46.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">97.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">133.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following tables summarize the effect of foreign currency forward contracts designated as hedging instruments on our condensed consolidated statements of income:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months Ended June 30,</font></div></td></tr><tr><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net Gains/(Losses)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Reclassified from AOCI into Operating Income</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net Gains/(Losses)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Recognized into Net Income</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;">(Ineffective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(4.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">40.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="19" rowspan="1"></td></tr><tr><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months Ended June 30,</font></div></td></tr><tr><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net Gains/(Losses)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Reclassified from AOCI into Operating Income</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;">(Effective Portion)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Net Gains/(Losses)</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Recognized into Net Income</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;font-style:italic;">(Ineffective Portion)</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">75.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">3.4</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Operating expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other income (expense)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the fair value and presentation in our condensed consolidated balance sheets of our outstanding derivatives including those designated as hedging instruments:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:40%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Balance Sheet Location</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of June 30, 2016</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Hedging Instruments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Asset derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Investments and other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">23.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Liability derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">14.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Other Derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Asset derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">4.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Liability derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">10.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Balance Sheet Location</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Hedging Instruments:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Asset derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">16.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Investments and other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Liability derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other long-term liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Other Derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Asset derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">10.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Liability derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Accrued expenses and other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Basic and diluted earnings per share are calculated as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Numerator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income attributable to Biogen Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,049.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">927.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,020.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,749.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Denominator:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Weighted average number of common shares outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">219.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">235.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">219.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">235.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Effect of dilutive securities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Stock options and employee stock purchase plan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Time-vested restricted stock units</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Market stock units</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Dilutive potential common shares</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Shares used in calculating diluted earnings per share</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">219.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">235.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">219.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">235.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">A reconciliation between the U.S.&#160;federal statutory tax rate and our effective tax rate is summarized as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Statutory rate</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">35.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">State taxes</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Taxes on foreign earnings</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(10.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(11.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(9.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(9.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Credits and net operating loss utilization</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(0.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Purchased intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Manufacturing deduction</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other permanent items</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Effective tax rate</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">25.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">23.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">26.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">24.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#160;%</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes share-based compensation expense included in our condensed consolidated statements of income:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Research and development </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">21.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">22.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">42.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">57.5</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Selling, general and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">28.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">26.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">63.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">81.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Restructuring charges</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Subtotal</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">50.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">48.3</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">104.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">139.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Capitalized share-based compensation costs </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(4.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(7.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Share-based compensation expense included in total cost and expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">45.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">46.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">97.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">133.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Income tax effect</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(12.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(12.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(27.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(39.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Share-based compensation expense included in net income attributable to Biogen Inc.</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">33.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">33.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">69.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">94.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The tables below present information about our assets and liabilities that are regularly measured and carried at fair value and indicate the level within the fair value hierarchy of the valuation techniques we utilized to determine such fair value:</font></div><div style="line-height:120%;padding-top:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of June 30, 2016 (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Quoted&#160;Prices</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">in Active</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Significant&#160;Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Observable&#160;Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">874.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">874.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable debt securities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,290.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,290.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Government securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,973.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,973.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Mortgage and other asset backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">648.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">648.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">32.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">32.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Derivative contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">30.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">30.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Plan assets for deferred compensation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">35.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">35.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6,885.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">32.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">6,852.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Derivative contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">24.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">24.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration obligations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">515.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">515.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">540.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">24.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">515.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of December 31, 2015 (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Quoted&#160;Prices</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">in Active</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Markets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Significant&#160;Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Observable&#160;Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Inputs</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">909.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">909.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable debt securities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Corporate debt securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,510.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,510.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Government securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,875.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2,875.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Mortgage and other asset backed securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">494.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">494.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Marketable equity securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">37.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">37.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Derivative contracts</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">27.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">27.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Plan assets for deferred compensation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">40.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">40.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5,895.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">37.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5,857.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Derivative contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">14.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">14.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Contingent consideration obligations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">506.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">506.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">520.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">14.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">506.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table provides a roll forward of the changes in our goodwill balance:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:87%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Goodwill, beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2,663.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Increase to goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">515.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(11.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Goodwill, end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">3,167.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The components of inventory are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">235.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">213.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Work in process</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">654.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">577.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">139.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">143.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total inventory</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,028.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">933.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Balance Sheet Classification:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Inventory</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">996.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">893.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Investments and other assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">32.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">40.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total inventory</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,028.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">933.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The notional value of foreign currency forward contracts that were entered into to hedge forecasted revenues and operating expenses is summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.02534113060429%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Notional Amount</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Foreign Currency: (In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Euro</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,126.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">945.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Swiss francs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">43.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">80.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Canadian dollar</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">39.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">76.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,209.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1,103.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Components of other income (expense), net, are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">15.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">26.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">7.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(65.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(129.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(12.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Gain (loss) on investments, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Foreign exchange gains (losses), net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(1.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(14.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Other, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(5.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(8.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(9.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(5.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total other income (expense), net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(58.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(10.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(111.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(25.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table summarizes the charges and spending related to our restructuring efforts during the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Workforce</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Reduction</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Pipeline</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Programs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Restructuring reserve as of December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">33.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">3.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">37.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">4.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">5.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">10.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Payments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">(28.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">(6.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">(34.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Adjustments to previous estimates, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">(3.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">2.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Restructuring reserve as of June 30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">6.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">5.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;">12.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Reserves for Discounts and Allowances</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">An analysis of the change in reserves for discounts and allowances is summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Discounts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Contractual</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Returns</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">56.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">548.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">57.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">662.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Current provisions relating to sales in current year</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">266.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">973.8</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">17.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1,258.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Adjustments relating to prior years</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(2.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(5.5</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(6.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Payments/credits relating to sales in current year</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(210.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(605.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(816.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Payments/credits relating to sales in prior years</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(51.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(384.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(10.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(446.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Balance, as of June 30, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">58.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">534.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">58.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">651.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The total reserves above, included in our condensed consolidated balance sheets, are summarized as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">As of <br clear="none"/>December 31, <br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Reduction of accounts receivable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">161.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">144.6</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Component of accrued expenses and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">490.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">518.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total reserves</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">651.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">662.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Based upon this analysis, the estimated future amortization of acquired intangible assets for the next five years is expected to be as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:87%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">As of <br clear="none"/>June 30, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2016 (remaining six months)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">181.6</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">325.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">298.2</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">282.7</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">277.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2021</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">265.0</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Summary of Significant Accounting Policies</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Business Overview</font></div><div style="line-height:120%;padding-top:6px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Biogen is a global biopharmaceutical company focused on discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological diseases, autoimmune disorders and rare diseases.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our marketed products include TECFIDERA, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for multiple sclerosis (MS), ELOCTATE for hemophilia A and ALPROLIX for hemophilia B and FUMADERM for the treatment of severe plaque psoriasis. We also have a collaboration agreement with Genentech, Inc. (Genentech), a wholly-owned member of the Roche Group, which entitles us to certain business and financial rights with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other potential anti-CD20 therapies.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In addition to our innovative drug development efforts, we aim to leverage our manufacturing capabilities and scientific expertise through Samsung Bioepis, our joint venture with Samsung BioLogics Co. Ltd. (Samsung Biologics) that develops, manufactures and markets biosimilars as well as through other strategic contract manufacturing partners. Under our commercial agreement with Samsung Bioepis, we market and sell BENEPALI, an etanercept biosimilar referencing ENBREL, and FLIXABI, an infliximab biosimilar referencing REMICADE, in the European Union (E.U.).</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In May 2016, we announced our intention to spin off our hemophilia business as an independent, publicly traded company. The new company will focus on the discovery and development of therapies for the treatment of hemophilia and other blood disorders, with existing marketed products ELOCTATE and ALPROLIX.&#160;The transaction is expected to be completed in early 2017, subject to the satisfaction of certain conditions, including, among others, final approval of our Board of Directors, receipt of a favorable opinion with respect to the tax-free nature of the transaction and the effectiveness of a Form 10 registration statement that will be filed with the Securities and Exchange Commission. The results of our hemophilia business will be included in our condensed consolidated financial statements until the transaction is completed.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring accruals, necessary for a fair statement of our financial statements for interim periods in accordance with accounting principles generally accepted in the United States (U.S.&#160;GAAP). The information included in this quarterly report on Form&#160;10-Q should be read in conjunction with our consolidated financial statements and the accompanying notes included in our Annual Report on Form&#160;10-K for the year ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> (</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form&#160;10-K). Our accounting policies are described in the &#8220;</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Notes to Consolidated Financial Statements</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8221; in our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form&#160;10-K and updated, as necessary, in this Form&#160;10-Q. The year-end condensed consolidated balance sheet data presented for comparative purposes was derived from our audited financial statements, but does not include all disclosures required by U.S.&#160;GAAP. The results of operations for the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, are not necessarily indicative of the operating results for the full year or for any other subsequent interim period. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We operate as </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">one</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> operating segment, which is discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological diseases, autoimmune disorders and rare diseases.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Consolidation</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our condensed consolidated financial statements reflect our financial statements, those of our wholly-owned subsidiaries and those of certain variable interest entities where we are the primary beneficiary. For consolidated entities where we own or are exposed to less than </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">100%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> of the economics, we record net income (loss) attributable to noncontrolling interests in our condensed consolidated statements of income equal to the percentage of the economic or ownership interest retained in such entities by the respective noncontrolling parties. Intercompany balances and transactions are eliminated in consolidation. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In determining whether we are the primary beneficiary of an entity, we apply a qualitative approach that determines whether we have both (1) the power to direct the economically significant activities of the entity and (2) the obligation to absorb losses of, or the right to receive benefits from, the entity that could potentially be significant to that entity. These considerations impact the way we account for our existing collaborative relationships and other arrangements. We continuously assess whether we are the primary beneficiary of a variable interest entity as changes to existing relationships or future transactions may result in us consolidating or deconsolidating one or more of our collaborators or partners.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The preparation of our condensed consolidated financial statements requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosure of contingent assets and liabilities. On an on-going basis we evaluate our estimates, judgments and methodologies. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity and the amount of revenues and expenses. Actual results may differ from these estimates under different assumptions or conditions.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">New Accounting Pronouncements</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (FASB) or other standard setting bodies that we adopt as of the specified effective date. Unless otherwise discussed, we do not believe that the impact of recently issued standards that are not yet effective will have a material impact on our financial position or results of operations upon adoption.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In May 2014, the FASB issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes all existing revenue recognition requirements, including most industry-specific guidance. The new standard requires a company to recognize revenue when it transfers goods or services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, which delayed the effective date of the new standard from January 1, 2017 to January 1, 2018. The FASB also agreed to allow entities to choose to adopt the standard as of the original effective date. In March 2016, the FASB issued ASU No. 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations, which clarifies the implementation guidance on principal versus agent considerations. In April 2016, the FASB issued ASU No. 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing, which clarifies certain aspects of identifying performance obligations and licensing implementation guidance. In May 2016, the FASB issued ASU No. 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients related to disclosures of remaining performance obligations, as well as other amendments to guidance on collectibility, non-cash consideration and the presentation of sales and other similar taxes collected from customers. These standards have the same effective date and transition date of January 1, 2018. We are currently evaluating the method of adoption and the potential impact that these standards may have on our financial position and results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">During 2015, the FASB issued the following new standards, which we adopted on January 1, 2016:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">ASU No. 2015-05, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Fees Paid in a Cloud Computing Arrangement. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">ASU No. 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:12px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:6px;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">ASU No. 2015-16, Business Combinations (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments. </font></div></td></tr></table><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The adoption of these standards did not have an impact on our financial position or results of operations. For additional information related to these standards, please read Note 1, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Summary of Significant Accounting Policies: New Accounting Pronouncements</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to our consolidated financial statements included in our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form 10-K.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In January 2016, the FASB issued ASU No. 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The new standard amends certain aspects of accounting and disclosure requirements of financial instruments, including the requirement that equity investments with readily determinable fair values be measured at fair value with changes in fair value recognized in our results of operations. The new standard does not apply to investments accounted for under the equity method of accounting or those that result in consolidation of the investee. Equity investments that do not have readily determinable fair values may be measured at fair value or at cost minus impairment adjusted for changes in observable prices. A financial liability that is measured at fair value in accordance with the fair value option is required to be presented separately in other comprehensive income for the portion of the total change in the fair value resulting from change in the instrument-specific credit risk. In addition, a valuation allowance should be evaluated on deferred tax assets related to available-for-sale debt securities in combination with other deferred tax assets. The new standard will be effective for us on January 1, 2018. The adoption of this standard is not expected to have a material impact on our financial position or results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). The new standard requires that all lessees recognize the assets and liabilities that arise from leases on the balance sheet and disclose qualitative and quantitative information about its leasing arrangements. The new standard will be effective for us on January 1, 2019. The adoption of this standard is not expected to have a material impact on our net financial position, but will impact our assets and liabilities. We are currently evaluating the potential impact that this standard may have on our results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In March 2016, the FASB issued ASU No. 2016-06, Derivatives and Hedging (Topic 815): Contingent Put and Call Options in Debt Instruments. The new standard simplifies the embedded derivative analysis for debt instruments containing contingent call or put options by removing the requirement to assess whether a contingent event is related to interest rates or credit risks. The new standard will be effective for us on January 1, 2017. The adoption of this standard is not expected to have an impact on our financial position or results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In March 2016, the FASB issued ASU No. 2016-07, Investments - Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting. The new standard eliminates the requirement that when an investment qualifies for use of the equity method as a result of an increase in the level of ownership interest or degree of influence, an adjustment must be made to the investment, results of operations and retained earnings retroactively on a step-by-step basis as if the equity method had been in effect during all previous periods that the investment had been held. The new standard will be effective for us on January 1, 2017. The adoption of this standard is not expected to have a material impact on our financial position or results of operations.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In March 2016, the FASB issued ASU No. 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The new standard requires recognition of the income tax effects of vested or settled awards in the income statement and involves several other aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. The new standard will be effective for us on January 1, 2017. This standard is not expected to have a material impact on our financial position, results of operations or statements of cash flows upon adoption.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The new standard changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investment in leases that are not accounted for at fair value through net income to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. The new standard will be effective for us on January 1, 2020. The adoption of this standard is not expected to have a material impact on our financial position or results of operations.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Equity</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Total equity as of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> increased </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$2,028.8 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> compared to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. This increase was primarily driven by net income attributable to Biogen Inc. of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$2,020.7 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and an increase in additional paid in capital related to our share-based compensation arrangements, partially offset by other comprehensive losses.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Share Repurchases</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In July 2016, our Board of Directors authorized a program to repurchase up to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$5.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> of our common stock (2016 Share Repurchase Program). This authorization does not have an expiration date. Repurchased shares will be retired. The 2016 Share Repurchase Program is in addition to the approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">1.3 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> shares remaining under our February 2011 Share Repurchase Program (2011 Share Repurchase Program), which has been used principally to offset common stock issuances under our share-based compensation plans. During the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we did not repurchase any shares of common stock under our 2011 Share Repurchase Program. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In May 2015, our Board of Directors authorized a program to repurchase up to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$5.0 billion</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> of our common stock, which was completed as of December 31, 2015. During the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, we repurchased and retired </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.1 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> shares of common stock at a cost of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$42.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Noncontrolling Interests</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The following table reconciles equity (deficit) attributable to noncontrolling interests (NCI):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Three Months <br clear="none"/>Ended June 30,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">For the Six Months <br clear="none"/>Ended June 30,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">(In millions)</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;color:#257acb;font-weight:bold;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:8pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">NCI, beginning of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">1.3</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">2.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Net income (loss) attributable to NCI, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(1.4</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(2.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(3.1</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">(4.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Fair value of net assets and liabilities acquired and assigned to NCI</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">0.9</font></div></td><td style="vertical-align:bottom;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Translation adjustment and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#dddddd;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">NCI, end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#dddddd;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">(0.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#dddddd;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#257acb;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">20.&#160;&#160;&#160;&#160;Subsequent Events</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">On July 21, 2016, we announced that George A. Scangos, Ph.D. will step down as our Chief Executive Officer after a successor has been identified. Dr. Scangos will remain on our Board of Directors until he steps down from his executive position. Our Board of Directors will begin a search for Dr. Scangos&#8217; successor immediately.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The preparation of our condensed consolidated financial statements requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosure of contingent assets and liabilities. On an on-going basis we evaluate our estimates, judgments and methodologies. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity and the amount of revenues and expenses. Actual results may differ from these estimates under different assumptions or conditions.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:12pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:12pt;color:#578196;font-weight:bold;">Investments in Variable Interest Entities</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Consolidated Variable Interest Entities</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Our condensed consolidated financial statements include the financial results of variable interest entities in which we are the primary beneficiary. </font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#538235;font-style:italic;">Neurimmune SubOne AG</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">In 2007, we entered into a collaboration agreement with Neurimmune SubOne AG (Neurimmune), a subsidiary of Neurimmune AG, for the development and commercialization of antibodies for the treatment of Alzheimer&#8217;s disease. Neurimmune conducts research to identify potential therapeutic antibodies and we are responsible for the development, manufacturing and commercialization of all products. Our anti-amyloid beta antibody, aducanumab, for the treatment of Alzheimer&#8217;s disease resulted from this collaboration. Based upon our current development plans for aducanumab, we may pay Neurimmune up to </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$275.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> in remaining milestone payments. We may also pay royalties in the low-to-mid-teens on sales of any resulting commercial products.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We determined that we are the primary beneficiary of Neurimmune because we have the power through the collaboration to direct the activities that most significantly impact the entity&#8217;s economic performance and are required to fund </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">100%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> of the research and development costs incurred in support of the collaboration agreement. Accordingly, we consolidate the results of Neurimmune.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We are required to reimburse Neurimmune for amounts that are incurred by Neurimmune for research and development expenses in support of the collaboration. Amounts reimbursed are reflected in research and development expense in our condensed consolidated statements of income. For the </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">three and six</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> months ended </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, these amounts were immaterial. Future milestone payments and royalties, if any, will be reflected in our condensed consolidated statements of income as a charge to noncontrolling interest, net of tax, when such milestones are achieved.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The assets and liabilities of Neurimmune are not significant to our financial position or results of operations as it is a research and development organization. We have provided no financing to Neurimmune other than previously contractually required amounts.</font></div><div style="line-height:120%;padding-top:12px;text-indent:18px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#538235;font-style:italic;">Other Variable Interest Entities</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We also consolidate the financial results of our other variable interest entities where we are the primary beneficiary. We may pay these variable interest entities up to approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$8.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> in remaining milestone payments. We have provided no financing to these entities other than amounts provided for in the contract.</font></div><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;color:#2573ba;font-style:italic;font-weight:bold;">Unconsolidated Variable Interest Entities</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We have relationships with other variable interest entities that we do not consolidate as we lack the power to direct the activities that significantly impact the economic success of these entities. These relationships include investments in certain biotechnology companies and research collaboration agreements. As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">June&#160;30, 2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, the total carrying value of our investments in biotechnology companies totaled </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$38.0 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">$29.2 million</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, respectively. Our maximum exposure to loss related to these variable interest entities is limited to the carrying value of our investments.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">We have also entered into research collaboration agreements with certain variable interest entities where we are required to fund certain development activities. These development activities are included in research and development expense in our condensed consolidated statements of income, as they are incurred. We have provided no financing to these variable interest entities other than previously contractually required amounts. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">For additional information related to our investments in variable interest entities, please read Note 18, </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;font-style:italic;">Investments in Variable Interest Entities</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> to our consolidated financial statements included in our </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2015</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> Form 10-K.</font></div></div> EX-101.SCH 7 biib-20160630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2119100 - Disclosure - Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 2419402 - Disclosure - Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Details) link:presentationLink link:calculationLink link:definitionLink 2419403 - Disclosure - Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Details 1) link:presentationLink link:calculationLink link:definitionLink 2319301 - Disclosure - Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Tables) link:presentationLink link:calculationLink link:definitionLink 2125100 - Disclosure - Collaborative and Other Relationships link:presentationLink link:calculationLink link:definitionLink 2425402 - Disclosure - Collaborative and Other Relationships Collaborative and Other Relationships - Collaborations (Details) link:presentationLink link:calculationLink link:definitionLink 2425403 - Disclosure - Collaborative and Other Relationships Collaborative and Other Relationships - Equity Method Investments (Details) link:presentationLink link:calculationLink link:definitionLink 2325301 - Disclosure - Collaborative and Other Relationships Collaborative and Other Relationships (Tables) link:presentationLink link:calculationLink link:definitionLink 2427401 - Disclosure - Commitments and Contingences (Details) link:presentationLink link:calculationLink link:definitionLink 2127100 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2427402 - Disclosure - Commitments and Contingencies Commitments and Contingencies (Details 1) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1003501 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Condensed Consolidated Statements of Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Derivative Instruments link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Derivative Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Derivative Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2120100 - Disclosure - Earnings per Share link:presentationLink link:calculationLink link:definitionLink 2420402 - Disclosure - Earnings per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2320301 - Disclosure - Earnings per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 2418402 - Disclosure - Equity (Details) link:presentationLink link:calculationLink link:definitionLink 2418403 - Disclosure - Equity (Details Textual) link:presentationLink link:calculationLink link:definitionLink 2318301 - Disclosure - Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - Fair Value Measurements (Details 1) link:presentationLink link:calculationLink link:definitionLink 2410404 - Disclosure - Fair Value Measurements (Details 2) link:presentationLink link:calculationLink link:definitionLink 2410405 - Disclosure - Fair Value Measurements (Details Textual) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Financial Instruments link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 2412403 - Disclosure - Financial Instruments (Details 1) link:presentationLink link:calculationLink link:definitionLink 2412404 - Disclosure - Financial Instruments (Details 2) link:presentationLink link:calculationLink link:definitionLink 2412405 - Disclosure - Financial Instruments (Details 3) link:presentationLink link:calculationLink link:definitionLink 2412406 - Disclosure - Financial Instruments (Details Textual) link:presentationLink link:calculationLink link:definitionLink 2412407 - Disclosure - Financial Instruments Financial Instruments (Details Textual 2) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 2122100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2422402 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2422403 - Disclosure - Income Taxes (Details Textual) link:presentationLink link:calculationLink link:definitionLink 2322301 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Intangible Assets and Goodwill link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Intangible Assets and Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 2409403 - Disclosure - Intangible Assets and Goodwill (Details 1) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - Intangible Assets and Goodwill (Tables) link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - Inventory Inventory (Details Textual) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 2124100 - Disclosure - Investments in Variable Interest Entities link:presentationLink link:calculationLink link:definitionLink 2424401 - Disclosure - Investments in Variable Interest Entities (Details) link:presentationLink link:calculationLink link:definitionLink 2126100 - Disclosure - Litigation link:presentationLink link:calculationLink link:definitionLink 2426401 - Disclosure - Litigation (Details) link:presentationLink link:calculationLink link:definitionLink 2123100 - Disclosure - Other Consolidated Financial Statement Detail link:presentationLink link:calculationLink link:definitionLink 2423402 - Disclosure - Other Consolidated Financial Statement Detail (Details) link:presentationLink link:calculationLink link:definitionLink 2423403 - Disclosure - Other Consolidated Financial Statement Detail Other Consolidated Financial Statement (Details Textual) link:presentationLink link:calculationLink link:definitionLink 2323301 - Disclosure - Other Consolidated Financial Statement Detail (Tables) link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Property, Plant and Equipment Property, Plant and Equipment link:presentationLink link:calculationLink link:definitionLink 2416401 - Disclosure - Property, Plant and Equipment Property, Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Reserves for Discounts and Allowances link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Reserves for Discounts and Allowances (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Reserves for Discounts and Allowances (Details 1) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Reserves for Discounts and Allowances (Details 1) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Reserves for Discounts and Allowances (Tables) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Restructuring Restructuring link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Restructuring Restructuring (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Restructuring Restructuring (Details Textual) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Restructuring Restructuring (Tables) link:presentationLink link:calculationLink link:definitionLink 2121100 - Disclosure - Share-based Payments link:presentationLink link:calculationLink link:definitionLink 2421402 - Disclosure - Share-Based Payments (Details) link:presentationLink link:calculationLink link:definitionLink 2421403 - Disclosure - Share-Based Payments (Details 1) link:presentationLink link:calculationLink link:definitionLink 2421404 - Disclosure - Share-Based Payments (Details 2) link:presentationLink link:calculationLink link:definitionLink 2421405 - Disclosure - Share-Based Payments (Details Textual) link:presentationLink link:calculationLink link:definitionLink 2321301 - Disclosure - Share-Based Payments (Tables) link:presentationLink link:calculationLink link:definitionLink 2128100 - Disclosure - Subsequent Events Subsequent Events link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2401402 - Disclosure - Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 biib-20160630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 biib-20160630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 biib-20160630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Restructuring and Related Activities [Abstract] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Restructuring Type [Axis] Restructuring Type [Axis] Type of Restructuring [Domain] Type of Restructuring [Domain] Workforce reduction Employee Severance [Member] Pipeline programs Contract Termination [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Restructuring reserve as of December 31, 2015 Restructuring Reserve Expense Restructuring Costs Payments Payments for Restructuring Adjustments to previous estimates, net Restructuring Reserve, Accrual Adjustment Restructuring reserve as of June 30, 2016 Goodwill and Intangible Assets Disclosure [Abstract] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Products and Services [Axis] Products and Services [Axis] Products and Services [Domain] Products and Services [Domain] TECFIDERA TECFIDERA [Member] TECFIDERA [Member] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Fumapharm AG Fumapharm AG [Member] Fumapharm AG [Member] Goodwill [Line Items] Goodwill [Line Items] Income tax benefit (expense) Income Tax Expense (Benefit) Increase to goodwill Goodwill, Acquired During Period Summary of roll forward of the changes in goodwill Goodwill [Roll Forward] Goodwill, beginning of period Goodwill Other Goodwill, Other Increase (Decrease) Goodwill, end of period Inventory Disclosure [Abstract] Products and Services [Table] Products and Services [Table] ZINBRYTA ZINBRYTA [Member] ZINBRYTA [Member] FLIXABI FLIXABI [Member] FLIXABI [Member] BENEPALI BENEPALI [Member] BENEPALI [Member] Inventory [Line Items] Inventory [Line Items] Pre-approval inventory Pre-approval inventory Pre-approval inventory Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Statement [Table] Statement [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Accumulated Net Unrealized Investment Gain (Loss) Accumulated Net Investment Gain (Loss) Attributable to Parent [Member] Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income Reclassification out of Accumulated Other Comprehensive Income [Member] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Other income (expense), net Nonoperating Income (Expense) Product, net Sales Revenue, Goods, Net Operating expenses Operating Expenses Net income attributable to Biogen Inc. Net Income (Loss) Attributable to Parent Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of Employee Stock Ownership Plan (ESOP) Disclosures [Table] Schedule of Employee Stock Ownership Plan (ESOP) Disclosures [Table] Plan Name [Axis] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] 1995 ESPP 1995 ESPP [Member] 1995 ESPP [Member] 2015 ESPP 2015 ESPP [Member] 2015 ESPP [Member] Employee Stock Ownership Plan (ESOP) Disclosures [Line Items] Employee Stock Ownership Plan (ESOP) Disclosures [Line Items] Employee stock purchase plan maximum shares Employee stock purchase plan maximum shares Employee stock purchase plan maximum shares Shares issued under ESPP Stock Issued During Period, Shares, Employee Stock Purchase Plans Organization, Consolidation and Presentation of Financial Statements [Abstract] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Component of accrued expenses and other Other Current Liabilities [Member] Statement [Line Items] Statement [Line Items] Accrued Expenses and Other Accrued Liabilities, Current [Abstract] Revenue-related reserves for discounts and allowances Valuation Allowances and Reserves, Balance Current portion of contingent consideration obligations and milestones Business Combination, Contingent Consideration, Liability, Current Employee compensation and benefits Employee-related Liabilities, Current Royalties and licensing fees Accrued Royalties, Current Other Other Accrued Liabilities, Current Total accrued expenses and other Other Liabilities, Current Other Income (Expense), Net Interest Income (Expense), Net [Abstract] Interest income Investment Income, Interest Interest expense Interest Expense Gain (loss) on sales of investments, net Gain (Loss) on Sale of Investments Foreign exchange gains (losses), net Foreign Currency Transaction Gain (Loss), before Tax Other, net Other Nonoperating Income (Expense) Other income (expense), net Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Award Type [Axis] Award Type [Axis] Equity Award [Domain] Equity Award [Domain] Market stock units Market Stock Units [Member] Market stock units. Time-vested restricted stock units Time Vested Restricted Stock Units [Member] Time vested restricted stock units. Cash settled performance shares Cash settled performance shares [Member] Cash settled performance shares [Member] Performance units Performance Shares [Member] Employee stock purchase plan Employee Stock Purchase Plan [Member] Employee stock purchase plan. Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Summary of share based compensation expense associated with different programs Summary of share based compensation expense associated with different programs [Abstract] Summary of share-based compensation expense associated with different programs. Share-based compensation expense Allocated Share-based Compensation Expense Subtotal Allocated Share-based Compensation Expense, Net of Tax Capitalized share-based compensation costs Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Capitalized Amount Share-based compensation expense included in total costs and expenses Share Based Compensation Expense Included In Costs And Expenses Share based compensation expense included in costs and expenses. Equity [Abstract] Equity Stockholders' Equity Note Disclosure [Text Block] Subsequent Event [Table] Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent event Subsequent Event [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Authorized amount of share repurchases under the 2015 Share Repurchase Program Stock Repurchase Program, Authorized Amount Equity increase during the period Stockholders' Equity, Period Increase (Decrease) Common stock shares authorized for repurchased Stock Repurchase Program, Number of Shares Authorized to be Repurchased Repurchase of common stock, shares Treasury Stock, Shares, Acquired Purchase of treasury stock Payments for Repurchase of Common Stock Restructuring Restructuring and Related Activities Disclosure [Text Block] Fair Value Disclosures [Abstract] Summary of assets and liabilities recorded at fair value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Summary of fair and carrying value of debt instruments Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block] Fair value of contingent consideration obligations Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Share-based compensation expense included in condensed consolidated statements of income Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Summary of share-based compensation expense associated with each of our share-based compensating programs Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block] Summary of equity grants to employees, officers and directors under our current stock plans Schedule Of Restricted Stock Unit Grants [Table Text Block] Schedule of restricted stock unit grants. Investments, Debt and Equity Securities [Abstract] Schedule of Cash and Cash Equivalents [Table] Schedule of Cash and Cash Equivalents [Table] Investment Type [Axis] Investment Type [Axis] Investment Type Categorization [Domain] Investments [Domain] Commercial paper Commercial Paper [Member] Overnight reverse repurchase agreements Repurchase Agreements [Member] Money market funds Money Market Funds [Member] Short-term debt securities Debt Securities [Member] Cash and Cash Equivalents [Line Items] Cash and Cash Equivalents [Line Items] Summary of financial assets with original maturities of less than 90 days included within cash and cash equivalents Cash Equivalents, at Carrying Value [Abstract] Cash equivalents Cash Equivalents, at Carrying Value Loss Contingency, Information about Litigation Matters [Abstract] Loss Contingencies [Table] Loss Contingencies [Table] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] Italy ITALY Loss Contingencies [Line Items] Reimbursement limit stated in the resolution Reimbursement Limit Stated In Resolution Reimbursement limit stated in the resolution. Sales Discounts, Returns and Allowances, Goods [Abstract] Analysis of the changes in reserves Analysis Of Amount Of And Change In Product Revenue Reserves [Table Text Block] Analysis of amount of and change in product revenue reserves. Total reserves included in condensed consolidated balance sheets Summary Of Product Revenue Reserves Included In Consolidated Balance Sheets [Table Text Block] Summary of total product revenue reserves included in consolidated balance sheets. Accumulated Other Comprehensive Income (Loss) Comprehensive Income (Loss) Note [Text Block] Commitments and Contingencies Disclosure [Abstract] Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table] Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table] Cumulative sales level [Axis] Cumulative sales level [Axis] Cumulative sales level [Axis] Cumulative sales level [Domain] Cumulative sales level [Domain] [Domain] for Cumulative sales level [Axis] Seven billion Seven billion [Member] Seven billion [Member] Eight billion Eight billion [Member] Eight billion Nine billion Nine billion [Member] Nine billion [Member] Each additional one billion up to twenty billion Each additional one billion up to twenty billion [Member] Each additional one billion up to twenty billion [Member] One billion One billion [Member] One billion [Member] Three billion Three billion [Member] Three billion [Member] Business Acquisition, Contingent Consideration [Line Items] Business Acquisition, Contingent Consideration [Line Items] Cash portion of consideration Payments to Acquire Businesses, Gross Maximum contingent consideration in the form of development and approval milestones Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Cumulative sales level Cumulative sales level Cumulative sales level Statement of Comprehensive Income [Abstract] Other comprehensive income: Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Unrealized gains (losses) on securities available for sale, net of tax Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax Unrealized gains (losses) on cash flow hedges, net of tax Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax Unrealized gains (losses) on pension benefit obligation Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax Currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Total other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax Comprehensive income attributable to Biogen Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive income (loss) attributable to noncontrolling interests, net of tax Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive income Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Intangible Assets and Goodwill Goodwill and Intangible Assets Disclosure [Text Block] Subsequent Events [Abstract] Subsequent Events Subsequent Events [Text Block] Long-term Purchase Commitment [Table] Long-term Purchase Commitment [Table] Switzerland SWITZERLAND Long-term Purchase Commitment [Line Items] Long-term Purchase Commitment [Line Items] Contractual commitments for the construction of the facility Other Commitment Summary of Contractual Maturities: Available-for-Sale Securities Available-for-sale Securities, Debt Maturities [Abstract] Due in one year or less, estimated fair value Available-for-sale Securities, Debt Maturities, Next Twelve Months, Fair Value Due in one year or less, amortized cost Available-for-sale Securities, Debt Maturities, Next Twelve Months, Amortized Cost Basis Due after one year through five years, Estimated Fair Value Available-for-sale Securities, Debt Maturities, Year Two Through Five, Fair Value Due after one year through five years, Amortized Cost Available-for-sale Securities, Debt Maturities, Year Two Through Five, Amortized Cost Basis Due after five years, estimated fair value Available For Sale Securities Debt Maturities After Five Years Fair Value This item represents the fair value of debt securities, which are expected to mature after five years from the balance sheet date and which are categorized neither as held-to-maturity nor trading securities. Due after five years, amortized cost Available For Sale Securities Debt Maturities After Five Years Amortized Cost This item represents debt securities, at cost, net of adjustments made for accretion, amortization, other-than-temporary impairments, and hedging, if any, which are expected to mature after five years from the balance sheet date and which are categorized neither as held-to-maturity nor trading securities. Total available-for-sale securities, Fair Value Available-for-sale Securities Total available-for-sale securities, Amortized Cost Available-for-sale Debt Securities, Amortized Cost Basis Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] TYSABRI product TYSABRI product [Member] TYSABRI product [Member] Indefinite-lived Intangible Assets by Major Class [Axis] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] In-process research and development In Process Research and Development [Member] Trademarks and trade names Trademarks and Trade Names [Member] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Out-licensed patents Out Licensed Patents [Member] Out-licensed patents. Developed technology Developed Technology Rights [Member] Acquired and in-licensed rights and patents In Licensed Patents [Member] In-licensed patents. AVONEX AVONEX [Member] AVONEX Biosimilars Biosimilars [Member] Biosimilars [Member] ALPROLIX ALPROLIX [Member] ALPROLIX [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Intangible assets Intangible Assets, Net (Excluding Goodwill) [Abstract] Estimated life, (in years) Finite-Lived Intangible Asset, Useful Life Indefinite lived intangible assets useful life Indefinite Lived Intangible Assets Useful Life Indefinite lived intangible assets useful life. Cost Finite-Lived Intangible Assets, Gross Cost and Net Indefinite-Lived Intangible Assets (Excluding Goodwill) Total intangible assets, gross Intangible Assets, Gross (Excluding Goodwill) Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Net Finite-Lived Intangible Assets, Net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Increase in acquired and in-licensed rights and patents Finite-Lived Intangible Assets, Period Increase (Decrease) Contingent payment made during the period Milestone Payments Made During Period Milestone Payments Made During Period. Deferred tax liability Deferred Tax Liabilities, Intangible Assets Intangible Assets and Goodwill (Textual) [Abstract] Intangible Assets, Net (Including Goodwill) [Abstract] Amortization of acquired intangible assets Amortization of Intangible Assets Accumulated impairment losses related to goodwill Goodwill, Impaired, Accumulated Impairment Loss Expected future amortization expense, 2016 (remaining six months) Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year Expected future amortization expense, 2017 Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months Expected future amortization expense, 2018 Finite-Lived Intangible Assets, Amortization Expense, Year Two Expected future amortization expense, 2019 Finite-Lived Intangible Assets, Amortization Expense, Year Three Expected future amortization expense, 2020 Finite-Lived Intangible Assets, Amortization Expense, Year Four Expected future amortization expense, 2021 Finite-Lived Intangible Assets, Amortization Expense, Year Five Accumulated Defined Benefit Plans Adjustment Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Accumulated Translation Adjustment Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Accumulated other comprehensive income [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Balance, as of the beginning of the period Accumulated Other Comprehensive Income (Loss), Net of Tax Other comprehensive income loss before reclassifications Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Amounts reclassified from accumulated other comprehensive income loss Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Net current period other comprehensive income loss Balance, as of the end of the period Accounting Policies [Abstract] Overview Business Overview [Policy Text Block] Describes an overview of the company and its operations. Basis of presentation Basis of Accounting, Policy [Policy Text Block] Consolidation Consolidation, Policy [Policy Text Block] Use of estimates Use of Estimates, Policy [Policy Text Block] New accounting pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Investments, All Other Investments [Abstract] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Domain] Major Types of Debt and Equity Securities [Domain] Strategic Investments Strategic Investments [Member] Strategic investments. Business Acquisition [Line Items] Business Acquisition [Line Items] Strategic investment portfolio Strategic Investment Portfolio Strategic investment portfolio. Reconciliation of equity attributable to non-controlling interests Reconciliation Of Equity Attributable To Non Controlling Interests [Abstract] Reconciliation of equity attributable to non-controlling interests. NCI, beginning of period Stockholders' Equity Attributable to Noncontrolling Interest Net income (loss) attributable to NCI, net of tax Net Income (Loss) Attributable to Noncontrolling Interest Fair value of net assets and liabilities acquired and assigned to NCI Noncontrolling Interest, Increase from Business Combination Translation adjustment and other Noncontrolling interest, increase (decrease) other Noncontrolling interest, increase (decrease) other NCI, end of period Earnings Per Share [Abstract] Basic and diluted earnings per share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Income Tax Disclosure [Abstract] Income Tax Contingency [Table] Income Tax Contingency [Table] Income Tax Authority [Axis] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] SKAT Foreign Tax Authority [Member] Tax Period [Axis] Tax Period [Axis] Tax Period [Domain] Tax Period [Domain] Tax Year 2007 Tax Year 2007 [Member] Tax Year 2008 Tax Year 2008 [Member] Tax Year 2009 Tax Year 2009 [Member] Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Notice of assessment of corporate withholding tax including penalties and interest Income Tax Examination, Penalties and Interest Accrued Payments to taxing authority Payments for Other Taxes Net benefit for a previously unrecognized position Unrecognized Tax Benefits Proposed deduction disallowance by tax authorities Proposed Disallowance By Tax Authorities For Payment For Services Proposed disallowance by tax authorities for payment for services. Reconciliation between the U.S. federal statutory tax rate and effective tax rate Effective Income Tax Rate Reconciliation, Percent [Abstract] Statutory rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent State taxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Taxes on foreign earnings Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Credits and net operating loss utilization Effective Income Tax Rate Reconciliation, Tax Credit, Percent Purchased intangible assets Effective Income Tax Rate Reconciliation, Nondeductible Expense, Depreciation and Amortization, Percent Manufacturing deduction Effective income tax rate reconciliation manufacturing deduction Effective income tax rate reconciliation manufacturing deduction Permanent items Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Effective tax rate Effective Income Tax Rate Reconciliation, Percent Other income (expense), net Schedule of Other Nonoperating Income (Expense) [Table Text Block] Accrued expenses and other Schedule of Accrued Liabilities [Table Text Block] Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Equity Method Investee, Name [Axis] Investment, Name [Axis] Equity Method Investee, Name [Domain] Investment, Name [Domain] Samsung Biosimilar Agreement [Member] Samsung Biosimilar Agreement [Member] Samsung bio-similar agreement. Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Contribution from Samsung to develop, manufacture and market biosimilar pharmaceuticals Investments By Third Party In Joint Venture As Per Agreement. Investments by third party in joint venture as per agreement Variable interest entity, qualitative or quantitative information, ownership percentage Joint Venture Owner Ship Percentage By Third Party. Joint venture owner ship percentage by third party. Contribution from Biogen to develop, manufacture and market biosimilar pharmaceuticals Equity Method Investments Percentage of stake in entity minimum Equity Method Investment, Ownership Percentage Percentage of stake in entity maximum Equity Method Investment Ownership Percentage Maximum Equity method investment ownership percentage maximum. Recognized loss Income (Loss) from Equity Method Investments Research and development Research and Development Expense (Excluding Acquired in Process Cost) Expected profit share with Samsung Bioepis Equity Method Investments, Expected Profit Share Equity Method Investments, Expected Profit Share Revenue related to technical development and technology transfer services Other Revenue, Net Measurement Frequency [Axis] Measurement Frequency [Axis] Fair Value, Measurement Frequency [Domain] Fair Value, Measurement Frequency [Domain] Fair Value, Measurements, Recurring Fair Value, Measurements, Recurring [Member] Fair value, beginning of period Business Combination, Contingent Consideration, Liability Additions Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases Changes in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Payments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Fair value, end of period Summary of financial assets with maturities of less than 90 days included within cash and cash equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Marketable debt and equity securities Available-for-sale Securities [Table Text Block] Summary of contractual maturities: available-for-sale securities Investments Classified by Contractual Maturity Date [Table Text Block] Proceeds from marketable debt securities Realized Gain (Loss) on Investments [Table Text Block] Investments in Variable Interest Entities [Abstract] Investments In Variable Interest Entities. Investments in Variable Interest Entities Variable Interest Entity Disclosure [Text Block] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] 6.875% Senior Notes due 2018 Senior Notes Six Point Eight Seven Five Percent Due Twenty Eighteen [Member] Senior Notes Six Point Eight Seven Five Percent Due Twenty Eighteen. 2.900% Senior Notes due 2020 Senior Notes Two Point Nine Percent Due Twenty Twenty [Member] Senior Notes Two Point Nine Percent Due Twenty Twenty [Member] 3.625% Senior Notes due 2022 Senior Notes Three Point Six Two Five Percent Due Twenty Twenty Two [Member] Senior Notes Three Point Six Two Five Percent Due Twenty Twenty Two [Member] 4.050% Senior Notes due 2025 Senior Notes Four Point Zero Five Percent Due Twenty Twenty Five [Member] Senior Notes Four Point Zero Five Percent Due Twenty Twenty Five [Member] 5.200% Senior Notes due 2045 Senior Notes Five Point Two Percent Due Twenty Forty Five [Member] Senior Notes Five Point Two Percent Due Twenty Forty Five [Member] Asset impairment charges Asset Impairment Charges Changes in valuation techniques Fair Value Measurements, Changes in Valuation Techniques Senior Notes interest rate Debt Instrument, Interest Rate, Stated Percentage Contingent consideration obligations Business Combination, Contingent Consideration, Liability, Noncurrent Commitments and Contingencies Disclosure Commitments and Contingencies Disclosure [Text Block] Collaborative and Other Relationships Collaborative Arrangement Disclosure [Text Block] Restructuring and related cost, expected percentage of positions eliminated Restructuring and related cost, expected percentage of positions eliminated Restructuring and related cost, expected percentage of positions eliminated Expected cash payments Restructuring and Related Cost, Expected Cash Payments Restructuring and Related Cost, Expected Cash Payments Expected restructuring charges Restructuring and Related Cost, Expected Cost Restructuring charges Restructuring Charges Proceeds from maturities and sales Proceeds from Sale and Maturity of Available-for-sale Securities Realized gains Available-for-sale Securities, Gross Realized Gains Realized losses Available-for-sale Securities, Gross Realized Losses Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share, by Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Stock options and employee stock purchase plan Stock options and employee stock purchase plan [Member] Stock options and employee stock purchase plan. Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Basic and diluted earnings per share Basic And Diluted Earnings Per Share [Abstract] Basic and diluted earnings per share. Numerator: Net Income (Loss) Attributable to Parent [Abstract] Net income attributable to Biogen Inc Weighted-average shares used in calculating: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted average number of common shares outstanding Weighted Average Number of Shares Outstanding, Basic Effect of dilutive securities: Dilutive Securities, Effect on Basic Earnings Per Share [Abstract] Stock units Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Dilutive potential common shares Weighted Average Number Diluted Shares Outstanding Adjustment Shares used in calculating diluted earnings per share Weighted Average Number of Shares Outstanding, Diluted Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Quoted Prices in Active Markets, Level 1 Fair Value, Inputs, Level 1 [Member] Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Asset Class [Axis] Asset Class [Axis] Fair Value by Asset Class [Domain] Asset Class [Domain] Corporate debt securities Corporate Debt Securities [Member] Government securities US Treasury and Government [Member] Mortgage and other asset backed securities Asset-backed Securities [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Summary of assets and liabilities recorded at fair value Fair Value, Assets, Liabilities and Stockholders' Equity Measured on Recurring Basis [Abstract] Assets: Assets, Fair Value Disclosure [Abstract] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Marketable debt securities Marketable equity securities Investments, Fair Value Disclosure Derivative contracts Foreign Currency Contract, Asset, Fair Value Disclosure Plan assets for deferred compensation Plan Assets For Deferred Compensation Fair Value Disclosure Fair values as of the balance sheet date of all assets of deferred compensation plans. Total Assets, Fair Value Disclosure Liabilities: Liabilities, Fair Value Disclosure [Abstract] Derivative contracts Foreign Currency Contracts, Liability, Fair Value Disclosure Contingent consideration obligations Total Financial and Nonfinancial Liabilities, Fair Value Disclosure Income Statement [Abstract] Revenues: Revenues [Abstract] Product, net Revenues from anti-CD20 therapeutic programs Revenues from anti-CD20 therapeutic programs Revenues from anti-CD20 therapeutic programs consists of our share of pre-tax co-promotion profits in the U.S.; reimbursement of selling and development expense in the U.S.; and revenue on sales of RITUXAN outside the U.S., which consist of our share of pre-tax co-promotion profits in Canada. Other Total revenues Revenues Cost and expenses: Costs and Expenses [Abstract] Cost of sales, excluding amortization of acquired intangible assets Cost of Goods Sold Research and development Selling, general and administrative Selling, General and Administrative Expense (Gain) loss on fair value remeasurement of contingent consideration Collaboration profit (loss) sharing Collaboration profit (loss) sharing Collaboration profit (loss) sharing Total cost and expenses Costs and Expenses Income from operations Operating Income (Loss) Other income (expense), net Income before income tax expense and equity in loss of investee, net of tax Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Income tax expense Equity in loss of investee, net of tax Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net income (loss) attributable to noncontrolling interests, net of tax Net income attributable to Biogen Inc. Net income per share: Basic earnings per share attributable to Biogen Inc. Earnings Per Share, Basic Diluted earnings per share attributable to Biogen Inc. Earnings Per Share, Diluted Basic earnings per share attributable to Biogen Inc. Diluted earnings per share attributable to Biogen Inc. Components of inventory Schedule of Inventory, Current [Table Text Block] Other Consolidated Financial Statement Detail Additional Financial Information Disclosure [Text Block] Charges and spending related to our restructuring efforts Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Overnight reverse repurchase agreements, percent of total assets Overnight reverse repurchase agreements, percent of total assets Overnight reverse repurchase agreements, percent of total assets Average maturity of marketable securities, months Average Maturity Of Marketable Securities Average remaining time to maturity of marketable debt securities, available-for-sale securities. Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments Derivative Instruments and Hedging Activities Disclosure [Text Block] Intangible assets Intangible Assets Excluding Goodwill [Table Text Block] Intangible assets excluding goodwill. Estimated future amortization for acquired intangible assets Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Summary of roll forward of the changes in goodwill Schedule of Goodwill [Table Text Block] Statement of Financial Position [Abstract] Preferred stock, par value Preferred Stock, Par or Stated Value Per Share Common stock, par value Common Stock, Par or Stated Value Per Share Schedule of accumulated other comprehensive income (loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Reclassification out of accumulated other comprehensive income Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Components of inventories Inventory, Net [Abstract] Raw materials Inventory, Raw Materials, Net of Reserves Work in process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Total inventory Inventory, net current and noncurrent Inventory, net current and noncurrent Inventory, current Inventory, Net Inventory, Noncurrent Inventory, Noncurrent Share-based Payments Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Reconciliation of equity attributable to noncontrolling interests Reconciliation Of Equity Attributable To Noncontrolling Interests [Table Text Block] Reconciliation of equity attributable to noncontrolling interests. Valuation and Qualifying Accounts Disclosure [Table] Valuation and Qualifying Accounts Disclosure [Table] Valuation Allowances and Reserves Type [Axis] Valuation Allowances and Reserves Type [Axis] Valuation Allowances and Reserves [Domain] Valuation Allowances and Reserves [Domain] Discounts Reserve for Cash Discount [Member] Contractual Adjustments Contractual Adjustments [Member] Contractual adjustments. Returns Sales Returns and Allowances [Member] Valuation and Qualifying Accounts Disclosure [Line Items] Valuation and Qualifying Accounts Disclosure [Line Items] Analysis of the amount of, and change in, reserves Analysis Of Amount Of And Change In Product Revenue Reserves [Abstract] Analysis of the amount of, and change in product revenue reserves. Balance as of December 31, 2015 Current provisions relating to sales in current year Current Provisions To Product Revenue Reserves Relating To Sales In Current Year Current provisions to product revenue reserves relating to sales in current year. Adjustments relating to prior years Adjustments To Product Revenue Reserves Relating To Sales In Prior Years Adjustments to product revenue reserves relating to sales in prior years. Payments/credits relating to sales in current year Payments Returns Applied Against Product Revenue Reserves Relating To Current Year Payments/ returns applied against product revenue reserves relating to current year. Payments/credits relating to sales in prior years Payments Returns Applied Against Product Revenue Reserves Relating To Prior Year Payments/ returns applied against product revenue reserves relating to prior year. Balance as of June 30, 2016 Income Taxes Income Tax Disclosure [Text Block] Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net income Adjustments to reconcile net income to net cash flows from operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Share-based compensation Share-based Compensation Deferred income taxes Deferred Income Tax Expense (Benefit) Other Other Noncash Income (Expense) Changes in operating assets and liabilities, net: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventory Increase (Decrease) in Inventories Accrued expenses and other current liabilities Increase (Decrease) in Accrued Liabilities Current taxes payable Increase (Decrease) in Income Taxes Payable Other changes in operating assets and liabilities, net Increase (Decrease) in Other Operating Assets and Liabilities, Net Net cash flows provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Proceeds from sales and maturities of marketable securities Purchases of marketable securities Payments to Acquire Available-for-sale Securities Acquisitions of business, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Purchases of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Contingent consideration related to Fumapharm AG acquisition Payments to Acquire Other Productive Assets Other Payments for (Proceeds from) Other Investing Activities Net cash flows used in investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Purchase of treasury stock Proceeds from issuance of stock for share-based compensation arrangements Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options Excess tax benefit from share-based awards Excess Tax Benefit from Share-based Compensation, Financing Activities Other Proceeds from (Payments for) Other Financing Activities Net cash flows provided by financing activities Net Cash Provided by (Used in) Financing Activities Net increase in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash and Cash Equivalents Cash and cash equivalents, beginning of the period Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents, end of the period Earnings per Share Earnings Per Share [Text Block] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Currency [Axis] Currency [Axis] All Currencies [Domain] All Currencies [Domain] Euro Euro Member Countries, Euro Swiss francs Switzerland, Francs Canadian Dollar Canada, Dollars Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Revenue Sales [Member] Operating expense Operating Expense [Member] Other income (expense) Other Nonoperating Income (Expense) [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] Cash flows, revenue Cash flows, revenue [Member] Cash flows, revenue [Member] Cash flows, operating expenses Cash flows, operating expenses [Member] Cash flows, operating expenses [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Foreign exchange contract Foreign Exchange Contract [Member] Interest rate swap Interest Rate Swap [Member] Other current assets Other Current Assets [Member] Investments and other assets Other Investments [Member] Accrued expenses and other Accrued Liabilities [Member] Other long-term liabilities Other Noncurrent Liabilities [Member] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Designated as hedging instrument Designated as Hedging Instrument [Member] Not designated as hedging instrument Not Designated as Hedging Instrument [Member] Minimum Maximum Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Summary of Derivatives designated as Hedging Instruments Derivative Asset, Fair Value, Amount Not Offset Against Collateral [Abstract] Derivative asset, fair value, net Derivative Asset, Fair Value, Gross Asset Derivative liability, fair value, net Derivative Liability, Fair Value, Gross Liability Derivative Instruments (Textual) [Abstract] Derivative Instruments (Textual) [Abstract] Derivative Instruments. Range of durations of foreign currency forward contracts Derivative, Remaining Maturity Aggregate notional amount Derivative, Notional Amount Gain/Loss on fair value of foreign currency forward contracts Unrealized Gain (Losses) on Foreign Currency Derivatives, Net, before Tax Amount of net unrealized gain (loss) related to the change in fair value of foreign currency exchange rate derivatives designated as cash flow hedging instruments. Recorded in accumulated other comprehensive income to the extent that the cash flow hedge is determined to be effective. Expected settlement time for contracts, in months Maximum Remaining Maturity of Foreign Currency Derivatives Net gains (losses) in product revenue for the settlement of certain effective cash flow hedge instruments Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Net gains (losses) in earnings of Foreign currency forward contracts due to hedge ineffectiveness Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Net gains (losses) of other income (expense) related to foreign currency forward contracts Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments Document and Entity Information [Abstract] Document and Entity Information. Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Filer Category Document Type Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Entity Common Stock, Shares Outstanding Inventory Inventory Disclosure [Text Block] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Schedule of stock option grants Schedule Of Stock Option Grants [Abstract] Schedule of stock option grants. Stock units Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Litigation Legal Matters and Contingencies [Text Block] Reconciliation between the U.S. federal statutory tax rate and effective tax rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Reduction of accounts receivable Accounts Receivable [Member] Summary of total product revenue reserves included in consolidated balance sheets Summary Of Product Revenue Reserves Included In Consolidated Balance Sheets [Abstract] Summary of product revenue reserves included in consolidated balance sheets. Total reserves Foreign currency forward contracts that were entered into to hedge forecasted revenue Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block] Summary of the effect of derivatives designated as hedging instruments on the condensed consolidated statements of income Derivative Instruments, Gain (Loss) [Table Text Block] Summary of fair value and presentation of derivatives Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Reserves for discounts and allowances Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Cash reimbursement as an adjustment to the Base Rate Reimbursement Under The Amended Agreement Amounts Payable [Table Text Block] Mechanism for reimbursement, under the amended agreement amounts payable. Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Notes Payable to Fumedica Notes Payable To Fumedica [Member] Notes payable. 6.875% Senior Notes due 2018 Debt Instrument [Line Items] Debt Instrument [Line Items] Notes payable, fair value Notes Payable, Fair Value Disclosure Notes payable, carrying value Notes Payable Debt instruments, fair value Debt Instrument, Fair Value Disclosure Other Liabilities [Abstract] Product Liability Contingency [Table] Product Liability Contingency [Table] Product Liability Contingency [Line Items] Product Liability Contingency [Line Items] Prepaid taxes Prepaid Taxes Amount reserved for this matter Deferred Credits and Other Liabilities, Current Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table] Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table] Type of Arrangement and Non-arrangement Transactions [Axis] Type of Arrangement and Non-arrangement Transactions [Axis] Arrangements and Non-arrangement Transactions [Domain] Arrangements and Non-arrangement Transactions [Domain] University of Pennsylvania University of Pennsylvania [Member] University of Pennsylvania [Member] Swedish Orphan Biovitrum Swedish Orphan Biovitrum [Member] Swedish orphan biovitrum. Biogen Hemophilia Biogen Idec Hemophilia [Member] Biogen Idec Hemophilia. ELOCTATE ELOCTATE [Member] ELOCTATE [Member] Royalty And Net Revenue Share Rates By Territory [Axis] Royalty And Net Revenue Share Rates By Territory [Axis] Royalty and net revenue share rates by territory. Royalty And Net Revenue Share Rates By Territory [Domain] Royalty And Net Revenue Share Rates By Territory [Domain] Royalty and net revenue share rates by territory. Sobi rate to Biogen on net sales in the Sobi Territory Sobi Rate To Biogen On Net Sales In The Sobi Territory [Member] Sobi rate to Biogen on net sales in the sobi territory. Biogen rate to Sobi on net sales in the Biogen North America Territory Biogen Rate To Sobi On Net Sales In The Biogen North America Territory [Member] Biogen rate to sobi on net sales in the Biogen North America territory. Biogen rate to Sobi on net sales in the Biogen Direct Territory Biogen Rate To Sobi On Net Sales In The Biogen Direct Territory [Member] Biogen rate to sobi on net sales in the Biogen direct Territory. Biogen rate to Sobi on net revenue from the Biogen Distributor Territory Biogen Rate To Sobi On Net Revenue From The Biogen Distributor Territory Member Biogen rate to Sobi on net revenue(1) from the Biogen distributor territory(2). Sobi Territory Sobi Territory [Member] Sobi territory. Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] Investments and other assets Other Assets, Noncurrent Future research and development commitment Future research and development commitment Future research and development commitment Potential future milestone payments Potential Future Milestone Payments Commitment To Third Party Approximately Potential future milestone payments commitment to third party approximately. Percentage of stock acquired Business Acquisition, Percentage of Voting Interests Acquired Reimbursement recognition period Reimbursement recognition period Reimbursement recognition period Reimbursement under the amended agreement method Reimbursement Under The Amended Agreement Method Reimbursement, under the amended agreement, method. Base rate after first commercial sale Base Rate After First Commercial Sale Base rate after first commercial sale. Rate during the reimbursement period Rate During Reimbursement Period Rate during the reimbursement period. Reimbursement cost achieving period Reimbursement Cost Achieving Period Reimbursement cost achieving period. Time period for paying remaining balance due Time Period For Paying Remaining Balance Due Time period for paying remaining balance due. Schedule of Variable Interest Entities [Table] Schedule of Variable Interest Entities [Table] Variable Interest Entities [Axis] Variable Interest Entities [Axis] Variable Interest Entity, Classification [Domain] Variable Interest Entity, Classification [Domain] Neurimmune Neurimmune [Member] Neurimmune. Other Variable Interest Entities Other Variable Interest Entities [Member] Other Variable Interest Entities [Member] Variable Interest Entity [Line Items] Variable Interest Entity [Line Items] Remaining potential development milestone payments and royalties on commercial sales under the terms of collaboration agreement Remaining Potential Development Milestone Payments And Royalties On Commercial Sales Under Terms Of Collaboration Agreement Expected total payments including upfront and milestone payments as well as the greater of an annual maintenance fee or usage-based royalty payments under the terms of collaboration agreement. Research and development cost in support of collaboration agreement Research And Development Cost In Support Of Collaboration Agreement Research and development cost in support of the collaboration agreement. Additional investments committed to if certain development milestones are achieved Investment in biotechnology companies that are determined to be unconsolidated variable interest entities Investment in biotechnology companies that are determined to be unconsolidated variable interest entities Investment in biotechnology companies that are determined to be unconsolidated variable interest entities. Financial Instruments Cash, Cash Equivalents, and Marketable Securities [Text Block] Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Table] Corporate debt securities Current Corporate Debt Securities Current [Member] Corporate debt securities Current. Corporate debt securities Non-current Corporate Debt Securities Non Current [Member] Corporate Debt Securities Non Current. Government securities Current Government Securities Current [Member] Government securities Current. Government securities Non-current Government Securities Non-current [Member] Government Securities Non Current. Mortgage and other asset backed securities Current Mortgage And Other Asset Backed Securities Current [Member] Mortgage and other asset backed securities Current. Mortgage and other asset backed securities Non-current Mortgage And Other Asset Backed Securities Non Current [Member] Mortgage And Other Asset Backed Securities Non Current. Marketable equity securities Equity Securities [Member] Schedule of Available-for-sale Securities [Line Items] Schedule of Available-for-sale Securities [Line Items] Marketable Debt and Equity Securities Available-for-sale Securities [Abstract] Fair Value Gross Unrealized Gains Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax Gross Unrealized Losses Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax Amortized Cost Available-for-sale Securities, Amortized Cost Basis Number of reportable segments Number of Reportable Segments Interest in subsidiary (less than given percentage) Interest In Subsidiary Interest in subsidiary. Summary of significant accounting policies Significant Accounting Policies [Text Block] Research and development Research and Development Expense [Member] Selling, general and administrative Selling, General and Administrative Expenses [Member] Restructuring charges Restructuring Charges [Member] Total share-based compensation expense, net of tax Parent [Member] Share-based Compensation Expense included in consolidated statements of income Share-based Compensation, Allocation and Classification in Financial Statements [Abstract] Share-based compensation expense Subtotal Income tax effect Employee Service Share-based Compensation, Tax Benefit from Compensation Expense ASSETS Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Marketable securities Available-for-sale Securities, Current Accounts receivable, net Accounts Receivable, Net, Current Due from anti-CD20 therapeutic programs Due from anti-CD20 therapeutic programs Receivable from anti-CD20 therapeutic programs for our share of the pre-tax co-promotion profits generated from our co-promotion arrangement for sales of RITUXAN. Inventory Other current assets Other Assets, Current Total current assets Assets, Current Marketable securities Available-for-sale Securities, Noncurrent Property, plant and equipment, net Property, Plant and Equipment, Net Intangible assets, net Goodwill Total assets Assets LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Current portion of notes payable and other financing arrangements Debt, Current Taxes payable Taxes Payable, Current Accounts payable Accounts Payable, Current Accrued expenses and other Total current liabilities Liabilities, Current Notes payable and other financing arrangements Long-term Debt Long-term deferred tax liability Deferred Tax Liabilities, Net, Noncurrent Other long-term liabilities Other Liabilities, Noncurrent Total liabilities Liabilities Commitments and contingencies Commitments and Contingencies Equity: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Biogen Idec Inc. shareholders' equity Stockholders' Equity Attributable to Parent [Abstract] Preferred stock, par value $0.001 per share Preferred Stock, Value, Issued Common stock, par value $0.0005 per share Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Accumulated other comprehensive loss Retained earnings Retained Earnings (Accumulated Deficit) Treasury stock, at cost Treasury Stock, Value Total Biogen Inc. shareholders’ equity Stockholders' Equity Attributable to Parent Noncontrolling interests Total equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total liabilities and equity Liabilities and Equity Property, Plant and Equipment [Abstract] Property, Plant and Equipment Property, Plant and Equipment Disclosure [Text Block] Fair Value Measurements Fair Value Disclosures [Text Block] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Facility Location [Axis] Facility Location [Axis] -- None. No documentation exists for this element. -- Facility Location [Domain] Facility Location [Domain] -- None. No documentation exists for this element. -- Solothurn, Switzerland Solothurn, Switzerland [Member] Solothurn, Switzerland [Member] Cambridge, MA Cambridge, MA [Member] Cambridge, MA [Member] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Land Land [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Land purchase Property, Plant and Equipment, Additions Construction in progress Construction in Progress, Gross Remaining lease obligation Contractual Obligation Accelerated depreciation Restructuring and Related Cost, Accelerated Depreciation EX-101.PRE 11 biib-20160630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 12 biib-2016630_alprolix.jpg begin 644 biib-2016630_alprolix.jpg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end GRAPHIC 13 biib-2016630_amortization.jpg begin 644 biib-2016630_amortization.jpg M_]C_X 02D9)1@ ! 0 0 ! #_VP!# $! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_ MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P 1" $] 3T# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#^_BBBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "OS3\6_MW:WIO[:GB_]DS2K7]F7PK!X"\,? WQ;J6M?&_\ :4N_AE\0/'6F M?%U_'MUJ\7PD^&5K\+O$R^,;KP/I'@"^GO3<^*M)M[V_U&RM;F;2+5)KY?TL MKY/'[(OP^OOBW^TW\4/$]W>>*+?]J'X9?"WX5>+_ EJ%EI\&G:-X;^&V@?$ M[PW.-$U>TC37(Y_%6F?%#5(M5=KJ-K)K"T;37B,MP6 .5@_X*(_LE3:;I^JG MXBZY;PZWJ?PYTSPQ97GPJ^+MCKGC4?&&Q\87WPBUCP'X:ULI^;_:J_;[\*_LQ>-_#?PXNO MA?\ $WQIXI\9_LU_M-?M%^';_3?#.O6/@6TL?V;O#'AKQ#?^%O&7C'^P]0M/ M"5]XE?Q+:Z>VHWD$MMX2E_L__A)H;6X\3^%+76?/=&_X)G:+%XD^#7C'Q=\= M/B%XX\3_ '\2?L^1> -6U/PWX$TIXOA7^S9_P +'F\$_#W6(-!TFQ@U+4_$ M6I?$B]U7Q_X\1+34=7FE:'H'B&UUGX6?M,^%_"OAWXE:2]AKB)_9NOI/X$\': MOX9\36-T)=)GTW4+&ZT_5-.UFZ@C ,3X=_\ !13]G/QQX#\,>)+K6_$FE^,= M?T3X37S?"K3_ (;_ !8\1?$*_P!3^,7P^UKXC^$+?P!X0L? $?B_XI>'-5\/ M>$O'FH:5XY\%>'-2\*W^E> ?&>K2:A9VGAK6S8>N_$?XZ:DW[.&L?'[]GFS\ M ?%BUMO!EU\0="M_%?C#Q'X$\-Z]X9TC3[S6-;0ZYH_@/QSKNDZY;V.GWEI! MI%_X22>WUV"72-=.C3V]WY'Q;\1/^"2WPC^(GB'PUXUU[Q8_B'Q5X"^%_P"S M5\./ L7C_P"&WP_^)7@>Q?\ 9Z\(_'KP%+K/B7X?^*;&XT;Q:/B#X8^/VO+K M.GW,VG-X;UOPUX7U[PIJFG7-OJ,=_P#=/AK]GSPMX2_9T7]G'0;E-+\,I\-] M=^'::EH_AGP;X6,,/B+2=5T_4]8LO"O@S0/#7@C2+B6[UF]U1-+T3P_IFC17 M,AC2S$;2,X!\ _"O_@JE8&Z^'"_M,_#[P[\&-&^(_P"QQ\-OVSH_%7@7Q3\1 M/C'X>\'> ?BCXO@\-Z59>/+BS^#7A>?PIIOA2TNK34O'_P 0];AT_P ">&3= MP+/J[V'G:E%]/[,D=YK6F67C/Q-XAU70OB-XX^$]UHW@_X3?%SQIK5] MX^^%^J^)M(^*.@^'M'\)^!]:U+Q3)\,Y_"FI7/Q OO#=MJFF>$-/O/#5]KEY M9Q>,/"8UKYY\3?\ !+OP/XE^&>N_#27XL>.;2QUS_@F]X7_X)Q2ZG!H_AEKR M#P9X7&I+!\38X9(/LS^,;H:E*)M)D4^'(P@$4 #N##XY_P""5_PF\::5H[:C MXAMM;\5>&/CU^UG\;/#.K?$7X7?#?XK>&=/A_;$^)][\3OB3X-N?AWXTTJ^\ M-ZA;:-J9T+_A#/$Z_9/$VD7OA?3KV[N=1L=2\2:)K(!]8:=^V3^SAK/C+PYX M(T7XCP:Y?^*5\#II7B#1/#GB_5_ATNI_$[P]9>+?AKX'DU7:^,?[4GP7^ =[;6WQ4\ M0:]X;LGTZSUK5?$L/P]^(NO^!_"&A:A?WFE6>O\ Q \>^'/"FK>#/A_HM:9HGC MSX*R?!K5-$OO!'P\^("^#8[6Y\8ZCIOCOX-7WCW1=7D^$/CW4K[QB8O'WB/P MM;_VEXVTGPIX%L3>:#>>$],U9 #UZ3_@H)^R/;:CXTT[4/BU#HX\ 3?&ZR\2 M:MK?@_Q]H_AB/6/V%H/#/B7Q;\/M4L'.J^$/#>JZMX MFN].N+/5]'TG4M,NX;DP? _]LK2?CA\0/VJ_".A_#OQI86'[,]_\,[ ?VGH? MBC0/'OC&Y^(/P:TKXN2Z9-\,/&WAGPAXD\)>(--358=!L=&U0SG6Y9;+4([J MTAO4BC\"\=?\$K_AG\1=$T7P]XD^*'Q!73M%^.G[9?QXAETRP\,66I0^*/VO M?$_C3QFRZ?<7.G7UO9M\(_%WBNRU_P "7>.O$*:3H7@,Z'?^ _AG!\+M M.D\"V?A6)9/#D3:'9V>HP":[U._L-=2XU&+4IC.L< !\O_#7_@IE%X\^"NO? M&^_\.? [0_"NGZ)\&]6G.E_M&3>-=2^&VO?%SXC>%?A_#\(_VAO!WA[X3?\ M"S?A)\8-$N?$ZI<:/:^ O%WA#_A(=/U3P]J_C#P_;Z=+KLWZ!_#?XZ?#+XMZ MAXCTGP#XADUW4O!US/IWBZS_ +%UW39?"^M6GB?Q1X0O?#FO'5=-LDTWQ/8Z MWX-U^.]\.7#+K%KI]OI^N2VBZ#K_ (>U/5?@SXA?\$RK/XQ3:UJGQB_:!\;> M.O%K>!O"WPM\-^-U^'GPK\+^*4^'^@_&[X)_'/4HOB'J7A?P_IQ^)GBO7=?^ M OA'2X_$6J)HFD>%M.U'Q9=>$/">BZMXEU2]G^K_ ('?LS6/P-\=?%;QOHOC MOQ-K"/AA/X>LO M,T.+P=\+/AX((X]9T[6]4U\ ^$_$W_!6BV\-_LD_M8_M!S? YY?B5^S;\1?B MQX+\._ ^3XBQ6UQ\5]!\%ZGXOO/!'Q L?&)\'RKX<\.>,_A]X$\;>,]:\WP[ MK#>#[CP!X^T#S]:#>>$]*\17?B>]D M\$_$"^\)Z7KO@SX37'QQ\:> (/'MCX4F\$ZO\3?"WPLLM0\;:I\-M)UV[\<) MH.G:A=)H+2V%_;6OS9XM_P""47PK\7^'?&VB7OQ-^(]O-XX_9T_:Q_9]U*:W M30/[,"_M.>+_ (L^(]*^),NA/9FTO/'?P0T;X]?&SP3\-;F>9=.;PQ\4O%T. MNVE[$_B):?$3PG??&+QYIWPQ\<>(/BQ\4[#X?V7A_P5+; M>%_CQ\8_@EXQ^"'BGXD67B&ZTN37-2TB"P\>>*_'^D_#_4+AM+M/B/K$NIRZ MK<^&;72O"FG &]XW_P""H?[./AS5O@[HWA*T^*'Q-OOB]\;?A7\'+>T\(_"G MXCPW_AJV^,O@KQ=X[^'GQ/U32]=\)Z9J6H_##Q=H?@W6)O"GBS0;74-+\5#3 MO$,FA7EW%X/\5MI.5^S]_P %3_V=OBW\$?!7Q1\=7M]\*?%7BKP5X;\8/\.I MO#_Q"\4W.HGQ9\6=/^!VAZ-\+M=M/ 6FP?&[5+KXKZ]X5^'DMG\,;'7[ZS\: M>*_#OA^]L[>ZUG36NX?$O_!-+POJWC+2OB/H_P 7O&.A>/?!^F?L8)X!U:7P M[X8UG2- \0?L:Z3\>O#F@ZUJ6AWL<,7B2#Q]X9_:%\:Z7XHTB:_T]-+GM='U M;P[?6-_:.\F#X>_X)9^#?#/@;X->"]+^+GB*\B^"_P"S)XZ_9FTMO%GPW^%' MCO0_%GA_QO\ &KX0_&>\U'QOX)\<>&M?\*ZW:R7_ ,(--\+7^A1:=9I\46&AZ]IP!]XQ_M!?"E/A!K7QVU?Q%>>$OAKX:L/$6H>)=6\>>%O M%W@+5O#J>%-0O-)UVSUSPAXPT'1?&.F:M9ZK8SZ=%HUQH"ZIJ=ZUK!H]IJ+7 M^G_:O)K[]N[]FS2_^$?M-1\3>-[+Q+XG\0^,_"&C?#V;X*_&H?%2?Q;X!\!: M7\4O$WA>X^%:^ &^(6GZ]:_#;6=,\>V.GW_ARWEUKPA>0>(-&-]ICBXKA[#] M@/X>7G[(OC_]D/Q_XQ\8>./!?Q*U'Q)K>J7MQ%IEC9>$;_7?%-AXUTO2/AEX M,FM=:\+^#?A_X'\2Z5IE]X,^'%S;:_X8L;>VGTS58-8T[4;^VGYKX4_\$Y? M?PO\8_!3QYI?B/1M(UGX1^/?C%\0KC1OAK\&OA5\'/ _BG5_BY\'=-^"T\-S MX4\ :+8+9QZ#X=TFSU.UU*^U+Q!XBU#6&N(+S6D\/1Z3H6D %_XO?\%)?@/X M(\.>$M5^&FHM\:-3\8>+OV0M%L%\+Z=XRC\$V?A[]L'XM?##P%X US6OBE9^ M#-8\!^'M:N_!GQ'7XI>&_!/B+6-(\0^*_#NFVBQP:7:^(-)U27TZU_;R_9=O M=!U[Q+;?$'4I-)T>#PM>:7*WPZ^)T%U\1=.\<>,+/X>^"M5^#&G7/@V'4?C= MH_C#QWJ&G>$/"^K_ FM?&&G:]KNJ:/;Z;_L:R_!:S\$^+M2UB336 MU;PS;^.?"WP)\!>'/B-X;\.74%AJ"Z-::GX?N_#MW+KL6OS?#W_@D;\&?A=X M5/AWP/XAL?"FH>#+OX77GP.\8^%/@O\ !/PMXS\ W7P7\8:9XT^']_XY\3:% MX/LM<^-VI+ZTJ59KR(/$6FZ'I,X\6>.]*\*Z?K5AIFG^'[:UL+/0+67PQ&VB MV926ZL;&>.PN;S4'M?MUQ],T %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% 'Y\?\ !0?QX=%\*?L_>!?#/C7D/B.#Q"ND:Y+FSW]KJLVGV4NIV,-S;66HR6EN]_:6]X8C=P6MXT9N;>"Z,$) MN8H94CN#%'YROL3%9_#^A2//(^C:4\ES>Z\[3[C[3,[0%I;CS M]*TR;SY"TOG:=8R[_,L[9H@#^>SQ[_P4[_:N\%^,O&_P@M]%^%VJ:Y\&?'/[ M1_A6_P#BQK*?"_X;>"_BWXF^$%Q\(M1\%^!;FQ^+?[1?P]L?!!NO#GQ6@F^) MDW@36?B7X]6 >'_$?@GP/'8W.JZ:GZG?M?ZWX'O/A%X-M?B9XMT3X?:AXHUB MWE\/>'/&?QR\=? ?X6>,/&$/@_6]3?P!\2_C'\.M)NM4L/#5O8G5] V&JQ+)I,OV+-H&AW#(T^CZ5,T>K1Z_&TNG64C1ZY#&(H=80O Q M358HE$<6I*1>QH B3JH JSJ6F:;K-C<:9J]A9:IIUVGEW>GZC:P7UC=1AE<1 MW-I=1RV\Z!U5PDL3J'56 W*" #^8O1_BOK=[\%O'%[\6_CQ\4=%\4_#?]D3X MA:_^Q3JO_"ZO&]I:_$C]I7PM^T9^UKX2UVZ^$6O6.J6UW^U1IGAP^&?V8/ ? MP%U'QQ_PGOBCXK_!+Q5X8\0^(?"=[?\ Q?\ &,>I_P! J?$/P_X@^$WC^V\9 M?%#PW\-O%G@+P"EI\=]=\,>+_#$%[^S]XFU;X6Z9XXUK4M8U'7H]4T;PC=^% M_#OB&T\=Z/=>,M.ETR/P[)HWB+4+*\T.Y'G^W3Z5IER+ 7&GV5P-*N8[S3// MM8)?[.NXH)K6*ZL/,C;[%<16UQ/;1SVWE2QV\TL".L4C(:,/ACP]!)XDEBT7 M30_B^Y6[\4%K2&4:_.NBV'AU7U995D2]5="TNPTE8IU>(6%K%;>7Y88, ?SQ M:;\5/#NN^#_BMX^_9O\ CIXB7]CWQ#XR_8M\$>,&O_VG/$?COXES_"V^_: F MA_:1_:\NK^]\:>+/B=\#?!7Q)^&_B+0O MYXBO\ 5? OB#5_">D>,/C/J.E^ M!4L/#OB:_P ?]K/XK)X1_8+_ &Y+WP3^U?XI\ _!OXF_'&TL M-4^*GAO3_A]\ ==\8?#_ ,,_%WQ3=W'CWQ?\._A[\;=9^,'AZTL_ _C:>XO] M(T&X^'%YX@N? N@3Z#=?T2Z%X!\#^&)+^7PWX/\ "V@2ZI'Y.IR:)X=T;2)- M0BW2/Y5\^G6-LUY'OEE8QW)E0M)(=N7;,FI^!_!FLV&EZ5J_A/PSJFF:($71 MM/U'0-(OK'25C@%K&NF6=W936VGJELJVZ"TBA"P@1+B,;: /P*_:Q_:+UF__ M &@/C-XT'BW2_$7@'X4>$?V9/&_[+'AWP/\ M+^._AYXH^/>E>+-:\8V?Q"3 M]F#3OA5J-UX9^+/QBU/XC:;_ ,*_U.Q\9:;\0_">HV&D>#OA?J6A>$]!^(/B MGQ-=_>'_ 4#_:N\=?L_R_#GPC\+O$?AO0O'7C/PS\5O'&GV_B[P[X.?1->L M_A(]?M?T0LO"WAG38=&M]/\/Z)8P>'1<#0(;/2=/M8M#^UQ2P77]CQV]M&FE_ M:89IHK@V"VYGBDDCEWH[*=&]TW3]2-F=0L;.^.GWL.I6!N[6"Y-EJ%NLB07U MH9XY/LUY LLJPW4'EW$2R2".10[ @'\]W@__ (*G?M->*/"VF_'6W\&?#[5/ M!=U\7/V-/AG9_ /1/#NL-X_\27O[7G[!GP&_:/CT;3_B)?\ BJWMM/\ $7AG MXJ?$^;P[X8AE\&7HUW19GTK6+>#43I^I6OLG[$7QY^('QM_;=FU[Q1\WLYP!+:P00PV[QQQ1JLMII&E6$LL]EIMA9S3RW<\T MMK96MO)--?W37U[++)#$CR2WEZS7=U([,]Q=,;B9GF)<@'\^/Q2^*EIJ?C;X M\:E^P=^T=XG^(7Q>^%?PJ_;1O?B-XAU3]H/3O'>I_''XVV7PZ\:+X$^!7PH^ M!2ZWJ>F:S?\ [//CN6V\2GQ3X&^%FA>'_ $?PZL_@UH^H>--9\6?%F#PYZOX M;\:_#BP?]J/PW\$OVLO$6A?LE0?LT_ WQ5&OCSXM\1_&"#Q/ MX9\-_&'XOZAXMB\&>-_BG\.M-^'NJ>.;33]7LO$W@_6=5T/QCH&E^$/&OC4: MW??LM8?#OP%I6M?\))IG@KPCIWB',Y&NV'AG0[/60;J.2*Y(U6UL(M0!N(II M8YB+C,L%=3TNZT34?#6@7^C7M[)J5YI-[HNF7>F76HS79U M":_N=/N+22SGO9;YC>RW)_BY;?"_P#9MU+Q%+JOB#X3_$_P2_B/ MXAZ2BZQ8^*QXN\=:UX[\))XQD\0V?@'Q:^J:SY/[W_ KQ=<_$#X)_"#QW>>$ M-4^'UWXT^%_@#Q7=> ]$_#5AIT.KIK\5C9:!I%I91Z[ M&4,>LQVEO91VZ:M&8HRFI+$+U#&FV<;1CJ?\^O\ .@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** /EOXX?M;_#7X"?&']EWX'>+M+\8ZEXX_:Z\>>-_AW\* MSX>TS2[K0[37OA_\/-5^)VO3>,-3U'6]+DT;36\-Z->1Z?/8V6LW%UJAAM7M M((6DNX_H0:KJQ (\.7>" ?\ D):.>ON+TC\B17XP?\%)_P#E))_P0I_[.M_: M@_\ 6.?B#7[>1_ZN/_<7_P!!% &'_:FK?]"Y=_\ @QTC_P"3:/[4U;_H7+O_ M ,&.D?\ R;6_10!@?VIJW_0N7?\ X,=(_P#DVC^U-6_Z%R[_ /!CI'_R;6_1 M0!@?VIJW_0N7?_@QTC_Y-H_M35O^A;NW;MOV6:;;LP,[]N=PVYPV-"B@ HHHH **** M"BBB@ HHHH **** /Q _X*3_ /*23_@A3_V=;^U!_P"L<_$&OV\C_P!7'_N+ M_P"@BOQ#_P""D_\ RDD_X(4_]G6_M0?^L<_$&OV\C_U#R/\ CY@KCS'%2P67X[&Q@JDL)@\5 MBHPDVHSEAZ$ZJ@VKM*3ARMI-I.Z!:M+N;_\ PD_AK_H8=#_\&UA_\D4?\)/X M:_Z&'0__ ;6'_R17X?_ +F>$]%\4:PUU>:3HO\ PF'B M&?P;\.M(U*VT#6/$45SX]\76FEZQ=Z/8ZI#HDV@^'+2TL1=>(O%NI:1HD-]I MWVAKBI/%'[46O^&?&_[)GA"Y^".M+9?M,^.D\%:KXWA\?^"-?\!> +V\^&/Q M?^).CV?ASQ1X9FOT^,.I:S8_"6YNH+OPWIFA>&;#PIX@T/Q!JFM6FL:G:>$J M_)8>)>=5*$,3#(<$Z-1XE0E+,>1R^J4E6KM1G&,WRPO;W?>E:$%*"F^(\T_[1C:/X>^'\?Q"?\ : ;X M)Q^#%T\?LZZKIEQ8)I'C"#Q]W^. MT6M?"S7?A)?_ 8^.NJ?!O\ X1SQ7K6BZOXHU"UM/AC\*_B9IWB#Q':^'GO= M&\+:U?V'Q/M;74/!UEK?B5O#LVGM:7NO76I&\M[,K>)6=X>G[2MD&#A#V-'$ M7>/;;H8B7)2JQ@HN_%+XV6'[1OA/X0MX"^#&I>!O$^G>,O&5WX@TGXD?$)_B5X3^%OA9+ M?2;/QGXE\(WOPKM?!4=]XC\>:KH/@C1=!L?'EQ_:%W01TK\[?%'Q6N/!'AS5O%OBWQUJ^A^&]!M$O=8U:YU+6[F.SMY+FWLH=MIIR MWNIW]W=WUW::?IVF:78WVJZKJ=Y9Z9I=C>:C>6MK-^B-U_Q[7'_7";_T6U?E MG\2_"]UXU^'_ (J\)6>E^!]E MBU^'2M1LH;BT&J:)Y^K:!?2V?B#3['4KK2HM-N^3Q3KU:6)X=C'$5\/2J3S! M5G0K3I/V:GEG-)N+LW",I.+DI)-O1W::7RW6]OS:=CP6/_@IA\"[7]GB^_:; M\5?$SXD?#_X>:7=7FF:AHWCKPG\0O#_Q+36[,7-P="TSX=36+^(/$^HSZ3:S M>(8Y?"D>MZ/;>'H-0U75=6TVWT/Q"=(]<^)G[7WA?X3^)M3\)>*/%/Q1U#6? M#7@:+XI>/1X)\*^._'6G?"[X73ZGX@T:W^)/Q1U3PY;W=GX+\&76H^$_%D5K MJ5Y)%?$VJ0:7)I&@:IJ%K^3OAK]C[]LC2/^"#?AYXR^/VJWGA_]FO1]!O%.O>,+/QWK[P^( M;SX>^'K2QT/PE;71BT;6+B75->L(/9?VE_V3?C;^TKKOB'Q_KG@KP3I7C;Q' M\)=+\ ?"^*#]HCQ5X73]EOQ98^)?$'B75?%GB*Z\!?#3^Q?VNO"'B'Q3;_#S MQZWP]\?:/'X=L7\.:O\ #H^$1H_BCQ!XJOO@G]46*<7G.,6&6)Q5-SAFU.GY=ET6G5:-;_>M7;[ZE_:T:V^ M+?ASX-WNA_M*6&N^,-5\1:5X4\7WOPZ\21_"KQ"/"OA^X\4:UK6E?$&'7)[* M?PM;Z/;I+'XFDT^'2IKG4-%L!,MYKFDPW<7Q0_;+\$_![7=2T#QMXW^(ZW'A MKPEI?Q!^(.I>&O#7COQ?X=^$GP]US5M3T+1?'OQ>U_P]:WMA\/\ PCJNIZ'K MR6>IZH\LW]G^'O$7B&YL;;POH6K:Y9Y?A[X<^*HOC]XS^*_BR_T?6-/B^"WP MP^%7PYFMD-KJ%M=Q:[XO\:?'+6[W1EA:T\/GQWXM_P"%9_9X=/O;\2Z/X-TZ MRDDCBTFV2;XV_:+_ &6OCC^T3X=UY6\-^#OA;XN_:)_9OM_@-^T=/X._:,\9 M-X0TZWDN/&ME%:>(/#:?!Z"Z^//A[X?Z#X]\2W/PYU7PQK7P,\8:KJFLZQX* M\>74_P -=15;'APN(A5Q-&%?,L;2H*A0]O5CF4HKV]1QJS'4H.$: MR]=.VU[MWW9^R?P[\1^(+SQKH%K=Z]JUW;374ZRPS M:K=75M,HLKIUR#<203Q%@KHZEXW 21&9=K5]AU\*?![3K71O%'@?1K$SM8Z- M;6>C6+74@ENFL='T%],LFNY0 );IK2TA:ZE EN#)( V*^ZZ_7_ LK5:V2 MX^5:M5KN.;5HQE5G.1_ZN/_<7_P!!% #Z*** "BBB@ HH MHH **** "BBB@ HHHH *X3XF_P#(A^)O^O!?_2F"N[KA/B;_ ,B'XF_Z\%_] M*8*\G/\ _D19U_V*'/!OA: MXCT:'PK::7HFEVVAQ_?3=3]3_.DK^4:688NA2A0IU(JE"I4J1A*AAZL>>K2= M&$?!'Q MU\3_ +3?A;P9/X.\!3:Q9_&_Q9=^+M5U+7=5^+KZ=_PLOQ#X+36_&NLWD7@# M4=25KG0DTOX=ZOXKU3XN?M ?$"'XK M:KKMK^SO\'M&N_"'Q"_L;X4>#]0U;PY93:CK^DWNBZG\/_A19>$Y?"^N6%Y; M6=SXBUCQ79:@FLVFE16_VS153S+&334ZL)IQC%^TPV%G>,:RKV;G0DVY5DJE M63O*LTO;.HDDE?\ R/.=*^&VF:5\7?B+\8$U+4;G5_B#X,^&/@-=&N4MVTSP MMX>^&.H_$76+2UT2Y&;Z8>(-8^).J:IK8OF;_3-/T][=L>8!]>_ ;_D.:[_V M"+?_ -+6KPBO=_@-_P AS7?^P1;_ /I:U>_P3.=3BW(Y3DY-5G33=M(4L#6I M4XZ)?#"$8WWE;FDW)MM_S>GZH^FKK_CVN/\ KA-_Z+:OSM7H/H/Y5^B5U_Q[ M7'_7";_T6U?G:O0?0?RK[?Q=_BY!_AS7_P!Y@A:***_&P"BBB@#N_AE_R/GA MO_K[N/\ T@NZ^W:^(OAE_P CYX;_ .ONX_\ 2"[K[=K]]\)O^1'F'_8WK?\ MJ%EX!1117ZF 4444 %%%% !1110 4444 ?AU_P %+Y3!_P %'O\ @A9*(9YR MG[5G[3Y$5N@DF?/['?Q 7Y$9XP0N=SDN-J!FY(VG]I$UN4(@_L/7N%4"O$,)TG M5[<26(4S7%K"D,>)X6W2.MW(RKQC(1N2..]>IUPGQ-_Y$/Q-_P!>"_\ I3!7 MDY__ ,B+.O\ L4YC_P"H=8<=UZK\SXC;J?J?YTE*W4_4_P Z2OY%$%%%% !7 MM7P3O&L]9UIUL[V\+Z7;ILLH4F=,7C-ND#S0A5/0$%LMQ@=:\5KW?X#?\AS7 M?^P1;_\ I:U?5\#?\E9DG_835_\ 43$#6TO3]4>^7&MR&WG']B:Z,PR#/V* MXRA&V.&62*(SR)&[QPJZ1M,ZJ66)7D98T,C (&=E12P+LJ@D $M%?$'BCX_\ MQ)\*>,?#NB^(?%_['_A+5O%'B_3_ 'X<^$WBGXR>(+7QYKOC'4M&LO$FG^# MX?$L6@I9VWC'4/#^HZ?JEOH-K\/=:#Q:KI#V=[J-KJNFW=Y]GZ5 MI6']E:AXL_MUL!;W@MIF>$74 6*<()455<* #\4 M/^"D_P#RDD_X(4_]G6_M0?\ K'/Q!K]O(_\ 5Q_[B_\ H(K\0_\ @I/_ ,I) M/^"%/_9UO[4'_K'/Q!K]O(_]7'_N+_Z"* 'T444 %%%% !1110 4444 %%%% M !1110 5PGQ-_P"1#\3?]>"_^E,%=W7"?$W_ )$/Q-_UX+_Z4P5Y.?\ _(BS MK_L4YC_ZAUAQW7JOS/B-NI^I_G24K=3]3_.DK^11!1110 5[O\!O^0YKO_8( MM_\ TM:O"*]W^ W_ "'-=_[!%O\ ^EK5]7P-_P E9DG_ &$U?_43$#6TO3]4 M?35U_P >UQ_UPF_]%M7YVKT'T'\J_1*Z_P"/:X_ZX3?^BVK\[5Z#Z#^5?<^+ MO\7(/\.:_P#O,$+1117XV 4444 =W\,O^1\\-_\ 7W:7X;UN_\0?LP?%SXIW_A'2=;TN_^+GC/ MPEXU3X$_!.P.N:Y=V>H:58>#_%/A_P"$"V-AJ>GZY;?N4HP,>Y)]R223[9ZX M[=*_"CXO?!N[U']LWQ'\0I?V;['7OBY'\?/@ROPUM8?V%_AAXR^$OC[X1QK\ M/V\3?%GXF?M?ZC\)-5\5^%OB1X-@;QUJ&F7EU\:? ^N>!=2\&>%M#\,?#+QU M;7L%SXU_==&XMKF"57BGMYX9'BGAD1DEB=T=65B" ?SL>"_@7\7-9^, MWPY\9>,?V1%_M"P\8_#7[9XPU+_@G;^SOX=OM(TOPE=^'M(TF\_X2K2_^"D7 MBC4O#L?AC0='L+;3];T[PIXEO]!LM,MKNST+6Y[..QN_Z+QT_%NV.I/U_/OU MXZ5_/[KOPC\ >)/VV/%E]9?!6[N[7X8?&[X4^$?#6M? O_@G;^S/XT\!>'-- M\*>%/AG=:7I/CKX^?%#X>ZE\3;3Q?X5CD@C\0:[\/]8L-#^'GA1/"VF>#)[; M7/#FH-!_0$/ZGMCN?\Y[]3S0!^'G_!2Z>.W_ ."C_P#P0LFE\S8G[5O[3V[R MH9KB3YOV._B @VPV\\)WEOINK?V@;F:RAO% M^RV9N(_)D>6)=S^8F'WP297' VG/-EY-:(+-[*YT?_"0:=_-_KAPO_P!#W+/_ II_P"? MG^?9CL^S^[^NZ^\]"_X2#3O[FJ_^"#7O_E;1_P )!IW]S5?_ 0:]_\ *VO/ M?^%V^"NG_$YSZ?V:?_CU'_"[/!7IK/\ X+3_ /'J/]<.%_\ H>Y9_P"%-/\ MS\_S[,+/L_N9Z%_PD&G?W-5_\$&O?_*VC_A(-._N:K_X(->_^5M>>_\ "[/! M7IK/_@L/_P >KTS2-4M=;TRQU:R\W[)J%NES;^='Y4OER#*^9'EMC>HR?K7? M@,\R?-*DZ679CA,;5IP]I.&'K1J2C3YHQYY).ZCS2C&_=I;@TUNFO4J_\)!I MW]S5?_!!KW_RMH_X2#3O[FJ_^"#7O_E;3M:\0Z+X=AAN-:U"'3X;B4P0R3B0 MK)*$:0H/+1SD(C-R ,#KGBN=_P"%F^ _^AFL/^^;G_XQ6N(S;*L)5=#%9GE^ M&K147*CB,;AJ-6*DDXMTZE2,TI)IQ;6J::T8K/M_7]-'0?\ "0:=__\ E;7/_P#"S? ?_0S6'_?-S_\ &*/^%F^ M_P#H9K#_ +YN?_C%8?V_D7_0[RC_ ,.6#_\ EWFOO'9]G_7_ Z^\Z#_ (2# M3O[FJ_\ @@U[_P"5M'_"0:=_"_^E,%9YS6HXCA[-ZV'K4J]&IE&8RIU:-2%6E./U.L MKPJ0+:!;KU7YGQ&W4_4_SI*5NI^I_G25_)0@HHHH *]L^"5]!8ZSK M4DXN2LFE6Z*+:RO;YLB\9B72RM[AXUQT>150GY0Q;BO$Z]W^ W_( M6B%HHHK\; **** .U^',\=MXV\/SRB0QQW4[,(8)[F4@V-THV06T&_P#K[N/_ $@NZ^W:_??";_D19A_V-ZW_ *A8#^OZU HHHK]3 M **** "BBB@ I#C!STP<\XX[\]OK2U3U&XDM+"]NH8X99;>TN9XHKBX:U@ED MA@DDCCFN5@NFMXG=562=;:X:%"T@@F*B-@#\RO&=A^PSJO[3^MW]SH?[0_BK MXWZ?\1O!.G^+]:^%.F_MU>*?AGH7Q"LM/\+7OAW2/&NK_":2\^ >B7>CZ+J/ MAB\\1Z-K\EOINBZ)>V\OC.TM;&YN%;]0![>I]?4YZ^_3MCIQBOPXTW1_CEK/ MQ;N_CW,;3X>^!/$_Q&\*>*_B#_P@/_!5..3X/6:Z(V@Z/J]\/A__ ,,O:=X? MO5DT;1XDU_0SXBT*X\5M#]AU76+26:.ZM/VYTO4[#6M-L-7TJ[AO],U2TM]0 MT^]MW\RWN[*\B6XM;F!\#?#/!(DL38PR.I&002 ?B?\ \%)_^4DG_!"G_LZW M]J#_ -8Y^(-?H9\;_P#D:=-_[%ZS_P#2S4*_//\ X*3_ /*23_@A3_V=;^U! M_P"L<_$&OT,^-_\ R-.F_P#8O6?_ *6:A7YYXG_\DM4_[#\%_P"ES _*/_@H MS\0OCO\ #;]GC5/$'P#U/5-%UV*[,OB?6?!=CX(UWXK:1X;@FTR"TU#X;^%? M']_9Z)K[OXEU#1]*\9O:6NN>(-(\.:LDVBZ)<->7=YIWRW\8_P!L;XX^&/A[ M\3?CEX0\6^,_$GA+X:?![X=^/_@M%X3_ &99;+X:_M,^(M&\5>)O#W[2>@?& M?5=*/!7B'P^_PT/PX?XD_#K4O VN+'XIT2]^(T^L6'A>S_ $Y^ M.7P!^$7[2/@2\^&_QG\%:;XT\+74\-Y!%(].>WUOPW MJ4\$3:=>WNCWMK+?Z1=7NDWIGL;N:$T-1_9H_9^U36?"NO77P@\$+>^"+3PO MI_A>TL;&]TGPYING^!=7N/$'@.PN/!FDZA8^"_$%IX"UZZNM<\#Q>*?#VN_\ M(CK-Q-JV@-8:C*]R?Q' YAEE##8>EBL$J]6G7JSJR6%PL_:T92H3C3E5K3E4 ME*?LI4&^6$:-"=7V<)UYTZ]%W_J^STU6FE_OTWMOX]>>(_C?HW[47@SP'I7Q M/'Q*CU?QAXXUKXS_ FTWX;^'M-\$?L_?LYS>&?%TWPC\0:GXXM=,;QQI/QF MUOQC9^ M!L=,\7^+M5A^,+:Q\1-8\,^ /"O@?P?I^O:=X/\ MF_M$?M"_ ?5 M/V@O&VD)X^TCP]\%OAG\+/'WP2\%Z!\%H?&OPX_:"O);Z\D^.V@?%WXJ7GAJ M^_X5GJ7AZ1+#P?X>T6/QO\+=4T2+4=#\=:4_Q&U'Q';^&+;ZW\/_ +(?[._A M3QGXH^('ASP#J.C^*?&_B?QCXT\8W=G\4?C0-*\4>+?B!8WFF>,?$6N^$IOB M1-X+U/5=G^'_A7*MS\,=/UG3;WQ#<:9XY/P[O5_M+P3?\ Q"LO M%NJ^&=7:36=)O[;59'O&FCC5:E3P]*E5IO X.FZU2.(C7J3<8U MY4H\\8_5?:N$ZWU64O>5>,:K';^O))=;:/YVVLNOT+,BQW,T:K*BQW$L:I. ML\:I*RB.X4 !;B,#9.H 42JX4 5]O?#K_D1O#'_ &";?^35\.@DMDDDEMS, MQ)9F)R68G)+$DDDDDDDDDFON+X=?\B-X8_[!-O\ R:OM_";_ )'68_\ 8K?_ M *EX8.B]7^43SSX]?\@+0O\ L,O_ .D%S7Q!\5/%'BKP7\._%OBKP3X,OOB' MXJT/38+S1_!VGP:M>76L.^JZ=9WTJZ?X?MKWQ'JL&A:3=:AXGOM%\,V5YXHU MS3]$NM&\,VMQK]_IL3?;_P >O^0%H7_89?\ ](+FOCOQ;X5T;QMX>U#PQKXU M8:7J1L9)IM!\0ZYX3UVSN=+U.QUK2]1T3Q/X9O\ 3-?T#5]+U;3;#4M-U32[ MZ"YM;NUB9O.MS/;3>5XARA'C'$RJKFIQAESJ1LWS4UAZ+G&RG3;YHW5E4@W? M2<7[R/R_KU_(_)[X)?M]_$CXE?"#]F;4-=^)/[*7AGQ'\9+WXD:7XS^.VN6/ MQ"L?A+X$\0> /!OA?Q;HOPS\:_#36?$?P_UWP+\;/B0?$M_<>'?"VI>/SH6H M> ?!6O>,/!\GB77M4TSPC:^AQ?MJ?&WQ/^R]X"_:X\*^"OA5H7A+Q!X2\%C2 M_A#XGE\?:O\ %+XX?&O6?B+XA^''B;X(_"J:UN?"\G@G4FU?PY*GPMU'Q'X0 M\>ZWXQGOVU+Q7X9\'>$_#7B'53[C\+_V'?AU\(_A=H'PY\&?$GX]Z+K.F76C M7_B#XM:+\3[C2_B=X^O/#WABW\%>'T\97=YI6N^%K[2/"_A2QTW2/ VAVWAB MWM/AU-IMIK_@&3PYXH^TZW!_B9\??A3_PJ+X;V/PK^ M&7AKX?>/?"C>$? _AB S_P!LWOAO2OB'\-OB'>Z5XS\WZ._;2SZ=>IZ-\8OB-X_P!.^*_P:^ GPEG\#:?X M[^+]M\7_ !*/&/Q(T?Q'XF\(^%_!_P &;+P4FIL?#GA'Q%X6O]=UWQ1XG^)/ M@K0[)$\5Z;9:)HC>)?$>S6[JPTK2;WH/V=_B\/CQ\$OAS\7#HX\.7?C+1K]M M:\/1WDVH6VA^*/#/B77? _C'2M/U&XM[.?4](LO%WA?7(=$U2>TMI]2T4:?? M3V\,\\D28_B/]GCP]XGN(=6O/B'\;;#Q?H_Q$\=_$3P/\0=%^)+6'CCX8M\2 M-$LO#GBSP!\.]6GT&^T_1?A+=Z)8P65G\/\ 5-&UZQTNXCM=:L+R'Q#I6B:M MI?J7@/P-X5^&7@KPK\._ VD1Z#X.\%:%8>'/#>CQ7%U>?8=*T^,I$DU]?SW. MH:C>W$KS7VIZIJ-U=:EJVJ75[JFHW-S?WES/)XU6>#^I4:=.+>*C*/M*O)RI MVGBY56Y$5[O\!O^0YKO_8(M_\ TM:OJ^!O^2LR M3_L)J_\ J)B!K:7I^J/IJZ_X]KC_ *X3?^BVK\[5Z#Z#^5?HE=?\>UQ_UPF_ M]%M7YVKT'T'\J^Y\7?XN0?X8(6BBBOQL HHHH [OX9?\CYX;_Z^[C_ M -(+NOMVOB+X9?\ (^>&_P#K[N/_ $@NZ^W:_??";_D1YA_V-ZW_ *A9> 44 M45^I@%%%% !1110 4444 >:7GP8^$.H>*!XWO_A9\.+WQFLZW2^+KSP+X5NO M$ZW",KI./$$^DR:L)E=5=9OMGFAU#!P0"/2_\^O\Z** /Q _X*3_ /*23_@A M3_V=;^U!_P"L<_$&OT,^-_\ R-.F_P#8O6?_ *6:A7YY_P#!2?\ Y22?\$*? M^SK?VH/_ %CGX@U^AGQO_P"1ITW_ +%ZS_\ 2S4*_//$_P#Y):I_V'X+_P!+ MF!XU1117\Y %%%% "KU'U'\Z^X_AU_R(WAC_ +!-O_)J^'%ZCZC^=?"_\ I3!7](9/_P FY?\ V3^9?^H^*''=>J_,^(VZ MGZG^=)2MU/U/\Z2OYO$%%%% !7N_P&_Y#FN_]@BW_P#2UJ\(KW?X#?\ (W:02/K\\%>(;:VOHY9Y;$+'&$F!9A/"V 6C"C@$\D" ML3X$\^%]5&3@:]-@9('.GZ=DX!QDX&3[#TKLOB:,> _$O7_CP'<_\_,'O7]( M9/\ \FY_[M_,K_\ @C%?I8<=UZK\SXD;J?J?YTE*W4_4_P Z2OYO$%%%% !7 MM7P3U&RTW6=:DO;A;=)-+MT1F5VW,+QF( 16/ YR0!7BM>[_ &_Y#FN]?\ MD$6W0D?\OK>E?5\#?\E9DG_835_]1,0-;2]/U1[Y<>)]!:WG4:E%EH90/W<_ M4HP'_+*O@L=!]!7Z(W(Q;7!!((@E((9L@^6W/6OSN7H/H/Y5]SXO?Q.'_P## MFM_ORW]+"%HHHK\; **** .U^'5Q!:>-?#]S9NV9WHN=VQL8ST.:^,?AE_R/ MGAO_ *^[@<<=;"\!_2OMW&/7\23_ #K]]\)O^1%F'?\ M>K_ .H6 _X !111 M7ZF 4444 %%%% !1110 4444 ?B!_P %)_\ E))_P0I_[.M_:@_]8Y^(-?H9 M\;_^1ITW_L7K/_TLU"OSS_X*3_\ *23_ ((4_P#9UO[4'_K'/Q!K]#/C?_R- M.F_]B]9_^EFH5^>>)_\ R2U3_L/P7_I

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biib-2016630_anticd20revenue.jpg begin 644 biib-2016630_anticd20revenue.jpg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end GRAPHIC 15 biib-2016630_benepali.jpg begin 644 biib-2016630_benepali.jpg M_]C_X 02D9)1@ ! 0 0 ! #_VP!# $! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_ MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P 1" $] 3T# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#^_BBBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "OS3\6_MW:WIO[:GB_]DS2K7]F7PK!X"\,? WQ;J6M?&_\ :4N_AE\0/'6F M?%U_'MUJ\7PD^&5K\+O$R^,;KP/I'@"^GO3<^*M)M[V_U&RM;F;2+5)KY?TL MKY/'[(OP^OOBW^TW\4/$]W>>*+?]J'X9?"WX5>+_ EJ%EI\&G:-X;^&V@?$ M[PW.-$U>TC37(Y_%6F?%#5(M5=KJ-K)K"T;37B,MP6 .5@_X*(_LE3:;I^JG MXBZY;PZWJ?PYTSPQ97GPJ^+MCKGC4?&&Q\87WPBUCP'X:ULI^;_:J_;[\*_LQ>-_#?PXNO MA?\ $WQIXI\9_LU_M-?M%^';_3?#.O6/@6TL?V;O#'AKQ#?^%O&7C'^P]0M/ M"5]XE?Q+:Z>VHWD$MMX2E_L__A)H;6X\3^%+76?/=&_X)G:+%XD^#7C'Q=\= M/B%XX\3_ '\2?L^1> -6U/PWX$TIXOA7^S9_P +'F\$_#W6(-!TFQ@U+4_$ M6I?$B]U7Q_X\1+34=7FE:'H'B&UUGX6?M,^%_"OAWXE:2]AKB)_9NOI/X$\': MOX9\36-T)=)GTW4+&ZT_5-.UFZ@C ,3X=_\ !13]G/QQX#\,>)+K6_$FE^,= M?T3X37S?"K3_ (;_ !8\1?$*_P!3^,7P^UKXC^$+?P!X0L? $?B_XI>'-5\/ M>$O'FH:5XY\%>'-2\*W^E> ?&>K2:A9VGAK6S8>N_$?XZ:DW[.&L?'[]GFS\ M ?%BUMO!EU\0="M_%?C#Q'X$\-Z]X9TC3[S6-;0ZYH_@/QSKNDZY;V.GWEI! MI%_X22>WUV"72-=.C3V]WY'Q;\1/^"2WPC^(GB'PUXUU[Q8_B'Q5X"^%_P"S M5\./ L7C_P"&WP_^)7@>Q?\ 9Z\(_'KP%+K/B7X?^*;&XT;Q:/B#X8^/VO+K M.GW,VG-X;UOPUX7U[PIJFG7-OJ,=_P#=/AK]GSPMX2_9T7]G'0;E-+\,I\-] M=^'::EH_AGP;X6,,/B+2=5T_4]8LO"O@S0/#7@C2+B6[UF]U1-+T3P_IFC17 M,AC2S$;2,X!\ _"O_@JE8&Z^'"_M,_#[P[\&-&^(_P"QQ\-OVSH_%7@7Q3\1 M/C'X>\'> ?BCXO@\-Z59>/+BS^#7A>?PIIOA2TNK34O'_P 0];AT_P ">&3= MP+/J[V'G:E%]/[,D=YK6F67C/Q-XAU70OB-XX^$]UHW@_X3?%SQIK5] MX^^%^J^)M(^*.@^'M'\)^!]:U+Q3)\,Y_"FI7/Q OO#=MJFF>$-/O/#5]KEY M9Q>,/"8UKYY\3?\ !+OP/XE^&>N_#27XL>.;2QUS_@F]X7_X)Q2ZG!H_AEKR M#P9X7&I+!\38X9(/LS^,;H:E*)M)D4^'(P@$4 #N##XY_P""5_PF\::5H[:C MXAMM;\5>&/CU^UG\;/#.K?$7X7?#?XK>&=/A_;$^)][\3OB3X-N?AWXTTJ^\ M-ZA;:-J9T+_A#/$Z_9/$VD7OA?3KV[N=1L=2\2:)K(!]8:=^V3^SAK/C+PYX M(T7XCP:Y?^*5\#II7B#1/#GB_5_ATNI_$[P]9>+?AKX'DU7:^,?[4GP7^ =[;6WQ4\ M0:]X;LGTZSUK5?$L/P]^(NO^!_"&A:A?WFE6>O\ Q \>^'/"FK>#/A_HM:9HGC MSX*R?!K5-$OO!'P\^("^#8[6Y\8ZCIOCOX-7WCW1=7D^$/CW4K[QB8O'WB/P MM;_VEXVTGPIX%L3>:#>>$],U9 #UZ3_@H)^R/;:CXTT[4/BU#HX\ 3?&ZR\2 M:MK?@_Q]H_AB/6/V%H/#/B7Q;\/M4L'.J^$/#>JZMX MFN].N+/5]'TG4M,NX;DP? _]LK2?CA\0/VJ_".A_#OQI86'[,]_\,[ ?VGH? MBC0/'OC&Y^(/P:TKXN2Z9-\,/&WAGPAXD\)>(--358=!L=&U0SG6Y9;+4([J MTAO4BC\"\=?\$K_AG\1=$T7P]XD^*'Q!73M%^.G[9?QXAETRP\,66I0^*/VO M?$_C3QFRZ?<7.G7UO9M\(_%WBNRU_P "7>.O$*:3H7@,Z'?^ _AG!\+M M.D\"V?A6)9/#D3:'9V>HP":[U._L-=2XU&+4IC.L< !\O_#7_@IE%X\^"NO? M&^_\.? [0_"NGZ)\&]6G.E_M&3>-=2^&VO?%SXC>%?A_#\(_VAO!WA[X3?\ M"S?A)\8-$N?$ZI<:/:^ O%WA#_A(=/U3P]J_C#P_;Z=+KLWZ!_#?XZ?#+XMZ MAXCTGP#XADUW4O!US/IWBZS_ +%UW39?"^M6GB?Q1X0O?#FO'5=-LDTWQ/8Z MWX-U^.]\.7#+K%KI]OI^N2VBZ#K_ (>U/5?@SXA?\$RK/XQ3:UJGQB_:!\;> M.O%K>!O"WPM\-^-U^'GPK\+^*4^'^@_&[X)_'/4HOB'J7A?P_IQ^)GBO7=?^ M OA'2X_$6J)HFD>%M.U'Q9=>$/">BZMXEU2]G^K_ ('?LS6/P-\=?%;QOHOC MOQ-K"/AA/X>LO M,T.+P=\+/AX((X]9T[6]4U\ ^$_$W_!6BV\-_LD_M8_M!S? YY?B5^S;\1?B MQX+\._ ^3XBQ6UQ\5]!\%ZGXOO/!'Q L?&)\'RKX<\.>,_A]X$\;>,]:\WP[ MK#>#[CP!X^T#S]:#>>$]*\17?B>]D M\$_$"^\)Z7KO@SX37'QQ\:> (/'MCX4F\$ZO\3?"WPLLM0\;:I\-M)UV[\<) MH.G:A=)H+2V%_;6OS9XM_P""47PK\7^'?&VB7OQ-^(]O-XX_9T_:Q_9]U*:W M30/[,"_M.>+_ (L^(]*^),NA/9FTO/'?P0T;X]?&SP3\-;F>9=.;PQ\4O%T. MNVE[$_B):?$3PG??&+QYIWPQ\<>(/BQ\4[#X?V7A_P5+; M>%_CQ\8_@EXQ^"'BGXD67B&ZTN37-2TB"P\>>*_'^D_#_4+AM+M/B/K$NIRZ MK<^&;72O"FG &]XW_P""H?[./AS5O@[HWA*T^*'Q-OOB]\;?A7\'+>T\(_"G MXCPW_AJV^,O@KQ=X[^'GQ/U32]=\)Z9J6H_##Q=H?@W6)O"GBS0;74-+\5#3 MO$,FA7EW%X/\5MI.5^S]_P %3_V=OBW\$?!7Q1\=7M]\*?%7BKP5X;\8/\.I MO#_Q"\4W.HGQ9\6=/^!VAZ-\+M=M/ 6FP?&[5+KXKZ]X5^'DMG\,;'7[ZS\: M>*_#OA^]L[>ZUG36NX?$O_!-+POJWC+2OB/H_P 7O&.A>/?!^F?L8)X!U:7P M[X8UG2- \0?L:Z3\>O#F@ZUJ6AWL<,7B2#Q]X9_:%\:Z7XHTB:_T]-+GM='U M;P[?6-_:.\F#X>_X)9^#?#/@;X->"]+^+GB*\B^"_P"S)XZ_9FTMO%GPW^%' MCO0_%GA_QO\ &KX0_&>\U'QOX)\<>&M?\*ZW:R7_ ,(--\+7^A1:=9I\46&AZ]IP!]XQ_M!?"E/A!K7QVU?Q%>>$OAKX:L/$6H>)=6\>>%O M%W@+5O#J>%-0O-)UVSUSPAXPT'1?&.F:M9ZK8SZ=%HUQH"ZIJ=ZUK!H]IJ+7 M^G_:O)K[]N[]FS2_^$?M-1\3>-[+Q+XG\0^,_"&C?#V;X*_&H?%2?Q;X!\!: M7\4O$WA>X^%:^ &^(6GZ]:_#;6=,\>V.GW_ARWEUKPA>0>(-&-]ICBXKA[#] M@/X>7G[(OC_]D/Q_XQ\8>./!?Q*U'Q)K>J7MQ%IEC9>$;_7?%-AXUTO2/AEX M,FM=:\+^#?A_X'\2Z5IE]X,^'%S;:_X8L;>VGTS58-8T[4;^VGYKX4_\$Y? M?PO\8_!3QYI?B/1M(UGX1^/?C%\0KC1OAK\&OA5\'/ _BG5_BY\'=-^"T\-S MX4\ :+8+9QZ#X=TFSU.UU*^U+Q!XBU#6&N(+S6D\/1Z3H6D %_XO?\%)?@/X M(\.>$M5^&FHM\:-3\8>+OV0M%L%\+Z=XRC\$V?A[]L'XM?##P%X US6OBE9^ M#-8\!^'M:N_!GQ'7XI>&_!/B+6-(\0^*_#NFVBQP:7:^(-)U27TZU_;R_9=O M=!U[Q+;?$'4I-)T>#PM>:7*WPZ^)T%U\1=.\<>,+/X>^"M5^#&G7/@V'4?C= MH_C#QWJ&G>$/"^K_ FM?&&G:]KNJ:/;Z;_L:R_!:S\$^+M2UB336 MU;PS;^.?"WP)\!>'/B-X;\.74%AJ"Z-::GX?N_#MW+KL6OS?#W_@D;\&?A=X M5/AWP/XAL?"FH>#+OX77GP.\8^%/@O\ !/PMXS\ W7P7\8:9XT^']_XY\3:% MX/LM<^-VI+ZTJ59KR(/$6FZ'I,X\6>.]*\*Z?K5AIFG^'[:UL+/0+67PQ&VB MV926ZL;&>.PN;S4'M?MUQ],T %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% 'Y\?\ !0?QX=%\*?L_>!?#/C7D/B.#Q"ND:Y+FSW]KJLVGV4NIV,-S;66HR6EN]_:6]X8C=P6MXT9N;>"Z,$) MN8H94CN#%'YROL3%9_#^A2//(^C:4\ES>Z\[3[C[3,[0%I;CS M]*TR;SY"TOG:=8R[_,L[9H@#^>SQ[_P4[_:N\%^,O&_P@M]%^%VJ:Y\&?'/[ M1_A6_P#BQK*?"_X;>"_BWXF^$%Q\(M1\%^!;FQ^+?[1?P]L?!!NO#GQ6@F^) MDW@36?B7X]6 >'_$?@GP/'8W.JZ:GZG?M?ZWX'O/A%X-M?B9XMT3X?:AXHUB MWE\/>'/&?QR\=? ?X6>,/&$/@_6]3?P!\2_C'\.M)NM4L/#5O8G5] V&JQ+)I,OV+-H&AW#(T^CZ5,T>K1Z_&TNG64C1ZY#&(H=80O Q M358HE$<6I*1>QH B3JH JSJ6F:;K-C<:9J]A9:IIUVGEW>GZC:P7UC=1AE<1 MW-I=1RV\Z!U5PDL3J'56 W*" #^8O1_BOK=[\%O'%[\6_CQ\4=%\4_#?]D3X MA:_^Q3JO_"ZO&]I:_$C]I7PM^T9^UKX2UVZ^$6O6.J6UW^U1IGAP^&?V8/ ? MP%U'QQ_PGOBCXK_!+Q5X8\0^(?"=[?\ Q?\ &,>I_P! J?$/P_X@^$WC^V\9 M?%#PW\-O%G@+P"EI\=]=\,>+_#$%[^S]XFU;X6Z9XXUK4M8U'7H]4T;PC=^% M_#OB&T\=Z/=>,M.ETR/P[)HWB+4+*\T.Y'G^W3Z5IER+ 7&GV5P-*N8[S3// MM8)?[.NXH)K6*ZL/,C;[%<16UQ/;1SVWE2QV\TL".L4C(:,/ACP]!)XDEBT7 M30_B^Y6[\4%K2&4:_.NBV'AU7U995D2]5="TNPTE8IU>(6%K%;>7Y88, ?SQ M:;\5/#NN^#_BMX^_9O\ CIXB7]CWQ#XR_8M\$>,&O_VG/$?COXES_"V^_: F MA_:1_:\NK^]\:>+/B=\#?!7Q)^&_B+0O MYXBO\ 5? OB#5_">D>,/C/J.E^ M!4L/#OB:_P ?]K/XK)X1_8+_ &Y+WP3^U?XI\ _!OXF_'&TL M-4^*GAO3_A]\ ==\8?#_ ,,_%WQ3=W'CWQ?\._A[\;=9^,'AZTL_ _C:>XO] M(T&X^'%YX@N? N@3Z#=?T2Z%X!\#^&)+^7PWX/\ "V@2ZI'Y.IR:)X=T;2)- M0BW2/Y5\^G6-LUY'OEE8QW)E0M)(=N7;,FI^!_!FLV&EZ5J_A/PSJFF:($71 MM/U'0-(OK'25C@%K&NF6=W936VGJELJVZ"TBA"P@1+B,;: /P*_:Q_:+UF__ M &@/C-XT'BW2_$7@'X4>$?V9/&_[+'AWP/\ M+^._AYXH^/>E>+-:\8V?Q"3 M]F#3OA5J-UX9^+/QBU/XC:;_ ,*_U.Q\9:;\0_">HV&D>#OA?J6A>$]!^(/B MGQ-=_>'_ 4#_:N\=?L_R_#GPC\+O$?AO0O'7C/PS\5O'&GV_B[P[X.?1->L M_A(]?M?T0LO"WAG38=&M]/\/Z)8P>'1<#0(;/2=/M8M#^UQ2P77]CQV]M&FE_ M:89IHK@V"VYGBDDCEWH[*=&]TW3]2-F=0L;.^.GWL.I6!N[6"Y-EJ%NLB07U MH9XY/LUY LLJPW4'EW$2R2".10[ @'\]W@__ (*G?M->*/"VF_'6W\&?#[5/ M!=U\7/V-/AG9_ /1/#NL-X_\27O[7G[!GP&_:/CT;3_B)?\ BJWMM/\ $7AG MXJ?$^;P[X8AE\&7HUW19GTK6+>#43I^I6OLG[$7QY^('QM_;=FU[Q1\WLYP!+:P00PV[QQQ1JLMII&E6$LL]EIMA9S3RW<\T MMK96MO)--?W37U[++)#$CR2WEZS7=U([,]Q=,;B9GF)<@'\^/Q2^*EIJ?C;X M\:E^P=^T=XG^(7Q>^%?PJ_;1O?B-XAU3]H/3O'>I_''XVV7PZ\:+X$^!7PH^ M!2ZWJ>F:S?\ [//CN6V\2GQ3X&^%FA>'_ $?PZL_@UH^H>--9\6?%F#PYZOX M;\:_#BP?]J/PW\$OVLO$6A?LE0?LT_ WQ5&OCSXM\1_&"#Q/ MX9\-_&'XOZAXMB\&>-_BG\.M-^'NJ>.;33]7LO$W@_6=5T/QCH&E^$/&OC4: MW??LM8?#OP%I6M?\))IG@KPCIWB',Y&NV'AG0[/60;J.2*Y(U6UL(M0!N(II M8YB+C,L%=3TNZT34?#6@7^C7M[)J5YI-[HNF7>F76HS79U M":_N=/N+22SGO9;YC>RW)_BY;?"_P#9MU+Q%+JOB#X3_$_P2_B/ MXAZ2BZQ8^*QXN\=:UX[\))XQD\0V?@'Q:^J:SY/[W_ KQ=<_$#X)_"#QW>>$ M-4^'UWXT^%_@#Q7=> ]$_#5AIT.KIK\5C9:!I%I91Z[ M&4,>LQVEO91VZ:M&8HRFI+$+U#&FV<;1CJ?\^O\ .@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** /EOXX?M;_#7X"?&']EWX'>+M+\8ZEXX_:Z\>>-_AW\* MSX>TS2[K0[37OA_\/-5^)VO3>,-3U'6]+DT;36\-Z->1Z?/8V6LW%UJAAM7M M((6DNX_H0:KJQ (\.7>" ?\ D):.>ON+TC\B17XP?\%)_P#E))_P0I_[.M_: M@_\ 6.?B#7[>1_ZN/_<7_P!!% &'_:FK?]"Y=_\ @QTC_P"3:/[4U;_H7+O_ M ,&.D?\ R;6_10!@?VIJW_0N7?\ X,=(_P#DVC^U-6_Z%R[_ /!CI'_R;6_1 M0!@?VIJW_0N7?_@QTC_Y-H_M35O^A ">*_-#]F/_ (*&W_[1S?M&:WI7P$\5S>"_@YXLT+0/"4W@'QEX#^(WCWQ- M-KW@OX8^)+3PEXY^'%AK>EZY\+OB:MY\09[?5-!UN6Z\*>$8O#7BFP\<^-/# M/B#P=XETZW /T2_M35O^A%?B[\]]]@^+/Q:7]GWPO\ M$[4?V?\ 61\7_$>A^$;BY^ VB^,]+OY_#?B7Q??Z=8MI/B#X@:WH_AG3['0_ M!J:F-5\>^)&\./=:+I&E:Z^D^'/$.JVEAI&J 'M?]J:M_P!"Y=_^#'2/_DVC M^U-6_P"A)?L[_ !XO_C7#\6-'\2>"%\!>/O@?\5K[X0?$ M/1=,\4VOCWPB_B6#P5X'^(MI>^"_'5II'AT^)=%N/"GQ$\-B^_M+PUX9U[0/ M$D>N>&= M!?!/QNUO1;&&W*+\*=1^(EI?^'[J72]:N])N_&>GPQ:?K%SX6EN!I^O:5&+V M._XNV^/WQB\7_$#_ ()=>,? _P <]:USX(_&OXN_$KX6?$7PWJ'PC\.^$_&W MQ$U_P?\ LO?M<>*M>N?BAK%I/J6D:--X1^('P>T**P\-_"G3/#WAS4-?T7Q! MXC'BCQ+X/N_#NE68!^O.]-VWZ+YG_P4>_;[A^#OQ%^%?P\\*?&>Z^#D?@GX_?L2:S\3-13PCKVH2_%C MP=\8/VD_AYX2\3?#3P_K4_@CQ#X,OB=K6AW\.OO<7?@'PIX M5U*/4;SQ3!9@'[:T4R*198TE1MR2*'1L$;D8;D." 1E2#@@'U&:?0 4444 % M%%% !1110 445\J?MO\ Q/\ &GP8_94^-?Q/^'>IP:-XT\'>$EU3P_J=SIMA MJ\%G?-K6DV9EDTW4X;BQNU^SW5AAZ;BIUZU.C! MS;45.K.,(N32DU%.2NU%M*]DWH88K$0PF&Q&*JJ3IX:A5Q%102]X_,1DWQL4D7<"I9''*. '\!B!_Q:WX>] ?^P'3?^'N'[>?_ $5OP_\ ^&L^'O\ M\HZ^M_U%SC_G]E__ (.Q'E_U"^?]69\'_P 1+R'_ *!LT_\ !&%\O^HWS_#U MM^^OP3_8(\3_ Z_8_\ "/['GC[XYVGQ%\(>!_%?PGO=%\1Z1\)K3P#J>I> M_AQ\5O"OQ3U?P%XKTX>/O%]AK2>.YO#]_P"&-9UNR;15MO#VN7$4>BW5Q \M MY]"?'KX1_M ?$O3?B+I/PH_:;F^!=IXN^'_@[PKX6NM-^$?AOQIK7@#Q5IWC MG5M9\?>/M,UK5/$6CW>HZCXW\!WMAX#TK3)_L=OX"OM-_P"$ZT6[O=(_ /B2WTW6=2O]%N?A_P###5?AA:1VFK>3?ZK<>([?7?B? M\6M=\8^--?\ $TVM^)_%?Q U[Q7-KWBO6-:N=0UU;O5FN]5U#Z/K^.7_ (>X M?MY_]%;\/_\ AK/A[_\ *.OU,_X)4?MK?M&_M/\ Q3^*GAGXT^-=-\3Z-X8^ M'VB:]HMK8^#_ QX;>UU2\\3OIMQ.]SH6G6=QAF$*V*E*%.56CAXTTXTY5'SRABJDDK1:34'K96WM^YU%%%?+'VH4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% 'X@?\ !2?_ )22?\$*?^SK?VH/ M_6.?B#7[/7_BGPUHLD-IK'B#1-*NGMXYTMM2U?3K"=X&+(LRPW=S#*T3/'(B MR!"A9'4,65@/Q<_X*71R2_\ !1__ ((61Q3R6LC?M6_M/[9XDAD=,?L=_$ G M:EQ'+"=R@H2\;8#%EPX5A\ _\%L[+R_VK/ ZWDW]IR_\*'\*D3WEIIZR*A\: M?$'$0%K:P1[%8%QE"P+L-Q4*![&1Y7'., M0^%_P =-,^%OQ.\!:I<6EY=^&_%.IZ#?6GVVPE$UG?6DPU".]TV_MW# M+'?:==6EWY$MQ:F8VMS<0R^9?$;]E_\ 8,^+FN^%?$OQ)^%/[/OC'7? VC:7 MX>\%:EK-KX4EG\'Z+HMOJ-EI.G>%E@O;>#P];:?I^KZIIMJFD169ATS4;[3% M86%U-;O_ !(?9;3_ )]+3_P%M_\ XW1]EM/^?2T_\!;?_P"-U]G_ ,0_I_\ M0UG_ .$G]U:?"S]D2/QQXA^)ZQIHC ML-3N;NTABA3HK;PU^S?9^ / _P *K33_ (36WPU^&@^&P^'W@."X\+Q>$O!G M_"G=4\/ZW\*O^$:T%+I=.T<_#O6/"GAK5/!ILH(CX>U#0-(N]-,$^GVSQ_P9 M?9;3_GTM/_ 6W_\ C='V6T_Y]+3_ ,!;?_XW1_Q#^G_T-9_^$*YMIXF^[)#/ \D,L;8^5XW93V)K_/#2UM-Z_Z):?>7_EU@]1_T MSK^V'_@GQIMZ_P"Q1^S,UOK=[90GX2^&2EM;V6C>3"ICF(2,RZ;+*57H-[LW M4DDL:\#B#AF.1X:AB(XR6)]M7]CR.@J7+^[G/FYE5J7^&UK+>]]+'U'"W&%3 MB/%XC#3R^&$5##.NIQQ,J[DU5I4^3E="E9?O+\W,]K6UT^Y**PO[+U3_ *&7 M4_\ P"T+_P"55']EZI_T,NI_^ 6A?_*JODS[DW:*PO[+U3_H9=3_ / +0O\ MY54?V7JG_0RZG_X!:%_\JJ -VBL+^R]4_P"AEU/_ , M"_\ E51_9>J?]#+J M?_@%H7_RJH W:^%/^"F/_)BG[27_ &(4?_J2:!7V=_9>J?\ 0RZG_P" 6A?_ M "JKX;_X*4V%_#^PS^T?)-KE]=QKX#C+6\UKI*1R#_A(]!&&>WT^&91SG]W* MAR!SQ7?E7_(TRW_L/P?_ *D4SR\[_P"1-FW_ &+<=_ZC53^,)_OM_O-_,TVG M/]]O]YOYFFU_0$=EZ+\C^6PHHHI@%?N/_P $*?\ DN7QT_[)-X:_]39Z_#BO MV\_X(:V]QJ?]#+J?_@%H M7_RJH_LO5/\ H9=3_P# +0O_ )55^''](F[16%_9>J?]#+J?_@%H7_RJH_LO M5/\ H9=3_P# +0O_ )54 ;M%87]EZI_T,NI_^ 6A?_*JC^R]4_Z&74__ "T M+_Y54 ;M%87]EZI_T,NI_P#@%H7_ ,JJOV5K1SA41F(4RTAZ'G;P>?3CKSQQUH ^>9OCKXD4R7M MG^SG\?=0\,1R2+_PDL6C_#JPFD@CE5#>P^ ]:^)FE_%%[=HB9UMY/!$.L.BE M(](>8K$_O6FZA;ZKI]EJ=JMVEMJ%K;WD"7]A?:5?)#RO[6VO+64/!,?%/Q=B\"12^(IO%?[Y+TYR>3U^IXY R!T!QR #0!^(/_ M 4G_P"4DG_!"G_LZW]J#_UCGX@U\%?\%N_^3L/ W_9!?"G_ *FOQ"K[U_X* M3_\ *23_ ((4_P#9UO[4'_K'/Q!KX*_X+=_\G8>!O^R"^%/_ %-?B%7UO!7_ M ".X?]@U?\X'PGB+_P DY/\ ["\-_P"EL_'.BBBOV,_ @HHHH OXC4^^O^\O\Q7]N7_!/+_DR3]F3_LD?A?_ M -%3U\)Q]_R+L%_V&_\ N"J?IGAA_P C7'_]B^7_ *DX8^S****_*C]L"BBB M@ HHHH *^%/^"F/_ "8I^TE_V(4?_J2:!7W77PI_P4Q_Y,4_:2_[$*/_ -23 M0*[\J_Y&F6_]A^#_ /4BF>7GG_(FS;_L6X[_ -1JI_%8_P!]O]YOYFFTY_OM M_O-_,TVOZ CLO1?D?RV%%%%, K]Q_P#@A3_R7+XZ?]DF\-?^IL]?AQ7[C_\ M!"G_ )+E\=/^R3>&O_4V>O XH_Y$&9?]>J?_ *?I'T_!G_)3Y1_U_J?^HU8_ MIYHHHK\./Z1"BBB@ HHHH **** "BBB@ HHHH **** "D;HEK% M\1RO#X?UR:.[-@\6CZI(E\MY!I[6;QV%PZW0OKJRU*VLS;L!,+NXT^^@MBGG MS6=U'&T$@!^%_P 2?'#^%/VPOB9XBT7XG^+/"&A6'[3WP/\ /BSX'6'[7&J M>$_BG\1_%'C:S^$NF6?C3X;_ +-,/PTU/P]JO@2^L/$MBU]I;^(AK7Q-\-^% M_&/B"7Q-H$FE6MA7[TJDWWAF#4+3^S?Z21T_$]\]S_ )QVZ'I0!^(/_!2? M_E))_P $*?\ LZW]J#_UCGX@U\%?\%N_^3L/ W_9!?"G_J:_$*OO'_@I9+%# M_P %(/\ @A7+-)'%&G[5O[3Y:261(HUS^QU\0%&YY&5!EB%4$@LQ"C+$ _!' M_!;2YM[K]JWP/);7$%S&/@/X50O;SQ3H&'C3XA$J7A=U# $':3G:RMC:RD_6 M\%?\CN'_ _P X'PGB+_R3D_\ L+PW_I;/QYHHHK]C/P(**** ')]]?]Y? MYBO[C_\ 05TW_P #[/\ ^/4?VWH__05TW_P/L_\ MX]0!J45E_P!MZ/\ ]!73?_ ^S_\ CU']MZ/_ -!73?\ P/L__CU &I7PI_P4 MQ_Y,4_:2_P"Q"C_]230*^U_[;T?_ *"NF_\ @?9__'J^&?\ @I7JFF7'["_[ M2$4&H6,TK^ XPD<5Y;22,?\ A(]!.%1)6=C@'A5-=^5?\C3+?^P_!_\ J13/ M+SO_ )$V;?\ 8MQW_J-5/XNW^^W^\W\S3:<_WV_WF_F:;7] 1V7HOR/Y;"BB MBF 5^X__ 0I_P"2Y?'3_LDWAK_U-GK\.*_<#_@AC=6UI\!Q1_R(,R_Z]4__ $_2/I^#/^2GRC_K M_4_]1JQ_4!167_;>C_\ 05TW_P #[/\ ^/4?VWH__05TW_P/L_\ X]7X)_#GP!T+X'^)-/U;2?'ES<7^F:7HFJ^/+35/B# MXDMM=N-1'A:'7+>TL_W8']3WSW/\O3MTYQ7YVZ]\,M$^'G[07B#5M'_;:L?@ MW-\4_B/X<^)&M_ 9O#'[*MLWB[7+JQ\,^%)]M_XQ\$77Q9U"?QO8>$M-T6;4 M[?7Y=3W6\4/AR>QN+6(#]$Q]<\G^?3\.GX**']J[P.L,44*'X# M>%6*11I$NX^-?B%D[8U52TM9';X2 M>&"SO;PLS$Q39+,4)).,DDDDY/4DU_$LGWU_WE_F*_MR_P"">7_)DG[,G_9( M_"__ **GKX3C[_D78+_L-_\ <%4_3/##_D:X_P#[%\O_ %)PQ]@?V=I__/C9 M_P#@-!_\11_9VG_\^-G_ . T'_Q%7**_*C]L*?\ 9VG_ //C9_\ @-!_\11_ M9VG_ //C9_\ @-!_\15RB@"G_9VG_P#/C9_^ T'_ ,11_9VG_P#/C9_^ T'_ M ,15RB@"G_9VG_\ /C9_^ T'_P 17PO_ ,%+;.SB_86_:1>*TMHW'@.,AX[> M)'4_\)'H(R&5 PZGH1_*OO2OA3_@IC_R8I^TE_V(4?\ ZDF@5WY5_P C3+?^ MP_!_^I%,\O._^1-FW_8MQW_J-5/XK'^^W^\W\S3:<_WV_P!YOYFFU_0$=EZ+ M\C^6PHHHI@%?N'_P0NAAF^./QS6:&*91\)O#9"RQI( 3XU<$@.K $CN.>GH* M_#ROW'_X(4_\ER^.G_9)O#7_ *FSUX'%'_(@S+_KU3_]/TCZ?@S_ )*?*/\ MK_4_]1JQ_3;_ &=I_P#SXV?_ (#0?_$4?V=I_P#SXV?_ (#0?_$5>X:&TMY;NZE6&)Y3';VL :>YGD"%(8(5:6:5DBC!=U!LU'-#%<12 MP3QI-!-&\4T4JJ\*/B!X^Z7IFGZ+IUAI&E6D&GZ9IEG;6&GV-K&(K:SLK.%+>VMH( MQPD4$,:1QJ/NJH% 'XG?\%)_^4DG_!"G_LZW]J#_ -8Y^(-?!7_!;O\ Y.P\ M#?\ 9!?"G_J:_$*OO7_@I/\ \I)/^"%/_9UO[4'_ *QS\0:^"O\ @MW_ ,G8 M>!O^R"^%/_4U^(5?6\%?\CN'_8-7_.!\)XB_\DY/_L+PW_I;/QSHHHK]C/P( M**** ')]]?\ >7^8K^W+_@GE_P F2?LR?]DC\+_^BIZ_B-3[Z_[R_P Q7]N7 M_!/+_DR3]F3_ +)'X7_]%3U\)Q]_R+L%_P!AO_N"J?IGAA_R-7GG_ ")LV_[%N._]1JI_ M%8_WV_WF_F:;3G^^W^\W\S3:_H".R]%^1_+84444P"OW'_X(4_\ )%E$+7-O=%D'C3X@D M/YELS1C)++M)#?)OQM=:^_\ _@I/_P I)/\ @A3_ -G6_M0?^L<_$&O@K_@M MW_R=AX&_[(+X4_\ 4U^(5?6\%?\ ([A_V#5_S@?">(O_ "3D_P#L+PW_ *6S M\7^8K^UK_@GW?ZG#^Q5^S1'!H7^8K^W+_@GE_R9)^S)_V2/PO_ M .BIZ^$X^_Y%V"_[#?\ W!5/TSPP_P"1KC_^Q?+_ -2<,?5G]J:S_P!"Y-_X M--,_^/4?VIK/_0N3?^#33/\ X]7045^5'[8<_P#VIK/_ $+DW_@TTS_X]1_: MFL_]"Y-_X--,_P#CU=!10!S_ /:FL_\ 0N3?^#33/_CU']J:S_T+DW_@TTS_ M ./5T%% '/\ ]J:S_P!"Y-_X--,_^/5\.?\ !2B_U.;]AK]H^.?1);6)O D8 M>=M1L)1&/^$CT([C%%(TC\@<*,_G7Z!U\*?\%,?^3%/VDO\ L0H__4DT"N_* MO^1IEO\ V'X/_P!2*9Y>=_\ (FS;_L6X[_U&JG\5C_?;_>;^9IM.?[[?[S?S M--K^@([+T7Y'\MA1113 *_;O_@AM/=6_QN^.+6MBU^Y^%'AP-&MS;VQ0#QHY M#;KAE5LGC:ISQ[BOQ$K]Q_\ @A3_ ,ER^.G_ &2;PU_ZFSUX'%'_ "(,R_Z] M4_\ T_2/I^#/^2GRC_K_ %/_ %&K']+/]J:S_P!"Y-_X--,_^/4?VIK/_0N3 M?^#33/\ X]7045^''](G/_VIK/\ T+DW_@TTS_X]1_:FL_\ 0N3?^#33/_CU M=!10!S_]J:S_ -"Y-_X--,_^/4?VIK/_ $+DW_@TTS_X]7044 <__:FL_P#0 MN3?^#33/_CU:%C=7ESYOVO3GT_9L\O?=6USYN[=NQ]F=]FS"YWXW;AMSAL:% M% !1110 4444 %%%% !1110 4444 ?B!_P %)_\ E))_P0I_[.M_:@_]8Y^( M-?!7_!;O_D[#P-_V07PI_P"IK\0J^]?^"D__ "DD_P""%/\ V=;^U!_ZQS\0 M:^"O^"W?_)V'@;_L@OA3_P!37XA5];P5_P CN'_8-7_.!\)XB_\ ).3_ .PO M#?\ I;/QSHHHK]C/P(**** ')]]?]Y?YBO[7_)DG[,G_9(_"_\ Z*GK M^(U/OK_O+_,5_;E_P3R_Y,D_9D_[)'X7_P#14]?"L?%+X3_ CQ1HO[,OQ%@^,'[05MXEU?P/\&?\ MA.?A==6EYX/\$>'O#_B7QC\1;/XKQ>(CX+O? 6FQ>*_#'ABQU*6.PUZ_\?>( M=+\,W7AK2;4:EKNG 'Z5T5YA\%_B[X0^/'PM\$_%SP))J!\,>.=$AUBPM=8M M%T_7-)G$T]CJOA_Q!IZ3W4>G^(O#>M6>H^'_ !!I\=U=166M:9?VL5U=11)< M2>GT %?"G_!3'_DQ3]I+_L0H_P#U)- K[KKX4_X*8_\ )BG[27_8A1_^I)H% M=^5?\C3+?^P_!_\ J13/+SS_ )$V;?\ 8MQW_J-5/XK'^^W^\W\S3:<_WV_W MF_F:;7] 1V7HOR/Y;"BBBF 5^X__ 0I_P"2Y?'3_LDWAK_U-GK\.*_HZAX?M?'O@75W M^W>%Y/%OA;R=2UI=0NVTWZ]H **** "BBB@ HHHH **** "BBB@ HHHH _$# M_@I/_P I(_\ @A3_ -G6_M0=!G_FSGX@^E?!?_!;L'_AJ_P/PW_)!?"G4$?\ MSK\0QW'KQ]:_<#]MW_@GI\)?V[)?@MJGQ ^(O[07PE\8?L_>+O$GC?X6?$3] MF[XN:E\&_B%X:UWQ;X9?P?KLUIXKTG3=1U"&.^\/2W.F/]C-I/\ 9;R]MS<& MWO+F&3\[O'?_ ;K_LU?%'5X/$'Q+_;1_P""J'Q UZUT^'2;76?&7[=/C/Q% MJEOI5O/&+FXCL8;F\N[B*V201)-=3R*H:5R?9R'-*>48]8RI2G M6BJ52GR0<8RO/EL[RTLK:GSW$^2U<^RN6 I5Z>'FZU*K[2I&4XVIMMJT6G=] M#^<3!]#^1HP?0_D:_H'_ .(8_P#8G_Z.8_X*2?\ B9?B'_YD*0_\&R'[$X!/ M_#3'_!23@$_\GE^(>PS_ -"A7W'^O^#_ .A?B?\ P;2_R/SG_B%^._Z&N$_\ M$5O\S^?G!]#^1HP?0_D:_7SX$_\ !O-^R3\2O%_[4&A:Y^TM_P %$%LO@]^T M3=?"SPM_9W[87B""?_A'8/@G\$/B#_Q.)!X5D^V:F=>^(>NL+ED@9=-.G6K1 M/]F%Q-]%_P#$,?\ L3_]',?\%)/_ !,OQ#_\R%'^O^#_ .A?B?\ P;2#_B%^ M/_Z&N$_\$5O\_P"O,_GZ0'>O!^\O8^HK^W'_ ()Y\?L2_LR9!_Y)'X8'W3VB MF]OZ^'/\ @AC\//!VA:7X M7\)?\%%_^"P_ACPUH=G%IVB^'] _X*'_ !)TK1M(T^#(@L=-TZST*&UL[2$$ MB*""-(T!(51FOGN(^):&=X6A0I8:K0=&O[9RJ3A)->SG#E2CK>\KW?8^JX3X M0Q/#N,Q.)K8RAB8U\,Z"C2IU(2C)U:53F;FVFK4VM-;M'[A9'O\ D?\ "C(] M_P C_A7XL?\ #E;P]_TDU_X+/?\ BQ_XI_\ RFH_X'O\ I)K_ ,%GO_%C M_P 4_P#Y35\>?>GZV_$OPOK7C7P-XB\+^'?%+>"]9UBR2WLO$+>&]#\7VELR M75O<36>K>%_$D$VDZ_H&LVT,VB>(M)F>QN;[0M1U&WTW5]$U1[/6+'\H?V6/ M^"7_ (^_9?\ A_\ "+6?!_Q@^'>D?M#_ YNO$S7-Q9?"?5+[]G5-!^(7PW^ M'W@#XA>$O#?PNL_&_A+Q-I*^)M4^%7P^^)^N^,+'QII.M^*_B7H5[JVNZ?\ MV5K]]I,5#_ARMX>_Z2:_\%GO_%C_ ,4__E-7S=I?_!+%KS]KCQI\#9?^"F?_ M 6*_P"$2\/_ +.GPR^*MB4_X*+?%!=:_P"$C\7?%'XN^#-5^TWO]E%Y=+.E M^!]&^Q6ODQK!="_E\V9[@^2 ?N;^SK\$M _9S^"_@+X-^'=0OM9LO!FDSP7F MOZC;6MIJ'B7Q%K.JZCXE\7>*;ZRT^./3[&\\4>+=;USQ!'O^DFO_!9[ M_P 6/_%/_P"4U '[3Y'O^1_PKX5_X*8\_L*?M)8!_P"1"C['_H9-!]O8_E7R M%_PY6\/?])-?^"SW_BQ_XI__ "FK \4?\$*_AOXWT#4_"GC/_@HG_P %A/%G MAC6K<6FL>'?$7_!0WXD:QHNJVHECG%MJ.FWVA36EW )H8I?*GB=/,C1\94$= M.#KK#8O"XF47*.'Q-"O**LG)4JL:CBF]$VHV5]+LY,PPTL9@<;A(R4)8K"XC M#QG)-QC*M2G34I):M)R3:6MEH?S$N#O;@_>;L?4TW!]#^1K^@?\ XAC_ -B@ M]?VF/^"DG_B9?B'_ .9"C_B&/_8G_P"CF/\ @I)_XF7XA_\ F0K](7'V#22_ ML_$Z*W\6D?D?_$+\=_T-<)_X(K?YG\_&#Z'\C1@^A_(U^Q'Q@_X-W_V1? GQ M)_96\(Z/^TM_P43.G?&?XX^)OAYXJ-]^V)K\US_8.C?LV?'WXL6PT>0^$XVM M-1/B?X;>'#+=*)BVD+JMD8<7GVFU]_\ ^(8_]B?_ *.8_P""DG_B9?B'_P"9 M"C_7_!_]"_$_^#:0?\0NQW_0UPG_ ((K?Y_U8_GXP?0_D:_> ?\ @WB_ M9T^%-_?ZK\,/VV?^"J_P[U/5;.+3]3U'P5^W=XV\-WNHV$,_VJ&RO;G2?#-K M+_Z2:_\%GO_%C_ ,4__E-1_P .5O#W_237_@L]_P"+ M'_BG_P#*:OS\_43]IR<@XR#C@[3Q[\C''O7Y-_%?_@FG??'+]LF^^//Q1^(_ MAW7/A/6FD1ZQ>>>?\.5O#W_237_@L]_XL?\ BG_\ MIJ^;?VO_ /@EB_P(_9H^,OQ=\(?\%,_^"Q)\3> O!=[K^B_VW_P45^*%[I(O MH+JS@C-_:/I4*W%N!B>(/$.N^,D?Q5XK7Q%\1?'FH^$/ M C^);[1/^$5\&V2^$8#X9\':1_:^I+7VSD>_Y'_"OQ67_@BQX>8$_P##S3_@ ML\/F=);*T_X14ZW_ M &XP\2&S\PZR-+T03[?[,AW 'VM1110 4444 %%%% !1110 4444 %%%% !1 M7PS\9?VWM&^%/B?XL6.F?"KQY\0O!/[-OAW0O%O[3GQ!\-7GA:ST[X3:%XAT M"7QB@T_0='?%' MB>QN;7P);ZO+XZM_AGXBL?!GB6R\+_$>737L]7O-.CUAM&L_ FHZ;XTNP#Z^ ML=)TO39=2GT[3K"PGUF_.JZM-96=M:RZIJ;6=GI[:CJ,EO%&]]?-8:=I]D;R MZ::Y-I8V=L9?(M8(X]"O ?&7QSN?!'C_ %_POJ/PL^)>J^%="^$UA\1T\?>$ M_#UUXML=:U_4O&\_@VT^%^A>&= AOO%&H^-I0MGKF$L4T>#2;^*YO[^QMK>^ MN[;Y>TK_ (*/>!->_9F^ W[0.G^ ='_#FA)KNL:] MI<%R ?H_17GWPJ\=S_$WX=^$?'MSX4UKP3-XIT:WU63POX@U#PMJ^I:29FD0 M1-K7@?Q!XJ\':[9SK&+S2=>\+^(]9T'7=(N;#5]+OY[2]B(]!H ***^;_C;\ M?[WX9^*_A_\ ##P-\-]?^+OQ=^)FF>-O$WAOP3HNM^'?"MC9>"?AL_A6#QQX MS\4>+?%-U;Z3HFC:7JGCGP5X:T^"*#4M6UKQ/XNT6RM-/BTN+7M;T0 ^D*SU MTC2DU6;74TW3UUJXT^VTF?5ULK9=4FTNSN;J]M-.FU 1"\EL+:\OKVZM[-YF MMH+F[NIXHDEN)G?\_/$7_!0;3K+X3'X]^%?@!\9/%/P<\(_#/Q'\5_C9XNN# MX'\)S_"?1? NO^./#'Q+\/$/BF!_B%\6?A=K'PV\;IX\\">"+V^BTRVT> MR.G^(=5U#Q5X.TO7_L'QM\1=0\+ZE\(;31? OB;QK9?%#XAP^"]4U70Q:6]K M\.]#F^'OCSQPOCWQ;%J3V]ROAT7G@[3O"+06<3ZH-?\ &&@HULL NS& >I45 M^>VG_P#!07PKKOP__:]\=Z3\*?B-I7_#*/CGPWX DT+XD#1/A9JGQ"U+QG\. M/A?\0_".N01>+[RWG^''A;6K7XK>'X#?_$ZU\.:OI&GPW>OZ[H&F6)@A?Z"_ M9G^-][\?OA]>^-[W2/ >C&V\4ZKX>@A^'?QH\%_'70+B/2[33)9;A_&7@2VM M=&M=12ZOI[6[T"5&U#3Q;0W%RP2_@10#Z'HHHH **^1/C)^V!X.^!7Q$O_AU MX\\+^*(-1U;X5O\ $'X07.FC3KU?C?XIT_Q;9>"==^#7@.U-Q#<'XIZ?KOBO MX8?8=#U,6]MK^E_$2TUC2[N33O"GC:?0OD;XJ_\ !3'XD_!C7OVGM,\=_LAZ MW%IG[+7PM^'OQ8\8:OHGQW^&NK-KN@_&/7OB+X6^%-EH.FOI5E<1ZGKVO_#/ M7;?7TU>6PM_"UA<:;J33ZO'/)%" ?K-=Z7IM_<:9=WVGV-Y=Z+>R:CH]S=6E MO<7&E:A-IU]I$U]ILTT;RV%Y+I6IZCILEU:/#.^GW][9/(;:[N(I+U?+GP;_ M &C=1\<_$'Q)\%OB?\,M8^#7QE\-^"M ^)0\*WWBCPSXY\/^*/A_XBUS6?"\ M7B7P9XS\+RI;:JNA^)]!O?#_ (MT75M(\/Z_X>OKK0KN;3;G1?$N@ZM?^6?& M?]NO3_@1\(;CXI^._@9\98I3\=]=^#5CX8TW1K"\E.B:9^T)8? 73/B[KGBE M[B#PAX6\ >)CK7A_QWXO^'M=L=-\/:!K6O+=V=L ?>U%?$GQ5_; M5T#X?_&JW^"?ASP#J_Q&\1:5=^!K3QT=*\<_"WPC>:+>_$>6^D\,^'?!NA?$ M/Q?X7U+XK>.K?P[IMUX^\1^!_!9EUK2? KZ9?VHU;Q#XA\.^%]5^V@ M./7V['J/;TZ4 +117@GQR^/N@? &;X9:IXYTJ^M_A[X[^(>F_#?Q'\21=6-O MX9^%NK>*;*]A\!ZSX\>Z>*6P\*>+O&D.D_#B+7X6>UT;Q;XM\*KK"V^D:A=Z MGIP![W6?JVD:5KVG7>D:WIFGZQI5_";>^TS5;*VU'3[R!BK-!=V5Y%-;7,+, MJDQ31.A*J2N0,?FQK'[?OQ$;XG_LU^"?!W[+'B#Q%X8_:ND\97?PF\:ZQ\6_ M!'@N>?PSX'TF\\7ZCXG\1>#-6TJZ\0Z)::U\/8=/\9>&-.9KG5[VVUK3]*UB MT\/ZHMY%;:O[-O\ P4';XX:5\ _%GC'X$^+_ (1?#_\ :IO-5TWX!>-]1\:> M!_&NF^(-:L/#?BCQIIOA;QM8>&[J#5OA_P")_%'A'P5XNUGPY;W5GK6A74WA MO4- OO$6G>([O0=*UH _2+_/Y]:*^>O%'QYO/!_B3XO:5JGPA^*^J:+\,_"7 MPL\0:!KO@WPX?&,_Q8UOXF:GXVTAO!/@'0-'D;46UWPE?>%M(7Q1?Z\^D>&M M'LO&.D:WJ^MZ5X?L-;U:P^4M>_X*.Z+%^SU^R9\>O#GP\T>VM_VKOAEI_P 6 M='T;XN?'+X6?!'2? GAB[\&^&?%D]GXF\>^++J^\,ZEXCMYO%^A:+!H_ADZI M_:$[:CJ=K='2-,N+M@#],J*YSP=KD_B;PCX6\275K8V-UX@\.:)K=S8Z9K=E MXETVRN-5TRUOYK33_$>FI'IVOV-O)<-%::W81QV6K6Z1W]HBV]Q&HZ.@ HHH MH **** "BBB@ HHHH **** "BBB@#\P/VIOV3?BEK-Y\=;GX.:FFJ_#G]LM? M!?@C]K;X<6^A^%G^)-QX/MOA]??!_P 4^,_@=XT\8^-?"'@S0_%?B'X:6_A# MP/XITWQ]:>(;'3O#FBS^-/ :IXVT]/#7BOMO#O[+_P"T':?M4Q?'+QG\5?@A MX[\ >&=0U;0_@]X#O?@Y\0=*UKX&?"O4=+729O#_ ,/+ZT^-\_@9?B3KEE$M MGXT^,NM^ -2\2Z[HES=>#M'M/"W@IG\.S?H310!R/CNV\)_"EG>"Y@:636= \/>)O!^LZE:M:+&O%^@>.?#?Q1^'VJ_&[4[W6Y;U_%J:IH.N>%/&'A:X\/ZKX:\ M/7AL]3BCU.SO_P!A:* / OV8?@/I_P"S1\$O"/P';SQCK-YJR:) MI_A?39=:\?\ COQ/\1?$-MX:\):3+/IG@SP5INO>+=2TSP+X)TZYO+'P9X.L M]#\,VM[?1:6MY/[[110 5\A?M)_!CXH:YXE\)?M"?L[:[X.T?]H;X1_#[XM> M"/"FC?$?P]<:]\.?B+X2^)W_ A6OZUX"\6OI&O>%?$?AY[CQI\+?A[K>A>+ MM&UY?[#N-,U&SU/2=7TC6[Z*W^O:* /Q[7]AG]H?4O!'P0\)>&_BAX!TGX0^ M#;"]^(OC+X!_M#_"/4O%]]X[_:1\6_%;Q+\9O&/Q-^+VI? ?]H/PMX'\6:5% MXZ\13^(?"WP>T^76?ACX;\3/)K]]<^-KS2_"$GA?]?8EG6WC65X6N1$HD>.. M1(&N-@\QTB>:258FEW.J/.\@0A6E9\R&>B@#\QOA_P#L??M,Z7XI_:]USQ[\ M;_V?=8M/VL?$7ACQ]J%GH/[-/B&[M_"7C?P/\,/@[\(O#=K<:+\2OC7X]\,> M,_ 5]X6^$<%UXJT#4-*TOQ#>ZKXBOYO#WB[PT]AI=S;?4/P$^!7B+X9^)_C! M\2_'WB_P_P"+/B5\;M>\'ZOXL;P+X+G^'G@#3+?P)X+L/!/AZUT+PQJ'BCQM MKMSJ'="TJS^F** "BBB@#YO^/'[/=K M\;?&W[+'C&?6[+1W_9H_:(/QZAM;OP[!KB\1KKD46HN/^$=&FBP#:BFH6'S3^TK^P%?_ ![7]MB;3_BK:>$[W]K; MX#?LW_!S36O/!$VOVGP_U#]GKQC\8O&%MXDOH8/%>BS^*[+Q1.=$^,'B?\ :'^./C[PEX_^+6N? M#K0OA)H%M\// .J_#OP#X%^'^D^)=5\9ZK9:1I?B+QS\1?%&L>(/&?BO4;35 M/%&N:QXG6R%EX<\*Z-H>@:4NF:IJ&O\ ._MW?LY?%K]JKX-)\&_AI\2?AS\, M],UCQ3X(\2^+=9\=_#?Q5\1KRX/PW^)'@7XH>%[3P];>'/B=\.+?3!=:YX*& MG:]/JC:RTVDZBPTM-.N[?SI_MBB@#\J/BI_P3BUKXPZ]\5?$?B7XB_#?2=3_ M &H_!GP5\,?M0WFC_!F^U#69M2^"MS>#2?%O[.7B'Q%\2=0OO@QXDU+19=-T M>'4O$,'Q*NO"VJ>'?#7CGPO-9>*=(,MY^JRKM&.O+'H!RS%CT]S]?4DY-+10 M 5\U_MB?L\P?M8_LO?'?]FZXU^T\*Q?&KX9^)_AXWB2^\/Q>*[70F\167V6/ M5IO#L]_I<6L"QD"7"V+:C9&5T0I=0.JN/I2B@#YD^)W[.Q^(?[0G[+7QRB\5 M1Z+#^S;J'QEOCX6&A_;/^$N3XL?#3_A7L<$>K+J=HF@C0#C5-W]FZH-14"Q5 M+'_CYKY1_9D_8#^)7PF\+_LL?#?XN?&OP-\1?AA^QKJ.H^(?A%H'@CX/ZMX" MUSQ-XS_X13QAX&\+^+/BCXB\2?$_XAQZ@?"'AKX@^,Y=.T#P;HWA+3[[Q1J6 MF>(-1NI+?0++1I?U)HH X/XEV'Q#U+P5K%A\*M8\$Z!XWN$M(M(U3XA^&?$' MC#PA;PF\MQJ::IX>\+^+_ FMWYGTK[9;V1L_%&F_9KZ2VNI_M=O!)9S_ 7\ M!?V/OVCO@C^SQ^S5\';;XV_L_P"N^)_V7_!UA\+/"'BK5_V8M;U70O$'P[T[ MP%X5\"VM_J>DZC\;V\;>&?B(L>B:G?7VK>"OB+HWA#7M/UF?PYK?@N[MXK'4 MM/\ TPHH \;_ &>_@UI7[/?P5^&WP7T35[_7M-^'7A73_#<&LZE;V-CEQ0:5HME+>7%P=,T#28(=)T#3/L>BZ9$EC86XKV2BB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH *\R^-GBG5_ WP:^+?C;0'MH]=\'_#'Q[XIT62\M MQ=VB:OX?\*ZKJVFO=6A>(7-LMY:0M/;F2,31!HRZ;MP]-KQ#]IH$_LW?M!@ MDGX(?%< $DD^ ]? !))/0 $D\ 5MATI8BA&23C*M2335TTYQ3375-:-'/ MBY2AA<3*+<91P]:49)V<9*G)II]&FDT^Y_+S%_P61_;=>*)SKWPMR\4;G'PQ M@ RR*QX_X2 XY)XSQ7Z<_P#!+O\ ;K_:"_:K^*WQ+\(_%_4?!U[HOA?X>:=X MDTE/#GA&/P]=)JESXHM]*E>XN4U.^^T6YLY&58#&FV4B3><;:_E[@M[CR(/] M&N?]1#_R[S_\\U_Z9U^X7_!"Z.5/CY\:R\4L8/P?T8 R121@D>.;0X!=5!.# MG .<YUBN(,KH8G,\=7H5:TXU*53$59TZD?85&E*+DU))QC*S5KJ_33^GZBBB MOR _>SXG^/\ ^U?XN^%?QT^%WP!^'?P7'Q4\7?$3X5?%7XQWE_J7Q5\(?"S0 MO#O@_P"$_C'X2^"M7@%[XGT_4GUG7]3U/XO:+-IFG6\=E9K9Z;J'?V;/V@/V?C\.O%?@?1_$$L%W\=_%?P;UVX^(WA M?Q/JTEU+X.\4^%M(^%NHZ'I=_H^DKK(?Q4VH6>N::=+:UU'Y_P# '_!+Z7PS M\6_#?Q7\9?%7P]\2-6DUKX)_$#XD7>O> O'EIJ?B3XN_ OX3_#;X2>'?&W@_ M1=+^.5E\'?!]EJUC\*?!WBZ;2]<^#OCK5_#/BJ/Q /#/B2VT?5](L?"H![I\ M1?\ @IK^QO\ #GP39>/Y_BFOC+P_?_%'X,?"FW?XO%X\'?# MOQ;#::9IIEU+X::M=P:QJ=K\0=$&J^&M=TSP[K,'@^]\3:_'9:'??37Q=^/W MP;^ VAZ5XB^+WQ#\-^ M*UR\EL=&FUZ[EBN-5N+73KC6=0&GZ;;076J7D6D: M+:7FN:Y%OCOX4\5:K\(M7^.7BC3M#C M\3WWA6V\!^(_!7P(U;X(?#RP\&W5P?#WA>SU.P\,S>'/L;XW?L^?$'XB>-O@ MS\8?AW\4O#GPZ^,7PC\,_$[P3#JOB#X;W7Q#\!:OX7^,UAX&3QRC>#4\=>#M M5M-:T_7_ (<>#O$7@_5#XON8[&/3=2\.:W8ZUI7B&^D@ .>^#_[<7PP^._[2 M_P ;/V>OAG!/-/TWQ+X=T/P;;KI4L'BW1 MI?!FJV.OS^,]-UO^R9Y+VRL=#M=XNY=#^-]GKNH_";5C:H/M$6G^/M/\ #'B._P##=U/'%#?6 M.@ZO=EH[?3KN2+PG]CO]B;2/V/KWXBVWAOQYJGBWPMXJ\*_LT^#/#&E:WI,5 MMJOAK1/VVU![3Q!J/B6V\'P>([VXM=(T*WT^:[;2[:TEM MK>&>O"/#?_!*[PGI'B^]UC4?B_XJOO"FMVG[3GASQ%X3TG0;#P_F M:KX0^!_@N#Q+#J%Y?V-K^R=\-_&OQ6\&?#+4$MI;C45^)&JZM>PV,]C;6\@! M]5V7[=7[(>I:%-XEL/V@OAK=Z+%XFT7PC'>PZXSB^UWQ1H/B+Q-X.M])MQ:_ M:]:M?'.A^$O$U_X"U;1[>^T;QTFAZG%X0U#6[FUDAKYK\7_\%7_V>/ _[,GC M']H3Q&9M.UWP[8?M,:KHOP5GUW1E^(?BS2_V:_C-\1O@GJ6IVCKOT?P_IWCG MQ/\ #N[C\'WWBJXTBVN[_5+3PV99O$=K?:?#AZ=_P37\5:AXZ^ ?Q'^(7QWT M7Q+XH^ 6O?LQ6&A'P_\ "%O"&CZY\,?V7M&^/-GX;T35M)D^(WB..+X@>+-< M^.5YX@U_QK82VOAW14\.V&C>#_ >BV]_JEW=^>:K_P $F?$Z?"#X_P#PA\)? MM'V&AZ9^U'\//BW\,?C+JFK_ ?/B.];P]XS_:+_ &H?V@? 5YX!C;XD:7:^ M%]9\(M^U)XQ\#>*YM7M_%6G^,]-L--\1Z1I_@OQ%'+-. ?M+10,X&<$XY(& M3WP,G ]LG'J:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "D90RLK ,K JRD @@C!!!!!!!P0001P12T4 4_[/L? M^?.U_P# :#_XW4L5M;P$M#!#$S#!:.*.,D YP2BJ2,\X.1FIZ*=WW?WBLNR^ MY!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % J%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9 end GRAPHIC 16 biib-2016630_cogs.jpg begin 644 biib-2016630_cogs.jpg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end GRAPHIC 17 biib-2016630_collabloss.jpg begin 644 biib-2016630_collabloss.jpg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end GRAPHIC 18 biib-2016630_eloctate.jpg begin 644 biib-2016630_eloctate.jpg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end GRAPHIC 19 biib-2016630_equityinloss.jpg begin 644 biib-2016630_equityinloss.jpg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�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end GRAPHIC 20 biib-2016630_finhighlights.jpg begin 644 biib-2016630_finhighlights.jpg M_]C_X 02D9)1@ ! 0 0 ! #_VP!# $! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_ MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P 1" &J 3T# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#^_BBBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D8[1G&?F4?]],% MS^&<^]+2,-PQ[J?^^6#?KC% 'Y+_ +.'_!3C3?C!8>-O'7CR?]F_P3X"\)^. M/B+\.W\"^ ?COXJ^,W[4MGXK\-_M":_^SW\/])\0?L_^&?@Y9:M::G\4?$?A M]IM"T71M8UW63>ZUHNCZ99:V9+N^MOL3P-^V9^SW\2?&OA3X<^"O%NMZWX[\ M7:'XA\1V?A-/AW\1K+7-$TCP?XV\1?#;QG<>.+#4O"EG-\/)?!?Q"\+ZIX)\ M76?CE?#]WX=\4MI6AZG#!J&OZ%!J/E.E_L"^#=!_9U\)_ S0_'/B+3=<^'/Q MOUW]H?X<_%*/1_#T^O\ AOXF7_QU\>_'72;J\T*ZMYM!\0Z%I^I?$+7_ ?J M&C:BB-JWA.^OO(O]&U^Y@UJQT/@#^PQX7^!/QFU#XZ0?$#Q/XP\<^)_ 'CGP MQXZN=9TKP]IMMXJ\6?$KXWZI\<_%_CHVNAVMG;Z/+)K>HP^&=$\.V$)T[2/" MNCZ3;RW.I:M'?:M?@'C?Q!_X*D^!?!?QA\=_"&V^$_Q+NKWX7_MA?L\?LF>, MO$.M>&/&6AZ1?7O[0'PQ;XD:=XL^'*6W@O5[OXBW6BK)8Z-#X,T*-]:\2?VC MIOB#2)6\.ZSH-_JGT3IG[?'[+6K0>$;JQ^(6HSVGBRQL]0GO5^'OQ+6P\ 6U M_P"/M?\ A3:M\9;Z3P?':?!!Y?BAX4\5?#P0_%R7P9.GB_PMXFT::*.;P]K+ M6/G7CC_@G[X;\8_M!:E\<(_B7XFTFQU[]H']GW]I[7O ZZ'H=]:W/Q<_9\^' MK?"71+S3_$4CV^I:=X:\2_#JVT/2]?\ #\MIJ#PZSHL>O:1J=@=0U+3KCQ;3 M_P#@D!\"M.\UGXS^)? ]]KOAV.[?Q)X.M=(NIM-TOQKI>F^+ M+( ^COVU/VD?C=^S?:_!W4_A7\*OA5\3-,^*7QG^%WP'N3X_^+7B_P"&M]H/ MC/XR^.=)\#>#-5@A\.?"#XF6^J^&=/O-0GOO%$LEUINJVMO;Q1:5I^IRSN8? M./AM_P %-/@]?+\9=.^.2I\&]>^#'Q/_ &D_AWK%Q#:>/_&'@?78_P!EOP9' M\0OB/J6B>/T^'NB^'9O$">!+3Q)X[L_ALMU-X\E\%>'-1\00Z/<6]M>"T^K_ M -H#X!:-\?\ 2?ACI6LZ]J>@1_#'X]_!?X]6$NEVUGL_!CQS8>.=+T*\ M6\!6'3-9O+!++4+F#_3(+:1Y+8^< :^,_B;_ ,$M_A]\3?!GCOP;?_$_QGIE MKXZ^.W[8GQVN[RSTC0)KBQUC]L/]FSXR?LV>)M#MHYQY4FF>$-"^,FJ>)- N M)O\ 2[W5]'T^UU/-C/= @'TSHW[;G[.6O^(_#GA?2_&&O37_ (GN/"-I:7LW MPU^)UGX=TF[^(VL7&B?"^S\8>*KSP?!X:\"WOQ8O8(I/A79^,M5T.Z^(FGZK MX*_"]UK'6?";]J7X)?&_6=1T+X:^++O6K^TT:?Q/I& M-+\:^$;;5O[ N/&WPUUOQ3X?T;2/B9X&@UPPZ5-XR\!7OB'PY'=7NE,VH_9M M;T2XU'Y>U+_@F9\%K_X^Z9\=WC\,WNK7$GP:U+QG%XJ^#OPC\>^)-:\0? CP M[HWA?P1J?A+XA^-/"^M>+/AC;:AHWASP]9^+-/\ "DQ>[?0M/U7PGJ'@GQ'+ MJVN:ITW[('_!/3X3?L<:Q?WWP\3PN;.S\$1?##P<^F_!WX0^"_%]CX!@U:TU MB&Q\=_$KPCX3T[QS\4]?B?3=&TUM?\1:O907^GZ)IU]K.B:IXM-_XJO@#S4_ M\%*/L_@C]OK6;WX-W$7C?]C[QUXK\)?#7P/!XU6X'[15A'J6K^ _AMK>FZRW MAB&3P6?&7QF\*>-OAOK]BND^+5\$Q^&V\237NLVUZEA#Z_\ "7_@H+\!?B'X M<^"\VMZW<>%?&?Q9^'WP;\57NA6F@^-_$W@[P7XP^-7PLTCXL>#_ (6:[\5[ M'PA;^ ['Q]KWAS5([GPCX5UO5-#\5>+[2YT*XTSP\MQXI\.6.I%/!6G>#?!=G\8/'5]\*-% MNOV;O&?B[X#/LWCGXP?LL?";X:?"+X8_$"Y\1Q:8OB#0=/FTGX.?"WQ M#XI\%Z7+-%\2 %SQI_P5;_9;T/X?^#OB'X);XH? M%G3/&WB[]E;2-"T[P-\'OBK+K.J^"/VN/B!IGP_^&OQ;T#3=1\%6MYXK^'3Z MK=WU@^M^%X-6BO?%VFI\.;)V\+?$'Q-U.X^ M#FJ^#_$'[4-I>Z9KNB^.]1T75/#?[,G[1?B3X >(=3\+>,?^$'T[0/&?BNXN M+3P9KNM_#7PA-KOC3PK<^/M&T&XTW4)4^W3\0?\ @ECX,M?"'PH\/Z-\7_&V MF:U\$_V9/V0?V?OA_P")FT#PQ?R6FM?L6?&[PI\?OA/\2M6TBY46.K7=_P". M?!NCP>+O"9>UT?4_#[W]A8WNFW<\&HVF[#_P31\,Q>'/AQH__"W?%*ZG\/G_ M &Y[H:R_@CX<:U::[??MV_$'4_B)\0UU;PAXTT3Q=X-OM&T'4-7U#1=-\/:Q MHFMZ9K'AV[N+'64>Z>.^A /MCPO\>/AKXH^'7B?XJ?VGK/A+P9X'C\23>-[S MXG>#O&7PHU'P;!X0TT:QXENO%.@?$C0?"^NZ+8Z3I!&K2ZG>:-/$6I^,/ G[1,/CNP\:Z#HFDZ5\//!'A#0/B M#X#TOX>ZWX2^"_P^T3^T=!^%?A,Z;IDGB-=#TR74K:7QYKOB?Q5.7EUN6RB\ MT^&7_!-'X=?#K4OA3K]GK_A[3]>^%_[0'A;X["?X<_ SX+_!G2_%ESX*^"?Q ME^"/A_0_$VE?#3PSHIU*XETOXU>(_%&M^(KZ_O[B?Q*C)X=TSPKX>O9M#C + M/QO_ ."GGP&^'GPH'Q$^%\FI?&S5+G2_@CX@LM"T'P_\0M,T73]$^.7QK\/_ M 7\*CQ[XWC\!:OH/PO\27NL7_B231_!7Q .@>*M9U/P=K&A#2K*Y1YXO:6_ M;N_9@CL/&FJS?$*\M]+\%VFH:@=4N/ GQ%ATSQQ8:;X\TGX67%Y\';]_"0MO MC?;M\2_$'ASP!;/\(I/&GV_Q?XG\+:'IPN[GQ1X>_M/Y"TS_ ())>$?#_P / M_$/PN\-?'3Q_HO@CXAZGX,\0_%C2H_"W@F]F\>>)_AA\?=8^.OPZU@:A>VDU M[X<%BVJVW@'Q58:3,;?Q7X2\-^'986\.ZY'KNI:_K>#O^"1WP0\":3XFT?PC MJNF>$OL]QX?O_A%XF\(?!GX)>'?B-\.]7\&_&3PK\>/ ^L^)?B1!X+N/%WQ@ MO?"?CWP-X3M;6#QMJ$6E:_X3TA=.\::;XF\2SOXQ4 ^O?V8?VH-*_::O?VC% MT7PMJOAK3?@/^T%=? NWFUVWU_2-<\2/9_!OX,_%6ZUO6/"7BKPWX7\1>!]1 MMKSXL3^&+GPOJ]C/>0/X<_M1KLIJT=G:>->$O^"D?P(;PS\8]>^+6H?\*LNO M@Q??MB^(/$>F+:>*O&A/P6_8^_:4\5?LW>*/BO\ :]"\)K%G6=>\/6>I#P59 M)J'B2Q.J-:6,6MVEBVK3^N?!7]FO7O@KX<_:';3/BWJ_B+XE_M$?$[4OC-K_ M ,0-=\(^'5M= ^(>H?"+X8?"B*;1O!NF2V6ER^&-,M/A9H>H:?X?OM0DNO*E MGTZ_UV_F#ZO/\C_$'_@DYX%\=_#W4?!8^,_Q"T36/'GPM_:D^%7QK\966@^" M)=3^*&C_ +6_Q>N_V@OB?>KIC:5#I/@N]@^,5W<:OX>_X1V'98^$K[4?"-T; MR>33O$FE 'U(W[?7[*,/B'Q=X!-8^,OAOQ3KFN>$/'6B>"],\4? ML_:?>ZW\7_"G_">:GX9MO!MYXJ\%>'--O_%=_P"&K#7+K6[SPE9W7B;2K&_T M:WFNT]J^$_QO^'GQIL=>NO ]]KJ7OA75+;1_%'AKQEX,\9?#;QMX:O;_ $JR MU[2AK_@;XA:#X8\7:1;ZUH6H66LZ'>WVC0V6L:;.+C3[B<17*P?!WQ'_ ."4 M_P &_BUX7UCP/X\\9>,-5\(^(_VB_P!K#]H77]*AL]!MI+W4?VK_ (9_$[X; MZ_X:AN9K6]AAT_P8OQ*E\1^&[RXL;]K_ %30-.M/$%AJ&DW6HV5Q]/\ [+?[ M*GA3]F3PYXRTS1!X+?5_'NNVNM^)-0^'WP;^%WP+TB>33-%M] TM8?#?PKT' M2(9KN.R@DO;S5M:U+6M1DU74-0.ERZ+H0TSP]I@!\N:Y_P %)Y?A[K_Q?T#X MG_#'P7!JOPQ^%&L_$B[\*_"SX]>%?BKXW\&^(QX^\ ?#CX>_!;X]:;9>'="\ M._"'XJ?&'7OB3H$OPZMK;Q3XT\-ZI:Z1X\D?6OL7@[^U=;^M_@9\=?$OC_QM M\6O@_P#$[P7H'@+XQ?!H> -6\3:-X.\:WOQ#\&:KX,^*FCZQJ7@7Q9X;\4:M MX/\ A_KDMO>:CX4\;^%M4T[6_!VC7=CKW@_4I+0ZEHM[I6I7/@6M?\$^=.^) M%WK)KWQEXD\3^$O# MUK_PL'XG:%XD^%?@37?"WB#6=)T_PQI.L:)_;,W@>_UJ[N-2/I/@3]F;XA^! M/%5Q\1A\=M8\4?%+Q]\1/A_JGQM\;ZOX&\%:?%XU^$GPR\'^,?#WA3X0:#X7 MTZPETSP9H]OJWB:7Q7_:B^)/[ M.EGXO\>K\#;?Q+\%/AAI/@?5O'/C+4/B38^&_%_B>;QIXG_X1MO#'P/\ P>& M/$2>/O%^@M<:2TVC>+_$OPSC\4ZYX@T'P=X(O->UJ\NY=-Y6P_;BN;KXBV*7 M?PVL+#X!:[^TSXT_8]\-_%5O'BW'C&^^.7@0^*M$U1K[X90^%6LK'X?ZK\2_ M!'BCX3:!K-OX^O\ Q;<^+[/2[Z^\$V/AO6EU/3KWQY_9,^+_ ,8/CCX0^+&E M?M)Q:!X5^'UIX?N_ 7P?\4_!'PC\1O!'A#Q_IE[>SZI\7-+:]\3^'+N]^)=_ MI]S#H6@^(/$<>NK\.]+AO9/A_:^']7U_Q#JFJ74_8ATB#XEIXEM_B;XJ'PQT MSXV>*OVG_#'P6N=%\-7?AS0OVB/%]AKT>I^-3XD:TC\5:EX7@\3^*/$/Q-T_ MP#=:!_P46M;CX/?M.?%3QQ\&==^&>H_ M7]IG0_V9/#OP_P#%_CCPC:^(/&GBWQYX<^ VI_#.Y\4ZQ#)-X3^&I\0ZO\>_ M#UGXGM7UGQ;#X T73-4UG5M0OKVROM$M/H/]F_\ :2C^-/PO\:?$;Q#%\-M/ ML_ GBSQ1X=U35_A+\4XOC-X*O[/POHFE:Y?ZG9:I!X5\(>,-&U"RBU*?3]8\ M'>,O ?ASQ987^FR75GI^K>'-6\-Z]K'RUX8_X)Q>*;C1/VC?#7Q?_:1O_B3H MW[1'Q<\(?M'WK:3\&_ W@?5? G[1?PZN/@C<_#_XE>$KN75O&6G3V'A:?X > M KR'P5XAT;5M(U6]35O[9NKW3=2ETQ?I+P5^R='HG@?]I#2?%/Q7\>Z[\2_V MK)=7N_BK\8/"O]E_#7Q/I5_=?"G1/@QX=O/A;8>&X;BP\ W?@;P3X;T3_A%M M4:;Q!X@3Q!:'7M8US5K@V\%H 90?'O_@J+\ ?A;\$?$/Q9^'3ZM\8]4TGP1X1\>0>% MM*\,_$?1+#3]*\9?%8_"#1[+XD^+_P#A7VKZ7\'->OO&&E^,]%T[PW\28?#_ M (AO]?\ OBG08]+2\TF^:VX3X;_ /!)GX;?#_XG^#_B[#X\\GQ9X<\9?L[^ M,M4LO!/PF^%_PN\*>)+_ /9NTS]IK1/"\$Z98H=5\1:9^TOKC>,?$5_ M>:QK>J7_ (:T>6UNK'3)$T;3\VZ_X)'^#X_ 7Q0^&GA[XZ?$+PYX1^.S:E-\ M:K.U\,^"+ZY\:W=G^T+\2OV@O 5Y9W^HV,UWX7F\+WWQ.U3P'K TR6:+Q=X+ MT?01)'H7B&VO=;OP#[P^._Q4^+7P\@M9OAE\*/"WC6PLO#'C;QIXT\8?$?XK MVOPB^'OA'1/!,.GW!TJZ\0Q>$?'NKS^*?$\5W?76C"3PS:>$-(TCP_X@U?Q9 MXMT$_A--+\#_AE\+?V;OBK^T)X@\8^-H?" MOQ$^&ND?M)^%]$\?Z=I6B> +/PSXBTKQ1K/PJ^'/B30?'?Q4M];\;^"8HM(U M.+3_ /-XNUR"YL(_=_VN?V7/B#^TP/ 6D:)\=!\/OA[X:NM:U/QM\*M8^%' MACXG> /C#JEQ)ILOA7_A9&FZQKGA[4-9\.^"KBUO]2L? S:FW@KQ+K-[9W_C MC0O$D6@Z/9VW)>-_V$X?B)JNLW7B?XN^)%T3XP^&_A)HO[5WA'0O"OAC2O#W M[0-]\(%ACTK5E^TC5-7^&)\7:;!;^#OB!8>%M5OH==\ 6&E^'],FT#5K)O%% MP :5K^VGJ3?&']L'X8:S\%?$WA73_P!E?X#>$/CEI7B+Q)XCT.UN_BUI/B/7 MOVAO#MS)HWA^Q346\*^&1J/P U$^&_$'B+4UU7Q-I^M1ZU)X6T32(=,NM;U_ MV-?VHO$'[2>E>*[KQ6/@/INL:#8^"-5@\/?!SXI>/?B+J%II7C'2]0O[75?$ M,?C[X.?!^>+0=2FLI[;P9XK\,6WBCPEXS73->FTO7 VDS0'F=%_9!^+UE^U' M\6?VB]1_:AU&2Q^+WPVTGX.ZUX(T'X/^$/#UYH7P]\$ZG\9]>^&$?ACQN^OZ MU>V7B_P9KWQM\0:G<>*-0T'5;;Q(^E:-!?>'[6&.[%SZ]\'?V=]9\"?$'Q!\ M7/B3\6/$/QE^)FJ^!O#_ ,+--\0ZKX9\)^"+#1/A[X9US6?$EI80^'?!EE:: M=>^(M$?"^D:)"NG7VI3Z_XQ\8^ M.-Z^U7%S9>-W7[8_A:?]D6+]K;P M]X(\77^C:AHMA=:3X"UVY\,^#_$DNO:GXVMOAU;Z#J6NZOK4O@C3;./Q9K:+J,<]K=:7\_^%?V5OB]X)^#'A[]G#2/B)\,O$'PYT;X?^(I&U/XB M?!M/'5E%\2KKXV:9\2?"GAC2/ &M^/KC1K']GOP9X2DUSX:^%?AK)=3>)?!_ M@^P\ P^%_B3::IX3CO)0"?0?VXY->\ _#K5])^%*>,/B9\8_B)XQ\!?"SX9_ M"_XT_!OXE6/B:W\!>'+WQ9XM\77GQ5T+Q%!\.M!\/>'M'TK44U:.\U.?6;;6 MI-$\/1Z7<:MK]E;KBZG_ ,%'O #^&[?Q;X+^%/Q:\=:-X:^$VI_''XZ1:?8> M%M'UKX"_#SP_XS\>?#KQ+'XNTC7?$MDWB;QUH'C7X4?%K2;OP-X N?$=]=P? M"OQK>:5?WTA\)67BS,B_8D^)5IXMB_: T_XF?#+3_P!IN#XTZO\ %^"\MOA3 MKD?P0CM?$GP#\/\ [//BCP0_@F/XB1^.)E\0^%_"GACQ3JWC@^/HO$-]XW\- M:%))8+X1L1X4DXMO^";?B;POX2\4>%OAE\;]+T:;XZ_!3Q3\#OVH_$'B;X6V M>L7_ (YLO''Q.^-7Q>\3?$?X;V>D>*=!LO ?CA?%O[1WQMMM#TWQ(?'_ (4L M=)\4>&TO['59O!(7Q* ?JCIFIV&LZ=8:OI5W;ZAIFJ6=KJ.G7UI*D]K>V%]! M'=6=Y;31DI+;W5M+%/!(I*R12(XX-72<<\_@"?T )K#\,>&]'\'>'- \)^'K M--/T'PQHNE>'M$L(V=H[+2-$T^VTO3+-&"M9\?\ AW]HSX8^'M!\9WGA_P 2>+M8T]_$NCZ% MJNI:1IVLK$M_::??75K!.D,SH?VV_P"$9TG_ )YW?_@UU?\ ^3Z -^BL#_A& M=)_YYW?_ (-=7_\ D^C_ (1G2?\ GG=_^#75_P#Y/H WZ*P/^$9TG_GG=_\ M@UU?_P"3Z/\ A&=)_P">=W_X-=7_ /D^@#?HK _X1G2?^>=W_P"#75__ )/H M_P"$9TG_ )YW?_@UU?\ ^3Z -^BL#_A&=)_YYW?_ (-=7_\ D^C_ (1G2?\ MGG=_^#75_P#Y/H WZ*P/^$9TG_GG=_\ @UU?_P"3Z/\ A&=)_P">=W_X-=7_ M /D^@#?HK _X1G2?^>=W_P"#75__ )/H_P"$9TG_ )YW?_@UU?\ ^3Z -^BL M#_A&=)_YYW?_ (-=7_\ D^C_ (1G2?\ GG=_^#75_P#Y/H WZ*P/^$9TG_GG M=_\ @UU?_P"3Z/\ A&=)_P">=W_X-=7_ /D^@#?HK _X1G2?^>=W_P"#75__ M )/H_P"$9TG_ )YW?_@UU?\ ^3Z -^BL#_A&=)_YYW?_ (-=7_\ D^C_ (1G M2?\ GG=_^#75_P#Y/H WZ*P/^$9TG_GG=_\ @UU?_P"3ZOV.F6FG>;]E69?. MV;_-N[RYSLW;=OVJXGV??;.S;NXW9PN #0HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** /P[\?_\ *Q!^SA_VB;_:2_\ 6I/A#7[B5^'?C_\ Y6(/ MVZ_\0/"?PL\!>"]-^QW=W+XF\?\ CWQ8US'H6A/< MV]KH-B-&\/\ BG6;_P 1:UH]FFD0Z=)J.L:9Y3:_ME^%;G]DGPW^UKZ;XWM=3;PW=Q7)]6^.OPP\9_%#0M*TGPCXT\(:!!;W]R_B7 MPI\3?A1H_P 9?A9\0-%N;)XH]'\9^#;G7O!6ORG1]5CT_P 0Z!?^'O'>@-:Z MM8(NKVFNZ=*;*+Y8MOV'_%%M\%?#/[-4?Q=E_P"%8^%_#O/@_/\%/\ A8WAQ/#D%UI_ MPDL_CM<_$+_A:YTAH)/A?)\,=2TRZLM8'@9/%<_B[4;?P9<>"K.^@U*]L.5N M_P#@I'H6I>&9_%G@#X+^//&.G?#WX/:O\=/VC=.GUSPEX<\1?!+P5X9\??$? MX8>*O#XTV[O+^S^('Q.T7QE\&/C-;#PCX?U:PT74M,^&&OWFG^,Y;[5_!FD^ M)N@7]A_Q7'XL7X\Q_%WPLO[6)^,EW\69_B@WP?E;X9SV%Y\&;'X!R?"X_"=/ MB;%XH7X>Q_#_ $S3M0A8?&0^,5^(%J/$TGBB71YI?"3<9)_P3:.A>$M;\*?# MCXWZEX6'Q>^"_B/X'?M.:YK/P[\/^)=:^+.@>,OB3\4_BOXH\:>%#::QX:TS MX9_$NZ\7_'GXWMI>K7.G^/?!^EZ1X_%E-X(U&Z\,:%?Q@'Z9:-K&F>(=(TO7 MM%O8-2T?6M.L=6TK4+9M]M?Z;J5K%>V%[;O@;X+NTGAN(6P"T'["#2M"\/:5IVAZ+IEMO^SZ?I.D64&G:; M8P>8SR>39V-M!;1;W9_+B7^$]L)W-U=7,AD$%Q+$")!A6XQM3;^]G_"+:!_T# M(/\ OJ7_ ..4 ;V1[_D?\*,CW_(_X5@_\(MH'_0,@_[ZE_\ CE'_ BV@?\ M0,@_[ZE_^.4 ;V1[_D?\*,CW_(_X5@_\(MH'_0,@_P"^I?\ XY1_PBV@?] R M#_OJ7_XY0!O9'O\ D?\ "C(]_P C_A6#_P (MH'_ $#(/^^I?_CE'_"+:!_T M#(/^^I?_ (Y0!O9'O^1_PHR/?\C_ (5@_P#"+:!_T#(/^^I?_CE'_"+:!_T# M(/\ OJ7_ ..4 ;V1[_D?\*,CW_(_X5@_\(MH'_0,@_[ZE_\ CE'_ BV@?\ M0,@_[ZE_^.4 ;V1[_D?\*,CW_(_X5@_\(MH'_0,@_P"^I?\ XY1_PBV@?] R M#_OJ7_XY0!O9'O\ D?\ "C(]_P C_A6#_P (MH'_ $#(/^^I?_CE'_"+:!_T M#(/^^I?_ (Y0!O9'O^1_PHR/?\C_ (5SY\,^'@,C3;<\A>&F/). #B0X&3R< M<#FOY/OVO/\ @LS\^+-=\&65_P")?!B^-?$' MC2\\,:G/HVK:_?SZQ>VL&C:;>:G8WB:1H^FV<5S%IRQ75]J5Q=W?D6/W' WA M[Q'XA8[%X'A^GA4\#AXXG%XK'5Y8?"4(5)^SHPE.G2Q%656O)25*G3HS;5.I M.7)"$I+XOC7CWA_@+ X7'9[/%-8VO+#X3#8&A'$8FO.$5.K.,9U:-*-*C"4' M4J5*T$G.G&/-.<8O^N'(]_R/^%&1[_D?\*_-K_@FS^U;I/[<'P E^('B/P=H MGACXA^#_ !5?>!/B!I6AOJ)T&XUBUT[3=:T_7]!CO9IKFRTO7M'U:TN1I5Q> M7T^DW\5_IYO;V"&WO+C]!_\ A%M _P"@9!_WU+_\V,8ZF@#0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /P[\?_P#* MQ!^SA_VB;_:2_P#6I/A#7[B5^'?C_P#Y6(/VOBZ]'"X6A6Q.)Q%6%# M#X?#TYUJ]>M5DH4Z5&E3C*I4JU)R4(4X1E*AA:%;$XFM2P^'P M].=:O7KU(4J-&C3BYU*M6K4<84Z<()RG.']!\9>$O$G@J7Q-+;PSW-U9>';K7[&VL-4U. MWMH'N6TF*Z34YK=7FM;2X2"X,/W?K?B'0?#6G3ZQXCUK2M TFU&ZYU36]1L] M(TZ!<%MTU]J,UM:QJ%4DEY5& 3TKTQ17R;JG[<7[,%KJ$ MVB^'?B?:_%#7HE(_L'X(^'O%GQQU9KC9N6T>#X3:%XPAM;ASA=E]4)_;7QE\2?#SX&Z (SN*S/8WVN^,_B2 MB, ,H_PX29<_/&AX.T>&<]Y8SKY?4R^G-)PJYO5P^34:BEJG2K9M6P5*K?I[ M.0,X')Q]!S^E?'IT3]N;QC]H34O''[.7P/L)L/#!X0\'>._CIXGMD*@ M^6OB/Q=K?PF\,I< D[I'\!ZE;HZC:DR9W.'[)NH^)&BF^+?[2_[2WQ,#1;+[ M1K#X@67P6\*7)90LD?\ 8WP#T'X:ZE):, 1]EU+Q%JF5/[V65OGI_P!DY?0U MQW$&7P<5^\PV7T<;F>*B[)I4YQH8?*:SU:;AFRBFM)-.XO[5Q];3!Y#CY*7\ M/$8^K@\NPS5[-U(2K5\SI*VJ4LKYVMXIIH^C/&?Q)^'?PXL1JGQ"\=^#? FF M%6?^T?&?BC0_"]CM7.YOM6N7]A"0N#DASC!KYSD_;F^ >IF>W^&U[X^^.6HP MR>6MI\#/A5\0_B=8RGYLM_PEVA>'3X"M8@0 T]_XMM( 64^;M)(['P9^Q_\ MLP^ ;P:IX;^!OPY77A*LY\5:[X=M/&'C)Y5Z22^,O&(U_P 4S29^8O)J[,6^ M;U$FM94\54 MJY13A)/6*G@:T5?WN9*S^01\:_VG/%TH3X??LC7_ (:T^Y0"VUW]H+XP>"?A MZB$A?](D\+_#&W^-OB8(K$_Z+?1:3=. =RP$C$:^ /VT_&"0/XK_ &@?A5\) MH ^9],^"GP;G\4:VL; DQIXY^,OB;7M(F:,G"SK\*[7S,*_DQ#GFTYI72YHY]7S7#QDT_>E0P]"[U2C9)/\ L6=7 M_?LYSG&+=4X8N&5PA*Z?NSR2AEE>44U[JKUZVFC;U;^/3^QAX+\0>>?BQ\5? MVB?C7]I"&:Q\<_&CQ1X?\,.XR6#^!?A$_P ,O \\+$L#;WOA^\B:,B-PRC%? MBG^T_P#\$#O%7BOXM^(?%W[,_P 1_AQX2^'?BK49M9'@+Q];>)[&3P-=WLAD MO=*\-:AXS;A*/LLN<%A<-.$H1<*F%IT9Q7-#F=.I4A/P M.(?#;@[B?"4\)FN4PFZ595X8RC5JT_8?^!5O\+-.\0-XP\3:SKU[XS\?>,&TY-*BUOQ3J5G8: M>8M,T[SKJ>QT+1=+TVPTC1[>ZN[F[>"VDO[R3[9?7"+]LT45\AF^;9AGN9X[ M.,UQ,L7F.8XBIBL7B)1A!U*U1W;5.G&%.G"*M"G2IPA3I4XQITX1A&,5]7E6 M5X#),NP>4Y9AXX7 9?AZ>&PN'C*<>@%%%% !1110 4444 %%%% !1144X=H95CD\ES'($EV+)Y;E&"R M>6WROL8A]C<-C:>": '[TSC"?#UEKFJ_$6R^%KMKWQ,T_2O%>E M6O@*T\1W,NK1?$+1M#UVSUKP5%;>*-$TB]CU.RLF[?\ :Y_9_P#B?^T9X/\ M#G@;P+\+XYTWXQ>#WTNYM5^&?BB>T\<_#[Q)HW@G M4M1FAO?%MIX6\2Z5?^,-+M6\(:Q?'PIJOB#2M8JV_P #OCJ/"?AKP*/CWHOA M?1O#_P (SX16Y^&OP3\!>%-/@^(&C^-_#.L^"/$_A_P9XAF\>Z/H7A#0/!>@ M7?@+4?AU]NOM(U72=9FNM.U#P_JEGI=]IH!Y-X=_;B\0>*- ^%VB^%O"OP-\ M?_&_XQ?%3Q[\.O"/@KX>_'_Q1JGPYT*Q^&?@K_A/O&VO?$KXA>)/@'X7\<># M+_0-";3H;SPA;_!?7M=?4O%W@9K19]!U^[\0:1R4G_!24ZYX4UGQ9\.?@?JG MBF'X2?!37/CI^TYHNL_$+P_X9U[X2:!X4^)'Q2^%/BGP7X5M[71_$NG?$WXF MZ;XN^ _QP%II$^I^ _".IZ5\/Q=IXVMKSQ/H.GR^@/\ L0ZZVJ)\7%^-U]'^ MU''\6G^+D7Q?7X=>'SX1CNKGX067P(O_ $/A*=:\M_AW??#G3M/%U:2^/)/ M&LOBW3M,\2OXZ:+3K31H^1N_^";>AZ;X6NO"?P_^-/CKP;:?$7X1:[\#OVC= M5G\/^$/$>O\ QK\&>+OB!\2/BCXL\0K=W-EI^G?#_P")NJ>,_C1\9KJT\6:# MI&H:#I.F?$W7K&V\$R7.D^#M2\- 'Z.:#KND^)]$TCQ'H%_!JFAZ_I>GZUHV MI6Q9K;4-*U:SAU#3;Z NJ,8;RRN8+F(LJL8Y5W*#D#5) &3G\ 6/Y*"?TK,T M31=+\.:/I7A_0[*#3=%T/3;#1](TZV4K;6&F:9:0V.GV5NI)*P6EG;PV\*DD MB.-023DG!\=_#WP9\3-";PSX[\/:?XFT)KRTU!M,U)9FMC>6#M):7!$$T#^9 M [LR'?C+'(- 'XV>/B#_ ,'$'[.!Y_Y1-_M)]58'_DZ3X0]B >WIZ>HK]Q,C MW_(_X5_/M<_"/X;_ Y_X.#/V>]%\$^$-'\.:7??\$H_VDKN\LM.BF6&XNA^ MT]\)[83R^=-,[2B"XEB#%\A6P"-J;?WK_P"$6\/_ /0*MORD_P#BZ -[(]_R M/^%&1[_D?\*P?^$6\/\ _0*MORD_^+H_X1;P_P#] JV_*3_XN@#>R/?\C_A7 MXF_\%U?A#\4OBA^RMX/U?X'[?4-1U+_A&Y/"GB M+08O$B:)8QRRZI:^&M1U2"XU PP7%UIEA>7&JI$+6UOIH?V4_P"$6\/_ /0* MMORD_P#BZ5?#&@HP9-,@1E.593*K*<$9#+("#@D<$<$CH:^BX2XCK\)<291Q M'AL/1Q=;*<7'$QPU=N-*O#DG2JTG.*E*E*=*I-4ZRC-T:G+4Y)\O)+P.*<@H M<4\/YKP_B<15PM'-,++#RQ-!1E4HR4X5:=10DU&I&-6G!U*3E%5:?-3*_#KZSHY^'_ (:T77[' M4=<\77?BS2ECF\*3:;IMK=_V/J4-W;:I)K+V5KHHFU*6".O[@=&_8E_9:TO5 M/[=U#X/Z!X[U\$LOB'XNWGB+XT^($E9@QN(=9^+>L>-+^VN&90YDM98 "; M5XKZ&M_!GA2S65;+P]I5DMPRO<+8V<5FMQ(A)22X6U6(3NA9BCS!V4LQ4@L< MS_\ "+>'_P#H%6WY2?\ Q=?H'B3XQYSQ]C\%B,'0Q/#."P6$J8;ZI@LUQ%:I MBI5JD:E6IB\12HX&-6"Y(1H470<:*]I+GE*M*WPGAYX291P-@L90Q=>AQ'B\ M7BJ>(^M8S+*%*GA8T:;A3AA,/5JXV5&;YI2K5E7YJO[N/+%4ES7=+TG2M#L; M?3-&TVRTG3;1!':Z?I=E!I]C;1C@)!9V<4%M$@ "QQ* .U: VCH,9ZX4C/Z M5A?\(MX?_P"@5;?E)_\ %T?\(MX?_P"@5;?E)_\ %U^/2E*4G*4G*4FW*4FW M*3;NVV[MMO5MZMGZQ&,8I1C%1C%)1222222226R225O)&]D>_P"1_P *,CW_ M "/^%8/_ BWA_\ Z!5M^4G_ ,71_P (MX?_ .@5;?E)_P#%TBC>R/?\C_A1 MD>_Y'_"L'_A%O#__ $"K;\I/_BZ/^$6\/_\ 0*MORD_^+H WLCW_ "/^%&1[ M_D?\*P?^$6\/_P#0*MORD_\ BZ/^$6\/_P#0*MORD_\ BZ -[(]_R/\ A1D> M_P"1_P *P?\ A%O#_P#T"K;\I/\ XNC_ (1;P_\ ] JV_*3_ .+H WLCW_(_ MX49'O^1_PK!_X1;P_P#] JV_*3_XNC_A%O#_ /T"K;\I/_BZ -[(]_R/^%&1 M[_D?\*P?^$6\/_\ 0*MORD_^+H_X1;P__P! JV_*3_XN@#>R/?\ (_X4N<^O MX@C^=8'_ BWA_\ Z!5M^4G_ ,75^QTK3]-\W[#:Q6WG;/-\O=\^S=LSN8_= MWMC'J: -"BBB@ HHHH **** "D.<''7!Q]:6JE_=K8V-Y>O#=W"6EK7LRV\+S-%9VENKSW5U*$*6]M"C2SS,D4:L[J" ?BMXTBEE_;I\=6_B_0? MVBM'\1Z]\7/@YJOA!OA#^SC^QG?> OB%X!^&VF>$9/!_B3QCXP^)/@7Q?^T= MXM3X=>*]2\:)X@\=6>MZ5IO@.QNR?AA'X=O=)FU1OVS'3\_0<9]NWI[5^#GQ M#\%1>)_VH-5N+/X=?$5=%^)WQX^ 'QFU+XIZU_P3]^/&O_';P'JOAVP^$UYI MGA#P/^T7;RV_@CPMX+L[;PY!HFHZ[K=I;W/P>TG6OB3X3O-#U^0W%Y8_O&.G M?J>OU/3V]/;% "T444 %%%% !1110!^'?C__ )6(/VVC2"XCVJ M1ONMQG@\//$"6WA+X7:=9>(-%_:VL[GP_X!^'0FN[!M*\/Z M396FN>&O@EJWD%]=6%E^ZX_J>V.Y_R3W//>@#QCXQ^*_C#X?M_#.G M?!GX;>'?'&O>(-5OH-7USQWXY;P'\/O FAZ9I-SJ4NK^(M0TK0O%_B_5+S5; MV.ST+0M(\-^$K]#*-+M[?Q#\1_BA\6M(^!WP_TS3/'KV(T^]^'_ (L\>Z]H^IZ% M\1[;0I!JGPVU&S\;V7AB62YAT)NZ_:W_ &;?%7[3GA#PYX'TCXV^(_A1X5M- M?EU/Q_X9TKP;X,\9>'/C%H']G36L'P^^(VF^*K8W-]X!DOY8]4UWPWI6IZ79 M^,5M8?#OB]=;\'W6L>'=5Y_Q%^RQXR^(/@31/A;\2OCEXAUGP5I?PXT[2)6\ M)>"OAW\/-5A^+W@WXH>#OB1\(_C3X931/#=Y9^%-=^$\_@O3+3PYX6M'O/ 6 MI,(YM?\ "VHBW$;@'DX_;=^),OC.']F^#X8_#<_M#]9TSPO:>'!\/?[?A^(<]QIMU.O MA6R/B^XXQ_\ @I)XD\3^%?$OBKX9?!'3-;_X49\$?$7QS_:DT#Q+\4;/1=5\ M!V7@WXF_&CX1^*?AQ\.;C2/"^OV/CWQS;>+/V<_C=<:3J'B,^ /"FI:7X4\. M?:=0TR;QN)/#/M(_8;B0IX]B^-GCR+]I1/BK<_%]OV@E\-_#LZK)KUW\*;;X M'3^%7^'S>&CX#/PW_P"%665CH$/A06 O(M8LK?QL/$!\8";5IN&;Q/#/CK6_&WQ8^+6KMXX\ V?AR[TR'XI^,[/2M.M"OA.Y\* 'W[X:\1:/X MN\/:%XJ\/7L>I:#XET?2]?T3480XAO\ 2-:L+?4],O8A(J.([NQNK>X0.JL% MD 8 @UMYQ_\ J)_E5#2M+T_0],T_1M)LX-/TO2;&TTW3;"UC6&ULM/L+>.TL MK.VB4!8[>UM88K>",<)%&B\XS6%XS\!>"/B-HI\.?$#PAX:\;^'VN[6_;1/% M>B:;X@TDWUDS/9WAT_5;:ZM37N MF^%_"NAZ#8WEVO[3_P );=;N[M=+L;6&YNDMYI+=;B9'F6!S"KB+"#]Y_P#A M&O#O_0"TC_P76G_QJ@#;HK$_X1KP[_T M(_\%UI_\:H_X1KP[_T M(_\%UI_ M\:H VZ*Q/^$:\._] +2/_!=:?_&J/^$:\._] +2/_!=:?_&J -NBL3_A&O#O M_0"TC_P76G_QJC_A&O#O_0"TC_P76G_QJ@#;HK$_X1KP[_T M(_\%UI_\:H_ MX1KP[_T M(_\%UI_\:H VZ*Q/^$:\._] +2/_!=:?_&J/^$:\._] +2/_!=: M?_&J -NBL3_A&O#O_0"TC_P76G_QJC_A&O#O_0"TC_P76G_QJ@#;HK$_X1KP M[_T M(_\%UI_\:H_X1KP[_T M(_\%UI_\:H VZ*Q/^$:\._] +2/_!=:?_&J M/^$:\._] +2/_!=:?_&J -NBL3_A&O#O_0"TC_P76G_QJC_A&O#O_0"TC_P7 M6G_QJ@#;HK$_X1KP[_T M(_\%UI_\:H_X1KP[_T M(_\%UI_\:H VZ*Q/^$: M\._] +2/_!=:?_&JNV>F:=IWF?8+"SLO.V^;]EMH;?S-F[9O\I%W[-[;=V=N MYL8R: +U%%% !1110 4444 %(QP"?0$]AT&>IX_/BEJK?6S7ME=V:7=U8O=6 MMQ;+>V+Q1WMHT\+PK=6DDT-Q"EU;EQ-;O+!-&LR(SQ2("C 'YF^)?VY-?3]I MSQ7\$=*\=_L,^ [#P1\3O!/PZO\ PM\:?VIE\-_M!>*E\2:1X0UR36O"OPIT M'P]J=I;MKR>*)]$^'NAZIKLFI^(]6TEFU(:,U\NG6?Z=C\.IZ>Q(_/U]#FO@ M+4?@]X#_ .%K_#N_O?VX?B]:^(_%NI6-SX'^&<_Q,_9^6S^)$_PLL-'M?%]K MHNB7GPDD\8>*EF.A2ZC\1_\ A'-9:\L;S4]7F2X\.PM9P:?]_#ZYZG\^?R]/ M:@ HHHH **** "BBB@#\._'_ /RL0?LX?]HF_P!I+_UJ3X0U^XE?AWX__P"5 MB#]G#_M$W^TE_P"M2?"&OW$H **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K'\0:@7]SI.NVL=[93VSW&BZK92P7FF:M"LIDTW4+2>&YLKU8+F"6.6) M&&Q10!_.UX1_8]_9^\(CPOX=\2_M9>/QXT\(ZM^S?X2T+PY'%\=_#'Q:T'X2 M_LT>)KKQQHWAWP[X!D\2:MXO3XB_$;Q_VF5X9@LB,!;5O%&A=E^T[\7_$GP9_9_\ &OQ1 M\(Z9HFI>)]'L?#4>C6OB.#Q)=^'[>_\ %/BKPWX6CU/6['P?:W_BJ_TC0_\ MA(&UC4-/\.VL^LW]KI\EGI^+J>-UI_M;_LWC]K/X'^-O@'J/Q6^('PH\'_$S MP_XB\%_$*_\ AOIWPYO=?\2^!O%GA[5/#GB#PN+OXC^!_'=CHL-[:ZG]I35] M$T^QUZTN[2W-KJ4<#7$$^>W[/_Q)U#2M+\/:]^U'\;+^RL/AUJ7A6Z\1:,GP MQ\$>+=1\8O\ $/0?&GAKXD/)X-^&NC>'[37/"6CZ%_P@\&B6^C'P-XJ\*:KJ MNG>.?!_B-[V[N;H ^8?#_P"V;\5=?M?AQ\*/#TOP>\6?M)?%#XQ?$;X?);ZA MX0^.WP<\'?##0/AG\,--^+/B"^^(WP^^*.F0?&.'Q7-X;UOPE_8.@+::+8^( MK+X@>&O%5AJR>&K:XNM0X]?^"C?Q'\9>%?&'BCX9_"/P3)/^SK\"_$WQR_:B M\-^*_B#J"7-A/X(^*WQV^#OB?X5_"C6=$T"6UU77G\1?LR_&K4]%\;>,=/TC M0;JPTOP/97_A^P?QIJFI^"_IJ3]B'P[)CQ5_PN#XNQ_'9?B='\6XOVAXS\,E M^($/BA/A:GP6?38?#!^&Q^$">"I_ABH\,3^##\-GTF>=(?%LYE\=6]OXGBYS M5?\ @G5\(9O#6G^$O"_CCXO^!-'U'X6ZK\%?BW_PC?BO2+C4?CY\-/$'BWQ5 MX^\2Z/\ %'5O$OAG7[^/7?$'C3X@?$K7[WQU\/YO WC.UG^)OCRVTC6M-M-8 MLX=* /N#PIXFTCQIX8\.^+_#]S]LT+Q3H6D>(]%N]C1FZTC7=.MM5TRY,;@- M&9[&\MYC&W*%]I)(S6K>7UEI\/VB_N[6RM]ZH9[NXAMH0[Y")YL[QIN8@A5W M;F/0&DL+&RTNRM-.TZUM[&PL+:WLK*RM(8[:TL[.TA2WM;6VMX52*"WMK>.. M""&-52**-$0!5 K#\6^"O!WC[23H'CCPIX:\9:&US;WK:-XKT'2?$>E&\LV9 M[2Z.G:S9WMD;FV=V:WG,'FP,S-$Z$DD _%;QIJ.GWW_!PY^SC/97UG=P_P## MIO\ :3_>VMU!<1\?M2_"0']Y#(Z<&*3/S<>6_P#<;'[E?:+?_GO#_P!_4_\ MBJ_ K5OAG\.? _\ P<(_L\Z5X+\ ^"O".F7O_!*/]I&[O-/\,>%- \/V-W=+ M^T_\)+=;FYL](T^SMI[A;>1X%FEB:00LT8;8S _O'_PCV@_] 72?_!;8_P#R M/0!I?:+?_GO#_P!_4_\ BJ/M%O\ \]X?^_J?_%5F_P#"/:#_ - 72?\ P6V/ M_P CT?\ "/:#_P! 72?_ 6V/_R/0!I?:+?_ )[P_P#?U/\ XJC[1;_\]X?^ M_J?_ !59O_"/:#_T!=)_\%MC_P#(]?-'[3/Q?TW]G[PYX:UVS^'WA_Q0^OZ_ M-HKVUW);Z0EJL6EW6H_:$EAT?46E9C;"+RFCC4!R_F$J$(!]4_:+?_GO#_W] M3_XJC[1;_P#/>'_OZG_Q5?DWIG[?B:AJ>F:>WP,\)1+J&IZ=I[2KK^]HEO[Z MWLS*J'PFH\/_?U/_BJ/M%O_P ]X?\ OZG_ ,57-W4'@JR;9>0^&+5Q'YI6 MYCT>!A'\W[PK,J'9\K?/C;\K<\''-7'BOX.6BJ]UXD^&ELCMM1KC6/"<*NP& M2JM)E 'I/VBW_ .>\/_?U/_BJ/M%O_P ]X?\ OZG_ ,57CUQ\ M2_@%;"3S/&WPK+1L%:*'6?"US-O+!=JP6TLTTC GE8XW( )("@D9[?%OX" D M1:_X4NPJ[F?3M'EU.-.N$>73])NHTE(!(B=Q*5*L$VLI(![C]HM_^>\/_?U/ M_BJ/M%O_ ,]X?^_J?_%5XG%\3/A-<';9Z+KNH/MWLFG_ ?\?7LB)Q^\D2#P M2YCC)8 .V%+$ ')JC>?%+X=6@+#P'XTF4ML@+?"37]/6Y(.#Y3ZSH^EI&%.[ M+736ZC:>?F3?$ZE.G%SJ3A3@MYSE&$5ZRDTOQ ]Z^T6__/>'_OZG_P 51]HM M_P#GO#_W]3_XJOG./XM>%;IRFF_!;XG:J%P&DLOAKIJQ!SD[ ]YJ5H'P!DR1 M[X1G;YNY75=A/%6J7D6[3OV=/&0?&[;K'_"J-%0KM)'S3>,KF;>3@%#; J,D MD%=IRI8O"U[^PQ-"O:Z?L*M.M9JUT_9REKJM-P/=1<0$@">$DD 2(223@ # M=R2> .YKP/4?VG_@SI>H7VF7?B_35N].O+FPNECU'1Y$6XM)GMYU5UU/#!98 MV7L000P5@5%275_BG.4&F_L\>%[(O*BI-KOCSPJC0C>!YMS#HFCZGL4'+C[+ M<7D@0*1&9"8U_!/Q<)O^$M\5_:K>"VNO^$H\2?:K:V;S+>VN?[;O_M%O;R%( MS)!!-OBAD,<9>)$P?T?>!OB3X.^(NF76K^$]9LM2L;.^;3[F2*\L9FANEABN/+E6UNKCR MBT4R.@E,;.N712@#'M/M%O\ \]X?^_J?_%5^;_\ P3JTS3KWX=?$!KRPLKMD M\>P*K7-I;W#*H\,:00JF:-R%RS' P,L3W.?T._X1[0?^@+I/_@ML?_D>NRC& MI"E"-:HJU6,4IU5!4U.762IJ4E!/HN:5N[>H&E]HM_\ GO#_ -_4_P#BJ/M% MO_SWA_[^I_\ %5F_\(]H/_0%TG_P6V/_ ,CT?\(]H/\ T!=)_P#!;8__ "/6 M@&E]HM_^>\/_ ']3_P"*IZ21R9\N1'QC.QE;&(&TGQ?=:AJ:Z18RWK6%BWA_4+9;N[$0/DVYN)8 MX?-?Y1(ZJ2 21]]57N[2WOK6YLKJ,2VUW!-;3QMT>&>-HY$SU&Y&(R.1U'-1 M5]I[.I['D]KR3]E[3F=/VG*^3VBBU)PYK&/A!\3=1\1:): M1_#SQ=3X6_ ML^Z>X-YX7\"S3([,T>I?9]6N)G);Y[B&_N+V:\F.XMOGCFD+X?.\*1=\!?"R MTT6;6I_$%C:ZD_VY[/21>10W,?\ 9L!+1WIC<.BRWN]1(K+N008Z.<^P6NGV M%BNRRLK2S3^[:VT-NO\ WS"B#]*\#*,3Q#C<#"OF&%P&6XBI.I^Z:Q-:5.$) MN$%4HN=)MO#FD02F31_A-H-B9%V&>\L_"FE%HR0VV0: M;;:G<[=P#>6T>M7,94W?;!X7#THOU6+6/E]TUWW>@<; M!I_B5%2.VA\(Z)#&-L26EC>:D\*G/$6&T2%2,G@0[,DG!&0UK^PM8G&+[Q9J MA']S3+/2]-3D8/S-:7MUCK@"Z!'7.0#7444?V?2EK5K8VM)[N6-Q5.,O*5+# MU:-"WDJ27D']?U?^ODYB)QC)MC>+: G)SBW'! M(^[@5?M?#^A63![31M+MY!C][%8VR2DCNTHC\QC[LQ.>TNMFZCBYMZ;N38" # P !P!TQCIC':EP!T %%%=@!_G\J^ M8+_]C;]G34[^^U.]\ -->ZE?7FHWLW_"3^+H_.O+^YEN[J7RX]=2./S;B:1] MD:)&F[:BJ@"CZ?KRGXD?&OX<_">Y\/6?C;Q!#I=UXDODM+&!8WN98+:DX4:%.=6K)0B MYS<803DU&$92E9:)-LY<;CL%EN&GC,PQ>'P6$I."J8G%5J="A!U)QITU.K4E M&$7.I.,(W:O*22U9?^&OPE\ ?"+3=1TCX?Z$="T_5=0&J7\!U+5=2\^^6U@L MA-YNJWM[+'BVMX8_+B=(ODW[-[,Q]'J*&:&YABN+>6.>">-)H9H766*:*50\ M.1&9'1@RDJ03+7.TTVFK-:-/=/LSI332::::333NFGJFFM&F MMF%%%% PHHHH **** "BBB@ HHHH **** "BBB@#Y _;O_:+\>?LH_LL?&/X M^?#OX60_%C7?A?X \9^.I]&U3Q38>#_#&DZ/X,\*:SXKU37/%6KR_:]I;VDV?^UG^SA'^UE\$?&OP$U3XJ_$/X5>#?B7 MX?\ $/@SXA7OPUL?AQ)/V5M7^(7A:T^'_ ,5/CO\ %7XA>$8_A[<> M';^:Y3X>>#O$-_\ $+3OBAX8^)GPY^,MO=?#OX?^$]-T'XA?"6]\):19^"+G M0]/L_#SK"E[XD\,Z[J227UR ?/W_ VA\8Y?B#%^RE;^%OA(?VL$^,E]\.+S M59=:\8CX,)X(T_X"Z7^T-_PM6/3!:_\ "=B6^\/ZWI?@2/X>-JC75GXT;4-2 M?QE=^%[&WN=2X>/_ (*-?$SQGX4\9>*?AI\)O IN/V<_@5XG^.7[4'AOQ7X\ MU3S[>Y\#_%?X\?!WQ-\*OA-K6B:$;:_UJ3Q#^S'\:=5T3QUXQTS3]#N+'3_ MNGW_ (:L7\8ZMJO@OZ@_X8A\+"VCU]/BU\78_CE'\6+GXT']HY9?AJWQ0E\: M7GPTA^#-Q!+HLGPV?X1-X.;X4VMIX*3P)_PK,>&(8;2V\316*^.(O^$I/.ZK M_P $Z_@[/X9TWPEX:\9_%[P)HU[\+=3^"OQ8'AGQ?I//$ MNB?%35O$OAKQ!J!UCQ!XS\>?$?7[[QSX"G\#>.+>X^)?CRVTG7]-LMQL+&V@L[*RM(8[:UM+2UB2"V MM;:WA5(H+>W@CCA@AC58XHD1$4*H%9^O^&_#WBJP.E>)M#T?Q#IAGAN3IVN: M78:O8FXMR6@G-GJ-O=6QFA9F:*7RO,C))1E).0#\,?$?C+PCXG_X.%OV=K_P MYXH\.Z_90?\ !)_]I*&>[T37-*U:V@F_X:A^$DHBFN-/N[B&.0Q1R2!'D#>6 MC/C:K$?NQ_:VF?\ 00L?_ RV_P#CM?A/XC\'>$O#/_!PM^SK8^'/"_AW0+*? M_@D_^TE-/::+H>EZ5;3S?\-0_"2(2S6^GVEO#)((Y9(P[QEO+=TSM=@W[L?V M3IG_ $#['_P#MO\ XU0 ?VMIG_00L?\ P,MO_CM']K:9_P!!"Q_\#+;_ ..T M?V3IG_0/L?\ P#MO_C5']DZ9_P! ^Q_\ [;_ .-4 ']K:9_T$+'_ ,#+;_X[ M4NI?$73+'1-%T[1K33?A5JBPC4]9TJ)' MN-6\0I,\L&B>(9%M8FTNQA2*.ZTNT1WMM:N1*\]R\UE%81^UP]DT\_S;"Y7# M$4<+]8D^:M6DE:$%S35&#:=>O**:I48M.)Q M_P!4A%0P^'A)\U6K)4Z[7Q5;ZC!'HL=E M:#4+F\O;IA;KIPT]HY5U*+4@YM+C3WC=+R*1HW XD3]R]!T7XU:SHVFWFO-\ M)?!VIW=A%/?:3:>"M7\3SZ7=3(N^S;4)/%^DV-S-;@[GEAMVMUN,VZ?:H(1= M7'U7&?!6&X>Q-">%S&A# XN#5.GC:DGBZ52E&*JWAAZ$YUJ,VU.-:%**IRE[ M&HDU3G5^$\-_$K&<7X+%T\=D^*GFF J1=:KEE&$KB)RJQBL11E*+JT\/[7_ &MIG_00L?\ P,MO_CM)_:^E?]!*P_\ VU_ M^/5Y/_PKKQY.V;OXFVEN#DE-$^&GA"S (4*@4ZR?$;!>KS!F9G?'E/ @,9LG MX47LPQ>_$_XA7 (0,MHO@30T8+R0#H?@;3YT+/\ ,9(YTFV@1&0Q HWQ7U/# M*U\TP4EVITLQO6:72^]OTM8_&RNHY)F$)='6KY1&'3>5',Z\TO- M4V^T7JCU!=5TQSA=0L6)P %O+8DD]!Q*>O;UJ4W]F!DW5L >A-Q !^9DQ7E/ M_"DO"5PI75M5\=ZWE2'&H^/O%<<I:9;8G "21+"L 3*1Q1@MF, M?L^?!MFWW7@'1M4?DE]S:U?7[-(J@(DK$R1Q?ND98\K1['+5=2 MQV+OWIY=2G![;2GF5&5O6FFK;7#V^*Y&_P#C M+\)-,#_;_B;X"MF179HW\6Z$TO[MMC@0QWSRLRO\I14+[LC;D'%FS^$WPMTX MAK#X;^!+-E8LK6_A'P_$X8KL+!UT\."4&TD-R,@]3GJ[;0=$LT2.TT?2[6- MJI';:=90(BH-J*BQ0*JA%^50 HX&!1_PEP6V/KN_P#-A\)=::?#C;=6GKV? M05L\J/XLJPJ?]W%X]K;^_ER=U?TWOT/+Q^T%\()&*V?C2TU4C=@Z'INNZ\K! M2 71]&TJ^1XRY$8E5C&TQ\D.9?DJ8_&GP[,?^)9X=^(>KY(4&U\!>(K1"VTO M(/-UJUTF)3$N"X=UW$A(?-?Y!ZK]AL\8^RVV!T'V># _#R\5$=)TP]=.L3]; M.U/\XJ/;9.!Q3\JN8TZD;^:IY?0EZ^_Z6W3^KYQ+2>9X%+O0RFM2J=.M; M-L53^;I;]&KQ?CFL_%?Q6VCZG+X4^$WBN]UI;*9M(A\1ZOX!\/:;-?LA-LE\ MTGC6?58[;HTHMM.ENB^RT\N":1I(?PR\>>*?%OC+Q=K?B#QQ>7=WXHN;V:'4 MQ=QFW:PEM)'@&DP61)73K33"KVMOI\>$M@K;C),\TTO]%_\ 9&E_] ZP_P# M*U_^,U\Q?&K]DOP-\8?$&B^)A=3>%-6M[JUA\2W6CVL ;Q)H4 PUK*A*16NL MPHJ06&N".=X;8M!=6MXD5D+7[O@3BS*,AQN)CCLOHX6EBJ2BLQH+$U\11]G> M?L*D:E6M)T*TDG_L\:;56--U8U(*,Z'Y;XI< \0\59;@I99F^(QM? U^>648 MJ6#PN#Q'M>6F\32E1HX:,<3AXN5EBYUDZ$JJH3HU7.&)\%_81^('Q$OK#5_" MNL1Q7OPUT"'R])U[5-0CMKC0M68QR+X8TL3%I-4L)+>1[MK4;$\/XC1;CR;V MVL8_T8_M;3/^@A8_^!EM_P#':Q_#W@KPKX5T33/#N@Z#IFFZ-H]HEEI]E#:0 MLD$"9)S)*DDTTTKEIKFXFDDGN;B22XGDDFD=SL?V3IG_ $#['_P#MO\ XU7R M/$>:X?.LXQF8X;!4\!1Q%2\:-._-.RL\17LW#ZQ7?[RM[)1ASM_'/GJU/T#@ M[(L7PWP[EV3XW,JV:8C"4>6>(JN\*=]5A<,Y)57A,*OW6']M*53V<594J?LZ M%(_M;3/^@A8_^!EM_P#':/[6TS_H(6/_ (&6W_QVC^R=,_Z!]C_X!VW_ ,:H M_LG3/^@?8_\ @';?_&J\,^G#^UM,_P"@A8_^!EM_\=JQ!=VMUN^S7$$^S&_R M9HI=N[.W=Y;MMSM.,XS@XS@U7_LG3/\ H'V/_@';?_&JL06EK:[OLUO!!OQO M\F&*+=MSMW>6B[L;CC.<9.,9- %BBBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH _#OQ__ ,K$'[.'_:)O]I+_ -:D^$-?N)7X=^/_ /E8@_9P_P"T M3?[27_K4GPAK]Q* "BBB@ K'\0>']%\5Z)J?ASQ%IMKJ^B:Q:266I:;>QB6V MNK>4#*NN0R.C!989HF2>WG2.>"2.:..1=BBJA.=.<*E.!/@WXCUKQ3:W%UXCU>XN[J/PS=:Q%$TWA;0[A'?#5WKE_X&^'=Q:>-_ M%MCX;TW6;WQ%=^'O#-[8:MJT&E26=M?V/FM=P^_5Q?Q#\$6?Q&\':UX.OM;\ M6^&H=7BM?*\0>!/%&K>#?%NBWVGW]IJFFZGHGB+1IH;RSNK/4+&UF>WF%WI. MJVRSZ/KVF:OH5_J.EW@!^=6A_MA?%CQ'>?#'X)>'?$WPWU?]HKXD?&3XB>!M M:U7Q?^SO\9?@OX<^$'A?X,/@IXJ^+FN^./$7BK6= UOP>OA1] M-^*WA_PMXFTOQK'XHL-4$'A/4=&U?S"S_P""CWQ=\7^!?C#\0_!W@3X8:;9_ ML*]?\ "/Q+^/7@3XB?#[X+^)+,:!8:#!HNC_LT M?$;Q?X<\<^*]"\81>)9]>\#>%+SPIH#2^(O$6E?93_L1?#Y],^VGQ_\ %\?% MP?$Z+XP)^T*OBGP^/C#'XZA\ M\*!=13?\(=_P *XC\.2?#!W\$2^ $^&X^' M\FFR-J;^&&\4!/$"X6H?\$\_@)&/"C?#[3OA1\2_#>@?$'4 MTT_X\_#K3O%_B/Q]_P (Q\:+K5K?5];\3'4O&7C7Q[K>O^)=%U;POXT\1K\0 M?'>A:[XEO_#'BS6=#N0#[>TW4+75M/L=4L9#+9:C:6U_9RE)(S+:WD$=S;2& M.54DC,D$L;F.1%="2C ,#6+XM\;>#O .D'7_ !SXK\->#=#6ZM[)M9\5Z]I/ MAS2A>7C,EI:'4=9O+&R%S=,C+;P&?S9V5A$CE2!TRJJ *H"J!@ < = !V ' M X JM>6-GJ$/V>_M+:]@WJ_D7=O#)/B[IEE MXV\2?M(_#O6=#\/:A!\(-$\>:CI]WJ6E^'=9O()+VR@M!%9,LEPDLMO'-]O? M\1"?_!(;_H[.?_Q'O]JC_P"<=7[)6>E:;IPD73["SL%E(:065K!:"0J,*9!; M1Q;R!P"V<#IBKNT>K?\ ?;__ !5 'XP?\1"?_!(;_H[.?_Q'O]JC_P"<=1_Q M$)_\$AO^CLY__$>_VJ/_ )QU?L_M'JW_ 'V__P 51M'JW_?;_P#Q5 'XP?\ M$0G_ ,$AO^CLY_\ Q'O]JC_YQU'_ !$*?\$A?^CLY_\ Q'O]JC_YQU?L_M'J MW_?;_P#Q5,DCW1NHW99& ^=NI4@?Q>M 'XOQ_P#!PS_P2 E\SR?VN3-Y4KP3 M>3\ /VI)O)N(L>;;S>7\$&\FXBW+YMO)MFBW+YB+N7,G_$0G_P $AO\ H[.? M_P 1[_:H_P#G'5]^_LR?"[Q?\-)OVA7\764%DOQ!_:>^+7Q-\,&VU*VOOM?A M'Q8GA@:+>S_9)7^Q7$YTR[\S3[G9=6VQ?.C7S%S]1;1ZM_WV_P#\50!^,'_$ M0G_P2&_Z.SG_ /$>_P!JC_YQU'_$0G_P2&_Z.SG_ /$>_P!JC_YQU?L_M'JW M_?;_ /Q5&T>K?]]O_P#%4 ?C!_Q$)_\ !(;_ *.SG_\ $>_VJ/\ YQU'_$0G M_P $AO\ H[.?_P 1[_:H_P#G'5^S^T>K?]]O_P#%4;1ZM_WV_P#\50!^,'_$ M0G_P2&_Z.SG_ /$>_P!JC_YQU'_$0G_P2&_Z.SG_ /$>_P!JC_YQU?L_M'JW M_?;_ /Q5&T>K?]]O_P#%4 ?C!_Q$)_\ !(;_ *.SG_\ $>_VJ/\ YQU'_$0G M_P $AO\ H[.?_P 1[_:H_P#G'5^S^T>K?]]O_P#%4;1ZM_WV_P#\50!^,'_$ M0G_P2&_Z.SG_ /$>_P!JC_YQU1O_ ,'#/_!("(QB7]KDPF:5((1-\ /VI(C/ M<2!C';P"3X(*9KB4(YBMXM\T@1RB,$8C]H]H]6_[[?\ ^*KY=_:8^%WB_P") M5]^SE/X2LH+V/X=?M._#+XF^*CW$,^MZ>L M=A:B2ZN!*[11LL3E0#X"_P"(A3_@D+_T=G/_ .(]_M4?_..H_P"(A/\ X)#? M]'9S_P#B/?[5'_SCJ_9V./:B*2V510?G<\@ 'G//UIVT>K?]]O\ _%4 ?C!_ MQ$)_\$AO^CLY_P#Q'O\ :H_^<=1_Q$)_\$AO^CLY_P#Q'O\ :H_^<=7[/[1Z MM_WV_P#\51M'JW_?;_\ Q5 'XP?\1"?_ 2&_P"CLY__ !'O]JC_ .<=7V=^ MR)_P4-_9 _;O?Q\G[*WQ:D^*#?# >&3XX#_#SXJ^!/[$'C#^V_\ A'<'XF>! MO!@U3^T/^$K?]]O_P#%4H '3/XDG^9- M "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 '3K2; MEQNR,>N1CGISTYKQC]H+[FC7WBPS^&?#FLZSH4%WHFG^*]8TCQ##X:EU$ZM::!J6IVUA&GY?\ M@3QS^TQXX\9? SX%>+/BM\9_AM\+?C5\0OVJ?%OPL^*NN:#X/\&_M,>)O@U\ M&_"?PDD^$?@[QI#XF\&?9O#?B/QIXC\9?$_XE:?#JGPZT_XDZK\'/AKX3L/B M+I^FZ_>?$."] /VHR..>O ]S@G _ $_0&F[T+;0ZEO[NX;ORSG]*_%?X:?M) M_M.?$'7/^"2OCC7?B18:7X'_ &@/&OQA^'7Q3\&Z%X%T6RE^+NH^"?V;?VK? M%6E?%'4O$QOM7CTWP?XJO/A/\/OB-X%\)>!]/\.6UI)KFI7&LZ[XDT9]#T;1 M_0_ OB3XQ>!OVIM)\6_%KQ7\3]>^'?QE_:4^.'P3^&$&B_M >!O$_P .=-U# M3],^(FN^!M+U+X'>'/A]'+HVAZ7X,^&6M:;HR^.? FC MZ3)OV'Q$\52:;J][\*/$4 M_CO2_&7C/XA7^F6'AGP5_P *B\'_ !%>T\%_9K^.G[1GBV[_ &0_%'_"V;[Q M5XH_;E^!G[0?C[Q?X*\8^'?#&N?#K]G3Q_X MO!VL^&7\.^&?"4W@_Q?!X0^ M&FL^(Y?@C\0/#5[X\OK[Q1K]SX>U'5->T/Q> MG!X-+UZ5^#O@W]I;]IO5?V0?V2O#]QXX\:^.OBM^T'^VS^U7^S=XI^+FD6WP M\\$>*IM#^$7Q+_;+U#PO8V>HW.AR>!?AM=>+M*^ WA?P$/$EKX1U^Z\,^'KC M5F\+:1JOCI_#L\GZ6_L2_$C5?B7\ ]+O/$FN^.?$'C'P9X[^+OPI\;W?Q(M_ M!1\86?C#X4?%+Q;X"U[1-4UOX;V&E^ O&4>@7>A_V-IOCOPSI>DQ>,],LK/Q M!K.BZ#XGOM=T33P#ZUHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@#S#XO?!;X3_ !]\%W'PZ^-'P]\*?$[P-=:KH6NW M'A7QGI%MK>B2:UX7U:VU[PWJQL;I6B&HZ#K=E9:QH]ZNVXT[5+.UO[22*ZMX M94\ZM/V._P!EVS^&\_P@7X$_#2Y^&5SXMD\>2^"M2\,V>KZ#_P )G+9QZ=-X MHCM=6%ZUOKDVG(VG3:C;R17,VGSWEA*[VE]>PW'TI10!\K_$;]B']DCXN>(? M#'BOXD?L\_"OQAXA\$Z/I&@>#-5UCPK927/A'1M!MKVRT?3O"X@\B'P_;:=I M^I:AIMK'I$5GY>EWMUI@/V">2W;TC1_V?O@?X?\ B5JGQBT3X2_#O2?BGK1O M7U7X@:?X0T.T\67L^IQ+;ZK=S:U#9)>_;]7MTAMM9U&.1+_6+:WMK?5+F\@M MH(X_8** "BBB@ HHHH **** "@@$$'D$8(]0:** /F%OV+OV56^+%Y\=%^ W MPWA^+VI>,M.^(FI_$*VT".U\3:IXZTFQT_2]-\6ZI?VTL)U+Q!8Z7I.EZ9:Z MG?1W%U#ING6-@KBTM884Z5OV7?V=C<_$^^C^"OPUM=0^-%CJ&F?%34;#PCI& MG:EX[L-6N7OM6M/$>HZ?;6M[?0ZMJ4LVJZJIG3^TM8FFU>_^T:I+)=M[S10! M\J^#_P!AW]D/P#X'\7_#7P=^SG\)/#WP_P#'FH:;K'B[P=IW@[3(_#NMZUHU M_>ZMI6MW6E21RVL>M:?K.HWVMVFL6D=MJ<&N74^LQW8U21KNOH3P;X+\(?#O MPQHW@KP%X8T#P9X0\.V:Z?H/ACPOI-CH6@Z/9+))*+73=*TV"VLK.$S2RSNL M,*>;/--/*7FEDD;IJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI M-P]>/7M^?3VZ]>* %HHHH ***;YB;MN]-V<;=PW9],9SF@!U%%&0, D9/0>O M?CUXYH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH 9(XC1Y"&8(C.0BL[D*I8A44%F8@850"6. M 20*^#3_P %#/A4"RGX/_MC95F4X_8X_:%()4E201X'P5.,JPX88()!%?>M M)@>_YG_&O4RW$930]M_:F6XK,.;V?L/JV9QR_P!ER\_M.?FR_'>V]I>'+;V7 ML^25^?G]WSRY.6IS7]I[3 MGBO<47S?E1^T)_P4[\+^ O@A\4_&/@+X1?M)P^-?#_@K6+WPK=?$3]E_XV^# M/ MEX@>-+/2+_P 5^)O$'A&QT32M#L;ZZ@O+Z34K^PMKJ. 6 O()KN)J_D\M M/V_?VV+'QVGQ&B_:@^,<_BF/5CK!2^\7ZE=^%)[LL&:TN?A_+*?!#Z%*JBWD M\/Q:#%IR69,-M%;RK'<)_?SXM\)>'/'?A?Q%X*\7Z19^(/"OBS1-3\.>(]#U M%&FL-7T36;.;3]3TZ[C#HS07=G<2PR;'210^^*2.14=?Q#LO^#?_ /91M_'J M:_=?$+XS:CX"34OMO_"L[K5O#B6DUB#YBZ!=>,+?0HO%$W'_A1PS@,^H<0<.5:&)Q M / ^2?0#K7W%HFB:3X;T;2?#V@Z?:Z1H>@Z98:-HVE6$0MK'3-)TNTAL-.TZ MRMX\1V]I96=O#;6T* )%#$B*,"M3 ]_S/^-?B^)S/@^KB<15H<+YG1HU*]6I M1HQXDII4J4ZCE3II/(ZC2A"T$G.;TUE+5R_8,-EW%M/#X>G6XDRVM6IT:4*M M67#]1RJU84X1J5&XYU"+^^+O[0GC#X8 M?#;]CO1OVG-/^!,7Q&L]-^'FI_$[Q)\?=7^#6GZ-J3'PIJ%YH7PQ2PFT>76X MWDU'3_"]I;:GXO:QO[FR>*;]U:X'6/A5\,_$.OZUXIU_P!X-USQ'XD\!W'PM M\0ZUK'AO2-3U'7?AM>7][J=WX!UBYOK2=]3\'7>H:CJ%Y=>'+WS])N+B]NY) MK1S<2[_DG:[LK*^BO>R[7TOZV/J5>RN[NVKM:[[VUMZ7/Q=\$/&%_X!^%W[-?Q;^&>L>% M_'LWP^U'Q+X2?3=*^-UCX>\1>&XO"_B?4A>7=]J::=XH;5_ >DIT'@K]OOXP M_%/]JW]GOX"Z]X>U7X5^(/"O[5MEX+^+>EV^@>)O#6D?$KX;_%#]@#]KOXZ^ M ;>7PY\2-'L?'.@-H'C;X165Q>1WUMIMSJ5WX?TG5(Q86U_J'AVS_3!OV//V M5'\+^'?!+_LZ?!9_"/A+7=5\3>'/#DGPW\)R:/I&OZ]IW]CZ_JUK8R:6T/VS M7]'QI&O2S++_ &WI*1:9JHN["""WBUO!G[+?[-_P[U#P]JW@3X%_"CPCJWA3 M4+'5_#FJ^'O OA[2M3T?5M,\,>-/!>GZK8ZA:6,=Y#J=GX1^(WCSPS;ZAYS7 MD>@^,/$>E+-]BU>\AD0SXG_:A_X*!^/O@/\ %[XJ?#GPS\'[/QQIGPU\-_L> MR+J-M<>.-7\0ZUXQ_;0^*_Q:^#/@'2K7PEX'\'>*M8ET;PGXA^&DGB7Q5>Z= M::AK&H:/-#X<\,:)J7B36;*33XO#W_!03XBS0>%M+\5_!*7POXK^(MOXV\"_ M#"S\21^,_ ?_ F_QK\%?&'P1\.H]-3PQX]\/Z)XW\-^$_%G@_XH>%?BCI=G MXCT6Q\<:1HGA/XM6>HZ3=VG@^QU_6/T*\2_!;X1>,IO'5QXM^&7@/Q--\3O# M'AOP5\1)->\*Z+J[^./"/@V]\0ZGX2\-^*C?VW MTB^U[5KRP2"XO9I6H:+\ _@CX^,OAEIVG^#M M!MK3P%XPU+2/$.@ZEXK\)Q16*C1/$VI:/XM\4Z=J6OV)BU;4+7Q'KD=[>7!U M2]:8 _(N+_@KIX_O?A#XZ^-^E_LT>('\$MX5TKQS\+YO$^F?%'X>V5YI5_\ MM(?##X$:=X7\5^+?&GP]TKPOK?BOQ5HWQ*MOB#87GPGNO&OASPJ=(UKPEXEN MKBYM-+UGQ#V_B7_@IW\0/ OB#XV>!?%OPE\$MXI_9_\ G[?.O>-]5T3QGXA MD\(ZGX@_9(^#'[*OQZ\$6>BW.J>'=/U"STSQ[X(_:@TZR\3-J<;7GA[6O"&K M2Z.^KZ9<1SP_HNW[)_[,C7/CJ\;]G_X.FZ^)M]9:E\0;C_A77A42^,;_ $_Q M+8>-+.Z\0NNEAM3EB\9:98>+R;@L)?%-K#XBG$NLJ;XZ'BC]F7]G?QL^K2^, M/@?\*?%$FO>-+WXC:U)K_@/PWJSZMX\U+P5I?PWU'Q?J+WVGS->>(=0\ :)H M_@N_U273[*V@C /SL^&W_!3/XB?$?Q]>Z5HG[.'B6_\'Z5 M?:IX$U+5/[-^(/A^RM_'V@_LZ6GQSU'7KWXJ^*?!.F_ O1_A]>>(KF/X9:;; M:AX];QG!;7>G_$_5;"V\+OJ6EZ7]3?L<_M0>,OCZOC/P]\4?"GASX=_$GPEH MGP\\7:C\/[2W^*VC>*=#\/?$BPUU[%=;T7XI?#CP5#K&F:9XC\+>*?"6C_$S MX<:]XZ^&_P 1;KPWK.I:#J>C/93:.GN%I^S3^SU8^,HOB)9_!'X4V_CJ#PS! MX,B\71> O# \0)X6MO#H\'V^A#5#IANCI\7A%5\)I$TC-_PBZKX<+G10+&M? MX5? CX+_ -M-7L/@W\*OA]\+K/7[BUNM:MO ?A+1/"T.IR6"3Q::MXND6=K MY]OI4%U<6^DV;DV>DVT\UOIMO:02R1L >L4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%)D>_Y'_"@!:*** M "BBF^8F[;O3=G&W<-V?3&.: "BBB@ HHHH *** M 0>001SR.>AP?R/!]Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** $9MJLQ!(4%B%!+' S@ (?#WQH\2:U%X9L5 MU+7;7X9^/O%-MJETK3+)=P^(8=.NX=8CDP,7T5U<)+@@2DJ0OK!_:/\ "X!/ M_"!_'#CT^"GQ"S_Z9J]&^%_@6/X:?#[PEX#CU.368_"NBVVCIJDEJMB]\+8N M1<-:1SW"6Y??_JUGE"X^^:[W ]_S/^- #(W$T22*)$$L:N%=&CD4.H8!T8!D M=0<,K ,K J0""*_"O]I7XK^+_P!FG]N#XQ^.[SXL_M">,/AI\-?V.='_ &G= M/^!:?% Z;\.-1^)_B/X_:O\ !RQTO54/AW4)M!^&$.G2Z1-KD+KJ.E^%[&UU M3Q?_ &=?7EB\K_"[X;>(->UGQ1KO@'P;K7B+Q'X%N/AAX@UO5_#>D M:EJ>N?#B[OKS4[OP'K%W>VD\NI^#KK4-1O[RY\-WIGTBXN;V[EFM':XE+@'X MK^./^"A'[4_@']L&/X5^.8OV?_!GPX^ /P@_:H\7_M&W']I>/KGP?XUU#P!\ M+?V:OBY\--7\,>.I? VJ^*/!\VDZ5\;[+P]XB\,VWAGQ;J?VJ[O=533/%3ZW MX#T:UZ+P3^WO\9/BC^U?^SY\!/$6@:K\+/$'A+]JVQ\&_%G3+70O$7AC2/B7 M\-_BE_P3^_:\^.?@*UN?#/Q M!XUT%O#WC;X1V5S=0Z@MA=:E=:#H^KK!I<- MY?>'K/\ 3<_LA?LL-X7\.^"F_9U^"C>$?"6N:IXF\->&F^&?A!M$T77]=T\Z M1KNKV&G-I+6T5_KNDL=)URW3=3^UV4<4":O@W]E_]G+X>7WA_5/ G MP+^$WA#5/"E_8ZKX;U/PYX!\,Z/J.B:KIGAKQEX,L-4TV^L=.ANK;4K/PE\1 M/'GAJWOUF-Y%H/C'Q+I*S_8M9OH9@#Y]\8_M;>-=-^/_ ,1OAWX7\%^"Y_A[ M\!+?X-?\+=U7Q?XOU3PYX]\1W?QQLO$&H^'X?@WH$.@WVB^))]&LM$M[6RT[ M5=4M[[XD>,+W4? 7AC^Q]:T 76K_ "_IO_!1_P".VJ>'/!LEG\"/!.L>)OC9 M\&_@1^TA\+8/!'B_Q=X[B\&_!GXT^*I?#^IM\0O#ECX5TCQ;XX^(7P_TV33? M$5GX*^$MK?:Q\5(5\:6'A#3K"/X>:EJFK_J=K_P:^$OBKQ[X7^*?B7X:>!-? M^)7@JV:R\(^/=8\*:'J/B_PU:&2ZF6WT3Q%=V4NJZ;##-?7\ULEK=1BTFU#4 M)K3R);^\>?@H_P!DC]ER'PYXP\(P_L[_ 4@\+_$#6+'Q!XUT"'X9>#H=)\3 MZ[I=U=W^D:SK%E%I"0WFIZ-J.H7^I:+?,HN='U&^OK_2Y+.\O+F:4 ^$/V;? MVOOV@/CK^VOHO@Z75?A5%\ +C]C"7XB>(O#'A_2O'R^(=(^/'AC]I3XD_ WQ MO9V^K?$'P1\/?&FG2:#JO@>;0O$O@KQGX1\/ZOX3O[>\TF_TJ76[*;5[\^,_ M_!2K7OA5\;)O"-AX#T'QK\+Y_BWXR_9VMO&'AN+X@31:)\8_#7P(\=?&.'3_ M !1XPU?PWX?\"37D.J>!KOP9XF\#^"[GQ9J'AR&\77+GQB^LZ=JO@FS_ $7T M3]G[X&^&M1^'6K^'/A#\-_#^J?"+3?$&C?##4-#\&:!I%YX!T?Q9'-'XGTGP MI<:?8VTNB:9XB,\LVMV%DT=KJMVQOKZ*>] N!E:M^S#^SGKOC+5_B'K7P*^$ M>J^.]?O++4=;\8ZC\/?"UWXEU74=.TN[T.RU&_UJ;3&U"YU+VXT87\L[7 MCZ2XTZ:>2SCAAC /S.\ _P#!2[XT>-_$/P.^%K?![X8:-\5/VG?AO^RA\9/A M3?7'CWQA<_#OPCX%_:/^&O[0'Q$U/3/B;J(\&1:G-XS\*1_LT^--(\/:=X;" MZ7X[U7Q9X7L(M0T)=)UN]N>D^#_[:WQ(\"?\$W=0_:<^(.DZE\8_B3_PTO\ M'CX3:7H^@S:KXAMKK4=;_P""A_Q)_9L^%^F0ZEX4\)76M:EX+\%:?=^%; :A MI7A&X\0ZGX7\/Q1V>E77B&^@@E_0[5OV8OV===T8^'=9^!OPHU303X)^'_PV M&D7W@+PUG@#X3ZCJNL?##P;';3:<\47AOX>:MKFLZGX)TF)8[3PO?ZIJ% MWHT=G/>3N_56WP;^$ME\/=1^$EI\,O -M\+-6C\00ZI\-X?"&@1^!=0A\5ZM M?Z[XF@O/"8L/[!N(-?UG5-1U75X9;!HK_4+ZZN[A'GF=R ?G3HW_ 4$^(\4 M_P #=)\9_"*'PIJ/Q@^/'B+]FY+[Q/9>-? +VWBO3=3\ :CX<^*$G@;QQING M>/\ PW\*_%OA7Q%KOA.*/QGI6D:_I7Q]O/A/\+5N-7T[XL:'XMM_"+C_ (*X M_$;0?AOX ^*.M_ +1==T3X[P_%[P[\&]$^'_ (B\;^*_%.E_$#X/_M8>"OV6 M-0B^)^DZ5X&U:XM/"&O:I\1="\1P7WA"'6=?TF^TJY\#OH^KZ_XDT.6U_6G2 M/V:_V?= \/VOA31?@K\+=,\,V6ES:+:Z!9^!?#4.D1:5=>)M/\:7MB-/&G?9 MF@U#Q?I.E^*-2WQM+J/B#3K#6;V2?4K.VN8O+O@U^PG^S!\$_ NN^ ]"^%GA M+Q3:^+K#QCH_CKQ#X^\*>#O$?BSX@Z!XX^(?BSXG:SX=\=:POANP7Q1H*>)O M&6JM::;JEI- +.'34N_MEU8Q7A /B/6/^"C?Q\A@\->'=)^ .A:=XXG^&W[: M?Q$UF?XH2_$CX6:/JNC_ +'P_9ZU9=4\/>$?$'A:3XEZ%9?%'1OC=)I5GIOC M70M/UCP=XAT:YNYAXGT&WM9O$&CJW_!475_#L[_$SQ1\)XO#G[/=_P##'0?' M?@G4;K_A/]9\;?$FX\1?LIV?[2VG:!X7\1^%/!'B#X/:#\1[C5Y[OX4:=\$_ MB=XN\ >.M?DT]/B-H%_J6C:]X3\.:_\ H]HG[-W[/_AO3=%T?0/@K\+='TSP MYX:\>^#M"L=-\#>'+.VTKPM\5)M#N/B9H-E';Z?&(M+^(5SX:\/W/C>UY7Q3 M&(U\/6$[_ ,2ZCH>F^)-%U74/ M#GBO0K:?QGX0\ ^+X;CP]XFT?5]"U/3?%7@KPMXET?5=.OM(UW0M.U.QNH%Y M>#]CS]E*U\&ZO\/+7]F_X'VO@;7M'-#\ M)>%?#]E%INA>&_#6DV&AZ%HVGPEC#9:7I.F6]K86%K&68I!;6\489F;;N9B0 M#H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH ***,@Y (R.H]._/IQS0 4444 %%%% !12 A@"I!!Z$$$'Z$<4M !11 M10 4444 %%!(&,D#)P,]SZ#U/!HH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** G )YX&>!D_@!R3[5Q!\=V )']A^,>/3PIK&/_ M $FKMZ*Y<33QE3D^JXJEAKFL?E,>Q)"QN ,;A9YY4R^H M\VC"5#$*GB)4*%3"-X*I[U9^YBZGM:D)0C[&#Y$G5JOG2=FT[;?UM^O]:'/V M7C'3K&SM;--'\;3+:P16ZS7'AC7)IY1$BIYLTLD#/)+(07D=B69F)-6O^$[L M/^@%XQ_\)36?_D:NWHKZ>&$S6$(PAF6%C"$8PC%98[1C%)12_P!NV25OZ0:> M?W_\#U_I:HIW*K8(W '# JPR,X93R".X/(/!K\:+O]KK]H#P_P#MI?'+]GKP M9%X8\:WGQ _:TM?@[\*H_B7K6KZ3X.^$^D>%O^"8WPD_:?U"1(?"NCWFN:KI M_B'QS<:^]_IZRI=K=^(IKNWOH((1 G[,5YN/@[\*%\:?\+&'PU\"CQ__ ,)+ M-XS_ .$U'A711XJ_X2VX\ V7PKG\3?V]]C_M/^WIOAGIUA\/Y=6^T?;9/!MG M:^&VF.DP1VJ^NMM=7U>UQ'Y:?"#_ (*C>)OC#\+M6_:2TOX5^#M"^"7@+X<> M&-?\?>$M7^(-^OQRUKQ=XA_9.T_]JNZL/A+H$OARRT'QMIEEIVK:=X)\,V+R M6NO_ !!F@\7>+=.70K#P&=-UB[\3>"]?_9=U&SU M2'2UBLO'G@OQ'I?BS0H/"T\MQIFF_I#X<_9M_9\\(:YX0\3>%?@A\)_#GB/X M?^#X/A]X%UW1/A]X5TS5_!_@:TL[S3[3PCX9U&TTN*[T3PY9Z?J6IV%GI&GS M065K8:GJ=C;Q1VFHWL-Q'X4_9H_9W\"0:/:^"?@9\(_"-MX>\;+\2=!@\-?# MOPGH<6B_$"/P]K/A*'QII4>F:5:K8>)K;PIXAUSPQ::S;".^L_#NK:AH=I+# MI=U+:L ?CYI'_!8KX@7GA7X8ZS?_ +/]BVK?M%?"_P"&'C#X-:3X.U+QU\0K MKP]K_B3X_P!E^SGX[M?B)I7ASP@=>UC0]$U^]C\:>#W\#Z<=<\46$EIX'O[# M1-ALO%=CI_B+3?#0\1^'_"OC;3+#6=%U*\MO#_C" MPN8[#4)+WZ^D_9;_ &;)M"A\,2_ /X.2^'+;P5??#>VT*3X;^$I-(MO &I>* M+'QO?^"[?3WTIK6#PQ=^,M,TWQ9-HL426+>)-/LM<$*ZG:6]U'VMI\(OA98? M#.\^"]C\./ UG\(M0\-ZWX.O_AC:^%M%M_ 5[X5\2P7UKXC\.WGA.&R31+G1 MM?@U/4HM;T^:R>VU5=0OC?I<-=W#2 'Y#_"[]M;X_> -#U/X,ZSX8\*^./%_ MPZ^*O[+G[*5K\2/&'C[QOJB^+_C=^TW\&O@[\;HO''C/5+K1Y]3TKP#X3TWX MC^(M+%J%;7/%WB8>"/ ^A)X5MKUM67"\";'XI3S_!#P'J%W^SM M\/?%/CKXPPV_COQ-#IWB%XS%X/&'@_4O M$NG);:;J,6M>!_$9N+FP?7K;]A-3^!?P7UK1O'OAW5_A/\.=3T'XI7.B7GQ) MT:_\&>'[O3/'EYX9T+P]X8\-WGBZRN+"2W\07GA_P]X2\+:+H=WJ<=Q<:1IO MAO0;33Y+:+2+ 08,G[,?[.4NCS^'9/@1\(&T"Z\"6GPON=%/PZ\)C2I_AO8> M(;GQ99> YM/72EM9?"%KXHO+OQ%!X?>(Z8FN75QJPMOM\\L[@'S5X<_;2\1: M-\"_VYOB9\4OA]IDWB?]A3QG\6_#/C+1?AMK&KZEI/C^U\ ?!'P%^T%HM[X: MFU[1K?5-&GU7P7\2O#^AZQ%J5KJ%MI.OZ;K6HP7-WHQM57PK4/V]?C]H_P 9 M? O[,&H^ /@5)\:/B#\2/"'@W2_&&D>//&NI_!BQTWXG?LP?M$?M"^$9IM0D MT"P\27_BC0KS]GG7_#FK^&K6.)O%'AS7_!OCG2+OPY'XDFT/0/U1TOP'X)T1 M_&%O#?A M_P .3W^J"ZN9=#T32M*DD:RL+:&/YD\4?L"_LG>*+;X5:*_P8\!Z#X)^$OQ% M\6_%'2OAGX7\&^#M%^&_B?Q5XS^$/C3X)ZM-XY\(P^'9-.\0V\/@OQO?#3<" MRO+#4=(\-O%>_P!G:-#IC@'PS\$_^"JWC[XY^.O &D^&OV;O%$'AJ36_@-X& M^)UW;Z-\0MD:-JEAIFF^).(UG_@K'\6[3X$ZA\;M-^%/PZUB?0/AY^T+\<- M9^&'AR^^*'BSQU!\(/V;_B+XW^&FO:[K=[I_ABP\$> =-\*?!'CB7X+?"I_&/PTT72O#?P\ M\4'X?^%/[=\#^']"22+0=%\)ZF-)%WH&E:#%-<1Z%8:7+:VVB)=7::3'9K=W M(EP]3_91_9CUK3O#&D:Q^SW\%=4TOP7'XLA\(Z;J'PQ\&WMCX:A\>7M_J?C: MWT2UN='EATZV\6ZGJ=]J?B.VMEC@UC4[F34;Z.:]*SJ ?DCX>_;Q^/=GX\\< M^+OBO):^(?A)IG_!0S4OA[\)/#WPPBU7PWXUL/@S9?\ !*GQ1^VS'X9\8Z;] MCN[+XGW-Y;-I2:?HTESIMQ=_$;4KN_CU[_A&_#OA71AZ8?\ @I!\=K+7O@K\ M/]0^$OP@N_&W[0=]^RAK_@?5/#GQ"\8:UX$\-^ ?VMO#G[0=]H%OXLU67PGI M][>^,/ >I_ NXNI#HZ1:1\2?#6I75_H5OX4N=,N5A_3JU_9R^ 5CXSTWXBV7 MP7^%UGX\T?\ X1DZ5XPM? OARW\2:=)X+\+ZWX(\(SV>L1:>E[;W7ACP9XDU M_P (Z#=I+]JTKPOK&H^'[*:'2;N6T-/PS^S#^SCX+CLHO"'P'^#_ (7BTWQQ M8?$O3H_#_P ./".C)8?$+2K#5=)TKQK9+IVDVPM?$^EZ5KFLZ7I>LP;+W3=. MU74+&QEM[6\N(9 #\VO"G_!3/XCZ[%\.?%7B/X7^ _ ?PO@O#X2^,?Q#U76O MB3XH\*:7\0=$_:@^*W[+WCO2K36O /@3Q-<_"/P_I6J?#"W\=> _%_QZ\/>& M_"'Q-MO&-MX.M_%'A>[\(^+?%%G^S ((R"#R1QZ@D'\B"#[^M>!2?LI_LRS: MSX9\13?L^_!>77O!>IZMK7A/6)/AEX.?4_#FK:[XPUKXAZOJ.CWKZ.UQ97FH M^/O$>O\ CBYGAD#OXQUG4_$ZE-;OKB^D]^H **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBL0>)= /B!O"HUG33XD72QK3:$+R# M^U1I+7!M!J1L=_GBS-R/)\_9L\S S@@U483GS<8>TJ2ORTXIX- !1110 4444 %% M%% !129&<9&?3(SP 3QUX!!^A![TM !1129&"%JX. MES_6L)4Q7-R\G)B?J_):_-?]Q6Y^:\?Y>7E>_-IP8ZAF%;V7U''4<%R\_M?: MX+ZY[2[AR77X\^+'[5D7@WP1JFLZ#\//B3'K&Z"PT MVY\8^ /$?ACPU97M\S16]WJFI:E;V\3QQ,"8=.AD6YU&X\JUC>%'EN(?R'3X MC>.(_''_ LA?$NICQP-3.K'Q$90;QKPCRV1XROV=K!K?_03I1B_L[^SO^)> M+86@$8_HHUK1=)\1Z3J&A:[I]KJNCZK:S66HZ=>PK/:WEK.I26&:)P0RL#D$ M8=&"R1LDBJP_..7_ ()\P-\1!I-N$4OPCQ0X+\0,[QN25\MS%YKA:%6G&GA\*HY5_9 M>.Y[QS.:>)GSQ4>5+%1JRKX7V;5.FE5E*7MWPI_:NM?&G@K3-9UGX>_$B365 M:;3]6F\&^ ?$?BCPW/J%EL2>?3-4TVWN(ECFW+))I\\C7>FRL]I,TRQQW,_H MQ_:"T, G_A7?QOX]/@]XTS_Z05[+H6A:/X8T?3O#_A_3K72=%TBUBLM.TVRB M$-K:6T*X2.)!D\\O)(Y:6:5GFF>261W;6K\^Q>-R*KBL14PV2XBCAYUJDZ-+ M^T_X=*4[PA9X2=K1LN7GGRW:YY?$_P!(K_V M,G[6M"G3C4J76.I*7-.,GS>SI\]^9P@Y.*B63S(5E573?$) LB&.1=R!@KHP M#(ZYPRD95@5/(-?@9\=_VFOVBOA%XC_;JU>X^*&O)\,/%'[0GA3X&?!K5KE= M,BC^ /Q@TKX>_LLZKX;\':%?0V7VD>%/V@-,^('C=8/[=%ZNE?%;08-&T^[$ MGQ2TK3[#]^.O6O.M<^$/PJ\3Z-XK\.^(_AKX#U_0/'7B32_&/C71-9\):%J> MD^+?%NB2>&IM&\3^)-/O;&:TUKQ!I,W@SPC+IFL:A%<:A82^%_#TMK<12:-I M[6_@O=VT71;V/JEMKJ^KVN?B)\9O^"FG[37B3]FW]L?X@_!+X57OPUO/!/P) M_:Y^(GP1^)'CKX=>-?[.\*:A^S!XZG\'2_\ "6CQ7I]GX.\?>(?'6E6.M>(= M!TOP,NLZ+\./$6GV7A;XC)K]C>'5I?T9^/OQ;\]T.*WN_HG3OV?_ (%:1XB\>^+M+^#7PLT_Q3\4['4]+^)?B*S\ M >%+?6OB!INMD'6M/\9ZE'I2W?B6QUEE5]8M-7EN[?5I%6748[J15<:6G?!C MX1Z3X>^'WA+3?AGX$LO"_P )[V+4OAAX?M_"VC1Z/\/-1M] U[PK!?\ @K3Q M9_9O#-Y#X9\4^)?#L-SH\=I-'H>OZQI2.MCJ-W!* ?D%\-_^"H_QG\;6G[/7 MA?4_A-\,-"^(W[7_ ,$OV1OC/\%KQ/%GB^^\ ^!=,_:4L_'7]KZ?\7+V32+/ M4KJ_\+R_#VZG\*VWAB:PC\R:C_P4 ^*=CX@O53X M=_"K4_#?PCU7]DOPI\;S3_#$&E^+? M#O@O49;2\:3Q#!;WWC+Q#;>+_AO9KX;USP7_LT_L[ZCH,/A:_P#@ M7\(KSPU;?#OPS\([;0;GX=^$Y]'MOA;X+U2#6_!WPZM].ETI[6W\%>$]:M;7 M6/#/AJ&*/2=!U6VM]1TJUM+R"*9+K?L]? 9M>\!>*6^"_P *3XE^%>DV6@?# M/7O^%>^$AJ_P^T/3&E;3='\%Z@-(%UX8TS36GG;3K#1I+.UT]Y[A[**W>XG: M0 _&>W_X*W?&\_#6Y^)TWP5^%+Z1;?LC^*_VTVLH_'7B^&Y?X;_!GXQ#X2?% MOP1]H_L"[@C\8:^+K3O%'PWUY1-H%C";_1O%MA.T%KK%U]>_LT_MY>/OC]\; M[SPG-\"_%GAOX5:WXF_:%\*^%/%VI>%?&NA3Z+')/AYKOPD?01\.O"?]CO\+/%&K1Z]XD^'#:;_ &5]D/@;7];BCU?6 M?"IB.B:EJ4:7MY937*+(.AT'X*?![PMX^\2?%7PU\+/AYX?^)GC&*2#Q9\0= M&\&>'=,\:>)(IFM7GCUSQ-9Z=#K.IK<-8V#W0N[R7[6]A8O=&9K*U,(!^=/Q MN_X*#^-OAY^T'I?PR\'^$O"7BWP%K/[17@+]D&3QC9Z;X]O;;P9\;_BGX$M? M$?AJ7QKXFNX_"WA2=_#VN:QH%MXG^&W@;_A+M6_X1?4HM;N?B!X;\0&?PA9_ MFU\-_P#@IM^WGX&^%?P*^.'QBU7X0_$_PWJ7_!*9_P!K?QSX,T;PC>^"]3\: M?%:Y^.OPP\!6%S'X@MW:V\-7O@/K/CV;XIZM\&/A7J?Q+N+[PSJ=Q\0+_P >%;OQG-J7@RXM;KPCJ4O MB6?2GUA]1\,SV-A)H5^UX;S2S86*VDT4=G;)%RFH?L@?LJZKIEGHNI_LX_ _ M4-'T[7/%_B73])O/A=X,N-,L-=^($EG-X[U2RL)-'-K:7?C*?3M/N?%#V\42 MZ]=6%C=:HEU)_'7BRX^"?B#5] _8*_8J^.7AF;2]-.@?\ "6Z5HOA;5/B3XA$&B:7.DVI: MIJ/BKXA7DUJ+A_#D/7^!?^"K_C/XBZ5X.U>Q^$7AWPDGQ$^-7_!/GX7>&;+7 M]?UG4+J'3?VU/A98^-]:UQ9(K31%\2P^"-8;5[?PW>:7!IEEXQ\,Z7_;);CQS\$/A-XPN/&6H_VOXMG\3_#WPIKDWB;5?[#\ M*^&/[2UZ;4M*N9-5OSX;\#>#/#[7=X\MPVA^%/#VDM(;#2+&WANW_P ?@9J MGB;P]XUU+X._"^_\7^$M/\,Z3X7\47?@+PM/X@\.:7X+U1=:\'Z=H6KOI9OM M)L?"NKJ-3\.6EC/!;Z)?%KC3([61G+ 'X2?#O_@JE^TOX _88^%_QP^*^E?# MSXW?%7PW^S7XQ_:J^/\ I/@CPIXYT;5X_AAHGCWQOX>T9IXM/L=.^'GPU75] M/\!^*;2T\7:UK^JR:AKWAW4=-TGX4WUCIFK^(DS?'O[?W[2W@O\ 9'_:L\5M MKFC:M:>*OB/_ ,%B/A=\%/'^F>*+L_&KX3>*/V>M)_:U^+_P>U_4= _L&;PR MG@?P7X)^$5EX-2W-R=4\*7">"-?U"_URQU^ZT_3/VZO/V//V4-1N9[N__9K^ M!-],=5GFO/A/X&NGEU'XAQ+#X]O',^AN#/XS50_BA@ -,?!_B7X?>++Q_AIX.:Y\2^!?&;7;^+_ =K MTYT?S=5\->*FOKL^)-%O7FL-<$\B:I#=(0H /B/]G_\ ;P^(_P 6?V@%^%A^ M"WBJ/X;V_P 3/BA\"Y/'M_X6\;:5/8^)_@QX5U&_UCX@ZUXMU?3K3X>:MH?C M7Q)X=UG0-&\#>%KN^\:Z/9WGAOQCJ<]WI&J:U8^%^0^)O[7_ .TI\(_VMOVP M/#-W'\.O%OP7\#^ /^">NA_!'PIJ-EK/A:]T'XJ?MB?&OXB?!)?%GQ$^(-E: M:OY'@'3_ !!HG]J>-95TN_>RT71?#5AX4@TS6=2\1W&I?I=IWP/^#.D?$2[^ M+NE_"CX<:=\5+_3(-%O?B18^"?#=KXYN])MM/MM)@TZX\50::FN2VD>E6-AI M:PO?%3IEA8:>VZSLK2"$\8_ _P"#7Q"UR?Q-X\^%7P[\9>(;OP3K'PUO-;\4 M>#?#VNZI??#OQ!=1WVN>!;^]U/3[J>^\'ZK>QI>7WAN\>?1Y[L&Z:S\]WD8 M_/KXM_M4_%/5_P#@GU_P4F\;0_V=\/\ XY_LH?#S]K?P$GC+X=:C>7WAFX^( M?PK^!S>/O#7Q!^'MYK]G]OM$MAXET 7^CZLNJ2^$O'>C>)/"UQJFOIH8U2]^ M,_"/[07QS^"/Q4\!?#3XE7W[0.D0>/O'W[!MQX<^&WQ:^.6@?%'QL;+XG_$O MXF^#?B9\3+7XF^ K?7OMG@+6KJR\(^$KOX%^);QKG5]7TO\ M[09=!TR\U:* M]_=NR^#OPFTWX9W_ ,%]/^&G@*R^$6JZ!KOA74_AA:^$M!M_ &I>&O%,5]!X MFT'4/",-BFA7ND^(HM3U)=>L;FQE@UC^T+YM16Y>[N&DX#P3^R1^RY\-K&+3 M? /[._P6\'V4/BCPKXVB@\/?#3PCI:IXO\"RWL_@CQ,'M=*CE_MSP=-J>I2^ M%=2,ANO#LFHWSZ1)9M>7)E /S(F_X*D_%/3?A_X#\8ZQ\+?AG&GQ_P#@[\#_ M (_?":[T/Q?XS\3V7PO^''QD^,'@?X6W5O\ '+3-,\,KXDUSQ5X+T[X@:/XK M&E?#'3WN_&.H:'\1?"MAIFA:9\/M5\=W<>C_ /!2?]I/2[CP-X9\4?LV>(M: M\:P?#/P9\;?B?I^A_#[XDV5K=>%/C!\=/BO\.OA_X9\%WD]FVE> /L'@7X97 M/C]?%OQSU309=%/N_XN_L#?LX_%+P=J?A+2_ OA MGX5?VU\1M"^*^O:E\-_ 'PNMX?&'C?PW#XE71[WXD^$/%?@7Q7\/_BKIEK>> M+-:UJ+0?B+X3\1Z9:>)YK;QAI<6F^+]-T[7;7<^&?[$/[.?P[\*_#_P[>_#G MPE\1M0^&7B#Q1XJ\$^+/B%X(^'^IZYX4U[QAXJG\:ZS-X)LM'\):%X5^'.E) MXCFCU#2/"_P[\.>%O#&B3V5CO WP\\7_# MKP=I/@7XK_'#]O3X!^!-7T#Q!KMWXMM?$O[$7Q2\:^%9_$GB;3M0T^/1HM#^ M(7A?PAJ%S%INGWCZEX M,9OB%^U1X ^"GPNMOB5JVKV'@SX3:=9_\$T+C]J/6M3@M?#&GRZUJMKK?C+P ME?&_TE+JWFN+C7IYH-2T]8Q)#^JFG_!SX3:3J>AZUI?PS\!:=K'AGQ)\0/&/ MAW5+'PEH5KJ.A>+?BQ>ZEJ7Q0\3:1>0V*7&G:_\ $34-8U:^\;ZM:217WBF[ MU._N-:GO);N=W?\ \*@^%/\ PF/_ L/_A6W@3_A/1XDC\8CQI_PBFB?\)5_ MPED/@.X^%L/B;^WOL7]I_P!O1?#6[NO $>K?:?MR>#+F?PTLXT>5[1@#\X_V M3?\ @H7XY_:UD\#^,_#?@/X7^!/AI-%\$?#/CW2?'?Q)OM*^)-QX]^,OP@T_ MXJO-\+[>XT2TT+Q7X7\-R:G9>&] MKV.V\0?$QK/QEJNF#PQ+X,_L7Q#^J]E M>VFI6=IJ%A"M5TSX=>$;'4?"7@B[ MBU:"Y\(^&[VWTB.YT7PW-;Z]KUN^BZ?+;V M]=UJ!8%AU?44NO1_!O@WPC\. MO"7ACP#X!\,>'_!/@;P5H&D>%?!_@[PII%AX?\,>%O#&@6,&EZ'X>\.Z%I4% MKIFC:)H^FVUMI^EZ7I]M;V5A900VUK#%#$B Z6BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B ABB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9 end GRAPHIC 21 biib-2016630_gainlossfairval.jpg begin 644 biib-2016630_gainlossfairval.jpg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

H^ MH_G7W'\.O^1&\,?]@FW_ )-7PXO4?4?SK[B^'1'_ @_ACD?\@FW[C_:K]4\ M)O\ D=9C_P!BN7_J7AA]%ZO\HG:T4F1ZC\Q1D>H_,5^^"%HI,CU'YBC(]1^8 MH 6BDR/4?F*,CU'YB@!:X3XF_P#(A^)O^O!?_2F"NZR/4?F*X3XFD?\ "!^) M>1_QX#O_ -/,%>3G_P#R(LZ_[%.8_P#J'6''=>J_,^)&ZGZG^=)2MU/U/\Z2 MOY%$%%%% !7N_P !O^0YKO\ V"+?_P!+6KPBO=_@,0-UQ_UPF_]%M7YVKT'T'\J_1&Z M(^S7'(_U$WW]CSQ^_[F[MRLT.[;LDV$>9$TD3':YK] MA6^%_A6]$7XON.[[O^O^&7W' MFW_"H_ /_0%?_P &>J?_ "91_P *C\ _] 5__!GJG_R97I-%'^K/#G_0AR?_ M ,-F"\O^G'E^+[A=]W_7_#+[CS;_ (5'X!_Z K_^#/5/_DRK2?#O3(%$5EK? MC&PM8P$M[*R\7:U;VEK$H 6&V@%PPBA0#"1@D*.E=_177@\HRO+YRJ8#+L#@ MJDX>SG4PN$P^'G.%XRY)2HTX2E'FBI:BUK,;GQ/J-ZAA6UGFPL=TTJH_F(A\Q &VAE)(;CQ7_A,O&/_0W^)O\ MP:R?_&Z]]^/7_("T+_L,O_Z07-?+ZJS,%4%F8X51R2>OZ $DG !8D $C\,\ M0,WS;"<3XRAA,TS'"T(T<&XT(-!U?3]7T3Q%% M-K/JFM[A=^7_ ("O\CN/^$R\8_\ 0W^)O_!K)_\ &Z/^$R\8_P#0W^)O_!K) M_P#&ZX8:]H+:GJ&AKKV@MKFDZ?#JVK:&NMZ2VN:3I-PNZWU;5M%6\.J:7I-P MOS6^J:A:6UA.I#17+JRDZ:LKJCHRNDB))&Z,KI)'(H>.1'4E'CD1E>-T+(Z, MKHQ5@2GG^?JU\[SE:)J^9XY:633UK[-)-=UKU"[\O_ 5_D?2OPRTV]\8:+>Z MAK/BGQG)U*D\1*O"J?\ MR97I-%=G^K/#G_0AR?\ \-F"\O\ IQY?B^X[ON_O_KLON/-O^%1^ ?\ H"O_ M .#/5/\ Y,H_X5'X!_Z K_\ @SU3_P"3*])HH_U9X<_Z$.3_ /ALP7E_TX\O MQ?<+ON_Z_P"&7W'FW_"H_ /_ $!7_P#!GJG_ ,F5+%\,/"]F2^D-K>AROA9I MM&\0ZO82W$8R5BG=+IC)$C$NB$85R6!R:]$HK;#Y#DF$K0Q&%RC+,/7I-NG6 MH8'"TJM-N/*W"I3I1G%N+:;BU=2DGHVA7??^OZ2^XX+_ (0"U[^)?'9&1D'Q MGK>#@YP<3@X/0C/(XJG_ ,*C\ _] 5__ 9ZI_\ )E>DT5T8W*\MS%TWF& P M>-]CS^R^MX6AB/9^T<'/V?MH3Y.?DAS M'/\ H0Y/_P"&S!>7_3CR_%]PN^[_ *_X9?<>)B =T;NA&&-=/H?A^+0_M/EZGKVH_:?*W?VWK5 M]J_D^3YF/LWVQW^S[_,/F^7CS=L>_.Q:WZ*]'!X# Y?3E1P&#PV"I3G[2=/" MT*6'A*HXQ@ZDH480C*;C",7)IR:BE>R22"BBBNL HHHH **** "BBB@ HHHH M _$#_@I/_P I)/\ @A3_ -G6_M0?^L<_$&OV\C_U/_"EUIWCS5K37=-TNSN[#X9:1H_B M3QQ+;1^)]!OIGT7PIX@FAT;QK!;)9FZ\1> K\7,7C_PG!K_@M--U:?7HM*O? MUAUSPYHGB2""VUNPCOX;:8W$$:YD_"OP M 00?#EL0>"#=:B01Z$&\YK\GXGX$S?.>(9YQ@L5EU.E_L$_AYXX^$VM_&#Q4_P8^%46J>+'^$MC>+/ OARPU9&FN_?_P!F/QW\'[#Q9\2/VAO#/PG\ M?_!/P?X8^!OP_P#A#X2_9]\(_LO?&_0O'DOPVT'XD0OHWQ ^*7A^+X7Z-I?C M/XN7.L>(]/TG0_ WA"\\>>(OA/\ "\>*=1\;>*M7U/6_&B^%?Z,;CX/_ TN MY+.:[\(Z;=3:??1ZGI\UR]W/+8:E%!6[1W*VUW M=6XD$-S,CWF^&?@=\!M#5@IRN[4-5;:<$97-\=IP2,C!P2.A-SE%^PA2I2=%.^V^C]--+ M:7[J[[][[?SK^#)?@UX\_;3\&Z%X3^&7B'X2VWP3^-OQF\1ZMXV\0? CXS:9 MXS_:5^+7C;PQXQ\)^/X+[XK:S\.SX7C_ &:+>W\2:[K,^M>//B1=6/Q>U_PS M\/M*^'WAOP_\.?!WAS4_$?V-^R?/J%Q^SI\*9;]G>#^Q_$$7AR61YY99O %M MX\\76OPMG>2Z5;B03?"^#P;+ \HR]HUNZ%HV1V_5VX^%G@&[MI[*Z\.P7-E< MP2VMS:7%YJVMH(XX+>")$B@ACCBB1(T M51QXOPVS_$THTEB\LCR+#QBZF-QM=I4?KR_J]SEO@1_R+&J_]AZ;_P!-^G5[=6-HGA[1_#EM+9Z+8I86 MTTYN98DDGE#SM''$9"T\LK F.*-#G"G-JTE\4(N_0D****]H HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** /Q _X*3_\I)/^"%/_ &=;^U!_ MZQS\0:_;R/\ U01E3D'! (R.#TJ'[):?\^UO_P!^8_\ XF@"C_;VB?\ 07TO_P &-E_\ M?H_M[1!UUC2__!C9?_'ZO?9+3_GVM_\ OS'_ /$TC6=J5.+6WS@X_<1=<<=5 MQ^?% '.:9X\\$:U<:U::/XP\+:K=>&]7?P_XAM]-\0Z1>SZ%KT>FZ9K$FBZQ M%;7DCZ;JT>DZUH^IOIUXL-VFGZKIUXT0M[VWDDUO[>T3_H+Z7_X,;+_X_7SG M^SY\+?$W@+QG^U?K'BG1=/L=/^*/[2]Y\1O!,T-SIUZ^I^$9O@5\!O!,>HW$ M5HTDFFSMXD\#^);)K"^$5YY5E#>M']FO+61_IK[):?\ /M;_ /?F/_XF@"C_ M &]HG_07TO\ \&-E_P#'Z/[>T3_H+Z7_ .#&R_\ C]7OLEI_S[6__?F/_P") MH^R6G_/M;_\ ?F/_ .)H H_V]HG_ $%]+_\ !C9?_'Z/[>T3_H+Z7_X,;+_X M_5[[):?\^UO_ -^8_P#XFC[):?\ /M;_ /?F/_XF@"C_ &]HG_07TO\ \&-E M_P#'ZR4\>^!Y-=N/"\?C'PJ_B6TT>R\0W7AY/$.D-KEMH.HW^H:5I^MW&E"\ M-]%I%[J>E:GIUIJ+P"TN+[3[ZTBF:XM9XTZ3[):?\^UO_P!^8_\ XFOE[2OA M5XHM?VR_'/Q>GT33U\ :U^S+\+/AOINK"ZTU[F;Q?X9^+?QE\5:SIS:2K'4( M8+;0_%^@7<>H21+9W,UW+;P2/T3_H+ MZ7_X,;+_ ./U>^R6G_/M;_\ ?F/_ .)H^R6G_/M;_P#?F/\ ^)H H_V]HG_0 M7TO_ ,&-E_\ 'Z/[>T3_ *"^E_\ @QLO_C]7OLEI_P ^UO\ ]^8__B:/LEI_ MS[6__?F/_P")H H_V]HG_07TO_P8V7_Q^C^WM$_Z"^E_^#&R_P#C]7OLEI_S M[6__ 'YC_P#B:/LEI_S[6_\ WYC_ /B: .OZO;:/JGB&YTO1;:>\275-1M]!T36=;FLK))KB+2=)U+ M47C%I8W,L>K_ &]HG_07TO\ \&-E_P#'Z^?_ (U?#/Q%XQ^*7[(OB;P]HUA> M:-\*?CUXK\<>.;F6XTZTDTOPUJG[+_[0WPULKVVM[DI/J%=&U'Q%XH\9>%?#GA M_1[9KW5M:C->6$T<,NI:DT-E9H8X)6,US*D0*J"0Q6@#Z5.NZ("0=7TL%25(_M&S M!!4D$$&?(((((."""",TG]O:)_T%]+_\&-E_\?JXEG; '=:V^2\A_P!3%R&D M9@>%ZD$$]\]>_.W?Y,C[-VUMN[&[!QG!P_P"R6G_/M;_]^8__ M (FI(X88L^5%''NQN\M%3=CIG:!G&3C/3- $E%%% !1110 4444 %%%% !11 M10 4444 &1D#(R>@[G'7'THR,XR,XSCOCUQZ5^//[2?QU^.-GJW_ 4)\?\ MA7XQ:M\+(OV"_AQX.\7?##X;6.B^!+[PI\7M2N_@E-\:M0U/XIQ^*-&U+Q-K MWAGXEZY&->\#RZ%J/A+Q)JWAW4+_P :2PW&D^H7WBCX^I^U5\,O M#W@CXR>,/B!K6L>.YO$_QZ^#\G@;P?8_!/\ 9_\ V8M6\#>++SPSHOBC7--T M.]\3:3\=[SQ6/!A\(75Y\2+SQ'\2+^;QCK*> -*^$.D2MX6 /TVR,XSSUQWQ MZTF1C.1CUSQ^=> ^,_!7QPNO'VN^+_ GQ=TW0M O?A7IG@S0O 7B7P#;D^'[/PW_ ,)?IFB3W%A:3W:VZ2WE MTWY%?#;]JG]J/Q[^RA_P3?\ "S>)/B/XL^+W[65]\<-,\=?%'PM;?##P-XRU MN\^$/A3XJ>,--T*TUKQ#X1O?AG\-;_QNOAJROM1UZS\#ZS)I_A/PEXGT?PAH M*:]JNFZSI(!^^E%?,'[&OQ/NOC!^SGX \:ZEX@\6^*-;%QXW\'^)M7\>:)X( MT#QD_B_X:?$3Q=\-/&%CXDL_AI//\.;S5M&\3^$=6T6[\0^ 6C\%>+'T_P#X M2GPM;6>B:Q96=O\ 3] !02 ,D@#U/ HKX=_:#\3?$'Q-^TA^S_\ LV^&OB7X MH^#/A/XC?#'X_P#Q6\3>./ ]MX._X3?Q%JWP?UKX(>'O#7PS\,ZKXST3Q;IV MCI?)\6]9\?>(Y;/PK?:U?Z7X#MM-MKRQT2Y\3>> ?<60,9(&>GO]*,@=3UX' MN?2OPXO?CG^TI\0/V9_ 7Q)\-?M"^*9?VB/$6G?%'X6_LY_"'X3_ Y^'%SI MW[0_QD^$WQC^*?PRL/CM\5[?5M%\6+%^SUX[\.^'_AUXU\=S^&]1^&W@;X6> M#]=\4:Y:>,;[Q!XC^&UGH/ZZ^-/"_P 0/$>H?"&^\.>/IO!-MX0^(4/BCXE: M5INFV%_:_$GPBOP^\>>'YO $TVJV-W=:5IC^-?$'A+QDFI:>^GZP#X-MK!KP M6U_?VET >HD@9R0,= O@[IW@_2OB1^S?^S'\0-7\'_#+4?B- M-K&@:?J5IJ_Q.\31^$]?^*6N^+M4O?%&IV-U?>=!<:9X9M/JC]C'Q9XEB/QD M^"_Q'U/XFZK\5/A#XUT"3Q9<_$;XD^$_BXITGXA>#=,\2^#_ /A&/''A'X?_ M N@?26TRVNVO?#NO>!]%\2:)K0U">0ZIXI@'W#1110 9'/(XZ^WU MIOF)_?3CK\PXQU[]J_./]KCXC?M$?";XT_!C1?ACXG@N?"?[7]W+^RYH%OJU MGH,Z_ 7XX6'AWQU\7-(^.NDP7<4%UXFT6\^#G@_XO6OB?PEJ5SJEO>_$#P+\ M$K32M/T[2/$GC_4#^=W[6?B[]HWX*>(_^"E%[X&_:[_:2\G]G_\ 9C_94^(_ MPLT?6M7^%>L:7H'BW]H_XB_M"^#?&E\ENWPABNM072-'\ >%G\&66JWNI6V@ MZK9W%](FII?36M ']%P((R""/4'(_,49'7(QTSGOG&/SX^O%? 7P5\3?$GX> M?M:>-?V8-8^)GC;XU^!+/]G?P5\:].\3?$>/PE=^/OAUXAU7XF>,?A_)X9U_ MQ#X0\,>#H=;\._$73]"E\3>"DU_0'UW3+_P7X^BBU_5M#N=+TWPYY+^W#K?[ M5W[//[*^N^-O!?Q_1]=T[]H_0M:U3Q# ]%\$_!SPS M(\-OX6T#1_"?PO\ '<_@#6O%>J>&?$OBW4])T2UGTB]L/$5]<>*[, _5C(&, MD#/3W^E%?BC^U#^U?\8?#'Q[_:2>RUSXQ?#_ .#O[&.D?LY>*?&&I_#G3?@Q M>:=?>%/BM;>(?$7B[Q]XL\,_%/2[KQ'\7="%MI[^!(/A_P##G6?!/B#1+'PM MXXU_PUK?B7XEZAX+T#3_ -K$.1WZL.<9X8C''!QC&>IZD \4 .HHKX?_ &^/ MBQ\0_P!G#X*3?M3^";^_U+P_^SA?7'Q*^,/PKM4T11\7_@M%I5[HWC_PWI>H M:P+<:-XX\,66I6WQ'^'E]'JNEV>I^*/!]OX0UZY70/%6HW%H ?;Q= <%E!]" MP!_+.:4,K9VL#CK@@X^N*_&3XE>'_P!I71?VIO\ @GWX*\8_M4_&?0[[X]WW MQUNOCGX.^&NJ?#[3/AH=6^'7PTN_BMI'AGP;;ZS\,-7\1V/A?0]:OH_!RW[Z MY%K/B?PIHEE<:S)'J]]?7+<%^QI\:_VA;3X5_P#!-OXO^,OCQ\1OC'K/[:_B MO5/"OQ8^&WQ!L_AU/I]C;ZA\(OC#\35^(7PL_P"$;\%>#?$'A*S^'>H?#'2( M-5TN34?$GAJ^\'>*[^'4;5O$4?AO6H0#]V"/CRVM__ _QELM(M/&?@_X6Z#\./#_ (D\"6GB[1_A+K7AS4O& MQ^)GC/2M)T^Z\-ZCXKU_QKH?B'P\FE:5XA\23>']-UWP;I%Q<63Z5=:QIVJ_ MFSX&\5?M?_M$?L7_ /!-?Q/X8\=^/]2^('Q3_9F\-_%+XT:WX3^*7PE^ _B[ MQGXJOOA3\/-5M_$&L:AXB^%GQ!D;PY?:OXDUFZU'3OAI\+VLX/$FK^$?[1G\ M.>&&_> '[9=>E%>%_LS?$[1?C'\ /A%\2?#\WBJXTOQ1X$T&ZBG\<7&D7OC" M6XM+4:5J,GB74O#V?#NKZTVIZ?>_;];\.,_AW6[C?JV@R2:1>V4C>Z4 %%%% M !1110 4444 %%%% !1110 4444 ?,7QY_9+^$GQ_P!=\"^-_$FDP:+\3/AM MX@T'7_!WQ)T;0?!NI^)K$>'[S4+VRT+5+;QGX9\5>'/%/AF.ZU;4=2L-#\4: M'J]IX;\32V?CGPC_ ,(_XYT?1_$=C!H?[%/[+'AGXK:E\;O#OP3\%:%\5-:\ M;:M\2-9\9Z1;:AIVJ:SX]UR/R=8\7ZO'::C%I^I^(=2@$=O>:G?6,]S/;V]K M;N_D6EK'#]244 $?$EK'9:WH=Z]U':ZA:Q7 M-O>1PS/9W%K=*JW-K;S PW$3;HERQ7(/SWX6_82_9 \%?#74?@[X6_9Y^&.B M_##4M=LO%$O@>T\/J?#UKXCTV&>WL-=TBQGGF&@:O9PW5XEOJ.@OIEW$+V]V MRC[;=^=]:44 <_X5\*>&/ WAS1?!_@OP[H?A+PGX;TZUT?P]X9\-:58Z'H&A MZ38QB&STS2-(TR"VL-.L+2)5CM[2TMXH(D 5$'.>@HHH *\5^/?[/GPH_:5^ M'NK?#;XM^%K3Q#H>H6]^-.U!%2T\3>$=5OM+O=''B?P3XBCC;4O"OBBSL-1O M;:TUG2Y8IS:W5UI]XEYI=[>V-S[510!\5ZM_P3[_ &5?&)\':K\3?A+X/^)' MCGP9\-/#?PCLOB'JOAO0_"7B:Y\ >$[N]U#0O"IM?AA8>!/"^E>&M,U#4+R^ MT[POX>\/:1X;TVZF:73]*MBL>S[-BMH8;>.UCC"V\4*6Z1@G:L*1B)4!)+8$ M8"@EB<#DD\U/10!\@>"?V!/V-OAWJ7C;5O"/[.GPPTR]^)6BWGA[XB--H3:O M;^.]&OTT>&ZL?&-CKEUJ=AXD1[;P_H=DDNL6MY<0:?I&FV%O-#9V5O!'[U\, M?A)\,_@QX=?PG\*_ WAKP'X?GOY]6O-.\-:7;Z='J.KW,-O;7&KZK/&IN]6U M6:TL[*SDU+4[B[OFL[&RLS*O# M.B^(-3^'/BL^.O E]JUA!>W7A+QB?#/B3P8?$N@33*7TW6CX4\8^*?#WV^W* MS_V1K^K66[R;V96X7QQ^SQ\#OB7;_%"T\??"KP-XMM_C3X/\+^ /BO'KOA^R MOQ\0?!?@F[\1WWA#PSXJ:5-^K:/X:O?%_B>[T.SN&*:;_O9+&PCCL;,P6J+",'X\?LO_ !_:>TK1-"^/WPK\)_% M;1?#EY-J&C:1XPL[C4=,LKZ>;3;EKM;%+J"VFGBN]'TN]MI+J*=K.]T^TO;0 MP74$)?V3/V:KJX^&]Y??!'X<:I>_"+3=*TCX=7^L^&;'6K_ ,+Z M9H&H-K'A^QL[[5EO;NYMO#VN,=?\/Q:G-?KH?B'_ (GVDBSUC_3J^AP .@Q] M*** "N1\>^ ?!?Q2\&>)OAW\1?"^B>-? WC/1K[P[XK\)^)-/@U70?$.AZE$ M8+_2=7TVY5[>]L+R$F.XMIE:.5"58$5UU% '&ZW\// _B/Q9X)\=:]X4T'5_ M&/PXF\0W'@/Q-J&G6]SK7A&?Q;H__"/^)I?#]_(IGTU]=T3_ (E6J-;LIO+' M_1YZIHVA-INF:E=6%A/>VD\EC:-#])T4 <'\2_AE MX$^,/@S5OA]\2?#EEXL\&ZZ;$ZMH.HO=QV=Z=-U"VU2Q\YK&YL[D?9[^SMKE M1'<(&>)5D#QED;P+0OV"_P!CGPU\.]*^$VB?LY?"FQ^'&@:ZWB3P[X/3PQ!- MHOAK5Y-*TW09I_#4%S)/)X<@N-!TC3]#NM/T2:PTR[T:W&E7-E-8/+;R?7-% M &;HVC:1X=TC2] T#2].T/0M$T^RTC1M%T>QM=,TG2=*TVVBL]/TS3--L8H+ M.PT^PLX8;6SLK2"&VM;:**""*.*-$&E110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ;%%%% !1110 4444 %%%% !1110 4444 ?__9 end GRAPHIC 22 biib-2016630_incometaxes.jpg begin 644 biib-2016630_incometaxes.jpg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end GRAPHIC 23 biib-2016630_interferon.jpg begin 644 biib-2016630_interferon.jpg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end GRAPHIC 24 biib-2016630_oie.jpg begin 644 biib-2016630_oie.jpg M_]C_X 02D9)1@ ! 0 0 ! #_VP!# $! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_ MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P 1" $] 3T# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#^_BBBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "OS3\6_MW:WIO[:GB_]DS2K7]F7PK!X"\,? WQ;J6M?&_\ :4N_AE\0/'6F M?%U_'MUJ\7PD^&5K\+O$R^,;KP/I'@"^GO3<^*M)M[V_U&RM;F;2+5)KY?TL MKY/'[(OP^OOBW^TW\4/$]W>>*+?]J'X9?"WX5>+_ EJ%EI\&G:-X;^&V@?$ M[PW.-$U>TC37(Y_%6F?%#5(M5=KJ-K)K"T;37B,MP6 .5@_X*(_LE3:;I^JG MXBZY;PZWJ?PYTSPQ97GPJ^+MCKGC4?&&Q\87WPBUCP'X:ULI^;_:J_;[\*_LQ>-_#?PXNO MA?\ $WQIXI\9_LU_M-?M%^';_3?#.O6/@6TL?V;O#'AKQ#?^%O&7C'^P]0M/ M"5]XE?Q+:Z>VHWD$MMX2E_L__A)H;6X\3^%+76?/=&_X)G:+%XD^#7C'Q=\= M/B%XX\3_ '\2?L^1> -6U/PWX$TIXOA7^S9_P +'F\$_#W6(-!TFQ@U+4_$ M6I?$B]U7Q_X\1+34=7FE:'H'B&UUGX6?M,^%_"OAWXE:2]AKB)_9NOI/X$\': MOX9\36-T)=)GTW4+&ZT_5-.UFZ@C ,3X=_\ !13]G/QQX#\,>)+K6_$FE^,= M?T3X37S?"K3_ (;_ !8\1?$*_P!3^,7P^UKXC^$+?P!X0L? $?B_XI>'-5\/ M>$O'FH:5XY\%>'-2\*W^E> ?&>K2:A9VGAK6S8>N_$?XZ:DW[.&L?'[]GFS\ M ?%BUMO!EU\0="M_%?C#Q'X$\-Z]X9TC3[S6-;0ZYH_@/QSKNDZY;V.GWEI! MI%_X22>WUV"72-=.C3V]WY'Q;\1/^"2WPC^(GB'PUXUU[Q8_B'Q5X"^%_P"S M5\./ L7C_P"&WP_^)7@>Q?\ 9Z\(_'KP%+K/B7X?^*;&XT;Q:/B#X8^/VO+K M.GW,VG-X;UOPUX7U[PIJFG7-OJ,=_P#=/AK]GSPMX2_9T7]G'0;E-+\,I\-] M=^'::EH_AGP;X6,,/B+2=5T_4]8LO"O@S0/#7@C2+B6[UF]U1-+T3P_IFC17 M,AC2S$;2,X!\ _"O_@JE8&Z^'"_M,_#[P[\&-&^(_P"QQ\-OVSH_%7@7Q3\1 M/C'X>\'> ?BCXO@\-Z59>/+BS^#7A>?PIIOA2TNK34O'_P 0];AT_P ">&3= MP+/J[V'G:E%]/[,D=YK6F67C/Q-XAU70OB-XX^$]UHW@_X3?%SQIK5] MX^^%^J^)M(^*.@^'M'\)^!]:U+Q3)\,Y_"FI7/Q OO#=MJFF>$-/O/#5]KEY M9Q>,/"8UKYY\3?\ !+OP/XE^&>N_#27XL>.;2QUS_@F]X7_X)Q2ZG!H_AEKR M#P9X7&I+!\38X9(/LS^,;H:E*)M)D4^'(P@$4 #N##XY_P""5_PF\::5H[:C MXAMM;\5>&/CU^UG\;/#.K?$7X7?#?XK>&=/A_;$^)][\3OB3X-N?AWXTTJ^\ M-ZA;:-J9T+_A#/$Z_9/$VD7OA?3KV[N=1L=2\2:)K(!]8:=^V3^SAK/C+PYX M(T7XCP:Y?^*5\#II7B#1/#GB_5_ATNI_$[P]9>+?AKX'DU7:^,?[4GP7^ =[;6WQ4\ M0:]X;LGTZSUK5?$L/P]^(NO^!_"&A:A?WFE6>O\ Q \>^'/"FK>#/A_HM:9HGC MSX*R?!K5-$OO!'P\^("^#8[6Y\8ZCIOCOX-7WCW1=7D^$/CW4K[QB8O'WB/P MM;_VEXVTGPIX%L3>:#>>$],U9 #UZ3_@H)^R/;:CXTT[4/BU#HX\ 3?&ZR\2 M:MK?@_Q]H_AB/6/V%H/#/B7Q;\/M4L'.J^$/#>JZMX MFN].N+/5]'TG4M,NX;DP? _]LK2?CA\0/VJ_".A_#OQI86'[,]_\,[ ?VGH? MBC0/'OC&Y^(/P:TKXN2Z9-\,/&WAGPAXD\)>(--358=!L=&U0SG6Y9;+4([J MTAO4BC\"\=?\$K_AG\1=$T7P]XD^*'Q!73M%^.G[9?QXAETRP\,66I0^*/VO M?$_C3QFRZ?<7.G7UO9M\(_%WBNRU_P "7>.O$*:3H7@,Z'?^ _AG!\+M M.D\"V?A6)9/#D3:'9V>HP":[U._L-=2XU&+4IC.L< !\O_#7_@IE%X\^"NO? M&^_\.? [0_"NGZ)\&]6G.E_M&3>-=2^&VO?%SXC>%?A_#\(_VAO!WA[X3?\ M"S?A)\8-$N?$ZI<:/:^ O%WA#_A(=/U3P]J_C#P_;Z=+KLWZ!_#?XZ?#+XMZ MAXCTGP#XADUW4O!US/IWBZS_ +%UW39?"^M6GB?Q1X0O?#FO'5=-LDTWQ/8Z MWX-U^.]\.7#+K%KI]OI^N2VBZ#K_ (>U/5?@SXA?\$RK/XQ3:UJGQB_:!\;> M.O%K>!O"WPM\-^-U^'GPK\+^*4^'^@_&[X)_'/4HOB'J7A?P_IQ^)GBO7=?^ M OA'2X_$6J)HFD>%M.U'Q9=>$/">BZMXEU2]G^K_ ('?LS6/P-\=?%;QOHOC MOQ-K"/AA/X>LO M,T.+P=\+/AX((X]9T[6]4U\ ^$_$W_!6BV\-_LD_M8_M!S? YY?B5^S;\1?B MQX+\._ ^3XBQ6UQ\5]!\%ZGXOO/!'Q L?&)\'RKX<\.>,_A]X$\;>,]:\WP[ MK#>#[CP!X^T#S]:#>>$]*\17?B>]D M\$_$"^\)Z7KO@SX37'QQ\:> (/'MCX4F\$ZO\3?"WPLLM0\;:I\-M)UV[\<) MH.G:A=)H+2V%_;6OS9XM_P""47PK\7^'?&VB7OQ-^(]O-XX_9T_:Q_9]U*:W M30/[,"_M.>+_ (L^(]*^),NA/9FTO/'?P0T;X]?&SP3\-;F>9=.;PQ\4O%T. MNVE[$_B):?$3PG??&+QYIWPQ\<>(/BQ\4[#X?V7A_P5+; M>%_CQ\8_@EXQ^"'BGXD67B&ZTN37-2TB"P\>>*_'^D_#_4+AM+M/B/K$NIRZ MK<^&;72O"FG &]XW_P""H?[./AS5O@[HWA*T^*'Q-OOB]\;?A7\'+>T\(_"G MXCPW_AJV^,O@KQ=X[^'GQ/U32]=\)Z9J6H_##Q=H?@W6)O"GBS0;74-+\5#3 MO$,FA7EW%X/\5MI.5^S]_P %3_V=OBW\$?!7Q1\=7M]\*?%7BKP5X;\8/\.I MO#_Q"\4W.HGQ9\6=/^!VAZ-\+M=M/ 6FP?&[5+KXKZ]X5^'DMG\,;'7[ZS\: M>*_#OA^]L[>ZUG36NX?$O_!-+POJWC+2OB/H_P 7O&.A>/?!^F?L8)X!U:7P M[X8UG2- \0?L:Z3\>O#F@ZUJ6AWL<,7B2#Q]X9_:%\:Z7XHTB:_T]-+GM='U M;P[?6-_:.\F#X>_X)9^#?#/@;X->"]+^+GB*\B^"_P"S)XZ_9FTMO%GPW^%' MCO0_%GA_QO\ &KX0_&>\U'QOX)\<>&M?\*ZW:R7_ ,(--\+7^A1:=9I\46&AZ]IP!]XQ_M!?"E/A!K7QVU?Q%>>$OAKX:L/$6H>)=6\>>%O M%W@+5O#J>%-0O-)UVSUSPAXPT'1?&.F:M9ZK8SZ=%HUQH"ZIJ=ZUK!H]IJ+7 M^G_:O)K[]N[]FS2_^$?M-1\3>-[+Q+XG\0^,_"&C?#V;X*_&H?%2?Q;X!\!: M7\4O$WA>X^%:^ &^(6GZ]:_#;6=,\>V.GW_ARWEUKPA>0>(-&-]ICBXKA[#] M@/X>7G[(OC_]D/Q_XQ\8>./!?Q*U'Q)K>J7MQ%IEC9>$;_7?%-AXUTO2/AEX M,FM=:\+^#?A_X'\2Z5IE]X,^'%S;:_X8L;>VGTS58-8T[4;^VGYKX4_\$Y? M?PO\8_!3QYI?B/1M(UGX1^/?C%\0KC1OAK\&OA5\'/ _BG5_BY\'=-^"T\-S MX4\ :+8+9QZ#X=TFSU.UU*^U+Q!XBU#6&N(+S6D\/1Z3H6D %_XO?\%)?@/X M(\.>$M5^&FHM\:-3\8>+OV0M%L%\+Z=XRC\$V?A[]L'XM?##P%X US6OBE9^ M#-8\!^'M:N_!GQ'7XI>&_!/B+6-(\0^*_#NFVBQP:7:^(-)U27TZU_;R_9=O M=!U[Q+;?$'4I-)T>#PM>:7*WPZ^)T%U\1=.\<>,+/X>^"M5^#&G7/@V'4?C= MH_C#QWJ&G>$/"^K_ FM?&&G:]KNJ:/;Z;_L:R_!:S\$^+M2UB336 MU;PS;^.?"WP)\!>'/B-X;\.74%AJ"Z-::GX?N_#MW+KL6OS?#W_@D;\&?A=X M5/AWP/XAL?"FH>#+OX77GP.\8^%/@O\ !/PMXS\ W7P7\8:9XT^']_XY\3:% MX/LM<^-VI+ZTJ59KR(/$6FZ'I,X\6>.]*\*Z?K5AIFG^'[:UL+/0+67PQ&VB MV926ZL;&>.PN;S4'M?MUQ],T %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% 'Y\?\ !0?QX=%\*?L_>!?#/C7D/B.#Q"ND:Y+FSW]KJLVGV4NIV,-S;66HR6EN]_:6]X8C=P6MXT9N;>"Z,$) MN8H94CN#%'YROL3%9_#^A2//(^C:4\ES>Z\[3[C[3,[0%I;CS M]*TR;SY"TOG:=8R[_,L[9H@#^>SQ[_P4[_:N\%^,O&_P@M]%^%VJ:Y\&?'/[ M1_A6_P#BQK*?"_X;>"_BWXF^$%Q\(M1\%^!;FQ^+?[1?P]L?!!NO#GQ6@F^) MDW@36?B7X]6 >'_$?@GP/'8W.JZ:GZG?M?ZWX'O/A%X-M?B9XMT3X?:AXHUB MWE\/>'/&?QR\=? ?X6>,/&$/@_6]3?P!\2_C'\.M)NM4L/#5O8G5] V&JQ+)I,OV+-H&AW#(T^CZ5,T>K1Z_&TNG64C1ZY#&(H=80O Q M358HE$<6I*1>QH B3JH JSJ6F:;K-C<:9J]A9:IIUVGEW>GZC:P7UC=1AE<1 MW-I=1RV\Z!U5PDL3J'56 W*" #^8O1_BOK=[\%O'%[\6_CQ\4=%\4_#?]D3X MA:_^Q3JO_"ZO&]I:_$C]I7PM^T9^UKX2UVZ^$6O6.J6UW^U1IGAP^&?V8/ ? MP%U'QQ_PGOBCXK_!+Q5X8\0^(?"=[?\ Q?\ &,>I_P! J?$/P_X@^$WC^V\9 M?%#PW\-O%G@+P"EI\=]=\,>+_#$%[^S]XFU;X6Z9XXUK4M8U'7H]4T;PC=^% M_#OB&T\=Z/=>,M.ETR/P[)HWB+4+*\T.Y'G^W3Z5IER+ 7&GV5P-*N8[S3// MM8)?[.NXH)K6*ZL/,C;[%<16UQ/;1SVWE2QV\TL".L4C(:,/ACP]!)XDEBT7 M30_B^Y6[\4%K2&4:_.NBV'AU7U995D2]5="TNPTE8IU>(6%K%;>7Y88, ?SQ M:;\5/#NN^#_BMX^_9O\ CIXB7]CWQ#XR_8M\$>,&O_VG/$?COXES_"V^_: F MA_:1_:\NK^]\:>+/B=\#?!7Q)^&_B+0O MYXBO\ 5? OB#5_">D>,/C/J.E^ M!4L/#OB:_P ?]K/XK)X1_8+_ &Y+WP3^U?XI\ _!OXF_'&TL M-4^*GAO3_A]\ ==\8?#_ ,,_%WQ3=W'CWQ?\._A[\;=9^,'AZTL_ _C:>XO] M(T&X^'%YX@N? N@3Z#=?T2Z%X!\#^&)+^7PWX/\ "V@2ZI'Y.IR:)X=T;2)- M0BW2/Y5\^G6-LUY'OEE8QW)E0M)(=N7;,FI^!_!FLV&EZ5J_A/PSJFF:($71 MM/U'0-(OK'25C@%K&NF6=W936VGJELJVZ"TBA"P@1+B,;: /P*_:Q_:+UF__ M &@/C-XT'BW2_$7@'X4>$?V9/&_[+'AWP/\ M+^._AYXH^/>E>+-:\8V?Q"3 M]F#3OA5J-UX9^+/QBU/XC:;_ ,*_U.Q\9:;\0_">HV&D>#OA?J6A>$]!^(/B MGQ-=_>'_ 4#_:N\=?L_R_#GPC\+O$?AO0O'7C/PS\5O'&GV_B[P[X.?1->L M_A(]?M?T0LO"WAG38=&M]/\/Z)8P>'1<#0(;/2=/M8M#^UQ2P77]CQV]M&FE_ M:89IHK@V"VYGBDDCEWH[*=&]TW3]2-F=0L;.^.GWL.I6!N[6"Y-EJ%NLB07U MH9XY/LUY LLJPW4'EW$2R2".10[ @'\]W@__ (*G?M->*/"VF_'6W\&?#[5/ M!=U\7/V-/AG9_ /1/#NL-X_\27O[7G[!GP&_:/CT;3_B)?\ BJWMM/\ $7AG MXJ?$^;P[X8AE\&7HUW19GTK6+>#43I^I6OLG[$7QY^('QM_;=FU[Q1\WLYP!+:P00PV[QQQ1JLMII&E6$LL]EIMA9S3RW<\T MMK96MO)--?W37U[++)#$CR2WEZS7=U([,]Q=,;B9GF)<@'\^/Q2^*EIJ?C;X M\:E^P=^T=XG^(7Q>^%?PJ_;1O?B-XAU3]H/3O'>I_''XVV7PZ\:+X$^!7PH^ M!2ZWJ>F:S?\ [//CN6V\2GQ3X&^%FA>'_ $?PZL_@UH^H>--9\6?%F#PYZOX M;\:_#BP?]J/PW\$OVLO$6A?LE0?LT_ WQ5&OCSXM\1_&"#Q/ MX9\-_&'XOZAXMB\&>-_BG\.M-^'NJ>.;33]7LO$W@_6=5T/QCH&E^$/&OC4: MW??LM8?#OP%I6M?\))IG@KPCIWB',Y&NV'AG0[/60;J.2*Y(U6UL(M0!N(II M8YB+C,L%=3TNZT34?#6@7^C7M[)J5YI-[HNF7>F76HS79U M":_N=/N+22SGO9;YC>RW)_BY;?"_P#9MU+Q%+JOB#X3_$_P2_B/ MXAZ2BZQ8^*QXN\=:UX[\))XQD\0V?@'Q:^J:SY/[W_ KQ=<_$#X)_"#QW>>$ M-4^'UWXT^%_@#Q7=> ]$_#5AIT.KIK\5C9:!I%I91Z[ M&4,>LQVEO91VZ:M&8HRFI+$+U#&FV<;1CJ?\^O\ .@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** /E;X\?MA_"3]G3XM?LQ?!KXAP^+CXI_:R\=>-_A[\,K MW0-"AU?0K'7O 7P^U/XDZS)XONAJ5M?Z3I\^@Z5<6^G7&FZ9K=>P^S-\5O $>/.\1VMNS*&5+JVU*TD9#T<1W-C%(4)R X7:2& .5('Y!_\ M%)R1_P %)/\ @A3@D?\ &5G[4(R"0<']CCXA C(P<$$@CN"0>#7Z'?&]F'BG M3?G;_D7K,_>8];W42>I[G)/N2:^9XMSVMP[E$LRH4*>(J1Q&'H*G5E*,+5I- M.3O%*Z[]0/;/^%L_#O_H:],_\FO\ Y&H_X6S\._\ H:],_P#)K_Y&KXNW MO_>;_OH_XT;W_O-_WT?\:_+O^(MYG_T*,!_X.Q']=_Z>CT\_N_X/K_3T^T?^ M%L_#O_H:],_\FO\ Y&H_X6S\._\ H:],_P#)K_Y&KXNWO_>;_OH_XT;W_O-_ MWT?\:/\ B+>9_P#0HP'_ (.Q']=_Z>AIY_=_P?7^GI]H_P#"V?AW_P!#7IG_ M )-?_(U3+\4/!#@-'K1E0\K)#I>MS1.",AHY8M,>.12.C(S*>QKXI5WR/F;J M/XCZ_6ON'X=Y;P/X8)+$_P!DVW)9B> 0._8<#T'%?8<&<;8OB?'XK"8C X;" MQP^$>)C.C4JSE*2K4J7*U/2UJC=UK=+N%M+^OX6_S*3_ !3\!Q8,^OQ6P/"M M=V.K6B,>?E1[G3XE=L G:I+ MC )J/_ (6S\._^AKTS_P FO_D:N.^/)9=" MT(*S '67R S8.+"ZP2,XR,G![9/J:_/+XJ?M)_ OX(>(OA[X4^+?Q5\)^ -? M^*>M2Z%X(T_Q'J8LSJ=Y#INKZF]W?W&UK3P[H.S0[^Q3Q-XCGTKP])K?V70T MU)M3NHK:N7B7CS,LFSROE&"RJAC52I4:L9-XAUI*>'C7J/DI)^[3BY-M+2,; MRLKM)?U;4_3[_A;/P[_Z&O3/_)K_ .1J/^%L_#O_ *&O3/\ R:_^1J_-WQ]\ M#O FOVOA3Q=XD\3:NNF:7HOBF]DT>&T\,2RRH M9+[Q%<3Z_HUM%H>D0ZCJ;75^EJ;47,%Y%;-\>?'/X1_"_P 4Z#X)^(?Q'\.> M$/%?B80/I&BZQOP>$[#4-5NK2SN],\+Z/J?BRYM_"FD:[XMOM!T3 M6/%$\?A[2M1O-8W62_/Q\4\[FXJ&0X>;GS6+YO9PJ0G.U^ M6$X2E:,TQZ?U\O/U_J]OTD_X6S\._P#H:],_\FO_ )&H_P"%L_#O_H:],_\ M)K_Y&K\Y_B9\8?AM\'+'2]0^)_C33_!\&N:E=Z1H<%[;:WJ>KZWJ6G:?<:QJ MMIH_AWPYI>M^)-5;1=&M+O6=>FL-(N+7P_H]K/JNMSZ?81FXK>\.>._"'C!; M63PIXKT3Q+#?^%_#?C?3KK0M3@U2QU/P;XQ6_;PKXJTJ_M'EL=5\/Z^-+U : M=JNG7%U:2O:2Q/)'+L1U_P 15SGV:K/(\*J,K\M7GQ?LI6:C+EJ6Y)6DU%V; MM)I.S=@T_KY>?K_5[??R?%/P)*,P:]''C*3I<^'IUIQI\S]_DDZ:3>^KMT!*[2[V*O_"V?AW_T M->F?^37_ ,C4?\+9^'?_ $->F?\ DU_\C5\7L[Y/S-U/\1]?K2;W_O-_WT?\ M:_+?^(MYG_T*<#_X.Q']=_Z>AIW?W?\ !]?Z>GVC_P +9^'?_0UZ9_Y-?_(U M'_"V?AW_ -#7IG_DU_\ (U?%V]_[S?\ ?1_QHWO_ 'F_[Z/^-+_B+>9_]"C M?^#L1_7?^GH:>?W?\'U_IZ?:/_"V?AW_ -#7IG_DU_\ (U/3XJ^ 93B#Q%;7 M+#DK:6NIW;J/[SI;6,K(IZ!G 4G@$GBOBO>_]YO^^C_C7NWP'9FUS7068C^R M+8XW-C/VUL'&>HRSP_XD8_.Q'XG>"AR=6E ]3H^O #ZDZ7@#U)X'4U!_PMGX M=?\ 0UZ9^=U_\C5WUSQ;W!!8$0RD$,P((1B""#D$'H:_.]7? ^9N@_B/I]:^ MAXUXOQ/"TLMCAL'0Q7UY8QS=>=2')]6>%Y>7V>_,L0[WVY5;=BT_I?\ !/M+ M_A;/P[_Z&O3/_)K_ .1J/^%L_#O_ *&O3/\ R:_^1J^+M[_WF_[Z/^-&]_[S M?]]'_&OA?^(MYG_T*,!_X.Q']=_Z>CT\_N_X/K_3T^T?^%L_#O\ Z&O3/_)K M_P"1J/\ A;/P[_Z&O3/_ ":_^1J^+M[_ -YO^^C_ (T;W_O-_P!]'_&C_B+> M9_\ 0HP'_@[$?UW_ *>AIY_=_P 'U_IZ?:2_%?X?.=L?B>QF<_=C@BOIY7]D MAALWE<@9)"(Q !8C )'2Z'XHT3Q&;D:/=O=?8_)^T;[+4+39Y_F>5@WUI;"3 M=Y4F?*W[=OS[=RY^0_AD[_\ "=^'/G;FZN ?F89!T^\!'!Z$<$=QP>*^V\8] M?Q)/\Z_2.#>)*_$^7XG&8C#4<+.AC9X50HRG.,HPP^&K<[<]>9NNXV6EHI[L M04445]> 4444 %%%% !1110 4444 ?B!_P %)_\ E))_P0I_[.M_:@_]8Y^( M-?H9\;_^1ITW_L7K/_TLU"OSS_X*3_\ *23_ ((4_P#9UO[4'_K'/Q!K]#/C M?_R-.F_]B]9_^EFH5^>>)_\ R2U3_L/P7_I

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end GRAPHIC 25 biib-2016630_otherrevenues.jpg begin 644 biib-2016630_otherrevenues.jpg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end GRAPHIC 26 biib-2016630_randdpiechart15.jpg begin 644 biib-2016630_randdpiechart15.jpg M_]C_X 02D9)1@ ! 0 0 ! #_VP!# $! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_ MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P 1" $* 3T# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#^_BBBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\P^ M-OQ&/P>^#?Q8^+(T9_$1^&/PT\>_$,:!'>'3WUP^"?">L>*!HZ7XM;TV3ZF= M*^PK=BSNC;&<3BVG\OR7]/KSCXQ?#JP^+WPF^)WPGU34;W2--^)WP]\;?#S4 M-5TZ&*XO],LO&_A?5?#%WJ%G#.K6\EU96^JR7-LEP# \\4:39C9A0!\!?L\_ M\%(?"WC_ .$WAGXL_%;7?@)+:?$.P\,S^!/"/[(OQ)^(W[8/CE=4NOA['\3/ M'/A[QCX4\"?!C2M?T+4?A]X5U#2-4UN:QTO5K2UL;DW.KR:/)>Z%;:O]A?"O M]J3X'?&[Q?XA\%?"?QI_PG>J^%= \(>)]?U#0-!\2W7A/3M%^(/@;P3\2O = MU)XV.D)X1E?QIX%^(/AOQ/X7LH-9EO\ 6M*?5KFRM9%\/ZY]@\F\1_L:P2>' M_P!G%OAM\5?$_P +_B1^S/X"O_ACX*^)&E^&O!_B*XU+P5XD\"^#O ?C'3-> M\*^)=/N] N+G5K;X?^"_$6EW\ @GT'Q-X6T=F75?#9UKPSK6Y^RA^QI\/?V0 M(OB+I?PUUGQ!>>'/'+_!Z&QT?7C87$GAO3?@U\ /AI^S_H=I#J-I;6LNJSZK MHOPTLO$>LW]Y;PR2Z]J^I"WA@L1;P1@'R-X>_P""OOPBUKQYHNA:C\,/B[X2 M\&R^)_V\O"/B3Q+XD^''Q//B?3-1_8:\;_#7PEK^J>'_ (<:'\/-7\2^+?#/ MBBU\<:QKVJ:MIZQ-\-X?"=]I/B^"+6#?6NF?<'AK]K_]GWQAX\TKX>^%_'4F MNZGKE[IFC:+XBTWPMXQN?AMJWBC6? %K\5=*\$:;\5U\/_\ "M;WQ[?_ VO M;7QS;>![?Q3)XG?PS,FI?V8!NC7YITS_ ()M>%=+^*WBSQ_%\5?%TWA[61^V MM<>'?!4^@^',>%]1_;SUGP-XN^-T_P#PDD(BU#7;2V\;^"O[?\%6>H64,VAV MNMWVAWM_JUE:Z;):X/[._P#P2I^"7[./Q&\">//"]QX?UF7P5;>$]7%SK_P8 M^#FH?$'4_B'X:^#F@?!B[\30_&&]\+7WQ(\/:#KNDZ!%XMN_!GAW6;!-/\87 MNHII'B&S\$WMM4\3^&_$/C+P'; M:7#XQ^'L#WS6GBBYUK0.X\/_ +;7PAG\9>/O OBGQ)HFF^(O#7QG\9_!WPWI M7AVV\?\ B"_\2:_X,M?@VU]X<>.^\ :!;GXC?:?C3X7N3X,\*W7B^UN?#4ES MXFT;Q#J^G^'_ !Q_PB3/VH/V2-3_ &E=-\8^#[WXU^+_ M\+?BIX"/PU^*? MPPF\)_#_ ,?^%]6\/R1Z[:W6N^"8O'>A:K)\//'U]IOB"YTR[\1V:ZYI$L6G M:%J(\*)X@TBWUEO*)_\ @F[X.&OZYXDTOXJ^/](U2/\ :(UC]J?X-?V@=#/P M2\)?&^V^(?ACX//&_@;5+SX)>+OA)H.N^!IM.L-?\&:SK7Q.^ M%'Q=\*?%+POJEY;W7V/QO\./'7P?\*ZYX4>>VN-.6]B,U[!-Y:(WE7_#NCPK MX7\=:O\ $_X/?$_Q1\*?']O\1?#WC?P!JNG^&?"GBC2? >AZ;^RK\*_V2-:^ M'\7A_P 26EQ8:_X]DM-9T?QGI6F7=K=SZ%#J>@ZX >HZ?_ M ,%!_P!DS6?$&F^'-#^)UQKUSJEQ\)K2WU70? ?Q'UOPK'<_'GPA9>-O@G;7 MGB[2_"-UX;T^Y^+.CZC9V?P\M;_4[6Y\6>*;B'P5I,-QXMECT9OD?X3?\%D? M@O\ $>W^&'B_7OAY\2OAG\*/B'^S!\2_VEM1\5^*_!OQ!O?$W@31/AA\'O .I7FF^ =.M/$!\;Z[\7+F]MO!/A[1;.07]WY2W5Y:>C^"O^ M"7/PE\ Z)>>&/"OCOQU:Z#)\4_V$_BC8V^H6FAW5Y;7O["NJ_#[6O"]A\!Z%X(^(7PX3 MXO\ C:Z\)>)?V0_VD_V*O!]O+H'AE-4\$?!_]HGQBGC:26?48P(_%?BKP+J$ MM]8:)J]]8:9!K&DRV::[8W&I6MQJ>H 'W+X&_:B^#7Q(^(NO_#'P7KGB'6]? M\.:MXN\/7VL0?#[XA0_#VY\2^ +V'3?'7A?1_BE=>%H/AOK?B;PAJ%Q'8Z_H M&E>*;O5+.[BO[=;::72-873Z^I_M7? W2/B=??".]\5:DOBW3-7C\+ZE<0>" M_'%WX-L/'$_@T?$.S^'%W\1;3PY-X!M_B9J'@9HO%.G?#R3Q(OB^^T>ZT^>W MTAY-4TR&\\8\"?L,Z3X*_:,L?C^GQ,UJ:[TK_A(IH])T3P)\.? >L^+T\3>$ MH/!W_"-_&+QYX&T#0M=^-'@?P;8VUKJ/PYT#QY;7^M>%],[GXHZ[;:E\&_A+XC\90?$ZX^ M&UG\+GUGPS\9O$?A2^^)OA;PW-HVEZ7KT_A30=:MI8?%MBU_HWB+1="U/6O# M>I '9^'?^"C'[)'BSPM;^+O#WQ$UW5=.U;0_A%XF\'Z?;?"OXL_\)1\2_#_Q MX34S\)]9^$W@]_!"^)_BIIOBZ?0O$5G;WOP_TKQ#;:9=^&O$46MS:8FB7\T/ M#_"#_@I;\"?B#H.HZKXMEU/P)=6WQ=^._@$6L/AWX@>*K+P_X)^$7[1GC[]G M;P]\4_BMJ^G^!K:T^"OAWX@^(_ EX;/_ (6@/#5II6KQZ]H7]J:BOA/Q!J=E MP]A_P2X\'^'G_9ZU[PE\7_&>A>/_ -EW]FS]G3]G_P"#_C*3P[X5U4Z5=?LZ M?\)C8:5XYUC0;V/^S=9G\;^%O'_B[P?XR\-%K.P_L76I;KP]J.AZ]::;K%CR MNG_\$?/@K8^,?^$[OO$MIXT\5^(/%WC+Q-\1_$GQ0^"?P(^*&N^)5\5_'_XD M?M&1?\(M<>-_ VL:;\,-;TSQE\5_&NAG6_"6D"UU+P=J-I97>@)K^A>'?$FD M 'T3J'[>WPZO/VD_@7^SSX"T?5O&3?%GQ]^T-\/-:\,8?".OZUX+A\(?%5M-\7:3>?#SQ./!WBNXB\)>([/4K74)IKW3;FP7 M>^.G[;'P_P#V=?CGX3^&'Q1M?[!\$>(/@5XX^,.I?$I9-7U631=1\._'G]G# MX!^&O"(\(Z'X?U34=07Q9XG_ &B=&D;7(KR*/0_[*Q>6$MC>76I:7Q7@7]@# M0? ?Q<^$OCW3_BMXSNO!'P#^(/[0/C_X.?"BXT3PE%HOA2X_:6T_Q?\ \+$T M>^\2VFG0>)_$FFZ=KOC36-0\$OJ=R+S0=,F.A:E/XBVP:M;3?'C]@7P[^TEX ML^)WB[XK_$[Q9?7/B+X7S?"?X56N@:#X5T6'X.Z!<_$GX7_&FXU2TD>RU.Y\ M=^(Y/BO\&OAOXB%QXI==&72O#+/^"AG[)_@S6?$7AW M6/B'K,^O^%-;^,^@:]HF@?#+XH^*M6LKW]GBV^&%_P#&JX73_#'@W5[N[TCX M>:7\8O .L:]KEG#/I":1JMWJ-K>W5OHFLM9>C>'?VMO@'XM^(=G\-/#7C:76 MM;U+4K?0-*UW3_"_B^X^'.K^+;GP-#\3H? VD?%=-!_X5IJGCX_#N=/&K>"+ M#Q5<>)D\.+/J#Z:HM+R.W^4_#G_!,KPCI/BSQCXYU?XN>-_$7BGX@:-^V99^ M++^XT3PU86]YJ_[:V@_L[:/X_P!6L;*QB6+3;?PM+^SQH\_@[28VFAAMM?O; M'5KK46L+6^GB_9X_X)9?!7]G/XG>#_B+X6F\/:M+X231]=BGUKX,_!Z[^(%[ M\0K+X3Z3\)=6\1K\9+KPO>_$O1_#^MZ?IDOBM_!NAZUIZZ9XKU74[;3?$$7@ M2=? Z 'JG[7/[8'B7]EN^T:]D^'G@3Q'X6U%/#]MI-CKGQOT/P7\7/C!XKUG MQ VCW?PP_9L^$Q\,^(M1^*OQ,T:PGTC6&T'6-8\#V.M3:]HNB:/JDTDVK:IH M67IO[<%W>?$G38;SX;Z;IWP"\1?M/^+_ -CCPW\59?'JR^+[OXX^"9O%'A_4 MIM1^&L7A4Z?I_P /-3^)?@KQ/\*=%UN+Q_>^*Y?%-GIFIW_@NR\,ZQ_:>F]S M^TC^RAJ_[14'BSPIJOQP\<>&_A'\3?"-OX'^)OPRM/#/@+Q!:WN@I]MCU*[^ M'GB;Q#H-YXA^&/B?Q'97B:?KGB#39=<>!=,TC6?"ECX6\66"^(I,>U_8H\/V M7Q3M/%;_ !$\7W?PKTGXX^(_VG_#_P #)=,\-MX:TK]H+Q59ZVFK^+QXK72Y M/%MQX;_X2'Q-XB^(^G^";FZ-E9?$S6[OQ%)JEYI%II'AC3 #Z0^+/BSX@^%? M#%G<_"[X;CXG>,=9\0:)H&FZ1?>*+/P7X7T:WU2>0ZAXL\:^)IK#7=3TSPKX M>L()[J]7PUX5\6^)M1O9-.TG2- N)+^2\L?A3P]^WU\0_B#>0?#[X8? 7P]X MI^.&@M^TM>_$'PC?_&,:)X"BT']E_P")6A_";Q+J/PT^(J?#K5+[QW)\0O'6 MO)X<^'O]L>"?!-A9:OX=\=Z9\0=0\)ZEX2>RU3W_ .*'P'^.?Q0_9H\*?!V/ M]J'Q/X ^*":;X(LOB5\;_!W@?PI#KOCR/1[6-?'>FVVC6;Z!9>"+3XASI):: MEJG@.Z\->(_#^EW%W%X-U7PYJ$MOJ5CY)I/["?B70_#?P]'AOX[M\-_B)\/? M _CWX,:9XQ^#_P %?AGX"\/I\!_B!JGAO6+CX>:=\-[H>*/#NBZIX1U?PKI> MN^ _&ME=M?Z+KIO[C5M*\1:7K&M:+J(!?T3]OK2O&GQ@_8N\#>!/A1XLU/X9 M_ME?#CQ-\1_"_P 9]>U;0M T;3;;3?@YIOQDT'P_I'AFUN-;UWQ3K%UH>H?9 M/%=ZPT'PYX4OQ!I]GK7B?5WO].TB/X"?MI:[\8_CWXJ^&&I6OP&\,^'-/\2? M&KPYX5L;3XK^/=5^,/B&;X/_ ! U?P+=M)X4U+X->'_AK-J2QZ%=^)/&'AGP MI\6_%GB/P!I.I:$=37%OB>*_P!@GQ4?B;^RMXJ^$_Q]D^%O@']CKPM_ MPA_P9^&+?"/P[XVM+30-2^'6G_"CQ19>(/%>L>)[#6-9.J>"].@MM,F%O:7& MC:HTFJ3/K(;[(/>-+_9J\12?%SPG\0_'?QR\=?$/PU\+_&?CCX@?"3P%K.@^ M!],B\)>)O'WAOQAX,O9=;\6:%HEEX@\;:=X6\'^/?%?A?P-8:G]A?3]+U477 MBN\\:^(-.TK6[$ ^L**** "B@D#J<=!SZDX _$\#WHH **** "BBB@ HHHH M**** /B[]N/X_P"J?L_?#+P=J>A>)M.\(:[\0OBEX>^&VE>(-8T/PGJ&D6,V MIZ!XK\271OO$'Q$^(OPP^&O@5I=.\*WD>G^*?'GB&^TE]3-IXC^'VL_&WP%XMU;P1XK\(> M UWP%?_LSV_P =?$ECX[U7 MQ&^N>$=5\)6?A#2/%?\ 0G?Z?8ZI:RV.I6=KJ%E/L\^SOK>&[M9O+D26,2V] MPDD,H26-)$#HVR1$D7#HK"O)HFCS3V=S+I6G27&G75U?:?<26-J\]C>WWF?; M;RSF:(R6MU>>=+]JN;=HY[GS)/.D?>V0#\K/^"DW[:WQ"_9D>ST;X3ZSX>MO M&VG_ 2^,/QQM_#'BSPWX3@TSQW_ ,*O&FC3/"ECXQ\=_%+P''?W&K7LUQ8: MCX$^%OAGQY\4KZWO+#5[27PE91V'_"2\)^W%XK\4?'+PS_P2NOO#W@&?QG;_ M !V_:&L/$7B+X.-\7_$WP@T7Q5I&J?L)?M)_%"'0/$/CKPS:7%_+IWA76M/T MKQ/:6%UI-U::OK/AG2TFM[:4QW-O^REYIFG:@]K)?6%G>264LD]F]U:P7#VD M\MO+:R36S31NUO-);3S6[RPE'>":6%F,4CHTGV&SQ9C[);8TY@U@/L\.+)A; M268:T^3_ $9A:S2VP,'ED6\DD&?*=T(!^!OPM_:7_:\^ ?QW\ ?L@>/#X8U/ M_A$/&_P6\.+/XR\?>"=8NOB'X#_:$\?ZSXBUJ;PQX[^*_P 7O!GQ^^(=I^SA MX&\0:?\ "+P#XA\*_!+QM?\ Q)\4?![Q/>?$J[T>?Q%Y7A)GP)_X*#?M'?$C M2_@MKGQ*^*OP&^#6G_$CX:1?%SP[?>*?AIKMSHWQ8U:+]H#7?@7=? KP*UKX MYM]:N_%.E:+X?TOQUXHNO#MAKOB6/6_BUX#L]$\/GPSX6<5V(Q=1VMRZ&>VCNA%$+E()(UN!'&)@X10(?[& MTC981C3-/$>E3FZTQ!96H33KEDFC:XL4$6VSN#'<7$9FMA%*8YYD+[99 P!_ M/)X@_P""HG[5ME\/OVM/'\7@[X=>&M8^$_PU_:-\7V'PW\6ZG\*[SQ!\*?$' MP=^-WASX:?#S0O$?ACP7\):2=-\6?VJ/VD/"7[7WPQ\*>-OC]IOA/X7_LZ_MC?%;X4_%S6/#?PS MGTKPW\9?"_C3_@GIX<_:M^$GA'Q/X<_X3'7KL^*;+Q)XCU[X<>"='T"]N-7\ M23499-+TYY-76W357>QM7?4TM$\JU34&:$ MM?);1$QVZW1F6"/Y(0B<4MSHND7@F%WI>G70N+VRU&<7%C:S":_TUK=].OI? M,B;S+RP>SM7LKI]UQ:-;6[6\D9@B* '\WL'_ 5K^-]EI_BRVO\ Q+\+IO#F MJ^"_V6?B?HOQBFT;X'];\+^!_B'\7-,\6Z!+J6JP^++GQ9JB^'/#&M=W\+_^"AG[7+^-/@I\/_$E MK\._$.J:OH/P!UR_U.\\:_L\6FC?':Y^._Q8\8Z-X]F\$:Y;_&OP_JUMIOPH M\-66F^&?"GAKX'> ?CW+I/Q&TC5/!WC_ ,:^*X($\27O[5_%;]GCX7?&+2?# MFG>)](U+2KWP7XKG\=^"/%'@/Q%KOP\\9>#/&=UI'B/0+OQ)X;\4^#+_ $;5 MK#4+_1O%WB73=41Y[BQU:TUO4(M4LKPSEEZ#X:_!WX??";PWI7ACP;H9@M-) MU7Q5K\6IZS?ZCXG\37GB/QSK5_XB\:^(]5\5^([K5/$6J:]XKUW4[_4]>U2\ MU*2XU">Y:.4BUC@MX@#X;_;J_:K^(OP)\6>'_"_ACQO\+_@SHTGP'^.OQJM/ MB%\7/#S>)="^)'Q!^$=[X#@\+?L\>&K1?&W@IH/$/C.Q\4ZOXBU%-,GU;QIJ M&B:/Y'@G2C;_ + 5I\3OC!\5?^"BGQ(^//B+7-3N]<^+GP]^$6C? M#'6[/4-%O?@OX$U3]D+]G;XS:A\)+:XTOQ,^GQ'PKKOQPUWP[JMYINAZ%KNH M>*-*USQ=J6J2ZGXBDL-'_7"[T^QU 6XOK.UO!:74%]:BZMX;@6U[;,7MKRW$ MR.(;JW8EH+F+9/"Q+12(234D-M;V[7#P00PO=S?:+IXHHXVN;CR8;?S[AD56 MGF\BW@A\V4O)Y4,4>[9&BJ ?SB_L\^($_9NC^)UOX&\5:3\(++XE?\%*_P!K M+]FK7?VC?C5XD\5_$CP)\#_A)\(=.\<^,_A=X.32_B%\3=)\.:;<:[KGAVR^ M'_@JZU76K+3+:76+JT>#6-:N]!TVXX'X1_\ !0']I>U\8?&_Q1\7/CCI'@W6 M/C;KG[)4/P3^%>N^$?!.E>&O!OA/Q=\#O&OB#Q3\3? %W\7/C+X&T/P;\-?B M'J'P]NM6T7Q?\1=:UW2QK_B#2O!O]D^,OB7K6BZ/+_3;/HVD7-I=V%QI>G3V M-_,]Q>V2>#;?QA\./ MV\?^"B7P/UKQGHVCKJVJZ-9WWCG2?A7X?U6^O=,N;Z*YLAIME:ZOJ>C:?I,P M^(O@WXJ^-OPSN?!_QZTGP!K=QJ^N_M3?\%5=:TKXA:#^T'\7_'OB_P#:CU+X M"_$/]L6Y^'G[&WBOX*ZYX33X<^!)OB-IOA=?^%::YI_B'QTNB6'P&6R\/:-H MWBO7M 6R_J.@T^QMII;BWLK2"XF4I-/#;0Q32H;FYO"LDL:+)(IN[R[NB'9@ M;FYN)R/-GE=V#2]-$<$0L+(1VUW)J%O&MK J6]]++/-+>PH(PL5W)-=7,KW, M86=I;B>1I"\LC, ?@;X._P""AG[3/BCX+ZIXKN/%WP TD'QO^S[I]QXZOO%O M[.T&JPVOQ4\)?$KQ!\0O!'@;1]'_ &F?%WP7L_%GA[4/"?A6?X8+\>_C%\-] M0\1^$]:\3V/B/3&\;:+X5@\97?"'_!3/X^^//BW\'O"WAK0_"$GAW6])_9K@ MBNO%=I\*OA1#\>+_ .*GQ U[P+\9/$?A'2?&7[2>J>/;#2/AY=:!J6C_ _B M^!^A_M%^'/%GB[1+S4+GQOK7@7Q+XXE/F3,[_-5AM)TQY]/NGT^R:YTJ M.:+2[AK6!I].BN(DAN(K"8QF2SCGACCAGCMFB2:%$BE5XU50 ?S=>+/^"MGQ M_P!*NO%-YX#NOASX\T#Q7\-=<^(7P^U76_"WAKP_-X/UKPE^UY^RQ\"CX/\ M%WP_\'?&'X@^.O" \0> _P!H'4]6O?#WQ;N_#7Q/T[7_ V;H:%H#)K7A70N MI_;!_:N^/%S^SC_P4-\'Z]\;_ '@_P >?"CX2_M0?#G1OA-I'A77?!?QSOK; MX7?!FP\5^&_VGM)\1>'O&M_J/A+P_P"/=7U&/Q'I"/HMGX1L/!6L^'O#^C>+ M[CXBVLLGB#^A7_A']"!N&_L;2MUW_&'4]!\37O[)?B7 MPSJ&G>-/!7P_UW3Y-8\(^//@%X=^-T6DS?#W3-?\4:OK>L>$+W4M8T&Q;0]3 M34_%VE0Z-;KIT7B'[5>ZC^8O@_\ X*A?M*>*/&?A;X>:)JWPPUV+XE>+_P!A M>]\+_$Q] \#:K9:7X;_:B^+WQ-^%7Q#\.W7A3X4_&?XC:+I^L>#K;PMX;\2^ M&] UWXAW/C+0[G4+C2?&USJEKJ%AJ$/]&L=K;137%Q%;P13W;1O=31Q1QS7+ MPQ+#$\\J*LDS10JL4;2,S1QJJ(54 #/@\/Z%;"-;?1M*@6*=KJ)8=.LHA'=/ M>2Z@US&$@4).U_-->M,FV1KN62Y9C/(\C '\R'[47[>G[1?CO]E/]LWP7KWQ M5^'OP=\1_"+X(?M)^#?#6NZ9X6UGPWXT_:H^(7PQ_:5_:*_9TU_5_@O-9?$N M/4O >J^!=#^"_A'Q'XBT;PJGC#5-%\7_ !4TR_NYK'P98Z7:ZS^@W[?^H_"J M7]LS_@G_ .%?CWX]L?!GP")= M4U?3O%W@ZWO]5TA=3\17.@6UWJ$LEL]QJ-Y911R))<1?K7+H.B3^7Y^CZ7-Y M,NH31"73[.01S:LLRZI+&'A(274DN)TOY$P]ZLTJW32K(X:'6_#/ASQ(EK%X MAT#1==CLI_M-G'K.DZ?JJ6EP +BV2_MKA8)@%4>;$$DPH&[@4 ?SJ^"_P!O MW]I_X>ZEX4^&V@6=MXL^'.GWWB#Q-\!/'OQ?\:_#73_$/[4WP9\3?M9_%GX; M?"NQG\9_&'XM_#KX@78T3X+^%?"1TWQC\/\ X??&;XC^+KOQK\+?'7BW3-2T M[Q5:?\)W[E\8?^"@W[2'@--5\$Z9H7AVY\1?";XZO^SU^T-XY_L;P=H=GX%F M^(7B[Q?XI^"WQ'MK?XH_$_X<_#71U\4_L_>$_!VK6EGXR^(VE^%AX[^/?@&U MNKZ^6RM/#WB+]QKC2].NYK&YNK&TN;C3)GN-.GGMX9I[">2%[>2:RFE1Y+29 M[>22W>6W:.1X'>%F,;%2EQI6F7<-_;76GV5S;ZJACU.">TMYH=1C-NMJ8[^* M2-H[Q#;(EN4N5E0P(L17RU"@ _G2U#]M+X]6GQ8\#?&'5=<\'^'M6U[]B70[ M+6Y4UZV\9_ _P;IWBO\ X*4>!/@+J'[3/B'1_!?Q(U'P7?6'@KX2:M/\4O%, M?A_X@ZQHFBVT&I>'A\0;KP;87WB.M[QC_P %*OCQH.J^(_"*?&']GS1--\(_ M![]M3Q]X ^.'B#P.UUX)_:D6WQ*TZSCB^(L_Q;\6_ M";Q'%X6\1ZU<:SXY^'NNZG\-+>!KN'1M$_H/.EZ:>MA9G_03IF3:P$_V?L1(&;3/V#]-D\?>$/ &N?"[PUK7F7 MJ6^C^!?$7BGP9XTU70K30DN5\.JLGB?X>^#M6M-0;2FU72I=$@ATJ^LK:XO( M;@ _'/PI^W#^UQ\3?BMX=\$:=J7PY^%]K\3/VI/VGOV6-.T?7/AG=>+O$GPN MU'X3?LN+^TWX>\4ZO.M L?%7B'0]1T?7?A3XF\,2VVDZ3JD5U%XGAU'3= M1TEM,U+E_P!E_P#X*??M*_M"_$;X#KJG@+P%X-T7XEZ/^S=-<>"+K7OA;HMW MXG\*?&3]F_P=\8O&GQ?\&Q>)?CFLT3/I]K+ M'$KVUB[00L]G"T=LS11LT1,:%0#^8/QW^WG^V;\0_P!G3X&:K?\ QN\%?"#7 M?B]\ ?\ @G)^VKK'Q!\"?#Z/1K/X8^"OB'^V#\%?@_\ '/P?KUUXB\:W=CJ? MPY7PEXY7Q]XH\0:G+H$.G^'M \9^&]9N!X1\0"?P_P#U Z5=V]_IFGWUIJ%K MJUK>65I=6VJ6,D,MEJ5O<6\H7Z1'I(UG9S7*QGD<.T04\C@]1UK5JI?V4&I6-YI]TK/ M;7UK<6=PJL49H+J%X)E5U^9&,+KG MP]\+I/VI?$'QI_9X\*_'[2H/#OB&U^&^F?"CXC_$;]G2WUCQ[X/TB3QA=Z]I M9\<_#C]J7X(-X$;4M;URWT7Q1XZF:]CUV#P[=65QU_AW_@KIHGA?QGXPN/BK MJ&AM\,+;P/X;M? 4U]HOA3X1^+?$OQC\2_MO_MH_LV#PYJ6L>,?C!J7PQ\,^ M$M,\)?LTV^MR>)/$OC+1K3[!H_B'Q;J-QIVH:]I?P_TW[N3_ ()W?LKQ6AMH M/ E_!,_@']E7X:3ZC#XIU]-1N?"G[&GC[2OB3\#;6>X^UF,WVD>)="T(^)-7 M2"/4_&FE:)HFB^)+F]TW1M*@M,NP_P"";W[,.D-J-WHFA^,M#URZMK$:3XHT MCX@>);'Q/X1U?2OCI\:?VBM)\3>#]9AN5N= \1:?\2_V@/BC.+Z#S8-0\+>( M[CP-K-GJ?A%KC2+D \^L?^"I?P/UN;X)IX:\+>+]=MOC5!JSZ3JJ^)O@MHN@ MP7OA[XKZK\%_$N@^&?$GB7XK:-X:^,OB?P_XST:]O[[P[\#M:^(>HWG@5M(\ M;Z''J^E>*_!L?B/F/@S_ ,%)?%/CVP\3:/XD_9F^(+_%N3]I[]KOX*?#/X3^ M ?$?PPUG6_&W@+]DSQS>>%O&OQ*N-<\0_$30O">@IHQ?P]H6LZ9JNOV5WJGC M;Q-HMAX2L=2T"^?7+'Z0\>?L*_!?XE>%=+\#^,];^-6N>$%\,77@OQKX&++ M5[3PA#:^'K?-U3]@+X"W>M^)/$6E7?Q1\%ZQX@^)OC;XM6.I>!?BOXQ\(:CX M/\8_%BVN(/C0_@?4](OH=3\-Z)\9;BY;6_B%X:MKV;0=0\5V^F^,=&L-"\5: M/I&L6(!XYH/_ 5@_9X\1WL&J:?X<^)*?"4>*?@CX1U;XWW^G^%-/\!:#JO[ M1/P-\&_';X4G4K"Y\6IXY>#5-!\:6'AS7_[,\*:C<>$/%D+VGB""UTV5-37U MG]C_ /X*!_ W]M*Z\06/PLN)4OM%\'^"?B-!:2>*?AIXO>]\ _$275X?"FKZ MA-\+_'7CVT\&^(99=$NUUSX<^.+GP]\0/#(GTZ36/#\,=\CQW[?_ ()\?LL6 M6F7V@:?X DL/#-]\3/@#\5'\+P:_JS^'8?$'[,_@/P+\,OA1IT.E7<]U#_PB MVE>#/AWX9T36/#4YGT[Q+%#?2:VMW-J=Z\WKGP/_ &=O ?P TZ[TGP3K/Q%U M+27T[0?#FA:;X[^)GC+Q[IW@[PAX42[A\+>#/!MGXHU:_MM!T+0X;V>W@:&. M;7-1MTL;;7=:U>#2-(CL #XI^)7_ 5O_9Y^$WB;XN^%?&GA_P 7P:S\*_ G MQ?\ B$NC^'_$7P@\:>)/%&B? GQ!X;T#XC6L?A7P;\3-?U[P5KMLGBG3-=\/ MZ#\2+/PGJFO:+'?*;73=>M&T%_0+[_@H5H,GC/Q;\&=#^"?Q=U']H/P5K7Q" ML?%GPBAE^$]WK'A/PKX"^'_PN^),_P 4-6UN+XIQ^#K[P9J?AKXX?"4Z/IVC M>)K[QGJ&N^*Y/#9\.6][H/B"XTZ/6_\ @ES^R7XBT:[\+:OHWQ"OO"RZ-\8_ M#'AKPI/\6?'$WA[P#X6^/,]CJ'Q1\-> ](FU26U\.:5XAU>Q@U<")+B^TNX" M6FF7UKHT%GI5MZGXN_8>^ WB_P"(GC3XMSP>-] ^(?C[Q='XK\5^+O!OQ&\5 M>$-7U**;X7_#OX.Z_P"$'O=!U"SEB\"^+/ WPJ\!V?B7PK&XL[O6O#FF>*[) M]-\465IJUN ><_"/]MM;C]DW_@GC\:_BYH%Q=>-?VU](_9?\-7%OX TZ"T\/ M:%\3/C[\)I?B!7Z;_ M ,%;/@QJ^BZWXGT[X4_&NX\+^"/AT?C%\4?$*Z=X!%C\-/A-:_M"?'G]G'6O M'6O03^/;>_U>TT#Q7^S]XN\3ZCH?A&UU_P 2R^![BTU73])O-3MK_18/KO4? MV1?@I?? ?X2?LZP:7KFC> _@5:?"N#X/76A>*=8TCQC\/[OX+V=AIOP[UCPY MXOM9UUB#5]#TRQ72YKN5YTU;2[S4M,U>"]L-3O;:;Y/T7_@E!\!-%^)^IZW9 MZGXJMO@O=? _P1\&S\%+#Q7XSL].URV\/?M$?'[]HGQ5%\0_$$7B@S?$+P;X MS\4?&][2_P#!FOZ?)Y=GH5YI]]K.IZ)XGUG1YP#R7X._\%3?$#>(OBE+^T/\ M*?%/@?14^+'[:NE>!-/T'3_ FH:9X#^"7_!/_P =>'OA]\>OB=\1/&6G_%;7 MKK6IK.3Q$GB:ZL+#POH=Z[:=<^&? VB>,6N-(UC5_H*Z_P""D_A+3=<\%> ] M9^ ?QVT7XM?$KQ3\,="\ _"C4H_A5_PD_B'1/C5\.?CO\1/A?XV?4K#XG:AX M1T;PYK$?[.WQ'\+>(H]9\166M>"/%.FPP>(=,BT>\L=8O/5O#W[&G[+,WB?5 MM3L-"M_$^H:+JO[7&F^*-#O_ !9<^(M+2[_;C\6^%_BK^T-X>\5: UW-"(O% M^HZ7H-]I^BZG%"V@^'[S[+I,,>F:F&DP/#_[%W[+?@#Q7X(U:^U?Q1J_C[X6 M:_X8^+_A?6_B-\9O$WBSQ?H_A_X1^!/B?\)_!=C<7?BK7;O49_A;\._#/QP^ M(-E:6%VC:5'X@\5WGB?Q'J6I^+;Z?5KH \]_9B_X*$7G[4?[36L?"SP;\'=? MTGX/V_[+GP[^.MA\3-=USPE%K=IXR\2_&'XV_![Q9\._$/A73O%&IW,$GACQ M;\&/$OAA-2T6+5K"?7_#?B&]_M.;PQJ/A#5]9_3*OC#X*?LM:/X!\4>&T33OB'J>K:5XY^'WC?XF>/OC#91>*]*N;J\L?$^F>'? MB-\5?'WB/P'K$<4$^@R^*]2L;/4;C3)X[-?L>ZFF@A,D%I->R!E M[=[:.1@ MQ +!KN>VA 0?,P,H8@856.!0!8HK"@UPOJ5MI=YIE]IUQ>6MY=VKW$FGS0S+ M826:7,8:ROKIXY5%]#(BR(B.@D*ON3:=V@ HHHH **** "BBB@ HHHH **** M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_(G_@HEXV_;.\._ M$[X=Z5\#)M=\._#"]^%/Q"OM.\5>$-"^*7B74)_VCH/$7AFV^'^D>+](^%/P M.^.&J:KX6L?#$VKZKIO@[Q1#\/? 7CV^FUG3O$GC:WN-(TA;;]=J0@'J,]1^ M!ZCZ' R.AP,T ?S_ /[67Q^_;(^"W@K]L+Q>FO?%;1?#/AW0_"6K?L]>--*\ M(6,VF#Q9_P +X^ ?@W]I/P]=6NO:5/<-I6C:WKT>F?LJ6VOF;_A._ WB/XM0 M6]QXGT[PUH&L/R?Q2^)'_!073?$WB+2?AQX@^.MQ^S7;>-OC;;_!OXF^.OA_ M\8M-^->K^-;#PE\"CX'T+QKX<\ ?LL_$+XB:C\.O#_Q1U;]H&/X?V7COP+X. M\/?%"P\,V'AWQ7XYFT&W\$OXI_H.\3^%/"_C71;OPWXR\-Z#XM\.W[6CWV@^ M)M'T[7M%O7L+ZUU2P>[TK5;:[L+EK+4[&RU&S:>W+?V^=,^)_BCQ4NO\ QEG>S_;@^'?P-T_PEH?P MS35/A9!\#_'O[ GPR\2_$+XF:-X9U/0_[0UOP_X3_:;O=>U3POX@U+QQ%HVA M^)=*NOAQJ7B5+6_\40W_ (79?&']OB'X>:'H.F/^T#XA\*V7Q#^&TOQU^,OB MC2/CCX8N[K1K_P"%?Q83Q#I'@/05_8J7]HWX6:EJOQE\,?#[4/BEHG@SP'\< MO GPQTGQGH/ASP9\3?#>AS>,AHO](&!T[>G..F,8]/;I[4;1Z>F/;'3'IC)P M!TR?6@#\+1\2?VV/#GQ"_9CU+QMJWQS^(>IZEX(_9U@UWX>?#;X9^/?AEH^K M:IJ_Q&U_3/BGXHUG5/$7[/\ XP^''BBZU3P!J/AJ_P#BMX*^-/B+]E[Q+\)[ M7P?J6O\ P\U'P[J?C6WM]+_1K1M:\?VW[/?QDU3X#7'Q%^+/Q3L/%W[0\/P^ MLOVF[?4OAG-<^/;/XD>,;/3O#*W>I_#_ ,*7*_!;PQK2?V3\+/$,/A[4K/Q3 M\*M*\-:GI_BSQ5::K#XOO_KC:OH/RXXZ9'0X[9Z=J7_/^?\ /':@#\.O^">@ M^)W[.OQ2_;HM?C3\ ?BGX!TGXB?M3?LQV/ASQ?#!K'QHU?XH_$/XC?LX_ ;X M?>+_ (BZWJOP[\&R6=WI%YXVL;GQ9\4/BP1!\.? 5_JFO>'M9U#P]I7@&^^R M>07?P6_:5^(__!0'3_$_[0W[/VO^$]&^(7[*O[6^@>.OC;X.^(>G?$CPOX(\ M+>&?VA?V6?B#\!/ ^A6.F^"K9KNPT73?AI;R2?"O4H!K?Q5UGQG\8_%$^FW& ME0ZOI]M_1'CZ]<]3V_'I[=#W')I7Q5%XJ\3Z?J=GK?@?P+=1R^/_ ?A6XO(+>V\":5:Z9XG\?^ M-?#>M_"_0[>+7_#GQ"NO$E_9O/\ #VP\/+!^LM9NIZMI6BV[7FJWUK86Z@_O M;F58]V,#;&A.^5SD )$CN<@ %[ MM-#M)(9+F*WDN!<36]Y=^3:K,L\F+%6>-6"$'Y@ >X^( (M:\'7>D>"O#$%K?6>H M61M]-O\ 6M0MKBQF>6(M>:EJ"6<^\,8I@=*C5HBPC$;-O'@7QE_;[_:K\)_" MGXA^)] ^)-G8ZUH7A;4M3TJZ/@?P3=):WD!B\F3[-=Z'/!.J;V CN$E1AC>& M(S7;EN!K9IF. RS#RIPQ&8XW"8"A.LY1HQK8S$4\/2E5E"%2<:<9U(NI*%.< ME!-QA)VB^/,,;2RW 8[,:\:DJ&7X/%8ZM&DHRJRHX2A4Q%2-*,Y0A*I*%.2@ MI3A%R:4IQ5Y+^C6BOX?M(_X+3_\ !0W2[Z.ZN_BSX2\1P1R1L^F:]\)? 2V, MR1R!VB=_#^F>']119E!BD>+4(Y!&OW',?HV M>)6"I.IAJ>1YO)*_LLNS1TZKVT7]J8;+*[G3- MU3Q=J7P3\;:G/!9VWAOXO6MMH6G7M[.TBI!IGCFPNM1\%7!D*HL,>H:QH]Y+ M)*D269D(6OU0M;NVOK>"[L[B"ZM;J&.YM;FVECGM[FWF19(9[>>)GBG@EC=7 MCFB=XY$8,C,I!K\&K-.CB:5] M/:X>I5IM[29^M9)Q%D7$>&6,R+-L#FF'T4Y8/$4ZLJ,FKJ&(I)^UP]6VOLJ\ M*=1+5QL6**@NKJVLK>:[O+B"TM;>-I9[FYEC@@AC7[TDLLK+'&B]V=@!W-4( M->T6ZFCM[?5+&>>5BL<,5S$\CL 6(5%8DD $D = 3VKQ#VCY5D_;(\!Z?^UC MX\_95\1:+J_AN_\ !/P(T#XZ)\2=6O=(A\$:Y87FJ^(;?Q7X3LB;D:K;>)/! M&@:3IGC#54NK86E]X=UI[K399&T/6%@\R^ __!2K]GOXN?"+PG\5?&>I2? F M7Q?XP^+WAFR\%_$V]LU\2:5IOPD^,'BCX/7_ (Q\4-H8U#3?"7A+5=:\.1SQ MZ]XEN]*T;1Y]5MM UC5+?7;>ZM$SOVA/^"?UI\>OB9XK^(-U\5;_ ,(-XI\1 M_L]W,MGI'AFTNK\^!OAMI?Q<\"?&OX=W6I7FJ!;C1?V@O@_\9O%WPYU2ZM[. MUN/"326/B:TCU?5-+TU+7YF^+W_!)#Q1\4_AU\8_A$_[1]O:_#[XRI^V0UYX M9U#P)XPGTKX?:Q^U+\>?C-\;=-\:^ M"\,_&3P?X*M(\4:IXV M^)OQ3^%OBW6=)UO3(=$^$>O?"/X3?%SXK>*S\0KR_>W@TUK.R^#?B;1[JR6< M7NGW$EKJM[%'H;?;G[]OVM_V 8I/&NG>#V1?&6H>$U/B*R\/SZ1_IE?"/BC_@DSX*^ M(\/AKP_\4/B'-XF\$VG[9/[6'[5OBWP[I6AZMX6NO%T'[2_PP^*OP_L_ DVM M:7XN^TQ'P)>_$73O$IUB_BU?3/$\_A.QL-0\,V]M.#;='\+/^";=_P"#/COI M_P :?&?Q3T;XC75Y\2-%^.WC9=4T'XJ66JZQ\==-^$NA_"?4/%WAO1[7X\+\ M&/#&GZO'X?M?%5N+GX,:]XM\-WNI>(?#6B>*T\.7VEQZ& ?0?P-_X*#_ +*O MQ_\ A]\!OB%X.^)%KI%M^T;X7T+Q7\-_#'C*TN/#OC)]/\2:D^@Z+!XAT:1; MF'P]<:MXGBN/">A7.H7Z:-XJ\46MQH?@[5O$5Z@1KEM^W)\#]=_:1^'W[-'@ M;Q!8>/O%GC2R^/I?L^GP!;^+M'UDEUEU"[;5?'B>'WN- M":_L=&\1>']>\/ZW<6FM6-Q80?"OPO\ ^"0]QX U#X6Q:O\ %CPOXS\.> / MO[-WP@U?2]4\*_&?2X?$OPQ_9#UR^O?@@Q\/>&OVDM"^'TOC>?1KY;+QY?\ MC;P;X_\ "-QXHL;'QSX*\(^$KHZAH=]]"?!S]@3Q-\*?BO\ L^^*I_C%I?B# MX=?LM>'?VF_!/PA\(#X=W6G^,;OP?^T=K'@O7Y(OB+X^N/'.K6OB;Q)X*N?! M]MI5IKND>%/#,'B;3II-1U[37UZ5[V, ^I=1_:W_ &;-)\;ZS\-]2^,_@2S\ M<>'Y_%]GK7AJXU@1ZGIVI> _!L/Q%\6:1/X[?#EF^)MS%;^!)/[>C6U\2+=:_#X3 MTZ_T^\:);,:+K7BVYMO"7A_Q!=7%MH7B+Q5<0>&M!U+4M%8_$GC+7M0OOV+_A?^S[ MX(\42^+-(^(5A!HWA#3_ !9'XOU7Q#X$U?PG'XKUR7PEIUA#XBTKPKXCF2;T M>_\ ^";&K?\ "(Z-\.=#^,UAI?@3Q5^S#^RY^RW\?+*Y^'EYJ.N^*O"'[+5W MK]SXYUD M ]C\8_\ !1[]E_P?\8M!^$\_Q"\.:A!/H?QVU?QQX[LM?TT^$_AI-\!=7^%W MAOQ-IGB:Y<^;=W%UXK^*6F^$5N-"_M&STKQ9I.L>&M8FMM=M)M/@]D\6_M?_ M +,G@2;5[?Q=\;?A[X?N= ^(.I_"[7+;4M>BM[C2/'&A^&O#7C+Q#HVIP%&E ML4\,^$_&/A;Q)XHUBY2/0/#&AZ]IFI^(-6TRTNHY3^>?C/\ X)-:KX[\,>&_ MAIK?QZL8OAA\+?A1^U!\(/@YI]A\,+E?&>CZ!^T'XQ^&'Q$T#5/B%XKN_B)= M6OCK6_AKXI^%?AZRDGTO1/!D7COPX;_^VQ9>(]0.N6G>>&O^">7Q<\(?$/X@ M?&WP_P#M$>#8?C%\6/%7QRO/&^H:I\#KG7?A]:>#_P!H3P1^R]X?\7:+X2\ MZC\4BMKKWA/Q#^S!X>UOP5K7BG6_%>DW^C:[J7ACQ_X<\601VU]" >Z>'/\ M@I%^R1K^J_'#1KKXDCPK>? +XWZI^S_XQ7Q;HVK:2=8\>Z)X-TSQYK+^!X(; M2^O/%WA_1_#=_=ZCK.L:9:LFAZ=H6M>(-;@T[PK'INOZG].^!_C3\*?B5XB\ M3>%/ 'C[PSXQUWPAX?\ A_XK\0V?AW48]52P\-?%72-1U[X=:\+ZU$FG7FD^ M,M%TG4-4T&^T^\N[>^L;9[A)!&T9?\^_''_!/#QAJ?CWXK^*/!?Q0^'MGI/Q M ^.K?M$Z#%XO^&WQ$'C_ ,$>/_$7P5\"? SQW%X<^+_P<^.WP7^(/A;3-2\- M_#K1=1TAO >K>$9WBUCQ3X0\7P^*?#M[H\FB?;'P(^'?Q?\ ACHMCX/^(GQC MM/C%X<\,_#KX4^$/"VN:IX(FT#XE:AXD\*>'KW2_B-XT^(?BF+Q;J^C>*[KQ M[J@T?5-'L=,\,>')O"L-E?VVK:KXSO\ 5&UB ]\HHHH **** "BBB@ HHHH M **** "BBB@ HHHH ***1F"@LQ"JH)9B< Q/CVQ7B?[0__ "0KXL_]B/J_\X*^ MR_C[X?\ [!^)NN/&FRUUY+7Q#;8&%+:A&8[]5QQ\FI6UVQ_ZZ#ZGXT_:'_Y( M5\6?^Q'U?^<%?1<(?\E;PK_V4F1?^K3"'@<5_P#)+<3?]D]G?_JLQ1^$C=3] M3_.DI6ZGZG^=)7^LL=EZ+\C_ "V$(#!E8!E8%65@&5E/!5E((92."I!!'!!K M[H_9'_X*'_M+?L=:II]OX!\87/B7X:Q7,;ZK\'O&EY>:IX&N[1I ]TN@+(TU M]X%U.9]*M3<*U*5ITYPDDUZ.59OF>1XVCF.48_%9=CJ#O2Q.$ MJRHU$KIN$G%VJ4IV2J4:BG2JQO"I"46T_P"[/]CO]OOX*?M[1V5OX=O?^$,\ M6^%-/MM?\5_!;Q-J-FWBJ75H)8BNJZ;)"L$'B[P%X?N)+:6+7--@B\[6I[$: MWIFBR6,-K=_I( !Z_B2?YFO\U'P3XW\8_#;Q7H7CKX?^)];\&>,O#-ZNH^'_ M !/X=OY=-UC2;T(T;2VEU%D%)X7DMKRTN(Y[#4;.6:QU&UN[*>>WD_M&_P"" M7_\ P4HTC]M#PA/X!^(8T_P_^T5X#T>WNO$MC:)'9Z-\1- B>.R/C[PI9AR; M*1+E[>#Q?X<0-'H.HWEK=Z?))HFIVB6?\,>,/@96X-IUN).&/;XWAE23QN$J MR=;&Y(ZDE&,G.W-BLMYY1A'$3;Q&'YH1Q+JQ4L5+^U/";QII<75*/#W$GL<) MQ&XN.$Q=.*I83.?9QO**IKW<-F'+&525&-J&(M.6'5)\N&CTG[9UUX[E^(]G MX7^"_P ?OB1;_M+>(]%\"7'P2^$/@[6]/TCX;_"C1]/\:>7X^^/O[16BQ1W- MAXG^$VHV4TNAZRGQ-6Y@UB/0HO WP*T-OBKK%SJI\G\ _&7XE_\ "U?A!\1) M_BIXQUCQQ\5/V_?VLOV:?BA\"-4\9://X*\%_ KX2Q?M"-X1N-,^'BQ+9^$] M<^'WA#X6?!SXH:KX^TR.W\0>*;;XJ:A'XLU?7-!\7^";71OTD\=?LK_LP_%' MQ7+X\^)G[./P&^(OCB:TT>QF\9>.OA!\/O%WBJ6R\.R7U#5Y M+70I;^_DT:W>\:+2Y+V\>Q2!KF(/#L4<$46@:WXG73AKFK:+%';6\<>E7]_<6")!"BP!88@G\X MG]!GP?\ M0?$+Q[IO[1?_!-[Q/X#^.YLO@Y\6/VB[GP/KOP^\(CP\?#_ ,2- M%U;]E#]JWXBP^(_$OC2*[U*^\4>&5U/P5X&NO!^A: VBZ%;ZK8W6O:O>>+)[ MG0(/#?AR_&_XJ? ;XYWGA3XU_$_Q-XQ\#:!JX\8^.M3\%7EYKID\0V$/C+Q" M]C=0ZN/#$8=2\+W,?AOPMH45W=1Z/X>T9;+2=,CN;A+*T@6:0-ZY=_#GX?Z@5-]X' M\(7A3Q5;>.4-UX:T6Y*^-;.VM[.S\7J9K)]OB>UM+2UM;;7AC58;:VMX([M8 MH8T4 [)2"."2 2N3URI*GK[@\]^M+110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %> _&3QJUO&?".FS8FN8DEUJ:-CNBMG^:+ M3@5(*/=+B:YY!%KLB(*W+8]E\0ZS;^']%U'6+G!CL;:258RVWSI\;;>W4_WI MYVCB7&3E\XXKX2O;VYU&\NK^\D,UW>SRW-Q(227FF8NQ&>BKD(B]$C5$'"B@ M"K1110 4444 ?)O[5/A_SM)\,>*(DR^GWMSH=ZX'(MM2C-Y9%CZ)>6=Q&,G@ MW.!RW'YB_M#_ /)"OBS_ -B/J_\ ."OVJ^*_A\^)_AYXKTJ--]U_9!Q7_P DMQ-_V3V=_P#JLQ1^$C=3]3_.DI6ZGZG^=)7^ MLL=EZ+\C_+8****8!7=?#'XE>-O@Y\0?"'Q2^'.N3^'/''@77+/Q!X#C5A&I2K4:L'"K2JTYIQG3J0E*$X23C*+<9)IM&E&M5P]:EB,/5J M4:]"I"M1K4IRIU:56E)3IU:3I M^E?$BR2>7X?ZXBR.L,=SJ\SW7@BY8%'NVUO15=G&G6Z#^TP'(S_G\??UK_,S MQ=X$_P!0.,<7EF&C/^Q\=!9GDLY.4W'!8BI9UT?Z->%/&_P#KUPEA,QQ$H?VM@IO+LZGI^DVLMU:V45SJ5[:V%O)>7LRV]G:)/=RPQ-1@ MITJ_+O\ :VT#PQ#^U-\+O&W[1GPVO_BS^S!;_L]_%?P?HNB1?!SQ-\/OA;9ZOX3\ >)+GPP\=K)8^,/"%KK^D:A MX[M=,\0@'Z=75]964:RWEW;6D3W%K:I)=3Q6\;75]O_M,/XY\ M>_!S_@BS8^%_#?\ 96M^/_!?AO7?@M_P44UCQ%\7TO;B'PMXL\-V?Q$_9[^$ M%U\*]=\7W_BWQ;/)?ZAJWC#Q;?MXOT(NVB?2?Q!^-_\ P4=\/W>I^!-)U;XB M0>$? 7Q,_;%\ ^ ?BUXB\(>-T\7_ ! \8^"_B!X%'[-T'CBS^%?[(GQR3Q[X M;D\#>(/$CZ9IMAX8^%FA?&==)NK6\^(W]O:#--<@']&^1G&1GTSS1D>HY( Y M')(R!]2.1[5\*_LCZE\>/%'Q'_:[UGXT^(_&4FG^#_VC=6^&?PG\*7N@VGA_ MP+'\.K'X4?!'Q9-XF\)M/X>LM?\ %%K>^/\ Q/X^TG3/$M[KVJ6,.D::FA11 M?VKIFKWUS^1FF_&3_@I_;_"C]ES7-7\2?$"SU[XH_LT:=\1;S7?%/@CQM87D M'[5E_KMMHJ_"_P 6?#[X7?LG?&O5[CPCX:\%Z5HNM)\-?$]Q\';GQYJ?B_Q_ MKDWQ(^U>'+;_ (0L _I=R,XR,CDC/(!Z'%&Y<9W#'KD8].O3KQ7X(?%[XY_M MX>#_ (G?M/:/\'Y/BW\7O'K:+\>%^%/AF+X^(/! MWBC]FM](\2:9H-MIGB+3/AM\2OAG^T+\1-7^/'CC5_#>GZ_\%Y[6ZU#0/!%& M/XU_M?W7PS\-:1/XH^,$NC^./C?XGT+P+\3- TWXM3R:#H&D_"[P;=V7ASXH M>--3_8"\.?%#Q--XG^*>MZQ-\.KCPI\ ? _A-Y]&\2_#[Q=\5M1;PUIWASQ& M ?OZ649R0, M:W5S-%#=/9W:6\LB+'.UM<+$SM!*$_G3^%?QT_X*-^//A]=?$/XL7OQL^']K M:^&/^">5G\5--\+_ FMK+6?A_X=^+WPK\-ZA^V-\1? OA:;X<:[KOB3QEX+ M\7:5]A?2M*TS7(?A18^)O'?B"+PU=ZCI.C1Z(SQ;<_M0^%/B9^T/^TG\(/$7 M[2&NZQX9_9P_X)QQ^#+KQ/\ !BQT35_V@-.T_P#;(_:_\.>)=!^)'A67P!]N MOSI?P:\86VHZW8^%=/\ A_XKL](\0>'_ (E:_I/A'5]0T^UT\ _HYHIJ$D.4:>: M63T+VZGL#7S;7I_Q?OVO/&][#O#QZ=9V%C'@YV'R/MDJGH WFW;!L>@YR"!Y MA0 4444 %%%% !Q_$H=?XD/(=?XD/LPRI]C7X@?MA^'SX6^'OQ_T#:5BTWP_ MXCCMA]*_;^ORP_X*4^'_L/PW^('B*)-L6O_##5 MK6X8#@ZAHDMO#DXZO)I]U9Y)R3Y)[#CZ+A#_ )*WA7_LI,B_]6F$/ XK_P"2 M6XF_[)[._P#U68H_F';J?J?YTE*W4_4_SI ">@)^G-?ZRK9>B_(_RV"BNH\' M^!_&GQ"U6/0O /A'Q-XVUF618ETSPEH6I^(;Q9'.%$\>E6UT+4'GY[MH(P 2 MS@#-?HY\)/\ @DM^TWX]^S7WCU_"WP6T6;8\B^*;[_A(O%OE-@D1^$_#$US' M;3E3\L>L:]I;*W$D8P5KX?C'Q-\/_#Z@Z_&?%^1HJ60Y'F.9^]R2K8?#S6$I2O:U?'5/9X/#^ MM>O36^I^78!/ &3Z"MWPUX7\3>,]5AT+P=X&-&U'7]3>1S MA5-EI5M=W"9/\4J(@ )9@H)']+WPG_X))_LQ^ VM[[QY-XM^,^K1%7:+Q/?+ MX:\)^:N"0/"WA:6WGNX=P.(]6U_449<+)$W.?T=\&^"/!?P[TB/0/A_X1\,^ M!]$B4(FE>$M#TWP_9%0-H\Z+3+>V-T^.LMVT\S$DO(Q))_D#CCZ?' N5^UPW M G#.<<68F-XPS'-)KAS)VW\-6C"I1QN;XF*WE0Q&7Y5*2T5:+=U^YQ_-!\%?\ @EI^ MUMXOO]'\1ZU#HGP(@L+VPU?3M7\::E]L\6Z??6%U#?:=J%EX.\-M?ZA#=V=W M!!=0)K.H:&RRQ)YA3G']N_@G4+W5?"'AG4-3N[>_U2ZT/3)-4O;2U-E:W6JB MTB34Y[>S,L[6L$U^ES)%;--,UNC"$RR%-[?!X ' &!Z"OKOX*7[7?@S[,\@9 MM,U2]M50$[HX9?*O8PV>Q:ZD"X)&T8Z@@?RQC/I"<;>,W$]"CQ;3R3!X+!8+ M'5,GR_)JE*GAU5E&? M+4JU%&/+ZXS!59CG"J6..N ,G'3FOGKX:_M-?#/XD:;\=M;CNKKP9H'[._Q= M\?\ P>^(GB#Q[<:%X=T*UUCX;Z5X=UGQ'XB@U9M9N+&W\(1V/B6SDBU;69M) MGC%O>O>V5I%%')+]".NY'4'&Y67/ID$9K\E!^Q_^UWH4/[8WP[\!?$?X)>%_ MA[^TW\;?BA\;M"^(4ECXWU3XG^"[_P $[JTN+OP/=Z% MJ'BC2/%>F>(]"TGQ(?%'A(V?BSP]IHN/7/OCZSU?]O#]DG2?%7P \'I\=OAU MK6J_M.?$'Q1\+?@[+X:\4:+XBTOQ/XX\'^%[KQ5KF@G5-*O[BTL;V"UBL-*@ MM[IUN+OQ'X@\,:#;P/?^(--2?W3X?_?%=_$$-4.B>*D M\$>+] \5/X;U@-.G]F:X-#U"^.EWQ>UND6WO/*D=[6Z1 SVTZQ_D=HG_ 3# M^+>D>--1^**?%C1/^$HUG]IC3?CM/X>O/&'QN\90:/HOB[]B7Q%^Q1\5O#NF M?%+XF^)/'/Q*OO%5CX?\2'XB> ?&&J,-.D\0:%I_A_4?"GA_1KB&XT;Z4_85 M_89U/]D^>2;Q%XBL?%5YX;^#_P -OV?O"&NQ>._V@O%^I:I\/_A;/J4VD:IJ MFE?%_P"*?C;PKX .I/>Q7)=5TO5K/1M# /:?C/^ MWA^R1\!?!GQJ\;?$'X\_#6WM/V>M!N?$/QG^'_ -I+]GOQ9XGM?!7A MCXX?"7Q#XPOM!A\46?A;1OB'X3U+Q#<^';C1(/$L&M0Z/:ZM)?OITOARZM?$ M"W(@V?V%=6VL-C39X[IOS5^(O_!-3XH_$G3?VD/AU%\5_!GPQ^$_QI^&W[5/ M@^/0_ VG?$S7=)U3Q#^T=KD'BW1O%=U\-_B%XW\2^$?A'>^"?%T4_B;QW#\" M]7\-:5\=O$6JZIKGB/0_"DLEI9V?EGQ[_P""?O[6?Q$AUCXL>,?%?@GXJ^-? M!WQ ^)OQT\/?"7PGXI^*F@^&_'!\=_LZ_%OX-W7[.FG^#]>\9^#?@5I>FV<7 MQ!AL;+XPZ]X/M?'_ ,0;%)8O&^L>%KR?4-7U( _5#3?VS/V4=8T#Q7XOTW]H M;X07?@GP3JWA_P /^)O'\?CO01\.]-\1^*+2;4-&\,K\07O$\&7_ (HN-/BC MO[CPUI>NWVNZ;87VD7VIZ?9VFMZ//??1>F:EIVLZ=8:QI%_9:KI.JV5KJ6F: MGIMU!?:?J.G7T$=U97]A>VLDMM>65Y;2Q7%K=6TLL%Q!)'-#(\;JQ_GB^"7[ M"_QO^(FD:%K&L0>-?#/COX*>-?AUXRT;XB^,O$GQ[_9VD^-VH6'[/WC?]F&^ M\%:KI'PT\5^'/B=X 7X,_#=/"MSX,^(WA6\O/#_CR3Q'XBTKQ!I/BJ\U'Q#X MK/[C?L^?"33O@+\$_AC\'M,>S:R^'OA#2/#,;V$WBB73Y);*(M=-I[^-O%7C M?Q8+%[N6X:RB\0^+_$>JPVIAAN]7O9(S*0#V2BBDR..1R,CGJ/4>HY'YT +1 M110!\LWG[;'[+.FIXUGU/XT>$=+T_P"'^G7>L^)-:U4ZOIGAY-"TSQ;H_@/6 MO$&B^(K_ $JVT'Q9X>\.>-/$&A>%O%&O^$=1U[1O"^NZQING>(K[2[F]MTDP MO%7[=_[+?AOP1=>-3\6?#&HI'J'Q'T*RT&WGU&W\37/B7X5:$OB+QQHM]X?N M--37?#L?AO2[K1-1\0ZUXBTO3- T/1_$OA?7-3U&'2/$F@W>I?G[XW_X(XZG M\1GN[_QG^TK+KOBD_#KXN?"Y_B'JOPRUC6/B%XU\._%+XK_ SXJQZO\ %G7M M;^+VKV?BGQ3X9N_@K;Z#IR^#](^'7@B/2M?N%TOP1HL.G65A']#^(/\ @GAK M_P#PO7X]_'_P'\<;?PQXO_: O_B7H/B*SUWX9MXOT;1/A/\ %?X,?LR_#+Q% MX;T2R'C[P^H\>:3XD_9GT/QUX8\>71FT.*+Q-JWA3Q+X \2V=CINI0@'TYX6 M_:S^%&H?LY? C]I+QSJL7PT\,_'OP;\(_$GA+0]! M],T_0+6\O_%7B:WL+V[:>R\/:;>2M9:/K&LF"#1]/OKNV\S^!'_!0G]GOXV> M"_A_XGD\2V7@W5/B7K7C[3_#/AG4;V77;B33/"?QJ^(GP0\.>(-1UK0-/N=! MT32?BAXG^'&JQ_#E]?O=*7Q?J4O_ C'AMM;\0V5U9J0_L9:CX;^#O[%'@CP M#\3+/2?B+^P[I/@;3/AYXZ\3^";KQ+X5\51^'O@+K7[._BB+QC\/M.\:^%;N M2S\4^"?$>KZA8C2?&NG:GX9\1QZ3=0:GJ6FV^J:5K/R)\,?^".OAKX:^)O#V MO2?%/3/'2W&O^&_$/Q*/C/P#XN>X\2:AX(_:!^)_QX\)7?A'2/#?QI\._#KP MU=077Q*DT354\:?#_P"*6EI>^'M*\8>%--\,:W)=QR@'Z.ZK^UG^SMHWASPY MXJN?BGX?GTCQEX2\%^./!_\ 946LZ]JGBWPY\19;^+P/=>%O#VAZ7J7B'Q#= M^*/[(UF71M%T;2;W7;RUT+7[Q-+%GH6L3V7G8_;F^!T'CWXB^&M5\0:?IW@K MP)\'/V;?C!IWQ135$U7P[X[M/VG?&?QJ\$^ /"_@_3=(MKW7==\2W>K_ :O M8-.TG2K74]2\27OB#3M*T33;C4;2[@/S3XK_ ."6VC>(-+8Q?%%;CQ#X0_:( MUSXQ?!%M;\-^,(/#'PW^'6I^$_BCX7TSX$ZCI_PZ^+?PV\9^(O"_A63XY?%G M7O#7B/1OB!X.UC3M6U_1H9+2[T?1K[2=>L6'_!,2U\+:[X<\9^ /BGI'A/Q; M\/O"O[)5M\.+>+X82W7@71/''[,OBO\ :T\0:SK>O^$U^(=MJ7B'PC\5-._: M]\?Z/?>%8?%NE>(O"U[96'BJV\>ZYXA=[D 'U9>3 MXRT;PKXBT2Y35+B>Q/A_QIXP\0?#W0-(9M*UNXM+&XIZW^WE^R!X;E\40:Y\>/ VF3>#+;Q1>^)8[N?5 MDDTVS\">.-2^'/Q!NG TIFO+7X<^+](OM,^)$]C]KA^'MO'#K'C1M"T&[LM3 MN/SS;_@F)\6+OXP_&G0)_BG86WP9^/\ ^S):> /CCXYD\&:7=^(?B#XV^*G[ M7O[3W[0G[0&C_#GP]%XYMKKX.,-,^,L.D^ M=U$?$/1-!TC652YTSQ3XMT.7 M76]KU'_@F':7^DVVDCXRM!]F\*_\%3_#"2KX#65P/^"EWQ;B^*4MZHE\8-+O M^#*1C0(HI)I)/'Z'^TY[GPJY:T8 ^U]1_:L_9VTGQ+XJ\(ZA\5O"\&L^"M U MKQ'XD4S7\^F:=8^&?"YM?'NH^/8?B?\ '+X8? '1C\-O M#/B#Q;)I?BWXP^'-7\7?#[7M=M;2QAO;;P'XFT#1-2U#0O&.G6VIZ7XECM;T M>&9-;.D:X-*^7?"__!(#P]X2M_&.CZ?\4M(NM)\3^#OBM;:=JNL>!/&^K^-? M#GQ(^,O[/NN? KQEXPTNZU#XXS_#VVT,1^)O$?B#2M(TWX8:9XXMM,U:3P/= M?$N[T%;B:_\ 0=9_X)F7+Z]X1\:^&OC5::?XS^&OA']@+2OA^VM?#B;5_"MK MXI_87;]H.TM]9\3Z%I_C[0-2UG0_B=H?[0&LZ==>'])\0>';[PC>:#INI6^O M>($EET]0#]7P<@'!'L>H/<'&1P>."0>Q(YH/0_0TB*41%)SM55R!C.T 9QD] M<9I3R"/4&@#X@^(!+>-?$Q8DG^UIER3D[5CA51GT50 !T XKCZ[/XAQ-#X MV\2HXY.I-*." 4GM[>9.H!^ZXSQC/0D(['19)](TVPC$M]?-?2PZ7=6ELA*JSR1W44Q#,J*+8N[HB M,X^S*\"_:2UK^ROAG1 MGW&M#PWR?'\?8C#K&4^#Z*XAC@74]BL?B,KJ0Q6$R_VUG[)X_%TZ.#52SY'7 M4DFU9^1Q!1CB,BSK#3FZ<<7E6881S6KB\5A:N'C))IIM2J*R:LWOH?SY_!__ M ()7?&KQ^UO??$+QO\-/A!H\ACDFM;WQ)I?C;QD(9/NJ/#WAK4_[)LIVY"IJ MGB:W=&PLEOD,M?J9\)/^"5'[*'@)K>^\4V^O?&O6(3&3)XVUF"U\->>F&(3P M?X4>PLID+998=8U#6/E(5Q(,D\G;21W$*2;$W8VN-BD!UX;&1T/# ]P15I&: M/!C9HR#N!C8H0W9@5((88&""",#!XK^F'LJXDX8\<\9D/"7$V58 M3-LJPW"?#%+**=3 9CAZ6(H*IF6&X@6?JI[.?LL7AJ^:S5*JJE"K1A.$XG\4 MY%FO!G!^)J8?'>&V&S?,L'6E1K8G.<\GC9>UI3<9-8.ME,\L237-3J4\'&37 M+)3:::_3SPOX2\.>"=(AT#P5X8T3PAH-NH2'1_"VB6.@:6BJ #9Z3:VEO*0 M ,O,LDC'[SL:W-I7@J5QQC&,>V*_+B#6=9M=OV76-6MBNXJ8-3OX=I;.XJ([ MA0-V3NP.+_$D052B@:S?L A.=H$D[@<@'(&1V/)S_.>/ M^B5G]>M6Q$./,!C\16G*I5KYAE6-H5:U23;E4K58X_,:DYRT,]9;Y57$[6MR %Z8\^UDP3_$P.YOXF-;$'QT^)L)YUVW MN!N#$7.C:3+D#'R?):1'8>X!!Y.&!YKYS$_1-X_IZX;/.$,0NT\9G-"3VZ/) M*D5K?[>R6MV>O1^D!PE.RK97Q%1;W<=H+VC*6 Z98QX;')VKGC;7Y!0?M$?$*+ E7P[= %B?,T=H2P M(X4FUO80 IP05 8]&)%?I-^Q1XVU[QYX1\::QK5EIUK';^)K33+1].BNXDN& M@T>VNKII%N9KA-T9O($ ADX^8R*K,I.&6>!?'? N9X?B#.EDT\LPOMJ5>K@, MQE7FI8JC5P]%1HUL/A:TKU:D+M0?+%\S5HRY?K^&O%/A;BK,J64Y6\RCC:]. MK4A3Q>"5*"C1I^VJ\.^(+SPY#X*N-(L/ WB;P]X'U+PMX@D;Q$FM^&[^_T_P 206VH:!'= MJO[(,H964YPRE3CK@C!QUYKXW\'?L$_LQ^%?$OQJ\8:C\-O#_C_Q-\>/&WQ; M\8>-M;^(7A_POXBU-+3XW>&O#WA#XA>"-)OET*RNX? VL^'/#=MHTND7\VHW MLNEWVJZ7=:G<:;?RV=?:'Z,?+.E?\%%/BC-+/K>K?!7P79^#O 6N_LEZ)\88 M;7XB^(KGQM9W'[:OB'PKI_PO7X9:,?A^-+\:+X%T?X@^";GQY>:IJ_AZSU[7 M3XV\/>#Y%D\'07OB+RWPA_P4\^._BG2+GQ\/@1X0@\(Z_P"//V3/A+X$TE=> M\<6]K;?$G]J7]H75_@W/X7\%/'7A2 M\T;QC8:WHOCZ]AN?#>G>)OU)\2_LQ? /Q7KWAOQ=JWPH\$?\)KX*\,V_A+P/ MXXL_#VF67C/P3HNG6M[;:!#X3\2P6RZIH<_A0ZEJ%UX0N[.=;GPI?WM[?:!) MI]S>WDD_S!^SS_P32^!WP"OK.82_\)]IN@:9X%TOPMH>O> ?A+X9TRVN_AGX MN\.^// GC_Q;%\.O GA$_$GXR>&?%OAC3M,_M_BK3=0FUF[TQ[*[\1 M:]<:B ?(WQ/_ ."O?B+X11^--0UKX2^&O&_A^W^$?[4GCOX<^*?A[JOQ0'@; MQ?XC_9%M;.Z\?:!;?$#QU\,/!WAOQ+9>)H$U]=.U;X?-XFT[PKK&C+H=_J?B M:"YEUZS]@U?_ (*)?%KP=\3?$'P^\6? KP/J'_"'?M0^(OV3-9F\*?%R\CN= M>^(OB#]E"Y_:_P#@KJ/AF7QEX&\-:#8^'=<\''1_AY\1+[QEK&A0>$_&>JW/ MB#3+O5_".D22WWVK?_L7_LF:G=>++W4/V77CEO&#>+9[CX>^&Y)->'Q M"TVZTGQY'?G["/,@\:65]?)XJMD$=OX@FO;V\U6*ZOKNXN9.\U?]G_X(Z_JF MIZUK?PH^'^KZKK7Q L_BKJ]_J?A;2;ZXU3XCZ?\ #I/A%9>-M0>YMI1>^);? MX7HOP_CU6X62X'A ?V"S-IY,) /DG]GG]JOXW?'*PO=''PZ^$O@WXF>%/&/P M5U'XC?#[QAXC^.?@#Q)X5^#WQ/&J3Z]K*>'/B#\!?#&KZSXMTB;P]XK\.?#O M4]";6/A#\7=;\*ZS-IWQ%\-166H6&G>0_MP?'3X[V?QUNO@I\*[KXI^%])\" M_LF>,?VH=2USX4:O\'_#&O>(;S0?B%!X0O(AXB^-F@^)/"=_;?#;1[)M='P\ M;3]*TSX@>(/&GA:P\;>,_"?A"PO;B]^XO#W['G[+/A/3+#1O#/[/WPCT/2]+ M\>^"OB?IMEIO@;0[6&P\>_#:]EU#X=^*+/R[57MM4\!7<\TG@IXG6#PJ)9(M M"@L(9'C;M_BI\!O@O\<8-"MOC#\+/ 7Q,M_#-W)(]*DOT@BU M.*T74[6XV66KPVEI!K6FMNTW6;>UMH-5L[R&WA1 #YM^.?Q6\?\ BO\ 8*\6 M?&C]G_XFV?A'Q+J/[->H?%W0/B-K7P^AU+7K'2KGX.:CX_T[6M+\!:EJT.D: M%XRU ?V9+$\0^'_ S>7$KZKX;\606"Z3??)'C3]H7]I;P)\'OV6?VA MI?B!HLOA;Q?^S=\'=6UVSUN*W-GJ'C+4_@UX^\;_ !I\5^+_ _IFCR:WKB: M3IDO@7XIZ=J'AR;3=.\-^'?AA\2M,N[:.[\3Z3IWB#]&?'?[)'[-/Q,M_B%: M^.O@C\.O$D'Q9U'P?JWQ-34/#MJ#X^O_ #X=/A'P;-XM>U-L^NKX<\+$^'= M+@U!IK:WT4G3/):S)BK0\ _LN_L]?##PQI/@OP'\'? 'AOPGH.F>,=%T3P]8 M^'[1](TG1?B!#I5MXTT?3[*\%W#::3XDM-#TBQU738%2RN-/T^UT_P A;*/R M" =%\$/&ND^/?AEX+2B^CF]CEET::?2I+.>3UBN=\)^$O#/@3P]IG MA/P?H>F^'/#FC0R0Z9HVD6L=G8VB3W$UY<-'#&.9;J\N;F\N[B0O<7=Y<7%W M=2S7,\LK]%0 4444 ?!GQ$_:;\>:1^U%JGP6\/WGP=\%^%?AYX2_9U\7>*9O MB_>Z[I?B?XNK^T+\5_&WPUM/#WP:O-,UFST_3=5\)R>"?LUE\;IX\^( MWBGPS\-38>"8KI_&+_&6B?\ !2/]H#Q#X1\%:YH7A;X!:YK'QU^"OA7XY?#_ M ,/:=XD_L[5O@?IVK?M$?#GX-ZM\+OBQ#XV^*'@SP_\ $[XP'1OB'>3^!?"F ME^,?@3-\0OBS\+_B5\&].AL;W3+/Q%-^R>M> ? WB/Q#X8\6^(/!OA37?%7@ MJ6]G\'>)=8\.:-JFO^%)M2A6WU&;PUK-]97&I:#+?VZK!>R:3=6CW<*K%.TB M*%&!_P *7^#_ -C\=:?_ ,*K^&_V#XH79O\ XE67_""^%?LGQ"OF9F:\\1XNNV9W+7/B&/49B68[\LQ(!^*R_MW_M/:I\;]/\ $/AOQ_\ !._\#>%? MV(?VU/$7BSX1^-/"^K? SPYKW[3_ .SC^T/X"^& TW7/B7\2O'\@^%-UI$/B MCP_#XAM;^^\9^"O#]K=>*;"T\:^+-*U[PO\ %/PY]P_L\?M/_$OXL>(M,\(> M)/&?P6\/^+_!?QJU+P'\8/!'B3X?^-/AI\0M9T+6?V?W^+'@/0_AUXV/C#6[CPY\2/C5X0U+X1:-K.IVMSX?\1SW=GX7^R%^"WP?33?! MNCI\*OANND_#I-33X?:8O@3PH-.\"IK6FWFC:PO@ZQ&D?9?"ZZKI&H7^E:DN MAPV"W^FWMW8W8FM;F:)XO#?P/^#'@V#PM:^$?A)\,?"]MX&US5_$W@JW\.^ M/"6AP>$/$?B#1K[P[KVO^%X=+T>TC\/ZWK>@:IJ6AZOJVD+9ZAJ6CZA?:9>W M$]C=SV\@!^2/_!63]J_X@?"FWT3PMX0O_C_\,="\ ^./V2?B!XB^(WPT^$?Q MUU;3_B/<^-OVM?A=X)N?A+8_$3P!\/\ Q!X5AT"R\ KXTU'XF>%[K7K+6_&V MH>)?AI\.=&L]8;Q'KFB7OM'AOQ%JGB3]L/PO:?!GX_?$WXCGPO\ %7XJ:E^U MC>>*/&@/P3\&> =4\!^*Y?AW^R]X>^&$DNG>&]*^-O@SQ#?_ X\023>#]%M M?B1X2\*^$_%VM?M >)#J'CGP[X2\1_I_KOA[0/%&G'2/$NB:3X@TIKS2M1.F M:WIMGJVGG4-#U6RUS1+XV5_!<6IO-'UK3=/UC2[HQ>?I^J6%EJ%G)#>6L$T? MDVE_LQ_LWZ)X]?XJ:-^S_P#!+2/B;)K.N>(W^(NF?"?P!8>.W\0>)VU!_$FN M/XOM/#T/B)M8\0OJVJMKFJ-J1OM6;4]0;4)[@WMR90#XH_:W^*OB*Q^-G_!. M#QO\.OVCX['X0_$[]J'PWX1UCP3X)U?PJOA3XH>%O$G[._[4?BT^)?$OC*SN M[_4/%O@^2_\ "?@U_"VA:/>:7X736=/EUW5)_%5Z^A0^'/(=6^-7Q-_9^^.6 MIZ+\6_BAXI\=_#S1=;?QMXYOO ^IZKJ\\FM:6GQ7^).G:/=0Z]=^']+\#V?_ M IG7O WBCQE\%O -SKZW&E_"OP!)X=L]8U#XS^([&3]'_$/[(O[*?BZU\+V M/BK]F;]GSQ-9>!_#%AX*\%V?B#X+?#36K7PCX.TM[B33/"?ABWU/PO=0Z!X: MTZ2[NGL=!TE+/2K1[B=K>TC::0MZU<^ ? UY$(;OP;X5N81XAT[Q-?%>D6MG8Z5XF6.6R=%\0:99Z?86FGZT%&IV5M96D%M=10VT"( =8I!'&>" M5YZY4E3^HZ]Z6BB@#Y*^-&GM:^,!>8)CU33+2<-V\VTWV4J^Q5(K=L9XW^IK MR2OJ?XV:$]_H%IK,",TNB7)\_:N?] OMD4SMCD+!/';2,>BQF5CTKY8H *** M* "BBB@ KXF_:NUKS=7\)>'4<8L=.O\ 6KA!VFU&X6RM2WN+>QG*CL)2>X ^ MV?IR>P]:_,KXYZU_;?Q1\52J^^#3KJ#0K?YMP$>CV\=K+MQP UY]K8@?Q,>^ M:_EGZ7W$+RCPFGE5.IRUN*,^RK*Y03M-X3!3J9Y7J*VO+&ME>$HSZ6Q"B_B1 M\YQ/7]EEKI)ZXFM3IOOR0?MI/TO3BG_B/-=.G\N7RV/RRX'/9Q]P_B,J1P/N M\\5OUR )!!!QCN.W<'MT/(]Q73VLPGA63^(?)(/1QU/'0,,,/J1VK[;]G#XT MK,\CSOP2SO%WQV0?6>)>"_;3UK9)C,3%Y_E%%R:7-EN:XF&;4*27"X[E7PXBG"V'K2M_S^HQ=&4M(QE0II^_ M55[%%%%?ZD'Y(%%%% .2!ZU^X/[%?AF7PY\ O#=Q.6$WBK4=:\5M&P(V0:A M>?8M/P"!A9=,TVSG&.#YV[J37XM^&/#FI>+_ !'H?A;1XVEU3Q%JMCHUBBJ6 M*SW\Z0"9@.D5K&TEW.YPL<$$CLRJI(_HS\.Z+IO@WPOHOA^R=8-(\,Z)8:5; M23.D:QV.DV,5JDT\C,$7,4'FS2.X )9F;J:_(_%O,8TLMR[*XR7M<7BI8RI% M-75#"TY4X\RM=1J5:]X/2\J$_P"5G]!?1_R>=?.LXSV<'[' 8".7T9NZC+$X MZM3K3Y']J5&AA6JBU48XFFVO>3.@HK'TGQ!H6NK.VB:SI.KK:M&MRVEZE8ZB MMNTH8Q+.;.><0M($X'KR?8<_P" Y/% "T49'K[_ (>M)D'H M0>W7OZ?J* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"K M?6=OJ-G=V%V@DM;VWFM;B,_Q0SQM'( ><':QVMU4X(Y KX5\1Z#=^&M9O='O M Q>UE(AF((6ZM7RUM=(3P5FBP6P?DE66,X9"*^]*\P^)O@?_ (2O3%O+"-/[ M=TU&-KDA/MML27EL'3:C=W>H7!W7%_=7%].>YFO9I+J7_Q^5J_2?X\:U_8 MOPM\3,CE)M6CM- @(ZDZM^.E?F>>I[5_G)]-GB%XGB?@[A:G M4O#*6Q^2;"')X#C_5MR?7*'C@$5G4=.E?R[X8\?YQX6 M\?<*\?Y$[YCPSFU#'J@ZDJ=/'X-J6'S/*J\XJ4HX;-LLK8O+<3*,7*-'%3G" MU2,6O@)P6)C MR5\+6J4*L=;<].3BW%M+FA)6E"5K3A*,EHT%%%>N?!7X0:_\:?&UEX5T<26V MGQ>5>^)M;"!HM!T+SA%/=C>/+EO[@A[;2;,\W5YEG"VEM=RP^WBL5A\#AJ^, MQ=6%##8>G*K6K5':,(1W;W;;=HQC%.4Y.,(IRDDZP& Q>:8W"Y=@*%3$XS&5 MH4,-0IJ\ZE6;LET48I7E.I?4KI^BI M=:#X0,JX%UK%RAAUS5801\\6FV3MI4,H!0W=[?HI$EFV/H/_ (*2:1JWB#_@ MGE^W=H6@:9J.M:YK7[''[3.DZ/H^D6-UJ>JZKJFH_!GQE:6&FZ;IMC%->ZA? M7MU+%;6EC9PRW5W/(EO;QO+(BGZU\*^&-%\&>'='\*^'+)-.T30K&'3M.M(\ MGRK>$?>D:>:0O/&?!_ M@_0=6\3^*?$>L72V6DZ#X>T*QGU+6=9U.\?"6FGZ;I]M<7EY=.0EO;PR2L0J MDU_*'%&?5>(\YQ.934H47:C@Z,FFZ.$I75*#M=<\VY5JMFU[:K4Y7RV/[WX' MX6H\'\.8+)J@Y14OJ]&ESKGYF_P M3\(?%SPQ\//@7X.T#]G'5?A5HGBGQG\5?"GAKXI_$S]C_P#9CU#]EGP/X7T: M+X3>(-1\&:)\8[CQ'\,/VN_%<.K:WXFL+_1/"OB?0? &I_VYXEOM,\%?:_ ( MU&[N=<\%\0?$_P#;=_:<_9E^(+_'O3OB!82^%?AS_P $S?$%]\*]'^%8T2W\ M4?%'6/V_/''A3XQ:Y<7%YX%TWQBMUI7@[X(^ _'%YH.C)X9M?#-SX@N]:U?0 M],\.:C8>'K'][K;]L7]EJ[M%O+3XZ?#R[A?QU M$;.RB$E_=ZYJ'AF2'Q'HMA:6\S^(?#\]MK6A?VGIEQ!=2%O^V5^RK=Z1X]UV MT^/GPPNM)^&5YH]CXUO;;Q98W$6CW7B#Q#<^$O#:1K%(\FKIXD\865]X/\.3 M:#'JEOXA\6V%_P"%M'EO]=L;O3H?GCZX\M_9(^(GQH^(OB_XT:/\2M7U.YLO M@!XMU+X 7M[>>&](T"+XB^/=&\2ZSXTG^)]M#I^GVT4FG:M\&?%?P113H+VW MAVS\8:I\0M'2PCN-#5+7\"?B7\*/&%[\%M1UKQ38 M?"N/Q+^TA:^,?"/PS\3>)XO'$UB]Q;?$/]D_A9^U+^PKX#\!Z!:?#[XH?#+P M'X*\16/B?XDZ!;7U[/X:/B#0=7\9^-[?6OB=&GB!(=5U3P]XL\7^&/%DMEXW MOVDLO%%XMM+8ZA=G6-$6^]"O_P!M?]E#2?#-GXOU?X\?#S1M!OQXL"7.LZX^ MDW-J_@.3PROC:#4M)U&"VUC1+GPA!XQ\+ZCXEM-6T_3[K0]'UO3]=U&&WT:; M^T% /QO^+G[<_P"U3X4^(_B/Q=\-/%?BQ?A5:ZS^TCX0UE_BYX+DN]%\%^&? M"_[,_P :O''[//QJG\*^&_V;_!FD:9X*^)?Q1\ >!-2\$^(+C]I#QEK'Q8\- M_$&RTF/P/H.J:U!X9\"\-9_M-_MK6]I;SZ/\5O',6E>*/&6KZGXZUGXK:AJV M@?&?X/6VE_!7X7V?P;^'GC;PKX4_8J^+/@OPEH_Q<^*\'[0?BSP?J'A#]F[2 MO^%H:?X3\.> M?\ BE'XZD?PM-^V'CS]IC]BWQAX ^(&D?$#XI?!OQGX BU^ M+X2^/_#&MW^F>+=,U/7/$/ARZ\36W@^_\*&WU2?Q%_;GA"QU/Q59P66E:G8Z MGX7T?6/$UK-/I&B:EJ%EK_ *+]E#PAKFI^ _@#J/@&3Q)XH^'W@/XY:HOAC7 M[GQ3KOBCX8^-K[Q-HGPU\>S^*KW4-;U#Q!X-U:ZT#Q3I_@RZ&N7NE11V>J1: M/!;6TK^< >R?"'4/&VK?"CX9:K\2X],B^(VI_#WP7J'CZ+1=,UW1='B\:7GA MO3+GQ3'I.C^)['3/$FDZ:NN27PL=,\0:=8:WI]MY=EJMG:W\$\*>BU\=Z5^V ME\-[_P#: ^.'P)U'P_XY\)Q? /X,:7\;/%_Q+\9:!+X7\"ZEX7G\7_$'P=K\ MGA8:JUOXCUO3_"5]\.-+O!>DZ7HGAGQ/HVM:UXE^&OB!;S2?%UL=0T?1/%VB^"?&/B#Q#\+ M?B2FBR:9XEU+X=>/-+TS5;+P]K^CW,=]=ZE%XATGP^ ?7E%?!'Q$_;MT[X3> M/-7\-_$/X(?%70O"T5G\8)?"_BRUN_A_K^K>*9?@IX#\6?$?Q'J(^&NB>+KS MQ]X<\&^)O#?@O7/^%?\ C;Q#I5GI.NZFNE66M1>%D\4>$[C7/7/@;^TWX?\ MCIJE]H6@>'=5M-4\+6WB2#XA2?;M,U70_"7B/1/&FH>#M-T"#7]/E-CXG;Q7 M_87B+Q+X?U+1%DLV\,:9!J&I#3[C5].LI0#Z;HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** /%OB/\,5UYI-;T".*'6,%KRT)6*'5,+Q(K<)#J P% M$C[8KH86=HY%68_+L\$UM-);W$4L$\+F.:":-HIHI%X9)(W"NCJ>JL >A&00 M3^A=<-XN\ :'XOC,EU&;/4T7;!JMJJBX4 ?+'<(<)>0 @8BF(>,9$$T!8D@' MQ117?^)?AKXH\-F2:2S.I:>F6_M#35>>-$'.ZYM\&YM2 1N+H\"G.+A@":X# ML3V'4CD9'4<=QW'6@#Y#_:OUK98>$/#B/SHZ[G6>Y?0RW=V MRYX)C..0:^*Z]X_:.UO^UOB?J%HC[X?#^FZ9HR8Z+.(6U&] ]3]HORC'UCQ@ M;:\'K_'#Z0W$/^LOC%QOBX3YZ& S19#ATG>,(\/X>CE%=0:NN2KC,'B<0K.S M=9O=L_+,\K_6,TQD[WC"HJ,>R5",:3MZSC*7FY-A1117XL>47]/G\J;8QPDV M$/H'_@;\SM)]&-=#6'HVB:SXBU2UT3P_I6HZWK-[(L5II6D6=QJ&I7$CYPL5 MI:QRSG@$F0HL:*"[NJJ6'Z,?!3]A7Q?XB^PZW\7IG\'Z.!'*WABQG@N/%&I( M,,([VZMWFL?#T4JE3((Y=0U0 O%Y6G3A9E_UX_9W^-5;#<)<5>&O$\5YRC0PJ MW$:,9KJ0 M$FSTNVW7MX59@L-LDUU#^XWP@^$'A/X,^$[?PQX8MR\KE+G6];N4C&J>(-4$ M822_OY$&%51F.RLHS]ETZUQ;VX),LLW7>$?!WACP'H5GX:\(Z-9:%HMBN(+* MQBV*TA55ENKF5BT]Y>W!17NKZ[EGN[F0;YYI&YKIJ_KKB_C?&<33^K48SP>4 MTI\U/"\R=3$2C\-;%RC[LI*W-3HQ;IT;Z.I->U?[+X>>&67<%4OKE><,QS^O M3Y*^.Y+4<+":7/ALOA-<\(/X:N(G:MB$KN-&G+V$2OE?]N?X9>,OC5^Q5^UY M\'/AUIB:U\0/BO\ LQ?'GX;>!]'DU#3=)CU7Q=XX^%_B?PSX$_V3OCU^S7X.\-Z:O\ PGWB M.XT?QK:7W[0?B[QKXF\>V][<6^IQ6>D>%?#^@:#8Z=#JL_RY\;O^"=GQ\\)_ M"SX/6?@[Q:_::; MX._:W^(O[1,_Q#\8ZUIOQQ\5^*=)UK]H+3/&MUI?Q>\,>&/C+J?C#0;[7?$' MB#PY\7K3Q+=:/HOVKKZ^T/2? ?BR M71]"U_\ :B_99_9E_9TOY=$O/&/Q4\8^)Y].\+WW[/5QXR?^W-?U/5-?_P"$ MPDTDWVCQZ9')-^UU% 'X[Q_\$OO$VBOIFJ>'_BUX+O=>\._"3]C'X;>'I?$7 M@'XAZ5)HFI?LJ?"_XY_#'5/&'A/QC\*OC3\,_B=\.?$/CO3_ (S%K;5O ?C/ M2[_2M!TK6_!'B$^,/#GC&^BL/OOX#?##XS?"C2/"7@OQO\:++XN^#_"7PB\% M^$UU?Q!X+O=.^*&O?$S2-:\3R^*_&^O>,%\8ZGIE]X9U?PS=^#]#\/\ A>Y\ M/W7BO2[SP]JNO>*/B+XVU#Q$[6/T;10!^9/BG]C7XY?$/]JOXQ_%OQ_\2?@O MJ7P0^-O[/%S^R9XM^&6D?#3X@Z;X]7X*KXB^+'B2TO++X@3_ !3O="C\?7> _@ MO\)?V9O!%_IWP$U30O#>O?!GP-\3?#'B_P 7:U\8=#TOXL1ZCX\^,7B7PII& ML^'?!OB;3=>\->$_AGXC\3^)O%UEX1\06OB?6O#+_J!10!\$2?LA>,M>_:0\ M%?''QGX[^&-V_P .O&/BGQ%H_BSP=\$+/P+^T#XY\'ZYH'CSPWH7P/\ BY\6 M],\7W&D>+O@YX3L?&=C=MX=M/ FF-XJUKP/X"UW5$T_6M!O]1URO\,_V*=7^ M'WQ?\#?%D?%)Y[K3EOM:\?:/I/AV70].\0>)[W3OB9H]QI?AJR@UR;3/#/PW MN])\>>#=*G\(W&G:O=0Z?^S]\%$M-6BNM$U*\N?O^B@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ KDM8\"^$]==IM1T2SDN'!#7,"O9W M+$G.YY[1X7D;/>3><<=.*ZVB@#\_O'G_ 3Y\ ^+-:UC7]*\=>,M!O\ 6KR? M4;B.\BT?Q!8Q7EU,99C&DUMIU^;<*1%# VH,T2JN)F VUY)-_P $T[\;C;_& M"T;]XH03>!YE_=&4!BYB\4M^\$19@%0(9 %)1"67]7**_$,X^CCX,YYC<3F. M/X,I/&8RM7Q.)K87.,_P*JXC$5)5:U:5'!YK0H>TJ59RJ2DJ2;E)WNK(\BKD M655IRJ3PBYY-RDXU:\.:4FVVU"HE=MMWL?D]=?\ !.:'1X8[W5?BU-99[SQ#?1(\"W:3)FVE4['#J1BO?_"?_ 3_ /@7 MH+Q3ZZ?%?C696W/%K>M_V=I[8(*@V/ANWTAI%X^99[N=6YXQ\M?7GC*VFNO" MVNQV\;RW,>G3W5K%&KO))=6(%[;1HB9=G>>VC5%4$LQ"A6)VFU:^(]%NY(88 M+Y'EN"HBC\N=69I!N52'B7:V#@A]I!!# $$5ME'T=_!C):L:^$X"RJO4C+F7 M]K5\RSVE>]])? MC#HD4.EZ?XPEL;OQGXCLHO@KXNU.ZCU+Q!HFEQ03:7%-K5NUS-);_47AC]K_ M /9O\57#V%G\6O"6EZC:>!(/B-J^F>)K\>%[OPYX8;P?IGQ U%_$C:\EA9:% MJ_AOP5K.E^*/%WAV_O(M>\):#?6VL^(M-TW2YX;R3YG_ &G?^":OPN_:E^+' MQG^+7Q ;PA?>(O'/[+OPM^!/PJUC6OAOHGB7Q1\"O'OPI^)?QH^*>A?&'P=X MCUBZED%X_B?XD^$[FY\,V5KI%OJ"_#^&UUK4]4TW6FL;#@/#W_!,*WTOXD_$ M7QIJ?CKP;XCTGQ]KGQ\^)(T7Q3X+^)/C>WT/XM?M+>!O%OA3XGWEOX,\9_'; M6/@7?^ 3?>//&2Z;X1ZD(0IQ4(1C"$5:,814 M8I=E%))+T1]F0?MH?LNW7@J?X@6_QJ\%R^&;;Q1:>"IKA;J^_M-?%.H:&_BK M3M$3PT; >*)K[4/!\ M 6^+W@>;Q/XTM_"UQX.;P+8:E MJME?^-(Y(V\+VVK"2/?^;M__ ,$L?'^LKX2\0:Q^T:USXJ^&GBRZU7X7^%K= M_P!IJS^$/@KP]KGPZO/AGXRTO1((OVM3\=-&N/$VF)X=U6VT[0?CIIGP_P#" MS^&H="T3P&;37O$^IZMK^(_^"66L:UJGPNTZW^-VGVOPX^$7B?\ 8S\9?#SP MG)X+\=E_AS?_ +)7CCX5^,KKPK\.+&#XV1^ M!\$?%2\^'VL7^NRZ_X'\7_$ M/2M7\9ZB'\>Z[I.E^'K+2.HH^VH?VXOV2;BQ\,ZI#^T#\,I-,\8ZP=#\-ZDO MB*+^S]5O8HM!>]E@O3$+:/2]*G\4^&]-UO7;F6#0M"US7M'\/ZUJ5AKNHVNF MRYWP"_;6^"?Q^\3>+?A_HOB+3_#WQ.\)_$G]H;X?7'PXUO5M./BG4(?V<_C- MXC^#/BWQ-IMK;.T5SIMQJ>AV7B Z?'+)K.AZ#XF\.76O65DNJ6LLWRU\(O\ M@FYXO^!/ACX+Z9\-?CGX?MM?\$_ &[_9I^)6K>)_@];>*]'\7_#VX^*FI?%B M+7?!7A34/&L.D>#?'<&JZWX@TNYNO$\?Q#\*Z]9ZO:W/B#PSJ,OA[3K>?O\ MX>_L W'@/XF_!GXAQ_%&"\3X4_M+_M_?M"7.DQ>#I+-_$);7PL MU^?$D_V*;X;+XZM[.;79K74/^$M;11N76MZ/+>S?\2^7PSX6N/'/B'2)]12V?2#XFT3P39W7C'5/ M"46H2>*;+PK;7'B*?1DTB&2\7EK/]MO]DW4?#6J>+M/^/WPTO] T?6? ^@75 M[9>(H+J6;5?B79'4_A]:Z3I\*-J>O'QMIT=[?>%)M!LM2MM?MM)UV73)KA- MUMM/^*_C;_P3(\8?&WXKW_Q#\3?M#F[M+#XQ^+OBQX%DUKPCXRUGQ7X5TGQK M\"_BC\$KSX3I<-\7K;X;VWP]\.VGQ';7/#Y\,?"[PSXDO9M-CB\5:UK6IW>L M:[K5_2/^":GBCP9X^^!/Q:\#_&[1+/XA?LZ? #]E#X,_#V+Q'\-M2U?P+?ZI M^SUX%_:<^%_B[Q!XJ\,Z;\0] O;[3OB-X&_:6U:#0M*TO7-+U7X>^(/"^FZM M%KWB2QU#4M&F /NO]F#]H;PM^U-\'-)^-7@NPN]/\,ZWXP^+?A/2TO+W3M1: M]7X3_%[QW\([K6[2]TF:>PN=*\17W@6ZU_19(978Z/J5B+C;#_"W[6O@/X/ZUX<^%:? 7X, M_L]>-=1\::KJFN:3\3?%>K_'SXO:AX4TJ3X336-S!I.FZ5X6L/!6JZ7?ZEJ= MEXAE\9^*]=?P7:P>%5TJ?6M4Q/#/_!0/XK>%M.@UF\\/^#M(^#?AOXH?M(S_ M !*\?^+_ !%X[^+FL:+HOAO_ (*'_M!?L^06?B*WT#Q)J'Q)^#G@K3?!GP^C M\0>$?B3K?P\^)7PPFU 7/PMLK7P#X=\"76M6_P"P/C'X/_";XB:KI>N^/_AA M\//'&M:'8ZAIFBZOXP\$^&?$VIZ1INKF(ZMI^EZAK>EWUWI]CJA@A_M&TLYH M8+TPQ&YCE,:$8VH?L^? 75K[PWJ>J?!+X1:CJ7@W6M:\2>$-0O\ X:^"KR]\ M*^(_$GB.[\8^(O$'AN[N=#EN-#UO7_%NH7_B?6M5TR2UOM4\17UYK=]//JES M-=N ?G!:_P#!0?XJR?"*Z^,UQHGP%L],^)'B70_"OPE\ ZSXV\0Z#\0OA7/X MB_:VT/\ 9.A\1_M!V##5(KWP?X3U;Q#;^)OBEK7A:#PDGP_\3Z?=?"%DUZ\O M+;Q] _PM_P %!OBU_P +&\6_!3Q9X.^&FH>/H/B9JOP)^%OB/PA/XF7PI\5O MBA\-OB!X)B^,T^CZ+?ZIJ6JVEIX0^#GQ5\+^.;[PC%KNIZAX=\2_#CXU^%KW MQ=K=MX:MM5A_2]/@M\'HI?B#/%\*OAM'/\64>+XIS1^!/"J3?$J.2&>W>/Q_ M(NDA_&:/;75S;.GB1M35X+B>)@4FE#W-&^$_PM\.6G@BP\/?#;P#H5C\,YM3 MN/AQ9:-X.\.:7:?#^?6M/U'2=8F\$VUCIL$/A275=*U?5M,U*304T][_ $[4 M]1LKMIK:^NHY0#\8O"G_ 51^/OB?X.Q_%R/]GO3M(LOB'9?LM^)OA9:>,8[ MOPCI^C:=^TG^U5\*_P!GNS\%>);]/&_B7Q!XYU+0]"^*5IXIN?B7X:\&>#/# M5MXCT#Q#X+O/!PO;/3YM7^NH?VI/C??^(OCA\#X&^ WASXW_ +\(?$WQ'XK M\9^.)/&6B_!K2=,O?#WA#5?V:_''B6TM]=N]=T#P7\2+GQ+XG7Q+&WBN]O-- M/P>^)NGZ7J+W5E;74?V78? ;X'Z5)XGETSX.?"O3I?&WB31/&7C*2Q^'?@^S MD\6^,/#7B"#Q7X<\5^)GM]&C;7_$OA_Q1:6GB31-=U8WFJ:5K]K;ZS8W4&I0 MQW*X5M^SM\-;G4/CA?\ C?3$^*R?M!I8:/\ $;2OB=I?A?Q/X=U+P!HVDW^C M:!\*/^$:'AVPT&]^'&B6VM^)IK?1?$&GZYJ&HWWBOQ)>>(=8UF;4BT0!\Z_\ M%-=?^*OA3]@/]J/Q]\*/B]=_!KQK\//V??C%\1HO&7A73-+OO$D\W@KX3>,/ M$=CI'@W5M=DGL?"FH:CXBL='D;Q2=(U[5;+0[?4K30K;2]?O].\4:%YK^VEX M[^+WA>?]@CQ7X(^,FJ^$O"GBC]KK]EWX?>._"'ARRTV*X^)=A\1]5U"RUJQ\ M6>+;NXO[^;PDUA:R%?"V@6FBW&IZTJ7NLZ_JNF6O]@/^@'Q)^#/P?^,WAVT\ M'__#;XK>$K"]AU.Q\+_$GP+X7\=>';+4K>SNM.M]0M-$\4:7JFF6]]!I M][>V,-W#:I/%9W=U:I(L%Q*C^8ZS^Q=^QUXCT3POX:\0?LG?LTZ[X<\#VFI6 M'@O0-9^!/PMU31/"%AK.JW&O:Q8^%]*OO"L]CX?L]6UR\N]9U.VTF"TAOM5N MKC4;I);R>69@#Q?]J7Q_J&O_ !*_97^"VB_$+5_!_P /OBC\<_%/P_\ C1XN M^'7CJ'PGXML=8\.? ;QC\4_ 7PC;Q?H]VGB'P-JWQ$UJRT;5)/[#O=#\8:KH MFC1Z/I=_;V7BAS>_ ,7Q\_:9T?X5?#WXV3_&U]=\.W%_\;?AGX9U;[4VJZUX MP^%?P3\>?M+_ _U/]H+4? 7AW3K/P5XRD\4_#V#X(?'"+XBO=Z'96GB;P?H M_@_1;&TT'XPW*:A^TES\!/@;>>'O%GA*[^#/PHN?"GCW4]*UKQUX9N/AUX/G M\/>--8T+0_#WAC1-5\6:++HSZ;XCU+1_#7A'PIX>TJ_UBVO+O3M#\,^'M)LY MH;#1=-M[7K_^$&\%^196O_"(^&?LVF>%KWP/IUO_ &#I7D6'@O4DTV+4?"5E M!]D\FU\,W\>C:1'>:! D>DW2:5IJ3VCI8VJQ '+?!;QKHWC[X;Z!KFA_\),M MK8S:_P"#+Z'QG-:W?BNT\1?#CQ+K/PZ\66'B+4-/OM4TW5M8T_Q3X4UFRO\ M6]*U/4](UNX@?5])U&^TZ]M;J7U.LK0]"T7PSI&G>'_#FD:9H&A:1:0V&DZ- MHMA::7I6F6-NNRWLM/TZQA@L[.U@3Y8K>WACBC7A5%:M !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 =10 4444 %%%% !1110 4444 %%%% !1110!__]D! end GRAPHIC 27 biib-2016630_randdpiechart16.jpg begin 644 biib-2016630_randdpiechart16.jpg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end GRAPHIC 28 biib-2016630_researchanddev.jpg begin 644 biib-2016630_researchanddev.jpg M_]C_X 02D9)1@ ! 0 0 ! #_VP!# $! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_ MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P 1" -( 3T# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#^_BBBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "OS6\6?MW:UIW[:?B_]DS2K+]FCPO#X"\,? WQ;J6M_&[]I:Z^&/C_QSIGQ M>?Q[=:M%\(_AC:_"OQ0OC*Z\#Z1X OY[W[3XLTBWO;_4;&TN)M)M5GOU_2FO MDT?LA_#Z_P#BY^TY\4/%%W=^*+?]J'X8_"SX5>+/">H6.G6]CHGAOX;>'_B= MX;G_ +#UFU1=F?%#5(]4D-S"UBUA:-ISQF6X+ ',0?\%$/V29],L-5 M/Q(UF"#6M3^'6F>&;.[^%GQ=LM;\:#XPV/C"^^$>K^ _#MYX%@U_QUX7^*8\ M!>++'X=^+?".FZSX<\8:SH\VA:)J5WK$MM93\W^U3^WWX3_9B\;^&OAQ=_#' MXF^,_%7C3]FS]IK]HOPY>Z;X8U^Q\#6MC^S=X8\-^(M0\+>,?&7]AW]EX2OO M$K^);6P.H7D,MMX2E_L__A)X;.?Q/X3M=:\ZT;_@F=I">)/@SXQ\8?';Q_XX M\3_ ?Q)^SW#X U74?#'@72&B^%7[-?\ PL>?P3\/M8@T+3;.#4=6\1ZE\2+S M5?'_ (\C6SOM;NM \.Q:+H7AFRM[^UO_ &O]K#]C/2_VG]0\)ZX/B'KWP]US MP[\*OVA/@;>W>F:#H/B.TUGX6_M,^%_"OAWXDZ4UAK7E?V;XABN/ ?@[5_#' MB:RNB^DS:=J-C=Z;JNGZSJ>%-0TGP%XRU=M1M+/PSK;6'KGQ'^.>I?\,XZQ\?OV>K+P#\6;6V\ M&77Q!T*W\4^,_$/@+PWKWAG2-.N]8UM/[=TCP'XZUO2M<@L-/O+6#2;_ ,)) M-!KL,FD:X=%GM[LV_P 5?$3_ ()+?";XB>(O#/C77?%S>(?%?@'X7_LT_#CP M+#X_^&W@/XD>!K)_V>O"'Q[\ SZSXF\ >)K:32?%B_$+PQ\?]=75]/GN=,D\ M,ZYX:\,:]X5U6QN(-2BOONKPU^SYX6\(_LYK^SAH-S'I?AE/AOKWP[34M&\, M>#?"PAB\1Z3JNGZGK%EX4\&Z%X;\$Z1/+=ZS?:HFEZ+H.FZ/'<2>6EJ$:1Y M#X$^%?\ P52TUKOX<)^TS\/O#WP6TCXC_L<_#7]LZ'Q5X(\5_$+XQ^'?!_@' MXI>+X/#>E6/CRXL_@SX6G\)Z?X5M;JTU+X@?$+6X;#P%X8-W EQK+V/FZE'] M<3_MX?LR1WFM:;9>-?$GB#5="^(OC?X3W>C^#_A/\7/&NM7GC[X8:KXFTCXG MZ!X?T?PEX&UK4O%,GPTG\)ZE,/"9UKYV\ M3?\ !+OP3XE^&>N_#27XM>-[2RUS_@FYX7_X)PS:I!HGAI[R#P=X7&I+!\3H MX)(OLS^+[H:E*)M'D!\.QA (H@'<&'QU_P $KOA3XTTK1GU'Q'::YXK\,?'K M]K3XU^&M5^(WPM^'?Q4\+V%O^V)\3[WXG?$GP9=?#OQA87/A[4+?1=3_ +!_ MX0SQ0DEGXDTJ]\+Z?>WD^HV&I^(]#U@ ^M-._;&_9RUGQEX=\#Z+\1X-;U'Q M2G@E-*U[1/#OB_6/AVNI?$SP]9^+?AOX=U7XIZ=X?N/AMH/BWX@>&-1TW7O! MGA'6_%6G^)/$>F:OH-QINF3?\)%X?75-GXP_M1_!;X"7MM:_%3Q#KOAJTDTZ MRUK5/$D7P^^(NO\ @GPCH6H:A>:39Z_\0/'GAOPIJ_@SX>Z%/J5C<6HU7QGK MNBVD:Q7%].\6F6EY?6_R3X2_X)%+:'2M0^%7B;4-*U/ MX&? K5O$+^,?@Q\._!WPQ\&:GX/\>MX#MM3^%7A^3P]\//!MWJ_A#X?:7HFE MVFOZ&-3\"W'@1-1U:SO;O[:?_!-GP5^VIJGC.;QQ\1=8TS0O'GP4D^#>I:%J M'@;X?_$)?!2VUUXQU'3O'WP8OO'>DZHWPA\?:G?>,/)\?>(_#5J^I^-=(\)^ M!;!;WP_>>%-.U90#V&3_ (*!_LCV^H^--.U#XN6^D?\ " 2_&ZS\2ZMK?A'Q M[HWAB+5_V/_VJO".@_#SQI8V'[,U_\-+#=J6A^*-!\>>, M;GX@?!O2OBW+IDOPP\;>%_"'B;PEX@TQ-4AT&QT75?/?6YI;+4(KFSAO4A3Y M_P#'?_!*[X:_$;0]$\.^(_BEX_33M%^.O[9?QYAETS3O#-GJ,/BC]KWQ/XT\ M:;=/N+FQO[6S;X1>+O%=EK_@>[FT^_35KSPW80>*K'4K&]U.TN/I'X*?LK7G MPP\4?M$^/_%'Q>\7?$#QY^TS-X#O/'/B"'1]#\!#0K_P%\,X/A=ITG@2S\,* M\OAZ%M$LK/4H!/>ZI?V.NK<:A'J4PG6* ^8OAK_ ,%,H?'GP5UWXXWWAKX( M:)X3L-$^#6KROI?[1K>-;_X O&'A#_ (2'3]4\.ZOXR\/Q:;-K*/%'@^]\.Z[_ &MIEBNF^)['7?!OB&&] M\.7#+K-K8VUCK+KOP?X1T;5?$NIWDWUA\#?V9K/X&^.OBOXWT;QWXDUR3XX MZM:^//BCH^L6]C_9FN?&&.>YT^]^)NF+ P?0+S4OA_;>!_AA/X=L_,T2+PA\ M*_A\8$36['7=5\0 'PKXE_X*TVGAO]DK]K']H2?X'2R_$C]FSXB_%?P5X>^! MTGQ&@MKKXKZ%X+U/Q;=^"?'^G^,#X0E3PYX=\:?#[P-XU\::QYWAW5V\'3> M?'N@F;7)?#C7UU]E:Q^W;^S1X7OM>TKQ9X\NM!OO"FD^(KSQ/=R>"_B!>^%- M*USP9\)I_CCXT\ P^/;'PI-X)U?XF>%OA99W_C?5?AKI.O7?CF/P_I]_>+H# M/8WL%M\T>+?^"4/PN\7>'/&^AWOQ0^(MO-XY_9T_:R_9]U*:WAT#^S/^,G/% M_P 6O$6C_$J70GM3:WGCKX'Z+\>_C9X(^&\\UPFG2>&?BCXMBUVUN[JZM)K/ M9^(G_!,KPM\1+/XB^$K[XQ^.M-^&'CCQ#\6?BII_@"R\.^#)8/"_QY^,GP1\ M8_!#Q3\1[/Q'=:?)K>IZ+;V7CWQ7\0-)^'VH2_V=:_$?5Y=0FUFY\+VFE^$] M/ .B\;_\%0_V;O#FJ_!S1_"=O\3OB;??%[XW?"SX-6UIX0^%/Q'CO_#4'QD\ M%^+?'?P]^)NJZ9KGA/3=1U#X8>+M"\':Q/X3\7:#:ZCI7BL:=X@ET"\O8?!_ MBQ](R?V?O^"IW[.WQ<^"/@KXH^.+^]^%7BGQ3X+\->+Y/AS/H/Q!\57=^?%O MQ8L/@?H6C?"_7+/P%IT'QNU2[^*VN>%OA[)9?"^Q\0WUGXU\5>'?#M[9V]YK M.F&[K>)?^":7AG5O&6D_$C1OB_XOT+Q[X.TW]B]/ .JS^&_#.M:/H'B#]C32 M?CWX;T/6=4T*\^SIXDM_'_AG]H7QKIGB?2)-1TX:3&/ OP9\%Z7\7->O8_@M^S'XY_9GTMO%_P -/A3X\T'Q9H'C;XU_ M"#XT7FI>-_!/CCP]KWA;6;62^^$&G>%K[0X;&R^T:%K6H7^C:WX<\4:?H>NZ M< ?>D?[0/PH7X0:S\==6\1W?A/X:^&[#Q%J'B35_'?ACQ;X"U7PZGA34+S2- M>L]=\(^,-"T7QCI>K66JV$^FQZ-=: FJZA>FVM]*M+][ZP^U>3W_ .W9^S7I M8\/VVI>*/&MCXD\3^(/&7A+1OA]G:]:_#?6=,\>6.FZAX:MIM:\(7D'B#1?M^F.+FN$L?V _A_>_LB?$#]D/ MX@^-/&/CGP;\2M1\2:UJE]/%IUE9>$;[7/%-AXUTG1OAEX-N8-=\-^#_ (>^ M!_$>E:9>>#?AS>1>(?#=E;6T^EZK%J^G:A?6LW,?"G_@G)X%^%_C+X*^/-,\ M1Z)I&L_"3Q]\8OB'=:+\-/@U\+O@[X(\4ZO\7/@WIOP5FAN/"_@32[0V::!X M>TBSU.VU._U3Q%XAU#5WN+:ZUF+P[%I&A:0 :GQ>_P""D?P&\#^'?"6J?#;4 MC\9]3\8>+OV0M%T^/PM8>,4\%VOA[]L'XM_#'P#X UW6?BE9^#=9\!>'M9N_ M!OQ&'Q2\-^"?$6LZ1XA\6^'-,M1#!IEKK^EZI)Z;;?MX_LNWF@:_XEM_B'J# MZ1HL'A>\TZ9_AY\38+GXA:?XW\86GP]\%ZK\&=.N?!L.H_&[1_%_CO4-/\(> M%]7^$MKXQTW7]>U31[33+JYCUK1[B_\ DSPG_P $F_#'@OX3^$/@9H?QY^(, M'PKL(_V/=7^(WAF3PMX&FE^*'C[]C27X*V7@OQ;J&L261U7PO:^.O"WP(\!> M'?B+X:\.W,=E?#1[35/#U[X=NIM=AU^;X>?\$C/@W\+O"O\ PCW@?Q'I_A34 MO!5W\+;SX&^,O"GP7^"_A?QGX#N?@OXPTSQI\/[[QYXFT7PK::W\;M16YT;3 M/#OBR7QEJ.GV'BKPQ%\/>&M;\(:A_T>3:3 MI=QJ-GJ\^G6$VJZ?!=6UAJ4MG;2:A96]\8C>P6EZ\1NK:"[,$/VJ&"6..X\J M/SD?RTQ4?PWX>>2XE?0]'>6ZN?MMS(VEV#27%YY^G77VJ=VMR\UR;G2-*N#/ M*7E\_3-/FW^;96KQ '\^7CS_ (*>_M6>#/&?C?X0VVA?"[5=?^#'C?\ :0\, M:G\5M6C^%_PW\$_%GQ'\'KCX1:AX-\#S6/Q>_:3^'-EX$-SX<^*UK-\3+GP3 MKGQ/\!!I]YJFG1?J=^UYKG@F\^$G@RU^)7B[1OA[J7BG6()/ M#WAGQ?\ '?QQ\ OAEXS\81>#M;U*3X??$;XS?#G1[W5[#PY;6!U?7K2QA-K! MXIU_POI%NUCJMJ)])E^P9O#F@7+(UQHFD3M'K,7B*-IM,L9&CU^",0PZVC/; ML4UB&)1'%JBD7T<8")<*H %G5-*TS7+"YTK6=.L=6TR]C$5YIVIV=M?V%U&' M601W-G=Q36UP@=$<)-$ZAU5@ R@@ _F/T;XMZ[??!;QW??%GX^_%'1/%/PS_ M &0_B'XC_8NU4?&SQE9VGQ(_:4\*_M&?M;>$-?N?A1K]AJMO<_M6Z7X8;PM^ MS%\/O@5JGCC_ (3WQ'\6O@QXK\,^)/$/A"[U'XQ>+8M1_H%3XA:#XA^$_CVW M\8?$_P -_#7Q;X%\ I:_'37/#7B_PM%>_L^^)]6^%^F>-]9U'6M0U]-4T7PE M=^%O#_B"S\=:1<^--.DTM/#LFC>(]0LKO0;H&?VF?1M)NAIPN=,L+@:/SMIO[,O(;>:TAN].\R)OL%S%:W$]M%/:>3+';S20(ZQ.R&E%X5\-POXFD MCT33 _C.X%UXK+V<$P\0SKHEAX;5M729)([]5T'2]/T@17"O"-/M8K;R_+#* MP!_/1I_Q4T/6_!_Q4\??LX_';Q./V/?$7C+]BSP-XMNM3_:<\1>.OB7([[5/ >M:OX7TKQ?\ M&JYTKP)#I_ASQ5JF-^UE\5W\(_L&_MRWO@C]K'Q7X"^#WPS^.4VB_LI>+M.^ M.%G9ZO\ %+PWI_P^^ .O>+_A]X<^,'BJZN?'OBWX??#OXV:W\7O#EO;>"O&M MQ>W^DZ!G:5I&L>#O"NJZ5 MH01=$TS4_#FBZAI^CK' +5%TJRO+&:UTY4M@+=!90P!80(AA/EH _!+]K+]H M[6[S]H#XT^,1XML-=\ _"7PC^S)XX_9>\/>!OVFO''PW\4_'?2/%NL^,K+X@ MG]F/2OA?>WOACXP?%_5?B)II^'VHZ9XVTSX@>$M2LM'\(?"Z\T/PGHWQ#\5> M)[G[O_X* _M7^.OV?9?AUX1^%WB'PSHOCOQEX7^*WCFQM/&'ASPA+HVO6'PM M?P+!)I,7C/XD?&;X.^$=,N[K4_&VFVTOA+0V\#_#EEIGAG MQ)X@LOT*LO"'A738=#M].\-Z!80>&1;VTM[LV.I6JR); M:A9FXBD^RWUNLTJPW<'EW$2RR".50[ @'\^7@_\ X*I?M*^)_"VG?'2W\%?# MS4_ ]S\6_P!C7X9V?P&T30-:?XB>)+W]KS]@WX#_ +2,.C:;\0[[Q5;6=AXC M\,_%+XH2^'/#,$O@J^_X2'1)FTO5H+74O[/U&#V3]B3X^?$+XW?MNS:[XI^. M'@CXIZ7XF_X)Q? CXCWNB_"2+6]!^''@GQOXS^._Q0O==\-OX7N_'7C6R7Q3 MX=T^73?#LFKZDVE^/GT.TT^T\8Z=:S_8/._9^/P[H$*)'%HFD1QQW5A?1I'I MEBB)>Z5;6]GIMVBI;JJW6GVEK;6UC< ":SM[>""V>**&-%FL]%TC3IIKBPTK M3;*>XEO)[B:TL;2VEGGU"[:_OIII8(8WEEO;YFO+N21F>YNF:XF9YB7(!_/Q M\5/BI#?^-/COJG["/[1_BOXB_%KX4_"G]M"_^)7B'5?V@=.\>77QL^-EE\.O M&?\ P@7P)^$_P*76M3TC5M5_9[\=RVGB1_$_@+X6Z%H/@"#X=VOP:L-1\;Z_ MXN^*UOX<]5\.>-?A]8R_M1>%_@E^UIXCT?\ 9.M_V:/@;XMG^/#_ +0Z>,-1 M\,?';Q=XB^,-OXG\->&OC#\7]0\70>#?&OQ4^'.E_#[6/&=I8ZK:>(?!NL:K MHGC/P]I/A'QCXV36;[]C].^&OP\TC7?^$GTKP)X-TSQ(&N&&OZ?X6T"QUL-= MQRPW3#5[73H=1#7,4TT<["YW31RR)*75W!T+_P %>#]4TF[T'4O"WAS4-#O[ MZ35+W1K[0M*N]*O-2FO#J$VH76FW%G+97%]+?DWLMY- ]S)=_P"DO*TWST ? MSRZ)XO\ WQ[_8V_X)K^+/$?[4?[/K#1?V#]'O\ QA)\"YO$WCW24&LV/BR3Q?XZUCQMX/'C-_$=MX"\6R:K MJ_D_O7\"O%\_Q!^"?P@\>77A'5?A_<^-?A?X \67'@379[VZUOP7-XB\)Z1J M\GA35[G4K:SU&XU/P\]X=)O9[^SL[Z:XM));RTMKEY8(^HL/ /@?2K"+2M,\ M'>%=/TR#64\10Z=8^'=&L["+7XMGEZY'9VUC%:QZQ'Y<>S5$B6^3RTVW VKC MK0,)-:T/Q?JVH^$?[5M=.T"&T\+>*_$6JZ MG<1^&8O#/B7R+X@_\%+-0^'FK>.-=\0_#[X>:+\,?@CXJ_9?\"?&P:K\9[6X M^*0U[]J'3_A9J&DZ_P#"3PIHGA/4?#?Q!^'W@:/XK:3%/XKG\4Z-!\1KOPS\ M2+'P9'!=^"!#KP!^LE%?FE\)?VV/&GCCXV?$3P/XAT[X56NB>'];_:'T+P+X M'\+W/Q7N?C)\0-1^!/CCQ'X3GT7PU?>,O _@_P""7BOQ==V/A>[U[7O"'A+X MCZIJOA:VU"R.JF#3;?4-7@]X_8[_ &D/$G[3?@#X@>+?%GPV3X4Z_P" _P!H M#XZ_!"_\'?\ "5V7C*XM)/@W\0M3\#I>ZCKFF6=KI#ZMJ<>GK>:K8:+)JFCZ M5?R7&FZ7KNOV=M#K%Z ?6M%?G_X?_; \<2_M=:1^S+XF\"?#+S_$T'Q%U--* M\"?&'_A,_BU\+?"'@BR;4_#/Q%^-7@@^$=)T/P]X-^*EG<:%:Z ?#WBO7-6\ M/>(?%7A31+^TUN+4->U7PK^@% !1110 4444 %%%% !1110 4444 ?,OQF_: MP^%_P+^,O[+OP,\:V_BN;QI^USX[\;_#SX5RZ'HUMJ&AVVO^ /AYJOQ,UU_% MNHS:I93:+I[^'-'NTL+BTLM5EN=1,=L]O!"9+J/Z9!# ,.A (^A&:_$'_@I/ M_P I)/\ @A3_ -G6_M0?^L<_$&OV\C_U>.WFDB!, MB13R6MRD$C*$F>VN$B9V@F" $U%-# @GD 8'*LO)Q@ $ G.0!C//'7BE+ ' MGGT5B?7D $C\1UXZT +110#D9Y_$$'\C@T %&0.IQ17R!^VM\1/&GPS^%&C: M_P"!-?NO#FL7/CO1]*GOK2"PN))-/N=(U^XGM3'J-I>P!))K2VD++$)08@%D M52X8 M_M=?LOWG[4G@G0?"FF?&?X@?!J]T/QCX%\3-J/A"#PSXBT37++PC\3 M?A]\1Y])\3>!?&^C:_X2UVY>Y\ 62>&=7X2Z!!XF\2I\)_A'X2^&7@S1OAE?>&_A/K5Q>>'?A-KFA^)O#G MAR3XO:M\/+KXX:;X,U[Q'X>TK6OB%X'TCXA6?ACQE<6L]A)8Z5H.N^*M&\0? M"/\ PUS^T?\ ]%5UK_P5>%?_ )GZ/^&NOVC_ /HJVM?^"KPK_P#,_0!^I5S^ MRSKM_P"-;+QAK7[1?Q>\31>!]8^(?B_X)^'?$UK\.=2TKX5>/?B)X1\;^"I? M%)O;?P7I_B'XA+X,\-_$+Q5H'@'0/'NLZMHVCZ'JLUGJ\'B&[M=(U+2_._V? MOV+_ (D? /0?'N@Z9^UW\3==3X@_'I_V@-7U"?X8_ ?2K^/Q#XJ^+,GQ3^,? MAB,V/@.6TD\(_%M;G4/!FIQ26A\1>$?#=_)<>"/$.B^(;>QUFU_/G_AKG]H_ M_HJNM?\ @J\*_P#S/T?\-<_M'_\ 15=:_P#!5X5_^9^@#]2]+_9.)^+'P_\ MB3XW^./Q8^)NE_!SQ=XT\=_!WP5XR_X0-[?P3XG\?>%_&?@K69[WQGHW@W2O MB#XTTO2?"'C[Q+X9\*:'XI\27NG:?IMS8W6O1^*-=T'P[K.D_7P([$'\/?&>H>)-,T_P % M#4[.TN[+1K9(+_\ M_3;3[2KZ;IEC,S_ &::6+;)(\>')V;PK _3JBBB@ H MHHH **** "BBB@ HHHH _$#_ (*3_P#*23_@A3_V=;^U!_ZQS\0:_;R/_5Q_ M[B_^@BOQ#_X*3_\ *23_ ((4_P#9UO[4'_K'/Q!K]O(_]7'_ +B_^@B@!]%% M% !1110 4444 %%%% !1110 4444 %%%'2@!&^ZW..#S@G''7 P3] !+,ZIX*^+'P9\(W^D>%? GPCU;P?%H6KSQZW\$-?\ @KX4\5>- MX?B#XKE_H/\ %G[2WP.\#>(=2\*>*_B%I>C>(-(>"/4M,GL]:EFM9+FT@OH% MDDM=+N+=C):W4$P\N9P%D4-A@RCDD_:R_9?COKG4X_B3X<34;RTL["ZOTT?7 M5O;FRTZ:^N+"SGNET(7$UK8SZIJ4UG;R2-#:RZA?2VZ1O>7+2@'XW_"#6_"" M:1^U_K9\5>"_V8OV+KO]G;X Z)J-Q\$/CMX\F^&R?M+0>*/C&OC6Q\(_'+Q- MX6\ RIXL^(OP_N?A7X<^++> -*T3QU%]H\&V_B+Q1I_Q8OM:M?#_ #7P7^(7 MP2^)/[.O_!.2]_: \8V_C#]E[PO_ ,$W-.\":S=Z9K'C;5X?#G[;WA_X=?L\ M177AKQ'+X/EGUC3/VA]&\ W'BV/X2:?J)C^(5CXGF\;1^#8X_&DT*R?M\/VP M/V; "/\ A:NC\^MCXE)]."=&)'X$<\]2:#^V!^S81C_A:NC_ (6/B4'TZC1@ M3^)Z\]: /D?1/CK^T ?V1?AO\,-(\/\ C3XF_MK^&/A!^RI8?M1>&_!LOA"S M^)_PD?XO>#))?&7Q,>V^*7B;X?>"]8\:11>$O&XT'2H?$UU'#\0197VKZ9)X M?L;^":W_ ,$=KG4!^P_HNA7OPZ^)/PSMO"/[0'[8_AG0M!^*5WINH>)F\-6? M[7/QLN]!)U&S\8>-+W48-&TZ^@\*7.I:SJBW>HZQX>U2]T[^U/#<^A^(M:^K MO^&P?V;/^BJ:+VX_L_Q'CCT']BX'X4H_;!_9MZ#XJ:+R?^@?XC/)]SHO^?I0 M!]+5\&?\%$?^2(:!_P!E+T#_ -,7BBOM3PMXIT#QKX?TKQ3X7U*'5] UNU%Y MI>I0)/'#>6QD>(2QIH:M M=)\1M"N'MM-LY[V=($T3Q*CS-%;I(ZQ(\D:M(5VJSH"06&0#\.-7GN[72-6N MM/6P?4+72M3N=/35;MM/TI]0M["XFL$U6_1)'L-+>\C@34K](Y'LK%KBZ2-V MA"G\XOA+^UAXB\*Z1\8;?]H#QYIEG\1M+^*^H^%O"/@/XD>&?#_PEL]*O=6\ M5_\ "(Z9:V/Q#T[Q-J7@7Q!\)M#UZ+4+76-9@U6_UOP7IGA_4[G5?$&KW.N: M'9K^J]Q\-/&]Y;W%I=^ ?$MU:7=O/:W5K=>&;^YMKJUN8G@N;:YMI[.2"XMK MF"22"XMYXY(9X9)(IHWC=E/D_P ,/V1-"^#9\4-\.O@EJV@OXP\1WOB;6Y'\ M.ZOJLKW-W=F^@TBQEU:"]DTWPKHUR\TGA_PM:-'H^C&YN6M;?S)F>@#\Z-%_ M:8^,NN_L5:3\9?"7Q*^&7C7Q7H'QGO? GQ"\>#(-5L+.Y^)?AKP_XW\6Z1X2N?'6L_#SX975]J47B[QYH_@Z+3]7; MQ%>Z";?1]/N#)H^NVOANQUN\\8ZEH>K6/AZYLI-#Q%^PQX(\4^"-.^&VJ_!+ MQK%X#TS7]<\4V_A;0=6^*_A'29O$'B+QF?B)JFJZG%X1\2:%)K=R?')'BC3A MK4NH0Z'JR13Z%%IB0PQQ]0?V3+%[?6;>?X6_$.];Q!:>!+35+_4-;^+%_K4C M_#/[TCQ%X>EU*\N(O%.CZEI_B34KJ5+K7-5U6>"WDB /( MOV*!?W=[\.?C5X_\ A9I_B;4_#*^#+_QMX=\-VOAK6O#O MBS4?"J16T>@ZQ=Z3XJM],UNPBT_1HSJ>DW%\-!T%[Y]&L?V-_P""!M"M?#7A+X8>(M#T2SFO[J*RMM"UV=I;[5K^YU M76-4O[Z_%YJ>K:QK.JWEYJFLZUJU[?:MJVI7=Q?:C>W-S*\A_1C_ ()\^%_$ MVA_%+QKUO2+>;P ((I]3TR\LH9)O^$ETJ3R8Y+B&-'E\M6DV*2VQ6;& M 30!^N=%%% !1110 4444 %%%% !1110!^('_!2?_E))_P $*?\ LZW]J#_U MCGX@U^WD?^KC_P!Q?_017XA_\%)_^4DG_!"G_LZW]J#_ -8Y^(-?MY'_ *N/ M_<7_ -!% #Z*** "BBB@ HHHH **** "BBB@ HHHH *1NA^A_E2T$9!'J,4 M?S__ +89/_#27Q0Y/_'_ *!W_P"I1\/U^5_[7OQK^(WP2\+>"]=\$V.BV&DZ MQX\\&Z'XL^(/BKPKXN\:>%/"5CJWQ!\!>'QI.M:/X)=-9TQ?$^C>(/$MQ#XJ ME+VVE1^&[FPTVVNO%.K^'XJ_?']H;]G>R\:?&3QOXGE\67NG2:K=:5(UE%H] MK>$]>2WT?QGH/B^#2KU])UZ!9M&U[6/ ]I'%=7-J MVH:;>:7/JGA'4=+US39+N, _._Q%\5?BCI.K?"_5["X^$.N>&OBCX\^%7@GP M7X)\+WNO^*?%/Q$T;QK;^'Y_'?Q(\)>.(]3TK2;/0OAWI^J:YXUALYO!6K:5 M=_#GPJ^L>*/$WA_6/%6B:?IO+_!3]IC4OBSXH\(7YO\ PWIO@/XHQ?%"3X?Z M/>^!OB+HVLWT7P\U6_M;:/0_B??7%S\/_'7BU](TC4/$7Q \#6^E^&[GP=IT MFSPYJOBR?PMXO6']$=&_X)3^ O!_CVR\<^#OC'\=_ UQIVA^#_">C>#?#E_H M=IX&T3P)X"M]/L](^'WASP]J_A_5M3T#P)(^FI>^(O#^AZ]8)X@UJ>]UK6KJ M?66AO+70'_!+CX617-T=.^(?Q7T4);?$5/!FDZ'K=YING_";5OBO::Q;^._% M/P>TZ&[<^!O%NJIKVN3:;K,3ZI_PBKZOJR^$;30K/5-1M;D _,3XE_M5:[\. M_'_C.QU"3P98Z)X"^*?P9^'I^&=]I?B"Z^+7Q$\'?%BY^'VEWWQJ\':C9ZY' M86OA/PSK?CRZLK.V7PAKNCW8\ >+K#Q/XF\.:[>Z39V/W6ZO%*\3-EHI7B8J M25+1N48J>Z[E.#WNFI_\ !.CP1K^OZ+K.M?%+XJZ[!HEYX2UB+P?J6MWV MH>!=1\2>!%L9/"_BK5_"DNH/!>ZWIE_IFG>(9TBN;3P]JWBO3K#Q=KGA_4?$ M5A:ZE%ZU_P ,FV"L%?QQJBL",B3P_9A_8MNU#=DCG)Y.<]Z /T[_ &2^?V)_'?A?PUJGCOXJWWB[2OA+X&L;[QW\ M/="NX/&&L^#= UZ^T74_%&B^*M>E\,ZOK3:)X6TF+PIXCU74-3U/5K#0?!OB MFU\4OVLO$?A#QE^R]X-\'^!_"_BFZ^,'QA_9V\!?K;QK<^)/"7PLT#]HN M36=-\&'P=XS\,Z=#I/Q%\5ZW?Z/J'B#PU(T&F:#>?#;1KCQIJ-M:)XH\'65] MZE^TE^SS%^T3X2TGPVGQ1^)_PFU#1O$WA#7[;Q#\-MT.Z,1UC1->\3US_@F7^Q= MJT'PHBL?@UI/ARX^$/CWX/\ CS0]8T6_U5=?\03?!+3XM(\'Z%XVU6[OKA_$ M.E7.DVFF:=KM[Y%IXBO+72=.CLM9TZ. 1D \]\0_\%#;KP'\.[#]HCQQX'\, M']G?Q_<_M)Z1\)9O#7B/79/BM>:U^SYH/Q5\0:&OC:RU;3T\&6MC\;[7X*^/ MX_#2^'[A[GX<7+>$H/%\9^#;K3B_C*PL-;MO$_@7QWX#UOPYJE MWL?1?%>FWWA_Q3HUMHHO-2\/:5R<_P"Q1\(=3EU/2O$U_P"-O%OPPF;XV7'A MKX)Z[K&D#X:^ M4_:,TSQ/H_QBU;PF-)\/Z7XT%QK^G>./'5MX8M=>\7ZWIO MPS3QSXM/P_M-".IVG]E]+X<_9L/AN?5M=B^.'QNU7XB:[<_!_3M6^*>M:E\/ M+KQM>_#/X+:_J&N^'_@VZ6GPZL/"T?@;Q0^N^*[?XD:I!X;C^('C2Z\7^(/$ M-SXQLO$;:1J.D &=X;^(/Q^N/VE-2^%.MM\!=9^'^A^"M0^(/BB_\':9\6=. M\>>"]'\3:UJFA?!;0M8O?$?B/4O!VK^+/&\^@>*]4U>TTW2M/M+#PWX-U;6K M4PC6?#UI!_CW\%_ =Q-^V%KERFO\ MA71);WPC\2?AKHUCI>C^ O@SX@\#'0-=\[6O@7XJ^"WAK7O&%K\0=:?^B7XH M?\CYX@_Z[6?_ *;;*O/$@@CN9;U(84O)X+.UFO$BC2[FM=.EO9]/MIKI5%Q+ M;:?/J6I3V%O)*T%C/J.HS6D<,M_>/. ?@Y8>&?AIK;?M%>'-,\2_!;3/V _C!\2/V/=._X1+XF?$=-8\-_%KP;K^M-JMW\<];L+?PQJOQ ML\97'BVR^&#>'+3X6R_%V+P[J$&I7>N\W^TWK?Q'U#_@GW^T!\,/AE\"-;U? M]GKPQ\._VQ)+?XK?LN^$?"OPL\%?%'3_ 9X,74/A/XAT[X>:_\ $_P]XM\- M>!_$'CS6_$/B_P").L_#;_A.-,\>7GP@M;'P!#?^&O']W80_T)&YNF=9&NKI MI$WA)&N9VD029\T)(9"Z>;EO-VD>9N;?NW',;22._FO)(\N5/FO([RY4 (?, M9B^4"J$.[*A5"X"@ _._P"/WBWX9?%WX"Z;\/\ QKXDT/P#J?@[4OV1O'GQ MI\(?&'X=Z]\2=+\!^'O%-[_PD7A>P^-/AKP-K$GAF?P_XGD\+7\EYJ<_CN\^ M'NBW^FVM_L6W=@WP@U/1/#WASP)I/@;P?\ %+X@^$OASXG^ M%_@.Z^&/P]^+'@C3[K2M1LOBQX5\"75YJ2:':>)-;UCQ!HNH7&DZGJ7ACQ'K MGA75?%7A*]E\-ZYID67,>R61/+,HQ*8]K#895^64KCS%^5] MPXI"[R/OD=Y'8KN>1VD=MH"KN=RS':H55R3M50HPH !]J_#;_D1_#?_  M_P#1T]1_ZN/_ '%_]!% #Z*** "BBB@ HHHH **** "BBB@ HHHH **** /BWXH? M\CYX@_Z[6?\ Z;;*N!KOOBA_R/GB#_KM9_\ IMLJX&@ HHHH *5>H^H_G24J M]1]1_.@#[7^&W_(C^&_^P:G_ *.GKD_CA_R*-G_V'K/_ -)-0KK/AM_R(_AO M_L&I_P"CIZY/XX?\BC9_]AZS_P#234* /E.BBB@ HHHH *]L^!7_ ",NL_\ M8#'_ *7VU>)U[9\"O^1EUG_L!C_TOMJ /J2BBB@ HHHH **** "BBB@ HHHH M _#K_@I=))%_P4>_X(6210/1_ZN/_<7_P!!% &)_:NJ?]"Y??\ @?HO_P L*/[5U3_H M7+[_ ,#]%_\ EA6]10!@_P!JZI_T+E]_X'Z+_P#+"C^U=4_Z%R^_\#]%_P#E MA6]10!@_VKJG_0N7W_@?HO\ \L*/[5U3_H7+[_P/T7_Y85O44 8/]JZI_P!" MY??^!^B__+"C^U=4_P"AH^H_G24J]1]1_.@#Z_\ A_J&H0^#?#\< M6AW=S&FGH$GCO=*1)1YLIW*DU[',HR2,21JW'3N>8^,E[>W/A:T2XTBYL4&M MVC"::ZTZ92PM;X",):W<\NY@2P8H$ 4@L"R@]_\ #;_D1_#?_8-3_P!'3UR? MQP_Y%&S_ .P]9_\ I)J% 'RG1110 4444 %>P?!>XN+;Q#JSVUC-?LVC!6BA MFM8&1?ML#>86NYX$9<@+A&9\D';MR1X_7MGP*_Y&76?^P&/_ $OMJ /IFSGG MN(3)<64MC)O91#-+;3.5&,2![6:>+:V2 I?>"IW*.,VZ** "BBB@ HHHH ** M** "BBB@#\0/^"D__*23_@A3_P!G6_M0?^L<_$&OV\C_ -7'_N+_ .@BOQ#_ M ."D_P#RDD_X(4_]G6_M0?\ K'/Q!K]O(_\ 5Q_[B_\ H(H ?1110 4444 % M%%% !1110 4444 %%%% !1110!\6_%#_ )'SQ!_UVL__ $VV5<#7??%#_D?/ M$'_7:S_]-ME7 T %%%% !2KU'U'\Z2E7J/J/YT ?:_PV_P"1'\-_]@U/_1T] M1_ZN M/_<7_P!!% #Z*** "BBB@ HHHH **** #IUK\]_V@/\ @I=^SA^SUX\OOAMK MS>-/&7BS1EC7Q'9^ M%TW4[3PW>30)=1:5JNIZQK>AV3:L;::">>PT^2^EL$ MFC743:3.L-?H.>G'^<=OQZ5_()^V[^S1\:?A[^T=\5M0U+P'XOUSP]XZ\>^* MO&GA+Q7H'AS6]>T;6]*\3ZO<:Y' M[I=IJ"VNK:0=0&EZIIEX\-W#-;+<11R M6%U:3R ']3/P*^//PU_:,\ 67Q'^%NM2:MH%S=W&F7D%Y:2:=K.AZS9K#)>Z M)KNF3%I=/U.UCN+>M>'_#&M6\UCKEKH>B:(-*CU?5=-G*SZ7)K=Q-,]I87 MEO;Z@NGV5K=W<4:7EM''^L= !1110!\6_%#_ )'SQ!_UVL__ $VV5<#7??%# M_D?/$'_7:S_]-ME7 T %%%% !2KU'U'\Z2E7J/J/YT ?:_PV_P"1'\-_]@U/ M_1T]Y( ZD@4 )17P1XK_ ."BOP+\,^*[ MWPU:Z9XV\4V6G7SZ?>^*?#]AI)T5IX)F@O'TR#4M4LM2U:UM95=%NH;>"*], M;-8F>%HIY?M?PGXJT#QQX:T3Q?X5U*'6/#OB+3X=4T?4X%ECCN[.?1_ZN/\ W%_]!%?B'_P4G_Y22?\ !"G_ +.M_:@_ M]8Y^(-?MY'_JX_\ <7_T$4 /HHHH **** "BBB@ I#G' R?3./U]NO\ (&EH M_P _Y^O_ .J@#\F=2_;Z^-^A:%_P4>U;Q%\#O!>CZS^QPOPQO? /@I_B$EUJ M.NZ'\0OAAH_CB34/B)XD@4>'SKVF#4;C5AX.^'?]MW6J6EO:>"_"^L^*?&>J M6;R>^?L7?M5:C^TKX8^*VK7-_P"$O&=I\-?'<7@VS\9> _"OCKX8IXHO6\'Z M'XHU/2;SX/?%K4KGXF> ]=T"YUB+247Q3'Y$TVXE6'DK'_@F MY\/SXU^,GCCQ;\=_VD?B)??''Q!\-/&OC#3?%?B3X56&F6?Q#^"-SX8OO@A\ M0O"TW@;X.>#==\-^*OA'J7@WPSJ?A*6RUHZ1>7^DP7/C#1_%+R7(F]:\$_L> M>&O _B6Z\=V/Q<^.FH_$;Q'\2_!7Q$^)7Q U/Q=X9C\0_%RP^'G@GQ'X%\'_ M O\?V>B^!]%\+/\*=&T_P 37FK1^%?"?ASPI=W/B6UM-=O=:N+M]0%\ ?GS M\.O^"GWQ4\;:C\'=&LM ^#7BSQ!^TE\,];^*/A_PC\,!X^\;>,_V4X? _CWX M2:1\3_ '[27A>SU)M6\6^/\ P!X'^*FH:YJF@>%[;X:^*+OQE\+O'/@FR\'3 M6DTWPOX+U[3M"\+_ &[X>Q^(;;4_&NG:[#9/ M9_$'5-0L([V2:U\'VOC@WG@[PC=3V4-WJ@\-:CKUQ,]AKVAQJSPO^QOX-\-^ M(_%/C&X^)GQM\4>,=7\$>-/AWX0\6^*O'5CJ7B/X3>%_B#=:3>>+!\/=5M?# M6G7,GBC5;CPSX.,WQ$\?OX]^(SVO@OPKI4GBR31](CT^3L?AO^RS\(_A-\0; MOXA>!=*U#1;Q_#MSX9TGP]%?H?"WAJPU/0_A/X;\02:%IHM5NXKKQ)HWP,^$ M]IJK:AJ6I6\;>#+:[TFVTR]UGQ-U.*XT[1%U*Z6*T?5[ZWN;33$E:]GMKF. P2?F/!^VI\9(_V^&[;6M(\-?V9>VNG:YXA^*VI^&=/\'^%-4T& _.3 MQ5^S5\?#/QIJFH6]U]AT^]T+P[JFMZ3KENK^5::EI>JZ=;7&GS M6U[$$G'FW,4MHSM!?);S12JO[Q?LK_#3Q!\(_@3X(\$>*F"^([5-7U?6+))X MKF+2+SQ!JUWJS:+'<0/+!/\ V9'<103RV\CV[WANC SQ;9&\W\%?M%^./B!^ MQ7XG_:#\&Z=HOB?QS!X(^+^K>"=/\->&?%U]8^+=5\"ZWXLT'PG?WWPHMM2U M7XB^'-I>$O <_@K6/$/PRGU'PC)\8_B.1X+^, MFL>%_%^ECXXKXI;0OA2WA36-,\;>$K;7()K6 _2^O;/@5_R,NL_]@,?^E]M M7QC\$OBMIWQ?\)WOB>SU3P_/./$6L12^'M'NUNM5\$Z1<7%KZWT MSQ+HDEU"\*:KX?U*[L-4M;#6;%F%QIUY/\ 0]>T[Q/X7UNWFL;:WT+38]+L/(^U:* /G/0O MV7?AMX7PYI6M?%J#P]J6A_%K3_%6D+\7O&MO'X]\3?&WQA8>//'WQ;\<: MEIU[I^O:S\;;CQ-937OA[XH6>KZ3K7A&WU?6M-\.0V&G7L-K9V](_9K^'VGP M^(SK&K_$?Q]K/C/6OAOJOC7Q7\2/'5WXM\4^,--^$>LS:_\ #_P/K]^UAIVG M/\.-$U:ZO;ZY\%:5H^DZ9X@N=3UJY\2MK%SKVM3W_P! T4 >4?"[X+> ?@]_ MPD@\#V6IVW_"476FR7O]JZO<:P;'2]"?6Y?#OAC16N$C;3O"_AN7Q-XCET33 M&-S<6SZYJ)N=0O \ M_L/X%?\C+K/_8#'_I?;5XG7MGP*_Y&76?^P&/_ $OM MJ /J2BBB@ HHHH **** "BBB@ HHHH _$#_@I/\ \I)/^"%/_9UO[4'_ *QS M\0:_;R/_ %NM,DFBU&T\$7/B' M2[?QK<6LMNZ3Q(OAZ6\34)XCO@TJ2_F!18VD0 ^F?#WQM^#GBWQ%)X0\+?%? MX;^)/%<1N5D\-:#XW\-:OKR-9H[WBG2=/U.XOBUFJ.;I4A8VX1S,$"L1Z?7\ M&'AJY\0Z5XA\/ZAX,:]L_%UEK6E3^$)]%#PZG%XE6]@&@KI+6H67[9+J9M8+ M>&W/^D&3[.5>*5T;^[?P^^K2:%H[Z]'#%K;Z7IS:Q%;[3!'JK6<#:E'#M9U\ MI+XW"1[69=@7:Q7!(!L4444 %%%% !1110 4444 %%%% 'Q;\4/^1\\0?]=K M/_TVV5<#7??%#_D?/$'_ %VL_P#TVV5<#0 4I!!P00?0\'T_GQ7Y_P#[?WQR M\=?"3P7X,T+P!JD_AW5/'NI:[#J'B6Q9%U;3](T&ST^2:RTB9T/X5_9._:>^,>G?&OP+X7\0>./$GC3PMXZ\1Z;X5UG M1_%6KW>MB ZNYL[+5]*NM2DN;K3;_3+EX9R+:9;>^MA<6EW!(TLN3^.'_ "*-G_V'K/\ ])-0 MKK/AM_R(_AO_ +!J?^CIZY/XX?\ (HV?_8>L_P#TDU"@#Y3HHHH **** "O; M/@5_R,NL_P#8#'_I?;5XG7MGP*_Y&76?^P&/_2^VH ^I**** "BBB@ HHHH M**** "BBB@#\0/\ @I/_ ,I)/^"%/_9UO[4'_K'/Q!K]O(^(T!Z[%_D*_#W_ M (*7P1W/_!1[_@A9!*&,;_M6_M/;@DLL+?+^QW\0'&)()(I5PR@_*ZY'RME2 M5/[21^&]+\M/EOA\B\#6-:P.!QSJ)/YDGWH \?\ VG_VD_A_^R9\%_&WQQ^) M5AXTUGPUX)\/^(]?GT'X>>$]2\9^,==3POX5U_QGJ=AH>CV*QVJ3Q>'O#.MZ ME<:IK^I:#X8TBQT^ZU'Q!K^D:;;S7D?G_P 4/VO/!G@R[T/PSIGPS^*'Q>UW M7_AEIGQ7U_PE\.M&\'ZIJOAGX;^)KBZTOP_?:Q8^+?&/A6W\1ZYXQOM-\3Z9 MX,^&O@B7Q=\1O'LWA#QA#X5\)ZN-$G66I^VY\"OB;\<_V8/C)\#O@K>>!M)\ M2?&KX=?$#X1ZOKGQ/UWXAC0?#_A;XD> O$_@_5-?L[#PE_:%[K6M:1<:Q87U MEHE]]ATG48H;J&ZU*SD^SN?ASXE_\$TOB;\8K*[\1>,6_9P7XB?$C]F'2/V3 MOB2NM:%\3?B3X2^'N@>"M=\?WGP\^-WP+;7M1\/:OIWQ:T#3?B-K_P!MM=:M M]+,^J6WA>?1/'6@0>']23Q4 ?:6N?!']G;]G[5=$^*GPO_9"F\9_$K7-?73? M#>G_ F\">&XO$&G:EJ.F:IJT^KW&I>-M?\ "/@3X9Z1;6>G74-[XAUS7/#, M$5Y=67A^P:ZUW6-.TB\YWPY_P4?^ OB.VTJ^BTGXD:197<&KV&K-K?ABPM;[ MPYX_T>/XOM-\++[2K77KZ_U?QA/<_ CXF:3IU_X0B\2>!M9UW3-$T?0_&&J7 MGBO0$N[OQ#^ 'QV\6> _%?PZGU/X$?$3P1;ZWXC\2R)9?$6X^+%KJ_C*/Q7X0\+:CX=U#PU:Z5X>U;PB^KZ MAJ/B&T\8TO\ X)S:W9?!SX>?#&3XA^'[74OA[H_Q0U3PWXHT'P_K>F7W@_7_ M !%X[OO&/P>^%?@34+K6]2\4^'_V=_@+I^NZGX<\'>%'\2W6OR2^'OAYXBBO M-,O?"D5G* ?J7IEW-?Z=87UQI]WI5Q>6=K=3Z7?M:M?:;-<01S2V%XUC]7B/P9^%.H^ /AOX<\*>+O$6H>*==TTZS+ M<:@-=\5W-MI]IJWB'5]:TGPIIE[K.L7.M:CH?@71]1L/!/A_5-=GEU[5-#\/ M:=J&MR-J=SHK!_P"$;TOTOO\ P<:U_P#+ M&C_A&]+]+[_P<:U_\L: -ZBL'_A&]+]+[_P<:U_\L:/^$;TOTOO_ <:U_\ M+&@#>HK!_P"$;TOTOO\ P<:U_P#+&C_A&]+]+[_P<:U_\L: -ZBL'_A&]+]+ M[_P<:U_\L:/^$;TOTOO_ <:U_\ +&@#Y+^*'_(^>(/^NUG_ .FVRKR37O%' MAGPL-"/B;Q%H7AP>*/$^D>"?#)UW5K#2/^$C\9^(#,-"\(Z"+^X@.L^)]9^S M7+:7H.FBYU2^CMKF6WM7BMYGC]4^(]O%:>-==MX0XBBEM HDFFG?G3K1CNFN M))9G)9B?AR/4_%G[)WBG0?@!\7_BUXZ^&7[4?[/_ ,2; MCQA\,OA+K/Q%;P)\(O!?CV_UKXFPP:I;7T-EHNN7\<6EW&+7QKX9T_ MXHVLAL;QO[6T#PO?WL7=Q9?#.U^*/BCP3X%@FU9Q%IUS=^'M'N=0M M)-=U:W.IVUA#?O/)9:7=ZG:0I&FIWVG,?+?#/PQ_:'TKXZZW>VWA_P")FIOX M]_;W\/\ [0=G?^*_A]\,V_9\M?V9?$OA3PA9W^H?$'Q%KEAJ/Q'\*_M)?!?P MQ9ZG\./AYIFA:EI?C#P?K_A[PSIWAK2KSX=>(/'6K7G4?M+>+]9^*7AY?!&D M?LB_M(^'1^TC\$]>^'7QN^,DW[-R_$'QU\-O@K+XF\7>']0^#UCX5\-:YXA2 MY^*_BE;_ ,1^*_!UIKNI1?#?X?:1XGT3XIZ[)XM\4MH'@0@'Z)1_$#P)+?:_ MI<7C/PK)J7A/6-(\.^)]/37],>^\.Z_K]_'I6A:'K-HMR;C3]7UC59$TG3=/ MN(TNKS52VEPQ-J$4]M%V X8?4?SK\J_B!\$?B/\ #CXAVOQ#_9S^&WBW5-)\ M!VKQ^&?#GC+ M-"&X MV1_:(892\45QY<9GC19C'&7V* ?;?PW_ .1'\-_]@U/_ $=-7)_'#_D4;/\ M[#UG_P"DFH5J?#[0M/N?!OA^>5;OS)=/1G\O4]5A3/FRCY8H;Z.&,)U[!\%[&WO_$.K17(F*IHP MD7R;JZM6W?;8%Y>TG@=EPQ^1V9,X;;N ( /K"BJEG906$)@MQ*(R[2'SKFYN MGW-C.)+J:>4+P,('V*(/\ KM9_^FVRKS]D1OO(K8Z;E!Q^8->@?%#_ )'SQ!_UVL__ M $VV5<#0 FU<@[1D# .!D#T!ZX]J:8XSC,:' P,JIP/09' I]% "8!Z@=0>@ MZCH?J,#'IBG+U'U'\Z2E7J/J/YT ?:_PV_Y$?PW_ -@U/_1T].?VA_^$,^(6G>%]=_:XFM?'%U\1D^'6H>%O"O[,UUXD^$WA'7A;?#.YN3X MUU@0WGB/2_"VDWGQF^$7A?7O&D_Q;TG1],\4?$KPOHFHSZ/JL]_9:7^D>E?V MD-,T\:R]C)JXL[8:G)ID=S#ISZ@(4%X]C%>2S7<5HUP)&MXKF:6>.(HDLLDB ML[ 'XH?\%)_^4DG_ 0I_P"SK?VH/_6.?B#7[>1_ZN/_ '%_]!%?B'_P4G_Y M22?\$*?^SK?VH/\ UCGX@U^WD?\ JX_]Q?\ T$4 /HHHH **** "BBB@ HHH MZ=: "BC(QG/'7/;'K10 444F1TR,^F: %HHH/ )]* /BWXH?\CYX@_Z[6?\ MZ;;*N!KBOCY^T!X-\'?%WQEX:U/3?$<]]I=SIB7$ME:Z=):N;C0M+O$,3SZE M;RL!%<(K;HDQ(' RH#'Q_P#X:F^'_P#T!_%O_@%I./S_ +8_/TR/6ORO'^-W MA/E>.QN69AQUD>$Q^78O$8'&X6K5K*KAL7A*T\/B;Y;3G.G/&48SA*4)Q;DG&47RRB_=W3NGZ/L?2M%?-7_#4WP^_Z!'BW MT_X\])Z^G_(8H_X:G^'V,_V1XMP<8/V/2<'/3_F,=^U+0 M/4V>D@?^GBE3]J?X?$KC2/%AY R+/23W]M8I_P#$?/!S_HX.0:_]/J_E_P!. M/-?U8X&O#$X+'X7#XW!X MFDVZ>(PN*I0KX>O3;2;A5HU(5(-I-QDKI'I0G&I",X24H3C&<)+:49)2C)>3 M331\IT445U%!1110 5[9\"O^1EUG_L!C_P!+[:O$Z]L^!7_(RZS_ -@,?^E] MM0!]24444 %%%% !1110 4AQ@Y (P<@XP1CH<\8/OQZTM5KR[M;"TNKZ]NK> MQL[.WGNKN]O)HK>TM+:VB>:XNKFXF9(8+>WA1YIYI72.*)'=V5%) !^ _C[5 MO@UKO[<_Q5\-ZIX__9)^&>JP?''X1>']9^&GQ9^-_P 8M0^(GCR\34O@Q\2D M\0^"O /A[Q_X;^&G@F[^*/C#P?X$BUSP98:)K)^(NM?"[P9>?%,:F))O#:?T M +P,<'!/3ZGK[_WCZYK\'OB5\:89_P!K>\T/1/VE?!T_CSQ7\;/@?K/P>\;6 M'_!0/X=^%_A/X*^".LV?PTOM;^%GB7]D4_%JQO\ Q]XN\?:2GBC^P/L_PC\= MW/Q(NO'_ (,\2Z;\3_ Z6NCP^$?WA7H,G/4=<]#T)[D="?7- 'X@_P#!2?\ MY22?\$*?^SK?VH/_ %CGX@U^WD?^KC_W%_\ 017XA_\ !2?_ )22?\$*?^SK M?VH/_6.?B#7[>1_ZN/\ W%_]!% #Z*_)7]I;]KWX[?!W]NK]GWX2WNI^"?A5 M\ /'-IJD4FO>//ASXL\4>'/BK=3ZA\,](:-_C#X9UA=,^"WB+1/$'BN[\)>& MM*\5^'_[#U77;_P_<:_K%]:>-?#UCH9X"_;D\5_'K]M;6_@7\+/B#\)-/^#? MB[]ECXR^*_A%K]I;:9XR^(%W\4OA9\7_ 5\-+GXC7=I!XSM=.O_ (?:M_PE M.O77@SP2;"UOO$6@>"CX\N?$MOHGBJRL-, /UJHK\N?AIX^_:ZUSX3?&KQU' M\;/!'C;P[H?Q3USPAX%\=6/[+7B76_%,W@KX33>)?"/Q<\2^$OA%\*_B1KVH M_$?7?$'Q2TB^\*_#+3#>6$']A^&;GQK<6OB:WU[2_#I]^_9.^.OQ(^-O[,UQ M\2M9TGPGKOQ+TO7_ (S^%;71; :M\-8->O\ X$H].^"GQX\(+NZUG4'&D>&K1;W6KY--DUR]$^K+H>@QW::-8_:5 !7QY^W?XQ^+G@;]F7 MXBZ]\$=4@TCQ]!IEQ]CO+6Z\*0^,XM)@T_4=1\17'PRM/'=U9^#=7^(VGZ)8 M7NJ^&]*\1S-IUPMA?S+;7M[;6=G/]A,RJ"S$*HY)8@ #U)/ KS7XL?"OX9?' M+P!XD^%_Q7\+:!XX\#>+-/GTW6M URW@NK>6.6)TBO+.8XN=+U?3Y'%YH^MZ M;-:ZMHVHQ6^HZ9>6MY;Q3( ?SV?&S_@J1XD^''_!.*6+0_VI+'PI^UKH_P"S M_P#%'QWKOQ ^,/@#P?X%^(OACQ)\)?#6BZG;_#B[^'NNPZQX$\7?&?X@>)M> M\-^&]&NM(TF;PWJW@6]\2?%.UTBUN+/0[#5?K#XY?M:?M"^#/'_BCXF^%=9^ M)&N?#NV^.7[&?A_X >"_ ?PD\/>*_P!G7]H#]F[X_P#B;X"^!_'OC_6OC[/X M6NO[,^+)\6_$OX@V/@GPO8_%7P;J=A)X0^&\FF_#WQ]HWC:_O=?_ $OTK]F? M]G[1?V?[C]EO3_AKX1@^ E[X'OOAUJGPT%L!H&M>$M6TY]+UO3]=6*:*\UFY M\06TUR_B'5M0NIM7UV]N[S4-3OKF]NIIWGUK]F_X >(OBOIGQOUSX9^#M4^* M.D3:7>V7BR\M3+=C6-!LY]-\/>([FQ-S_8VH>*O#FFW,^F>'/%FH:9=^)O#^ MG2O8:+JUC:'R0 ? G[-'[2?QQ\2^+?V-O%GC3QS?>.-"_;=\&_'OQ7KOPQ/A M?P7I.D_ +4/ -M8^,O"EIX.U'P_I-KXMGT;PYH\DGPH^(B>.]?\ &U[K/C[4 MO#^O65YX/EEO?#M_[S\8K+XEWO[7'P-\'?#W]HSXR>&1XI&K_%CX@?#>PMO@ MA>?##3/@U\'9/".C>(M-%KKGP?U3XCMJWQ6\=>,O!WA/S4^(EK/8:3J/CSQ% MH%UIUUX:TNP;V0?LD_LQK+\6IXOA#X&MY?CAX7\9^"OB8]K:SVA\0>%?B.US M-\0]#MQ;7L*^'+#Q]J%W/K7C:+PHN@MXK\1&/Q)KSW^OP0:E%ZAHWPQ^&WA_ MQ'I'B_1_#.B6/B;0O %A\+-)UR+>VI67P^TS4(-5L?"L5S+<2.=*M]1MH+U8 MY/,F:XB2229R.0#T89QRM(W0_0_RIBRQ,0JRQL3T"NI)^ M@!R:>W0_0_RH _GZ_;&!/[2GQ/ ZF^T #MR?"/A_')R!^(-?B+X2^*?CFV_; M.^(/@W7_ (GZOJFG>+M MM!^%6G^'=1\'>-O@S%K=K??M):EI>B>)?!M@FD? M$/P#XN\,Z+X \CQ=?6FIW UGQ)X,U?2/%WBW3K/QAX!T[2_VZ_;'_P"3E/BA M_P!?V@?^HCX?KXF;X4_#-O%7BWQP_@'PD_B_QYX9L_!GC3Q&VA:>=6\4>%;$ MZMY.A:U>>3YEY8R)KFIPWP:WMM4FO;?3M+BLO\:N+>#OVAOVG?!&F?$75/"&AWE[IWASX?>)'M[*UT#PE;FR\-Z7-IF MFP7%GX5MKZ/6M-\./+:W.L67BLV<\6H^::]\0OC)+^Q1^R;\6-,^)>JZ1X@\ M06'[#UY\1]531M/U#Q-\0+CXK^/_ (%>'O$MO=^(;M?LNB:7K]GXI\3R>)FT MG1!JVO2ZA;6FG:KH%@E_#J/U5IW[,W[.>D:-X@\.Z3\"?A+IF@>+'LI?%&BV M'@70K32_$PRW:2RBZ9IF=G)-5KC]EO\ 9IN] M TKPI=?L_P#P=N/"^A7MWJ.B>&YOA_X>DT'1]0OETM+R]TS26LS96-U<+HFC M!YK:&-U_LG33&4:R@*>)3XEX:CF#Q<\'*='_ %CPV<*A_JOP_P KP4<+5I8[ M+^3ZXJ<:6)G4A'#X=1>%RYTEC<%2I8F;C')8B@JG.XMKZQ&KRK#T/@Y6IT_C M2L[KEC\-.W-!*3L=I\7+GPY;>!_'M[XB\6>+?"6C>"]$U3QGXFU+X=^+I?"/ MC;2M$\,6.H^(9X[;4]/\S4-.74['2[J"&":&.+5MGV96>(2XSO@;X?\ %'AS MX8^$K;QIXA\5>)/%6J6G_"3ZW<>,?$=WXLU?1;KQ2ZZW'X.37K^..^U#3O!5 MI=VWA>TNKP/=7LFF76I3/YE^8XMJP^%OPSTNUUJQTWX>^"["S\2^&-!\$^([ M:U\-:3##X@\'>%M.O](\,^%-<5;7_B;>'O#VDZKJ>F:)I%^;BRTRPU&^M;2* M*&[G1^]7[Z_[R_S%?(U,?AX96\JPOMJL*F84L94Q&)HT:4[4<)"E"G1A"KB) M45/$5L7+$+V\XUZ='+YM0G2G Y7.*ING&[3FIN4DEHHI)))NVKES:OF2AM8_ MH2_9)_Y-R^$G_8IP?^E^H5M_'_4M.TKP78W.IZA8Z;;MXBL8EGU"\MK*%I6L MM298EENI8HVD94=EC#%V5'(!"G&)^R3_ ,FY?"3_ +%.#_TOU"O$_P#@HJ ? M@AX?! (_X67H/! (_P"0%XG[$'GWZU_KO1XIK<$^ N3<5X?!TLPK9%X<<-X^ MG@JU65"EB94\ERZ/LYUH0J3IQ:D_>C"35MF?IT<0\)DU'$J*FZ. P\U!OE4K M4:>C:3:WWLS@_P#A,O"'_0U^&?\ PH-'_P#DVC_A,O"'_0U^&?\ PH-'_P#D MVOY[/VK/V@M0_9X\(>&M>+?!NB MWT>O^)K#1M:;3=6U/2_$FH7?AP7L5CI21Z!KVKW]]/'HB:%K?1:C\9M>L?C- M\!OA3)\,7M=.^,VD^.KN?QI<>+/#NHZ5I6M^#_AU#X]'AOPLNA?;CXTB F2P MU?Q>ZZ%X>59K*;PZ->:ZN1IG\Z4?I:\O:'JOBG7(=+UK2-2FC\/B62'3]3L; MZ6.+^TK9/->.UN)72/>0N]E";F"YW$"OYF+/XJ>-K/XG>!O _C+X(M?\+^$M>DO=5UJ2;3?V,_X)OJH^+/CHA54_\*Y RJJO'_"3:3Z 5]-P M-])_B/B?COA/@_,N"\GR^AQ15J*EF.!XA_M.,'P\L/5<,;E>* MPLHNM&\JZAL4@T?5)FO;B_CTN M"T6*PN)&N9M2EM+^+3XK<*9I+Z2QO([1$:Y>UN5B,,FS2'@$\\ ].3T[ ]30 M!_.AX,^)7C?1?C3\.O"_C#]KKX>'6KKQE\-I;CP?J/\ P56^&WBG7]8T[Q+= M^'=7T6UM_! _X)U^%]3\6?\ "3Z#JNFW.B^'K;Q/X=E\36&J:?9V.NZ.NH6^ MH6W]%X^N>3WSW/'0=.F.W3)QFOQ/U[Q!XTUO]M'XEV=]>?%'Q%I?AWX[?#W1 M]'.J?\%"=5_9HT/PWH?_ BWP\OO[$\.?LM^#-673_B5X/M[RZU#4XM:\86T M6N?%S5M2\1:!>VAT&PTBYO/VP']3WSW/^<=NG:@#\0?^"D__ "DD_P""%/\ MV=;^U!_ZQS\0:_;N,XCCZ_<7L3V'H*_$3_@I/_RDD_X(4_\ 9UO[4'_K'/Q! MKU#]O[QCXO\ #GQ.\$6GA[Q9XGT"TG^'D=S/:Z'XAUC2+::X_P"$BU6+[1-! MIU[;12S^4B1^23>"+C1-5^)/P\AOQX8\8ZGX4N/A]X6FT*;4;#R9FTC M2$\0P:[!X=\,1:+T?A[]C3]F+PC\<])_:.\(_!?P#X2^+FB>!O$OP]T_Q/X5 M\+:)X;,?A_Q=KNB^(-?DDL-$TZPL[C6[Z\T*SMCXBFB?6H])N-5T>.\73=8U M.VNOY]_BY^U#XU^#W@'6O'FM^//BAJD.G?9[+3M'TWQUK-O>:WKVI&2'1-&C MO]7\0Z?HVDKJ5X@@EU;6+^TTZPC+2R//<&UL;SSBV_;6^,5W\/\ PMX\MO"? M[4$O]K_#B;XI^)-$F\96NDR>$/"EEI-IK-S,NOZYX]T_PWXPU+4]/N)]3\&: M+X7U*XU/Q5H-E<:U/%X=B"6[@']++?LH_"*#X1^ _@SHD/C;PEX9^%UR=1^' MNL>#?B-XY\*>.?"NKO9^(-/N-6L/'.AZU9>(KJ]U"Q\5>(;35UU>[U*RUNVU M:]@UFROTEP*WAG]DSX6^![&SL? ^I_%/P>MOX;^,NC7TV@_%WXC6]QXDU_X[ MZSHWB/Q]\4?&EZC\;OB%XDT[X>:]\7/$FD^$_'_V*3PY\-?#FJ#1+[Q#/<>*O&6AVFK: ME?ZNEYI_ASPKI$T^JZY-I>J.9=/M[:&:Z /Z(/V:/V2_A]^RM;>-;'X=^+?C M)KNG>/?%&O\ CC7-.^)_Q9\8?$RQB\9^,/%/B#QMXV\3Z/!XINKL:-JWC3Q7 MXGUC7?$TM@T4&H7MPA6W@B@BB7ZESG_]1'\Z_F&\+_'?QGXS\,^&_&/ACXL^ M/-6\->+O#VA^*O#FJP>-?%:0ZGH'B32K36]%U&))=426-+W3+^UN1%,B30^: M8ID25'0?L[^P1KVN>(?@SK5]X@UK5]>O8_B)KULEYK6J7VK7:6T>B^&I([=+ MG4+BYG6!'EE=(5D$:/)(RJ&=B0#U+]K0E?V'?#OAS3+_ %W7M?UOQ5IVEZ-HFCZ3;R7NHZMJFI7UC%9V-A86L,EQ M.?B+XOTGQ+X?O=+=:L=9LG\:>/=.^+.N>'_A]!=#7CX8BU?4M$^'NE MV\NK/::=MZ'^P1^RUX)LO#WP!O\ X]_$2Y\1QWNA>._A-X2UKXH_!?P[\4/" M&K>$;G6+V+QK\-] \,_#CPIKFM7=[&-+\1R>'?"WBCQC M\+=-36+/^QO$7BF8?\(_H/C#2-2\.:C')KMS'9M5O-'NK_4IM.CO[NE^S MG\>[OXTKXT0:SX:\16WA1/!#_P#"0^%_#OQ$^'N+_P 9:%>^(;CPQJOP^^*M MP_CK3+WP]IR://'XFN(H- \3Q:T]MI<46J^'O$%M;_>&G?L)?LA^-8/%GPJL MOBIXU\=6^D6_C.R^,?P\L/CEX5U[4M8\:?$#Q;H?B^]^(?Q;TK0-+/B32OB? MI'BCPW;R>#M6/_"+:=X8WW>A67ATV5II^G:;Z9X9_8O^!G@?QWJ.OZW\0OB5 MXP^*_P 4]'MM(CUOXD_$3PQ=^,_$7A'X93ZSK4.@^%]'TGPMX5M+CP_X+NO' M>K:QK4NCZ!)=3D-W8; "K^QU+*W[27PQ#2RL#>>(#_ !'I,OB!M0TV?5'MEO=5 MBN+8FXT+5+23S85LHBX\JXD*XD7:^UN=N#^FYX4CT!_E0!_/U^V/_P G*?%# M_K^T#_U$?#]?,M?37[8__)RGQ0_Z_M _]1'P_7S+7^(/BC_R_[*7H/_ *8O$]>U_LD_ M\FY?"3_L4X/_ $OU"O%/^"BG_)$/#W_92]!_],7B>O\ 6?C'_E%FK_V:GA__ M -4^5GZ5BO\ DG'_ -BVA_Z:IG\]7QV^#MW\:/"EIX']2E>[!U M#2;G6-!UCSZX_9D:KH?PS\%6W@KX?>++2T ML?$/A*W\%>)3K7B3Q1IMSXCUBYUK1(,Q2O<6\>@ZA-)=Z+#;Q);VD/U;17^6 MN$XFSK X*EEV&Q5*.!HRQ\H8:K@,NQ5)RS/"2P.-E4CBL)7]M*K@JE?"0E5Y MY8?#XK&T<.Z5/&XJ-;\[CB*L(*G&2Y$YM1<*I'DFVI1E=N#<+N[4934;* M4K_-LO[+GP]U)Y='\27NM^*OAC;7WQ,U+PU\'M8_LN'P;X6OOB_%KUMX[-KJ MND6.F^,M7L+BR\6^+[#PSI>L>()[;P=9>+?$%OI+R)/I9T>EX%_94\$_"KQ+ M\2_%?PL\1^,? NJ_%/QA\*?$GB)H-5G\71PZ)\,M.T32+[P-8_\ "P;KQ6RZ M)\0=.TB>W\3:U,9/%VD)K%ZGA#7-$AM=+AL_I^BKJ<6<1UJ=6A5S?%U,-7I1 MI8C"3<)8+$Q6.I9G*>*P3A]4Q->OF%&GC,7B:]&IB<9B/:5<75KRK5G4;Q-= MIIU9.,ERRB[?A[\#_$O@?XB^*/B'J7Q MI\1^.[GQA=WTFN67B;X=_#:WU-]&\R]E\+^#M/\ &>D:9;>(=%\$>!9+M7\. M>%M'^PZ5-/#-J>MP:GKNJ:MK%[^R?_!.#_DK'CK_ +)T/_4FTFOSRK]#?^"< M'_)6/'7_ &3H?^I-I-?J?@7F6,S7QP\/,3CITJE:.9+#1E1PF$P<50P^4XZE M0I^RP5##TFJ-*,*--N#E&C3I45)4J5.$?1R>I.IF^"E-IR]HHW480TC2DHJT M(Q6B22TT226B27[)T445_L(?J 4444 %%%% !2'&#GI@YXSQWXYS].]+5/47 MN4L+U[,H+M;2Y:U,EK)>QBX6"0P%[.&YLY;I!*$W6\=W:R3KF)+B!G$J 'Y\ MZY>?#/QG^T#XCD\._P#!/+4?BUK/@CXE^'/"OB_]HVY\$?LMZ#;Z/XRM-+\) M^(YM;L-0^*7CSPS\8/$MGX(TK7]$NW\3^'/"^H+<7MC=V/@Z?6KK2UW?HD/I MCD^GKUX]>OKSSS7X&W/PO\+ZO\?K/XN_$[Q;^P[J'Q;G\<^#_$7BVRM_V+OV MN/#7Q[UVZ\)WNE161TOPU&]0?P-XGT>RF2WN$T_5[ 3 M077[QZ5?+JFFV&I+:WUBNH6EO>K9ZG:2Z?J5JMU$LZV]_8S?OK.\B#A+FUEQ M+!,KQ2*KHR@ _$__ (*3_P#*23_@A3_V=;^U!_ZQS\0:^A/VV?@[XF^(WQ"\ M'ZMHE]HEK;6/@5-.E34[B\AF:<:YJ5UOC6VL;I#%YT+XO? '4/A M_865YJ?Q3^'OBO2_BU:>%/$^M:C8:!:KX"\/7'@_5[;6='^ NER:1?7VH?#^ M2[BD^(.MZQJ][XFOK?PIJ=WX#D^@OVI/CMXW^%G[=7P.GUKXR>+M'^!UA#?: M1K/A/X.^(OAIK-WX;U7Q$GP2T=K#X[_!3Q5I+^+_ !?8^,=>\=:1+X8\4^$= M5U?Q)H?@WQ,=2^'/A+3]=\'>+-9U[Z6^#LWQC\0_M4?MU_!GXE?%GQ)XDT?1 MO"?[*=WX$M?"-E:_#BT^%47QA\._'E=6T[XUW7-8\3::_B&T_LC3CIOA[2P#Y/^(/_ 3M^-'Q+UKPU?:[X]^ UC:Z!K'@ M77]+\4Z'X'UVR^+OPSN?#6H>&-7\2^'_ (.?$!;J.#0_#WC6^T#4+&>\\0:1 M>:KIGAKQ)JOA^]L_$UBMG%:5_B7_ ,$Z?CS\5M-T.Y\0^-/V#?BI:V^G^$O&^MM-HUOX?M-(\?:1/JPT7P_9Z)%XE\!_$*Y\5?"_P = M^+=,@\1WFA:3:V=MI$_H/AS1OBIXO^%%EXI^&/QU^-FMZ%\;/VI+;1OAIIWQ M)_:TU7PAXJG^!_PRL/BSX,5_"GQ3U'PUXE\8PZO\7O&/A9_BOXA\)^!/#OB# MQ/JGP\L= T3PYI871O$&HW/V'^SWXWO/&OP:N=)TC5K[3OB)X5\1?&3X4R7/ MQ*^($WQXN;CX@_"CQEK/@W7?$:>,HYO!FO?&#P#9^(Q9SVNJV\'A/4GT9K?P MEJ__ B^O6%RML ?/G@;]BSQ)\/?!/@[P!X9U'PM;^'/ GA/PWX+T"";4-0> M>/1O"FBV.@:8+AX=$AA>Z-EI\+W3PPPQ/?"C5] M#UJXT^YNY_'6LZFDFFRSRVX@N-)T"!$9KBWMI!*'M9"RB,J%9"')) _.3]AK MQ/\ $;Q3\(OB(_Q2\?:W\3O%7A+]K7]L7X8KXTU_3-&T6]U#P_\ #+]H'QCX M.\,646C>'K.QT31M.T?1=-M=.TO1=.@:'2=/AM[%KF]EADO;C]<_@?\ \BC> M?]AZ\_\ 233Z .K^)7_(C>)/^P-HKKP_\1/#^DZE#:MXF\"MI M^JZQJVCW%QJ7A?2[KQ/HFCM#^ROQ*_Y$;Q)_V#F_]'P5\4G[Q/((;(()!!!R M"".000"",$$ @Y% 'X ZGX+U]/V//V,E\??LN^.KCXH?#W]I3]EWXD_#V'X/ M_LW?$.]GTSX,^#/C;\!O''Q"^,OCOX8_#G_A-?!GPB^,GBGP=HWB.]U^PO[R M7X@>)M*TZ]U'18=$U+Q[XJ\$6OM_QV^#WQ1\>?$GQQIGP>T/QW8O^T-\?_V+ M_P!HVT\?>,_V=/$&FZ[\++OX2ZA\%[C7-1TGX\ZKXDM]'^'G@SPAX&^&%Y!J MGPN\8^#M*^-GA[Q[XD\6^!? N@ZQH/Q*O]?T7]CB,\M\Q)));YB23N)).226 M)8D\DDDDDTFU,XY]LG'U- 'Y6?!_Q#X0U7XOGXK:-^S+\>O@3X M&_9K^$?Q^\*_!'X/6'[*?Q7\.>._'?AOQ+J>@>(_'FO^*?$-]X9TSPKKOB'Q M8W@334^!/P&T[QAXG\4:WXBUO5?'OC#Q!)\0/$%GX>\+Z7Q5E\-6/_!0+]DS MXPZ3\$/C[>ZAIWPZ^/WAWXJ_$C3/V?\ XS^*=*\/6/Q5^%GPEL/@[X3O_$]C MH6L^&]"L;?5[?Q%%XMT7PQ-OC[05)!*SWZDJ0RDKIM\"58$JRDC*LI*L,%200:^SVZ M'Z'^5?%_PN_Y'SP__P!=;[_TUWU?:#=#]#_*@#^?K]L?_DY3XH?]?V@?^HCX M?KYEKZ:_;'_Y.4^*'_7]H'_J(^'Z^9:_Q!\4?^3F>(G_ &77%W_K09@?D>8_ M\C#'?]AF*_\ 3\PHHHKX4XPIR??7_>7^8IM.3[Z_[R_S%..Z]5^8']"7[)/_ M ";E\)/^Q3@_]+]0KQ3_ (**?\D0\/?]E+T'_P!,7B>O:_V2?^3*?\%%/^2(>'O\ LI>@_P#IB\3U_K/QC_RBS5_[-3P__P"J?*S]*Q7_ M "3C_P"Q;0_]-4S\5J***_R7/S4**** "OT-_P""<'_)6/'7_9.A_P"I-I-? MGE7Z&_\ !.#_ )*QXZ_[)T/_ %)M)K]E^CU_R>CP^_['-7_U6X\]7(_^1K@O M^OK_ /3YD7]JW]I_; DD43/G]COX@ X>=XXAM4ER&==P4JN6 M*@_HE\9+BXN-?T=KBQEL&70U18II[2X9U%[<'S%>SGGC"Y)7#,K$J2%VD$@' MR[K?PA^%OB3XC>!OB]K_ ,/?!VL?%'X9V>O6'@'Q_J/A_3;OQ7X3L_$R6,>L MPZ/K,MNUY;B8:=:O9.TDDNBS&[N=#?3;G4]3FO.4\'?LR_LY_#OQ[ M72H$6XE#^X44 !;;X7ZS\-_ FK?#:S@M+:R\ :GX2T*^\&V,& MGW+WE@EAX=NK&72[!K"[DDNK":RM[>XL+F1Y[.:"5V(V^'?@W1?"1UY[:XN[NWDU@:/:VRZA-%=W][=":Y#S-?]AZ\_P#233Z^4Z^F?@W>WMMX6NTM](N;Y#K=VQFANM.A4,;6Q!C* M75W!+N4 ,6"%"& #$JP !WWQ*_Y$;Q)_V#F_]'P5\4MU/U/\Z^O_ (A:AJ$W M@WQ!'+H=W;1O8,'GDO=*D2(>="=S)#>RS,,@#$<;-D],[D22] M*V\@A9+F2*%2H)<')P,';W/ ]37P+X4^(GQ:_X5AJ^C>)?B7XDU35M3_X M*-^-_P!FS7_BO':>'O#&M>%?AFGQ)O-'A'AR&"R;0_!\EQ-8:7\//"LL5OJ% MUX8E\964MM=7_B"&SU.3.^(OQ"^-6D_"WQ9<^'/BCKMEIOPD_;@^&GP63Q5/ MIFBZYXR^)_@+6OCE^SWX>F\/ZUXQ9!9VL?A^/XB^/?AEXUU:QT!/%?BZ[\,6 MEO=ZOHVHP^*)-:XW] _Z-48.;R+C9\N'^L2@N*Y\\;0=6<))I1_=TH3G.I&4 MJ3<72ISG5<(/CCQ-Q?*JJ2S+)DY8U8.-1X.O[*=ZM.A"JI*AS)5:U6G3A1G" M%>*FJM6G2H*52'Z&?V5..LD/_?1_^)I4TN?*D2P$9!!#D@\^RUY#^T/XKU?0 MM/\ _A_P]X@N?"Y\;?'GX4?##QCXGT34-+L_$/@;P9XYU365N=2L9[]+I?# MVJ^)KW2-+\">']>N;%YK"_\ %D=]HRMJ]O8S0.^ 7B/Q#K-C\5= UW5]4\46 MOPR^.OC_ .&/A?QCK=S97VL^)_#'A_3_ GJUNVM:E80VT&KZWX2UGQ'KOP[ MU?67M;>^U.]\&R3ZQ&VNC5IIN[_B0+Z-BQBPG]D<8(Y.>SGR

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end GRAPHIC 29 biib-2016630_reserves.jpg begin 644 biib-2016630_reserves.jpg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end GRAPHIC 30 biib-2016630_restructuring.jpg begin 644 biib-2016630_restructuring.jpg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end     GRAPHIC 31 biib-2016630_sellgenandadmin.jpg begin 644 biib-2016630_sellgenandadmin.jpg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end GRAPHIC 32 biib-2016630_tecfidera.jpg begin 644 biib-2016630_tecfidera.jpg M_]C_X 02D9)1@ ! 0 0 ! #_VP!# $! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_ MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P 1" $] 3T# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#^_BBBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I"< GT!/I MT]Z6@\@CUH _*?X5_P#!2G2_&GC_ ./4'CC4/V8OAW\-_@#\7?CO\+?%6CI^ MT-K_ (P_:>%M\'_BM>?!K0_%LG[.^A?"'[:ME\2?&C^&[;PWI&G>*M6U2Z;Q MAX;TK18]?U[5M.TR[^JO#'[;/[.?C#Q1X(\"^'_&&O7?CWX@7_CG2M%\!S?# M7XFZ?XWT[4OAAKG@;P_\2++QEX3U'PA::[\/Y? MW\2O M]XGD\;V.@6NF^' MO%.B>*7N'\-ZE9:I<<%!^PCX(A^#?Q7^%$?C3Q-;7WQ&_:8\=?M5Z-\0;'2? M"L7BKP'\4/$'[1\?[4/@R;2(KO2=0TC6M*^'OQ(L-#6QT[Q'97]MXCT32SIO MB"&:.]N"J?![]A[2?AA\>[#]I75_B;XH\<_%?4/#7QWTSXB:GJ&A>&M"TKQS MKOQRO/V7H9M:32-#MXH?#%AX"\)?LH?#OP5X/\/Z=+=QRZ3)J6I^)=4UWQ', M^K3 'E/QJ_X*?>!/A%\6?C-\(7^%/Q+OM7^!GCG]A[POXO\ %6L^'?$N@^ - M0TG]LWXVZ)\(K?6O"?B:V\,:W%XAU'P#;ZP_B"+PY9PM>_$"ZT_4_#_A.62? M0_$5[I'O/_#??[+']EZ9JW_"PM6,-U_PGKZ]9K\-?BD^L_#6S^%OBH^!OB-K M'QGT&/P6^L_!7P_X*\7JV@^(_$7Q3L?">B:=)O"5OXYU_]C[Q9X^\)V6@^']7MM;\3?L3_'6S^-?PFU+2 M=*?#_B)K+P]<:( ?5/[<'[17Q9 M_9B^%.C?%?X8_#3X.?BAXG^&MW8W?QF^+WPW^#'@O4 M]!N/#OPK^)T&L6=CXB^(<6K>*(K\:+-;:'I;G1O[8O[M+6'SKX;?\%#O UQX M[^+GPE^/6G6'PH^(WPF^,0^"DC^&C\0_B'\/?%GBRT_9=^&_[3FHV^C^/V^& M7AC2-*U>]T'Q9XRL?!O@WQ$--\8>,K#X=ZAK&E:0;K5;718OIG]H_P" .C?M M&?"-_A'JNO:GX4TL^/O@CX\35-#L].N;R*?X(_&KX>?&?2=+CMM0C:R%EK.H M?#RRT#4) @GM=+U"ZN+$I>PV[+\T_$#_ ()W^$/B!JGQ$U.[^)?C#3F^(?[8 MVA_MAWEO::7X?EBTWQ'H?[,7AS]F6+P79_:(6,OAZXT7PW;^*Y=0N-VL+KD\ MEHDO]FQPHH!Z9H?[??[+'B2'P=>Z)\0=8U#1_'6C>"O%&B>(H_AE\5(_#%KX M-^)6K-H'PV\=^*?$DW@J/0_ _@/XCZ_'<:/\/?&GC*_T+PUXWO+#5&\,ZEJ= MEI.I7EKZ3X!_:>^"WQ-\;ZC\/O!OBJ]U'Q!9/XV2PGN_"7C+1/#/BX_#3Q+! MX-^([?#OQIKOA_3?!_Q)C\ >++JU\.^,Y? FM^((O#FK7$-KJ;PF17/Q#;_\ M$F?@=8ZU\#M>74=*UK5?A9\$OV<_@7XGU?QS\'?@_P#$C6O&/AK]F&TGM_A] MK?AW5/'7A;7W^$WB?55OM5L?&6H^$89[35=)N+%-+L=#\0:)I7B6V]5_9H_X M)V?!W]E[XI:[\0? 5OX86VEC^(%OX5MD^$?PKTOQOH]G\3_%R^-/$ECXF^,^ MG^&Q\3O'MMIE^#H_A2+5M6&O>-O^$-\-:IXL\,_!V[^.?Q4\1^)];MO#7BG M4M#\$?#CP3%;V$]UHGA[Q3XA\0>-IT\,6.A6<#_VU%Q=O^V?\5?$O@7Q=XB\ M$? #PP^N_!C5OC?X?_:+7Q_\=])\#?#CX8>)O@==Z9+?>&M)^(%M5M/B!X#UO6/!/@KPOIO@.7^U?B3J_@C7%7PQ+N>*?V.M0UCQ#XU\2> M%/%]M\-_&FE?'?5/VCO@5\2=,T?3?%%SX4\;^/O@V?A#\3/#?C?P3KMG'IOB M[P=XCM)-?N-4L(=6TS4;^R\4V$FBZSX:\2^#M(UL_.\'_!/WXU>-OA9X$T'Q M9\;;3P!K5QXZ^(OQ:_:/\ 7G@CPC\=/AC^T3\:_%GB>UU*P^('C>"ZM?A7<7 MOA#PY#I5A/\ #WX026*^!?#^F0>%+#QCH_C/5_ ^C:O$ ?>'P3_:,T;XSS: MMMX9UWPD/&7P-^$'[0/A*P\3HMGXAG\%?%K3K^0:9X@T41DZ%XN\':QIS:3X MHT=;O4(+8ZGHTT-[))U\ ^&/&'C76- M4\7_ Q^*GAK2-4\(?#SQ)HGA+Q]XF\%:IK7@NQLOB#H?@S7?$FA6WB'4O!, MVNVUC:ZG:ZNKS:*YU%>]\$?"/Q)8?&/4/BOXWUC2M>UFS^"_P^^$&DZSIUBN MDW>NW&EZSK?C/XA>+;_1H!<6GA^U\3>)-1T2WTKPW::GJD6EV_A^ZE.H3+J< M$<'YQ^,?^"+OPS\;OXDN-:^-/C>;7-8\(_'_ ,!0>.9/ OPSF^)NK>&?C_K_ M (;\4:Q+\4?B6^B#QA\7_$_A+5_#5O;^$-=\6ZHL&GZ%-+ITFC/=^9JTP!]O MZ[^WG^SAH]KJL,?B?Q/>^+-*U_QKX6NOA[%\*OB^?B%INL> ?"?ACQSXEN_$ MW@.#P!<^,_"7@[2O!_CKP'XJOOB#X@\/V7@R'PWXZ\&ZM'K,\?B?0X[[SCQ! M^WHFB?L/?LW_ +8DOPYM+&+]HCPG^S=XAETSQ!XU?2/AI\'5_:$\/^']<_X2 M'XM_%BW\)ZM)X=^&7@1M;73M;\=P^";I;J_ET6)M*TN#69+W3#Q#^P#8S_M M?%K]I3P1\:/''P^^)GQA\07\?B._TWPUX+UZSM?AEXG^#O[/?PF\8?#G3K/Q M%IM_#&U]=_LV^ ?B#X?\82H^L^&?%;:K:O;:WX7O;C0YO7_#?[,>H_#_ /9C M^!'[.GPP^,OCSP)=?L]> ?A7X"\(?$&PT_PQJM]XATSX6>![7P%:67Q!\*:U MIMYX9\4Z#XHT6W8^)="":;(+Y[;5O#^KZ%K.F:7JEJ >9>%?V\/"(OO ,'Q1 ME^&/@W3O&/PW^)OQ&/B'P/\ %&\^,WA34/#?@+XV?"+X,67Q#\'^-/!/@0^# M]1^#M_J7Q=T*_P#%'C'QIKG@#Q+\.Q+"WB3P,?#VG>+_ !5X5^D/%/QV\+Z1 M\'9?C%X(=7^)7B/5)_B' MX0^/7@OXUZ)IO@_P7X1\(?$;0?VE?'7[.'B7XOZ/IOA;PS8V.F_#W1/%'A/] MG#1OAW=V_A8'5;W3_&_COQMK.OZM\3=;D\8'Z"M5\ M4_9)M)=2^*_C']FG1?A;IB?M+^&O&^K16G M@?7?&U_8>%+WX"OX7F\4>#?VFKSQ1I_@S5M7M/AIXGOWLOA3<067A?5-0TOX MWQ^(/ <,FJV7AVZ\0S_,7@S_ (*$?M5>+[WX9>'H_P!FS]GVS\4?%S]KS]I# M]DGPK&W[2_Q*FT#3];_91TW]HV\^*'C'Q%J0_9?34H-*UR?]GRYB\ Z9I6C: MG>7EOXIMI_$DWA^72IK6[_0>Q_9]TJ#]J/5OVIWU_5%\1ZY^S_X7^ MQX1-K MIK:+::5X:^)7BWXEPZY'J21C5)=4GOO%USI4ULTG]FBTLH+F&-;F69C\O:W_ M ,$^=0LK3X8WWPM^/&N>!/''PH_:_P#VI?VNO#?B;6/AWX5\=:=/K7[5DOQZ MC\8^"-4\-7FH:%!<:%H&G?'S7K/P[JEOJEKK'F:)I%WJ;79EOH9P#UWX/_M> M1?$;Q/8>!O$_P^O? ?C*T^*7Q7^ _CC25\06_B?3_"_QE^&/A/1/B=9Z#IFM MVVEZ4OB7PM\0?@]K'_"S?!OB:33M U)=&CM]+\1^%]#\03WFFZ;R%I^W;HFG M_M*_M7_ 7QWX%N/"FA_LY?#/PY\3O#/Q#MO$"ZTOQ5T^+P1X1\7_ !5T&U\. M'1]-/AOQ%\-W^)GPHLK:P.LZXWBV+X@Z9=6HTR2UGM)-[X?_ +(R_#[Q?\+M M57Q3?^,9?#OQ/^+O[1?Q/^(7BW^SE\:_$?X\_$?P#=?">RU)=*T33--\.>'O M"^A_#SQ-X@\.Z1I6CP6T'A[PWX7\!>&K6/4S#JVKRYOC_P#8,\"_$;XLK\6M M5\=^-=,U:/\ :3^'O[0[Z;HL6AV=GJ47@?X.>#/A'J/PFUV:XL+F[UCX8^.V M^'G@GQCXMTF9HKF^\1>%= 6*Y2QTZ.)P#S[]G?\ X*;_ D^)OP.^#?Q(^-& MG2_ KX@_$G19=7\8?#6UC\9?%'1_@Y&WQC\8? W3;[XE_$[PWX#LO"_@KPMK M?Q#\&:KX;T3QCX\C\&Z%JNKV.M6]C/+:>'M9OK._\9_^"IG[+WPG^#_QC^*^ MDW?C[XFR_"'P/\9_&DG@[P?\-?']OK/C3_AGWXA)\*?C)HO@O5=?\+Z;X:US M4/A=X^GLM'^)3V.JW4'@+3[ZW\3>)39>'#)J4?!^'O\ @E?X3\,>"'^'&G_' M+XD_\(5XY\$)\+OC]H\GAWP)++\9?AQIGQP^,OQR\/>'GU.31)M2\ 7MMJ'Q MZ^)7@?7=>\,3M>^(/ NN+ (M*\4:9HOBC2[OBW_@E9\,_'/P]T?X:^)/B=X^ ME\.V/A/_ (*)^$-0?3M/\,V&H:AI_P#P42^)-_\ $KQE\=Z3HWB"/P_P#LQ_#_ /:CO;KQ=K.L^"=&T#X5^-E\!^)O&5[_ M ,*M\7ZQ%XN.D?#?7M9C@D9VTZU^K/@U^T#\,OCWHM[X@^&][XJN-+L8M(O# M+XN^&_Q'^&D]]I'B*Q?5?#?B+1K/XD>%/"EWKWACQ#I*_P!HZ-XDT6&_T6]@ M\R-;U+JWN;>'X[M/^"==M>6OV[Q=\$- \#^$?A)\*=(LO"L'B:U&NZ'\*?A MO::?X)T3X@^-;?Q/+!\3/&.@V.B1^+H- \(P1:%HEMX,;CXGW%AX6TN7X?&UU[4_ /Q*TO3O%FD_%/XC:'\(_ 7BWX=3:EX/M3\3? M ?B3XD>)-"\)6'COX?KXD\)MJ&L:3.^K)IVKZ5>WWG_QA_X*5_LZ_#CX*_$; MXH^&M4UWQYXE\#?"_P#:%^(8^&-OX%^*&C^*M/N/V<=-O5\=:3\5-/?P!J&N M? _3;'Q;'I7@V^\4?$K0-&TNVU+6K*XLAJML2Y\:\ _\$B/@Q\./ I^'OA+Q M#8>'=%T;Q!^S9-X+U7PM\%_@KX0\;V/@[]FCX_\ PP^/OACPYXX\=^&O"6F^ M*_B?J_B'4_A1X9\+>)/%7B34[N+H+>-5N/$EYL>*/^"6OAW5M2_:7 MU7PW\=OB)X)OOVM(OV@O#/QAN=)\-^!M1FO_ (:?'RRM?/\ ".AOK6F7@T75 MO &L#7+_ ,&^,8EGOOL?C#Q-IFMZ9J;?\(YJ/AT ^EO!G[)+O7-%\6V/PZT76_#'@"/XD?$?P7:?O#>F_#+Q#XN^&7A M5=0UGQMX=T;Q+OB9\(? ?A MWQ%'X>^'_P #/@/\:+7QIXI\/>./ 6K:]!\"_"?B&P MTJTTKX.67B;1O%.^[L/%%AXOCBM;>S?1IWNOFKPI_P $A?V=?#VJ^/X+R/1M M4\&_$3PO\6M%US3D^$_PFT_XBG4/COX&UWP'\5)XOCJOA>\^*MMH6K6/BSQ? MJN@^'[#6K&?PYJ'B6]TO^WM5\&VNF^%;/ZD^ W[+.M?"7XL>./C3XT^-?B_X MQ^._'/P>^$/P3OKWQ%X8\%>%;&S\*?!3Q9\7_$_A.\M-.\':;I\!UW5)?C#K MC>*[V7=;ZIJ5O%?:;9Z)8O!HE@ ?8%%%% !1110 4444 %%%% !1110 4444 M %%%% !7XJ?\%&_VB?B1\+OC7I?BO]G;Q/9>*/'7[._[#/[=_P 3?&WP[L=6 MN?%&@Z%XC@U[]C2X^&^I?%OX>:!KUE*6DT&Z\>ZAX-'B!+#49M/C\47OAR^U8V[:I>P6EO#=ZBUI!]FM6O[F.)9KUK:W_ M '%N;EY3!#^ZBV1DK0!^'MQ^W[\?/B7^TMXC^"_P<\?VF_ '@ M?XEKX&O/B%;R^!O@O^Q)^R!^T+X?U71SI_C_ ,/Z+XROKWXD?&+Q[H^I:O;Z MK:Z+=^&/L5K8A-3T2/4-0YG]E?\ X*?_ +1W[1OQ7^"<-[\./A[X-\)_$NV_ M9]\[P1J?BKX6Z/K&M>#_ (P?LR?#WXY^(/BSX);7?C?'\;/$$&E^)/&.JZ9X M-TK0?@+KW@C6?!O@WQ!%J_CJ'Q;'JTWA3]X+;0-#L_LWV31M*M19QF*T%OIU ME +6-K*VTUH[?RH$\A#I]E:6)2+8IL[:WM2/(@BC1]OH>C6EQ:WEKI.F6UW8 MZ:-&LKFWL+2&XM-(#PRC2[6:*%);;31);P2?8(6CM/,AB?R=T:$ 'Y!?\%3O M$WAG2/"7C/4-!^+UKX/^-W@OX-ZGXK\+>'M5_:6^)?P0U[PSIK6_C:>Q^)W[ M.WP^\+VEOX1^/W[0L6O:-_8WAGP3XPU.7P_>7MAX9\)>)+KP]H7C6^A\4>7K M\3/%5W\<[[Q%<^/?&NF_M:3_ /!07X1?#GP=\%KWQYXHL+FZ_8I\3:)\,;SQ M#%J'P+%Y'X;/@Q/@9J_Q$^,GBCQ>_A*5-%^-^@ZO;MXUM]:\'VN@Z?\ NA>Z M1I6I36%SJ.FV%]<:5="]TR>\L[>ZFTZ\"/&+RPEGBD>RNA&[Q_:;5HI]C%/, MVG%2'3=/.H+JQL;0ZHEF^GIJ1MH/MZV$D\=U)8K>[/M*V>- M)7C,BJP /D+]I3XQ?LUW'[,NN?%#XB?M%Q>!O@%!KNDVOB#XD?#7XCV^AMXJ MN-"\?1^&[OX6:3XN\,2SZ]/?^-O&NE3?"_5_#G@/4-.\=ZQ?W&I^#-$U'3-7 MNIVB_+GP1XDL=0D^!VG_ !@^-MSX:_8D^)/QC_:HURWT7_AJ2ZU:'X.7?A_P M!\)9?V=?V=?B]^T5X%^(6H/%J$MG!\>/CE%X(F^+E[HO@OQ3=^#_ (>:'X@\ M4:?\/_"+WG[R1>!/!D7AU/"2^%M!?PS'-<7 T*YTJRO=*-Q=WUSJ=WW=]7-QRT>YO$:V=;JXTNVLHK":Y5[.T99Y;=Y5:UMF#AH(B@!^ _A_]H;6- M#\6_\$=?%WQ\_:NU'PCKWB3QG\3-(\7?#'QQ\7/"7@+3O%/PNN/V6_VQ9_A= M\:/BWX3U'_A&/%7BWQ/\2+#P[\(M634?'[3^&-!\9J1X:\/Z5XQU^_N[CJO@ M[\8O'-Q^V5X=U7XD7UYK/Q2\0_MH?M-? 75?A;X>^/OQ%M_B=X"^%?AE/C'< M?!_QOXA_9^22/X6WG[,,OPA\*?#KQ5]HO/"^F:W-XN\<>'/C/;?$B]\1:]-X M#U;]Q];^'O@/Q-?#4_$7@OPGKVI"WAM/M^M>&M$U:]^RV\S7$%M]LU"PN;GR M(;AFGBA\WRXYF:5%60ECT8TS35U%]86PLAJTEG'ISZF+6 :@^GQ3R7,5B]Z( M_M3V45Q-+/':-*;>.:1Y4C61F8@'Q/=^&]1^/WQ:_:/\!>)O%7C;P?I7P^\4 M?LJ#PD/"/B:_\.WATKPCJ7AC]H:_U"!]*U"WG6R^(/BRTN_ASXU$ZI'KWA#P MU>>')DGTV2]@N?@#XD?M :[\/OV^OVS/#OPO_:-7XM?%I/\ @G3XD\3?!OX& M:I\2_!.HZ?I7[0_A[XE_&:X\&_"[P-\(=&O=/LQXNCM]'\/66N1ZAI.J_$3Q M-"\#^*]5GTV+2K#3?W!@\(^'K;Q7J/C>WTY8/$^L:#I/AG5=3BGN4.I:+H-_ MJ^IZ)9WMLLPL[@Z1>:_KDFGW,ENUW;)J^H6\"_" M M!_#ESX@^_O\ @H'^U=X[_9_D^'/A'X7^(O#>A>._&?ACXJ^.+"V\7^'?!K:+ MKEG\+V\#0'0T\:_$CXP?"?PEIU_=ZGXVTZTD\'Z!%XY^*/BS3YKS4?!^@:;I MGAGQ)K]K]^:Y\/O!?B/2[C1-8\.Z;^)-)\7:AIL4/V*TU3Q%HFM:=XBT M[4]6AL3;+JLJ:UI&F7UTFH?:8=2>RAAU*.\M=\#=)>:9IVHFS-_8V=Z=/O8= M2L#=VL%R;+4+=9%@O[0SQR&VO85EE6*[@\NXB$L@CD4.^0#^>_P?_P %3OVF MO%'A;3?CK;^#/A]JG@NZ^+G[&GPSL_@'HGAW6&\?^)+W]KS]@SX#?M'QZ-I_ MQ$O_ !5;VVG^(O#/Q4^)\WAWPQ#+X,O1KNBS/I6L6\&HG3]2M?9/V(OCS\0/ MC;^V[-KWBCXX>"_BKIOB7_@G'\"?B)?Z/\)H-9\/_#KP1XY\8?'CXGWNO>%W M\+77CCQG91^*?#EC+IWAV74M4?3?B#_8EKI]GXTL8+@V!E_:2/0=$B14BT?2 MXT2YL;Q$CTZR15N]-@@M=/NE58 %N;&VMK>WLYP!+:P00PV[QQQ1JLMII&E6 M$LL]EIMA9S3RW<\TMK96MO)--?W37U[++)#$CR2WEZS7=U([,]Q=,;B9GF)< M@'\]OB?XJ1:SX@_:%\2_L#_M*>(_B=XT^%_[._[8T?BWQ'J_[0>E?$[Q%^TM M^T/:^&[AO GASX6_!?\ MK6[*Y3]G;Q7INLW:>-_ WPQ\)>#-+N;+2_@EX#C M\8:;=>/AX2];\-^-?AQ8/^U'X;^"7[67B+0OV2H/V:?@;XJN/CL?VAQXIOO# M7QY\6^(_C!!XG\,^&_C#\7]0\6Q>#/&_Q3^'6F_#W5/'-II^KV7B;P?K.JZ' MXQT#2_"'C7QJ-;OOV6TOX=^ M$U?B1/E?<.*T+[PAX5U/2[K1-1\-:!?Z->WLFI7FDWNBZ9=Z M9=:C-=G4)K^YT^XM)+.>]EOF-[+=RP/<279-R\C3?/0!_.[H?B_X?_'O]C7_ M ()K^+/$O[4?[/#IH?["&D77B^7XY_'/XOVFE>)_BY;?"_\ 9MU+Q%+JOB#X M3_$_P2_B/XAZ2BZQ8^*QXN\=:UX[\))XQD\0V?@'Q:^J:SY/ZKZY\4_$GBCX M,?L4:S;^&O$'PMMOCOXZ_9\3QMX6O;^\C\0_#_1-7\ ZM\4IO VM:CJ4>F:K M+-<>(_"6@_#+7AFZ=X3\-6&G0 MZNFOQ6-EH&D6EE'KL90QZS':6]E';IJT9BC*:DL0O4,:;9QM&)O%/A+P_P"- M-+BT;Q)IZZE80:MH.O6J&>YMIK36_"^M6'B/P]JMG=VDT%W:W^D:YI=AJ5G< M03(Z3VRJY>)Y8Y #\?/^"@UMH7[,/[._P7L6_:W\:?#V2P_;/^ _C&VTCQ3\ M9M \(ZK\4-/^*O\ P4.^#OB7Q[IGB;Q'XCU"W\;^(?AK\-/!GQ%\5Z#_ ,(7 MHOB'3O!5AX'GTVW\<65_X9\/:;IUMRO[0/BWP5I?[4VH?'S2_B)\$/C%JNF> M*OV6I_A;\%+7XM?&D?&3Q5X=\83>%M,L)_@YX4\)^/=%^%6M6#W^OW_Q%T+6 M;3X??%OPUX^E&MZ#XU\2>#-.\/7.H:'^U7B'P7X0\6-9MXH\+>'/$;:>MTEB MVO:%I.LM9)>K&EXEH=3L[HVR7211INFZ;_ M &CK>L2Q>?B@D@$ =17YR?LZ M?\%#-/\ VA+7X\^)M(^!7Q-@^'OPG\1:9HOA#Q3X4O\ P;\4-7^(DFJ^!_A1 MXMLO#]]X#\">(-4\7_#SXCRS?%2PM[GP5XHTT6?AVPTW5I/&OB;PKXA\->.? M#/A/WK]G+]J/PS\?_P!E?P'^U7-X=UKX>>%?&7P_OOB)?^'-?GL-_'MAXE^*W[/P_:B_9T\)0^.OA1?:O\ %CX-?\)'\._#5_JVLW=S MXITC0_ACKGA-_BW\.?$7C?3?$.J:EHVD>$_$-QJ6A^)?%&J>'O$&A:?T7@7] MM+QO\4O"M^WPW_9M\5^,OB#H/Q4\0_"OQ)8Z+\1/ E[\'-/NO#?@CPAX_NO% MFF_M 69N_"WB/PIJ.F^.=!\):1_8GA^Y\3-\4(/%/@76?#>AR>"/%VJZ. ?H M!17SS\*?VFOAK\4_VIZ5/'H%SHNK1OJNA:CJ^A:S;6D>J^'=3U;2;_3KRZP/V2_VG+3 M]JGP)XV\:V_P^\4?#*?P3\;/C#\&;_PMXRN])N?$*7GPG\9WGA8ZMJ$.C37% MKI4VNVT-MJLGA^>>;4O#TUS-HFJR-J-A+M+\8ZEXX_:Z\ M>>-_AW\*SX>TS2[K0[37OA_\/-5^)VO3>,-3U'6]+DT;36\-Z->1Z?/8V6LW M%UJAAM7M((6DNX_H0:KJQ (\.7>" ?\ D):.>ON+TC\B17XP?\%)_P#E))_P M0I_[.M_:@_\ 6.?B#7[>1_ZN/_<7_P!!% &'_:FK?]"Y=_\ @QTC_P"3:/[4 MU;_H7+O_ ,&.D?\ R;6_10!@?VIJW_0N7?\ X,=(_P#DVC^U-6_Z%R[_ /!C MI'_R;6_10!@?VIJW_0N7?_@QTC_Y-H_M35O^A2.2,>'[Z(NC()(M2T9 M9$W*1O1FNG4.N(/AM\$?B)XX\*SVMMXA\.:&M_I M<][9I?VL=P=1L;E.M44(MQ4IN,&HIRBG*R&M5\(?L^:-JNL_M(^'?AGXS^'Z?JGP M3U!O!L^@:WX*\,^$V\:>-?%FE:7:ZQ\2O%FAV'IW[)7[.?[2G[+/P+^ _P"S M]-\2/AUX^\,_"OQ)+IFN>(-+^%$_@S5?$?PC_P"$1\>S#P^]GJ_QI\=6EEXX MD^)>M^%=8C\5V/\ Q*$\,:1J.@3>%)+K4CKEK\.G_@H+^TN"0-?\(XRO_ %]4G_#P7]IC_H/^$?\ PBK#_P"2J_6EX&<9/_F)R+I_S&8OK;_J7^;^ MX_+O^(S\)_\ 0/G7_A)A?+_J.\W]WF?3OPQ_X)YZQ\+_ !#K'CWPWXG\!^$_ MB#9?#R_^%_PXU'X=_L^^ O#?@K0O"?B?QUX+\+QK\/->^)/C"R\2K\35 M^'OA?PEK?ACP%K?PE\!>"/"__"0M\(O#'@+7_$UYJ]MC:K^P3\?++P'XM\$_ M#+XX>"/AII/Q=^*?_"POCCX'\,_!74?"7PAU_P /6WP]\+^!+?X5?"GPIX _ M:)\*^+?@OX.\27'A>+Q7\6M8\-^/;KQG\4=:U/6K:?7/#&EZSJ-K9^B6L_LU^./B+\/[' MX0?%;7-"L?A#IW@'X4:/IG@3]G'PYJ_[.\GAKX@_"GQ]=>+M*\3^#O%.D_&# MQ-JNA_#X:1I7PZ\/:5\)7M[S3],D\'ZE=7OB'6M(\3+X);OQ OAVWN-:\1ZO/=W M-@+G;KGB(RVUSXOU?S_$&HV5M>7+1+^=/_#P7]IC_H/^$?\ PBK#_P"2J^U_ MV(?VE_BQ\6:":5IHS M HC90%;Y@<]?)SSPDXHR#*<9G&-KY3/"X&G"I6CA\5B9UG&I5I48JG"I@J4) M/GK1NG..B;W5CT\F\4>',]S/!Y3@Z&:QQ6-G*G1E7PV'A14H4IUGSSABZDHK MEIS2:A+5)6L[K]"O[4U;_H7+O_P8Z1_\FT?VIJW_ $+EW_X,=(_^3:WB0 23 M@ $D^@')-?&6G_MO?#;5?VF=<_9KTSP?\5=1G\-Z!J&I:]\7=.\$W=_\'-$U M[1M1O=/UOP?K7B>TFFU#1]2TB2R:&_\ $&I:-;>!X=6DB\--XG'B*6+3I?R\ M_2#ZO_M35O\ H7+O_P &.D?_ ";1_:FK?]"Y=_\ @QTC_P"3:\0_9P_:D^&' M[4^F_%'6?A7'XO;2?A1\5M0^$.M7OBWPGJG@XZUKUAX'\!?$.+7/#&G:ZMKK M%_X/U?PS\1_#=[X?U^_TW2EUV"634=.M9M&FTW4]0Y;Q3^UM9>!?B_I7PJ\; M? [XU^%M)UE/B!J5G\8M3F^"4WPLC\(_#'PQ+XI\8?$+4QI7QIU+XEZ)X$TN MW;2M)GU[6OAM8"V\0^)?#&D7MM:3ZY9%P#Z8_M35O^A&/B[X#2S\(_##Q_X+\.>, M? ]II_BOXM>"OC7X\T?X7?"CQ#\.](L/$6J)*GB_XA^)/#'A.XT3QE>>#/%' M@34/%'ARY^)^A>"-*UFRU&3Z ^'_ .T'X5\;^%?B1XDU3P[XW^'5]\'M4U#2 M/BCX-\;Z+83^+O!E]8>"]"^(PAN;?P%K/CK1=?%[X&\3Z!XCT]_!VN^)!=V^ MIPZ>JIK<5UI< !ZU_:FK?]"Y=_\ @QTC_P"3:OV-U=W/F_:M-FT_9LV>; = M^*VF>#OB_P"%=/\ "^N>)/AEXDU6\T+3O&>C6^D^(?$L-O!!K=DVD^(/"_B* M?0/'WA"_N]+M_%OA+16U;3C-+KW^ M%/\ DJ>&O^Q_D_\ ZL<,>%Q1_P DUQ#_ -B3-?\ U!KG\YUG8WNIWMOIVFV= MUJ&H7LWD6=C902W5Y=S$,PAMK:!7FGE*JS!(T9MJLV, D00Q2W!(MXI;@B.2 M8K;Q23L(84,DTQ6)798H8U:2:5@(X45GE9%!(^D/V6=5FTSXH6\<$^C12:G! M:ZRO9AX4U]HFM(]4C-G&VH:3>S01:[H3:A91BXE00UZCX M.UOX::5XQ\:I!\6C>ZYXLT?XB6OB3Q3KNARZ@;W09/A+J:66@V?BG0ULM!U> MYE\57,\OB#5;*UM#XXOO#OAZWT>WD.I3?:_[9Q_$%; XK'X6.75<3]4R^CC: M4J*Q%9U7)U/:QJPP^%KO#TXPIRY*E32I4CR4^>]5X;^/<#D=+&87 XF6/I8? MZUCJN$J1K>PIJDH*E[-TY5\505>I*52+G"%O9TY<]1PM26(^(A9W;01W2VEV MUK-Z1J^FJCZEI&KZ8 MLC%8VU+2M0TY96 +%8FO;:!9&"@L50LP4%B, D?4MWKUFG@J]N8_$]A+\-V_ M9Y\/>$-$\,QZ_;)>0?%K3KG2'#P>#?MO]JZ?XDM?%]MK/C:Y\3/IL2G0[UI6 MUB87JVC^>>.+K6?$3_#SX(P]6=*ABJ#"U%^; M2[%B9C;K?&UN!8MG?\(]K>M1:KI>O7'@F M/X(F_P#[2TKQI#=3W.BW'CN:T%\MUH]WXHO+**#5$OAZY_P3%_Y*9\3_ /L1 MM'_]2)Z^-XYS*IF7 '%TJF&EAGAW1P\$YJI[6G''8"<*CLDZ4VIVGAJRIXJA M)"\!# <<\*QAB(XA5W4KR:@X>SF\'C83IJ\I*K!.-X8BDYX:O M%J6'K5H7DOVD/(('!(.,C(_$<9^F:_)/Q'^P[\<-7_X*)6_[5FD>)OA5X.\) MZ3X/TU7\7>!-+\5>"OBW\11IGB'Q+=1?!?XL:;INN7W@+QKX-O\ 2M3T/3M8 M^)?B#0-;\1Q^'/#'AS2_#/ACP]XKTB#QDOZPZCIS;6LM[G]'<2\8Y+P MI+!QS>6)B\>L1+#_ %>@Z]UAG057GM*/+;ZQ3Y=^;WNQ]&? /X2_MS_!:?\ M;$\3ZCX7_9;U#Q%^T%\:3\>?!&GZ!\2?B_KEAHGBG4O ?P%^$-WX0\4'6?A5 MX,FN- M_#/PMUKQ2?%>EWT>H#5M2L-'_ .$7-A:7.IR_1/C+]F)OBC\2OVD= M<^(NJV%]X%^-'[-GAW]FOPUINDB\M_$OA'PGJ3?%BX^+MTEW+/'MAXFN]"@]2_9H_9E_:1_9<\/>)- ^&=O^SMH?@OQY\2/B;\1)/@I:ZS M\5Y/A]\$UU7X3Z?8>%?"OPA\1W.A_P#"0:II_C7X[:3(9[JV\. MZAJUUH?PW\'^ ?%OPM\%:/\ "OX.^#QK^MWGAKPYI'B/Q7KFJ:]JNK^)_'.N M>*/%FMZGXDF^^J_)#]G_ /;J^,'Q1^,?@/P!XBT3X?VVB^)M4O+*_GTG2-.(Q&%CC*:P]=5X>QE6K45S248VEST)WC9Z6=]3[+ASB;*^*<)6QN5 M2KRH4,3+"5/K%%T9^VC2HUFE%RE>/)7I^]?>ZZ7%HHHKYL^@"BBB@ HHHH * M*** "BBB@#\0/^"D_P#RDD_X(4_]G6_M0?\ K'/Q!K]O(_\ 5Q_[B_\ H(K\ M/O\ @I=')+_P4?\ ^"%D<4\EK(W[5O[3^V>)(9'3'['?Q )VI<1RPGIE$/\ PDNI_<7_ )J?]#+J?\ MX!:%_P#*JC^R]4_Z&74__ +0O_E50!NT5A?V7JG_ $,NI_\ @%H7_P JJ/[+ MU3_H9=3_ / +0O\ Y54 ;M%87]EZI_T,NI_^ 6A?_*JC^R]4_P"AEU/_ , M M"_\ E50!NT5A?V7JG_0RZG_X!:%_\JJ/[+U3_H9=3_\ +0O_E50!NT5A?V7 MJG_0RZG_ . 6A?\ RJH_LO5/^AEU/_P"T+_Y54 ;M%87]EZI_P!#+J?_ (!: M%_\ *JC^R]4_Z&74_P#P"T+_ .55 &[7S)^V4"?V8_C" "2?"Z8 Y)_XG&E] MJ]^_LO5/^AEU/_P"T+_Y55\$?\%0FU_0OV!?VG-5L/%>M6][9?#^*6WGM1I^ MGW$3_P#"3>'T+0WFGV-K>V[%79=]O<1/@D;L'!^DX-I.OQ?PK13476XDR.DI M-7474S/"P3:6K2;NTMSY[BZHJ/"G$U9IR5+(,XJN*=G)4\OQ$VD]4FTK)O2[ MU/P_*N&)"N#D\@,#U]1S32C'JC'ZJ3TZ=1V[>G:OPX?XG_$ON>I_Z?J;_PM#XF?]%$\<_^%7KG_P G5_I0N$<39?[90V7_ "[J>7GZ_AYG M^>7^MM#_ * ZW_@R'^7K_2U_>O-?AM_PM#XF?]%$\<_^%7KG_P G4?\ "T/B9_T43QS_ M .%7KG_R=3_U1Q/_ $&4/_!=3R\_7\/,7^MN'_Z ZO\ X'#R_P OR[:_N1Y; M9W>6=V-N[9\VW^Z6QN(]LX]J_3+_ ()B@CXE_$[((_XH71NH(_YF)O6OY!?^ M%H?$S_HHGCG_ ,*O7/\ Y.K]Y/\ @@7XG\9^*_CQ\?+36?&WBB^AM?A!X9N( M%U'4Y=82.5_'#QEXX=8%_#$Y3Y3)%&DC*=K.5 _.?%OANO@O#GBG%3Q-*I& MC@\+)PC":ST2TN?H'A7Q'1QGB#PSA8X:I"5;&8B*DYQ:36 M7XR3;25W\+^]=C^JC6O^01JG_8.O_P#TDFK^4K1])U+7M1L-'TBT>^U/4'6" MSM$D@A,TBP-,^Z>YE@M;>&&"*6XN;JZG@M;6VAFN;F:*"&21?ZFM8TS4QI.I MD^)-28#3[XX-EH>#BUF.#C2P>?8^U?RZ>%-5AT/Q!HVL7%UKMC'IUPES]N\, M3V5OX@LI%MI$AO-)DU*.33WN[69XY_LE\JV>HP)-IUS-;PW;W$7X/X"2JQPG M&,J,8RK164RHQFFXRJJEFSIQE&+C)Q:JK*+2E&DZN4JI*+DG%24&W%R32:5TUH^YUOX-^*_#^N:CH^J:EX*M+73- M-M]7N?$]SXW\.P>$OL%U=16$$B:T]XV;E]1E^PC3?LHU(2(]T]HFF@7Q2U^" MWCVYUF\\.R6V@Z=X@MO$#^%+/1-7\5^'M.U3Q#XD6QMM331_"MK-?YU^YN;" M^T^YL9[1ETZ_74M.BL[Z:ZO8;=O5?B%\1OA9XE^(+^)-&N]3T/6=/LL6_P 0 MK;X;>#M3L?$NHS,D;/X@^'-Y/'8S_P!G:,1I6GZXUP=2N;J MJFGRVD6G75N MFE?%KX>VGQ0UGXFP3^*]&EU#Q&E]J^B3>$O#'B<>,=!2PT^*]M['5+W58;[X M6RK2A4 MR[&QMCXO#JC1E&G4F_9XI3K3O&*JT^54\9ALKY'4J?E<\OX?CBITUBY2H+,8 MTHSAC\&T\#-5G5JQF>)]2\,+-_:EEH=Y/=6?EW4D1EA@O;& M]N[:VL;RVN9(O"?PW\3>-(K=]$?0!/J.JOH&AZ=JOB;1='U;Q-KZ6L5VVB>& MM,O[N*[U;4C#<6P2-4@MI;F[M;&&ZDO[B.V/K+?%_P .0^!=-%8C MQ1J]Y::-;1767\-O%_P[^'?BA]>LO$'BV>+3]=G6>"Y\ >%;]_&_@U!&UOIU MK/=:T=0^&WB&[675+"^U33]3U%[."\M-2TK4([RQ-I-UO,,\6#Q\GA(QQE*M M46!C]3QDZ->-.E2;C-0=>*,I;5G_ *OT M;IVNO^%#,='9M:>3:[-G[QX)_P#).9IK?_A#SZ<=>>..M 'SS-\=?$BF2]L_V<_C[J'AB.21?^$EBT?X=6 M$TD$\@2_L+[2KY(;F)9HTO-,U.WL]1T^Z57"SV5_:VUY:RAX+F"*9'C7\ M&?C+INO>,_VQO%.A_P#"V?%/B9/!/[1/PWUWP->>!O!'[8GQ"L?A9XS\3WW[ M,EWXFTWQ=?\ PZ^$7B'X!^!-=^%WPA^'OBCPGX5\.77CF71]?L/VFO&/BGXN MQ>!(I?$4WBO]\EZG_!5O_E'G^U-_P!DZB_]2GPY7U7 O_);\&_]E5P] M_P"K?!GS'&W_ "1O%O\ V36>_P#JLQ1_!H_WV_WF_F:;3G^^W^\W\S3:_P!7 M8[+T7Y'^7P4444P"OZ!_^#>?_DX+]H3_ +(UX6_]3QZ_GXK^@?\ X-Y_^3@O MVA/^R->%O_4\>ORWQK_Y-;QA_P!@.$_]6N7GZ9X.?\G-X1_[#L3_ .JS'']7 M/B&9;?0=:N&4LL&DZG,RKC'NZ#_I[K^Y#Q9_R*_B/_ + .L_\ IMNJ_P T2/\ U47_ %RB_P#1 M:U^!?1=RW"9C1XU^M0E/V53A_DY:DX6YXYSS7Y6KWY8[_JS]R^DIF>+R^MP< ML+.$?:T\_P"?FIQG?V_^2Z/^&W_ W_0C M^,O_ ,\/?\ R77YJT4?ZM93_P ^:O\ X/J__)>7Y]V'^LN;?\_J7_@BG_E_ M5WY6_?#_ ()^_M8>$O'O[9/P%\'Z?X3\46%YKWBG6+6"\OKK17M+=H?!'BN^ M9YTMKE[AE9+1HU\I&(=U)&T$C^N=>54^P_E7\%G_ 2K_P"4A'[+W_8[>(/_ M %6WCFO[TD^XO^ZO\A7\1_29P.&R_C+)*6&A*$)<,4*DE*:YK&]Y-O: M*5EZ[L_L?Z.>.Q.8<)9S5Q,HRG#B3$4XN,(P2BLKRB6T4KN\F[CJ***_G$_H M,**** "BBB@ I&Z'.>AZ=>G;WI:Q?$0:>UF\=A M<.MT+ZZLM2MK,V[ 3"[N-/OH+8IY\UG=1QM!( ?A?\2?'#^%/VPOB9XBT7XG M^+/"&A6'[3WP/\ ^+/@=8?M<:IX3^*?Q'\4>-K/X2Z99^-/AO^S3#\--3\/: MKX$OK#Q+8M?:6_B(:U\3?#?A?QCX@E\3:!)I5K85^]*G(S]??N>A[CT/<8K^ M;;PI^TI=^/\ ]H/X6>(Y_P!I7X5G6IO$OPZ\)V>GZ%^WO^S-XLU6739+OP]H M>J:/H\%Q_P $Z++X@:F/&LL5SJ&N^%-"^(_A>+Q+K.N:G9Z3?>&8-0M/[-_I M)'3\3WSW/^<=NAZ4 ?B#_P %)_\ E))_P0I_[.M_:@_]8Y^(-?MY'GRDP,GR MUP.F3M'&:_#_ /X*62Q0_P#!2#_@A7+-)'%&G[5O[3Y:261(HUS^QU\0%&YY M&5!EB%4$@LQ"C+$ _M='J^DM&H&IZ-M9EU'PCX?^%6M:?82BZTV[L[S4Y/$-UI@;Q"W_X*G_&'2/!^ MKSV]Y\"OC'XPU_\ 9.TC]I'1SX+\*^//"&D?!_QU9?%WX._##XF_L[^,=%U[ MQOJ6K?$[XJ^%;?XT:3J/@3X7:=K'PS^,GQ"\8>%;SX9:EX1\):_X[\(W-G^C MFJ_L4?LXZY^T?#^TOJ]QXDU'Q-!IH,?@.]^(^OW7PB7QI#X@L/$6G_%"/X=3 M:R^A6_C[2;[3H+K2K^VAATJPUM4\9V^CQ^.K>U\30MA_8E_9QGM?$*^*=1\? M?$36]8B\%6FC^-?B3\:_'7C;Q_X!T[X:>,;;XA_#FS^'/C?6O$#_ M !Y96'B^TU_3]0?Q7KNOZ;I-]XRU_P 3-I&F):*Z[K^O^'7WCL^S_K_AU]Y\ M,Z7_ ,%)/B9K\N@?"3PUJ6G:W\3_ !-\5OC'X3TCQ>?V7?C#I'CIO"7P0^$O MPS\=^+8-4_8XU[QQI'Q-\,?$C4/%7Q2T'1_"^F^-_&WA#0]=^%UIJ'QHM8Y- M&N/#6E^)/MB[_:%^)'B[]A[1?CM\)KSPOX_^)'B+PSX,,.K?#'X7_%#Q_P"' M5U?4_'6A^"_'6N:%\&=4E\*?%B[E\%P2^)]5OOAEXFO=!\5:!JOAZ_\ "WBS M5+&?2-5U%7Q?L/?L^0V,MZGB3XD+\49_&Y^(D_Q^'QC\1?\ "]9O%;>![?X8 MRSO\0/MPE&AR_#BTMO!K^#8],3P6NG6]OJ,7A^/Q';V^MQ=7I?[)OP+\/^'$ M\$^%]?\ B+X2\!VGPU\.?#?1_!/A;XY?$/0/#^@-X8\>:G\2K+XC:,FF^*K? M4K3XS:CXPU235/$_Q*X+KNOZ_X=?>%GV?]?\.O MO+G[(WQ7\4?$?PCXRTCXD>*;O6OBM\/O&TWAWQWH.K_!J7X&:_X.;4_#^A^) MO#6EZEX-_P"%C?%;3-1@U/P[J]IK^F>+O#_CC6-#UJTU(V,9L]5T75[&V^LZ M\,^#WPF^&_P4T_Q'%X;UC5]<\0>-M=A\3^//'7COQI>>,_'/C;7[30])\,6& MH^(O$>L7P'6]'!P=4TT$ M=0;^T!'X>=3$:=%9?]MZ/_T%=-_\#[/_ ./5^4_[??[7OQO_ &>/B_\ LX0> M%/$G@KX9_ +Q1XMN+7Q]\6O%OPP\0?%WP7J=]9?"OX_>+M;\%?$'4O WBFR\ M2?!;PUX?M? W@7Q6/B!'X>U*TFM-2U[Q+K&NZ+X-^%OC30_%P!^ME%?B7X7_ M ."A_P 29OVE-7\.^)_$WP_TKX5WWQ?^/WPX\*:UK7@O4/#/[-^K>!_A+X#\ M:>+_ SXE\+?MI3^)=1\&^+?B_?7OARTM?B/\,XM ME\'QZ-\9=(L=*N/^%/ MWOC#7Z_[+7[:_P"TY\=-.\4>%]8USPWX-^*5_P# 'PE\;SIGQ#_9P\;^"I?# M%SJ/BW3=*\;Q_L^^#!\0)M8_:O\ A;I?A]-?3PC\0-(U?3;1?%E]\+DU_5M8 ML?B2NC: ?MY17PC^Q5^T!X_^-'PY^+!\>ZOX?N_%_PT^+WBGX;:+<:WX/U7 MX.^-[[1K#PIX-\0^&M1^,?P8UG4M5U[X3>+M2NO$]RT.BM-Y7BCP$O@_XFZ1 MIFB6GCFU\.:9P?[-_P"T1\:]1_:=^)7P!^-'BGP?KEOX=^&-IXZAU:Z^$_B? M]GZ_G\86WCJY\'^*['X-Z-XQ\3>))?C5\"M-B.F30_$ZRO&NO#6JZEX>TO6M M8\22>.=.7P^ ?I57YZ?\%6_^4>?[4W_9.HO_ %*?#E?>_P#;>C_]!73?_ ^S M_P#CU?GS_P %5=4TRX_X)[_M210:A8S2O\.X@D<5Y;22,?\ A*/#IPJ)*SL< M \*IKZK@7_DM^#?^RJX>_P#5O@SYCC;_ )(WBW_LFL]_]5F*/X0W^^W^\W\S M3:<_WV_WF_F:;7^KL=EZ+\C_ "^"BBBF 5_0/_P;S_\ )P7[0G_9&O"W_J>/ M7\_%?T ?\&]]U;6G[0'[03W5Q;VR-\&_"X5KB>*!6(\=N2%:5T!('4 D\CCD M5^6^-?\ R:WC#_L!PG_JUR\_3/!S_DYO"/\ V'8G_P!5F./ZN/%G_(K^(_\ ML ZS_P"FVZK_ #1(_P#51?\ 7*+_ -%K7^E1XJUK2&\,>(E75--).@ZP /M] MGR3IMU_TW_SUZ5_FKQ_ZJ+_KE%_Z+6OQ'Z)_\+CK_KYPY_Z3G9^Q?2B_C\$_ M]>^(_P#TK(A]%%%?V ?RB%%%% 'Z"?\ !*O_ )2$?LO?]CMX@_\ 5;>.:_O2 M3[B_[J_R%?P5?\$L)8H?^"@O[,$LTD<,2>-?$!>25TCC4?\ "M_' !9W*JN2 M0HR1EB .2!7]Y=I>V=XI%I=6USY2H)/L]Q#/LW [=_DN^W=M;;NQNVG&<''\ M(_2F_P"2WR+_ +)7#_\ JWS<_MGZ,W_)'9W_ -E/B/\ U4Y.7****_F4_H\* M*** "BBB@ JIJ%J;ZQO;(7%W:&[M+FU%U83"VOK8W$+PBXL[@JX@NH=_FV\Q M1A%,B2;6VX-ND(R"/4$?G0!^$_B_QSK.B_MC7/P[O?VF]+^',7@SXD_!_P * MV'@#XU_\%';OP)\0_B;I,GAWP#+!XG\.? '0O@?XDT_5M)\>7-Q?Z9I>B:KX M\M-4^(/B2VUVXU$>%H=?M!>(-6T M?]MJQ^#+M+5:M0X0JSH5:M&I_:&!2G2G*G.SG.ZYH-2L[*ZOK8^:8O$ M'[1\WA%_'D/B;XNR^#X]0&F/X@B\0>*)=/%RP(W;TNV]T;3=3UKXS66H>(KUM-T.REUSQ*]UJFIIY7F:7;0P7\ MSC5H!/"USI4XAU&TCECENK6&)@]=YHOBKP?-\"[;1];\66Z>)].O+33O"IL= M+\4^'/&?A;5H+.[ETA=4U'1WN-'\1_#_ $>^N[B^O-5OH+J\72Y#IUCIT?B: MSTU*FL_$W@SP)?Z/X>TCQOI7B+PKJ&H>/+WQ5XUL5\2WWBN_\;>.?AUX@\#Q M>/I]!NO#]B^D>'O#2:S(+73K6_U;Q1J2WFHZOJLT^I7%KI^G?T8ZTE/%PAP[ M@9SH8G,848?V'7C"O0PV'C5P\X8F45%RG4=.DE&A*>,JSY,+1A1HU<8?@4:4 M7#"3EGV,A"MA\OG6G_;-&4Z%;$U_9UX3P\9.2C"FI5+NM&.#ITU/$U9UJM+" M/SM=7_:8?7W\++XA^+C>((].36)-,'BC6_,32)-GE:NUV=5_LT:3*TD<<.J? M;OL$T\B6T5R]RPA.1'XV^/\ +XB/A"/QA\6F\5+J$NDOX<_M_P 4C6H]3@9U MGL9=.:[%S%<0>7(TZRHBP11O/*R0(TH]:TGQIX+TSX<+\)UU+P/JNM6/A'1K M>T\8>*/#WB/5_AM)?6WQ)\1>,+KPG)9G0AJ>H:3INFZY;W.E7.I^'GT.7Q'; M748L0T&EWQ\_U.S\$Z_\3=5U;P]\1K?P!X3USQ%JVCO>WUEXXGU/3O#4GA:U MCUK5(K86M_?3^'O$]Y-J_AWPYH>H:O)J4=G+;:?XD^Q:4DUW71AITYU,;#$\ M/X2A3H4L6\-B(Y%7G3Q+PZP[HXKV=.%6O&GC(U9RH8"-.IBH_5:U.5>53V<9 M88B-2%+!SP^>8FO4KU,(L10>=483PZQ$JL:N&YYRI495,(Z5.-;&RJ4\-+ZQ M1G&A&FJDHX6O>._CSX5U!=+\2>-_B?HM^UO;WL=K?^*]>0SV5T&-M>6LT6I2 MVU[97 1Q!>6<]Q:RM'*B3%XI%3]\OV7Y9-<_9]^$>K:T[:OJM_X)TFYO]3U, M_;K^]N)%DWW%W>7/F7%Q,^!OEFD=V(RS$\U^ GQ2OK*ZOO#&B^'+C1[KPCX1 M\-CP]X4M]$OM4UFXM-.;6=3UB]E\0ZE?Z!X?6?Q#K&L:I?ZQ?1:;I\>C6,=W M;Z?I2K;6JF3]^?V3 1^S=\&0001X#T;((((^63J#R/QK\L\9:%%<)9%B5@,+ M@\16S;]XJ&%AAI\GU7&O&$:T_TKPDK5GQ1G M.'>,Q.+H4LI?(ZV(GB(<_P!:P7,X2?+&:C)SA3K>RHRJ4TIRHT7-T8>]_P!G MZ>/^7&S_ / 6$_RCKY1^._[#O[.'[2'C;X?>/_BGX+O-2USX?:B]R(-(\0Z_ MX:+[5?WVFS33 M>%O$'B[P[XC\:_X*2^(->\/_ Z^',^@:[K6A3W'CVY@GGT35]1TB:> >%]7 MD$,TNFW-K)-$)%6012,T8D57"[U!'YK^"-.^)WB_P?XH\:WGQK\1>%='T 26 MMM=:WXP\?O97NK0W?AN&:UU'4-,EOK3P[8B'Q-8&'4M5=!PLM8U# M3OS[AOPP>?\ #^%X@JY]0RZABL5/"0H2P%?%5/:K%/#4XQ]C64ZDJDES6A2? M)&\I-0A*2^YXA\1_[#S[$Y%3R.MCZN&P]/$SKQQU'#0]E+#QQ,Y2]M2<8*G! MN-Y5/?ERQBG*2B_V&?\ 81_9?GU>*\O_ (=S:OX9M-5\8>(=,^$VM^*_&>L? M G1?$WQ L?&6E^-O$NB? O4==N?A3I.M^)M/^(7C:WU&ZL_"D42OXK\0WMC; M66HZQJ%Y<5H?V#/V;A]LFO\ 0?'NOZJ=(T/PYX:\2>)_C-\8_$GBSX;^&_#/ MB70?&7A[0?A/XJUCQQ=Z_P##&PTSQ5X8\/:XS>#-0TF]U:\T+18_$%YJ]EH^ MFV=K^-5TOQAM_!OA?Q='\4?$VH/XM\4+X5T[PYI7Q#\2ZCKMM?W.DV>K:8-5 M6UU=['3[G5HKZ!+/2);DZK")(9]1@LDN(4;IM:T/XC>'[ZTL=5_: U?3V6ZU M^TUJXU+Q#\5=*M=//AJR:YU2ZT";4(X4^(6GO>1S:#IMWX/:Z;4_$"Q64%O' M9W5MJ4GO/P6A%Q7^MN%E*O?$_P")?B&[^*_B3QO\,F^$.OZA\;9] M:\47K?&2(> 19:'H.E?$3^W]$\(IHGANX\):;HESX:T*33]OX5_LI_!?X/>( MG\7>%M'\3ZMXFA\)Q_#[1-=^(?Q"^('Q2U/PC\.H;ZRU.+X?^"[OXB^)/$TO MA/PBVI:;IE]?:7HC6C:S=:1HDNN7&IMH.B_8/P>\6ZQ\2/"EYH /Q<\8ZQHO MBG0-.\4Z#KMCXK\;VR7>A:C>W^F^?<:3J&HP:G87EG?Z5J=KJ^,/#_A[P[XATWXY^-]?B\376K1Z?8MJ'Q#\.WQT_1I%M+K6 MPFJ:W,DNE/JIET>UF5D>ZO[+4E@1XM/N)!M'P/G/ZKR\446L9.=/#M9+CFI5 M*<93J4ZDE6<)=&I%TJD7'FIS4O3G*K3Y:F'56#52E)2Y:D7+^E;^S]//_ "XV?_@+"/YQU^>_ M_!5>SLXO^">O[4KQ6EM&X^'<1#I;Q(ZG_A*/#HR&5 PZGH1_*K7_ 3AUW7- M?^$/C*ZU[6]9URZB^)-[;Q7.M:KJ&KW,5NOA?PQ*L$4^HW-S-' ))))!"CK& M)))'"[G8E/\ @JW_ ,H\_P!J;_LG47_J4^'*^)R?)I\/>*7#V2U*\<3/+^,> M'J$L1&#I1J/^T\!4YE3^&N>YO"C+#1Q_">>5E0E M-5)4U_9V,ARN:C!2^%NZBM':Q_!H_P!]O]YOYFFUI:GI.J:3;Z5?ZKIM_IEC MX@TZ?6]!O=0M)[*TUO1H-0O-*GU?2;FX2.'4=,AU+3[ZPEOK1Y;:.[L[B!Y% MDB853N;:YLYY;6\MKFSNH&V3VMY;SVEU ^U7V3VUS'%/"^QE?9+&C;&5L;64 MG_4&$X22Y91E\2]UIZTYO2@]I1]Y76I#171:CX/\8:.+!M8\'^+]'75;B.TTIM7\*>(M*75;N8*T M-II3:AIEL-3NYE96AM; W%Q,K*8XV#+G+NM,U2QU"32+[2]4L=8AN([.;1[W M3;ZSUB&\F,:PV)*;=[.:SEC2ZBNTN ;=[22);A9P8&B$HV5_0=_P & M^^FZEI'[1_[1>FZOINI:1J5K\&_"0NM-U?3[W2M2M3+XX,L0NM/U&"VO+8RQ M.DL8F@C,D3I*FY'5C^7^- M58$'!P1D<$ CD"O[SK>WMX%S!!##O52_DQ1Q;L#C=L5.:_O23[B_[J_R%?PC]*;_DM\B_[)7#_P#JWS<_ MMGZ,W_)'9W_V4^(_]5.3CJ***_F4_H\**** "BBB@ JM>7"VEI=73Q7$RVUO M/<-#:6\MW=2K#$\ICM[6 -/*:*55>.6*12DD(H=& M^+7QD\#^-;F+XQ_\$?/VD/%'Q \.7T&F^#?"-X!^T3KGQ9\/V7AFT2S\,V-W MI.OWO@B+P_\ #E4^V6^BS:=I\MM-^ZX.1GW/8CN>QY_QZX&:^=7_ &8? !N/ M+MO$GQCTSPZ8Y(CX(TCXY_%K2_!@CD)+6MOHUEXNADT_3,'RQHFF7UCH:V^Z MU735M9)(6]]TO3-/T73K#2-*M(-/TS3+.VL-/L;6,16UG96<*6]M;01CA(H( M8TCC4?=50* /Q._X*3_\I)/^"%/_ &=;^U!_ZQS\0:_+_P#X+U>(=?TK]L3P M#;:7KVN:9;/^SOX0F:WTW6-2T^!IF\=_$E6E:&SNH(FE941&D*%RJ*I8JJ@? MJ!_P4G_Y22?\$*?^SK?VH/\ UCGX@U^5'_!?G_D\OX?_ /9N?@[_ -3WXEU^ M]?1PC&7B7AU)*2_L;-=&DU\-'HS\.^D)*4?#K$.,G%_VMEFJ;3_BSZH_&'_A M,_&/_0W^+/7_ )&;7<_G_:&:7_A,_&1Z^,/%I_[F?7O_ )85S5%?Z%>QI?\ M/JG_ . 1_P C^#/:U?\ GY4_\#E_F=)_PF?C+.?^$P\6Y]?^$GU[/_IPH_X3 M/QE_T.'BW_PI]>_^6%UJ_P#/RI_X'+_/R7W'3)XS M\9;T/_"7^+#\R]?$^O'N/74*_O0_X)JW5S>_L&_LJ75YD_>;>V8Y>NK['R]_P62^+OA_X0_"'X/ZMX@T[6=2@U;XJ7NEV\>C)9/-' M.G@C7[TR3"]N[1!$8X&0%&=]Y7Y-N6'XR?!S_@IY\(_A59>)7;X:?$G4=:U" MTA2PGL]>T[3M&UCRM:\/:@NA>-M";5+O3]7\/I#I5\C/:PVNH7=CJFK>'KN2 M2RU9;W3/T5_X.&O^2 _L_P#_ &7#4?\ U6OBFOY-Z[O!'A7)N(/"O+(9G1K5 MJ=;'YDZD*>)KX>,U0S*I*$9.A.$G&\%S1?\([$^F1745G_ &K_ M &A\QMY;UXUW'L]5_P""I/P'\1WEPOB?X/?&+Q!H.M?$"_\ B?XCT35?'.@W MT;>)KC2+[3+31_#<\BP/HW@N&34KFXU337:75];M+31='FU2UL]*22X_#&BO MUNIX=\,59NI/#XUU>>O.-6.9X^G5A+$N,JCA4IUX3@U4A&K2<6O85%[2A[.5 MV_RNGX@<2THJ$,1@_9J%"#I2R[!5*4HX=.--3IU*,H3O"3IU>9/VU-\E;GBD ME^O_ (T_X*#_ 7\6ZKKFM3>"_C-<:C>Z5H]GHD M:!::9I@\+6OAR)-'\/\ A[2XM*719U2Z-Q=0(UK)C>,/^"@/PQ\47>A26_@C MQYIECX?\&^%/"-C8NWAZY")X>TM+>]O%D34X%7^V-9FU36Y(O++13:E*CRSN M&F?\F:*[:'!>0X=4%3H5TL-!TZ$7BJ\H4H.%&FXTZ(G&I7DL+1C.K.,ZM12J345.;\/Z?JVFVFG?&34M(FAUA;-;A[B/P1X*O6DC%E=7< M9A,=Y&H+.K[U?*;=K'V/_@JVJO\ \$]/VID9@BO\.XD9V0RJBMXI\.*SM$JN MTJHI+-$J.TJ@HJ,S!3\0_P#!OE_R:G\7/^SA=8_]5M\.:^WO^"K?_*//]J;_ M +)U%_ZE/AROX3XCP]/#>/\ ##T;JG2X]X>C"[YI)?7K>[N^J/[6R"O4Q M/@7.O5:=2IP1GDI-*R;^IYAT3T]%8_G&_:G\8Z]XM\!_L^Z]X4^(_@/4?BV9 MKS6? GPTT;XF>!/BA\$M=5M8^/EK>?%'P?I/Q2M-.7X/6_@]+70+3PUX=\=: ME:Z2TVM:)X+T_P -6VN_""'9\H?MA>"O$/B3]J/X^_$"TU'PEX@\,S:M#\4[ MCQ-:?$/P5XDL-5\)+J'P^\':EK0N/#>OZ[>7]R_B?7K:"\T>.V?Q)<6C:CJ] MII%W8V-S,OPW,!(760"12QRL@#J?F)Y5LJ>>>G7GKS2PNUO'<16[-;Q7:QI= M10,T$5TD4T=Q$EU'$42X2*XBBGB299%CGBBF0++&CK_<>3<)/)*F%J83&8=J MA1S/#VGE[55X;-,RP>/J4HXF.,53EH+")4/K"Q+C6Q&*J(AB\'73KUDL1EN78K PK2P\L(Z?-B'BG*O]7>&BZ5##4^5U MH5\3BOUM\77'B7X@^/'\1>&O'?PI^#/QG\3?&/Q9_P *W\267[6LWQ/\#3?" M7QKX,\=R_$OXF7^J^,/%FOV/PYO?#BW6BZ=\-/$?A?0_AEX[UR?Q1=^$_"O@ M&RUW0;:]TWE]6\<>!?"WQ<\%7GCGQUKV@>*_@]\*? GP\^!/Q3\56>D?&/Q! MXOUE_B%X@O?$?QI^(%U\-O'?BQ?"NM>$=,UG6-(^"GA37O$&M7_@?35\'ZKK M^I7%SX0C2Z_+4QQD,#'&5=M[J44AWZ;G!&&;'\3 GWH2..,%8XXXU)R51%12 M2,$D* "2 !DC. !VK.GP5",84:F8/ZM3PKPL(T<*OK5*#GC<%+!U^;"8!5?;.A6EB?U$TV;X<>'_ -OKXF?%V_\ 'OA# M7?ASXA^-/[5.D?#_ ,:P>+M#\-3Z?\5]7\*^,M8^'GB&1]4O-:U'PQX8T[QE MXH\/V'AGXWZEIMQX*?74C\6Z3>2C0YQ9?KS_ ,$F+^TU#]H[76N->N+KQE9? ML@^%M,\=^"7^+C_';3_A?J%I\=O&&=+^*5SJ.OZEK":QX@R<#FOZ!_^ M#>557]H#]H-5555?@SX6"JH"JH_X3V0X55 &23@ .JUZF7\/95EB4J?L_;4L'F*HT9SC&K]7A.</S_,\RDXSYO8U<7@/:U80E*DJ\XPE@8PH1J8 MB5.%&M65>GBL0L+B<+_5GXK!/ACQ&!R3H.L #U)TVZQ7^=X/V;_B?'\&+'XV MO;^&U\,WDUB+;P^WB_PXGQ N- O[:T;3?&5MX&;41X@N_#6IW-W!::>;2SGU MFZB=-;ATA_#,K?4A:^%] \6^'/!^L:=\)-8ET71T3XI_#7XCVIT[QGI?A M[1[I->N](^&D8CO+G5M=U/PWJNIR^#V@U5OQOZ-F+S;"4.)Y95AEB?;9SPE0 MQ\?85*\X8"<,_P#;SIJG4IQISBU!^UK2C1@D^:7,X4ZOZS](;"97B\1PXLSQ M#PSHY1Q76P,O;TZ$9XV$^'_8PJ.=.I*I"2X_L#7X M-3\-ZM;:IXF6TAV[?\ 9_\ B)>^"[KQKIK>#=86P\(Z M3\0M2\%:+X[\-ZQ\4=+^'^O:_IWA?1_&NI?#O3[NXUVUT*_UW6=%LE0A]LC4)+[4?%^C^'5\/79M]0N+J2]U1=3ED^SV% MQTOP;_:,^&_P4^'M[;Z#)XT\3:EJ^E^ ]NOZKJ9OGLL MNPL\+@W6S18RG'$T*N59E@:.(PDL?6H1=+V[F\'.KA*$\1%XJM*A1;I?6L31 M56C'$?S'2RO)%F&*AB<6J.6/"3EAZ]/,\NQE:AB8X&A7:J^P45BX4\56C0DL M-2C7K)5/JV&JNG6=#R6;]E3XN)XETKPA9GX=:UXCO-=\6>%]=TS0/BKX%U>; MX=>(_ 7AB\\:>.M(^*AM]65/ K?#K7[+QMX?\ '<&J^(KWPA9K MX7U;31']NNSXMTW4/#-QI]Q;66H6FMV899?T#O/VSOA)#XSLO%L0^ M(7BC78?B?\4?B/\ #KQIJWPV^'OA[6OV9+3QQX,UK1?"W@SPIH&B>)4L/C'X M>\+>*M9M_%.O>&O$FK^&O!'B)O#ME/!HK:IKOB.*]\%^-'QS\#?$/Q+\/_'F MF^+O'P^)OPD\&?#_ $O2_B!I/PS\&_#Q/B+XL\,_$Z^U^WUB+P;HGB:[\,?" M=?A_X&N=/L_#5[I&E:HOCWQ=HPU/Q3H&C-J5[J$_)EN<<6U<5AH8_*J5+#U, M*U4JQPF/BEC:E3&1A)QE'FIX.$U@*%65;V>+HRG7KPPF,RV4LVPG5F&4\+4L M-B)X+,JM3$4\2G3IRQ6!E?!PIX.4XIQDE4QDX2QM:G&E[3"U%&E1GBL+F,5E M>*^EO^">OP*\>?"O]O?]E?6?$,G@[6-&?XP^// -_J_@/QOX?\=Z9X>^(/AO MX6^,[W7? 7B6[T"XFCT;Q7I]E,+P6%=,L6\.:#XT\>)JOB&Z37- M\_KX3[B_[J_R%?QM](C$YGB^)N'JV;8>.'Q3X:C%15*K0T"M&4I4[MP?$HA_,MF:,9)9=I(;Y-^-KK7Z MP_\ !2?_ )22?\$*?^SK?VH/_6.?B#7Y4_\ !?CG]LOX?C./^,<_!W/I_P 5 M[\2^:_>_HW?\G,P__8FS7_TF@?AOTAO^3%?$7@3P3#(NIP7?@3XA6UMK\GC+P1JT9L MK.ZD^(.NZ(F@0:KKGA_2[31=6T'46U\7?"_[/?P9^(/BC]F[PCHFH?%[P1KG MQZU#Q/K0T[Q/J7@3QC=VOPWTJR\067A#5+630O"7A"ST;7?B?XV\,:QH'ARZ M\1RR>%O#WAZS'CKQ9>6F@W431_W0^*\I4,753Q,J. Q>8X+&58X>;5"OE>#G MCL6I4VU6DHX:G4G%TZ4W)Q4$E*I24_XJCPQFDIX6DUAXU<=A^)EOXF^*_C7QUX>\+:7;?$/1K:\^%&L>' M9/"7P\\0^/I]7T>PN[RWD?3?!%_;:?J\]UJ5EX!XS^$OAKX9_M :M\*/&OBC M7KOP=H^O:?$OBGPEH.FW'B?7_#GB3PUIOB[P3-I6A:UK%CHVFZ]XFTSQ!X;L M;N/5M8;2O#.H:C>W=W+J5CI30WFV!XERK,?:?5*M6M[.A7KWIT9U8U8X6&"J M8F.'G2YX8ITH9C@)QGAY5*6)CBZ,L)4Q"YW#+&\/9GE_LOK=.G1]I7H8?]Y5 MA3E2EBIXJ&&EB(5'">&52> QT91Q$:57#RPE6.*IT'R*?@R??7_>7^8K^]7_ M ()JW^IP_L%_LI1P:'+//AQI_CW4/!_CF;PQJWB3P1=7GB7Q'H,.C7?B MWP+CP1XOMM2L="MO$FGZEX>6WETZUU=-"\0V%AKNGW<+?VQ?\$S/^3!?V3_^ MR,>%/_1=Q7\Y_29QN'S+@7AC&X2?/0K<1R<)])>SP&84I\LDW&I#GA+DJTY3 MHUH*-6A4J49PJ2_H'Z.>#Q&7\:\1X/%0]G7H\/VJ0OK'GQV658J2:4H2Y)Q< MZ52,*U&?-2K4Z=:$Z6ESO;_A6_B@ M;-EN[,I(RV6X&W!Y=+?%_A-/"MMI'A6"98/^$J\9^&?"-UXNUFUU#PG97WAGP9#XBU/ M3AK6N6$?C7PY=W@+VVFP-J^C:0^H#7O$&A:9?_8^ 6-PF7^$^48C'8FCA:'] MI9I3]K7J1I4^>MFE:%./--I7'K8JM]0R MRI[*A3E5JBO:]+^!'BG7O M[X]\.>*OA= MXCM=.?P3:WOA70_''VKQ_;ZU\1-:B\/>$?"Q\+7&BV:S>+=5U:2:!/#UIJ=Q M?1PZ;K%\0UCI%_*O!VJZUX2^)GA'Q%X8 M\#>*? GAN\\9>-M$^(WB.SO5TOP9+X4\):;JOB75M1OYIM!ET?2-6N=&U?5Y M-.NH$_99YYE%.52%7,<)1E2G6IU8UJT*+ISP]"GB:RFJKBX>SP]6G6;DDO9S MC--QDF_R&&2YM4C3G2R_%5HU8T9TY4:,ZJG&O6EAZ+@Z:ES<]>$Z*2N_:PE! MKF31\VT5W?CGX<>*/A]K.D:-K,>F:G_PDFA:+XI\(ZSX1U6W\5>&_&GAOQ$\ M\&BZWX1UG3%,>M6=]?6E]I/D+!!J=GKFGZAH>HZ=9ZM97%FG0_$?X)^,_A9: M"Y\3W_@*ZGMO$M]X*\1Z/X4^(?A;Q=XA\"^-M,L(]2U#P=X\T+1KZ;4/#>OV MEJTRSHT5YI27]AJNC'5SK6E:AIUOTQS' 2>%C'%X=RQJG+"156'-B%3Y?:.D MKWER.<(SM\,YQ@[3E%/G> QL5B92PF(4<$X+%2=*?+AW4OR*J[6@YJ,I0NUS M0C*<;QBVOZ@?^" %W?6_[*WQ:6UTI[]&_:"U=FD2]L[;:W_"N/AT"ACN'1S@ M!6W ;6WX!RCU]L?\%4;_ %.;_@GS^U)'<:)+:Q-\.X@T[:A83",?\)1X=.3% M%(TC]/X1GMW&/CG_ (-\O^34_BY_V<+K'_JMOAS7V]_P5;_Y1Y_M3?\ 9.HO M_4I\.5_GUQ7_ ,I#/_LO^'O_ %-RL_O#AA_\:%6G_-#9XOOP>8Z_*_X'\&C_ M 'V_WF_F:;3G^^W^\W\S3:_T0CLO1?D?P(%%%%, K]^_^#?2>ZM_C]^T$UK8 MM?N?@YX7#1K&?$0;P],H.A:P"QU73.!_9USS_KO_U=3P#7^;%'_JHO^N47_HM:_P!+OQ9_ MR*_B/_L ZS_Z;;JO\T2/_51?]^[M;KS=P; M=@VSMMV;5R7QNW#;G!Q_!Y_P2K_Y2$?LO?\ 8[>(/_5;>.:_O23[B_[J_P A M7\(_2F_Y+?(O^R5P_P#ZM\W/[9^C-_R1V>?]E/B/_53DXZBBBOYE/Z/"BBB@ M HHHH **** "BBB@#\0/^"D__*23_@A3_P!G6_M0?^L<_$&ORH_X+\G'[9?P M_/I^SGX./_E^_$NOU7_X*3_\I)/^"%/_ &=;^U!_ZQS\0:_*C_@OS_R>7\/_ M /LW/P=_ZGOQ+K][^C=_R-M#^"FI_!K1_#?P^TLZQ#=Z%J/Q'T[PG86/Q#O? 6H^'+KPUJG@J]U M6U$5G?#4]-NGTR\\6W=C-XMF\-#_ (1B74Y+,I<1<]:?M!^/+'QQHOCJVMO# M'VO2/A'I7P+FT"?1Y[CPKKOPOL?A^OPSU+PQK>F'44O)(?%'AAKK_A(;O2]4 MTF^?5K^\U72;G2;AXQ'X;17]\0R/*(/%..7X=/&/$/$MPNZOUJ-.->,FV[1F MJ4%R1M&%G[-1YI7_ (A*I-\[O M.5USRERQM].-^U-XH?1[7P/)\._A))\';+PHGA"U^!\V@^*Y?AS':1>.;SXE M1:R9W\;_ /">GQ4OC;4=2U'M0N]-EY6]^/GB36O%FI M>._%/@[X7>,O%VO>,?$GBGQ+K'BOP6NJ)XCTOQ/X5@\'7/P\O])75+;1K#X? MZ+I-NDOA#3_#UCHOB+PCJ2P7^A>*+26PTX6GAM%*GD64TG4E3P5.$JRK*M-2 MJ<]9XGE^M5*L^?FJUL6X4I8RO-RK8N=##SQ,ZLL/0=-SSK-*BIQJ8RI.-)T7 M2A*--PI+#! M]$;0/"G@WP?\-]%U/P_X$\$>"K#4[+P]X%/_1=Q7\" M2??7_>7^8K^^W_@F9_R8+^R?_P!D8\*?^B[BOYP^D_AZ.%X*X=H4(*G3CQ+. M?*G*3E4K8',*U:K.,_A;\5HH_%OPVNWT":V\30Q:C\-_%MQH?AWQ!I>H^.]-GOU;P]>6 M>JZ;%9^,_!?A6WU7]U?^#AK_ )(#^S__ -EPU'_U6OBFOY-Z^B\#LIPN=^$& M4X'&.JJ+S3,*]Z,U"HIX;-ZE>#C-QGROF@DIQ2J4V_:49TJ\*=6'@>-.:XG) M_%?-,;A%2=99=@*-JT'.FX8C**%&:E%2CS>[-OE;=.HDZ=:%6A.I2G[;?^.O M"5]\(_A;\+;0Z[H,5K\4/'_Q!^*M_;Z='J<;R:V?"OA7P+/H4\OX_I^7X]? +P1-I7@3X8:M\09_@+>^& M/BWX#\4>&[KX;V&A?$B[E^,'PYN/ FM?'#Q%XJN_B!JNC>-OB1I0@T6'0_!- ME9>$/!.@>$;:_P#"GAZXM)M4U?Q!J_YYT5^R8KAS!8M1A5K8SV*J9C6E0C4H MNG4KYE.K.I7FZE"I5]MA8U9TL!5A4A/"4;4ZVE3 MR^C&LZ=55*='+H4HTZ,%"O"E['$NC"IC:4ZI./,HN/UAXA^+?P[COO M@[/X6O\ Q??C]F'PEX%M?AC/KOA+3+!/BMXQL_CCJOQ?\HS_#C MPKYGB34[3PE:Z==>,]7>'2K&VU3[%/JUU=6'6?M-?M#^ OB_X:U73M#E\6^) M]8UWXV:_\5/#][XS\"^!_!K_ 3\#:]I6KQ7GP1\)7WA/4M4NO%NBWVNZK8Z MQJFJ7/\ 8>A&?PEI&KZ?H">(=?\ $=V/B.BE#AK+HXK!8QRQ$\1@:E>K1J3E M14G/%5(XC$.4X4(5(*OB_:XNJJ,Z*G/$XC#R3P%18.)/B''RPV,PBC0A0QM. MA2JPC&JXJ&%@Z&'483K3IR='"*EA:;K0JN$,/0Q$6L=!XN7]=_\ P;Y?\FI_ M%S_LX76/_5;?#FOM[_@JW_RCS_:F_P"R=1?^I3X_\ 4W*S^W>& M/^3"_P#=CYY_ZAY@?P:/]]O]YOYFFTY_OM_O-_,TVO\ 1".R]%^1_ H4444P M"OZ!_P#@WG_Y."_:$_[(UX6_]3QZ_GXK^@?_ (-Y_P#DX+]H3_LC7A;_ -3Q MZ_+?&O\ Y-;QA_V X3_U:Y>?IG@Y_P G-X1_[#L3_P"JS'']6/BS_D5_$?\ MV =9_P#3;=5_FB1_ZJ+_ *Y1?^BUK_2[\6?\BOXC_P"P#K/_ *;;JO\ -$C_ M -5%_P!_P"QV\0?^JV\DGW%_P!U?Y"OX+?^ M"5?_ "D(_9>_[';Q!_ZK;QS7]Z2?<7_=7^0K^$?I3?\ );Y%_P!DKA__ %;Y MN?VS]&;_ )([._\ LI\3_P"JG)QU%%%?S*?T>%%%% !1110 4444 %%%% 'X M@?\ !2?_ )21_P#!"G_LZW]J#H,_\V<_$'TK\J?^"_(/_#97P_."/^,<_!_4 M$?\ ,_?$L=P._'UXK^B+]MW_ ()Z?"7]NR7X+:I\0/B+^T%\)?&'[/WB[Q)X MW^%GQ$_9N^+FI?!OXA>&M=\6^&7\'Z[-:>*])TW4=0ACOO#TMSIC_8S:3_9; MR]MS<&WO+F&3\Y/B%_P;D?LM?%O6K?Q)\5?VPO\ @J'\2O$5GIL.C6FN^.OV MW_%OBG5[;1[:XNKNWTJWU#6/"MW=1:?!=WMY[N)50/,Y/Z-X6\; M83@#BNEQ#C<#B,PH4\#C,(\/A:E*G5YRPY&Y+=]#\_\2^#<3QW MPQ4R'"8VA@*L\;A,5]8Q-.I5IJ.'G*4H\M)J7-*ZL]E9WZ'\FM%?U'_\0N_[ M!W_1P'_!0_\ \2[U?_YBZ1O^#7C]@X G_AH#_@H?P"?^3N]7[#_L2S7]+_\ M$U?#W_1*9U_X68#R\_-_=YG\Z_\ $L6>_P#14Y1_X18W_/\ JS\K_P N-%?T M"? C_@W,_8P^)/B_]J#0M<^/_P"WX+/X/_M$W7PL\+?V?^UGJT$X\.P?!+X' M_$#_ (F\@\(2?:]3.O?$+76%R4MV73CI]JT3_9A<3?1?_$+O^P=_T_Z)3.O_"S >7GZ_=YA_P 2Q9[_ -%3E'_A'C?\_P"K M/?2_\N2??7_>7^8K^^W_ ()FKY!]?^1+KZ#\+_ /!"SX;^"/#^D>$O!G_!1/\ X+!^ M$O"OA^RBTW0O#?AS_@H9\2-&T+1=.@R(+#2M+L-!@L["S@#$0VUM#'%&"0B M5^2^+WC-EGB3DF695@Q_(^E?R;U_77\1O\ @WW^ M WQAT_3M)^+7[='_ 5A^)VE:1?/JFE:9X^_;U\<^++#3-3>VELGU&PM=:\- MWD-K>M9SSVC74*),;::6$OYK_P#S%U[? MAEX]91P)PC@N&\9D&98^OA<1CJTL3AL1A:=*:Q>*G7C&,*KYTX1GRR;WDG;1 MH\;Q&\#\UXWXJQG$.%SW+\#1Q5#!4HX?$8;$U:L'A<+2P\I2G3?(U-TW**6J M6CU/Y<**_J/_ .(7?]@[_HX#_@H?_P")=ZO_ /,77S;I?_!NA^QC>?M<^-?@ M?+\?OV_/^$2T#]G/X9?%2Q*?M9ZL-:'B/Q;\4OB[X-U4W-Y_PB!,NF-IG@?1 MOL5M]GC6"Z%_)YLS7&(?O_\ B:OA[_HE,Z_\+,!Y>?F_N\SX7_B6+/?^BIRC M?_H#QNW??H?@%17]1_\ Q"[_ +!W_1P'_!0__P 2[U?_ .8NC_B%W_8._P"C M@/\ @H?_ .)=ZO\ _,71_P 35\/?]$IG7_A9@/+S\W]WF'_$L6>_]%3E'_A% MC?\ /^K/RO[!_P &^?\ R:G\7.#_ ,G"ZQS@D?\ )-OAQW QW'YCUK[>_P"" MK?/_ 3S_:FP#_R3J+L?^AH\.^WL?RKXC^'?_!O]\#/A#I-YH'PG_;N_X*S? M#/0M1U%]8O\ 1O 7[?'COPKI=[JTEM;64FJ7=CHWARTMY]0DL[*SM'NY8VF: MVM+>$N8X44;GBW_@A-\,?'_AS5?!_CK_ (*'?\%@/&7A+7K<6>N>&/%'_!0K MXC:YH&L6BS17 M=3TG4= N+*^MQ/!#-Y-Q#)'YD4;E=R C^9TFL-*,9?"G)7V9_1F4\'XG+ MO#K_ %*GC*%3%?ZOYADWUZ-.HL/[7&4,32A7]F_WGLX.O&4HWYFHM+='\>C_ M 'V_WF_F:;7]1_\ Q"[_ +!YZ_M ?\%#_P#Q+O5__F+H_P"(7?\ 8._Z. _X M*'_^)=ZO_P#,77]-+Z5?#R27^JF=:)+_ 'S >7GZ_=YG\Y_\2Q9[_P!%3E'_ M (18W_/^K/RO_+A17]!_QA_X-QOV+? GQ)_96\(Z/\?_ -O_ /L[XS_''Q/\ M//%1O?VM-5FN?[!T?]FSX^_%BV&D.?!R&UU$^)_AMX<:6Y GSI":K9F#_3!< MVOT!_P 0N_[!W_1P'_!0_P#\2[U?_P"8NC_B:OA[_HE,Z_\ "S >7GZ_=YA_ MQ+%GO_14Y1_X1XWRWU]>^WF?RX5_0/\ \&\__)P7[0G!_P"2->%N@)_YGR3T M^A_*OHC_ (A=_P!@[_HX#_@H?_XEWJ__ ,Q=>A_#K_@W4_9E^#^HZCK'PE_; M,_X*E_#'5M7L8M,U;4_ /[=W MBCG)E10Y)/R/'OTA\EXOX0SOAO#<.YI@Z^:X>C1IXG$8G"3HTI4L9AL2W.%/ MWY)JC*"Y=;M/8^KX'\ \WX4XKR;B+$<09;BZ.5XBK6J8:CA<53JU54PM?#J, M)S;A%IUU)N6C46MVC]Y?%9SX7\1X!/\ Q(=9_A;_ *!MU[5_FBQ_ZJ+_ *Y1 M_P#H"U_9?-_P10\,W$4L$_\ P4P_X+-S031O#-#+_P %'?BC)'+%*I22.1&T M4JZ.C,CJP*LI*D$$BOF+_B%V_8.& /V@/^"AX '_#7>K\ < #_ (HOH!P* M^!\'/%?+O#*'$,IJI[?XG4^N1<>7;V(]3(9X+-<)EO]D1S.-58JA6K>V>/>7N#I^Q:Y?9K!2YN:]^=6V9_ M+A17]1__ !"[_L'?]' ?\%#_ /Q+O5__ )BZ^;/VP?\ @W1_8R^!7[,_QF^+ MGA#X_P#[?9\3> _!5[K^BG6OVLM6O-*%];W5E!&;^U/A&W%Q;@7#%XC/$&QC M>I(8?MG_ !-7P]_T2F=?^%F \O/S?W>9^._\2Q9[_P!%3E'_ (1XW_/^K/RO M^ =%?U&K_P &O/[!S@G_ (7_ /\ !0\?.XQ_PUWJYQM=EXSX+SCCC.2.A)/) M=_Q"[_L'?]' ?\%#_P#Q+O5__F+H_P")J^'O^B4SK_PLP'EY^;^[S'_Q+#GG M_14Y1_X18W_/^K>E_P =/^"5?_*0C]E[KQXV\0= 3_S3;QSZ5_>DGW5ZC"C. M01V]P*_G:\)_\&TO['7@+Q%I7B_P-^U-_P %+?!OBS0IY+K1/$_AC]M#Q)H> MOZ/$;>]LII;.ZN;222WFC=[:XGA8F.5U;]4?V0?V*-._9 M;Q\UA^TY^VC^T5_PGR^&ED7]KG]I#Q3^T OA$>&3KA0^ E\2V5I_PBIUO^W& M'B0V?F?VR-+T03[?[,AW?SSXO>(>"\2<_P NSC Y=BLMI8+)Z66SHXNK1JU) MU(8W&XIU(RHOE4''%1A9^]S0D]FC]Y\*> ,9X>9)F&4XS,,-F-3&9M4S&%;" MTJM*$(5,'@<-[*4:MY.:EA)2;7NM32W3O]K4445^4'Z@%%%% !1110 4444 M%%%% !1110 45\,_&7]M[1OA3XG^+%CIGPJ\>?$+P3^S;X=T+Q;^TY\0?#5Y MX6L].^$VA>(= E\8H-/T'7-6L=?^(FM^&/A]'%\3/'.A^%[9+G0_ NH:/%7V-2_:]E\/?%?P7X-\5_!3XD^&?AQ\2_BU'?%'B>QN;7P);ZO+XZM_AGXBL?!GB6R\+_$>737L]7O-.CUAM&L_ MFHZ;XTNP#Z^L=)TO39=2GT[3K"PGUF_.JZM-96=M:RZIJ;6=GI[:CJ,EO%&] M]?-8:=I]D;RZ::Y-I8V=L9?(M8(X]"O ?&7QSN?!'C_7_"^H_"SXEZKX5T+X M36'Q'3Q]X3\/77BVQUK7]2\;S^#;3X7Z%X9T"&^\4:CXVE"V>N82Q31X-)OX MKF_O[&VM[Z[MOE[2O^"CW@37OV9O@-^T#I_@'7-+UG]HQ?$K>!/ACXT\:?#K MP9=Z%#X+A\4ZCXVU;XC_ !!U7Q _P\\'>&?!>C^$[NX\0^(EUG6+(ZKJ7A_P MYH2:[K&O:7!<@'Z/T5Y]\*O'<_Q-^'?A'Q[<^%-:\$S>*=&M]5D\+^(-0\+: MOJ6DF9I$$3:UX'\0>*O!VNVTO8B/0: " MBBOF_P"-OQ_O?AGXK^'_ ,,/ WPWU_XN_%WXF:9XV\3>&_!.BZWX=\*V-EX) M^&S^%8/''C/Q1XM\4W5OI.B:-I>J>.?!7AK3X(H-2U;6O$_B[1;*TT^+2XM> MUO1 #Z0K/72-*359M=33=/76KC3[;29]76RMEU2;2[.YNKVTTZ;4!$+R6PMK MR^O;JWLWF:V@N;NZGBB26XF=_P _/$7_ 4&TZR^$Q^/?A7X ?&3Q3\'/"/P MS\1_%?XV>+K@^!_"<_PGT7P+K_CCPQ\2_!@TCQ#XI@?XA?%GX7:Q\-O&Z>// M G@B]OHM,MM'LCI_B'5=0\5>#M+U_P"P?&WQ%U#POJ7PAM-%\"^)O&ME\4/B M'#X+U35=#%I;VOP[T.;X>^//'"^/?%L6I/;W*^'1>>#M.\(M!9Q/J@U_QAH* M-;+ +LQ@'J5%?GMI_P#P4%\*Z[\/_P!KWQWI/PI^(VE?\,H^.?#?@"30OB0- M$^%FJ?$+4O&?PX^%_P 0_".N01>+[RWG^''A;6K7XK>'X#?_ !.M?#FKZ1I\ M-WK^NZ!IEB8(7^@OV9_C?>_'[X?7OC>]TCP'HQMO%.J^'H(?AW\:/!?QUT"X MCTNTTR66X?QEX$MK71K744NKZ>UN] E1M0T\6T-Q#O@5\1+_X=>//"_BB#4=6^%;_$'X07.FC3KU?C?XIT_P 6V7@G7?@U MX#M3<0W!^*>GZ[XK^&'V'0]3%O;:_I?Q$M-8TN[DT[PIXVGT+Y&^*O\ P4Q^ M)/P8U[]I[3/'?[(>MQ:9^RU\+?A[\6/&&KZ)\=_AKJS:[H/QCU[XB^%OA39: M#IKZ597$>IZ]K_PSUVWU]-7EL+?PM87&FZDT^KQSR10@'ZS7>EZ;?W&F7=]I M]C>7>BWLFHZ/2Z5J>HZ;)=6CPSOI]_>V M3R&VN[B*2]7RY\&_VC=1\<_$'Q)\%OB?\,M8^#7QE\-^"M ^)0\*WWBCPSXY M\/\ BCX?^(M,_"\J6VJKH?B?0;WP_XMT75M(\/Z_X>OKK0KN; M3;G1?$N@ZM?^6?&?]NO3_@1\(;CXI^._@9\98I3\=]=^#5CX8TW1K"\E.B:9 M^T)8? 73/B[KGBE[B#PAX6\ >)CK7A_QWXO^'M=L=-\/:!K6O+= MV=L ?>U%?$GQ5_;5T#X?_&JW^"?ASP#J_P 1O$6E7?@:T\='2O'/PM\(WFBW MOQ'EOI/#/AWP;H7Q#\7^%]2^*WCJW\.Z;=>/O$?@?P69=:TGP*^F7]J-6\0^ M(?#OA?5?MH'(SC'7CCU]NQZCV].E "T45X)\.=*OK?X>^. M_B'IOPW\1_$D75C;^&?A;JWBFRO8? >L^/'NGBEL/"GB[QI#I/PXBU^%GM=& M\6^+?"JZPMOI&H7>IZ< >]UGZMI&E:]IUWI&MZ9I^L:5?PFWOM,U6RMM1T^\ M@8JS07=E>136US"S*I,4T3H2JDKD#'YL:Q^W[\1&^)_[-?@GP=^RQX@\1>&/ MVKI/&5W\)O&NL?%OP1X+GG\,^!])O/%^H^)_$7@S5M*NO$.B6FM?#V'3_&7A MC3F:YU>]MM:T_2M8M/#^J+>16VK^S;_P4';XX:5\ _%GC'X$^+_A%\/_ -JF M\U73?@%XWU'QIX'\:Z;X@UJP\-^*/&FF^%O&UAX;NH-6^'_B?Q1X1\%>+M9\ M.6]U9ZUH5U-X;U#0+[Q%IWB.[T'2M: /TB_S^?6BOGKQ1\>;SP?XD^+VE:I\ M(?BOJFB_#/PE\+/$&@:[X-\.'QC/\6-;^)FI^-M(;P3X!T#1Y&U%M=\)7WA; M2%\47^O/I'AK1[+QCI&MZOK>E>'[#6]6L/E+7O\ @H[HL7[/7[)GQZ\.?#S1 M[:W_ &KOAEI_Q9T?1OBY\&+OP;X9\63V?B;Q[XLNK[PSJ7B.W MF\7Z%HL&C^&3JG]H3MJ.IVMT=(TRXNV /TRHKG/!VN3^)O"/A;Q)=6MC8W7B M#PYHFMW-CIFMV7B73;*XU73+6_FM-/\ $>FI'IVOV-O)<-%::W81QV6K6Z1W M]HBV]Q&HZ.@ HHHH **** "BBB@ HHHH **** "BBB@#\P/VIOV3?BEK-Y\= M;GX.:FFJ_#G]LM?!?@C]K;X<6^A^%G^)-QX/MOA]??!_Q3XS^!WC3QCXU\(> M#-#\5^(?AI;^$/ _BG3?'UIXAL=.\.:+/XT\!JGC;3T\->*^V\._LO\ [0=I M^U3%\)/B[\%_%_Q+_8S\ M8^.=>^!?C*?X"^*SX)U/0?B=X:\7Z!XY\-_%'X?:K\;M3O=;EO7\6IJF@ZYX M4\8>%KCP_JOAKP]>&SU.*/4[._\ V%HH \"_9A^ ^G_LT?!+PC\'--UQO$<7 MAV\\8ZS>:LFB:?X7TV76O'_COQ/\1?$-MX:\):3+/IG@SP5INO>+=2TSP+X) MTZYO+'P9X.L]#\,VM[?1:6MY/[[110 5\A?M)_!CXH:YXE\)?M"?L[:[X.T? M]H;X1_#[XM>"/"FC?$?P]<:]\.?B+X2^)W_"%:_K7@+Q:^D:]X5\1^'GN/&G MPM^'NMZ%XNT;7E_L.XTS4;/4])U?2-;OHK?Z]HH _'M?V&?VA]2\$?!#PEX; M^*'@'2?A#X-L+WXB^,O@'^T/\(]2\7WWCO\ :1\6_%;Q+\9O&/Q-^+VI? ?] MH/PMX'\6:5%XZ\13^(?"WP>T^76?ACX;\3/)K]]<^-KS2_"$GA?]?8EG6WC6 M5X6N1$HD>..1(&N-@\QTB>:258FEW.J/.\@0A6E9\R&>B@#\QOA_^Q]^TSI? MBG]KW7/'OQO_ &?=8M/VL?$7ACQ]J%GH/[-/B&[M_"7C?P/\,/@[\(O#=K<: M+\2OC7X]\,>,_ 5]X6^$<%UXJT#4-*TOQ#>ZKXBOYO#WB[PT]AI=S;?4/P$^ M!7B+X9^)_C!\2_'WB_P_XL^)7QNU[P?J_BQO O@N?X>> -,M_ G@NP\$^'K7 M0O#&H>*/&VNW.IRZ?:S3Z_XG\1^+-8U?5V;3=,A&FZ!X=T+2K/Z8HH **** M/F_X\?L]VOQM\;?LL>,9];LM'?\ 9H_:(/QZAM;OP[!KB\1KKD46HN/^$=&FBP#:BFH6'S3^TK^P%?\ Q[7]MB;3 M_BK:>$[W]K;X#?LW_!S36O/!$VOVGP_U#]GKQC\8O&%MXDOH8/%>BS^*[+Q1 M.=$^,'B?]H?XX^/ MO"7C_P"+6N?#K0OA)H%M\// .J_#OP#X%^'^D^)=5\9ZK9:1I?B+QS\1?%&L M>(/&?BO4;35/%&N:QXG6R%EX<\*Z-H>@:4NF:IJ&O\[^W=^SE\6OVJO@TGP; M^&GQ)^'/PSTS6/%/@CQ+XMUGQW\-_%7Q&O+@_#?XD>!?BAX7M/#UMX<^)WPX MM],%UKG@H:=KT^J-K+3:3J+#2TTZ[M_.G^V** /RH^*G_!.+6OC#KWQ5\1^) M?B+\-])U/]J/P9\%?#'[4-YH_P &;[4-9FU+X*W-X-)\6_LY>(?$7Q)U"^^# M'B34M%ETW1X=2\0P?$JZ\+:IX=\->.?"\UEXIT@RWGZK*NT8Z\L>@'+,6/3W M/U]23DTM% !7S7^V)^SS!^UC^R]\=_V;KC7[3PK%\:OAGXG^'C>)+[P_%XKM M=";Q%9?98]6F\.SW^EQ:P+&0)<+8MJ-D971"EU ZJX^E** /F3XG?L['XA_M M"?LM?'*+Q5'HL/[-NH?&6^/A8:']L_X2Y/BQ\-/^%>QP1ZLNIVB:"- .-4W? MV;J@U%0+%4L?^/FOE']F3]@/XE?";PO^RQ\-_BY\:_ WQ%^&'[&NHZCXA^$6 M@>"/@_JW@+7/$WC/_A%/&'@;POXL^*/B+Q)\3_B''J!\(>&OB#XSET[0/!NC M>$M/OO%&I:9X@U&ZDM] LM&E_4FB@#@_B78?$/4O!6L6'PJUCP3H'C>X2TBT MC5/B'X9\0>,/"%O";RW&IIJGA[POXO\ FMWYGTK[9;V1L_%&F_9KZ2VNI_M M=O!)9S_!?P%_8^_:.^"/[/'[-7P=MOC;^S_KOB?]E_P=8?"SPAXJU?\ 9BUO M5="\0?#O3O 7A7P+:W^IZ3J/QO;QMX9^(BQZ)J=]?:MX*^(NC>$->T_69_#F MM^"[NWBL=2T_],** /&_V>_@UI7[/?P5^&WP7T35[_7M-^'7A73_ W!K.I6 M]C8W.HO;>9/=72:7I<4&E:+92WEQ<'3- TF"'2= TS['HNF1)8V%N*]DHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH *JWLKP6=U-&0)(K:>1"1D!XX7=21W&Y1D=QQ5JJ.I_\ (.OO^O.[ M_P#2>6JCK*-_YE^9,G:,FMU%O\#^+:3_ (+C_M]++*@\0_"'"33(O_%IX?NI M*ZKG_BI3D[0,GN'/ 47A_4SJ?A]-$;3734EUF]98%-]<>?!]G(FRF738,_S!36UR9[C_1KG M_CXN/^7:X[32#_GE7Z]?\$.(9H_V^=!9X9T7_A3_ ,5_F>"9%!\OPQ@%G15R M>PSD]J_T4\0_#W@/+^!.*\=@>%.'\+C<)D&95\+B:&682E7H5Z>%E*G5I5(4 ME*$X2490E%III-.Y_ 7 /'O&V/XWX6P6-XISW%8/%9YEM#$8>OF.)J4*]&KB M:4*E*K3E4<9PG'W91:::;3/[4Z***_SI/[_/G[XG?M :/\,OC+^S;\'+[P[J MVJ:E^TAXI^)7A;1=:L;K3X=.\,S_ V^$WB7XL7UWK-O=2+>7<&IZ?X:GTBR M334DEAO[J&>Y"VB2./+M+_;X_9M@;4+'XA_$3PS\*O$-GX[^*?A&+PYXTUNT M@U*XT;X8_M">/_V<)/B!,]HDUIIG@C6_'7P^U"./7=5GL]/T$7UA:>([S3KF M:,S=?^T1^SYKGQ:\3_ KXG> ?&6A^!OBM^SQXZ\4>-/ VJ>+?!U[X^\&:G!X MX^&7B_X5^+?#GBCPSI7B_P !ZS+::AH/BQK_ $[5-%\6:5J.DZWI&G3NNI:9 M+J6E7OQ7XV_X):7?C/0/C[I]Q\=A;:Y\?OV.OCM^S1XBUV'X:16\.F>-?VA? MCW\5/V@O'OQ2TO2;?QH#%H7_ E?Q6U73]*^'3ZG+-!I&G:>E]XTU*[$ERP! M[[H/_!1G]G>[^-MA^S]XD\10>'_'FJVO[56O6^JVMR?$/PVT?PK^R7\48?AC M\0;SQK\2;*SM?"_@O7X[J2]U34O#>LW07P:OAWQ'I'B_6-+UB'P_;^)?9(OV MP_V:9?!^G^.E^+_A1/#VJ^-+/X=Z;).^IVVK7WC;4-*;Q#9>&[7PS&;QMYH\)PRZTGPQXU_X)5Q^,]-\9:'??&B3^Q?B9'_ M ,%&_"'CRT'@W4(+EOA?_P %#/COX0^/VMZ?X3O+'QU9+HWCWX8>)_AYX1TG M2_$VJVVO^&_%^@MXBM=:\&64FHZ=+I/6_#[_ ()SZ[\-_$O@SXL>%OB9X!T? MXW^#?B-K?BB/Q##\-_BIXB\"^(/"GB7X:2?"W6/#OB?0/B1^TCX]^(^JZU:Z M48=;\*^)O^%NVT?A6\ME\-V6B3^$]0UVRU< ].TC_@H3\.M1_89\)?MSW'A# MQ'8^"/&MOX231/#4NM>$([J&_P#'WQ4LOA#X3GU_QI?ZQIO@'PUX1?Q'JNEZ MOXF\?:WKEGX5\)>#Y;WQ+JUY]DT^5)$A_P""AOPT\,>+?V?/AG\:O!OC/X4_ M$C]I+QGXV\%_#BTA;1/B5\/M7/@?P19^/+WQG9?%3P!?ZGX9F^'^J:9?V^E: M7X@OXM(O[?Q%#JMGX@T+0M,T34]9M^A^#O[(?B;X(?L:^ ?V5?!/QD4:SX T ME-&@^(^M_#'PUX@T7Q9I[^,=3\1:QHOC7X7:IJ$FE:CX5\7Z/JM]X6\5Z+HW MB'P_J7]FWEU<^%_$7AK44L+FS^:]*_X)@:UX"?@GX1M/B7^S:G[,GCG3_A3\)W^(6KKX+\77&@D_$^U\::AX M@\2:;J?Q=B_MOQ5X*UK1;R[T=P#Z!^)/_!2[]C_X8^!K7X@ZE\2I_$N@W?Q. M^#'PLCB\#^%O%/B75QJ7QZ\8Q^#/AYXL31[?2(;^^^&VIWB:MJ4/C_28-2\. M:SI_AW7+/PE>>)?$D-EX?O\ W*3]JW]G*WU7XAZ/=_&3P'877PIT;Q!X@^($ M^I:W%IFE>&M)\'R6T'C6[O==U!+;0YQX'O+ZQT[QS!I^I7MUX+U2^LM*\4V^ MD:E=VUI+^:VC?\$E/$FE:MJ?CF7]H32+OXFS>$/V6=,A\0/\-O'=_IGB7QS^ MR#^U-H'[3_P\^(?Q.C\6_'OQ?XM\8:CXZU?P_#X9^)VFZ;XU\,V\MA=2W_@Z M7P[?QM)===X-_P""4?A[PI<_$J.7Q9X \1:5XMT3]H2+PM'XU^&?CCXD76@: M]^TIXIU;QAX]3Q+HGQ&^.OB7X7>)/!D=_P"(-=T0^'/#7PT^'NL^*O"MSIEO MXO\ %>H>)=(F\4ZN ?IK\+?B_P##CXT>'[OQ-\,_%5AXITK3=8N_#VKFVBO[ M'4="\06-O9WEUH?B#1-8L]-USP_K$5AJ6FZB=,UK3;"]?3=2TW4HX'L=0L[B M;TFOE+]E+]G[QQ^S_H'CG2_&GQ?U7XF?\);XNL_$6A: /^$Y/@OX8:39>$O# MWAEO"O@$_%+XD_&+XDQZ/JE]HESXLU.V\0_$C6-.M-=UN_M_#&E>'M'1+&3Z MMH *_/C]N#]HSXF_ >]^&\'P]NM"MX_$UKXJEU4:SHJZLSOI$^@1V9MV:[MO M("KJ%SYH ?S"8SE=GS?H/7Y#?\%0D=]3^#&U';%CX]SM1WQ_I7A/&=JMC/;/ M7!K] \+\!@LSXWR?!9CA:&-P=:.8NKAL33A6HU'3RO&5:?/3FG%N%6$)QNKJ M44UJD?#>)&-QF7<'9MC,!B:V$Q=&67>RQ&'J2I5J:J9G@Z53DG!J4>:G.<)6 M>L9-/1G@0_X*&?M)D@'4O!') _Y$V/\ ^6M?LY\"/&&M?$#X.?#?QKXC>UEU MWQ-X1TC6-5DLK86=H][>0>9.UO:B246\1;[D0D?8.-QZU_,.L$V1^ZEZC_EC M+Z_[E?TH_LJ C]G'X+@@@CX>^'@0000?LO0@@$'V(!K]/\9^',@R;(\JKY3E M.7Y?6JYI[*I4P>&I4)SI_5*TE"4J<8MQ)JUH0J?6L/#GBIR:4N1N-UK9M=3Z!IK-M&<9^95_P"^F"@_ M@3FG4UEW #.,,C>OW'5L?CMQ[9SSTK^<#^@#\MO@E_P4TTCXCM\-O$OQ"^$= MQ\'_ (3?&CQ=\:O!OPU^(^K_ !9^'?B,07OP+TSXL>)/&&L_$_PM82:7JWPU M\)#PG\%_&VM_\)7/<>(-#T21-%TWQ7>:#<:Y822?55U^VC^S#8^"K+X@7?QA M\,6_AS4?$MSX.L?-BUM=>NO$UEH8\5WNC0^#O[(_X3)[RS\'LGC:[7_A'Q%: M^")(_&<\L?A>2/5F_/2Q_P""+?PBT_X0:;\.K#Q-X>T'Q9XA\ ?M5_";XY_% M/PC\*M!\,^+_ (S_ \_:7\5ZO\ $:UM]=U"QU8:POBGX9_$73_AIK>@>(=7 MUS7UU/0/#'B_P==V-II/Q#O9-(]'M_\ @FIJ-AX.,.G^,OA%!\2)_BM!\2+W MQ<_PV^.UPN+#X?/\.=*_L+QE=_M9W/[1G@_Q;INDW.HB'Q;X9^/MA#/H&IWO MP_O?#]UX5= @!]:?"#]M3X"?';XZ?%[]GWX9^(-5\0^-/@MX5^&7C7Q+J\.A M7_\ P@FM>&OBSH1\2>$M6\%>-4230_%%E-I$EC=37-E-?'_ ,0O!OA#S_$?C%=. M^'UO9R>+=*T'2[*$V^N>(/#UWJNB:7XFTRQOI6\%7NN:4WCF3PS8W+7D>5^S M7^R#XP_9X^)VN^/;SXY:K\78O'WP*^ _PV^)U_\ $+PS*_Q#\4_$;X >']2\ M)Z'\4(?%NF^*(M'M;;QCH.O:I)XP\+W_ (3U749=>M=.U>T\8D3:M;7WSK\4 M?^"7FJ?$[P%\1_A'>?'B+3OAA?Z/^W7<_!O3H?AI)-XN\ ^._P!O+PY\7- \ MO>(CC:!'*=!\":/J'BG61<:9ITECINGZK,T$D.F7$].\7?MA?LR>!/#UMXJ M\5?&OP%I.@7T^CV]CJW<<8TKXR_"'7/B'\)O$%X\\\VEZ/X[OM4A@ MOKFPBMI_F3PQ_P $\O%/PMM?A[KGP@^/=MI'Q/\ A[J?[2VBZ?XK^('PL@\= M^&;GX1_M!:QX$M]"\!/X,TSQOX*EAU;X'_#WX,? ?X?_ ]\4+XD>WU#1?AG M=6WB3P_>6?C'4+?30#V3XH?M[_ CP%XM^'W@3PYXATWXH>+?&GQS^#?P2U?1 M/ ^MZ;>W'@:?XUZ=HNN>$_%WB6X'?$WAKQ%IT=I>27OB+1-:M]2T M!+VTM[Z:VL_"W]NKX*_&S]HIO@#\)]5M_'R1_ V[^.#?$;PYJEE>>#YM*MOB M5;?#:#2[ .L-_JL>J7G2S:WXRT?X93^*/^$YLK6P3PQ>^(/[-TSPU/!I,%S<>X_LV?L1>+/@C\6? MA_\ $[Q9\9-'\?1?"W]D?0/V.O!NA:-\+QX%9O ?@WQEH/B7PSXL\2ZDWCCQ M4NJ>-;JQT2/3?$JZ38^'_"D]SY=_X;\.>'(6O+&[ /T/HHHH **** "BBB@ MHHHH **** "BBB@"E_9UA_SY6G_@+;__ !JI(K.TA?S(;:WB< @/'!%&P!Z@ M,B*V#CD9P>]6:*IRD]'*379M_P"8N6/\J^Y>7^2^Y!1114C"BBB@ HHHH ** M** "BBB@ HHHH *C>**3'F1QR8SC>BOC.,XW XS@9QUP*DHH3:U3L^Z$TGH] M5_EJ0?9;;_GW@_[\Q_\ Q-3*JJ JJ%51@*H Z 8 ]!2T4VV]VWZML%%+ M9)?U;] HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * >*** "BBB@ HHHH **** "BBB@ HHHH **** /__9 end GRAPHIC 33 biib-2016630_tysabri.jpg begin 644 biib-2016630_tysabri.jpg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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

    /D)ZP#U"?8 \PG_ /(*_P#Q"O\! M\0O_ ?$+_P'Q"_\!\0O_ ?\?(P#_'R$ _QXA /\9) #_%RP _Q4W /\31 #_ M$5 !_Q!< ?\.9P'_#G(!_PY[ ?\.A '_#HL!_PZ2 ?\.F '_#IT!_PZC ?X. MJ '\#JX!^PZU /H.O@#X#LD ]0[; /(.Z@#N#O4 [ [_ >L/_P'J#_\!ZA#_ M >D0_P'I$/\!Z1#_ ?\B'P#_(AP _R$< /\?( #_'RD _QPT /\:0 #_%TP! M_Q58 ?\48P'_$VX!_Q-W ?X3@ '\$X@!^A*. ?D2E0'X$IH!]A*@ ?42I@'T M$JP!\Q*S ?$2O 'P$LD3Z 'F$_4!Y!3_ >(4_P+A%?\"X17_ N 5 M_P+@%?\"X!7_ O\E&P#_)A< _R06 /\E' #_)B4 _R0P /\A.P#_'T@ _QU4 M ?T;7P'Y&FD!]QIS ?09? 'R&80!\1F+ >\9D0'N&9L9HP'I&:H! MZ!FQ ><9N@'E&<4!XQG5 =\:Z '<&_4"V!O_ M4<_P/4'/\#TQS_!-(<_P32 M'/\$TAS_!/\I%P#_*A, _RD2 /\L& #_+"$ _RPK /\I-P#])T, ]R5/ ?,C M6@'O(F0!["%N >DA=P'G(7\!Y2&& >0AC0'B()0!X2": =\@H '>(* .\U* #G,S4 X#)" -LR3P#5,5H! MT#%D LTP;0++,'4#R3!\ \U,.X)LC#["K P_PNN,/\+KC#_"ZTP_PNM,/\+K3#_"_\S M# #_-@8 _SP) /\^# #]/1 [SP5 .0Y'P#;.2T TCH\ ,TZ20'(.50!Q#E> M L$X9P._-V\$O3=V!;LV?0:Y-H0'MS:+![8UD@BT-9H)LS6A";$UJ@JO-;0+ MKC7!"ZPUU NI-NH,IC;X#:4V_PZC-_\.HC?_#J(W_PZB-_\.HC?_#O\W!P#_ M.P( _T # /)"!0#I0@D Y3\. -@^%@#.0"< QT$V ,)!1 &]04\"N4!9 [8_ M802T/FD&L3UQ!Z\]> BN/'\)K#R&"JH[C0NI.Y4,ISN=#:4[I@VC.K .HCN\ M#Z [S0^>.^80FSSU$9H\_Q&9//\1F#S_$9@\_Q&8//\1F#S_$?\Z 0#_0 M[T4 .%( #92 4 TT8) ,Q%$@#$1R( O4@Q +A(/P&S1TH"L$94!*Q%706J M1&0'IT-L"*5"0) /G$"8$)I H1&80*P2ET"X$I5 MR!.30.$3D4'S%)!!_Q2/0?\4CD+_$XY"_Q..0O\3CD+_$_\\ #Y1 Y$H M -A. #.3P( R4T& ,-+#P"[31T M4XM *]..@&K348"ITQ/!*1+6 :A2F ( MGDEG"9Q(;@N:1W4-F$9\#I9&@P^418L1DD64$I!%G1..1:@4C$6T%8M%Q!:* M1=P6B$;P%H9&_1:&1O\6A4?_%85'_Q6%1_\5A4?_%?\_ #L2 W4\ ,]3 M #&50 P%,# +M1# "S4AD K5,I *A3-@&C4D("GU%+!)Q05 :93UP(EDYC M"I1-:@R13'$.CTMX#XU+?Q&+2H<2B4J0%(=)FA6%2:47@TFQ&())P!B!2M89 M?TKM&'Y+_!A^2_\7?4O_%WU+_Q9]2_\6?4O_%O]# #F3 UE, ,E8 # M60 NE@! +16"0"L5Q8 IE@E *%8,@&=5SX"F%9(!)5540:25%@(CU)?"HQ2 M9@R*46T.B%!T$(5/>Q*#3X03@4Z-%7].EQ=]3J$8>TVN&7I.O1IX3M$:=T[K M&G=/^AEV3_\9=D__&'9/_Q=V3_\7=D__%_A& #B4 T%< ,1< "[7@ MM%T *Y:!@"F6Q, H%PB )M<+P"76SL"DEI% X]930:+6%4(B%=<"H968PR# M56H.@51Q$'Y4>!)\4X 4>E*)%GA2E!AV4I\9=%*K&G)2NAMQ4LT<<%+H&W!3 M^1IP4_\:<%/_&7!3_QAP4_\8<%/_&.]) #=4P RUH ,!? "W8@ KV$ M *A> @"A7Q FV > )9@+ "18#@!C5Y" XE=2P6%7%('@EM9"H!:8 Q]66<. M>UAN$'A8=1)V5WT4=%>'%G)6D1AO5IP:;E:I&VQ6N!QK5LL=:E;F'&I7]QMJ M5_\::E?_&6M7_QEK5_\9:U?_&>M, #85@ R%X +QB "S90 JV4 *-B M "<8@X EF,< )%D*0",8S4!B&(_ X1A2 6 8% '?5]7"7I>70MW760-=5QK M$'-<A/ #360 Q&$ +EF "P: IVD )YE "7 M9@T D6<9 (QH)P"'9S(!@V8] G]E1@1[9$T&>&-4"75B6PMR86$-<&%I#VU@ MC1EE7I@:8UZE'&%>M!U@7L<=8%[C'6!>]1Q@7O\;8%[_ M&F%>_QIA7O\:85[_&N12 #/7 P&0 +9I "L; HVP )EI "2:@L MC&H6 (=K) "":S !?FHZ GII0P1V:$L&6\X G5N00-R;4D%;FQ0!VMK5PII:UX,9FIE#F1I;!%A:703 M7VA^%EUGB1A;9Y4:66:B&U=FL!Q69L,=5F;?'59F\QQ79O\;5V;_&E=F_QI7 M9O\:5V;_&MM9 #'8@ NFH *]P "F

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

    &5@ 6AF, M%89Q !2&@0 2AI, $8:F !&%NP 0A=8 $8/O !&"^P 2@O\ $H'_ )%N "! M;0 =&X &EN !=< 4W, $EW ! ? -X "^# GAP (8H !J- M!@ 5CPT $Y 3 !*0&@ 2D"( $9 J !"1,@ 0D3L #Y%$ Z13P -D5P #)%J M N1>@ *D8T ")"? >0LP 'C\D !X_F >.] (C?P "(W_ (ES ![

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�"G Q4 H@4@ )\'+ "<"#8 F0@_ )<)1P"5"4X MDPE4 )$*6@"0"E\ C@IE (T*:P"+"G( B@MY (@+@@"'"XP A0R7 (,,H@"! M#; @ W '\-V !]#N\ ? _] 'L/_P![$/\ >Q#_ .87 #1'@ O1T *\< M "F&0 H14 )X0! "=#0\ F X9 )0.)0"1#R\ CQ Y (P000"*$$@ B!!/ M (<050"%$%L A!%A ((19P" $6X ?Q%U 'T1?@!\$H@ >A*4 '@2H !W$ZX M=1.^ '04U0!S%>X <1;] '$6_P!Q%O\ 1A< '<88@!V&&D =!AQ ',9>@!Q&80 ;QJ0 &X:G0!L&ZL :QR[ M &HP :![[ &@>_P!G'O\ 9Q[_ -$F "]*@ JRH )TJ "3* MC24 (@B "&'08 @QL0 '\<&@!\'20 >ATN '<>-@!V'CX =!Y% '(?2P!Q M'U$ ;Q]8 &X?7@!L'V4 :R!M &D@=@!H(8$ 9B&- &4BF@!C(J@ 8B.X &$C MS0!@).D 8"3Z %\D_P!?)/\ 7R3_ ,HL "V+P I"\ )8O ",+0 A2H M ( H !]) >B(- '8C%0!S(R <20I &\D,@!M)#H :R5! &HE1P!H)4T M9B54 &4E6@!D)F$ 8B9I &$F<@!?)WT 7B>* %THEP!;*:4 6BFU %HJR@!9 M*N< 6"KX %@J_P!8*O\ 6"K_ ,4Q "O,P GC, ) S "&,@ ?R\ 'DM M !U*@ 3, ',Q !O M+P :RX& &@M$ !D+A@ 8BXA & O*@!>+S$ 7"\Y %LO0 !9+T8 6"]- %

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

    * #(GP R*\ M ,B\ $9Z Y@0 +HD "*0 7F #Y\ >E J@ *\ "S MMP +P "_ P0 ,( #$ Q0 ,< #) RP ,T #/ M P T@H -80 #<&@ W2H -X\ #?4 X&4 .%[ #AD0 XJ( .*M M /\ @#_ _P # /\ # #_ !, _P = /\ * #^ #, ^P ^ /< 2 #S % M\ !7 .T 7@#K &0 Z !I .< ;P#E '0 XP!Y .( ?P#@ (4 W@", -P DP#9 M )P U@"F -, L0#1 , SP#: ,X \0#, /\ RP#_ ,L _P#& /\ P0#_ /\ M #_ _P /\ " #[ ! ]@ 9 /( ) #O "X [0 Y .@ 0@#C $L X !2 M -T 60#9 %\ U@!D -, :0#1 &X SP!T ,X >0#, '\ R@"& ,@ C@#& )8 MQ "@ ,( JP# +D O@#- +P Z@"[ /P N@#_ +H _P"Z /\ M@#_ /\ #_ M _@ /0 ! #K T Y 4 -\ 'P#; "D V S -, /0#. $4 R@!- ,< M4P#% %D PP!? ,$ 9 "_ &D O0!N +L %T G0!B )L 9P": &T F !S )< >P"5 (0 E ". )( F0"0 M *8 C@"T (T R ", .8 BP#Y (H _P"* /\ BP#_ / #; QP +H M "P J * *0 $ "@ !@ G0 A )L *@": #, F [ )8 00"4 $@ D@!- M )$ 4@"/ %< C@!< (P 80"+ &< B@!N (@ =0"' 'X A0"( (, E "" * M@ "O '\ P !^ -T ?0#R 'T _P!] /\ ?0#_ . #& M0 *H "B M FP % )4 #0"2 !, D < (T ) "+ "T B@ T (@ .P"& $( A0!' (, M30"" %( @0!7 '\ 7 !^ &( ?0!H 'L < !Z 'D > "# '8 CP!U )P = "J M '( N@!Q -$ < #L ' ^P!P /\ < #_ ,T$ "W!@ IP< )L& "3! MC@ (H " "& \ A 6 ($ '@!_ "< ?0 N 'P -@!Z #P >0!" '< 1P!V M $P =0!2 ', 5P!R %T <0!C &\ :P!N '0 ; !^ &L B@!I )@ : "F &< MM@!F ,L 90#G &4 ]P!E /\ 90#_ , , "K#0 FPX (\. "� @0L M 'X' 0!\ 0L >0 1 '< & !U "$

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�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

    XM@ -]0 #;O $0I Z*0 ,2D "LI F M* (B< !TH 8*0 $RL ! N -, "3( 4U !-P #D" [ M!0 / @ #X+ _#0 01 $,4 !#&P 0R, $,N !#.0 0T< $)7 M !":@ 08$ $": _L@ /L\ #[O #\L V+ +RP "HK E*@ M'RL !DM 4+P $#( TU (. !#H \ /P $$ !# @ M104 $8( !("P 2@X $P1 !-%@ 31X $TH !-- 3$( $Q1 !+ M9 2WL $J4 !)K0 2,H $?L #LP S+P +2\ "@M B+P &S$ M !4T 0-P #3H @] "0 $, !& 2 $H !, 3@$ M $\$ !1!P 4PL %4. !8$@ 61D %@B !8+@ 5SP %=+ !67@ M5G, %6- !4IP 4L( %+F #@S Q,@ +#$ "4R =-0 %C@ !$\ M ,0 !T0 !' 2@ $T !0 4P %4 !7 60 %H M !< P 7@< &$+ !D#@ 9A, &<< !F)P 9C0 &5$ !D5P 9&L M &*% !AGP 8+D %[< #4W P-0 *#< " Z 8/0 $4( Q& & M2@ $\ !3 5@ %D !< 7P &$ !D 90 &< !I M ; $ &X& !Q"P = \ '<5 !W( =BT '8] !U3P =&, '-[ M !RE0 <*\ &_) #4Z K.P (C\ !I# 22 #$T 52 5P M %P !@ 9 &@ !K ;@ '$ !S =0 '< !Z M? '\ ""! A@H (H/ ",%P BR0 (HS ")10 AUL (9R "% MBP @Z4 (*\ "] E1 '$D !-. -5 !%H !A 9@ &L M !O = 'D !] @ (, "% AP (H ", CP M )( "6 F0( )X) "B$ HAH *$I "@.P GU )UG ":@0 MFID )FO "E) ?3@ %50 Y; %8@ &D !P =P 'T "" M A@ (L "/ DP )4 "7 F@ )T "@ HP *8 M "J K@ +( "W"@ NQ$ +H? "Y, MT4 +5< "T= L8X M *^D ")4 86P $&( =J

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�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

    : !6MP 5>, M %3] !4_P!./0 0ST #P\ U.P +#P "0^ <00 %40 !!( + M2P !4X !1 5 %< !9 6P %T" !>!@ 8 L &(. !D M$@ 9Q@ & )9 &D !O = '@ !\ M @0 (0 "' B (L ". D ), "6 F0< )T- M "A% H"$ * Q ">1 G5L )QV "9E@ F;4 );E "5_@ _4@ M,E4 "9: ;8 $6< EM = 'L "! A@ (L "0 ME )< "9 G )\ "A I *< "J K0 +$& "U M#0 N!8 +P#- (4 R@"1 ,< G@## *X P #% +T MZP"[ /\ L #_ *0 _P"< /\ F #_ )4 _P#_ ^@ /0 #Q \@ M .H !0#G X X@ 5 .$ '@#A "@ V Q - .0#+ $ R !' ,4 30#" %, MOP!8 +T 7@"[ &0 N0!K +8 0#_ M '< _P!R /\ < #_ &\ _P#= RP +8 "G G0 )0 ". $ MBP * (D $ "( !4 AP = (< )0"$ "P @@ R '\ . !] #T >P!# 'D 2 !X M $X =@!4 '4 6P!S &, <0!N &\ >@!M (D ; ": &H K@!I ,P : #V &< M_P!E /\ 9 #_ &, _P#* M *$ "3 B0 (( ![ > % M '8 # !U !$ = 8 ', 'P!R "4 < L &X ,@!L #< :@ \ &D 0@!H $@ M9@!. &4 50!C %T 8@!F & <@!> ( 70"2 %L I0!: +X 60#I %D _P!9 M /\ 6 #_ %@ _P"Y H@ ) "# >0 '$ !M :0 ! &8 M"0!E X 9 3 &, &0!C " 80 F & + !> #$ 7 W %L / !: $( 6 !( M %< 3P!6 %< 5 !@ %, ; !1 'D 4 "* $\ G@!. +0 30#: $T ^P!- /\ M30#_ $T _P"J E (( !U :P &0 !@ 70 %H !0!8 M P 5P 0 %8 %0!6 !L 50 A %, )P!2 "P 40 Q $\ -P!. #T 30!# $P M2@!* %( 20!; $@ 9@!& ', 10"$ $0 EP!# *P 0@#) $( \0!" /\ 0P#_ M $, _P"> B0 '@# !J! 800 %H# !5 0 4@ % @!. D M30 - $P $0!+ !< 2@ < $D (@!( "< 1P M $4 ,@!$ #@ 0P ^ $( 10!! M $T /P!6 #X 80 ] &X .P!^ #H D0 Y *8 . "_ #@ Z X /\ .0#_ #D M_P"5 P @ < &\) !B"@ 6 L %$* !," 208 $<# !& 8 1 + M $, #P!" !, 00 8 $$ '@ _ ", /@ I #T +@ [ #0 .@ Z #D 00 X $D M-P!2 #8 70 T &H ,P!Z #( C Q *$ , "X "\ W@ O /D +P#_ # _P", M"0 > P &@- !<#@ 4@X $L. !%#0 00P #\* ^" ( /00( #P! M#0 [ ! .@ 5 #D &@ X " -@ E #4 *P T # ,P W #( /@ Q $8 +P!0 M "X 6@ M &< *P!W "H B0 I )T * "S "< T0 G /( )P#_ "< _P"&# M<@X &,0 !6$0 31$ $41 ! $ / \ #D. W#0 -@L$ #8("@ U M!@X - 42 #($%P Q!1P , 4B "\%* N!BX +08T "L&/ J!D0 *0=. "<' M60 F!V4 ) =U ",'AP B!YL ( :P " &RP ?!>T 'P;^ !\'_P" #@ ;1$ M %X2 !2$P 2!, $$3 [$P -Q( #01 R$ , \! # -!@ P"PL M+PH0 "T*% L"QD *@L? "D+)0 H#"L )PPR "8,.@ D#$, (PQ- "$-6 @ M#64 '@UU !P-B :#9P &0VQ !@,R@ 7#.L %PW\ !@,_P![$0 :1, %H5 M !.%@ 118 #T6 X%0 ,Q4 # 4 M$P *Q( "H0 P J#P@ *0X- M "@.$0 F#A8 )0\= "0/(P C#RD (1 Q " 0.0 >$$( '1!, !L06 9$&8 M%Q!V !40B0 4$)X $A"S !$0S@ 1$.X $A#^ !(0_P!W$P 914 %<7 !+ M& 0AD #H9 T& ,!< "P7 I%@ )Q4 "84 0 E$@0 (Q(+ "(2 M#P A$A0 (!(: !X3( =$R< '!,N !H3-@ 9%$ %Q1* !845@ 4%&0 $A1T M !$4AP 0%)P #A2Q T4R@ -%.L #A/^ X3_P!S%0 81@ %,: !(&P M/QL #<; R&@ +1H "D9 F& )!@ "(7 @%@$ 'A8( !T6#0 ; M%Q( &A<7 !D7'0 8&"0 %A@K !48- 4&#T $AE( !$95 0&6( #AER T9 MA ,&9@ "AFM D8Q@ )&.< "1CZ H7_P!O& 7AH % < !%'0 /!T M #4= O'0 *AP "8; C&P (1H !X: <&@ &AL% !@;# 6'! M%1P5 !0<&P 3'"( $ATI !$=,0 0'3L #AU% T>40 ,'EX "AYM D>@ ' M'I0 !1VJ ,=P@ #'>8 !!SX 4<_P!K&@ 6QT $T> !"'P .A\ #(? M M'P *!X "0> A'0 'AT !P= 8'@ %1\" !,@"0 2(0X $"$2 M ! A& .(1\ #B(F TB+@ ,(C< "B)! DB30 '(EH !2)I ,B? !(I$ M "*H AP (>4 "#X @_P!G'0 5Q\ $HA ! (0 -R( # A J M(0 )B "(@ ?'P '!\ !D@ 6(0 $B," ! D!P .)@P #"80 LF M%0 *)AP "28B @F*@ &)S, !"<] ,G20 !)U8 "=F G>0 )X\ ":F M FOP )>0 "7Y D_P!C( 5"( $(0 &B( !? WN@ -N0 M #7\ U_P!5*@ 2"P #TL T+ +2L "@J D*0 'BH !DK 4 M+0 $2\ TQ *- !S8 (X! .@< #L* ]#0 /A $ 4 ! M&P 0"0 $ N ! .0 0$< $!6 ! :0 0( #^; ^MP />, #S\ M \_P!0+P 0R\ #DO R+P +"T " 'L !^ P @0H (4/ "'%P MAB0 (4T "$1@ @ET (%V !_E@ ?K8 'SG !Z_P _1 ,T4 "A( M =3 $U( Q7 #70 &, !H ;0 '$ !V >@ 'X M "! @P (8 ") BP (X "2 E0$ )D) ">$ GAH M )TI " M "U, LT8 +%@ "O?@ K* *O! "I[@ Q50 )%L !AA .:0 M!7$ !Y @0 (@ "/ E )H "? I *@ "I MK *\ "S M0 +D "] P0 ,8 #+ T0H -,4 #1 M)0 T#L ,U4 #*<0 R)( ,6S ##W@ I8@ '&D !%Q '>P (0 M "- E0 )T "C J0 *\ "T N0 +P "^ P@ M ,4 #( S - #4 V@ -\ #D Z@ .X, #M&@ M["\ .I) #H90 YH8 .2E #BQ@#_ _P /\ #\ $ _ ( /X M#@#_ !0 _P = /\ )@#_ # _P Z /\ 0@#_ $D _@!0 /L 5@#Y %P ]@!B M /0 : #R &\ \ !V .T ?P#J (D YP"5 .0 HP#@ +4 VP#0 -4 ]@#* /\ MM@#_ *@ _P"? /\ F@#_ )8 _P#_ ^P /8 #S \P /8 "0#Z M X _0 6 /L ( #W "H \@ S .T .P#I $, Y@!) .( 3P#> %4 VP!; -8 M8 #2 &< SP!N ,P =@#) ( Q@", ,( F@"_ *H NP#! +@ Z0"V /\ IP#_ M )H _P"2 /\ C0#_ (H _P#Z \0 .H #G YP .0 0#@ L MVP 1 -H &@#; ", T0 L ,H - #& #L P@!" +\ 2 "\ $X N@!3 +@ 60"V M %\ LP!F +$ ;@"N '< K "# *D D0"F *$ HP"U * V "> /L E0#_ (L M_P"% /\ @ #_ 'X _P#O XP -H #3 Q@ +\ "Y 8 MP . M +0 % "T !T LP E *X +0"K #0 IP [ *0 00"A $8 GP!, )T 40"; %< MF0!> )< 90"5 &X DP!Y ) AP". )< C "I (D Q "( .\ A0#_ 'P _P!V M /\ )0 )@"1 "T CP T (P .@"* #\ B !% (< 2@"% % @P!6 M ($ 7@" &8 ?@!Q 'P ?0!Y (T =P"@ '4 M@!S -\ <@#_ &X _P!I /\ M9P#_ &4 _P#, O@ *L "= DP (H "% @@ % ( #0!_ M !$ ?P 8 ( ( !] "8 >@ M '< ,P!U #@ = ^ '( 0P!P $D ;P!/ &T M5@!L %X :@!H &@ =0!G (0 90"6 &0 JP!B ,D 80#V & _P!< /\ 6P#_ M %H _P"] J0 )< ") ?@ '@ !S ;P ! &T "0!L X M:P 3 &L &0!J " : F &8 + !E #( 8P W &( / !@ $( 7P!( %T 3P!< M %< 6@!A %D ;0!7 'L 5@". %4 H@!3 +L 4@#I %( _P!0 /\ 3P#_ $\ M_P"M F (8 !X ;@ &< !C 8 %T !0!< L 6P 0 M %L %0!; !L 6@ A %@ )@!6 "P 5 Q %, -@!2 #P 40!" $\ 20!. %$ M30!; $L 9@!* '0 20"% $@ F0!' +$ 1@#8 $8 _ !% /\ 10#_ $4 _P"? M B0 '@ !L 8@ %L !6 4P %$ @!/ @ 3P - $X M$0!. !8 30 < $P (0!* "8 20 L $@ ,0!' #< 10 ] $0 1 !# $P 0@!5 M $ 8 _ &X /@!^ #T D@ \ *D .P#' #L \P [ /\ .P#_ #P _P"3 M?@ &X !A 6 %$ !, 20 $< !% 4 1 + $, #@!# M !( 0P 7 $( '0! "( /P G #X + ] #( .P X #H /P Y $< . !0 #< M6P U &@ - !X #, C R *( ,0"\ #$ YP Q /\ ,@#_ #, _P") =@, M &8% !9!P 4 < $D& !#!0 0 , #X! \ , .P ( #H #0 Z ! M.0 4 #D &0 W !X -@ C #4 * T "X ,P T #( .P P $, +P!, "X 5P M M &0 + !S "L AP J )P *0"U "D W I /L *0#_ "H _P"!! ;@@ %\* M !3"P 2@L $(+ ]"@ .0D #8( U!0 - (& #, "@ R X ,0 1 M #$ %0 P !H +P ? "X ) L "H *P P "H -P I #\ * !) "< 5 F & M) !O ", @@ B )< (0"N "$ S A /, (0#_ "( _P!["0 : P %H- !. M#@ 10X #T. X#0 ,PT # , N"P +0D# "T&" L! P *P(/ "H! M$@ I 1< * $< "< (0 F "< )0 M "0 - C 3T (@%& "$!40 ? 5T '@%L M !P!?P ; )0 &@"J !H Q0 : .L &0#_ !H _P!U# 9 X %4/ !*$ M0! #D0 S$ +P\ "P. I#@ )PT! "<,!0 G"@H )@@- "4'$ D M!A0 (@89 "$&'P @!R0 'PG !,&OP 2!>0 $@7Z !(%_P!Q#@ 7Q %$1 !&$@ /1( M #82 P$@ *Q$ "@1 E$ (Q "(.! A#0< (0P+ " +#@ ?"Q( M'0L7 !P,' ;#"( &@PI !D,,0 8##D %@U# !4-3P 3#5P $@UK ! -?@ / M#9( #@VG T,O@ -#. #0SU T,_P!M$ 7!$ $X3 !#% .A0 #(4 M M% *!, "43 B$@ (!$ !X1 P <$ 4 ' \( !L/# :#A &0\4 M ! &%(T !!2C M ,3NP "$]T 1+T (2_P!E$P 518 $@7 ]& -!@ "T8 H& M(Q< " 7 =%@ &A4 !@5 @ 6%00 %!4% !(6" 1%@T $!<0 X7%0 . M%QL #1A 7 MN0 %]T !;U 6_P!A%@ 4A@ $4: [&@ ,AH "L: E&@ (1D M !X8 ;& &!< !87 @ 4%P, $A@% ! 9!P .&PL #!L/ L;$P *&Q@ M"!P? <<)@ %'"\ !!PX (<1 '5$ !U@ =<@ '(@ !R@ ;N0 M&]X !KV :_P!>& 3QH $(< X' +QT "D< C' 'QL !P: M 9&0 %QD! !09 @ 2&@, $!L$ X=!P ,'@L "1\. 8@$0 %(!8 R < M $A(P (2L "$U A0 (4X "%= A;P (88 ""> @N ']X M ![X >_P!:&P 2QT #\> U'P +1\ "<> B'0 'AT !L< 8 M&P %1L !(< 0'0( #A\$ PA!@ )(@H !2,- (D$ )1, "49 F M( )B@ "8R F/0 )DH "9: F; )H, "6< EMP )-\ "/Y M C_P!5'@ 1R #PA R(0 *R$ "4@ @'P '1X !H= 6'@ M$QX ! @ .(0 #"," @E!0 %)PD "@+ J#@ *Q$ "P6 L'0 M+"4 "PN L.@ +$< "Q6 L:0 +( "N: JM0 *=\ "G[ H M_P!1(@ 1", #@D O) *", ",B ?(0 '" !<@ 3(0 $", M XD +)@ ""@ 0J! + < "X) P# ,0\ #,3 S&0 ,R$ M #,J S-0 ,T, #-2 S90 ,GL #*7 QLP ,-X "_[ N_P!, M)0 /R8 #4G M)@ )R4 "(D >(P &2, !0D 1)@ #B@ LJ M '+ R\ Q @ ,P0 #4' W"@ .0T #H0 [%0 .QT #LF M [,0 .SX #M. [8 .G< #F2 XL -]L #;\ U_P!'*0 M.RH #(J K*0 )2< "$F ;)P %2@ !$J .+ "B\ 8Q ! M- #8 X .P$ #T$ _!P 00H $,. !%$0 11@ $4A !% M+ 1#D $1( !$6P 0W$ $*- !!JP 0-( #_Z ^_P!"+0 ."X M "\M I*P )"H !TJ 7+ $2X TQ )- !#< Z / M #\ !! 1 $8 !( P 2@< $P+ !.#@ 4!, % < !0)P M3S0 $]# !/50 3FH $V& !,I 2LH $GX !(_P ^,@ -3$ "XO M I+@ ("X !DQ 2,P #C< DZ "/0 $ !$ 1P $D M !, 3P %$ !3 50$ %@& !:"P 70X %\5 !>( 7BP M %T\ !<3@ 6V, %I^ !8G0 5\ %7R !4_P Z-@ ,S0 "TR D M,P &S8 !,Y ./0 "$$ !% 20 $P !0 4P %8 !9 M 6P %T !@ 8@ &4 !H!0 :PL &\0 !O& ;B4 &TT M !M1@ :UL &IU !HE 9K8 &3I !B_P X.0 ,C< "@Y >.P M%3\ Y$ '20 $T !2 5@ %H !> 8@ &4 !H M:P &T !P

    JH '?6 !U_0 X/0 +#X ")! 71@ #TL M =1 5P %P !B 9@ &L !O = '@ ![ ?@ M ( "# A@ (H "- D0 )8# ";# G1, )LA ":,P METD )1B "3?P D* ([% ",\P Q1 )4@ !I- 04P "%H !A M : &X !T >0 '\ "$ B0 (T "1 DP )8 M "9 G0 * "D J *P "R P MPT +<7 "U* LCX M +!6 "L

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

    @#_ ($ _P"' /\ C0#_ ), M_^)]$$E#0U]04D]&24Q% ! 2_P"9 /\ H #_ *< _@"O /P N@#Z ,D ^0#A M /@ \P#W /\ ]@#_ /4 _P#Q /\ Z0#_ .0 _P#A /\ _P / /\ #0#_ T M_P . /\ % #_ "$ _P N /\ / #_ $@ _P!3 /\ 70#_ &8 _@!M /P =0#[ M 'L ^0"" /@ B #W (X ]@"4 /0 FP#S *( \0"J .\ M #M ,$ ZP#5 .H M[ #H /P YP#_ .4 _P#F /\ X #_ -D _P#4 /\ _P + /\ " #_ 8 _P ) M /\ $ #_ !P _P I /\ -@#_ $( ^P!. /< 5P#T & \@!H .\ ;P#M '8 M[ !\ .H @@#H (@ YP". .4 E0#C )P X0"D -\ K@#= +D V@#* -< Y #4 M /8 T0#_ - _P#0 /\ SP#_ ,L _P#' /\ _P # /\ #_ _P $ /\ M#0#Z !8 ]@ C /, , #P #P [0!' .D 40#E %H X@!B -\ :0#= &\ V@!V M -@ ? #4 (( T@"( - CP#- )8 RP"> ,D J #' +, Q0#! ,( V # .\ MOP#^ +X _P"] /\ O #_ +P _P"\ /\ _P( /\ #_ _P /0 !P#M M !$ Z < ., *0#? #4 VP!! -8 2P#1 %0 S0!< ,H 8P#( &D Q@!O ,, M=0#! 'L OP"" +X B "\ ) N@"8 +@ H@"U *P LP"Y +$ RP"O .< K@#X M *P _P"K /\ K #_ *P _P"K /\ _P0 /\ #V [@ .< #? P MU@ 5 ,\ (@#* "X QP Z ,, 1 # $T O !5 +D 7 "W &, M0!I +, ;P"Q M '4 KP![ *T @@"K (H J0"2 *< G "E *8 HP"S *$ PP"? -X G@#R )T M_P"< /\ G #_ )L _P"; /\ _P< /8) #I"P WPH -4$ #. 4 Q@ 0 M , &@"[ "< MP R +, /0"P $8 K0!/ *H 5@"H %P I@!C *0 : "B &\ MH0!U )\ ? "= (0 FP"- )D EP"7 *( E0"N ), O0"1 -, D #M (\ _ ". M /\ C0'_ (T!_P"- ?\ ^0X .H2 #<%0 S14 ,01 "^# N@(* +0 M$@"N !X J@ J *8 -0"B #\ H !( )T!4 "; E8 F0)< )<#8P"5 VD DP-O M )$$=@"0!'\ C@6( (P%D@"*!IX B :J (8'N@"%",\ A KK ((+_ "!#/\ M@ S_ ( ,_P" #/\ \14 . = #-( P2$ +@= "Q%P K! *@)#0"B M!Q8 G0DC )D*+@"5"S@ DPQ! ) ,20".#5 C U7 (H-70"(#6, APUJ (4. M<0"##GH @@Z$ ( .CP!^#YL ? ^H 'L0N !Z$,X >!'L '82_P!U$O\ =!/_ M '03_P!T$_\ Z!X -,F ##*@ N"H *XH "G(P H!P )L3 P"6#Q MD! ; (P1)P")$C( AA,[ (030P""%$L @!11 'X45P!\%%X >Q5E 'D5; !W M%70 =A9^ '06B@!R%Y8 <1>D &\8M !N&,D ;1GH &L:_ !J&_\ :AO_ &H; M_P!J&_\ X"8 ,HM "\,0 L#, *QLV 'D;/@!W'$4 =1Q, ',<4P!Q'5D A0!H'Y( 9Q^@ &4@L !D(<4 8R'D &(B^@!A(O\ 82+_ &$B_P!A M(O\ URP ,,T "V. JCD *$X "8-0 D"\ (@H " (0@ >R 2 '@!1 M,8@ 4#*7 $XRJ !-,[L 3338 $PT\P!,-/\ 3#3_ $PS_P!,,_\ QCH +9" M "I1@ GDD )5) "+1P @4( '<] !M-P 9#() & R$@!=,AP 6C(E M %@S+0!6,S4 53,\ %,T0P!2-$H 4311 % T60!/-6$ 335L $PV=P!+-H4 M2C>5 $@WI@!'.+@!1SC3 48X\0%&./\!1CC_ $8X_P!&-_\ P3X +)% "F M2@ G$T ))- "(2P ?D< '-" !I/0 7S<& %HV$ !7-Q@ 5#TP &]& !E0@ 6CT" %0[#@!1.Q4 3SL? $T[)P!+ M.R\ 23PV $<\/0!'/$0 1CU+ $4]5 !$/EP 0SYG $(_%$ &Q+ !A1P 5D( $] # !,/Q, 24 < $= ) !&0"P M1$ S $- .@!"04( 04%) $!"40 _0EH /D-E #U#<0 [0W\ .D2/ #E$H X M1;,!-T7+ 3=%[ $W1?\!-T3_ 3A$_P$X0_\ MTD *E0 ">50 E%@ (M9 M " 6 =E8 &A0 !=3 4T@ $I%"0!&1!$ 1$09 $)$(@!!12D /T4Q M #Y%. ]13\ /$9' #M&3P Z1U@ .4=B #A(;@ V2'P -4B- #1)G@ S2;$ M,DG) #%)ZP R2?X ,DC_ #)(_P S2/\ M$P *=4 "<60 DEP (A= !^ M70 *@ C7C( (EXZ M "%>0P @7TP 'U]7 !Y?8P <8'$ &V"" !E@E0 88*D %V# !9@X@ 77_D M&%[_ !E>_P 97?\ I& )EH "0;@ AG 'QR !R<@ 9G$ %AN !, M; 06L #9I M9P (V8( !]F#P =9A4 '&8= !MF)0 :9BT &6 8'< %-V !&= M.W, #%R G<0 'G$ !9P"@ 30 ?GP '1^ !F?@ 67X $U^ ! ?0 -7T M "I\ A? &'P !%\! ,? P "GP1 E\&0 (?"$ !WPI 9\,@ $?#T M WQ( %\50 ?&, 'QT !\AP >YP 'NQ !ZRP >>L 'GZ !Y_P M>/\ EG< (Q\ "#@ >8, &R$ !>A0 488 $6' YAP +8< ".' M :AP $H< V( 0 &B0H 8D/ ")% B!L (@C ")+ B38 (E" M "(3@ B%T (AM "(@0 AY4 (>K "&Q A>8 (3X "$_P A/\ MD'X (># !^AP <8D &.+ !6C0 28\ #R1 PD0 ))$ !J2 2 MDP #90 :5 E@8 )8, "5$ EA4 )8= "6) EBX )8Y "6 M1@ EE4 )9E "6> E8X )6D "4O D]\ )/U "2_P DO\ BX8 M (.* !UC0 9Y %F4 !,EP /YD #*: FFP &YP !*= ,GP M!* "B HP$ *,' "C# HQ *05 "D' I24 *8O "F/ MIDL *9; "F;@ I80 *6; "DLP H] */O "B_ HO\ AHT 'B1 M !JE0 7)D $Z= !!H ,Z( ":C ;I0 $:< JI !JP *T M "O L + "P!0 L0L +(/ "S% M!L +4D "W, MS\ M +=0 "W8@ MW@ +>0 "VJ0 ML( +;D "V]0 M?X >Y, &V8 !? MG0 4*( $*F TJ0 )JL !JM 0KP ";( "T MP +H "\ M O0 +X "^ P ( ,$( #"#0 Q!( ,89 #)) RC( ,M# M #+50 S&H ,R# #,G R[4 ,S. #,Z0 S/8 <)L &&A !2I@ M1*L #:P GL@ &K4 !"X 'NP +X #! Q ,@ #+ MRP ,T #. T -( #5 P V H -L0 #>& XB0 .,U #D M2 Y5P .9S #FC0 YJ4 .:\ #FTP Y^< 8Z0 %6J !&L .+4 M "BY :O #\ 7$ QP ,L #/ U -@ #< W0 M -\ #A XP .4 #H Z@ .T& #Q#@ ]18 /@E #Y. M^4T /IC #[? _)4 /RJ #\NP _ )< W "? -D J0#6 +0 TP#$ - W@#. /, S #_ ,L M_P#* /\ R #_ ,( _P"^ /\ _P /\ #_ _P /L "P#V !, \0 @ M .T + #J #@ YP!# ., 30#@ %8 W != -D 9 #5 &L T@!Q - =@#. 'P MS "# ,H B0#( )$ Q@"9 ,0 HP#! *T OP"[ +T SP"[ .L N0#\ +< _P"W M /\ M@#_ +0 _P"Q /\ _P /\ #_ ]@ .X !0#G \ X0 9 -L M)0#5 #$ T@ \ ,X 1@#* $\ QP!7 ,0 7@#! &0 OP!J +T < "[ '8 N0!\ M +@ @P"V (H LP"3 +$ G "O *< K0"S *L Q0"I .$ IP#U *8 _P"E /\ MI #_ *0 _P"D /\ _P /P #Q Z . #4 L S 3 ,< 'P#" M "H OP U +P /P"X $@ M0!0 +, 5P"P %X K@!D *P :0"K &\ J0!U *< M? "E (0 HP", *$ E@"? *$ G0"M )H O "8 -( EP#N )4 _@"4 /\ E0#_ M )4 _P"5 /\ _ $ / % #C!P U04 ,P #% 0 O@ . +@ %P"S ", MKP N *L . "I $$ I@!* *, 40"A %< GP!= )T 8P"; &D F@!O )@ =@"6 M 'T E "& )( D "0 )L C@"G (P M@"* ,D B #G (< ^0"' /\ A@#_ (8 M_P"& /\ ] P .00 #1$@ Q1$ +T. "V" L0 ( *L $0"F !L H0 F M )X ,0": #H F !# )4 2@"3 %$ D0!7 (\ 70". &, C !I (H < "( '< MA@" (0 BP"" )8 @ "C 'X L0!] ,0 >P+A 'H#]0!Z!?\ >07_ '@&_P!X M!O\ ZA, -8: #&'0 NAP +$9 "J$P I T )\%# "9 !0 E0 ? )$" M*0"- S, BP0\ (@%1 "&!DL A 91 (('5P"!!UT ?P=C 'T(:@!["'( >@A\ M '@)A@!V"9( = J@ ',*KP!Q"\$ < S? &\-]@!N#O\ ;0[_ &T._P!M#O\ MX1P ,LC "\)@ L28 *@D "@'@ F1@ ),0 @"."PX B L7 (0,(@"! M#2P ?@TU 'P./0!Z#D4 > Y+ '<.40!U#U@ '$090!P$&X ;A!W &P0 M@@!K$(\ :1&= &@1K0!F$L 91+? &03]@!C%/\ 8Q3_ &(4_P!B%/\ UB0 M ,,J "U+@ JB\ * M "8* D"( (D; ""$P@ ?1$2 'D2' !V$R< M0!8'X< M5B"6 %4@I@!4(;@ 4R'2 %(B\0!2(_\ 4B/_ %(B_P!2(O\ R"\ +@V "K M.@ H#P )8[ "-. @S( 'HM !R)@ :B , &8@$P!C(1T 82$F %\B M+P!=(C8 6R(] %HC1 !8(TH 5R-1 %4C6 !4)&$ 4R1J %$E=@!0)8, 3R:3 M $XGHP!,)[4 3"C. $LH[@!+*?\ 2RC_ $LH_P!+*/\ PS0 +,[ "G/P MG$$ )) ")/@ ?SD '4S !L+0 8R<( %XF$0!<)AD 62SX '$Y !G- 7BX$ %@K#@!5*Q8 4BP? % L)P!/+"\ M32TV $PM/ !*+4, 22U* $@N4@!'+EH 1B]D $4O< !#,'X 0C"- $$QG@! M,K$ /S+( #\SZ@ _,_X /S+_ #\R_P _,O\ NSP *U# "A1P EDD (Q) M "#2 >$0 &T^ !C.0 6C0 %(P# !/,!, 3# < $HP) !),2L 1S$R M $8Q.0!$,4 0S)' $(R3P!!,U@ 0#-B #\T;0 ^-'L /36+ #PVG [-J\ M.C?& #DWZ Y-_P .C?_ #HV_P Z-O\ MT *I& ">2P E$T (I. " M3 =4@ &I# !@/@ 5CD $TU"0!)-!$ 1S49 $4U(0!#-2@ 034O $ U M-@ _-CT /C9% #TW30 \-U4 .SA@ #HX:P Y.7D .#F) ## "9'E0 E2*@ )$B^ "-(X D2/< M)4?_ "5'_P F1_\ JD\ )]5 "46@ BUX (%? !W7@ :UP %]8 !5 M50 2U$ $!- U2@< ,$D. "Y)%0 M21T +$DD "M**P J2C, *$H[ "=+ M0P F2TP )4M6 "1,8@ C3' (4R "!-DP ?3:8 'DV[ !U.W0 >3?8 'DS_ M !],_P @2_\ IU, )Q: "27P B&, 'YD !T8P :6$ %Q> !26P M1U@ #Q5 R4@( *E , "=/$@ F4!D )5 @ "10* C4"\ (E$W "%10 @ M44D 'E)3 !U27P <4FT &E-] !E3D 84Z0 %E.Y !53V0 64_0 %U+_ !A1 M_P 94?\ HUD )A@ "/90 A6@ 'MI !Q:0 9F< %ED !-80 0E\ M #A< N6@ )5@( "!7#@ >5Q0 '5<< !Q8(P ;6"L &E@S !E8/ 86$4 M%EE0 !596P 466D $UIZ !):C0 16J$ $%JW Y:U0 06?, $%G_ !%8_P 1 M6/\ GU\ )5F ",:P @FT 'AN !N;P 8FT %5J !(: /F8 #-E M I8P (&$! !A@"P 58! %& 7 !-@'@ 28"8 $F N !%A-P 084 #V%+ M YA6 -868 #&)V MBB0 *89T "6&R AARP (8>L "6#] I?_P +7_\ MFV8 ))M "(<0 ?G, '5U !J= 7', $]R !#< .&\ "UN D M; &VL !-K! .:@P #6H2 QJ&0 +:B$ "FHI EJ,@ (:CP !VM' 5K M4P $:V$ FMQ !JA :I@ &JM !IQ@ :>< &GX !H_P :/\ EVT M (US "$=P >WH '![ !C>P 5GH $EZ ]>0 ,7@ "=W ==@ M%78 ]V @ )=@H !'8/ !V%0 =AP '8D !U+ =38 '5! !U3@ M=5P '5L !U?@ =), '2H !SP <^, '+W !R_P "")@ @B\ (([ ""1P @E4 M (%E "!> @8T ("B !_N@ ?]T '[T !]_P ??\ C7P (2! ![ MA ;H8 &"( !2B@ 18L #F, LC (8P !>, 0C0 "8X */ M D , (\) "/#@ CQ( ) 8 "0'P D"@ ) R "0/P D$T )!= M "/< CX4 (Z< ".LP C= (SP "+_@ B_\ B(0 ("( !RBP M9(T %:0 !(DP .Y4 "Z6 BE@ %Y< ^8 (F0 )L "= MG0 )T# "="0 G0T )X1 ">%P GQ\ )\I "@-0 H$, *!4 "@ M9@ GWL )Z3 ">JP G<8 )WI "<^0 G/\ @XL '6. !GD@ 698 M $N9 ]G ,)X ".? 7H #J( >D I@ *@ "J J@ M *H "K 0 JP< *P, "M$ KA8 *\> "Q*0 L3@ +%( "Q6@ ML6\ +&( "QH L+H *_= "O\@ K_T >)$ &J6 !I .JP !:X "P L@ +4 "W MP +@ M "Y N@ +P# "]"0 O@X , 4 ##'@ Q2L ,4\ #&3@ QF( M ,9Z #&E QJT ,;( #%Y0 Q?, ;)D %Z> !/I 0:@ #*L D MKP %K$ VT #MP +H "] P ,0 #& Q@ ,@ #) M RP ,P #. T 8 -,- #8$P W!X -XM #?0 X%0 .%K M #AA0 X9\ .&W #ASP X>8 8*$ %*G !#K0 -+( "6U 7N0 M#;P &_ PP ,< #* SP -, #6 UP -H #< MWP .$ #C Y@ .D! #L"P \!( /,? #T,0 ]D8 /=< #X M= ^(\ /FF #YN ^,D _P - /\ "P#_ L _P . /\ $P#_ !\ _P L M /\ .0#_ $4 _P!0 /\ 60#_ &( _P!J /\ <0#_ '< _P!^ /\ A #^ (H M_0"0 /P EP#Z )X ^0"G /< L0#V +X ]0#2 /, [ #Q /X \ #_ / _P#F M /\ W #_ -( _P#- /\ _P ' /\ ! #_ ( _P & /\ $ #_ !L _P G /\ M,P#_ #\ _P!* /X 5 #[ %T ^0!D /< :P#U '( \P!X /( ?@#P (0 [P"* M .T D0#L )D Z@"A .@ JP#F +8 Y #' .( XP#@ /< W@#_ -T _P#9 /\ MS #_ ,4 _P#! /\ _P /\ #_ _P ! /\ #0#_ !8 _ B /D +@#V M #D \P!% .\ 3@#L %< Z0!> .8 90#D &P X@!R . =P#? 'X W0"$ -L MBP#8 )( U0"; -( I #/ *\ S0"^ ,L U0#) .\ QP#_ ,4 _P#$ /\ O@#_ M +@ _P"U /\ _P /\ #_ _@ /< "0#Q !$ ZP < .< * #D #, MX0 ^ -T 2 #8 %$ TP!8 - 7P#. &4 S !K ,H <0#( '< Q@!] ,0 A #" M (P P "4 +X G@"[ *@ N0"V +< R "U .8 LP#Z +$ _P"P /\ L #_ *P M_P"I /\ _P /\ #Z \0 .@ P#@ T V 6 -$ (@#- "T R@ W M ,8 00#" $H OP!2 +T 60"Z %\ N !E +< :@"U ' LP!V +$ ?0"O (4 MK0"- *L EP"I *$ IP"N *4 O@"B -@ H #R )\ _P"> /\ G@#_ )X _P"< M /\ _P /< #K X0 -8 #+ D Q0 1 +\ &P"[ "8 MP Q +0 M.@"Q $, K@!+ *L 4@"I %@ IP!> *8 9 "D &D H@!P * =@"> 'X G "& M )H D "8 )L E@"G )0 M@"2 ,H D #I (\ _ ". /\ C0#_ (P _P"- /\ M^ .D" #; P S $ ,0 "] ( M@ - + %0"K " IP J *0 - "A M #P G@!$ )P 2P": %( F !8 )8 70"5 &, DP!I )$ < "/ '< C0" (L MB@") )4 AP"A (4 KP"# ,$ @0#@ ( ]0!_ /\ ?P#_ '\ _P!_ /\ [@H M -P. #*$ O@X +4+ "O P J0 ' *, $ "> !@ F0 C )8 + "3 #4 MD ^ (X 10", $L B@!1 (@ 5P"& %T A0!C (, :@"! '$ ?P!Z 'T A ![ M (\ >0"< '< J@!U +L = #4 '( \ !R /\ <@#_ '$ _P!Q /\ XQ$ ,T7 M "_&0 LQD *H5 "C$ G0H ) != '8 9 !T 6L <@%T ' "?P!N HL M; .8 &L#I@!I!+< : 7. &<'[ !F"/T 9@G_ &4)_P!E"?\ UAH ,0@ "V M(P JR, *$@ "9&P DA0 (P. 0"&!PT @ 04 'P&'@!Y!R@ =@@P '0( M. !R"3\ < E% &\*3 !M"E( ; I8 &H+7P!H"V< 9PMP &4,>@!C#(< 8@R5 M & -I !?#;8 7@W. %P.[0!<#_\ 6Q#_ %L0_P!;$/\ S2$ +PH "O*P MI"L )HI "2) B1\ ((8 ![$04 =0T/ '$-%P!N#B$ :PXJ &D/,@!G M$#D 91! &001@!C$$T 81!3 %\16@!>$6( 7!%K %L1=@!9$H, 6!*2 %83 MH@!5$[0 5!/+ %,4[ !2%?\ 4A;_ %(5_P!2%?\ QB@ +8N "I,@ GS( M )4Q ",+0 @R< 'HA !R&@ :Q,+ &<3$P!D%!P 810E %\5+0!=%30 M7!4[ %L60@!9%D@ 6!9/ %875@!5%UX 4Q=G %(8<@!0&'\ 3QF. $X:GP!, M&K 2QO' $L;Z0!*'/T 2AS_ $H<_P!*'/\ P2T +$T "E-P FC@ ) W M "'- ?2\ '0I !L(P 9!P' %X9$ !;&A@ 61LA %<;*0!5&S 5!PW M %(;@!)'WP 1Q^+ $8@G !%(:X M1"'$ $,BY@!#(OP 0R+_ $,B_P!#(O\ O#( *TX "A/ ESX (T] "# M.@ >34 &\P !F*@ 7B0" %<@#0!4(!0 42 = $\A)0!.(2P 3"$S $LB M.@!)(D 2")' $0 E$( (I" " /P M=CL &PV !B, 62H %$E"P!-)1$ 2R49 $DE(0!')B@ 128O $0F-@!# M)CT 0B=$ $$G2P _*%0 /BA= #TI:0 \*78 .RJ& #DKEP X*ZD -RR_ # M0?\ I4T )I3 "06 AEL 'U< !R6P 9U@ %M4 !14@ 2$X #U* M S1P *D,+ "9#$ E0Q8 )$,> "-$)0 B1"P (40T "!%/ >144 '45/ M !Q&6@ ;1F@ &49X !A'B@ 71YX %D>S !1(S@ 51^\ %D?_ !=&_P 71O\ MHE( )=8 "-70 A& 'IA !P8 95X %E: !/6 1%0 #E1 O M3@ )DL& "!*#@ >2A, '4H: !Q*(0 ;2R@ &DLP !E+. 72T( %DQ, !5, M5P 43&4 $TUU !)-B 139P $$VQ Y.S /3>X $$W_ !%,_P 13/\ GE< M )1= "+8@ @64 '=F !M9@ 8V0 %9A !*7@ /UL #58 K5@ M(E0! !I2"@ 64A %5(6 !12'0 34B0 $E(L !%2- 14CX $%-( ]35 . M4V( #51R Q4A +5)@ "52M A4Q0 )5.< "E/[ M2_P +4O\ FUT )%D M "(: ?FL '1L !K; 7VH %)G !%9 .F( #!@ F7@ '5T M !5;!0 06@P #EH1 Y:& -6R #%LG M;, *6SH "5M% =;40 &6UX M!%MM -;@ !6Y0 %NH !;P 6N( %KV %:_P "6?\ EV0 (YK "$ M;@ >W ')R !G<0 67 $QN ! ; -6L "II A9P &&8 !%F M 0 ,90H !V4/ 1E% #9!L F0C !D+ 9#4 &1 !D3 9%H &1I M !D>P 9(\ &.D !CNP 8MT &+T !B_P 8?\ DVP (EQ " =0 M>'< &UX !@=P 4G8 $9U Y= +G0 "-R :<0 $G$ UQ & M<0@ ' - !P$@ P TX 'M> ![;P M>H0 'J: !YL0 >,X '?O !V_@ =O\ B7H (%_ !X@@ :X, %V% M !/A@ 0H< #6( IAP '8< !2' -B !HD "* B@ (D& M ")# B0\ (D3 ")&@ BB( (HL "*. BD8 (E6 "): B7P M (B4 "'JP AL8 (7J "%^P A/\ A8( 'V& !OB 88L %.- !% MCP .)$ "N1 ?D@ %)( V3 $E )8 "7 F )< "7 M!0 EPL )@. "8$P F1H )DB ":+@ FCT )E- "97@ F7, )B+ M "8HP E[P );B "6]P E?\ @(D '*, !DCP 5I, $B6 ZF0 M+)H !^; 4G #)X .? H0 *, "E I0 *4 "E MI@( *<( "G#0 J!$ *D9 "K(P JS$ *M! "L4P K&< *N "J MF@ JK, *K0 "I[P J?L =8\ &>4 !9F 2IP #R? MH@ (*, M !.E +IP :D "K K@ +$ "R L@ +, "T M0 M +8 "X! N0L +L0 "]& OR0 +\U # 1P P%L ,!R # C0 MP:8 ,#! "_XP OO, :I< %N< !-H0 /J4 "^I AJP $ZT NP M LP +4 "X O +\ #! P0 ,, #$ Q@ ,< M #) RP ,X( #1#P U1@ -@G #9.0 VDT -MD #;?@ W)D M -RP # M X .0 #G!@ ZPX .\9 #P*@ \C\ /-5 #T;0 ](@ /2A M #TM@ ],< _P ) /\ !@#_ < _P , /\ $0#_ !P _P H /\ - #_ $$ M_P!, /\ 50#_ %T _P!E /\ ; #_ '( _@!X /P ?@#[ (0 ^@"+ /D D@#W M )D ]@"B /0 K #S +D \0#+ / Z #N /L [0#_ .P _P#A /\ T@#_ ,D M_P#$ /\ _P ! /\ #_ _P $ /\ #@#_ !< _P C /\ +P#_ #L _0!& M /H 4 #W %@ ] !? /( 9@#P &P [P!R .T > #L 'X Z@"% .D C #G ), MY0"< ., I@#A +$ WP#! -T W0#; /0 V0#_ -8 _P#/ /\ Q #_ +T _P"Y M /\ _P /\ #_ _P /\ "P#\ !, ]P > /0 *@#R #4 [@! .D M2@#F %( XP!9 . 8 #> &8 W !L -H <@#7 '@ U !^ -( A0#0 (T S@"5 M ,P GP#) *H QP"X ,4 S0## .L P #^ +\ _P"^ /\ M@#_ + _P"M /\ M_P /\ #_ ^0 /( !@#K \ Y@ 9 .$ ) #> "\ V@ Y -, 0P#/ M $P S !3 ,D 6@#' & Q0!F ,, :P#! '$ OP!W +T ?@"[ (8 N0". +< MF "U *, LP"P +$ P@"N . K #W *L _P"J /\ J #_ *, _P"@ /\ _P M /\ #U ZP .$ #6 P SP 3 ,H '@#& "D P@ S +\ /0"[ $4 MN !- +8 5 "S %H L0!? + 90"N &H K !P *L =P"I '\ IP"' *4 D0"C M )P H "I )X N "< ,X F@#N )D _P"7 /\ E@#_ )8 _P"3 /\ _0 /$ M #E V0 ,T #$ 8 O0 / +< & "S "( L L *T -@"I #X IP!& M *0 30"B %, H !9 )\ 7@"= &0 FP!J )H < "8 '< E@" )0 B@"1 )4 MCP"B (T L "+ ,, B0#C (@ ^0"& /\ A@#_ (8 _P"& /\ \P ., #1 M Q0 +T "V K@ + *@ $@"D !P H F )P +P": #< EP _ )4 M1@"2 $P D0!2 (\ 6 "- %T BP!C (H :@"( '$ A@!Y (0 @P"" (\ ?P"; M 'X J0!\ +L >@#5 '@ \@!X /\ =P#_ '< _P!W /\ YP< -$, ###0 MN P *X( "H H@ % )L #@"6 !4 D@ ? (X * "+ #$ B Y (8 0 "$ M $8 @@!, ( 4@!_ %< ?0!= 'L 8P!Z &L > !S '8 ?0!T (@ <0"5 ' MI !N +0 ; #* &L Z@!J /P :@#_ &H _P!J /\ VA ,84 "X%@ K14 M *02 "<#@ E@< ) "0"* ! A0 8 ($ (0!^ "H >P R 'D .0!W $ M=0!& ', 3 !R %$ < !7 &X 7@!M &4 :P!N &D =P!G (, 90"1 &, GP!B M *\ 8 #$ %\ Y !? ?@ 7@+_ %X"_P!> O\ SA@ +T= "P( I1\ )L< M "3%P BQ$ (0, !^! L >0 2 '4 &P!R ", ;P K &T!,P!K 3H :0) M &<#1@!F TP 9 12 &,$60!A!& 7P5I %X% !L%P 91$' %\.$ !<#Q< 6A ? %@0)P!6$"X 5! U %,0.P!2 M$4( 4!%( $\14 !.$5< 3!)@ $L2:P!)$G@ 2!.' $83EP!%%*D 1!2^ $,5 MWP!#%O@ 0Q;_ $,6_P!#%O\ NBL *LQ "@- E34 (LT "!,0 >"L M &\F !F( 7AD! %<4#0!4%!, 410; $\5(P!.%2H 3!4Q $L6-P!)%CX M2!9$ $<73 !%%U0 1!== $,89P!!&'0 0!F# #\:E ]&J8 /!N[ #L;VP [ M'/8 /!S_ #P<_P \'/\ M3 *@V "<.0 D3L (9 ['G$ .1^ #@?D@ W(*0 -B"X #4AU@ U(?0 M-2+_ #4A_P V(?\ LC0 *0Z "9/@ CS\ (4_ ![/ <#@ &,^T 'S/_ " S_P A,O\ MID, )I) "030 AD\ 'Q0 !S3P :$P %Q& !20P 23\ #\[ V M-@( +C(, "LR$0 I,A< *#(> "8R) E,RL )#,R ",T.@ B-$, (35- " U M6 ?-F4 'C9U !PWAP ;-YL &C>O !DXR 9..L &CC_ !LW_P ;-_\ HT< M )A- ".40 A%, 'M4 !Q4P 9E %I, !020 1T4 #U! S/0 M*CD) "4W#@ C-Q0 (C@; "$X(@ @."@ 'S@P !XY. =.4$ '#I+ !HZ5@ 9 M.V, &#MR !8[A0 5/)D %#RM !,]Q@ 3/>D %#S] !4\_P 6._\ H$L )51 M "+50 @E@ 'E9 !N6 9%8 %A1 !.3P 14L #I' P0P )T % M " ^#0 =/A$ '#X7 !L^'@ :/B4 &3XM !@_-0 6/SX %3]( !1 4P 30& M$D%P !%!@@ 009< #T&L Y"Q .0N< #T'\ !!!_P 00/\ G5 )-6 ") M6@ @%T '9> !L70 8EL %97 !,50 05$ #9. L2P (T@ !M% M"0 71 \ %404 !1%&P 312( $D4I !%%,0 113L $$9% ]&4 .1UX #4=M M Q'?P +1Y, "4>G A'O@ (1^ "4?V I&_P +1O\ FE4 )!; "'8 M?6( '-C !J8@ 8&$ %-> !'6@ /%< #)5 H4@ 'U !=.! 1 M3 P #TP1 Y,%P .3!X #4TE Q-+@ +33< "DU" E-30 '3EH !DYI 1. M>P "3H\ 4ZD !-N@ 3=L 4WR %-_P "3/\ EEL (UB "$9@ >F@ M '%I !H:0 7&< $]D !"80 -U\ "U< C6@ &E@ !)7 0 -5@D M"54. =5$P &51H !%4B -5*@ "530 %4^ !52@ 5E< %9E !5=P M58L %6@ !5M@ 5-0 %3Q !3_0 4_\ DV( (IH " ; =VX &]O M !C;@ 5FP $EJ ]: ,F8 "=E =8P %6( YA )8 @ V - M !?$0 7Q< %\> !?)@ 7R\ %\Z !?10 7U, %]A !><@ 7H< M %V< !=L@ 7,\ %SO !;_0 6_\ D&H (9O !]<@ =70 &IU != M= 3W, $)R V< *V\ "!N 7;0 $&P IL ":P8 &L+ !J M#P :A0 &H: !J(0 :2H &DT !I0 :4X &E< !I;0 :(( &B8 M !GK@ 9LH &7M !E_ 9/\ BW$ ()V !Z>0 <'L &)[ !5>P M2'H #MZ O>@ (WD !EX 1=P "G< -W =P( '<( !V#0 M=A '85 !V&P =B, '8N !U.@ =4< '56 !U: ='P '22 !S MJ@ - M ;C0 $8X J. CP )$ "2 D@ )( "2 0 D@< )(, M "2$ DQ4 ),= "4* E#8 )1% "35P DVL )." "2G D;8 M )#8 "/\P C_\ ?H< '"* !AC0 4Y $63 WE0 *98 !R7 1 MF "9D "; G )X "@ H * "@ H0 *$$ "B M"0 HPX *04 "E'0 IBH *8Z "F3 I6 *5X "ED@ I*P *3) M "CZP HOH L KP +$ M "T N +L "\ O +X "_ P ,( #$ Q@ M ,@# #+"P SQ( -$@ #1,@ TD8 --= #4=@ U)( -6K #5Q MU.( 6YT $RB ]IP +ZP !^O 1L0 ![4 "X NP +X #" M QP ,H #, S ,X #0 T@ -4 #8 VP -\ M #B Y@L .L3 #L) [3@ .Y. #O9P \(( /"< #PL@ \<4 M_P # /\ 0#_ 0 _P ) /\ #P#_ !@ _P D /\ , #_ #P _P!' /\ 40#_ M %D _P!@ /T 9P#\ &T ^@!S /D >0#X '\ ]@"% /4 C #S )0 \@"= / MIP#N +, [ #$ .L X0#J /@ Z0#_ .< _P#9 /\ RP#_ ,( _P"] /\ _P M /\ #_ _P /\ # #_ !0 _P @ /\ *P#^ #< ^@!" /8 2P#R %, M\ !; .X 80#L &< Z@!M .@ "U ( LP"( +$ D@"N )X K "J M *D NP"H -4 I@#S *0 _P"C /\ H0#_ )L _P"8 /\ _P /L #P MY0 -@ #. D QP 1 ,( &@"^ "0 NP N +< . "T $ L0!( *X 3@"L M %0 J@!: *D 7P"G &4 I0!K *0 <0"B '@ H "! )X BP"< )8 F0"C )< ML@"6 ,< DP#H )( _@"1 /\ D #_ (T _P"+ /\ ^0 .L #= SP M ,8 "\ 0 M0 - + %0"L !X J H *4 ,0"B #D GP!! )T 2 "; $X MF0!3 )< 60"6 %X E !D )( :@"0 '$ C@!Z (P @P"* (\ B "< (8 J@"$ M +P @@#< ($ ]@" /\ ?P#_ '\ _P!^ /\ [ -H #) O@ +8 M "N IP ) *$ $ "< !@ F B )4 *@"2 #( D Z (T 00"+ $< B0!- M (< 4@"& %@ A != (( 9 "! &L ?P!S 'T ?0![ (@ > "5 '8 HP!U +0 MP!' 'D M3 !W %( =@!7 '0 70!R &0 < !M &\ =@!L (( :@"/ &D G0!G *X 90## M &0 Y !C /H 8P#_ &( _P!C /\ T X +\2 "R$P IQ( )T0 "5"P MCP, (D !P"" X ?@ 5 'H '@!V "4 = M '$ - !O #H ;@! &P 1@!J M $P :0!2 &< 6 !F %\ 9 !G &( <0!@ 'P 7@") %P F !; *D 60"\ %@ MW !8 /0 6 #_ %< _P!7 /\ QA8 +8: "J'0 GQP )49 "-% A0\ M 'X) !W 0H <@ 0 &X %P!J !\ : G &4 +@!D #0 8@ [ & 0 !? $8 M70!, %P 4P!: %H 6 !B %< ; !5 '< 4P"% %( E !0 :4 3P&X $X"T@!- M!/ 307_ $T%_P!-!?\ OQT + B "C)0 F24 (\B "%'0 ?1@ '42 M !N#0( 9P8, &,#$0!? AD 70,A %L$* !9!"\ 5P4U %8%.P!4!D$ 4P9' M %$&3@!0!U4 3@=> $T(9P!+"', 20F! $@)D@!'"J, 10JV $0+T !$#.\ M0PW_ $,-_P!$#?\ N20 *HI ">+ E"P (HJ " )@ =R$ &X; !F M% 7P\% %D+#0!5"A, 4PL; %$+(@!/#"D 30PO $P,-@!+#3P 20U" $@- M20!$ 10Y: $0.9 !"#G 0 Y_ #\/D ^$*( /!"V #L0T0 [$?$ .Q'_ M #L1_P \$?\ M"D *8O ":,@ D#( (8Q !\+0 B I'YL *!^N "<@QP F(.H )R#^ "@@_P H(/\ MJ38 )T\ "2/P AT$ 'U !T/@ :3H %\U !6, 32L $0E [ M( < -AX. #,>$P R'AD ,!X@ "\>)@ N'RT +1\T "P@.P K($0 *B%. "DA M6 G(F4 )B)T "4CA0 C(YD (B2M "$DQ0 A)>@ (B7] "(D_P C)/\ ICH M )H_ "/0P A44 'M$ !R0P 9S\ %TZ !3-@ 2C$ $$L X)@, M,2,, "XB$0 L(A8 *B(= "DB(P H(RH )R,Q "8D.0 E)4$ )"5+ ",F5@ B M)F, (2=R !\G@P >*)< '2BK !LIPP ;*>8 '"G[ !TI_P >*/\ HSX )A# M "-1P @TD 'I) !P1P 9D0 %H_ !1.P 1S< #XR U+0 +"@) M "@G#P G)Q0 )2<: "0G(0 C*"< (B@N "$I-@ @*3\ 'RI) !XJ5 =*V M&RMO !HL@0 9+)4 %RVI !8MP0 6+>0 %RWZ !@M_P 9+?\ H4$ )5' "+ M2P @DT 'A- !N3 9$D %A$ !/0 1CT #TX S- *B\& "0L M#0 A+!( ("P8 !\M'@ >+24 '2TL !PN- ;+CP &B]& !@O40 7,%X %C!M M !4Q?P 3,9, $C&H !$ROP 1,N( $C+Y !,Q_P 3,?\ GD4 )-+ ")3P M@%$ '92 !M4 8DX %9) !-1@ 1$, #L_ Q.@ )S8# !\R"P < M,A &S(5 !DR&P 8,B( %S,I !8S,0 5-#H %#1$ !,T3P 2-5P $35K ! V M?0 /-I$ #C:F TWO --]T #3;V XV_P /-O\ FTD )%/ "'4P ?E8 M '56 !J50 8%, %5/ !,3 0DD #A% N00 )#T !PZ" 6. X M%3@2 !0X& 3.1\ $CDF !$Y+@ 0.3< #SI! XZ3 -.UD #3MH L[>@ * M.XT "3RB <\N '/-4 "#SP D[_P *._\ F$X (Y4 "%6 ?%L '); M !H6@ 7E@ %-5 !)4@ /DX #1+ J1P (40 !A" P 20 L $#\0 M X_%0 ./QP #4 C Q *P +0#0 "D ^ E!2@ '058 !D%E 1!=@ #08H M 4&? !!M 0= 4'N %!_ "0/\ E50 (Q9 "#7@ >6 '!@ !F M8 75X %%; !%5P .E0 "]1 E3P '$P !1* .2 @ "T<. A' M$@ '1QD !D<@ 5(* #2#$ D@[ !(1P 2%, $AB !(

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

    M !T ;0 < 'X &@"2 !D IP 8 +T %P#? !2T ' K !F* 720 %0? !+&@ 0Q0 #L0 T#0( +0D) "D%#0 F M Q ) $3 "("&0 A AX ( (D !X#*@ = S( &P0Z !H%1 9!4\ %P9< !8& M:@ 4!WP $P>0 !('I0 1![L $ ?; ! (\@ 0"?\ ERL (PO "!,0 =S( M &XQ !D+@ 6RH %$E !)( 0!L #@6 Q$@ *0X$ ",,"0 ?"0T M'0<0 !L'%0 9"!H & @@ !<))P 6"2X %0HW !,*00 2"TT $0M: ! +:0 . M#'L #@R0 T,I0 ,#;L "PW9 L-\0 ,#?\ E2\ (HS !_-@ =C8 &PU M !C,P 62\ % K !')@ /B$ #8= N& )Q, " 0!0 9#@H %0P. M !0,$0 3#!8 $@P< !$-(P 0#2L #PTT X./P -#DH # ]8 L/9P *$'D M"!"- <0H@ &$+@ !1#4 40[P &$/\ DC, (@W !^.@ =#L &LZ !A M. 6#4 $XP !%+ /2< #4C M'P )AH !X6 0 7$P8 $1 + X. M#@ .#Q, #1 9 T0( ,$"@ "Q$R H1/ ($D@ !Q)5 8390 $$W8 Q.+ M $4H $[8 !/1 3[@ $_L D#8 (8[ !\/@ 6&@( $!4) P3#@ * M$Q( "107 @4'P '%28 !A4O 06.@ #%D8 1=3 78@ &'0 !B) 8 MGP &+4 !?0 7[0 %_L CCH (0_ ![0@ 1@ 540 $M M !#/0 .SH #,W J,@ ("T !" GF0 )K "7, M E[@ )/T B$@ '], !V4 ;E$ &52 !<40 4T\ $I, !!20 M-40 "M A/ %SD ! V *,@$ S ' O"P +@X "T1 M%@ M+1X "TG M,0 +3T "U* M60 +6L "V LEP +*\ "O+ J M[@ *OX A4T 'U2 !U50 ;%< &-7 !;5@ 4U4 $=1 [30 ,$D M "5& <0P $S\ T] &.@ #@% W"0 -@T #4/ T% -!L M #0D T+@ -#H #1' T5P -&@ #1] SE0 ,JT #'* Q[@ M,/\ @U, 'M8 !S6P :ET &)= !;70 3UH $)6 V4@ *D\ "!, M 620 #D< A$ 0@ $$# _!P /@L #T. ]$0 /!@ #PA M \*P /#< #Q$ \4P /&4 #MZ ZD@ .JL #G( X[0 -_\ M@5H 'E> !Q80 :6, &)D !78@ 25X #Q; O6 )%4 !E3 0 M40 "D\ %- 3 $H !)! 2 @ $<, !&#P 1A0 $4< !% M)P 13, $5 !%4 1&$ $1V !#CP 0J@ $'& ! [ /_\ ?F$ M '9E !O: :&H %UI !/9@ 0F0 #1A H7P '5T !); +60 M E@ !6 5@ %0 !3 4@0 %$) !0#0 4! $\8 !/(@ M3RX $\\ !/2P 3ET $YR !-BP 3*4 $O" !)Z@ 2/\ >VD '1L M !N;P 9&\ %5M !'; .6H "QI @9P %&4 UD #8@ &( M !A 8 %\ !> 70 %P$ !<"0 6PT %L2 !;' 6B@ M %HV !:1@ 65@ %EM !8A0 5Z %:] !5Z 4_X >7 '-T !I M=0 6W0 $QS ^

    @ M4'H $)Z S>P )7L !AZ .>0 !'D !Y >0 'H !Z M>@ '@ !X =P '< !W =P$ '<( !W#@ =Q@ '& !(B .8H "J, M ;C0 #XT 2. D )$ "3 E0 )< "8 E@ )< M "7 EP )@ "8 F0 )H "; G0< )T1 "=(0 G3, M )U) "<8@ G'\ )R< "8&%B8V5F9VEJ:VQN;W!QGQ]?H"! M@H.%AH>(BHN,CH^0D9.4E9:8F9JOL[>[P\?+T M]?;W^?K[_/[_________________________________________________ M_____P ! P0%!@@)"@L-#@\1$A,4%A<8&AL<'1\@ M(2(D)28H*2HK+2XO,#(S-#8W.#D[/#T^0$%"1$5&1TE*2TU.3U!24U155UA9 M6UQ=7F!A8F-E9F=I:FML;F]P<7-T=7=X>7I\?7Z @8*#A8:'B(J+C(Z/D)&3 ME)66F)F:G)V>GZ&BHZ2FIZBJJZRMK["QL[2UMKBYNKN]OK_!PL/$QL?(RHJJNLK:^PL;.TM;:XN;J[O;Z_P<+#Q,;'R,G+S,W/T-'2U-76U]G:V]W> MW^#BX^3FY^CIZ^SM[O#Q\O3U]O?Y^OO\_O__________________________ M____________________________ $" P0%!@<("0H+# T.#Q 1$A,4%187 M&!D:&QP='A\@(2(C)"4F)R@I*BLL+2XO,#$R,S0U-C'EZ>WQ]?G^ @8*#A(6&AXB)BHN,C8Z/D)&2DY25EI>8F9J;G)V> MGZ"AHJ.DI::GJ*FJJZRMKJ^PL;*SM+6VM[BYNKN\O;Z_P,'"P\3%QL?(R+CY.7FY^CIZNOL[>[O\/'R\_3U]O?X M^?K[_/W^_VUF=#$ P$A ! 0 M $ ! @,$!08'" @)"@L,#0X/$!$2$Q05%A<8&1H:&QP='A\@ M(2(C)"4F)R@I*BLL+2XO,#$Q,C,T-38W.#DZ.SP]/C] 04)#1$5&1TA)2DM, M34Y/4%%24U155E=865I;7%U>7V!A8F-D969G:&EJ:VQM;F]P<7)S='5V=WAY M>GM\?7Y_@(&"@X2%AH>(B8J+C(V.CY"1DI.4E9:7F)F:FYR=GI^@H:*CI*6F MIZBIJJNLK:ZPL;*SM+6VM[BYNKN\O;Z_P,'"P\3%QL?(RW^#AXN/DY>;GZ.GJZ^SM[N_Q\O/T]?;W^/GZ^_S]_O\ 0$" M @,#! 0%!@8'!P@("0D*"PL,# T-#@\/$! 1$1(3$Q04%186%Q<8&1D:&AL< M'!T>'A\@("$B(B,D)"4F)B9 MFYV?H:.EIZBJK*VOL+*SM;:WN;J[O+V_P,'"P\3%QL?(RKKZ^SL[>[N[^_P M\/'R\O/S]/3U]O;W]_CX^?GZ^_O\_/W]_O[_ $! @(# P0$!08&!P<(" D) M"@L+# P-#0X/#Q 0$1$2$Q,4%!46%A<7&!D9&AH;'!P='AX?(" A(B(C)"0E M)B8G*"DI*BLL+2TN+S Q,C(S-#4V-S@Y.CL\/3X_0$)#1$5&2$E*3$U/4%)3 M55=86EQ>8&)D9FAJ;6]Q='9Y?'Z!@X:)BXZ0DI67F9N=GZ&CI:>HJJRMK["R ML[6VM[FZN[R]O\#!PL/$Q<;'R,G*R\S-S<[/T-'2TM/4U=;6U]C9V=K;V]S= MW=[?W^#AX>+CX^3EY>;FY^CHZ>GJZ^OL[.WN[N_O\/#Q\O+S\_3T]?;V]_?X M^/GY^OO[_/S]_?[^____________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M_______________T_________________________________________^O1 M__________________________________________?I_O______________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M_________________________________________^'-U_______________ M________________________W:^6M_3_____________________________ M________Q8QHI^?_____________________________________S)R)I.?_ M____________________________________^LZ[QO7_________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M_________]S%O?7_____________________________________OY-ZA<7_ M___________________________________;D%L]9:CV________________ M__________________Z\=30 5)OK________________________________ M_].4?DDL3IKL________________________________V-3*LWYE;:7Y____ M________________________________],6NK\G_____________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M______________________________________#6QNS_________________ M___________________FNY%T8ZOW________________________________ M]L2:ZVO______________________________U;*LLLSD^O__ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M________________________________Y;N7=V+(____________________ M_____________]N>9S8* *,________________________________R'\_ M!0 !>S______________________________9@3D \JO______ M______________________^>3 CD/______________________ M_____]QO&@ 0??G__________________________Z]( M ;^[__________________________X03 9.;_________ M________________[%$ 5][_________________________ MN!4 2-;_________________________=!0 M.,_________________________YHEH3 (\7_____________ M____________WYM<+ #;K__________________________^^Q M?54Y(A$' 0(1(K+______________________________]^_I9F8FJ"LO=K_ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M_^.^G8!\^_________________________________*WA%_______________________________]YMW6TM#3V>3_____ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M________________________________[]2[UO______________________ M___________GN(]J2R\5;_______________________________Y*%G- < M /,G____________________________6@CL $I?_________ M_________________^V%,0 &__________________________ M_Z9" %#A________________________[&D M #?)________________________LR\ "*V____________ M____________>0 !"G_______________________R- M "9______________________^I ", M______________________]& !_________________ M_____]\ !T_____________________Y< M !J_____________________\X !C____ M__________________\I(@$ !A____________________ M__^YHX!7-Q< !H___________________________ZTZZ4AGQU M<7!R=X&4____________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M_________________________________________]NZG8)I:=/_________ M_____________________\B393T9 '9[_________________________ M___;CDP3 &[__________________________]M\+ M $77_________________________XLJ "*T____________ M____________PD0 .7________________________?0$ M !________________________G-@ !J M______________________^= !8________________ M______]& !'^/___________________^D M UZ?___________________Y8 EV___ M_________________[P 8SO__________________ M_^L /PO____________________\ M *N?____________________\G *M?______ M______________]P -N?_____________________@ MG(QP54(S)AL4#PT.$AHFO_____________________________GDV-+.S,O, MS];@_/______________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M_____________^O3O./________________________________2J85E2"P2 M 87____________________________QJW$\#P $_@____________ M_____________]5_-0 !^R________________________XW4= M ")________________________D", !G M_______________________50P !(]O______________ M______^* NW?____________________\X M 7R/___________________[X $MO__ M_________________YP I?__________________ M_[H D____________________]P M @O____________________\ =/______ M______________\3 :/____________________]" M 8/____________________]Z M 7?_____________________1 8?__________ M____________) 9O______________________R:R9 MB7UV<6QI9V9G:W!ZC/__________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M_____________________^+%JI%Y87?_____________________________ MW:9W4"P, #'$_________________________^"23A, "/ M________________________TG = !@________________ M_______N;P\ WXO____________________^6' M 4P/____________________] H___ M_________________ZX B?__________________ M_YX #]O_________ M__________^/ !M#____________________0 M ,K_____________________*P M ,C_____________________@ ,O_____________ M________]Q8!!04# 0 08-&,O_______________________SKX=C/ MS,W/T-+4U]SBZO______________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M_______________________________________________________QVL;_ M______________________________'&HX1H33(8 !6K________________ M__________^Y?$88 !Q________________________UWPO M [X______________________?9 D ,M?__ M__________________]T P C?__________________ M_\45 :O___________________YD M 2____________________[8 ,/W_____ M_____________]< &>?___________________8 M !=/___________________\. M ,'___________________\O *__________ M__________]2 )[___________________]Y M ([___________________^E M (#____________________8 '3_____________ M________-@ &W_____________________? M &G_____________________UPT &C_ M_____________________W &'_________________ M______]0/$9.5%E=861H;'!V?HG_________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M_^_5NZ.+262D M H/______________________B38 9_______ M______________]F ,O;__________________Y4 M \C__________________Z< M *#__________________]< 'S_________ M__________\ %[___________________\E M $/___________________]( M "S___________________]J !C_____________ M______^+ 7S__________________^O M #A___________________5 #/ M____________________) "^________________ M____5 "N____________________BP M "?____________________RPX "2____ M_________________U< "&____________________ M_ZH* !Y______________________]M M !F_______________________W50 !%________ M_________________VHC*S4_2E5@:G5^AY&<________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M___________________________________________HS[:=@VE.N?______ M___________________LLH-<.AT" >_______________________ MQ6TI 0/____________________^#&P M !\O__________________Y( )C_________ M_________Z0 &K__________________]T M $'___________________\. M !W___________________\Y #H____________ M______]@ #.__________________^% M "W__________________^H "C M___________________+ "0________________ M___O%@ !]____________________/@ M !L____________________:0 !:____ M________________F0 !)____________________ MTA8 Y_____________________U@ M I_____________________Z( 9________ M______________56 $______________________^[ M+P ^/______________________JRD M S________________________\E' <3("X^4FB$[?__________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M__________________35R?____________________________K2L))W74(H M# 2O_______________________\5]11< $=C_________ M___________$4 )___________________Z(, M &C__________________Y0 M #;__________________]H ?L____________ M______\5 #$__________________]( M "B__________________]U "# M__________________^= !I________________ M___# !2___________________G#P M ^____________________,P K____ M________________6 8____________________ M@0 %____________________K M ____________________WB( \O______ M_____________UP W____________________Y\ M S/___________________^A* M M_____________________^@%@ G/__________ M____________>@( =________________________WH+ M %3/________________________^B5VAT@(VSL*VIJ*7____________________=?E,_,",9 M$0D" #;_________________W8 "G M_________________[H !U________________ M__\' !&__________________]. M :__________________^, _?__ M_______________! V__________________Q M&0 OO__________________1 M I/__________________:P C?______ M____________D0 >?__________________MP M 9O__________________WB$ M 4____________________TH /___________ M_________W< *____________________ZP* M %O___________________^=% M /____________________^* /______________ M_______630 /W_____________________IRX M -7______________________Y@J &&"U%8.#_ M______________________^H8W2!CYRKN\WB^O______________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M___B,X!)0T-?4%)/1DE,10 2$O__________________________________ M____________________________Y\NWJ9V5CHF$@'QX='!L:&60________ M_________[QJ2"T9"@ Q__________________\ M #__________________]" M W/________________^. LO__________ M_______. C?__________________*0 M :___________________6@ M3O__________________A@ -/______________ M____K@ 'O__________________U!< M "O__________________^CT /__ M_________________V4 /__________________ M_XX /___________________[P9 M .____________________%. -C_____ M______________^+ +_____________________, M0P *'_____________________D1D M 'K_____________________\G0* $5__________ M_____________^AT$Q\L.$538G*%F[32]?__________________________ MU^CT________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M___________________________________________________[]_/Q[NSK MZ^SQ___________________9LIF'>6UD75912T9!/#@R+2@CQ/__________ M______]+)0L DO________________^( M 9O_________________7 M/?__________________,P &/______________ M____; /__________________G0 M /__________________R0P /;_ M________________\34 -__________________ M_UL ,O__________________X( M +?__________________ZD& */_____ M_____________],O (W___________________]> M '?___________________^3!P M %[____________________-0P $#_________ M____________AQ !S_____________________V%X M #______________________[]. .'"P^4FJ& MI M "+__________________M2 M !M__________________^ !1____________ M______^I&P Z___________________00@ M C___________________U: , M____________________CQ0 ________________ M____N#X ____________________Y6T# M _____________________Y\W 0+U!T____ M_________________]UR% &%RI!6G64MMK_____________________ M__^\6$149'6&FJ_(X_______________________________TLWA\?______ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M_________/OZ^_W______________________^ZYJ)V6CXJ&@G][>'9T'^0_________________^M/.C H(1L5$ L' @ C____________ M______]I __________________^;"@ M ___________________(.0 M___________________P8P ________________ M____B@X ____________________L#0 M ____________________U5L ____ M_________________X4: #[/__________________ M_[%) 8.5V!_____________________^5['@ #"$X M4F^/L]G_______________________^[6"DY25IL@)>PS>W_____________ M________________LYZTQ=?K____________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________^N_GX=S9 MUM32T-#0T=/9X.OW__________________^XBGYW<6QH9&%>6UE85U=97F5Q M__________________^_,1\6$ H% ________________ M___M5@ Z/__________________@@0 M S/__________________JR\ L___ M________________TE< F___________________ M]WP0 A?___________________Z(W M 4KE/___________________\MA @ PL4':>T?______ M______________6-, #2,[5W:9ON7________________________# M8Q@J.TQ?=(VGQN?_____________________________J'^6J+O0Y_______ M______________________________W_____________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M________________________________________________W<[%O[RYMK2S ML;*RM;G R=7C____________________EVQD7EE544],2DA'1DA+4%EFH?__ M________________IR8.!P( 5O__________________ MSE .O__________________]'D+ M (?___________________Y\R #O______ M_____________\18 "#%:A/___________________^E_ M'P !B=+<9K"Z?____________________^G20 "%R]*:(JN MU?S________________________3=1XF.$I>=8^KR^__________________ M____________KG*%F*S"V_;__________________________________]_O M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M_____________________________________________[^RJJ:CH:"?GZ&C MIJRTP,W=[/___________________XI:4T]+2$9$0T)!0D-'3EEI??______ M_____________YXN!@ /___________________\-6 M 50?___________________^=[&@ ) M-&"+M/____________________^?/P $)4IQF<+K____________ M___________&9@\ 3*D1B@Z?-]?_________________________KCC4K M/E%H@9V\WO______________________________OG9_E*G!W/G_________ M_________________________]+8\_______________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M]O+P[^_O\?/X_?____________________________BPGYJ7EI:6F)N?I*RV MPM'A[O____________________Z.4$I'141$1$5&1TM16FB#J?__________ M__________^F00$ 7C MX^3FZ.WQ^?_____________________________]L922DI69G:.ILKS0[?__ M________________________G5-'24U15F!SBJ_6_/__________________ M________LE8 &C50;8NNTO?_____________________________S6\^7WN9 MM]?Y________________________________[I^#IL+A________________ M_____________________^/.Z___________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M____________________________________________________________ M_________________P M M M ____________________________________________________ M____________________________________________________________ M__________________________________________________________\ M #_[@ .061O8F4 9( _]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! @(" @(" @(" @(# P,# P,# P,#_\ M% @"10;/! $1 (1 ,1 01 /_$ )L 0 !@,! 0 $!08' M"0H#" L" 1 0,# @,#! L%#PX%$ $5 $" P0%!A$'(1((,1,)\$%187&! MD:&QP=$B,A0*X15V.'CQ0B.5M=46MC=7E[<86!I28C/3))0V5I87UQDY67*2 MU-:(@J+20U2T)56&QD>'F+C(2;+"4W,T-2:FJ-CR1'5C@[-D=$5E)W?_V@ . M! $ @ # 0 #\ W^#?X-_@W^ "W^YFZVW&S>*UF M;;I9I8,&Q>A5&37?(*^.CBEG>BK%1T,'SJNYW&?1>[IJ:.6>14^:Q2G\ERK' M,-M4U[RF]6^QVN#1'U=PG;"QSU^C# SC+4U#_P ['&U\CO,BGQ))'$U7R/:Q MJ>=R^\GG50239/?3:WJ(P2DW)VARJERS$ZNON-K^N14]7;ZVCN-KJ7TU50W6 MSW."DNUGK.5&3LBJH8I)*::*9K5CE8YT%A6:&HI95CE@JZ.ICAJZ.;31[62L8YT3V/1.5S57\BFCG8DD3N9JJJ:\45%3M M147147V?,"[95IR L!O7U5]-W3G1R5>^&]FW.VTC:=M5%:>9&*J)24S\ZU08D-W/M"721B3)J?9_"MS=[*QKG?5;E]0I]M\/K(FJ]G>1W3 M)F566Q.5[?HOL#=$UU5')REG*/J_VMR2U)=\!6Y9A1.GFIVU;:>2R4O>P.Y9 M(Y672)EUIY.*.1LE(U58Y'=BH8 ?$4^T1; ] .YERV2J>GG?;<[=&BM5KO\ M0OJ8\+#G=QK>"1[9X9(VRRK MN<=(]8UBD<_1%\S6*B^='?.5?<,:&YWVAKJJR5\U/MAMCM#M?;9'JZ*HN--? M]P]70;[C6O[:AZ?\#E9_]!&J=6_ M6]&7.F9+'*[)]TLXOZRLG9%%.R1;K?:M7LFC@8UZ+JCFL:B\$0I"KRG)J_5: M[(K[6JY%1WUN[W"IYDNJ& M3Q3NS3>[N61E1#31LD1=4>V-J+JC4TAW3SO^E-*[_A M2/7X54M'7W&X72H6KN=?6W&J5C6+4U]5/65"L8FC&+-4/DD5C$7@FNB$FDEE MF=SRR22OT1.>1[GNT3L3F[7RK6OO5TN-WKG,9$ZMNE;4W"K='& MBI'&M15RRS*R-%^:FNB>8XU55XJJJOKXD&<9+C\)I:[Y>K(^26S7BZ6B27N^ M]DM=PJZ!\O=*YT7>/I)HG/[MSE5NNNBJNAS15$\"JL$TT*KIJL4CXU73BFJL M02O94TM M-?HZ:KAEDIHUDCE8^.1&(CD5$T)]29EEU Y'4649#2JBZZ07FXQ-7BURHYC* MA&O:Y6IJBHJ+IQ.R.$]=W6YMM41U. =8/4_ALC)>^6/'-^=T;32SJLU-/)'6 M45'E$5'74T\M'$LL4TP[7X%XP'B'[ M?NI8Z3J'N^44%-W+9+;GN,87F3:V.%-&QU5VO6/3Y+\]/IOBKHI7]JO5>)6- MNWLW,MJL1F33U<;.5%BN-)0UR2(WS/FGIG57'SJDB.7TG>O:W[0)XMFU+Z&. MAZM;_FUJH_J[9;/NEA>W6X;+C#3IRMAKK]D6)U69?HB?V22&YPSR+Q<]5XD2 MRYUK--)U9[6.U]E5;S>^=]]K/M%>_MC=3T^\6QNV&X='&YC)*W"KID6V] M[DA5-'S5#KC+G]GJ:IKEYD2*EI(W(B-T:JJ\N-9^IW(Z=6MO>/VFYL1419*" M:JM4ZM\[G+*MR@<]/ZUC$\WK,IFQ_P!KIZJ,:?2TG4'TR[*;LVZ)\<7;/9)+3JFDM15ON\^ZF/U=@RK;& M?++JZE61W+]9N%GM<3=%<_D;\XCXKQ2/X/YX5_KF\S?:5G,ONHAEHVRWCVGW MHL3%9-:,BIZ5\B.TIZ_[V5=1);JQJM5'PSMCF8YJM;2ENGWEKJN6T5[',US7L:YJHDRCEBE3FBD9(GI8Y':>SHO!2Y)-"\1R M M M M M M M $+75U%;*.JN-RK*6WV^@IYJNNKZZHBI*.CI*>-TM15555.^."G MIX(FJY[WN1K6HJJJ(<4\\%-#+4U,T5/3P1OFGGGD9%##%&U722RRR*UD<;&H MJJY51$3M"JB(JJNB)Q55X(B)VJJ@PH=7'C#85@*W/"NF>@M^Y.5,9-25.XMT M;4)@%DJ-%C<^QT;/J];F=5 [FY94?3VY'(U[)*N-7,.E>[?5_9;!]9LNVD%/ MDEU:CXIOO>R#7(WCWBW5WURJHS3=O.+]G.03<[(:F\56M';*=ZM)(Y99)G<\KW/=ZUX)ZD1.#4]@'8/H+ZT\*Q.T21J>CS.3^N;[X-TS$LLQO.\8L&9X?>*+(<6R MBTT-]L%[MTBRT5SM5RIV55'5P.5&O1LL,B*K7-:]CM6N:CD5$S16F[6V^VR@ MO5GK(+A:[I205UOK:=W-#54E3&V6&:-51'(CV.3@J(YJ\%1%14*J:YKVM>U4 MKJZ2WTE57U]53T5#14\U765E7-'34E)24T;IJBJ MJJB9S(:>GIX6*][WJC6-15541#BFFAIH9:BHEBIZ>GBDFGGFD9%###$Q7RRR MRO5K(XHV-57.541$353\]S6L:U7.Y5/4KN)2++ VT[;5]+#@-%5Q2.CEYM$9*57HL'WRW#J*BKSF2L M;$G)*M#66VDGYG:TR(J-;BSW7Z_.H;>EADU76)$T1+(7W=3+;RKXX:Q+/2.U1(+7S0RJW7ASU MKE=5J_3@O(YC5_J08E;I=+G?+C77B]7&ON]WN=5-6W*Z72LJ+A<;A65#UDJ* MNNKJN26IJZJ>1RN?)(YSW.75553IA5UE7<*JHKJ^JJ:VMJYGU%565<\M355, M\KE?)-45$SGRS32.75SG*JJO:I;J2225[Y97OEDD/[FXJRY7O9GW58W_U+M.Q?/R.\Z%<1R1S,;)$Y'L>B M.:Y$5-45-471R(Y-4\RHBF4"P7^U9/9Z"^V2KCK;;<8&ST\S%XHB\'PS,^E# M4P/1621NTKF/7ZK=K-5T5?3ZNC:OS)$XM3T$715]=;:AE7;JVKH*N/^QU-%434M0S ML7YDT#XY&\4\RE9X#N/N'M3DU#FNUV>9GMMF5LU^]N6X#E%\P[)K?S/CD=]1 MOV.UUNNM)J^)KE[N5NJM1?,A]-O*G>M1"^ M6*]0V:658J>]-I\GH6Z(OUO2DN;6(O9'<*>-6O737C-%*Y?2AL/='7VH+KXZ M?GVO'=_8,8ZNMO:1T<4W[-FQX9NQ2T39&JL5MW-QJVRTUPEY'/5TM\L]YJ9% MY4[YC6Z$T@N]3%HDG+.W^N^:_3U/3XT4V-NE#Q6ND3JQEMV/6'-'[;;F5_

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end XML 35 R1.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Document and Entity Information - shares
    		 6 Months Ended
    Jun. 30, 2016
    Jul. 15, 2016
    Document and Entity Information [Abstract]    
    Entity Registrant Name BIOGEN INC.  
    Entity Central Index Key 0000875045  
    Current Fiscal Year End Date --12-31  
    Entity Filer Category Large Accelerated Filer  
    Document Type 10-Q  
    Document Period End Date Jun. 30, 2016  
    Document Fiscal Year Focus 2016  
    Document Fiscal Period Focus Q2  
    Amendment Flag false  
    Entity Common Stock, Shares Outstanding   219,120,762
    XML 36 R2.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Condensed Consolidated Statements of Income (Unaudited) - USD ($)
    shares in Millions, $ in Millions
    		 3 Months Ended 6 Months Ended
    Jun. 30, 2016
    Jun. 30, 2015
    Jun. 30, 2016
    Jun. 30, 2015
    Revenues:        
    Product, net $ 2,466.0 $ 2,198.6 $ 4,775.4 $ 4,370.9
    Revenues from anti-CD20 therapeutic programs 349.2 337.5 678.7 668.1
    Other 79.0 55.6 166.9 107.6
    Total revenues 2,894.2 2,591.6 5,621.0 5,146.6
    Cost and expenses:        
    Cost of sales, excluding amortization of acquired intangible assets 370.3 286.1 683.3 598.6
    Research and development 473.1 490.7 910.4 951.3
    Selling, general and administrative 492.4 491.9 989.7 1,052.3
    Amortization of acquired intangible assets 92.9 92.0 181.7 187.9
    (Gain) loss on fair value remeasurement of contingent consideration 10.6 (2.2) 12.9 5.6
    Restructuring charges 0.0 0.0 9.7 0.0
    Collaboration profit (loss) sharing (5.6) 0.0 (5.6) 0.0
    Total cost and expenses 1,433.7 1,358.5 2,782.1 2,795.6
    Income from operations 1,460.5 1,233.1 2,838.9 2,351.0
    Other income (expense), net (58.5) (10.9) (111.3) (25.9)
    Income before income tax expense and equity in loss of investee, net of tax 1,402.0 1,222.2 2,727.6 2,325.1
    Income tax expense 353.6 292.5 710.0 574.4
    Equity in loss of investee, net of tax 0.0 4.9 0.0 5.7
    Net income 1,048.4 924.8 2,017.6 1,745.0
    Net income (loss) attributable to noncontrolling interests, net of tax (1.4) (2.5) (3.1) (4.8)
    Net income attributable to Biogen Inc. $ 1,049.8 $ 927.3 $ 2,020.7 $ 1,749.8
    Net income per share:        
    Basic earnings per share attributable to Biogen Inc. $ 4.79 $ 3.94 $ 9.23 $ 7.44
    Diluted earnings per share attributable to Biogen Inc. $ 4.79 $ 3.93 $ 9.21 $ 7.42
    Weighted-average shares used in calculating:        
    Basic earnings per share attributable to Biogen Inc. 219.1 235.3 219.0 235.1
    Diluted earnings per share attributable to Biogen Inc. 219.4 235.7 219.3 235.7
    XML 37 R3.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)
    $ in Millions
    		 3 Months Ended 6 Months Ended
    Jun. 30, 2016
    Jun. 30, 2015
    Jun. 30, 2016
    Jun. 30, 2015
    Statement of Comprehensive Income [Abstract]        
    Net income attributable to Biogen Inc. $ 1,049.8 $ 927.3 $ 2,020.7 $ 1,749.8
    Other comprehensive income:        
    Unrealized gains (losses) on securities available for sale, net of tax 4.5 (0.2) 7.0 1.1
    Unrealized gains (losses) on cash flow hedges, net of tax 29.3 (96.2) (18.3) (8.9)
    Unrealized gains (losses) on pension benefit obligation 0.7 2.9 0.9 4.1
    Currency translation adjustment (58.0) 63.0 (48.4) (37.8)
    Total other comprehensive income (loss), net of tax (23.5) (30.5) (58.8) (41.5)
    Comprehensive income attributable to Biogen Inc. 1,026.3 896.8 1,961.9 1,708.3
    Comprehensive income (loss) attributable to noncontrolling interests, net of tax (1.4) (2.3) (3.1) (4.5)
    Comprehensive income $ 1,024.9 $ 894.5 $ 1,958.8 $ 1,703.7
    XML 38 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
    $ in Millions
    Jun. 30, 2016
    Dec. 31, 2015
    Current assets:    
    Cash and cash equivalents $ 1,362.0 $ 1,308.0
    Marketable securities 2,434.8 2,120.5
    Accounts receivable, net 1,293.0 1,227.0
    Due from anti-CD20 therapeutic programs 334.1 314.5
    Inventory 996.4 893.4
    Other current assets 1,027.4 836.9
    Total current assets 7,447.7 6,700.3
    Marketable securities 3,477.6 2,760.4
    Property, plant and equipment, net 2,301.8 2,187.6
    Intangible assets, net 3,967.6 4,085.1
    Goodwill 3,167.1 2,663.8
    Investments and other assets 1,153.0 1,107.6
    Total assets 21,514.8 19,504.8
    Current liabilities:    
    Current portion of notes payable and other financing arrangements 4.8 4.8
    Taxes payable 212.8 208.7
    Accounts payable 225.9 267.4
    Accrued expenses and other 2,072.7 2,096.8
    Total current liabilities 2,516.2 2,577.7
    Notes payable and other financing arrangements 6,538.3 6,521.5
    Long-term deferred tax liability 105.6 124.9
    Other long-term liabilities 951.0 905.8
    Total liabilities 10,111.1 10,129.9
    Commitments and contingencies
    Biogen Idec Inc. shareholders' equity    
    Preferred stock, par value $0.001 per share 0.0 0.0
    Common stock, par value $0.0005 per share 0.1 0.1
    Additional paid-in capital 69.1 0.0
    Accumulated other comprehensive loss (282.8) (224.0)
    Retained earnings 14,229.1 12,208.4
    Treasury stock, at cost (2,611.7) (2,611.7)
    Total Biogen Inc. shareholders’ equity 11,403.8 9,372.8
    Noncontrolling interests (0.1) 2.1
    Total equity 11,403.7 9,374.9
    Total liabilities and equity $ 21,514.8 $ 19,504.8
    XML 39 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares
    Jun. 30, 2016
    Dec. 31, 2015
    Statement of Financial Position [Abstract]    
    Preferred stock, par value $ 0.001 $ 0.001
    Common stock, par value $ 0.0005 $ 0.0005
    XML 40 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
    $ in Millions
    		 6 Months Ended
    Jun. 30, 2016
    Jun. 30, 2015
    Cash flows from operating activities:    
    Net income $ 2,017.6 $ 1,745.0
    Adjustments to reconcile net income to net cash flows from operating activities:    
    Depreciation and amortization 325.1 292.5
    Share-based compensation 84.1 93.7
    Deferred income taxes (30.2) (90.6)
    Other 19.8 (5.8)
    Changes in operating assets and liabilities, net:    
    Accounts receivable (65.0) (38.9)
    Inventory (128.3) (81.3)
    Accrued expenses and other current liabilities (162.3) (169.9)
    Current taxes payable (151.7) 102.0
    Other changes in operating assets and liabilities, net 50.1 (66.4)
    Net cash flows provided by operating activities 1,959.2 1,780.3
    Cash flows from investing activities:    
    Proceeds from sales and maturities of marketable securities 2,823.6 975.5
    Purchases of marketable securities (3,833.3) (2,045.0)
    Acquisitions of business, net of cash acquired 0.0 (198.8)
    Purchases of property, plant and equipment (263.7) (227.7)
    Contingent consideration related to Fumapharm AG acquisition 600.0 250.0
    Other (65.9) (10.1)
    Net cash flows used in investing activities (1,939.3) (1,756.1)
    Cash flows from financing activities:    
    Purchase of treasury stock 0.0 (42.2)
    Proceeds from issuance of stock for share-based compensation arrangements (23.9) (34.7)
    Excess tax benefit from share-based awards 9.0 69.7
    Other 1.1 15.0
    Net cash flows provided by financing activities 34.0 77.2
    Net increase in cash and cash equivalents 53.9 101.4
    Effect of exchange rate changes on cash and cash equivalents 0.1 (24.2)
    Cash and cash equivalents, beginning of the period 1,308.0 1,204.9
    Cash and cash equivalents, end of the period $ 1,362.0 $ 1,282.1
    XML 41 R7.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Summary of Significant Accounting Policies
    		 6 Months Ended
    Jun. 30, 2016
    Accounting Policies [Abstract]  
    Summary of significant accounting policies
    Summary of Significant Accounting Policies
    Business Overview
    Biogen is a global biopharmaceutical company focused on discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological diseases, autoimmune disorders and rare diseases.
    Our marketed products include TECFIDERA, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for multiple sclerosis (MS), ELOCTATE for hemophilia A and ALPROLIX for hemophilia B and FUMADERM for the treatment of severe plaque psoriasis. We also have a collaboration agreement with Genentech, Inc. (Genentech), a wholly-owned member of the Roche Group, which entitles us to certain business and financial rights with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other potential anti-CD20 therapies.
    In addition to our innovative drug development efforts, we aim to leverage our manufacturing capabilities and scientific expertise through Samsung Bioepis, our joint venture with Samsung BioLogics Co. Ltd. (Samsung Biologics) that develops, manufactures and markets biosimilars as well as through other strategic contract manufacturing partners. Under our commercial agreement with Samsung Bioepis, we market and sell BENEPALI, an etanercept biosimilar referencing ENBREL, and FLIXABI, an infliximab biosimilar referencing REMICADE, in the European Union (E.U.).
    In May 2016, we announced our intention to spin off our hemophilia business as an independent, publicly traded company. The new company will focus on the discovery and development of therapies for the treatment of hemophilia and other blood disorders, with existing marketed products ELOCTATE and ALPROLIX. The transaction is expected to be completed in early 2017, subject to the satisfaction of certain conditions, including, among others, final approval of our Board of Directors, receipt of a favorable opinion with respect to the tax-free nature of the transaction and the effectiveness of a Form 10 registration statement that will be filed with the Securities and Exchange Commission. The results of our hemophilia business will be included in our condensed consolidated financial statements until the transaction is completed.
    Basis of Presentation
    In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring accruals, necessary for a fair statement of our financial statements for interim periods in accordance with accounting principles generally accepted in the United States (U.S. GAAP). The information included in this quarterly report on Form 10-Q should be read in conjunction with our consolidated financial statements and the accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2015 (2015 Form 10-K). Our accounting policies are described in the “Notes to Consolidated Financial Statements” in our 2015 Form 10-K and updated, as necessary, in this Form 10-Q. The year-end condensed consolidated balance sheet data presented for comparative purposes was derived from our audited financial statements, but does not include all disclosures required by U.S. GAAP. The results of operations for the three and six months ended June 30, 2016, are not necessarily indicative of the operating results for the full year or for any other subsequent interim period.
    We operate as one operating segment, which is discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological diseases, autoimmune disorders and rare diseases.
    Consolidation
    Our condensed consolidated financial statements reflect our financial statements, those of our wholly-owned subsidiaries and those of certain variable interest entities where we are the primary beneficiary. For consolidated entities where we own or are exposed to less than 100% of the economics, we record net income (loss) attributable to noncontrolling interests in our condensed consolidated statements of income equal to the percentage of the economic or ownership interest retained in such entities by the respective noncontrolling parties. Intercompany balances and transactions are eliminated in consolidation.
    In determining whether we are the primary beneficiary of an entity, we apply a qualitative approach that determines whether we have both (1) the power to direct the economically significant activities of the entity and (2) the obligation to absorb losses of, or the right to receive benefits from, the entity that could potentially be significant to that entity. These considerations impact the way we account for our existing collaborative relationships and other arrangements. We continuously assess whether we are the primary beneficiary of a variable interest entity as changes to existing relationships or future transactions may result in us consolidating or deconsolidating one or more of our collaborators or partners.
     Use of Estimates
    The preparation of our condensed consolidated financial statements requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosure of contingent assets and liabilities. On an on-going basis we evaluate our estimates, judgments and methodologies. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity and the amount of revenues and expenses. Actual results may differ from these estimates under different assumptions or conditions.
    New Accounting Pronouncements
    From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (FASB) or other standard setting bodies that we adopt as of the specified effective date. Unless otherwise discussed, we do not believe that the impact of recently issued standards that are not yet effective will have a material impact on our financial position or results of operations upon adoption.
    In May 2014, the FASB issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes all existing revenue recognition requirements, including most industry-specific guidance. The new standard requires a company to recognize revenue when it transfers goods or services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, which delayed the effective date of the new standard from January 1, 2017 to January 1, 2018. The FASB also agreed to allow entities to choose to adopt the standard as of the original effective date. In March 2016, the FASB issued ASU No. 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations, which clarifies the implementation guidance on principal versus agent considerations. In April 2016, the FASB issued ASU No. 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing, which clarifies certain aspects of identifying performance obligations and licensing implementation guidance. In May 2016, the FASB issued ASU No. 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients related to disclosures of remaining performance obligations, as well as other amendments to guidance on collectibility, non-cash consideration and the presentation of sales and other similar taxes collected from customers. These standards have the same effective date and transition date of January 1, 2018. We are currently evaluating the method of adoption and the potential impact that these standards may have on our financial position and results of operations.
    During 2015, the FASB issued the following new standards, which we adopted on January 1, 2016:
    •
    ASU No. 2015-05, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Fees Paid in a Cloud Computing Arrangement.
    •
    ASU No. 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory.
    •
    ASU No. 2015-16, Business Combinations (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments.
    The adoption of these standards did not have an impact on our financial position or results of operations. For additional information related to these standards, please read Note 1, Summary of Significant Accounting Policies: New Accounting Pronouncements to our consolidated financial statements included in our 2015 Form 10-K.
    In January 2016, the FASB issued ASU No. 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The new standard amends certain aspects of accounting and disclosure requirements of financial instruments, including the requirement that equity investments with readily determinable fair values be measured at fair value with changes in fair value recognized in our results of operations. The new standard does not apply to investments accounted for under the equity method of accounting or those that result in consolidation of the investee. Equity investments that do not have readily determinable fair values may be measured at fair value or at cost minus impairment adjusted for changes in observable prices. A financial liability that is measured at fair value in accordance with the fair value option is required to be presented separately in other comprehensive income for the portion of the total change in the fair value resulting from change in the instrument-specific credit risk. In addition, a valuation allowance should be evaluated on deferred tax assets related to available-for-sale debt securities in combination with other deferred tax assets. The new standard will be effective for us on January 1, 2018. The adoption of this standard is not expected to have a material impact on our financial position or results of operations.
    In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). The new standard requires that all lessees recognize the assets and liabilities that arise from leases on the balance sheet and disclose qualitative and quantitative information about its leasing arrangements. The new standard will be effective for us on January 1, 2019. The adoption of this standard is not expected to have a material impact on our net financial position, but will impact our assets and liabilities. We are currently evaluating the potential impact that this standard may have on our results of operations.
    In March 2016, the FASB issued ASU No. 2016-06, Derivatives and Hedging (Topic 815): Contingent Put and Call Options in Debt Instruments. The new standard simplifies the embedded derivative analysis for debt instruments containing contingent call or put options by removing the requirement to assess whether a contingent event is related to interest rates or credit risks. The new standard will be effective for us on January 1, 2017. The adoption of this standard is not expected to have an impact on our financial position or results of operations.
    In March 2016, the FASB issued ASU No. 2016-07, Investments - Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting. The new standard eliminates the requirement that when an investment qualifies for use of the equity method as a result of an increase in the level of ownership interest or degree of influence, an adjustment must be made to the investment, results of operations and retained earnings retroactively on a step-by-step basis as if the equity method had been in effect during all previous periods that the investment had been held. The new standard will be effective for us on January 1, 2017. The adoption of this standard is not expected to have a material impact on our financial position or results of operations.
    In March 2016, the FASB issued ASU No. 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The new standard requires recognition of the income tax effects of vested or settled awards in the income statement and involves several other aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. The new standard will be effective for us on January 1, 2017. This standard is not expected to have a material impact on our financial position, results of operations or statements of cash flows upon adoption.
    In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The new standard changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investment in leases that are not accounted for at fair value through net income to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. The new standard will be effective for us on January 1, 2020. The adoption of this standard is not expected to have a material impact on our financial position or results of operations.
    XML 42 R8.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Restructuring Restructuring
    		 6 Months Ended
    Jun. 30, 2016
    Restructuring and Related Activities [Abstract]  
    Restructuring
    Restructuring
    On October 21, 2015, we announced a corporate restructuring, which included the termination of certain pipeline programs and an 11% reduction in workforce. Under this restructuring, cash payments will total approximately $120 million, of which $15.9 million were related to previously accrued 2015 incentive compensation, resulting in net expected restructuring charges totaling approximately $105 million. These amounts will be substantially paid by the end of 2016.
    For the three and six months ended June 30, 2016, we recognized restructuring charges totaling $0.0 million and $9.7 million, respectively. We previously recognized $93.4 million of restructuring charges in our consolidated statements of income during the fourth quarter of 2015. Our restructuring reserve is included in accrued expenses and other in our condensed consolidated balance sheets.
    The following table summarizes the charges and spending related to our restructuring efforts during the six months ended June 30, 2016:
    (In millions)
    Workforce
    Reduction
     
    Pipeline
    Programs
     
    Total
    Restructuring reserve as of December 31, 2015
    $
    33.7

     
    $
    3.6

     
    $
    37.3

    Expense
    4.9

     
    5.4

     
    10.3

    Payments
    (28.7
    )
     
    (6.0
    )
     
    (34.7
    )
    Adjustments to previous estimates, net
    (3.5
    )
     
    2.9

     
    (0.6
    )
    Restructuring reserve as of June 30, 2016
    $
    6.4

     
    $
    5.9

     
    $
    12.3
    XML 43 R9.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Reserves for Discounts and Allowances
    		 6 Months Ended
    Jun. 30, 2016
    Sales Discounts, Returns and Allowances, Goods [Abstract]  
    Reserves for discounts and allowances
    Reserves for Discounts and Allowances
    An analysis of the change in reserves for discounts and allowances is summarized as follows:
    (In millions)
    Discounts
     
    Contractual
    Adjustments
     
    Returns
     
    Total
    Balance, as of December 31, 2015
    $
    56.1

     
    $
    548.7

     
    $
    57.9

     
    $
    662.7

    Current provisions relating to sales in current year
    266.8

     
    973.8

     
    17.6

     
    1,258.2

    Adjustments relating to prior years
    (2.4
    )
     
    1.6

     
    (5.5
    )
     
    (6.3
    )
    Payments/credits relating to sales in current year
    (210.2
    )
     
    (605.1
    )
     
    (0.7
    )
     
    (816.0
    )
    Payments/credits relating to sales in prior years
    (51.5
    )
     
    (384.9
    )
     
    (10.4
    )
     
    (446.8
    )
    Balance, as of June 30, 2016
    $
    58.8

     
    $
    534.1

     
    $
    58.9

     
    $
    651.8


    The total reserves above, included in our condensed consolidated balance sheets, are summarized as follows:
    (In millions)
    As of
    June 30,
    2016
     
    As of
    December 31,
    2015
    Reduction of accounts receivable
    $
    161.3

     
    $
    144.6

    Component of accrued expenses and other
    490.5

     
    518.1

    Total reserves
    $
    651.8

     
    $
    662.7
    XML 44 R10.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Inventory
    		 6 Months Ended
    Jun. 30, 2016
    Inventory Disclosure [Abstract]  
    Inventory
    Inventory
    The components of inventory are summarized as follows:
    (In millions)
    As of
    June 30,
    2016
     
    As of
    December 31,
    2015
    Raw materials
    $
    235.0

     
    $
    213.0

    Work in process
    654.6

     
    577.6

    Finished goods
    139.1

     
    143.0

    Total inventory
    $
    1,028.7

     
    $
    933.6

     
     
     
     
    Balance Sheet Classification:
     
     
     
    Inventory
    $
    996.4

     
    $
    893.4

    Investments and other assets
    32.3

     
    40.2

    Total inventory
    $
    1,028.7

     
    $
    933.6


    Inventory included in investments and other assets in our condensed consolidated balance sheets primarily consisted of work in process.
    As of December 31, 2015, our inventory included $24.7 million associated with our ZINBRYTA program, $24.2 million associated with the FLIXABI program and $18.4 million associated with the BENEPALI program, which had been capitalized in advance of regulatory approval. The European Commission (EC) approved the marketing authorization applications for BENEPALI and FLIXABI, two anti-tumor necrosis factor (TNF) biosimilars, for marketing in the E.U. in January 2016 and May 2016, respectively, and the U.S. Food and Drug Administration (FDA) approved ZINBRYTA for the treatment of relapsing forms of MS in the U.S. in May 2016.
    XML 45 R11.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Intangible Assets and Goodwill
    		 6 Months Ended
    Jun. 30, 2016
    Goodwill and Intangible Assets Disclosure [Abstract]  
    Intangible Assets and Goodwill
    Intangible Assets and Goodwill
    Intangible Assets
    Intangible assets, net of accumulated amortization, impairment charges and adjustments, are summarized as follows:
     
     
     
    As of June 30, 2016
     
    As of December 31, 2015
    (In millions)
    Estimated
    Life
     
    Cost
     
    Accumulated
    Amortization
     
    Net
     
    Cost
     
    Accumulated
    Amortization
     
    Net
    Out-licensed patents
    13-23 years
     
    $
    543.3

     
    $
    (514.9
    )
     
    $
    28.4

     
    $
    543.3

     
    $
    (506.0
    )
     
    $
    37.3

    Developed 
    technology
    15-23 years
     
    3,005.3

     
    (2,604.5
    )
     
    400.8

     
    3,005.3

     
    (2,552.9
    )
     
    452.4

    In-process research and development
    Indefinite until commercialization
     
    692.3

     
    —

     
    692.3

     
    730.5

     
    —

     
    730.5

    Trademarks and 
    tradenames
    Indefinite
     
    64.0

     
    —

     
    64.0

     
    64.0

     
    —

     
    64.0

    Acquired and in-licensed rights 
    and patents
    6-18 years
     
    3,405.4

     
    (623.3
    )
     
    2,782.1

     
    3,303.2

     
    (502.3
    )
     
    2,800.9

    Total intangible assets
     
     
    $
    7,710.3

     
    $
    (3,742.7
    )
     
    $
    3,967.6

     
    $
    7,646.3

     
    $
    (3,561.2
    )
     
    $
    4,085.1


    For the three and six months ended June 30, 2016, amortization of acquired intangible assets totaled $92.9 million and $181.7 million, respectively, as compared to $92.0 million and $187.9 million, respectively, in the prior year comparative periods. In-process research and development amounts include adjustments for foreign exchange rate fluctuations.
    Developed Technology
    Developed technology primarily relates to our AVONEX product, which was recorded in connection with the merger of Biogen, Inc. and IDEC Pharmaceuticals Corporation in 2003. The net book value of this asset as of June 30, 2016 was $392.8 million.
    Acquired and In-licensed Rights and Patents
    Acquired and in-licensed rights and patents primarily relate to our acquisition of all remaining rights to TYSABRI from Elan Corporation plc (Elan). The net book value of this asset as of June 30, 2016 was $2,633.4 million.
    The increase in acquired and in-licensed rights and patents during the six months ended June 30, 2016, primarily reflects:
    •
    $50.0 million in total milestone payments due to Samsung Bioepis, which became payable upon the approval of BENEPALI and FLIXABI in the E.U. in January 2016 and May 2016, respectively;
    •
    $20.0 million milestone payment due to AbbVie Biotherapeutics, Inc. (AbbVie), which became payable upon the regulatory approval of ZINBRYTA in the U.S. in May 2016; and
    •
    $26.5 million upon the approval of ALPROLIX in the E.U. in May 2016, which is comprised of a $20.0 million contingent payment due to the former owners of Syntonix Pharmaceuticals, Inc. (Syntonix) and $6.5 million related to the establishment of a corresponding deferred tax liability.
    For additional information on our relationship with Samsung Bioepis, please read Note 17, Collaborative and Other Relationships to these condensed consolidated financial statements. For additional information on our relationship with Syntonix, please read Note 21, Commitments and Contingencies to our consolidated financial statements included in our 2015 Form 10-K. For additional information on our relationship with AbbVie, please read Note 19, Collaborative and Other Relationships to our consolidated financial statements included in our 2015 Form 10-K.
    Estimated Future Amortization of Intangible Assets
    Our amortization expense is based on the economic consumption of intangible assets. Our most significant intangible assets are related to our AVONEX and TYSABRI products. Annually, during our long-range planning cycle, we perform an analysis of anticipated lifetime revenues of AVONEX and TYSABRI. This analysis is also updated whenever events or changes in circumstances would significantly affect the anticipated lifetime revenues of either product.
    Our most recent long range planning cycle was completed in the third quarter of 2015. Based upon this analysis, the estimated future amortization of acquired intangible assets for the next five years is expected to be as follows:
    (In millions)
    As of
    June 30,
    2016
    2016 (remaining six months)
    $
    181.6

    2017
    325.1

    2018
    298.2

    2019
    282.7

    2020
    277.1

    2021
    265.0


    Goodwill
    The following table provides a roll forward of the changes in our goodwill balance:
    (In millions)
    As of
    June 30,
    2016
    Goodwill, beginning of period
    $
    2,663.8

    Increase to goodwill
    515.0

    Other
    (11.7
    )
    Goodwill, end of period
    $
    3,167.1


    The increase in goodwill during the six months ended June 30, 2016 was related to $600.0 million in contingent milestones achieved (exclusive of $85.0 million in tax benefits) and payable to the former shareholders of Fumapharm AG or holders of their rights. Other includes changes in foreign exchange rates. For additional information related to future contingent payments to the former shareholders of Fumapharm AG or holders of their rights, please read Note 19, Commitments and Contingencies to these condensed consolidated financial statements.
    As of June 30, 2016, we had no accumulated impairment losses related to goodwill.
    XML 46 R12.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Fair Value Measurements
    		 6 Months Ended
    Jun. 30, 2016
    Fair Value Disclosures [Abstract]  
    Fair Value Measurements
    Fair Value Measurements
    The tables below present information about our assets and liabilities that are regularly measured and carried at fair value and indicate the level within the fair value hierarchy of the valuation techniques we utilized to determine such fair value:
    As of June 30, 2016 (In millions)
    Total
     
    Quoted Prices
    in Active
    Markets
    (Level 1)
     
    Significant Other
    Observable Inputs
    (Level 2)
     
    Significant
    Unobservable
    Inputs
    (Level 3)
    Assets:
     
     
     
     
     
     
     
    Cash equivalents
    $
    874.6

     
    $
    —

     
    $
    874.6

     
    $
    —

    Marketable debt securities:
     
     
     
     
     
     
     
    Corporate debt securities
    2,290.3

     
    —

     
    2,290.3

     
    —

    Government securities
    2,973.4

     
    —

     
    2,973.4

     
    —

    Mortgage and other asset backed securities
    648.7

     
    —

     
    648.7

     
    —

    Marketable equity securities
    32.4

     
    32.4

     
    —

     
    —

    Derivative contracts
    30.1

     
    —

     
    30.1

     
    —

    Plan assets for deferred compensation
    35.6

     
    —

     
    35.6

     
    —

    Total
    $
    6,885.1

     
    $
    32.4

     
    $
    6,852.7

     
    $
    —

    Liabilities:
     
     
     
     
     
     
     
    Derivative contracts
    $
    24.8

     
    $
    —

     
    $
    24.8

     
    $
    —

    Contingent consideration obligations
    515.7

     
    —

     
    —

     
    515.7

    Total
    $
    540.5

     
    $
    —

     
    $
    24.8

     
    $
    515.7


    As of December 31, 2015 (In millions)
    Total
     
    Quoted Prices
    in Active
    Markets
    (Level 1)
     
    Significant Other
    Observable Inputs
    (Level 2)
     
    Significant
    Unobservable
    Inputs
    (Level 3)
    Assets:
     
     
     
     
     
     
     
    Cash equivalents
    $
    909.5

     
    $
    —

     
    $
    909.5

     
    $
    —

    Marketable debt securities:
     
     
     
     
     
     
     
    Corporate debt securities
    1,510.9

     
    —

     
    1,510.9

     
    —

    Government securities
    2,875.9

     
    —

     
    2,875.9

     
    —

    Mortgage and other asset backed securities
    494.1

     
    —

     
    494.1

     
    —

    Marketable equity securities
    37.5

     
    37.5

     
    —

     
    —

    Derivative contracts
    27.2

     
    —

     
    27.2

     
    —

    Plan assets for deferred compensation
    40.1

     
    —

     
    40.1

     
    —

    Total
    $
    5,895.2

     
    $
    37.5

     
    $
    5,857.7

     
    $
    —

    Liabilities:
     
     
     
     
     
     
     
    Derivative contracts
    $
    14.7

     
    $
    —

     
    $
    14.7

     
    $
    —

    Contingent consideration obligations
    506.0

     
    —

     
    —

     
    506.0

    Total
    $
    520.7

     
    $
    —

     
    $
    14.7

     
    $
    506.0


    There have been no material impairments of our assets measured and carried at fair value during the three and six months ended June 30, 2016. In addition, there were no changes in valuation techniques or inputs utilized or transfers between fair value measurement levels during the three and six months ended June 30, 2016. The fair values of Level 2 instruments classified as cash equivalents and marketable debt securities were determined through third party pricing services. For a description of our validation procedures related to prices provided by third party pricing services, refer to Note 1, Summary of Significant Accounting Policies: Fair Value Measurements, to our consolidated financial statements included in our 2015 Form 10-K.
    Debt Instruments
    The fair and carrying values of our debt instruments, which are Level 2 liabilities, are summarized as follows:
     
    As of June 30, 2016
     
    As of December 31, 2015
    (In millions)
    Fair
    Value
     
    Carrying
    Value
     
    Fair
    Value
     
    Carrying
    Value
    Notes payable to Fumedica
    $
    6.4

     
    $
    6.1

     
    $
    9.4

     
    $
    9.0

    6.875% Senior Notes due March 1, 2018
    598.2

     
    561.9

     
    602.6

     
    565.3

    2.900% Senior Notes due September 15, 2020
    1,561.7

     
    1,507.9

     
    1,497.5

     
    1,485.5

    3.625% Senior Notes due September 15, 2022
    1,061.0

     
    992.7

     
    1,014.2

     
    992.2

    4.050% Senior Notes due September 15, 2025
    1,887.3

     
    1,734.1

     
    1,764.6

     
    1,733.4

    5.200% Senior Notes due September 15, 2045
    1,996.3

     
    1,721.3

     
    1,757.6

     
    1,721.1

    Total
    $
    7,110.9

     
    $
    6,524.0

     
    $
    6,645.9

     
    $
    6,506.5


    The fair value of our notes payable to Fumedica was estimated using market observable inputs, including current interest and foreign currency exchange rates. The fair values of each of our series of Senior Notes were determined through market, observable and corroborated sources. For additional information related to our debt instruments, please read Note 11, Indebtedness to our consolidated financial statements included in our 2015 Form 10-K.
    Contingent Consideration Obligations
    The following table provides a roll forward of the fair values of our contingent consideration obligations which includes Level 3 measurements:
     
    For the Three Months
    Ended June 30,
     
    For the Six Months
    Ended June 30,
    (In millions)
    2016
     
    2015
     
    2016
     
    2015
    Fair value, beginning of period
    $
    508.3

     
    $
    461.8

     
    $
    506.0

     
    $
    215.5

    Additions
    —

     
    36.0

     
    —

     
    274.5

    Changes in fair value
    10.6

     
    (2.2
    )
     
    12.9

     
    5.6

    Payments
    (3.2
    )
     
    —

     
    (3.2
    )
     
    —

    Fair value, end of period
    $
    515.7

     
    $
    495.6

     
    $
    515.7

     
    $
    495.6


    As of June 30, 2016 and December 31, 2015, approximately $304.0 million and $301.3 million, respectively, of our contingent consideration obligations valued using Level 3 measurements were reflected as components of other long-term liabilities in our condensed consolidated balance sheets with the remaining balances reflected as a component of accrued expenses and other.
    XML 47 R13.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Financial Instruments
    		 6 Months Ended
    Jun. 30, 2016
    Investments, Debt and Equity Securities [Abstract]  
    Financial Instruments
    Financial Instruments
    The following table summarizes our financial assets with maturities of less than 90 days from the date of purchase included in cash and cash equivalents on the accompanying condensed consolidated balance sheet:
    (In millions)
    As of
    June 30,
    2016
     
    As of
    December 31,
    2015
    Commercial paper
    $
    56.9

     
    $
    21.9

    Overnight reverse repurchase agreements
    66.3

     
    134.7

    Money market funds
    531.5

     
    673.8

    Short-term debt securities
    219.9

     
    79.1

    Total
    $
    874.6

     
    $
    909.5


    The carrying values of our commercial paper, including accrued interest, overnight reverse repurchase agreements, money market funds and our short-term debt securities approximate fair value due to their short-term maturities. Our overnight reverse repurchase agreements are collateralized with agency-guaranteed mortgage-backed securities and represent approximately 0.3% and 0.7% of total assets as of June 30, 2016 and December 31, 2015, respectively.
    The following tables summarize our marketable debt and equity securities, classified as available-for-sale:
    As of June 30, 2016 (In millions)
    Fair
    Value
     
    Gross
    Unrealized
    Gains
     
    Gross
    Unrealized
    Losses
     
    Amortized
    Cost
    Corporate debt securities
     
     
     
     
     
     
     
    Current
    $
    913.4

     
    $
    0.3

     
    $
    (0.2
    )
     
    $
    913.3

    Non-current
    1,376.9

     
    7.8

     
    (0.4
    )
     
    1,369.5

    Government securities
     
     
     
     
     
     
     
    Current
    1,521.3

     
    0.6

     
    —

     
    1,520.7

    Non-current
    1,452.1

     
    3.1

     
    (0.6
    )
     
    1,449.6

    Mortgage and other asset backed securities
     
     
     
     
     
     
     
    Current
    0.1

     
    —

     
    —

     
    0.1

    Non-current
    648.6

     
    1.4

     
    (0.9
    )
     
    648.1

    Total marketable debt securities
    $
    5,912.4

     
    $
    13.2

     
    $
    (2.1
    )
     
    $
    5,901.3

    Marketable equity securities, non-current
    $
    32.4

     
    $
    0.9

     
    $
    (2.1
    )
     
    $
    33.6

    As of December 31, 2015 (In millions)
    Fair
    Value
     
    Gross
    Unrealized
    Gains
     
    Gross
    Unrealized
    Losses
     
    Amortized
    Cost
    Corporate debt securities
     
     
     
     
     
     
     
    Current
    $
    394.3

     
    $
    —

     
    $
    (0.5
    )
     
    $
    394.8

    Non-current
    1,116.6

     
    0.1

     
    (4.1
    )
     
    1,120.6

    Government securities
     
     
     
     
     
     
     
    Current
    1,723.4

     
    0.1

     
    (1.1
    )
     
    1,724.4

    Non-current
    1,152.5

     
    —

     
    (3.1
    )
     
    1,155.6

    Mortgage and other asset backed securities
     
     
     
     
     
     
     
    Current
    2.8

     
    —

     
    —

     
    2.8

    Non-current
    491.3

     
    0.1

     
    (1.8
    )
     
    493.0

    Total marketable debt securities
    $
    4,880.9

     
    $
    0.3

     
    $
    (10.6
    )
     
    $
    4,891.2

    Marketable equity securities, non-current
    $
    37.5

     
    $
    9.2

     
    $
    —

     
    $
    28.3


    Summary of Contractual Maturities: Available-for-Sale Securities
    The estimated fair value and amortized cost of our marketable debt securities available-for-sale by contractual maturity are summarized as follows:
     
    As of June 30, 2016
     
    As of December 31, 2015
    (In millions)
    Estimated
    Fair Value
     
    Amortized
    Cost
     
    Estimated
    Fair Value
     
    Amortized
    Cost
    Due in one year or less
    $
    2,434.8

     
    $
    2,434.1

     
    $
    2,120.5

     
    $
    2,122.0

    Due after one year through five years
    3,255.9

     
    3,245.4

     
    2,575.9

     
    2,583.9

    Due after five years
    221.7

     
    221.8

     
    184.5

     
    185.3

    Total available-for-sale securities
    $
    5,912.4

     
    $
    5,901.3

     
    $
    4,880.9

     
    $
    4,891.2


    The average maturity of our marketable debt securities available-for-sale as of June 30, 2016 and December 31, 2015 was approximately 13 months and 16 months, respectively.
    Proceeds from Marketable Debt Securities
    The proceeds from maturities and sales of marketable debt securities and resulting realized gains and losses are summarized as follows:
     
    For the Three Months
    Ended June 30,
     
    For the Six Months
    Ended June 30,
    (In millions)
    2016
     
    2015
     
    2016
     
    2015
    Proceeds from maturities and sales
    $
    1,642.5

     
    $
    601.9

     
    $
    2,823.6

     
    $
    975.5

    Realized gains
    $
    0.6

     
    $
    0.3

     
    $
    1.0

     
    $
    0.5

    Realized losses
    $
    (1.2
    )
     
    $
    (0.5
    )
     
    $
    (1.6
    )
     
    $
    (0.8
    )

    Strategic Investments
    As of June 30, 2016 and December 31, 2015, our strategic investment portfolio was comprised of investments totaling $98.3 million and $96.0 million, respectively, which are included in investments and other assets in our condensed consolidated balance sheets. Our strategic investment portfolio includes investments in equity securities of certain biotechnology companies and investments in venture capital funds where the underlying investments are in equity securities of biotechnology companies.
    XML 48 R14.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Derivative Instruments
    		 6 Months Ended
    Jun. 30, 2016
    Derivative Instruments and Hedging Activities Disclosure [Abstract]  
    Derivative Instruments
    Derivative Instruments
    Foreign Currency Forward Contracts - Hedging Instruments
    Due to the global nature of our operations, portions of our revenues and operating expenses are recorded in currencies other than the U.S. dollar. The value of revenues and operating expenses measured in U.S. dollars is therefore subject to changes in foreign currency exchange rates. In order to mitigate these changes we use foreign currency forward contracts to lock in exchange rates associated with a portion of our forecasted international revenues and operating expenses.
    Foreign currency forward contracts in effect as of June 30, 2016 and December 31, 2015 had durations of 1 to 18 months. These contracts have been designated as cash flow hedges and accordingly, to the extent effective, any unrealized gains or losses on these foreign currency forward contracts are reported in accumulated other comprehensive income (loss) (referred to as AOCI in the tables below). Realized gains and losses for the effective portion of such contracts are recognized in revenue when the sale of product in the currency being hedged is recognized and, beginning in the fourth quarter 2015, in operating expenses when the expense in the currency being hedged is recorded. To the extent ineffective, hedge transaction gains and losses are reported in other income (expense), net.
    The notional value of foreign currency forward contracts that were entered into to hedge forecasted revenues and operating expenses is summarized as follows:
     
    Notional Amount
    Foreign Currency: (In millions)
    As of
    June 30,
    2016
     
    As of
    December 31,
    2015
    Euro
    $
    1,126.5

     
    $
    945.5

    Swiss francs
    43.5

     
    80.8

    Canadian dollar
    39.9

     
    76.7

    Total foreign currency forward contracts
    $
    1,209.9

     
    $
    1,103.0


    The portion of the fair value of these foreign currency forward contracts that was included in accumulated other comprehensive income (loss) in total equity reflected net losses of $16.4 million and net gains of $1.8 million as of June 30, 2016 and December 31, 2015, respectively. We expect all contracts to be settled over the next 18 months and any amounts in accumulated other comprehensive income (loss) to be reported as an adjustment to revenue or operating expense. We consider the impact of our and our counterparties’ credit risk on the fair value of the contracts as well as the ability of each party to execute its contractual obligations. As of June 30, 2016 and December 31, 2015, credit risk did not change the fair value of our foreign currency forward contracts.
    The following tables summarize the effect of foreign currency forward contracts designated as hedging instruments on our condensed consolidated statements of income:
    For the Three Months Ended June 30,
    Net Gains/(Losses)
    Reclassified from AOCI into Operating Income
    (Effective Portion)
     
    Net Gains/(Losses)
    Recognized into Net Income
    (Ineffective Portion)
    Location
     
    2016
     
    2015
     
    Location
     
    2016
     
    2015
    Revenue
     
    $
    (4.3
    )
     
    $
    40.4

     
    Other income (expense)
     
    $
    2.1

     
    $
    1.2

    Operating expenses
     
    $
    (0.1
    )
     
    $
    —

     
    Other income (expense)
     
    $
    —

     
    $
    —


    For the Six Months Ended June 30,
    Net Gains/(Losses)
    Reclassified from AOCI into Operating Income
    (Effective Portion)
     
    Net Gains/(Losses)
    Recognized into Net Income
    (Ineffective Portion)
    Location
     
    2016
     
    2015
     
    Location
     
    2016
     
    2015
    Revenue
     
    $
    4.5

     
    $
    75.4

     
    Other income (expense)
     
    $
    4.0

     
    $
    3.4

    Operating expenses
     
    $
    (0.2
    )
     
    $
    —

     
    Other income (expense)
     
    $
    (0.3
    )
     
    $
    —

    Interest Rate Contracts - Hedging Instruments
    We have entered into interest rate swap contracts on certain borrowing transactions to manage our exposure to interest rate changes.
    In connection with the issuance of our 2.90% Senior Notes, we entered into interest rate swaps with an aggregate notional amount of $675.0 million, which expire on September 15, 2020. The interest rate swap contracts are designated as hedges of the fair value changes in the 2.90% Senior Notes attributable to changes in interest rates. Since the specific terms and notional amount of the swaps match the debt being hedged, it is assumed to be a highly effective hedge and all changes in the fair value of the swaps are recorded as a component of the 2.90% Senior Notes with no net impact recorded in income. Any net interest payments made or received on the interest rate swap contracts are recognized as a component of interest expense in our condensed consolidated statements of income.
    Foreign Currency Forward Contracts - Other Derivatives
    We also enter into other foreign currency forward contracts, usually with durations of one month or less, to mitigate the foreign currency risk related to certain balance sheet positions. We have not elected hedge accounting for these transactions.
    The aggregate notional amount of these outstanding foreign currency contracts was $557.2 million and $721.0 million as of June 30, 2016 and December 31, 2015, respectively. Net losses of $18.6 million and $16.2 million related to these contracts were recognized as a component of other income (expense), net, for three and six months ended June 30, 2016, respectively, as compared to net gains of $13.6 million and $3.9 million, respectively, in the prior year comparative periods.
    Summary of Derivatives
    While certain of our derivatives are subject to netting arrangements with our counterparties, we do not offset derivative assets and liabilities in our condensed consolidated balance sheets.
    The following table summarizes the fair value and presentation in our condensed consolidated balance sheets of our outstanding derivatives including those designated as hedging instruments:
     
     
    Fair Value
    (In millions)
    Balance Sheet Location
    As of June 30, 2016
    Hedging Instruments:
     
     
    Asset derivatives
    Other current assets
    $
    2.0

     
    Investments and other assets
    $
    23.6

    Liability derivatives
    Accrued expenses and other
    $
    14.8

     
    Other long-term liabilities
    $
    —

    Other Derivatives:
     
     
    Asset derivatives
    Other current assets
    $
    4.5

    Liability derivatives
    Accrued expenses and other
    $
    10.0

     
     
     
     
     
    Fair Value
    (In millions)
    Balance Sheet Location
    As of December 31, 2015
    Hedging Instruments:
     
     
    Asset derivatives
    Other current assets
    $
    16.6

     
    Investments and other assets
    $
    0.3

    Liability derivatives
    Accrued expenses and other
    $
    10.2

     
    Other long-term liabilities
    $
    2.5

    Other Derivatives:
     
     
    Asset derivatives
    Other current assets
    $
    10.3

    Liability derivatives
    Accrued expenses and other
    $
    2.0
    XML 49 R15.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Property, Plant and Equipment Property, Plant and Equipment
    		 6 Months Ended
    Jun. 30, 2016
    Property, Plant and Equipment [Abstract]  
    Property, Plant and Equipment
    Property, Plant and Equipment
    Property, plant and equipment are recorded at historical cost, net of accumulated depreciation. Accumulated depreciation on property, plant and equipment was $1,471.0 million and $1,330.1 million as of June 30, 2016 and December 31, 2015, respectively.
    Solothurn, Switzerland Facility
    On December 1, 2015, we purchased land in Solothurn, Switzerland for 64.4 million Swiss Francs (approximately $62.5 million). We are building a biologics manufacturing facility on this land in the Commune of Luterbach over the next several years. As of June 30, 2016 and December 31, 2015, we had approximately $247.8 million and $99.0 million, respectively, capitalized as construction in progress related to the construction of this facility.
    Cambridge, MA Manufacturing Facility
    In June 2016, as a result of an evaluation of our manufacturing capabilities and capacity needs based on current and expected future demand, we determined that we intend to cease manufacturing in Cambridge, MA and vacate our 67,000 square foot small-scale biologics manufacturing facility in Cambridge, MA and 46,000 square foot warehouse space in Somerville, MA by the end of 2016.
    We are currently considering alternatives for the facility, which may include a sale of our rights to the facility and related assets. In the event we are unsuccessful with a sale, we will close the facility by December 31, 2016.
    As of June 30, 2016, the carrying value of associated assets totaled approximately $43.0 million and our remaining lease obligation related to these facilities totaled $26.3 million.
    An impairment assessment as of June 30, 2016 was performed related to the assets, which resulted in no impairments.
    The anticipated departure from these facilities has shortened the expected useful lives of certain leasehold improvements and other assets at these facilities. As a result, we recorded additional depreciation expense to reflect the assets' new shorter useful lives. As of June 30, 2016, we recognized approximately $15.8 million of this additional depreciation, which was recorded as cost of sales in our condensed consolidated statements of income.
    XML 50 R16.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Equity
    		 6 Months Ended
    Jun. 30, 2016
    Equity [Abstract]  
    Equity
    Equity
    Total equity as of June 30, 2016 increased $2,028.8 million compared to December 31, 2015. This increase was primarily driven by net income attributable to Biogen Inc. of $2,020.7 million and an increase in additional paid in capital related to our share-based compensation arrangements, partially offset by other comprehensive losses.
    Share Repurchases
    In July 2016, our Board of Directors authorized a program to repurchase up to $5.0 billion of our common stock (2016 Share Repurchase Program). This authorization does not have an expiration date. Repurchased shares will be retired. The 2016 Share Repurchase Program is in addition to the approximately 1.3 million shares remaining under our February 2011 Share Repurchase Program (2011 Share Repurchase Program), which has been used principally to offset common stock issuances under our share-based compensation plans. During the six months ended June 30, 2016 and 2015, we did not repurchase any shares of common stock under our 2011 Share Repurchase Program.
    In May 2015, our Board of Directors authorized a program to repurchase up to $5.0 billion of our common stock, which was completed as of December 31, 2015. During the six months ended June 30, 2015, we repurchased and retired 0.1 million shares of common stock at a cost of $42.2 million.
    Noncontrolling Interests
    The following table reconciles equity (deficit) attributable to noncontrolling interests (NCI):
     
    For the Three Months
    Ended June 30,
     
    For the Six Months
    Ended June 30,
    (In millions)
    2016
     
    2015
     
    2016
     
    2015
    NCI, beginning of period
    $
    1.3

     
    $
    2.7

     
    $
    2.1

     
    $
    5.0

    Net income (loss) attributable to NCI, net of tax
    (1.4
    )
     
    (2.5
    )
     
    (3.1
    )
     
    (4.8
    )
    Fair value of net assets and liabilities acquired and assigned to NCI
    —

     
    —

     
    0.9

     
    —

    Translation adjustment and other
    —

     
    0.2

     
    —

     
    0.2

    NCI, end of period
    $
    (0.1
    )
     
    $
    0.4

     
    $
    (0.1
    )
     
    $
    0.4
    XML 51 R17.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss)
    		 6 Months Ended
    Jun. 30, 2016
    Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
    Accumulated Other Comprehensive Income (Loss)
    Accumulated Other Comprehensive Income (Loss)
    The following table summarizes the changes in accumulated other comprehensive income (loss), net of tax by component:
    (In millions)
    Unrealized Gains (Losses) on Securities Available for Sale
     
    Unrealized Gains (Losses) on Cash Flow Hedges
     
    Unfunded Status of Postretirement Benefit Plans
     
    Translation Adjustments
     
    Total
    Balance, as of December 31, 2015
    $
    (0.8
    )
     
    $
    10.2

     
    $
    (37.8
    )
     
    $
    (195.6
    )
     
    $
    (224.0
    )
    Other comprehensive income (loss) before reclassifications
    6.6

     
    (13.9
    )
     
    0.9

     
    (48.4
    )
     
    (54.8
    )
    Amounts reclassified from accumulated other comprehensive income (loss)
    0.4

     
    (4.4
    )
     
    —

     
    —

     
    (4.0
    )
    Net current period other comprehensive income (loss)
    7.0

     
    (18.3
    )
     
    0.9

     
    (48.4
    )
     
    (58.8
    )
    Balance, as of June 30, 2016
    $
    6.2

     
    $
    (8.1
    )
     
    $
    (36.9
    )
     
    $
    (244.0
    )
     
    $
    (282.8
    )

    (In millions)
    Unrealized Gains (Losses) on Securities Available for Sale
     
    Unrealized Gains (Losses) on Cash Flow Hedges
     
    Unfunded Status of Postretirement Benefit Plans
     
    Translation Adjustments
     
    Total
    Balance, as of December 31, 2014
    $
    (0.4
    )
     
    $
    71.7

     
    $
    (31.6
    )
     
    $
    (99.2
    )
     
    $
    (59.5
    )
    Other comprehensive income (loss) before reclassifications
    0.9

     
    66.1

     
    4.1

     
    (37.8
    )
     
    33.3

    Amounts reclassified from accumulated other comprehensive income (loss)
    0.2

     
    (75.0
    )
     
    —

     
    —

     
    (74.8
    )
    Net current period other comprehensive income (loss)
    1.1

     
    (8.9
    )
     
    4.1

     
    (37.8
    )
     
    (41.5
    )
    Balance, as of June 30, 2015
    $
    0.7

     
    $
    62.8

     
    $
    (27.5
    )
     
    $
    (137.0
    )
     
    $
    (101.0
    )

    The following table summarizes the amounts reclassified from accumulated other comprehensive income:
    (In millions)
    Income Statement Location
    Amounts Reclassified from Accumulated Other Comprehensive Income
    For the Three Months
    Ended June 30,
     
    For the Six Months
    Ended June 30,
    2016
     
    2015
     
    2016
     
    2015
    Gains (losses) on securities available for sale
    Other income (expense)
    $
    (0.6
    )
     
    $
    (0.2
    )
     
    $
    (0.6
    )
     
    $
    (0.3
    )
     
    Income tax benefit (expense)
    0.2

     
    0.1

     
    0.2

     
    0.1

     
     
     
     
     
     
     
     
     
    Gains (losses) on cash flow hedges
    Revenues
    (4.3
    )
     
    40.4

     
    4.5

     
    75.4

     
    Operating expenses
    (0.1
    )
     
    —

     
    (0.2
    )
     
    —

     
    Other income (expense)
    —

     
    —

     
    0.1

     
    —

     
    Income tax benefit (expense)
    0.1

     
    (0.2
    )
     
    —

     
    (0.4
    )
     
     
     
     
     
     
     
     
     
    Total reclassifications, net of tax
     
    $
    (4.7
    )
     
    $
    40.1

     
    $
    4.0

     
    $
    74.8
    XML 52 R18.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Earnings per Share
    		 6 Months Ended
    Jun. 30, 2016
    Earnings Per Share [Abstract]  
    Earnings per Share
    Earnings per Share
    Basic and diluted earnings per share are calculated as follows:
     
    For the Three Months
    Ended June 30,
     
    For the Six Months
    Ended June 30,
    (In millions)
    2016
     
    2015
     
    2016
     
    2015
    Numerator:
     
     
     
     
     
     
     
    Net income attributable to Biogen Inc.
    $
    1,049.8

     
    $
    927.3

     
    $
    2,020.7

     
    $
    1,749.8

    Denominator:
     
     
     
     
     
     
     
    Weighted average number of common shares outstanding
    219.1

     
    235.3

     
    219.0

     
    235.1

    Effect of dilutive securities:
     
     
     
     
     
     
     
    Stock options and employee stock purchase plan
    0.1

     
    0.1

     
    0.1

     
    0.1

    Time-vested restricted stock units
    0.1

     
    0.2

     
    0.1

     
    0.3

    Market stock units
    0.1

     
    0.1

     
    0.1

     
    0.2

    Dilutive potential common shares
    0.3

     
    0.4

     
    0.3

     
    0.6

    Shares used in calculating diluted earnings per share
    219.4

     
    235.7

     
    219.3

     
    235.7


    Amounts excluded from the calculation of net income per diluted share because their effects were anti-dilutive were insignificant.
    XML 53 R19.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Share-based Payments
    		 6 Months Ended
    Jun. 30, 2016
    Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
    Share-based Payments
    Share-based Payments
    Share-based Compensation Expense
    The following table summarizes share-based compensation expense included in our condensed consolidated statements of income:
     
    For the Three Months
    Ended June 30,
     
    For the Six Months
    Ended June 30,
    (In millions)
    2016
     
    2015
     
    2016
     
    2015
    Research and development
    $
    21.5

     
    $
    22.1

     
    $
    42.9

     
    $
    57.5

    Selling, general and administrative
    28.7

     
    26.2

     
    63.4

     
    81.8

    Restructuring charges
    —

     
    —

     
    (1.8
    )
     
    —

    Subtotal
    50.2

     
    48.3

     
    104.5

     
    139.3

    Capitalized share-based compensation costs
    (4.4
    )
     
    (2.2
    )
     
    (7.5
    )
     
    (5.6
    )
    Share-based compensation expense included in total cost and expenses
    45.8

     
    46.1

     
    97.0

     
    133.7

    Income tax effect
    (12.7
    )
     
    (12.9
    )
     
    (27.9
    )
     
    (39.6
    )
    Share-based compensation expense included in net income attributable to Biogen Inc.
    $
    33.1

     
    $
    33.2

     
    $
    69.1

     
    $
    94.1


    The following table summarizes share-based compensation expense associated with each of our share-based compensation programs:
     
    For the Three Months
    Ended June 30,
     
    For the Six Months
    Ended June 30,
    (In millions)
    2016
     
    2015
     
    2016
     
    2015
    Market stock units
    $
    7.9

     
    $
    9.1

     
    $
    21.3

     
    26.1

    Time-vested restricted stock units
    33.9

     
    31.8

     
    64.0

     
    63.7

    Cash settled performance units
    4.6

     
    3.2

     
    4.8

     
    27.0

    Performance units
    1.3

     
    1.2

     
    8.2

     
    14.4

    Employee stock purchase plan
    2.5

     
    3.0

     
    6.2

     
    8.1

    Subtotal
    50.2

     
    48.3

     
    104.5

     
    139.3

    Capitalized share-based compensation costs
    (4.4
    )
     
    (2.2
    )
     
    (7.5
    )
     
    (5.6
    )
    Share-based compensation expense included in total cost and expenses
    $
    45.8

     
    $
    46.1

     
    $
    97.0

     
    $
    133.7


    We estimate the fair value of our obligations associated with our performance units and cash settled performance units at the end of each reporting period through expected settlement. Cumulative adjustments to these obligations are recorded each quarter to reflect changes in the stock price and estimated outcome of the performance-related conditions. 
    Grants Under Share-based Compensation Plans
    The following table summarizes our equity grants to employees, officers and directors under our current stock plans:
     
    For the Six Months
    Ended June 30,
     
    2016
     
    2015
    Market stock units
    166,000

     
    179,000

    Cash settled performance shares
    86,000

     
    115,000

    Performance units
    56,000

     
    89,000

    Time-vested restricted stock units
    594,000

     
    375,000


    Employee Stock Purchase Plan (ESPP)
    In June 2015, our stockholders approved the Biogen Inc. 2015 ESPP (2015 ESPP). The 2015 ESPP, which became effective on July 1, 2015, replaced the Biogen Idec Inc. 1995 ESPP (1995 ESPP), which expired on June 30, 2015. The maximum aggregate number of shares of our common stock that may be purchased under the 2015 ESPP is 6,200,000.
    For the six months ended June 30, 2016, approximately 109,000 shares were issued under our 2015 ESPP, compared to approximately 98,000 shares issued under our 1995 ESPP in the prior year comparative period.
    XML 54 R20.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Income Taxes
    		 6 Months Ended
    Jun. 30, 2016
    Income Tax Disclosure [Abstract]  
    Income Taxes
    Income Taxes
    A reconciliation between the U.S. federal statutory tax rate and our effective tax rate is summarized as follows:
     
    For the Three Months
    Ended June 30,
     
    For the Six Months
    Ended June 30,
     
    2016
     
    2015
     
    2016
     
    2015
    Statutory rate
    35.0
     %
     
    35.0
     %
     
    35.0
     %
     
    35.0
     %
    State taxes
    1.0

     
    0.4

     
    1.0

     
    —

    Taxes on foreign earnings
    (10.0
    )
     
    (11.1
    )
     
    (9.0
    )
     
    (9.8
    )
    Credits and net operating loss utilization
    (1.2
    )
     
    (0.7
    )
     
    (1.2
    )
     
    (0.7
    )
    Purchased intangible assets
    1.1

     
    1.1

     
    1.1

     
    1.0

    Manufacturing deduction
    (1.6
    )
     
    (2.1
    )
     
    (1.7
    )
     
    (1.8
    )
    Other permanent items
    0.6

     
    0.9

     
    0.6

     
    0.7

    Other
    0.3

     
    0.4

     
    0.2

     
    0.3

    Effective tax rate
    25.2
     %
     
    23.9
     %
     
    26.0
     %
     
    24.7
     %

    For the three and six months ended June 30, 2016, compared to the same period in 2015, our effective tax rate increased primarily due to a state tax benefit in 2015 resulting from the remeasurement of one of our uncertain positions, described below, and a higher relative percentage of our earnings being attributed to the U.S., a higher tax jurisdiction.
    Accounting for Uncertainty in Income Taxes
    We and our subsidiaries are routinely examined by various taxing authorities. We file income tax returns in the U.S. federal jurisdiction, various U.S. states and foreign jurisdictions. With few exceptions, including the proposed disallowance we discuss below, we are no longer subject to U.S. federal tax examination for years before 2013 or state, local or non-U.S. income tax examinations for years before 2004.
    In March 2015, we received a final assessment from the Danish Tax Authority (SKAT) for 2009 regarding withholding taxes and the treatment of certain intercompany transactions involving a Danish affiliate and another of our affiliates. In April 2016, we received final assessments for 2011 and 2013 regarding withholding taxes for similar intercompany transactions. The total amount assessed for 2009, 2011 and 2013 is estimated to be $66.9 million, including interest. For the assessments related to 2011 and 2013, we have made payments to SKAT totaling $13.0 million. We continue to dispute the assessments for all of these periods and believe that the positions we have taken in our historical filings are valid.
    During the six months ended June 30, 2015, the net effect of adjustments to our uncertain tax positions was a net benefit of approximately $24.0 million primarily related to the state impact of a federal uncertain tax item.
    It is reasonably possible that we will adjust the value of our uncertain tax positions related to our revenues from anti-CD20 therapeutic programs and certain transfer pricing issues as we receive additional information from various taxing authorities, including reaching settlements with the tax authorities. In addition, the Internal Revenue Service (IRS) and other national tax authorities routinely examine our intercompany transfer pricing with respect to intellectual property related transactions and it is possible that they may disagree with one or more positions we have taken with respect to such valuations.
    In October 2011, in conjunction with an examination by the IRS, the IRS proposed a disallowance of approximately $130.0 million in deductions for tax years 2007, 2008 and 2009 related to payments for services provided by our wholly owned Danish subsidiary located in Hillerød, Denmark. We initiated a mutual agreement procedure between the IRS and SKAT for the years 2001 through 2009, to reach agreement on the issue. Over the past year, we have reached agreement with the IRS and SKAT regarding the tax treatment of these items for the years up to and including 2009. We have recorded the results of these agreements, which were not significant to our results. In addition, we applied for a bilateral advance pricing agreement for the years 2010 through 2014 to resolve similar issues for those years. In June 2016, we withdrew from the bilateral advance pricing agreement process. We believe that the positions we have taken in our historical filings are valid and supportable and potential changes in these positions are not expected to have a significant impact on our financial position or results of operations.
    XML 55 R21.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Other Consolidated Financial Statement Detail
    		 6 Months Ended
    Jun. 30, 2016
    Organization, Consolidation and Presentation of Financial Statements [Abstract]  
    Other Consolidated Financial Statement Detail
    Other Consolidated Financial Statement Detail
    Other Income (Expense), Net
    Components of other income (expense), net, are summarized as follows:
     
    For the Three Months
    Ended June 30,
     
    For the Six Months
    Ended June 30,
    (In millions)
    2016
     
    2015
     
    2016
     
    2015
    Interest income
    $
    15.4

     
    $
    4.3

     
    $
    26.6

     
    $
    7.6

    Interest expense
    (65.9
    )
     
    (5.8
    )
     
    (129.2
    )
     
    (12.5
    )
    Gain (loss) on investments, net
    (2.7
    )
     
    0.3

     
    (1.1
    )
     
    (1.4
    )
    Foreign exchange gains (losses), net
    0.2

     
    (1.5
    )
     
    2.3

     
    (14.5
    )
    Other, net
    (5.5
    )
     
    (8.2
    )
     
    (9.9
    )
     
    (5.1
    )
    Total other income (expense), net
    $
    (58.5
    )
     
    $
    (10.9
    )
     
    $
    (111.3
    )
     
    $
    (25.9
    )

    Other Current Assets
    Other current assets includes prepaid taxes totaling approximately $704.1 million and $550.6 million as of June 30, 2016 and December 31, 2015, respectively.
    Accrued Expenses and Other
    Accrued expenses and other consists of the following:
    (In millions)
    As of
    June 30,
    2016
     
    As of
    December 31,
    2015
    Current portion of contingent consideration obligations and milestones
    $
    556.7

     
    $
    504.7

    Revenue-related reserves for discounts and allowances
    490.5

     
    518.1

    Employee compensation and benefits
    228.4

     
    270.8

    Royalties and licensing fees
    183.7

     
    167.9

    Other
    613.4

     
    635.3

    Total accrued expenses and other
    $
    2,072.7

     
    $
    2,096.8


    Pricing of TYSABRI in Italy - AIFA
    In the fourth quarter of 2011, Biogen Italia SRL, our Italian subsidiary, received a notice from the Italian National Medicines Agency (Agenzia Italiana del Farmaco or AIFA) that sales of TYSABRI after mid-February 2009 exceeded a reimbursement limit established pursuant to a Price Determination Resolution (Price Resolution) granted by AIFA in December 2006. In January 2012, we filed an appeal in the Regional Administrative Tribunal of Lazio (Il Tribunale Amministrativo Regionale per il Lazio) in Rome, Italy seeking a ruling that the reimbursement limit in the Price Resolution should apply as written to only "the first 24 months" of TYSABRI sales, which ended in mid-February 2009. That appeal is still pending.
    In June 2014, AIFA approved a resolution affirming that there is no reimbursement limit from and after February 2013. As a result, we recognized $53.5 million of TYSABRI revenues related to the periods beginning February 2013 that were previously deferred. AIFA and Biogen Italia SRL are still discussing a possible resolution for the period from February 2009 through January 2013. We have approximately EUR75 million recorded as accrued expenses and deferred revenue both included in our long-term liabilities in our condensed consolidated balance sheet for this matter as of June 30, 2016 and December 31, 2015.
    For additional information relating to our agreement with AIFA relating to sales of TYSABRI in Italy, please read Note 17, Other Consolidated Financial Statement Detail to our consolidated financial statements included in our 2015 Form 10-K.
    XML 56 R22.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Investments in Variable Interest Entities
    		 6 Months Ended
    Jun. 30, 2016
    Investments in Variable Interest Entities [Abstract]  
    Investments in Variable Interest Entities
    Investments in Variable Interest Entities
    Consolidated Variable Interest Entities
    Our condensed consolidated financial statements include the financial results of variable interest entities in which we are the primary beneficiary.
    Neurimmune SubOne AG
    In 2007, we entered into a collaboration agreement with Neurimmune SubOne AG (Neurimmune), a subsidiary of Neurimmune AG, for the development and commercialization of antibodies for the treatment of Alzheimer’s disease. Neurimmune conducts research to identify potential therapeutic antibodies and we are responsible for the development, manufacturing and commercialization of all products. Our anti-amyloid beta antibody, aducanumab, for the treatment of Alzheimer’s disease resulted from this collaboration. Based upon our current development plans for aducanumab, we may pay Neurimmune up to $275.0 million in remaining milestone payments. We may also pay royalties in the low-to-mid-teens on sales of any resulting commercial products.
    We determined that we are the primary beneficiary of Neurimmune because we have the power through the collaboration to direct the activities that most significantly impact the entity’s economic performance and are required to fund 100% of the research and development costs incurred in support of the collaboration agreement. Accordingly, we consolidate the results of Neurimmune.
    We are required to reimburse Neurimmune for amounts that are incurred by Neurimmune for research and development expenses in support of the collaboration. Amounts reimbursed are reflected in research and development expense in our condensed consolidated statements of income. For the three and six months ended June 30, 2016 and 2015, these amounts were immaterial. Future milestone payments and royalties, if any, will be reflected in our condensed consolidated statements of income as a charge to noncontrolling interest, net of tax, when such milestones are achieved.
    The assets and liabilities of Neurimmune are not significant to our financial position or results of operations as it is a research and development organization. We have provided no financing to Neurimmune other than previously contractually required amounts.
    Other Variable Interest Entities
    We also consolidate the financial results of our other variable interest entities where we are the primary beneficiary. We may pay these variable interest entities up to approximately $8.0 million in remaining milestone payments. We have provided no financing to these entities other than amounts provided for in the contract.
    Unconsolidated Variable Interest Entities
    We have relationships with other variable interest entities that we do not consolidate as we lack the power to direct the activities that significantly impact the economic success of these entities. These relationships include investments in certain biotechnology companies and research collaboration agreements. As of June 30, 2016 and December 31, 2015, the total carrying value of our investments in biotechnology companies totaled $38.0 million and $29.2 million, respectively. Our maximum exposure to loss related to these variable interest entities is limited to the carrying value of our investments.
    We have also entered into research collaboration agreements with certain variable interest entities where we are required to fund certain development activities. These development activities are included in research and development expense in our condensed consolidated statements of income, as they are incurred. We have provided no financing to these variable interest entities other than previously contractually required amounts.
    For additional information related to our investments in variable interest entities, please read Note 18, Investments in Variable Interest Entities to our consolidated financial statements included in our 2015 Form 10-K.
    XML 57 R23.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Collaborative and Other Relationships
    		 6 Months Ended
    Jun. 30, 2016
    Organization, Consolidation and Presentation of Financial Statements [Abstract]  
    Collaborative and Other Relationships
    Collaborative and Other Relationships
    University of Pennsylvania
    In May 2016, we entered into a collaboration and alliance with the University of Pennsylvania (Penn) to advance gene therapy and gene editing technologies. The collaboration will primarily focus on the development of therapeutic approaches that target the eye, skeletal muscle and the central nervous system. The alliance is also expected to focus on the research and validation of next-generation gene transfer technology using adeno-associated virus gene delivery vectors and exploring the expanded use of genome editing technology as a potential therapeutic platform.
    During the second quarter of 2016, we paid Penn an upfront amount of $20.0 million, which was recorded as research and development expense in our condensed consolidated statements of income, and prepaid research and development expenditures of $15.0 million, which was recorded in investments and other assets in our condensed consolidated balance sheets. We also expect to fund an additional $47.5 million in the aggregate in research and development costs extending over the next three to five years in seven preclinical research and development programs, as well as the exploration of genome-editing technology.
    If all of the collaboration programs are successful and we exercise all of our options under the Penn collaboration and alliance, we may be required to make future payments of over $2.0 billion in research funding, options and milestone payments, in addition to royalties payable on net sales of products.
    Swedish Orphan Biovitrum AB
    In January 2007, we acquired 100% of the stock of Syntonix. Syntonix had previously entered into a collaboration agreement with Swedish Orphan Biovitrum AB (publ) (Sobi) to jointly develop and commercialize Factor VIII and Factor IX hemophilia products, including ELOCTATE and ALPROLIX. Under an amended and restated collaboration agreement, we have commercial rights for North America (the Biogen North America Territory) and for rest of the world markets outside of the Sobi Territory, as defined below (the Biogen Direct Territory). Following its exercise of an option right, Sobi has assumed commercialization rights for ELOCTA, the trade name for ELOCTATE, and ALPROLIX, in substantially all of Europe, Northern Africa, Russia and certain countries in the Middle East (the Sobi Territory). For additional information on our collaboration agreement with Sobi, please read Note 19, Collaborative and Other Relationships to our consolidated financial statements included in our 2015 Form 10-K.
    Sobi had its first commercial sale of ELOCTA in January 2016. In March 2016, the EC approved the transfer of the marketing authorization for ELOCTA from Biogen to Sobi, making Sobi the marketing authorization holder of ELOCTA in the E.U. As the marketing authorization holder, Sobi assumes full legal responsibility for ELOCTA, from a regulatory perspective, during its entire life cycle in the E.U. As of June 30, 2016, approximately $157.0 million in expenditures for ELOCTA, net of an escrow payment and other royalty adjustments as described in the table and its footnote (3) below, are reimbursable to us by Sobi under our collaboration agreement due to Sobi's election to assume final development and commercialization of ELOCTA in the Sobi Territory, which is the Opt-In Consideration for ELOCTA. This reimbursement will be recognized by us as royalty revenue in proportion to collaboration revenues, over a ten year period, consistent with the initial patent term of the product.
    ALPROLIX was approved in the E.U. by the EC in May 2016 and Sobi had its first commercial sale in June 2016. As of June 30, 2016, approximately $130.0 million in expenditures for ALPROLIX, net of an escrow payment and other royalty adjustments as described in the table and its footnote (3) below, are reimbursable to us by Sobi under our collaboration agreement due to Sobi's election to assume final development and commercialization of ALPROLIX in the Sobi Territory, which is the Opt-In Consideration for ALPROLIX. This reimbursement will be recognized by us as royalty revenue in proportion to collaboration revenues, over a ten year period, consistent with the initial patent term of the product.
    We expect to recognize the effect of the cash reimbursement as an adjustment to the Base Rate in the table below over a ten year period, consistent with the initial patent term of the products. Under the collaboration agreement, cash payments are as follows:
     
     
     
    Rates post Sobi Opt-In(3)
    Royalty and Net Revenue Share Rates:
    Method
     
    Base Rate following
    1st commercial sale in
    the Sobi Territory:
     
    Rate during the
    Reimbursement
    Period:
    Sobi rate to Biogen on net sales in the Sobi Territory
    Royalty
     
    12%
     
    Base Rate
    plus 5%
    Biogen rate to Sobi on net sales in the Biogen North America Territory
    Royalty
     
    12%
     
    Base Rate
    less 5%
    Biogen rate to Sobi on net sales in the Biogen Direct Territory
    Royalty
     
    17%
     
    Base Rate
    less 5%
    Biogen rate to Sobi on net revenue(1) 
    from the Biogen Distributor Territory(2)
    Net
    Revenue
    Share
     
    50%
     
    Base Rate
    less 15%

    (1)
    Net revenue represents Biogen’s pre-tax receipts from third-party distributors, less expenses incurred by Biogen in the conduct of commercialization activities supporting the distributor activities.
    (2)
    The Biogen Distributor Territory represents Biogen territories where sales are derived utilizing a third-party distributor.
    (3)
    A credit will be issued to Sobi against its reimbursement of the Opt-in Consideration in an amount equal to the difference in the rate paid by Biogen to Sobi on sales in the Biogen territories for certain periods prior to the first commercial sale in the Sobi Territory versus the rate that otherwise would have been payable on such sales.
    If the reimbursement of the Opt-in Consideration has not been achieved within six years of the first commercial sale of such product, we maintain the right to require Sobi to pay any remaining balances due to us within 90 days of the six year anniversary date of the first commercial sale.
    Samsung Bioepis
    Joint Venture Agreement
    In February 2012, we entered into a joint venture agreement with Samsung BioLogics Co. Ltd. (Samsung Biologics), establishing an entity, Samsung Bioepis, to develop, manufacture and market biosimilar pharmaceuticals. Samsung Biologics contributed 280.5 billion South Korean won (approximately $250.0 million) for an 85% stake in Samsung Bioepis and we contributed approximately 49.5 billion South Korean won (approximately $45.0 million) for the remaining 15% ownership interest. Under the joint venture agreement, we have no obligation to provide any additional funding and our ownership interest may be diluted due to financings in which we do not participate. As of June 30, 2016, our ownership interest is approximately 9%, which reflects the effect of additional equity financings in which we did not participate. We maintain an option to purchase additional stock in Samsung Bioepis that would allow us to increase our ownership percentage up to 49.9%. The exercise of this option is within our control and is based on paying for 49.9% of the total investment made by Samsung Biologics into Samsung Bioepis in excess of what we have already contributed under the agreement plus a rate that will represent their return on capital.
    Based on our level of influence over Samsung Bioepis, we account for this investment under the equity method of accounting and we recognize our share of the results of operations related to our investment in Samsung Bioepis one quarter in arrears when the results of the entity become available, which is reflected as equity in loss of investee, net of tax in our condensed consolidated statements of income. During the three and six months ended June 30, 2015, we recognized a loss on our investment of $4.9 million and $5.7 million, respectively. During 2015, as our share of losses exceeded the carrying value of our investment, we suspended recognizing additional losses and will continue to do so unless we commit to providing additional funding.
    Commercial Agreement
    In December 2013, pursuant to our rights under the joint venture agreement with Samsung Biologics, we entered into an agreement with Samsung Bioepis to commercialize, over a 10-year term, three anti-TNF biosimilar product candidates in Europe and in the case of one anti-TNF biosimilar, Japan. Under the terms of this agreement, we have made total upfront and milestone payments of $46.0 million, which have been recorded as a research and development expense in our condensed consolidated statements of income as the programs they relate to had not achieved regulatory approval. We also agreed to make an additional milestone payment of $25.0 million upon regulatory approval in the E.U. for each of the three anti-TNF biosimilar product candidates. During the six months ended June 30, 2016, we made a $25.0 million milestone payment and accrued another $25.0 million, which have been capitalized in intangible assets, net in our condensed consolidated balance sheet as BENEPALI received regulatory approval in the E.U. in January 2016 and FLIXABI received regulatory approval in the E.U. in May 2016.
    We began to recognize revenue on sales of BENEPALI in the E.U. in the first quarter of 2016. We reflect revenues on sales of BENEPALI to third parties in product revenues, net in our condensed consolidated statements of income and record the related cost of revenues and sales and marketing expenses in our condensed consolidated statements of income to their respective line items when these costs are incurred. We share 50% of the profit or loss related to our commercial agreement with Samsung Bioepis. This profit share with Samsung Bioepis is recognized in collaboration profit (loss) sharing in our condensed consolidated statements of income.
    Other Services
    Simultaneous with the formation of Samsung Bioepis, we also entered into a license agreement, a technical development services agreement and a manufacturing agreement with Samsung Bioepis. For the three and six months ended June 30, 2016, we recognized $14.2 million and $16.9 million, respectively, in relation to these services as other revenues in our condensed consolidated statements of income, as compared to $17.2 million and $36.1 million, respectively, in the prior year comparative periods.
    For additional information related to our other significant collaboration arrangements, please read Note 19, Collaborative and Other Relationships to our consolidated financial statements included in our 2015 Form 10-K.
    XML 58 R24.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Litigation
    		 6 Months Ended
    Jun. 30, 2016
    Loss Contingency, Information about Litigation Matters [Abstract]  
    Litigation
    Litigation
    We are currently involved in various claims and legal proceedings, including the matters described below. For information as to our accounting policies relating to claims and legal proceedings, including use of estimates and contingencies, please read Note 1, Summary of Significant Accounting Policies to our consolidated financial statements included in our 2015 Form 10-K.
    With respect to some loss contingencies, an estimate of the possible loss or range of loss cannot be made until management has further information, including, for example, (i) which claims, if any, will survive dispositive motion practice; (ii) information to be obtained through discovery; (iii) information as to the parties' damages claims and supporting evidence; (iv) the parties’ legal theories; and (v) the parties' settlement positions.
    The claims and legal proceedings in which we are involved also include challenges to the scope, validity or enforceability of the patents relating to our products, pipeline or processes, and challenges to the scope, validity or enforceability of the patents held by others. These include claims by third parties that we infringe their patents. An adverse outcome in any of these proceedings could result in one or more of the following and have a material impact on our business or consolidated results of operations and financial position: (i) loss of patent protection; (ii) inability to continue to engage in certain activities; and (iii) payment of significant damages, royalties, penalties and/or license fees to third parties.
    Loss Contingencies
    Forward Pharma German Patent Litigation
    On November 18, 2014, Forward Pharma A/S (Forward Pharma) filed suit against us in the Regional Court of Dusseldorf, Germany alleging that TECFIDERA infringes German Utility Model DE 20 2005 022 112 U1 (the utility model), which was issued in April 2014 and expired in October 2015. Forward Pharma subsequently extended its allegations to assert that TECFIDERA infringes Forward Pharma's European Patent No. 2 801 355, which was issued in May 2015 and expires in October 2025 (the '355 patent). Forward Pharma seeks declarations of infringement and damages for our sales of TECFIDERA in Germany. Under German law, disgorgement of profits on infringing sales is a measure of damages. With respect to the '355 patent, the hearing has been stayed pending the outcome of opposition proceedings that we and others have filed in the European Patent Office, and with respect to the utility model the hearing has been stayed pending the outcome of those proceedings and proceedings in the German Patent Office.
    ALPROLIX Patent Licensing Matter
    We are in discussions with Pfizer regarding its proposal that we take a license to its U.S. Patent No. 8,603,777 (Expression of Factor VII and IX Activities in Mammalian Cells) and pay royalties on sales of ALPROLIX. An estimate of the possible loss or range of loss cannot be made at this time.
    Italian National Medicines Agency
    In the fourth quarter of 2011, Biogen Italia SRL received notice from the Italian National Medicines Agency (Agenzia Italiana del Farmaco or AIFA) that sales of TYSABRI after mid-February 2009 exceeded a reimbursement limit established pursuant to a Price Determination Resolution (Price Resolution) granted by AIFA in December 2006. On January 12, 2012, we filed an appeal in the Regional Administrative Tribunal of Lazio (Il Tribunale Amministrativo Regionale per il Lazio) in Rome, Italy seeking a ruling that the reimbursement limit in the Price Resolution should apply as written to only “the first 24 months” of TYSABRI sales, which ended in mid-February 2009. The appeal is still pending. In June 2014, AIFA approved a resolution affirming that there is no reimbursement limit from and after February 2013. AIFA and Biogen Italia SRL are discussing a possible resolution for the period from February 2009 through January 2013.
    For additional information regarding this matter, please read Note 15, Other Consolidated Financial Statement Detail to these condensed consolidated financial statements.
    Qui Tam Litigation
    On July 6, 2015, four qui tam actions filed against us by relators suing on behalf of the United States and certain states were unsealed by the U.S. District Court for the District of Massachusetts. All but one of the actions has been voluntarily dismissed. The pending action alleges sales and promotional activities in violation of the federal False Claims Act and state law counterparts, and seeks single and treble damages, civil penalties, interest, attorneys’ fees and costs. The complaint was recently amended, and we intend to move to dismiss. The United States has not made an intervention decision. An estimate of the possible loss or range of loss cannot be made at this time.
    Securities Litigation
    We and certain current and former officers are defendants in In re Biogen Inc. Securities Litigation, filed by a shareholder on August 18, 2015 in the U.S. District Court for the District of Massachusetts. The amended complaint alleges violations of federal securities laws under 15 U.S.C. §78j(b) and §78t(a) and 17 C.F.R. §240.10b-5. The lead plaintiff sought a declaration of the action as a class action, certification as a representative of the class and its counsel as class counsel, and an award of damages, interest and attorneys' fees. On July 1, 2016 the U.S. District Court dismissed the case. An estimate of the possible loss or range of loss cannot be made at this time.
    Other Matters
    Interference Proceeding with Forward Pharma
    In April 2015, the U.S. Patent and Trademark Office (USPTO) declared an interference between Forward Pharma’s pending U.S. Patent Application No. 11/576,871 and our U.S. Patent No. 8,399,514 (the '514 patent). The '514 patent includes claims covering the treatment of multiple sclerosis with 480 mg of dimethyl fumarate as provided for in our TECFIDERA label. A hearing has been scheduled for late 2016.
    Inter Partes Review Petitions and Proceeding
    On March 22, 2016, the USPTO instituted inter partes review of the '514 patent on the petition of the Coalition for Affordable Drugs V LLC, an entity associated with a hedge fund. A hearing has been scheduled for late 2016.
    On April 18, 2016, Swiss Pharma International AG filed petitions in the USPTO for inter partes review of U.S. Patent Nos. 8,349,321 and, 8,900,577, relating to specific formulations of natalizumab (TYSABRI), and U.S. Patent No. 8,815,236, relating to methods for treating multiple sclerosis and Crohn’s disease using specific formulations of natalizumab (TYSABRI). The USPTO has not yet decided whether to institute review.
    European Patent Office Oppositions
    On March 10, 2016, the European Patent Office verbally revoked our European patent number 2 137 537 (the '537 patent), which includes claims covering the treatment of multiple sclerosis with 480 mg of dimethyl fumarate as provided for in our TECFIDERA label. In June 2016 the European Patent Office issued a written decision confirming its position from which we intend to appeal.
    Patent Revocation Matter
    In December 2015, Swiss Pharma International AG brought an action in the Patents Court of the United Kingdom to revoke the UK counterpart of our European Patent Number 1 485 127 (“Administration of agents to treat inflammation”) (the '127 patent), which was issued in June 2011 and concerns administration of natalizumab (TYSABRI) to treat multiple sclerosis. The patent expires in February 2023. Subsequently, the same entity brought actions in the District Court of The Hague (on January 11, 2016) and the German Patents Court (on March 3, 2016) to invalidate the Dutch and German counterparts of the '127 patent. A hearing has been scheduled in the UK action for late 2016 and in the Dutch action for early 2017. No hearing has yet been scheduled in the German action.
    '755 Patent Litigation
    On May 28, 2010, Biogen MA Inc. (formerly Biogen Idec MA Inc.) filed a complaint in the U.S. District Court for the District of New Jersey alleging infringement by Bayer Healthcare Pharmaceuticals Inc. (Bayer) (manufacturer, marketer and seller of BETASERON and manufacturer of EXTAVIA), EMD Serono, Inc. (manufacturer, marketer and seller of REBIF), Pfizer Inc. (co-marketer of REBIF) and Novartis Pharmaceuticals Corp. (marketer and seller of EXTAVIA) of our U.S. Patent No. 7,588,755 ('755 Patent), which claims the use of interferon beta for immunomodulation or treating a viral condition, viral disease, cancers or tumors. The complaint seeks monetary damages, including lost profits and royalties. Bayer had previously filed a complaint against us in the same court, on May 27, 2010, seeking a declaratory judgment that it does not infringe the '755 Patent and that the patent is invalid, and seeking monetary relief in the form of attorneys' fees, costs and expenses. The court has consolidated the two lawsuits, and we refer to the two actions as the “Consolidated '755 Patent Actions.”
    Bayer, Pfizer, Novartis and EMD Serono have all filed counterclaims in the Consolidated '755 Patent Actions seeking declaratory judgments of patent invalidity and non-infringement, and seeking monetary relief in the form of costs and attorneys' fees, and EMD Serono and Bayer have each filed a counterclaim seeking a declaratory judgment that the '755 Patent is unenforceable based on alleged inequitable conduct. Bayer has also amended its complaint to seek such a declaration. Trial has been set for September 2017.
    Government Matters
    We have learned that state and federal governmental authorities are investigating our sales and promotional practices and have received related subpoenas. We are cooperating with the government.
    On March 4, 2016 we received a subpoena from the federal government for documents relating to our relationship with non-profit organizations that provide assistance to patients taking drugs sold by Biogen. We are cooperating with the government.
    On July 1, 2016, we received civil investigative demands from the federal government for documents and information relating to our treatment of certain service agreements with wholesalers when calculating and reporting Average Manufacturer Prices in connection with the Medicaid Drug Rebate Program. We are in the process of responding to the government.
    Product Liability and Other Legal Proceedings
    We are also involved in product liability claims and other legal proceedings generally incidental to our normal business activities. While the outcome of any of these proceedings cannot be accurately predicted, we do not believe the ultimate resolution of any of these existing matters would have a material adverse effect on our business or financial condition.
    XML 59 R25.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Commitments and Contingencies
    		 6 Months Ended
    Jun. 30, 2016
    Commitments and Contingencies Disclosure [Abstract]  
    Commitments and Contingencies Disclosure
    Commitments and Contingencies
    Fumapharm AG
    In 2006, we acquired Fumapharm AG. As part of this acquisition we acquired FUMADERM and TECFIDERA (together, Fumapharm Products). We paid $220.0 million upon closing of the transaction and agreed to pay an additional $15.0 million if a Fumapharm Product was approved for MS in the U.S. or E.U. In the second quarter of 2013, we paid this $15.0 million contingent payment as TECFIDERA was approved in the U.S. for MS by the FDA. We are also required to make additional contingent payments to former shareholders of Fumapharm AG or holders of their rights based on the attainment of certain cumulative sales levels of Fumapharm Products and the level of total net sales of Fumapharm Products in the prior twelve month period.
    During the six months ended June 30, 2016, we paid $600.0 million in contingent payments as we reached the $7.0 billion and $8.0 billion cumulative sales levels related to the Fumapharm Products in the fourth quarter of 2015 and first quarter of 2016, respectively, and accrued $300.0 million upon reaching $9.0 billion in total cumulative sales of Fumapharm Products in the second quarter of 2016.
    We will owe an additional $300.0 million contingent payment for every additional $1.0 billion in cumulative sales level of Fumapharm Products reached if the prior 12 months sales of the Fumapharm Products exceed $3.0 billion, until such time as the cumulative sales level reaches $20.0 billion, at which time no further contingent payments shall be due. These payments will be accounted for as an increase to goodwill as incurred, in accordance with the accounting standard applicable to business combinations when we acquired Fumapharm. Any portion of the payment which is tax deductible will be recorded as a reduction to goodwill. Payments are due within 60 days following the end of the quarter in which the applicable cumulative sales level has been reached.
    Solothurn, Switzerland Facility
    On December 1, 2015, we purchased land in Solothurn, Switzerland where we are building a biologics manufacturing facility over the next several years. As of June 30, 2016, we had contractual commitments of approximately $226.0 million for the construction of this facility.
    XML 60 R26.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Subsequent Events Subsequent Events
    		 6 Months Ended
    Jun. 30, 2016
    Subsequent Events [Abstract]  
    Subsequent Events
    20.    Subsequent Events
    On July 21, 2016, we announced that George A. Scangos, Ph.D. will step down as our Chief Executive Officer after a successor has been identified. Dr. Scangos will remain on our Board of Directors until he steps down from his executive position. Our Board of Directors will begin a search for Dr. Scangos’ successor immediately.
    XML 61 R27.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Policies)
    		 6 Months Ended
    Jun. 30, 2016
    Accounting Policies [Abstract]  
    Overview
    Biogen is a global biopharmaceutical company focused on discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological diseases, autoimmune disorders and rare diseases.
    Our marketed products include TECFIDERA, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for multiple sclerosis (MS), ELOCTATE for hemophilia A and ALPROLIX for hemophilia B and FUMADERM for the treatment of severe plaque psoriasis. We also have a collaboration agreement with Genentech, Inc. (Genentech), a wholly-owned member of the Roche Group, which entitles us to certain business and financial rights with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other potential anti-CD20 therapies.
    In addition to our innovative drug development efforts, we aim to leverage our manufacturing capabilities and scientific expertise through Samsung Bioepis, our joint venture with Samsung BioLogics Co. Ltd. (Samsung Biologics) that develops, manufactures and markets biosimilars as well as through other strategic contract manufacturing partners. Under our commercial agreement with Samsung Bioepis, we market and sell BENEPALI, an etanercept biosimilar referencing ENBREL, and FLIXABI, an infliximab biosimilar referencing REMICADE, in the European Union (E.U.).
    In May 2016, we announced our intention to spin off our hemophilia business as an independent, publicly traded company. The new company will focus on the discovery and development of therapies for the treatment of hemophilia and other blood disorders, with existing marketed products ELOCTATE and ALPROLIX. The transaction is expected to be completed in early 2017, subject to the satisfaction of certain conditions, including, among others, final approval of our Board of Directors, receipt of a favorable opinion with respect to the tax-free nature of the transaction and the effectiveness of a Form 10 registration statement that will be filed with the Securities and Exchange Commission. The results of our hemophilia business will be included in our condensed consolidated financial statements until the transaction is completed.
    Basis of presentation
    In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring accruals, necessary for a fair statement of our financial statements for interim periods in accordance with accounting principles generally accepted in the United States (U.S. GAAP). The information included in this quarterly report on Form 10-Q should be read in conjunction with our consolidated financial statements and the accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2015 (2015 Form 10-K). Our accounting policies are described in the “Notes to Consolidated Financial Statements” in our 2015 Form 10-K and updated, as necessary, in this Form 10-Q. The year-end condensed consolidated balance sheet data presented for comparative purposes was derived from our audited financial statements, but does not include all disclosures required by U.S. GAAP. The results of operations for the three and six months ended June 30, 2016, are not necessarily indicative of the operating results for the full year or for any other subsequent interim period.
    We operate as one operating segment, which is discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological diseases, autoimmune disorders and rare diseases.
    Consolidation
    Our condensed consolidated financial statements reflect our financial statements, those of our wholly-owned subsidiaries and those of certain variable interest entities where we are the primary beneficiary. For consolidated entities where we own or are exposed to less than 100% of the economics, we record net income (loss) attributable to noncontrolling interests in our condensed consolidated statements of income equal to the percentage of the economic or ownership interest retained in such entities by the respective noncontrolling parties. Intercompany balances and transactions are eliminated in consolidation.
    In determining whether we are the primary beneficiary of an entity, we apply a qualitative approach that determines whether we have both (1) the power to direct the economically significant activities of the entity and (2) the obligation to absorb losses of, or the right to receive benefits from, the entity that could potentially be significant to that entity. These considerations impact the way we account for our existing collaborative relationships and other arrangements. We continuously assess whether we are the primary beneficiary of a variable interest entity as changes to existing relationships or future transactions may result in us consolidating or deconsolidating one or more of our collaborators or partners.
    Use of estimates
    The preparation of our condensed consolidated financial statements requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosure of contingent assets and liabilities. On an on-going basis we evaluate our estimates, judgments and methodologies. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity and the amount of revenues and expenses. Actual results may differ from these estimates under different assumptions or conditions.
    New accounting pronouncements
    From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (FASB) or other standard setting bodies that we adopt as of the specified effective date. Unless otherwise discussed, we do not believe that the impact of recently issued standards that are not yet effective will have a material impact on our financial position or results of operations upon adoption.
    In May 2014, the FASB issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes all existing revenue recognition requirements, including most industry-specific guidance. The new standard requires a company to recognize revenue when it transfers goods or services to customers in an amount that reflects the consideration that the company expects to receive for those goods or services. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, which delayed the effective date of the new standard from January 1, 2017 to January 1, 2018. The FASB also agreed to allow entities to choose to adopt the standard as of the original effective date. In March 2016, the FASB issued ASU No. 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations, which clarifies the implementation guidance on principal versus agent considerations. In April 2016, the FASB issued ASU No. 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing, which clarifies certain aspects of identifying performance obligations and licensing implementation guidance. In May 2016, the FASB issued ASU No. 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients related to disclosures of remaining performance obligations, as well as other amendments to guidance on collectibility, non-cash consideration and the presentation of sales and other similar taxes collected from customers. These standards have the same effective date and transition date of January 1, 2018. We are currently evaluating the method of adoption and the potential impact that these standards may have on our financial position and results of operations.
    During 2015, the FASB issued the following new standards, which we adopted on January 1, 2016:
    •
    ASU No. 2015-05, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Fees Paid in a Cloud Computing Arrangement.
    •
    ASU No. 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory.
    •
    ASU No. 2015-16, Business Combinations (Topic 805): Simplifying the Accounting for Measurement-Period Adjustments.
    The adoption of these standards did not have an impact on our financial position or results of operations. For additional information related to these standards, please read Note 1, Summary of Significant Accounting Policies: New Accounting Pronouncements to our consolidated financial statements included in our 2015 Form 10-K.
    In January 2016, the FASB issued ASU No. 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The new standard amends certain aspects of accounting and disclosure requirements of financial instruments, including the requirement that equity investments with readily determinable fair values be measured at fair value with changes in fair value recognized in our results of operations. The new standard does not apply to investments accounted for under the equity method of accounting or those that result in consolidation of the investee. Equity investments that do not have readily determinable fair values may be measured at fair value or at cost minus impairment adjusted for changes in observable prices. A financial liability that is measured at fair value in accordance with the fair value option is required to be presented separately in other comprehensive income for the portion of the total change in the fair value resulting from change in the instrument-specific credit risk. In addition, a valuation allowance should be evaluated on deferred tax assets related to available-for-sale debt securities in combination with other deferred tax assets. The new standard will be effective for us on January 1, 2018. The adoption of this standard is not expected to have a material impact on our financial position or results of operations.
    In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). The new standard requires that all lessees recognize the assets and liabilities that arise from leases on the balance sheet and disclose qualitative and quantitative information about its leasing arrangements. The new standard will be effective for us on January 1, 2019. The adoption of this standard is not expected to have a material impact on our net financial position, but will impact our assets and liabilities. We are currently evaluating the potential impact that this standard may have on our results of operations.
    In March 2016, the FASB issued ASU No. 2016-06, Derivatives and Hedging (Topic 815): Contingent Put and Call Options in Debt Instruments. The new standard simplifies the embedded derivative analysis for debt instruments containing contingent call or put options by removing the requirement to assess whether a contingent event is related to interest rates or credit risks. The new standard will be effective for us on January 1, 2017. The adoption of this standard is not expected to have an impact on our financial position or results of operations.
    In March 2016, the FASB issued ASU No. 2016-07, Investments - Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting. The new standard eliminates the requirement that when an investment qualifies for use of the equity method as a result of an increase in the level of ownership interest or degree of influence, an adjustment must be made to the investment, results of operations and retained earnings retroactively on a step-by-step basis as if the equity method had been in effect during all previous periods that the investment had been held. The new standard will be effective for us on January 1, 2017. The adoption of this standard is not expected to have a material impact on our financial position or results of operations.
    In March 2016, the FASB issued ASU No. 2016-09, Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. The new standard requires recognition of the income tax effects of vested or settled awards in the income statement and involves several other aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. The new standard will be effective for us on January 1, 2017. This standard is not expected to have a material impact on our financial position, results of operations or statements of cash flows upon adoption.
    In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The new standard changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investment in leases that are not accounted for at fair value through net income to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. The new standard will be effective for us on January 1, 2020. The adoption of this standard is not expected to have a material impact on our financial position or results of operations.
    XML 62 R28.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Restructuring Restructuring (Tables)
    		 6 Months Ended
    Jun. 30, 2016
    Restructuring and Related Activities [Abstract]  
    Charges and spending related to our restructuring efforts
    The following table summarizes the charges and spending related to our restructuring efforts during the six months ended June 30, 2016:
    (In millions)
    Workforce
    Reduction
     
    Pipeline
    Programs
     
    Total
    Restructuring reserve as of December 31, 2015
    $
    33.7

     
    $
    3.6

     
    $
    37.3

    Expense
    4.9

     
    5.4

     
    10.3

    Payments
    (28.7
    )
     
    (6.0
    )
     
    (34.7
    )
    Adjustments to previous estimates, net
    (3.5
    )
     
    2.9

     
    (0.6
    )
    Restructuring reserve as of June 30, 2016
    $
    6.4

     
    $
    5.9

     
    $
    12.3
    XML 63 R29.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Reserves for Discounts and Allowances (Tables)
    		 6 Months Ended
    Jun. 30, 2016
    Sales Discounts, Returns and Allowances, Goods [Abstract]  
    Analysis of the changes in reserves
    An analysis of the change in reserves for discounts and allowances is summarized as follows:
    (In millions)
    Discounts
     
    Contractual
    Adjustments
     
    Returns
     
    Total
    Balance, as of December 31, 2015
    $
    56.1

     
    $
    548.7

     
    $
    57.9

     
    $
    662.7

    Current provisions relating to sales in current year
    266.8

     
    973.8

     
    17.6

     
    1,258.2

    Adjustments relating to prior years
    (2.4
    )
     
    1.6

     
    (5.5
    )
     
    (6.3
    )
    Payments/credits relating to sales in current year
    (210.2
    )
     
    (605.1
    )
     
    (0.7
    )
     
    (816.0
    )
    Payments/credits relating to sales in prior years
    (51.5
    )
     
    (384.9
    )
     
    (10.4
    )
     
    (446.8
    )
    Balance, as of June 30, 2016
    $
    58.8

     
    $
    534.1

     
    $
    58.9

     
    $
    651.8
    Total reserves included in condensed consolidated balance sheets
    The total reserves above, included in our condensed consolidated balance sheets, are summarized as follows:
    (In millions)
    As of
    June 30,
    2016
     
    As of
    December 31,
    2015
    Reduction of accounts receivable
    $
    161.3

     
    $
    144.6

    Component of accrued expenses and other
    490.5

     
    518.1

    Total reserves
    $
    651.8

     
    $
    662.7
    XML 64 R30.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Inventory (Tables)
    		 6 Months Ended
    Jun. 30, 2016
    Inventory Disclosure [Abstract]  
    Components of inventory
    The components of inventory are summarized as follows:
    (In millions)
    As of
    June 30,
    2016
     
    As of
    December 31,
    2015
    Raw materials
    $
    235.0

     
    $
    213.0

    Work in process
    654.6

     
    577.6

    Finished goods
    139.1

     
    143.0

    Total inventory
    $
    1,028.7

     
    $
    933.6

     
     
     
     
    Balance Sheet Classification:
     
     
     
    Inventory
    $
    996.4

     
    $
    893.4

    Investments and other assets
    32.3

     
    40.2

    Total inventory
    $
    1,028.7

     
    $
    933.6
    XML 65 R31.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Intangible Assets and Goodwill (Tables)
    		 6 Months Ended
    Jun. 30, 2016
    Goodwill and Intangible Assets Disclosure [Abstract]  
    Intangible assets
    Intangible assets, net of accumulated amortization, impairment charges and adjustments, are summarized as follows:
     
     
     
    As of June 30, 2016
     
    As of December 31, 2015
    (In millions)
    Estimated
    Life
     
    Cost
     
    Accumulated
    Amortization
     
    Net
     
    Cost
     
    Accumulated
    Amortization
     
    Net
    Out-licensed patents
    13-23 years
     
    $
    543.3

     
    $
    (514.9
    )
     
    $
    28.4

     
    $
    543.3

     
    $
    (506.0
    )
     
    $
    37.3

    Developed 
    technology
    15-23 years
     
    3,005.3

     
    (2,604.5
    )
     
    400.8

     
    3,005.3

     
    (2,552.9
    )
     
    452.4

    In-process research and development
    Indefinite until commercialization
     
    692.3

     
    —

     
    692.3

     
    730.5

     
    —

     
    730.5

    Trademarks and 
    tradenames
    Indefinite
     
    64.0

     
    —

     
    64.0

     
    64.0

     
    —

     
    64.0

    Acquired and in-licensed rights 
    and patents
    6-18 years
     
    3,405.4

     
    (623.3
    )
     
    2,782.1

     
    3,303.2

     
    (502.3
    )
     
    2,800.9

    Total intangible assets
     
     
    $
    7,710.3

     
    $
    (3,742.7
    )
     
    $
    3,967.6

     
    $
    7,646.3

     
    $
    (3,561.2
    )
     
    $
    4,085.1
    Estimated future amortization for acquired intangible assets
    Based upon this analysis, the estimated future amortization of acquired intangible assets for the next five years is expected to be as follows:
    (In millions)
    As of
    June 30,
    2016
    2016 (remaining six months)
    $
    181.6

    2017
    325.1

    2018
    298.2

    2019
    282.7

    2020
    277.1

    2021
    265.0
    Summary of roll forward of the changes in goodwill
    The following table provides a roll forward of the changes in our goodwill balance:
    (In millions)
    As of
    June 30,
    2016
    Goodwill, beginning of period
    $
    2,663.8

    Increase to goodwill
    515.0

    Other
    (11.7
    )
    Goodwill, end of period
    $
    3,167.1
    XML 66 R32.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Fair Value Measurements (Tables)
    		 6 Months Ended
    Jun. 30, 2016
    Fair Value Disclosures [Abstract]  
    Summary of assets and liabilities recorded at fair value
    The tables below present information about our assets and liabilities that are regularly measured and carried at fair value and indicate the level within the fair value hierarchy of the valuation techniques we utilized to determine such fair value:
    As of June 30, 2016 (In millions)
    Total
     
    Quoted Prices
    in Active
    Markets
    (Level 1)
     
    Significant Other
    Observable Inputs
    (Level 2)
     
    Significant
    Unobservable
    Inputs
    (Level 3)
    Assets:
     
     
     
     
     
     
     
    Cash equivalents
    $
    874.6

     
    $
    —

     
    $
    874.6

     
    $
    —

    Marketable debt securities:
     
     
     
     
     
     
     
    Corporate debt securities
    2,290.3

     
    —

     
    2,290.3

     
    —

    Government securities
    2,973.4

     
    —

     
    2,973.4

     
    —

    Mortgage and other asset backed securities
    648.7

     
    —

     
    648.7

     
    —

    Marketable equity securities
    32.4

     
    32.4

     
    —

     
    —

    Derivative contracts
    30.1

     
    —

     
    30.1

     
    —

    Plan assets for deferred compensation
    35.6

     
    —

     
    35.6

     
    —

    Total
    $
    6,885.1

     
    $
    32.4

     
    $
    6,852.7

     
    $
    —

    Liabilities:
     
     
     
     
     
     
     
    Derivative contracts
    $
    24.8

     
    $
    —

     
    $
    24.8

     
    $
    —

    Contingent consideration obligations
    515.7

     
    —

     
    —

     
    515.7

    Total
    $
    540.5

     
    $
    —

     
    $
    24.8

     
    $
    515.7


    As of December 31, 2015 (In millions)
    Total
     
    Quoted Prices
    in Active
    Markets
    (Level 1)
     
    Significant Other
    Observable Inputs
    (Level 2)
     
    Significant
    Unobservable
    Inputs
    (Level 3)
    Assets:
     
     
     
     
     
     
     
    Cash equivalents
    $
    909.5

     
    $
    —

     
    $
    909.5

     
    $
    —

    Marketable debt securities:
     
     
     
     
     
     
     
    Corporate debt securities
    1,510.9

     
    —

     
    1,510.9

     
    —

    Government securities
    2,875.9

     
    —

     
    2,875.9

     
    —

    Mortgage and other asset backed securities
    494.1

     
    —

     
    494.1

     
    —

    Marketable equity securities
    37.5

     
    37.5

     
    —

     
    —

    Derivative contracts
    27.2

     
    —

     
    27.2

     
    —

    Plan assets for deferred compensation
    40.1

     
    —

     
    40.1

     
    —

    Total
    $
    5,895.2

     
    $
    37.5

     
    $
    5,857.7

     
    $
    —

    Liabilities:
     
     
     
     
     
     
     
    Derivative contracts
    $
    14.7

     
    $
    —

     
    $
    14.7

     
    $
    —

    Contingent consideration obligations
    506.0

     
    —

     
    —

     
    506.0

    Total
    $
    520.7

     
    $
    —

     
    $
    14.7

     
    $
    506.0
    Summary of fair and carrying value of debt instruments
    The fair and carrying values of our debt instruments, which are Level 2 liabilities, are summarized as follows:
     
    As of June 30, 2016
     
    As of December 31, 2015
    (In millions)
    Fair
    Value
     
    Carrying
    Value
     
    Fair
    Value
     
    Carrying
    Value
    Notes payable to Fumedica
    $
    6.4

     
    $
    6.1

     
    $
    9.4

     
    $
    9.0

    6.875% Senior Notes due March 1, 2018
    598.2

     
    561.9

     
    602.6

     
    565.3

    2.900% Senior Notes due September 15, 2020
    1,561.7

     
    1,507.9

     
    1,497.5

     
    1,485.5

    3.625% Senior Notes due September 15, 2022
    1,061.0

     
    992.7

     
    1,014.2

     
    992.2

    4.050% Senior Notes due September 15, 2025
    1,887.3

     
    1,734.1

     
    1,764.6

     
    1,733.4

    5.200% Senior Notes due September 15, 2045
    1,996.3

     
    1,721.3

     
    1,757.6

     
    1,721.1

    Total
    $
    7,110.9

     
    $
    6,524.0

     
    $
    6,645.9

     
    $
    6,506.5
    Fair value of contingent consideration obligations
    The following table provides a roll forward of the fair values of our contingent consideration obligations which includes Level 3 measurements:
     
    For the Three Months
    Ended June 30,
     
    For the Six Months
    Ended June 30,
    (In millions)
    2016
     
    2015
     
    2016
     
    2015
    Fair value, beginning of period
    $
    508.3

     
    $
    461.8

     
    $
    506.0

     
    $
    215.5

    Additions
    —

     
    36.0

     
    —

     
    274.5

    Changes in fair value
    10.6

     
    (2.2
    )
     
    12.9

     
    5.6

    Payments
    (3.2
    )
     
    —

     
    (3.2
    )
     
    —

    Fair value, end of period
    $
    515.7

     
    $
    495.6

     
    $
    515.7

     
    $
    495.6
    XML 67 R33.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Financial Instruments (Tables)
    		 6 Months Ended
    Jun. 30, 2016
    Investments, Debt and Equity Securities [Abstract]  
    Summary of financial assets with maturities of less than 90 days included within cash and cash equivalents
    The following table summarizes our financial assets with maturities of less than 90 days from the date of purchase included in cash and cash equivalents on the accompanying condensed consolidated balance sheet:
    (In millions)
    As of
    June 30,
    2016
     
    As of
    December 31,
    2015
    Commercial paper
    $
    56.9

     
    $
    21.9

    Overnight reverse repurchase agreements
    66.3

     
    134.7

    Money market funds
    531.5

     
    673.8

    Short-term debt securities
    219.9

     
    79.1

    Total
    $
    874.6

     
    $
    909.5
    Marketable debt and equity securities
    The following tables summarize our marketable debt and equity securities, classified as available-for-sale:
    As of June 30, 2016 (In millions)
    Fair
    Value
     
    Gross
    Unrealized
    Gains
     
    Gross
    Unrealized
    Losses
     
    Amortized
    Cost
    Corporate debt securities
     
     
     
     
     
     
     
    Current
    $
    913.4

     
    $
    0.3

     
    $
    (0.2
    )
     
    $
    913.3

    Non-current
    1,376.9

     
    7.8

     
    (0.4
    )
     
    1,369.5

    Government securities
     
     
     
     
     
     
     
    Current
    1,521.3

     
    0.6

     
    —

     
    1,520.7

    Non-current
    1,452.1

     
    3.1

     
    (0.6
    )
     
    1,449.6

    Mortgage and other asset backed securities
     
     
     
     
     
     
     
    Current
    0.1

     
    —

     
    —

     
    0.1

    Non-current
    648.6

     
    1.4

     
    (0.9
    )
     
    648.1

    Total marketable debt securities
    $
    5,912.4

     
    $
    13.2

     
    $
    (2.1
    )
     
    $
    5,901.3

    Marketable equity securities, non-current
    $
    32.4

     
    $
    0.9

     
    $
    (2.1
    )
     
    $
    33.6

    As of December 31, 2015 (In millions)
    Fair
    Value
     
    Gross
    Unrealized
    Gains
     
    Gross
    Unrealized
    Losses
     
    Amortized
    Cost
    Corporate debt securities
     
     
     
     
     
     
     
    Current
    $
    394.3

     
    $
    —

     
    $
    (0.5
    )
     
    $
    394.8

    Non-current
    1,116.6

     
    0.1

     
    (4.1
    )
     
    1,120.6

    Government securities
     
     
     
     
     
     
     
    Current
    1,723.4

     
    0.1

     
    (1.1
    )
     
    1,724.4

    Non-current
    1,152.5

     
    —

     
    (3.1
    )
     
    1,155.6

    Mortgage and other asset backed securities
     
     
     
     
     
     
     
    Current
    2.8

     
    —

     
    —

     
    2.8

    Non-current
    491.3

     
    0.1

     
    (1.8
    )
     
    493.0

    Total marketable debt securities
    $
    4,880.9

     
    $
    0.3

     
    $
    (10.6
    )
     
    $
    4,891.2

    Marketable equity securities, non-current
    $
    37.5

     
    $
    9.2

     
    $
    —

     
    $
    28.3
    Summary of contractual maturities: available-for-sale securities
    The estimated fair value and amortized cost of our marketable debt securities available-for-sale by contractual maturity are summarized as follows:
     
    As of June 30, 2016
     
    As of December 31, 2015
    (In millions)
    Estimated
    Fair Value
     
    Amortized
    Cost
     
    Estimated
    Fair Value
     
    Amortized
    Cost
    Due in one year or less
    $
    2,434.8

     
    $
    2,434.1

     
    $
    2,120.5

     
    $
    2,122.0

    Due after one year through five years
    3,255.9

     
    3,245.4

     
    2,575.9

     
    2,583.9

    Due after five years
    221.7

     
    221.8

     
    184.5

     
    185.3

    Total available-for-sale securities
    $
    5,912.4

     
    $
    5,901.3

     
    $
    4,880.9

     
    $
    4,891.2
    Proceeds from marketable debt securities
    The proceeds from maturities and sales of marketable debt securities and resulting realized gains and losses are summarized as follows:
     
    For the Three Months
    Ended June 30,
     
    For the Six Months
    Ended June 30,
    (In millions)
    2016
     
    2015
     
    2016
     
    2015
    Proceeds from maturities and sales
    $
    1,642.5

     
    $
    601.9

     
    $
    2,823.6

     
    $
    975.5

    Realized gains
    $
    0.6

     
    $
    0.3

     
    $
    1.0

     
    $
    0.5

    Realized losses
    $
    (1.2
    )
     
    $
    (0.5
    )
     
    $
    (1.6
    )
     
    $
    (0.8
    )
    XML 68 R34.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Derivative Instruments (Tables)
    		 6 Months Ended
    Jun. 30, 2016
    Derivative Instruments and Hedging Activities Disclosure [Abstract]  
    Foreign currency forward contracts that were entered into to hedge forecasted revenue
    The notional value of foreign currency forward contracts that were entered into to hedge forecasted revenues and operating expenses is summarized as follows:
     
    Notional Amount
    Foreign Currency: (In millions)
    As of
    June 30,
    2016
     
    As of
    December 31,
    2015
    Euro
    $
    1,126.5

     
    $
    945.5

    Swiss francs
    43.5

     
    80.8

    Canadian dollar
    39.9

     
    76.7

    Total foreign currency forward contracts
    $
    1,209.9

     
    $
    1,103.0
    Summary of the effect of derivatives designated as hedging instruments on the condensed consolidated statements of income
    The following tables summarize the effect of foreign currency forward contracts designated as hedging instruments on our condensed consolidated statements of income:
    For the Three Months Ended June 30,
    Net Gains/(Losses)
    Reclassified from AOCI into Operating Income
    (Effective Portion)
     
    Net Gains/(Losses)
    Recognized into Net Income
    (Ineffective Portion)
    Location
     
    2016
     
    2015
     
    Location
     
    2016
     
    2015
    Revenue
     
    $
    (4.3
    )
     
    $
    40.4

     
    Other income (expense)
     
    $
    2.1

     
    $
    1.2

    Operating expenses
     
    $
    (0.1
    )
     
    $
    —

     
    Other income (expense)
     
    $
    —

     
    $
    —


    For the Six Months Ended June 30,
    Net Gains/(Losses)
    Reclassified from AOCI into Operating Income
    (Effective Portion)
     
    Net Gains/(Losses)
    Recognized into Net Income
    (Ineffective Portion)
    Location
     
    2016
     
    2015
     
    Location
     
    2016
     
    2015
    Revenue
     
    $
    4.5

     
    $
    75.4

     
    Other income (expense)
     
    $
    4.0

     
    $
    3.4

    Operating expenses
     
    $
    (0.2
    )
     
    $
    —

     
    Other income (expense)
     
    $
    (0.3
    )
     
    $
    —
    Summary of fair value and presentation of derivatives
    The following table summarizes the fair value and presentation in our condensed consolidated balance sheets of our outstanding derivatives including those designated as hedging instruments:
     
     
    Fair Value
    (In millions)
    Balance Sheet Location
    As of June 30, 2016
    Hedging Instruments:
     
     
    Asset derivatives
    Other current assets
    $
    2.0

     
    Investments and other assets
    $
    23.6

    Liability derivatives
    Accrued expenses and other
    $
    14.8

     
    Other long-term liabilities
    $
    —

    Other Derivatives:
     
     
    Asset derivatives
    Other current assets
    $
    4.5

    Liability derivatives
    Accrued expenses and other
    $
    10.0

     
     
     
     
     
    Fair Value
    (In millions)
    Balance Sheet Location
    As of December 31, 2015
    Hedging Instruments:
     
     
    Asset derivatives
    Other current assets
    $
    16.6

     
    Investments and other assets
    $
    0.3

    Liability derivatives
    Accrued expenses and other
    $
    10.2

     
    Other long-term liabilities
    $
    2.5

    Other Derivatives:
     
     
    Asset derivatives
    Other current assets
    $
    10.3

    Liability derivatives
    Accrued expenses and other
    $
    2.0
    XML 69 R35.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Equity (Tables)
    		 6 Months Ended
    Jun. 30, 2016
    Equity [Abstract]  
    Reconciliation of equity attributable to noncontrolling interests
    The following table reconciles equity (deficit) attributable to noncontrolling interests (NCI):
     
    For the Three Months
    Ended June 30,
     
    For the Six Months
    Ended June 30,
    (In millions)
    2016
     
    2015
     
    2016
     
    2015
    NCI, beginning of period
    $
    1.3

     
    $
    2.7

     
    $
    2.1

     
    $
    5.0

    Net income (loss) attributable to NCI, net of tax
    (1.4
    )
     
    (2.5
    )
     
    (3.1
    )
     
    (4.8
    )
    Fair value of net assets and liabilities acquired and assigned to NCI
    —

     
    —

     
    0.9

     
    —

    Translation adjustment and other
    —

     
    0.2

     
    —

     
    0.2

    NCI, end of period
    $
    (0.1
    )
     
    $
    0.4

     
    $
    (0.1
    )
     
    $
    0.4
    XML 70 R36.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Tables)
    		 6 Months Ended
    Jun. 30, 2016
    Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
    Schedule of accumulated other comprehensive income (loss)
    The following table summarizes the changes in accumulated other comprehensive income (loss), net of tax by component:
    (In millions)
    Unrealized Gains (Losses) on Securities Available for Sale
     
    Unrealized Gains (Losses) on Cash Flow Hedges
     
    Unfunded Status of Postretirement Benefit Plans
     
    Translation Adjustments
     
    Total
    Balance, as of December 31, 2015
    $
    (0.8
    )
     
    $
    10.2

     
    $
    (37.8
    )
     
    $
    (195.6
    )
     
    $
    (224.0
    )
    Other comprehensive income (loss) before reclassifications
    6.6

     
    (13.9
    )
     
    0.9

     
    (48.4
    )
     
    (54.8
    )
    Amounts reclassified from accumulated other comprehensive income (loss)
    0.4

     
    (4.4
    )
     
    —

     
    —

     
    (4.0
    )
    Net current period other comprehensive income (loss)
    7.0

     
    (18.3
    )
     
    0.9

     
    (48.4
    )
     
    (58.8
    )
    Balance, as of June 30, 2016
    $
    6.2

     
    $
    (8.1
    )
     
    $
    (36.9
    )
     
    $
    (244.0
    )
     
    $
    (282.8
    )

    (In millions)
    Unrealized Gains (Losses) on Securities Available for Sale
     
    Unrealized Gains (Losses) on Cash Flow Hedges
     
    Unfunded Status of Postretirement Benefit Plans
     
    Translation Adjustments
     
    Total
    Balance, as of December 31, 2014
    $
    (0.4
    )
     
    $
    71.7

     
    $
    (31.6
    )
     
    $
    (99.2
    )
     
    $
    (59.5
    )
    Other comprehensive income (loss) before reclassifications
    0.9

     
    66.1

     
    4.1

     
    (37.8
    )
     
    33.3

    Amounts reclassified from accumulated other comprehensive income (loss)
    0.2

     
    (75.0
    )
     
    —

     
    —

     
    (74.8
    )
    Net current period other comprehensive income (loss)
    1.1

     
    (8.9
    )
     
    4.1

     
    (37.8
    )
     
    (41.5
    )
    Balance, as of June 30, 2015
    $
    0.7

     
    $
    62.8

     
    $
    (27.5
    )
     
    $
    (137.0
    )
     
    $
    (101.0
    )
    Reclassification out of accumulated other comprehensive income
    The following table summarizes the amounts reclassified from accumulated other comprehensive income:
    (In millions)
    Income Statement Location
    Amounts Reclassified from Accumulated Other Comprehensive Income
    For the Three Months
    Ended June 30,
     
    For the Six Months
    Ended June 30,
    2016
     
    2015
     
    2016
     
    2015
    Gains (losses) on securities available for sale
    Other income (expense)
    $
    (0.6
    )
     
    $
    (0.2
    )
     
    $
    (0.6
    )
     
    $
    (0.3
    )
     
    Income tax benefit (expense)
    0.2

     
    0.1

     
    0.2

     
    0.1

     
     
     
     
     
     
     
     
     
    Gains (losses) on cash flow hedges
    Revenues
    (4.3
    )
     
    40.4

     
    4.5

     
    75.4

     
    Operating expenses
    (0.1
    )
     
    —

     
    (0.2
    )
     
    —

     
    Other income (expense)
    —

     
    —

     
    0.1

     
    —

     
    Income tax benefit (expense)
    0.1

     
    (0.2
    )
     
    —

     
    (0.4
    )
     
     
     
     
     
     
     
     
     
    Total reclassifications, net of tax
     
    $
    (4.7
    )
     
    $
    40.1

     
    $
    4.0

     
    $
    74.8
    XML 71 R37.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Earnings per Share (Tables)
    		 6 Months Ended
    Jun. 30, 2016
    Earnings Per Share [Abstract]  
    Basic and diluted earnings per share
    Basic and diluted earnings per share are calculated as follows:
     
    For the Three Months
    Ended June 30,
     
    For the Six Months
    Ended June 30,
    (In millions)
    2016
     
    2015
     
    2016
     
    2015
    Numerator:
     
     
     
     
     
     
     
    Net income attributable to Biogen Inc.
    $
    1,049.8

     
    $
    927.3

     
    $
    2,020.7

     
    $
    1,749.8

    Denominator:
     
     
     
     
     
     
     
    Weighted average number of common shares outstanding
    219.1

     
    235.3

     
    219.0

     
    235.1

    Effect of dilutive securities:
     
     
     
     
     
     
     
    Stock options and employee stock purchase plan
    0.1

     
    0.1

     
    0.1

     
    0.1

    Time-vested restricted stock units
    0.1

     
    0.2

     
    0.1

     
    0.3

    Market stock units
    0.1

     
    0.1

     
    0.1

     
    0.2

    Dilutive potential common shares
    0.3

     
    0.4

     
    0.3

     
    0.6

    Shares used in calculating diluted earnings per share
    219.4

     
    235.7

     
    219.3

     
    235.7
    XML 72 R38.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Share-Based Payments (Tables)
    		 6 Months Ended
    Jun. 30, 2016
    Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
    Share-based compensation expense included in condensed consolidated statements of income
    The following table summarizes share-based compensation expense included in our condensed consolidated statements of income:
     
    For the Three Months
    Ended June 30,
     
    For the Six Months
    Ended June 30,
    (In millions)
    2016
     
    2015
     
    2016
     
    2015
    Research and development
    $
    21.5

     
    $
    22.1

     
    $
    42.9

     
    $
    57.5

    Selling, general and administrative
    28.7

     
    26.2

     
    63.4

     
    81.8

    Restructuring charges
    —

     
    —

     
    (1.8
    )
     
    —

    Subtotal
    50.2

     
    48.3

     
    104.5

     
    139.3

    Capitalized share-based compensation costs
    (4.4
    )
     
    (2.2
    )
     
    (7.5
    )
     
    (5.6
    )
    Share-based compensation expense included in total cost and expenses
    45.8

     
    46.1

     
    97.0

     
    133.7

    Income tax effect
    (12.7
    )
     
    (12.9
    )
     
    (27.9
    )
     
    (39.6
    )
    Share-based compensation expense included in net income attributable to Biogen Inc.
    $
    33.1

     
    $
    33.2

     
    $
    69.1

     
    $
    94.1
    Summary of share-based compensation expense associated with each of our share-based compensating programs
    The following table summarizes share-based compensation expense associated with each of our share-based compensation programs:
     
    For the Three Months
    Ended June 30,
     
    For the Six Months
    Ended June 30,
    (In millions)
    2016
     
    2015
     
    2016
     
    2015
    Market stock units
    $
    7.9

     
    $
    9.1

     
    $
    21.3

     
    26.1

    Time-vested restricted stock units
    33.9

     
    31.8

     
    64.0

     
    63.7

    Cash settled performance units
    4.6

     
    3.2

     
    4.8

     
    27.0

    Performance units
    1.3

     
    1.2

     
    8.2

     
    14.4

    Employee stock purchase plan
    2.5

     
    3.0

     
    6.2

     
    8.1

    Subtotal
    50.2

     
    48.3

     
    104.5

     
    139.3

    Capitalized share-based compensation costs
    (4.4
    )
     
    (2.2
    )
     
    (7.5
    )
     
    (5.6
    )
    Share-based compensation expense included in total cost and expenses
    $
    45.8

     
    $
    46.1

     
    $
    97.0

     
    $
    133.7
    Summary of equity grants to employees, officers and directors under our current stock plans
    The following table summarizes our equity grants to employees, officers and directors under our current stock plans:
     
    For the Six Months
    Ended June 30,
     
    2016
     
    2015
    Market stock units
    166,000

     
    179,000

    Cash settled performance shares
    86,000

     
    115,000

    Performance units
    56,000

     
    89,000

    Time-vested restricted stock units
    594,000

     
    375,000
    XML 73 R39.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Income Taxes (Tables)
    		 6 Months Ended
    Jun. 30, 2016
    Income Tax Disclosure [Abstract]  
    Reconciliation between the U.S. federal statutory tax rate and effective tax rate
    A reconciliation between the U.S. federal statutory tax rate and our effective tax rate is summarized as follows:
     
    For the Three Months
    Ended June 30,
     
    For the Six Months
    Ended June 30,
     
    2016
     
    2015
     
    2016
     
    2015
    Statutory rate
    35.0
     %
     
    35.0
     %
     
    35.0
     %
     
    35.0
     %
    State taxes
    1.0

     
    0.4

     
    1.0

     
    —

    Taxes on foreign earnings
    (10.0
    )
     
    (11.1
    )
     
    (9.0
    )
     
    (9.8
    )
    Credits and net operating loss utilization
    (1.2
    )
     
    (0.7
    )
     
    (1.2
    )
     
    (0.7
    )
    Purchased intangible assets
    1.1

     
    1.1

     
    1.1

     
    1.0

    Manufacturing deduction
    (1.6
    )
     
    (2.1
    )
     
    (1.7
    )
     
    (1.8
    )
    Other permanent items
    0.6

     
    0.9

     
    0.6

     
    0.7

    Other
    0.3

     
    0.4

     
    0.2

     
    0.3

    Effective tax rate
    25.2
     %
     
    23.9
     %
     
    26.0
     %
     
    24.7
     %
    XML 74 R40.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Other Consolidated Financial Statement Detail (Tables)
    		 6 Months Ended
    Jun. 30, 2016
    Organization, Consolidation and Presentation of Financial Statements [Abstract]  
    Other income (expense), net
    Components of other income (expense), net, are summarized as follows:
     
    For the Three Months
    Ended June 30,
     
    For the Six Months
    Ended June 30,
    (In millions)
    2016
     
    2015
     
    2016
     
    2015
    Interest income
    $
    15.4

     
    $
    4.3

     
    $
    26.6

     
    $
    7.6

    Interest expense
    (65.9
    )
     
    (5.8
    )
     
    (129.2
    )
     
    (12.5
    )
    Gain (loss) on investments, net
    (2.7
    )
     
    0.3

     
    (1.1
    )
     
    (1.4
    )
    Foreign exchange gains (losses), net
    0.2

     
    (1.5
    )
     
    2.3

     
    (14.5
    )
    Other, net
    (5.5
    )
     
    (8.2
    )
     
    (9.9
    )
     
    (5.1
    )
    Total other income (expense), net
    $
    (58.5
    )
     
    $
    (10.9
    )
     
    $
    (111.3
    )
     
    $
    (25.9
    )
    Accrued expenses and other
    Accrued expenses and other consists of the following:
    (In millions)
    As of
    June 30,
    2016
     
    As of
    December 31,
    2015
    Current portion of contingent consideration obligations and milestones
    $
    556.7

     
    $
    504.7

    Revenue-related reserves for discounts and allowances
    490.5

     
    518.1

    Employee compensation and benefits
    228.4

     
    270.8

    Royalties and licensing fees
    183.7

     
    167.9

    Other
    613.4

     
    635.3

    Total accrued expenses and other
    $
    2,072.7

     
    $
    2,096.8
    XML 75 R41.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Collaborative and Other Relationships Collaborative and Other Relationships (Tables)
    		 6 Months Ended
    Jun. 30, 2016
    Organization, Consolidation and Presentation of Financial Statements [Abstract]  
    Cash reimbursement as an adjustment to the Base Rate
    We expect to recognize the effect of the cash reimbursement as an adjustment to the Base Rate in the table below over a ten year period, consistent with the initial patent term of the products. Under the collaboration agreement, cash payments are as follows:
     
     
     
    Rates post Sobi Opt-In(3)
    Royalty and Net Revenue Share Rates:
    Method
     
    Base Rate following
    1st commercial sale in
    the Sobi Territory:
     
    Rate during the
    Reimbursement
    Period:
    Sobi rate to Biogen on net sales in the Sobi Territory
    Royalty
     
    12%
     
    Base Rate
    plus 5%
    Biogen rate to Sobi on net sales in the Biogen North America Territory
    Royalty
     
    12%
     
    Base Rate
    less 5%
    Biogen rate to Sobi on net sales in the Biogen Direct Territory
    Royalty
     
    17%
     
    Base Rate
    less 5%
    Biogen rate to Sobi on net revenue(1) 
    from the Biogen Distributor Territory(2)
    Net
    Revenue
    Share
     
    50%
     
    Base Rate
    less 15%
    XML 76 R42.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Details)
    		 6 Months Ended
    Jun. 30, 2016
    segment
    Accounting Policies [Abstract]  
    Number of reportable segments 1
    Interest in subsidiary (less than given percentage) 100.00%
    XML 77 R43.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Restructuring Restructuring (Details) - USD ($)
    $ in Millions
    		 3 Months Ended 6 Months Ended
    Dec. 31, 2015
    Jun. 30, 2016
    Restructuring Cost and Reserve [Line Items]    
    Restructuring reserve as of December 31, 2015   $ 37.3
    Expense   10.3
    Payments   (34.7)
    Adjustments to previous estimates, net   (0.6)
    Restructuring reserve as of June 30, 2016 $ 37.3 12.3
    Workforce reduction    
    Restructuring Cost and Reserve [Line Items]    
    Restructuring reserve as of December 31, 2015   33.7
    Expense   4.9
    Payments   (28.7)
    Adjustments to previous estimates, net 15.9 (3.5)
    Restructuring reserve as of June 30, 2016 33.7 6.4
    Pipeline programs    
    Restructuring Cost and Reserve [Line Items]    
    Restructuring reserve as of December 31, 2015   3.6
    Expense   5.4
    Payments   (6.0)
    Adjustments to previous estimates, net   2.9
    Restructuring reserve as of June 30, 2016 $ 3.6 $ 5.9
    XML 78 R44.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Restructuring Restructuring (Details Textual) - USD ($)
    $ in Millions
    		 3 Months Ended 6 Months Ended
    Jun. 30, 2016
    Dec. 31, 2015
    Jun. 30, 2015
    Jun. 30, 2016
    Jun. 30, 2015
    Restructuring Cost and Reserve [Line Items]          
    Expected cash payments $ 120.0     $ 120.0  
    Adjustments to previous estimates, net       (0.6)  
    Expected restructuring charges 105.0     105.0  
    Restructuring charges $ 0.0 $ 93.4 $ 0.0 9.7 $ 0.0
    Workforce reduction          
    Restructuring Cost and Reserve [Line Items]          
    Restructuring and related cost, expected percentage of positions eliminated   11.00%      
    Adjustments to previous estimates, net   $ 15.9   $ (3.5)  
    XML 79 R45.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Reserves for Discounts and Allowances (Details)
    $ in Millions
    		 6 Months Ended
    Jun. 30, 2016
    USD ($)
    Analysis of the amount of, and change in, reserves  
    Balance as of December 31, 2015 $ 662.7
    Current provisions relating to sales in current year 1,258.2
    Adjustments relating to prior years (6.3)
    Payments/credits relating to sales in current year (816.0)
    Payments/credits relating to sales in prior years (446.8)
    Balance as of June 30, 2016 651.8
    Discounts  
    Analysis of the amount of, and change in, reserves  
    Balance as of December 31, 2015 56.1
    Current provisions relating to sales in current year 266.8
    Adjustments relating to prior years (2.4)
    Payments/credits relating to sales in current year (210.2)
    Payments/credits relating to sales in prior years (51.5)
    Balance as of June 30, 2016 58.8
    Contractual Adjustments  
    Analysis of the amount of, and change in, reserves  
    Balance as of December 31, 2015 548.7
    Current provisions relating to sales in current year 973.8
    Adjustments relating to prior years 1.6
    Payments/credits relating to sales in current year (605.1)
    Payments/credits relating to sales in prior years (384.9)
    Balance as of June 30, 2016 534.1
    Returns  
    Analysis of the amount of, and change in, reserves  
    Balance as of December 31, 2015 57.9
    Current provisions relating to sales in current year 17.6
    Adjustments relating to prior years (5.5)
    Payments/credits relating to sales in current year (0.7)
    Payments/credits relating to sales in prior years (10.4)
    Balance as of June 30, 2016 $ 58.9
    XML 80 R46.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Reserves for Discounts and Allowances (Details 1) - USD ($)
    $ in Millions
    Jun. 30, 2016
    Dec. 31, 2015
    Summary of total product revenue reserves included in consolidated balance sheets    
    Total reserves $ 651.8 $ 662.7
    Reduction of accounts receivable    
    Summary of total product revenue reserves included in consolidated balance sheets    
    Total reserves 161.3 144.6
    Component of accrued expenses and other    
    Summary of total product revenue reserves included in consolidated balance sheets    
    Total reserves $ 490.5 $ 518.1
    XML 81 R47.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Inventory (Details) - USD ($)
    $ in Millions
    Jun. 30, 2016
    Dec. 31, 2015
    Components of inventories    
    Raw materials $ 235.0 $ 213.0
    Work in process 654.6 577.6
    Finished goods 139.1 143.0
    Total inventory 1,028.7 933.6
    Inventory, current 996.4 893.4
    Inventory, Noncurrent $ 32.3 $ 40.2
    XML 82 R48.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Inventory Inventory (Details Textual)
    $ in Millions
    Dec. 31, 2015
    USD ($)
    ZINBRYTA  
    Inventory [Line Items]  
    Pre-approval inventory $ 24.7
    FLIXABI  
    Inventory [Line Items]  
    Pre-approval inventory 24.2
    BENEPALI  
    Inventory [Line Items]  
    Pre-approval inventory $ 18.4
    XML 83 R49.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Intangible Assets and Goodwill (Details) - USD ($)
    $ in Millions
    		 3 Months Ended 6 Months Ended
    Jun. 30, 2016
    Jun. 30, 2015
    Jun. 30, 2016
    Jun. 30, 2015
    Dec. 31, 2015
    Intangible assets          
    Total intangible assets, gross $ 7,710.3   $ 7,710.3   $ 7,646.3
    Accumulated Amortization (3,742.7)   (3,742.7)   (3,561.2)
    Intangible assets, net 3,967.6   3,967.6   4,085.1
    Intangible Assets and Goodwill (Textual) [Abstract]          
    Amortization of acquired intangible assets 92.9 $ 92.0 181.7 $ 187.9  
    Accumulated impairment losses related to goodwill 0.0   0.0    
    Expected future amortization expense, 2016 (remaining six months) 181.6   181.6    
    Expected future amortization expense, 2017 325.1   325.1    
    Expected future amortization expense, 2018 298.2   298.2    
    Expected future amortization expense, 2019 282.7   282.7    
    Expected future amortization expense, 2020 277.1   277.1    
    Expected future amortization expense, 2021 265.0   265.0    
    Out-licensed patents          
    Intangible assets          
    Cost 543.3   543.3   543.3
    Accumulated Amortization (514.9)   (514.9)   (506.0)
    Net 28.4   $ 28.4   37.3
    Out-licensed patents | Minimum          
    Intangible assets          
    Estimated life, (in years)     13 years    
    Out-licensed patents | Maximum          
    Intangible assets          
    Estimated life, (in years)     23 years    
    Developed technology          
    Intangible assets          
    Cost 3,005.3   $ 3,005.3   3,005.3
    Accumulated Amortization (2,604.5)   (2,604.5)   (2,552.9)
    Net 400.8   $ 400.8   452.4
    Developed technology | Minimum          
    Intangible assets          
    Estimated life, (in years)     15 years    
    Developed technology | Maximum          
    Intangible assets          
    Estimated life, (in years)     23 years    
    Developed technology | AVONEX          
    Intangible assets          
    Net 392.8   $ 392.8    
    Acquired and in-licensed rights and patents          
    Intangible assets          
    Cost 3,405.4   3,405.4   3,303.2
    Accumulated Amortization (623.3)   (623.3)   (502.3)
    Net 2,782.1   $ 2,782.1   2,800.9
    Acquired and in-licensed rights and patents | Minimum          
    Intangible assets          
    Estimated life, (in years)     6 years    
    Acquired and in-licensed rights and patents | Maximum          
    Intangible assets          
    Estimated life, (in years)     18 years    
    Acquired and in-licensed rights and patents | Biosimilars          
    Intangible assets          
    Increase in acquired and in-licensed rights and patents 25.0   $ 50.0    
    Acquired and in-licensed rights and patents | ZINBRYTA          
    Intangible assets          
    Increase in acquired and in-licensed rights and patents     20.0    
    Acquired and in-licensed rights and patents | ALPROLIX          
    Intangible assets          
    Increase in acquired and in-licensed rights and patents     26.5    
    Contingent payment made during the period     20.0    
    Deferred tax liability 6.5   $ 6.5    
    In-process research and development          
    Intangible assets          
    Indefinite lived intangible assets useful life     Indefinite until commercialization    
    Cost and Net 692.3   $ 692.3   730.5
    Accumulated Amortization 0.0   $ 0.0   0.0
    Trademarks and trade names          
    Intangible assets          
    Indefinite lived intangible assets useful life     Indefinite    
    Cost and Net 64.0   $ 64.0   64.0
    Accumulated Amortization 0.0   0.0   $ 0.0
    TYSABRI product | Acquired and in-licensed rights and patents          
    Intangible assets          
    Net $ 2,633.4   $ 2,633.4    
    XML 84 R50.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Intangible Assets and Goodwill (Details 1) - USD ($)
    $ in Millions
    		 3 Months Ended 6 Months Ended
    Jun. 30, 2016
    Jun. 30, 2015
    Jun. 30, 2016
    Jun. 30, 2015
    Goodwill [Line Items]        
    Income tax benefit (expense) $ 353.6 $ 292.5 $ 710.0 $ 574.4
    Increase to goodwill     515.0  
    Summary of roll forward of the changes in goodwill        
    Goodwill, beginning of period     2,663.8  
    Other     (11.7)  
    Goodwill, end of period $ 3,167.1   3,167.1  
    TECFIDERA | Fumapharm AG        
    Goodwill [Line Items]        
    Income tax benefit (expense)     85.0  
    Increase to goodwill     $ 600.0  
    XML 85 R51.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Fair Value Measurements (Details) - USD ($)
    $ in Millions
    Jun. 30, 2016
    Mar. 31, 2016
    Dec. 31, 2015
    Jun. 30, 2015
    Mar. 31, 2015
    Dec. 31, 2014
    Assets:            
    Marketable debt securities $ 5,912.4   $ 4,880.9      
    Fair Value, Measurements, Recurring            
    Assets:            
    Cash equivalents 874.6   909.5      
    Marketable equity securities 32.4   37.5      
    Derivative contracts 30.1   27.2      
    Plan assets for deferred compensation 35.6   40.1      
    Total 6,885.1   5,895.2      
    Liabilities:            
    Derivative contracts 24.8   14.7      
    Contingent consideration obligations 515.7 $ 508.3 506.0 $ 495.6 $ 461.8 $ 215.5
    Total 540.5   520.7      
    Fair Value, Measurements, Recurring | Corporate debt securities            
    Assets:            
    Marketable debt securities 2,290.3   1,510.9      
    Fair Value, Measurements, Recurring | Government securities            
    Assets:            
    Marketable debt securities 2,973.4   2,875.9      
    Fair Value, Measurements, Recurring | Mortgage and other asset backed securities            
    Assets:            
    Marketable debt securities 648.7   494.1      
    Quoted Prices in Active Markets, Level 1 | Fair Value, Measurements, Recurring            
    Assets:            
    Cash equivalents 0.0   0.0      
    Marketable equity securities 32.4   37.5      
    Derivative contracts 0.0   0.0      
    Plan assets for deferred compensation 0.0   0.0      
    Total 32.4   37.5      
    Liabilities:            
    Derivative contracts 0.0   0.0      
    Contingent consideration obligations 0.0   0.0      
    Total 0.0   0.0      
    Quoted Prices in Active Markets, Level 1 | Fair Value, Measurements, Recurring | Corporate debt securities            
    Assets:            
    Marketable debt securities 0.0   0.0      
    Quoted Prices in Active Markets, Level 1 | Fair Value, Measurements, Recurring | Government securities            
    Assets:            
    Marketable debt securities 0.0   0.0      
    Quoted Prices in Active Markets, Level 1 | Fair Value, Measurements, Recurring | Mortgage and other asset backed securities            
    Assets:            
    Marketable debt securities 0.0   0.0      
    Significant Other Observable Inputs (Level 2) | Fair Value, Measurements, Recurring            
    Assets:            
    Cash equivalents 874.6   909.5      
    Marketable equity securities 0.0   0.0      
    Derivative contracts 30.1   27.2      
    Plan assets for deferred compensation 35.6   40.1      
    Total 6,852.7   5,857.7      
    Liabilities:            
    Derivative contracts 24.8   14.7      
    Contingent consideration obligations 0.0   0.0      
    Total 24.8   14.7      
    Significant Other Observable Inputs (Level 2) | Fair Value, Measurements, Recurring | Corporate debt securities            
    Assets:            
    Marketable debt securities 2,290.3   1,510.9      
    Significant Other Observable Inputs (Level 2) | Fair Value, Measurements, Recurring | Government securities            
    Assets:            
    Marketable debt securities 2,973.4   2,875.9      
    Significant Other Observable Inputs (Level 2) | Fair Value, Measurements, Recurring | Mortgage and other asset backed securities            
    Assets:            
    Marketable debt securities 648.7   494.1      
    Significant Unobservable Inputs (Level 3) | Fair Value, Measurements, Recurring            
    Assets:            
    Cash equivalents 0.0   0.0      
    Marketable equity securities 0.0   0.0      
    Derivative contracts 0.0   0.0      
    Plan assets for deferred compensation 0.0   0.0      
    Total 0.0   0.0      
    Liabilities:            
    Derivative contracts 0.0   0.0      
    Contingent consideration obligations 515.7   506.0      
    Total 515.7   506.0      
    Significant Unobservable Inputs (Level 3) | Fair Value, Measurements, Recurring | Corporate debt securities            
    Assets:            
    Marketable debt securities 0.0   0.0      
    Significant Unobservable Inputs (Level 3) | Fair Value, Measurements, Recurring | Government securities            
    Assets:            
    Marketable debt securities 0.0   0.0      
    Significant Unobservable Inputs (Level 3) | Fair Value, Measurements, Recurring | Mortgage and other asset backed securities            
    Assets:            
    Marketable debt securities $ 0.0   $ 0.0      
    XML 86 R52.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Fair Value Measurements (Details 1) - USD ($)
    $ in Millions
    Jun. 30, 2016
    Dec. 31, 2015
    Debt Instrument [Line Items]    
    Notes payable, carrying value $ 6,524.0 $ 6,506.5
    Debt instruments, fair value 7,110.9 6,645.9
    Notes Payable to Fumedica    
    Debt Instrument [Line Items]    
    Notes payable, fair value 6.4 9.4
    Notes payable, carrying value 6.1 9.0
    6.875% Senior Notes due 2018    
    Debt Instrument [Line Items]    
    Notes payable, fair value 598.2 602.6
    Notes payable, carrying value 561.9 565.3
    2.900% Senior Notes due 2020    
    Debt Instrument [Line Items]    
    Notes payable, fair value 1,561.7 1,497.5
    Notes payable, carrying value 1,507.9 1,485.5
    3.625% Senior Notes due 2022    
    Debt Instrument [Line Items]    
    Notes payable, fair value 1,061.0 1,014.2
    Notes payable, carrying value 992.7 992.2
    4.050% Senior Notes due 2025    
    Debt Instrument [Line Items]    
    Notes payable, fair value 1,887.3 1,764.6
    Notes payable, carrying value 1,734.1 1,733.4
    5.200% Senior Notes due 2045    
    Debt Instrument [Line Items]    
    Notes payable, fair value 1,996.3 1,757.6
    Notes payable, carrying value $ 1,721.3 $ 1,721.1
    XML 87 R53.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Fair Value Measurements (Details 2) - USD ($)
    $ in Millions
    		 3 Months Ended 6 Months Ended
    Jun. 30, 2016
    Jun. 30, 2015
    Jun. 30, 2016
    Jun. 30, 2015
    Business Acquisition, Contingent Consideration [Line Items]        
    Additions $ 0.0 $ 36.0 $ 0.0 $ 274.5
    Changes in fair value 10.6 (2.2) 12.9 5.6
    Payments (3.2) 0.0 (3.2) 0.0
    Fair Value, Measurements, Recurring        
    Business Acquisition, Contingent Consideration [Line Items]        
    Fair value, beginning of period 508.3 461.8 506.0 215.5
    Fair value, end of period $ 515.7 $ 495.6 $ 515.7 $ 495.6
    XML 88 R54.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Fair Value Measurements (Details Textual) - USD ($)
    $ in Millions
    		 6 Months Ended
    Jun. 30, 2016
    Dec. 31, 2015
    Business Acquisition, Contingent Consideration [Line Items]    
    Asset impairment charges $ 0.0  
    Changes in valuation techniques 0  
    Contingent consideration obligations $ 304.0 $ 301.3
    6.875% Senior Notes due 2018    
    Business Acquisition, Contingent Consideration [Line Items]    
    Senior Notes interest rate 6.875%  
    2.900% Senior Notes due 2020    
    Business Acquisition, Contingent Consideration [Line Items]    
    Senior Notes interest rate 2.90%  
    3.625% Senior Notes due 2022    
    Business Acquisition, Contingent Consideration [Line Items]    
    Senior Notes interest rate 3.625%  
    4.050% Senior Notes due 2025    
    Business Acquisition, Contingent Consideration [Line Items]    
    Senior Notes interest rate 4.05%  
    5.200% Senior Notes due 2045    
    Business Acquisition, Contingent Consideration [Line Items]    
    Senior Notes interest rate 5.20%  
    XML 89 R55.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Financial Instruments (Details) - USD ($)
    $ in Millions
    Jun. 30, 2016
    Dec. 31, 2015
    Summary of financial assets with original maturities of less than 90 days included within cash and cash equivalents    
    Cash equivalents $ 874.6 $ 909.5
    Commercial paper    
    Summary of financial assets with original maturities of less than 90 days included within cash and cash equivalents    
    Cash equivalents 56.9 21.9
    Overnight reverse repurchase agreements    
    Summary of financial assets with original maturities of less than 90 days included within cash and cash equivalents    
    Cash equivalents 66.3 134.7
    Money market funds    
    Summary of financial assets with original maturities of less than 90 days included within cash and cash equivalents    
    Cash equivalents 531.5 673.8
    Short-term debt securities    
    Summary of financial assets with original maturities of less than 90 days included within cash and cash equivalents    
    Cash equivalents $ 219.9 $ 79.1
    XML 90 R56.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Financial Instruments (Details 1) - USD ($)
    $ in Millions
    Jun. 30, 2016
    Dec. 31, 2015
    Marketable Debt and Equity Securities    
    Fair Value $ 5,912.4 $ 4,880.9
    Gross Unrealized Gains 13.2 0.3
    Gross Unrealized Losses (2.1) (10.6)
    Amortized Cost 5,901.3 4,891.2
    Corporate debt securities Current    
    Marketable Debt and Equity Securities    
    Fair Value 913.4 394.3
    Gross Unrealized Gains 0.3 0.0
    Gross Unrealized Losses (0.2) (0.5)
    Amortized Cost 913.3 394.8
    Corporate debt securities Non-current    
    Marketable Debt and Equity Securities    
    Fair Value 1,376.9 1,116.6
    Gross Unrealized Gains 7.8 0.1
    Gross Unrealized Losses (0.4) (4.1)
    Amortized Cost 1,369.5 1,120.6
    Government securities Current    
    Marketable Debt and Equity Securities    
    Fair Value 1,521.3 1,723.4
    Gross Unrealized Gains 0.6 0.1
    Gross Unrealized Losses 0.0 (1.1)
    Amortized Cost 1,520.7 1,724.4
    Government securities Non-current    
    Marketable Debt and Equity Securities    
    Fair Value 1,452.1 1,152.5
    Gross Unrealized Gains 3.1 0.0
    Gross Unrealized Losses (0.6) (3.1)
    Amortized Cost 1,449.6 1,155.6
    Mortgage and other asset backed securities Current    
    Marketable Debt and Equity Securities    
    Fair Value 0.1 2.8
    Gross Unrealized Gains 0.0 0.0
    Gross Unrealized Losses 0.0 0.0
    Amortized Cost 0.1 2.8
    Mortgage and other asset backed securities Non-current    
    Marketable Debt and Equity Securities    
    Fair Value 648.6 491.3
    Gross Unrealized Gains 1.4 0.1
    Gross Unrealized Losses (0.9) (1.8)
    Amortized Cost 648.1 493.0
    Marketable equity securities    
    Marketable Debt and Equity Securities    
    Fair Value 32.4 37.5
    Gross Unrealized Gains 0.9 9.2
    Gross Unrealized Losses (2.1) 0.0
    Amortized Cost $ 33.6 $ 28.3
    XML 91 R57.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Financial Instruments (Details 2) - USD ($)
    $ in Millions
    Jun. 30, 2016
    Dec. 31, 2015
    Summary of Contractual Maturities: Available-for-Sale Securities    
    Due in one year or less, estimated fair value $ 2,434.8 $ 2,120.5
    Due in one year or less, amortized cost 2,434.1 2,122.0
    Due after one year through five years, Estimated Fair Value 3,255.9 2,575.9
    Due after one year through five years, Amortized Cost 3,245.4 2,583.9
    Due after five years, estimated fair value 221.7 184.5
    Due after five years, amortized cost 221.8 185.3
    Total available-for-sale securities, Fair Value 5,912.4 4,880.9
    Total available-for-sale securities, Amortized Cost $ 5,901.3 $ 4,891.2
    XML 92 R58.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Financial Instruments (Details 3) - USD ($)
    $ in Millions
    		 3 Months Ended 6 Months Ended
    Jun. 30, 2016
    Jun. 30, 2015
    Jun. 30, 2016
    Jun. 30, 2015
    Investments, Debt and Equity Securities [Abstract]        
    Proceeds from maturities and sales $ 1,642.5 $ 601.9 $ 2,823.6 $ 975.5
    Realized gains 0.6 0.3 1.0 0.5
    Realized losses $ (1.2) $ (0.5) $ (1.6) $ (0.8)
    XML 93 R59.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Financial Instruments (Details Textual)
    		 6 Months Ended 12 Months Ended
    Jun. 30, 2016
    Dec. 31, 2015
    Investments, Debt and Equity Securities [Abstract]    
    Overnight reverse repurchase agreements, percent of total assets 0.30% 0.70%
    Average maturity of marketable securities, months 13 months 16 months
    XML 94 R60.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Financial Instruments Financial Instruments (Details Textual 2) - USD ($)
    $ in Millions
    Jun. 30, 2016
    Dec. 31, 2015
    Strategic Investments    
    Business Acquisition [Line Items]    
    Strategic investment portfolio $ 98.3 $ 96.0
    XML 95 R61.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Derivative Instruments (Details) - USD ($)
    $ in Millions
    		 3 Months Ended 6 Months Ended 12 Months Ended
    Jun. 30, 2016
    Jun. 30, 2015
    Jun. 30, 2016
    Jun. 30, 2015
    Dec. 31, 2015
    Derivative Instruments (Textual) [Abstract]          
    Gain/Loss on fair value of foreign currency forward contracts $ 16.4   $ 16.4   $ 1.8
    Expected settlement time for contracts, in months     18 months    
    Net gains (losses) of other income (expense) related to foreign currency forward contracts 18.6 $ 13.6 $ 16.2 $ 3.9  
    Minimum          
    Derivative Instruments (Textual) [Abstract]          
    Range of durations of foreign currency forward contracts     1 month   1 month
    Maximum          
    Derivative Instruments (Textual) [Abstract]          
    Range of durations of foreign currency forward contracts     18 months   18 months
    Not designated as hedging instrument          
    Derivative Instruments (Textual) [Abstract]          
    Aggregate notional amount 557.2   $ 557.2   $ 721.0
    Other current assets | Designated as hedging instrument          
    Summary of Derivatives designated as Hedging Instruments          
    Derivative asset, fair value, net 2.0   2.0   16.6
    Investments and other assets | Designated as hedging instrument          
    Summary of Derivatives designated as Hedging Instruments          
    Derivative asset, fair value, net 23.6   23.6   0.3
    Accrued expenses and other | Designated as hedging instrument          
    Summary of Derivatives designated as Hedging Instruments          
    Derivative liability, fair value, net 14.8   14.8   10.2
    Other long-term liabilities | Designated as hedging instrument          
    Summary of Derivatives designated as Hedging Instruments          
    Derivative liability, fair value, net 0.0   0.0   2.5
    Foreign exchange contract | Designated as hedging instrument          
    Derivative Instruments (Textual) [Abstract]          
    Aggregate notional amount 1,209.9   1,209.9   1,103.0
    Foreign exchange contract | Other current assets | Not designated as hedging instrument          
    Summary of Derivatives designated as Hedging Instruments          
    Derivative asset, fair value, net 4.5   4.5   10.3
    Foreign exchange contract | Accrued expenses and other | Not designated as hedging instrument          
    Summary of Derivatives designated as Hedging Instruments          
    Derivative liability, fair value, net 10.0   10.0   2.0
    Interest rate swap | Designated as hedging instrument          
    Derivative Instruments (Textual) [Abstract]          
    Aggregate notional amount 675.0   675.0    
    Revenue | Foreign exchange contract          
    Derivative Instruments (Textual) [Abstract]          
    Net gains (losses) in product revenue for the settlement of certain effective cash flow hedge instruments (4.3) 40.4 4.5 75.4  
    Operating expense | Foreign exchange contract          
    Derivative Instruments (Textual) [Abstract]          
    Net gains (losses) in product revenue for the settlement of certain effective cash flow hedge instruments (0.1) 0.0 (0.2) 0.0  
    Other income (expense) | Cash flows, revenue | Foreign exchange contract          
    Derivative Instruments (Textual) [Abstract]          
    Net gains (losses) in earnings of Foreign currency forward contracts due to hedge ineffectiveness 2.1 1.2 4.0 3.4  
    Other income (expense) | Cash flows, operating expenses | Foreign exchange contract          
    Derivative Instruments (Textual) [Abstract]          
    Net gains (losses) in earnings of Foreign currency forward contracts due to hedge ineffectiveness 0.0 $ 0.0 (0.3) $ 0.0  
    Euro | Foreign exchange contract | Designated as hedging instrument          
    Derivative Instruments (Textual) [Abstract]          
    Aggregate notional amount 1,126.5   1,126.5   945.5
    Swiss francs | Foreign exchange contract | Designated as hedging instrument          
    Derivative Instruments (Textual) [Abstract]          
    Aggregate notional amount 43.5   43.5   80.8
    Canadian Dollar | Foreign exchange contract | Designated as hedging instrument          
    Derivative Instruments (Textual) [Abstract]          
    Aggregate notional amount $ 39.9   $ 39.9   $ 76.7
    2.900% Senior Notes due 2020          
    Derivative Instruments (Textual) [Abstract]          
    Senior Notes interest rate 2.90%   2.90%    
    XML 96 R62.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Property, Plant and Equipment Property, Plant and Equipment (Details)
    SFr in Millions, $ in Millions
    		 3 Months Ended
    Jun. 30, 2016
    USD ($)
    Dec. 31, 2015
    CHF (SFr)
    Dec. 31, 2015
    USD ($)
    Property, Plant and Equipment [Line Items]      
    Accumulated depreciation $ 1,471.0   $ 1,330.1
    Property, plant and equipment, net 2,301.8   2,187.6
    Solothurn, Switzerland      
    Property, Plant and Equipment [Line Items]      
    Construction in progress 247.8   99.0
    Solothurn, Switzerland | Land      
    Property, Plant and Equipment [Line Items]      
    Land purchase   SFr 64.4 $ 62.5
    Cambridge, MA      
    Property, Plant and Equipment [Line Items]      
    Property, plant and equipment, net 43.0    
    Remaining lease obligation 26.3    
    Accelerated depreciation $ 15.8    
    XML 97 R63.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Equity (Details) - USD ($)
    $ in Millions
    		 3 Months Ended 6 Months Ended
    Jun. 30, 2016
    Jun. 30, 2015
    Jun. 30, 2016
    Jun. 30, 2015
    Reconciliation of equity attributable to non-controlling interests        
    NCI, beginning of period $ 1.3 $ 2.7 $ 2.1 $ 5.0
    Net income (loss) attributable to NCI, net of tax (1.4) (2.5) (3.1) (4.8)
    Fair value of net assets and liabilities acquired and assigned to NCI 0.0 0.0 0.9 0.0
    Translation adjustment and other 0.0 (0.2) 0.0 (0.2)
    NCI, end of period $ (0.1) $ 0.4 $ (0.1) $ 0.4
    XML 98 R64.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Equity (Details Textual) - USD ($)
    shares in Millions, $ in Millions
    		 3 Months Ended 6 Months Ended
    Jun. 30, 2016
    Jun. 30, 2015
    Jun. 30, 2016
    Jun. 30, 2015
    Jul. 18, 2016
    May 31, 2015
    Subsequent Event [Line Items]            
    Authorized amount of share repurchases under the 2015 Share Repurchase Program           $ 5,000.0
    Equity increase during the period     $ 2,028.8      
    Net income attributable to Biogen Inc. $ 1,049.8 $ 927.3 $ 2,020.7 $ 1,749.8    
    Common stock shares authorized for repurchased 1.3   1.3      
    Repurchase of common stock, shares       0.1    
    Purchase of treasury stock     $ 0.0 $ 42.2    
    Subsequent event            
    Subsequent Event [Line Items]            
    Authorized amount of share repurchases under the 2015 Share Repurchase Program         $ 5,000.0  
    XML 99 R65.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
    $ in Millions
    		 3 Months Ended 6 Months Ended
    Jun. 30, 2016
    Jun. 30, 2015
    Jun. 30, 2016
    Jun. 30, 2015
    Accumulated other comprehensive income [Line Items]        
    Balance, as of the beginning of the period     $ (224.0) $ (59.5)
    Other comprehensive income loss before reclassifications     (54.8) 33.3
    Amounts reclassified from accumulated other comprehensive income loss     (4.0) (74.8)
    Net current period other comprehensive income loss $ (23.5) $ (30.5) (58.8) (41.5)
    Balance, as of the end of the period (282.8) (101.0) (282.8) (101.0)
    Accumulated Net Unrealized Investment Gain (Loss)        
    Accumulated other comprehensive income [Line Items]        
    Balance, as of the beginning of the period     (0.8) (0.4)
    Other comprehensive income loss before reclassifications     6.6 0.9
    Amounts reclassified from accumulated other comprehensive income loss     0.4 0.2
    Net current period other comprehensive income loss     7.0 1.1
    Balance, as of the end of the period 6.2 0.7 6.2 0.7
    Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges        
    Accumulated other comprehensive income [Line Items]        
    Balance, as of the beginning of the period     10.2 71.7
    Other comprehensive income loss before reclassifications     (13.9) 66.1
    Amounts reclassified from accumulated other comprehensive income loss     (4.4) (75.0)
    Net current period other comprehensive income loss     (18.3) (8.9)
    Balance, as of the end of the period (8.1) 62.8 (8.1) 62.8
    Accumulated Defined Benefit Plans Adjustment        
    Accumulated other comprehensive income [Line Items]        
    Balance, as of the beginning of the period     (37.8) (31.6)
    Other comprehensive income loss before reclassifications     0.9 4.1
    Amounts reclassified from accumulated other comprehensive income loss     0.0 0.0
    Net current period other comprehensive income loss     0.9 4.1
    Balance, as of the end of the period (36.9) (27.5) (36.9) (27.5)
    Accumulated Translation Adjustment        
    Accumulated other comprehensive income [Line Items]        
    Balance, as of the beginning of the period     (195.6) (99.2)
    Other comprehensive income loss before reclassifications     (48.4) (37.8)
    Amounts reclassified from accumulated other comprehensive income loss     0.0 0.0
    Net current period other comprehensive income loss     (48.4) (37.8)
    Balance, as of the end of the period $ (244.0) $ (137.0) $ (244.0) $ (137.0)
    XML 100 R66.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Details 1) - USD ($)
    $ in Millions
    		 3 Months Ended 6 Months Ended
    Jun. 30, 2016
    Jun. 30, 2015
    Jun. 30, 2016
    Jun. 30, 2015
    Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
    Other income (expense), net $ (58.5) $ (10.9) $ (111.3) $ (25.9)
    Income tax benefit (expense) 353.6 292.5 710.0 574.4
    Product, net (2,466.0) (2,198.6) (4,775.4) (4,370.9)
    Net income attributable to Biogen Inc. 1,049.8 927.3 2,020.7 1,749.8
    Reclassification out of Accumulated Other Comprehensive Income        
    Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
    Net income attributable to Biogen Inc. (4.7) 40.1 4.0 74.8
    Accumulated Net Unrealized Investment Gain (Loss) | Reclassification out of Accumulated Other Comprehensive Income        
    Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
    Other income (expense), net (0.6) (0.2) (0.6) (0.3)
    Income tax benefit (expense) 0.2 0.1 0.2 0.1
    Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges | Reclassification out of Accumulated Other Comprehensive Income        
    Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
    Other income (expense), net 0.0 0.0 0.1 0.0
    Income tax benefit (expense) 0.1 (0.2) 0.0 (0.4)
    Product, net (4.3) (40.4) (4.5) (75.4)
    Operating expenses $ (0.1) $ 0.0 $ (0.2) $ 0.0
    XML 101 R67.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Earnings per Share (Details) - USD ($)
    shares in Millions, $ in Millions
    		 3 Months Ended 6 Months Ended
    Jun. 30, 2016
    Jun. 30, 2015
    Jun. 30, 2016
    Jun. 30, 2015
    Numerator:        
    Net income attributable to Biogen Inc $ 1,049.8 $ 927.3 $ 2,020.7 $ 1,749.8
    Weighted-average shares used in calculating:        
    Weighted average number of common shares outstanding 219.1 235.3 219.0 235.1
    Effect of dilutive securities:        
    Dilutive potential common shares 0.3 0.4 0.3 0.6
    Shares used in calculating diluted earnings per share 219.4 235.7 219.3 235.7
    Stock options and employee stock purchase plan        
    Effect of dilutive securities:        
    Stock units 0.1 0.1 0.1 0.1
    Time-vested restricted stock units        
    Effect of dilutive securities:        
    Stock units 0.1 0.2 0.1 0.3
    Market stock units        
    Effect of dilutive securities:        
    Stock units 0.1 0.1 0.1 0.2
    XML 102 R68.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Share-Based Payments (Details) - USD ($)
    $ in Millions
    		 3 Months Ended 6 Months Ended
    Jun. 30, 2016
    Jun. 30, 2015
    Jun. 30, 2016
    Jun. 30, 2015
    Share-based Compensation Expense included in consolidated statements of income        
    Subtotal $ 50.2 $ 48.3 $ 104.5 $ 139.3
    Capitalized share-based compensation costs (4.4) (2.2) (7.5) (5.6)
    Share-based compensation expense included in total costs and expenses 45.8 46.1 97.0 133.7
    Income tax effect (12.7) (12.9) (27.9) (39.6)
    Research and development        
    Share-based Compensation Expense included in consolidated statements of income        
    Share-based compensation expense (21.5) (22.1) (42.9) (57.5)
    Selling, general and administrative        
    Share-based Compensation Expense included in consolidated statements of income        
    Share-based compensation expense (28.7) (26.2) (63.4) (81.8)
    Restructuring charges        
    Share-based Compensation Expense included in consolidated statements of income        
    Share-based compensation expense 0.0 0.0 (1.8) 0.0
    Total share-based compensation expense, net of tax        
    Share-based Compensation Expense included in consolidated statements of income        
    Share-based compensation expense $ (33.1) $ (33.2) $ (69.1) $ (94.1)
    XML 103 R69.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Share-Based Payments (Details 1) - USD ($)
    $ in Millions
    		 3 Months Ended 6 Months Ended
    Jun. 30, 2016
    Jun. 30, 2015
    Jun. 30, 2016
    Jun. 30, 2015
    Summary of share based compensation expense associated with different programs        
    Subtotal $ 50.2 $ 48.3 $ 104.5 $ 139.3
    Capitalized share-based compensation costs (4.4) (2.2) (7.5) (5.6)
    Share-based compensation expense included in total costs and expenses 45.8 46.1 97.0 133.7
    Market stock units        
    Summary of share based compensation expense associated with different programs        
    Share-based compensation expense 7.9 9.1 21.3 26.1
    Time-vested restricted stock units        
    Summary of share based compensation expense associated with different programs        
    Share-based compensation expense 33.9 31.8 64.0 63.7
    Cash settled performance shares        
    Summary of share based compensation expense associated with different programs        
    Share-based compensation expense 4.6 3.2 4.8 27.0
    Performance units        
    Summary of share based compensation expense associated with different programs        
    Share-based compensation expense 1.3 1.2 8.2 14.4
    Employee stock purchase plan        
    Summary of share based compensation expense associated with different programs        
    Share-based compensation expense $ 2.5 $ 3.0 $ 6.2 $ 8.1
    XML 104 R70.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Share-Based Payments (Details 2) - shares
    		 6 Months Ended
    Jun. 30, 2016
    Jun. 30, 2015
    Market stock units    
    Schedule of stock option grants    
    Stock units 166,000 179,000
    Cash settled performance shares    
    Schedule of stock option grants    
    Stock units 86,000 115,000
    Performance units    
    Schedule of stock option grants    
    Stock units 56,000 89,000
    Time-vested restricted stock units    
    Schedule of stock option grants    
    Stock units 594,000 375,000
    XML 105 R71.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Share-Based Payments (Details Textual) - shares
    		 6 Months Ended
    Jun. 30, 2016
    Jun. 30, 2015
    Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]    
    Employee stock purchase plan maximum shares   6,200,000
    1995 ESPP    
    Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]    
    Shares issued under ESPP   98,000
    2015 ESPP    
    Employee Stock Ownership Plan (ESOP) Disclosures [Line Items]    
    Shares issued under ESPP 109,000  
    XML 106 R72.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Income Taxes (Details)
    		 3 Months Ended 6 Months Ended
    Jun. 30, 2016
    Jun. 30, 2015
    Jun. 30, 2016
    Jun. 30, 2015
    Reconciliation between the U.S. federal statutory tax rate and effective tax rate        
    Statutory rate 35.00% 35.00% 35.00% 35.00%
    State taxes 1.00% 0.40% 1.00% 0.00%
    Taxes on foreign earnings (10.00%) (11.10%) (9.00%) (9.80%)
    Credits and net operating loss utilization (1.20%) (0.70%) (1.20%) (0.70%)
    Purchased intangible assets 1.10% 1.10% 1.10% 1.00%
    Manufacturing deduction (1.60%) (2.10%) (1.70%) (1.80%)
    Permanent items 0.60% 0.90% 0.60% 0.70%
    Other 0.30% 0.40% 0.20% 0.30%
    Effective tax rate 25.20% 23.90% 26.00% 24.70%
    XML 107 R73.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Income Taxes (Details Textual) - USD ($)
    $ in Millions
    		 1 Months Ended 6 Months Ended
    Oct. 31, 2011
    Jun. 30, 2016
    Jun. 30, 2015
    Income Tax Contingency [Line Items]      
    Net benefit for a previously unrecognized position     $ 24.0
    Tax Year 2007      
    Income Tax Contingency [Line Items]      
    Proposed deduction disallowance by tax authorities $ 130.0    
    Tax Year 2008      
    Income Tax Contingency [Line Items]      
    Proposed deduction disallowance by tax authorities 130.0    
    Tax Year 2009      
    Income Tax Contingency [Line Items]      
    Proposed deduction disallowance by tax authorities $ 130.0    
    SKAT      
    Income Tax Contingency [Line Items]      
    Notice of assessment of corporate withholding tax including penalties and interest   $ 66.9  
    Payments to taxing authority   $ 13.0  
    XML 108 R74.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Other Consolidated Financial Statement Detail (Details) - USD ($)
    $ in Millions
    		 3 Months Ended 6 Months Ended
    Jun. 30, 2016
    Jun. 30, 2015
    Jun. 30, 2016
    Jun. 30, 2015
    Dec. 31, 2015
    Accrued Expenses and Other          
    Revenue-related reserves for discounts and allowances $ 651.8   $ 651.8   $ 662.7
    Current portion of contingent consideration obligations and milestones 556.7   556.7   504.7
    Employee compensation and benefits 228.4   228.4   270.8
    Royalties and licensing fees 183.7   183.7   167.9
    Other 613.4   613.4   635.3
    Total accrued expenses and other 2,072.7   2,072.7   2,096.8
    Other Income (Expense), Net          
    Interest income 15.4 $ 4.3 26.6 $ 7.6  
    Interest expense (65.9) (5.8) (129.2) (12.5)  
    Gain (loss) on sales of investments, net (2.7) 0.3 (1.1) (1.4)  
    Foreign exchange gains (losses), net 0.2 (1.5) 2.3 (14.5)  
    Other, net (5.5) (8.2) (9.9) (5.1)  
    Other income (expense), net (58.5) $ (10.9) (111.3) $ (25.9)  
    Component of accrued expenses and other          
    Accrued Expenses and Other          
    Revenue-related reserves for discounts and allowances $ 490.5   $ 490.5   $ 518.1
    XML 109 R75.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Other Consolidated Financial Statement Detail Other Consolidated Financial Statement (Details Textual)
    € in Millions, $ in Millions
    		 3 Months Ended 6 Months Ended
    Jun. 30, 2016
    USD ($)
    Jun. 30, 2015
    USD ($)
    Jun. 30, 2014
    USD ($)
    Jun. 30, 2016
    USD ($)
    Jun. 30, 2015
    USD ($)
    Jun. 30, 2016
    EUR (€)
    Dec. 31, 2015
    USD ($)
    Product Liability Contingency [Line Items]              
    Prepaid taxes $ 704.1     $ 704.1     $ 550.6
    Product, net $ 2,466.0 $ 2,198.6   $ 4,775.4 $ 4,370.9    
    Italy              
    Product Liability Contingency [Line Items]              
    Reimbursement limit stated in the resolution     24 months        
    Product, net     $ 53.5        
    Amount reserved for this matter | €           € 75  
    XML 110 R76.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Investments in Variable Interest Entities (Details) - USD ($)
    $ in Millions
    		 6 Months Ended
    Jun. 30, 2016
    Dec. 31, 2015
    Variable Interest Entity [Line Items]    
    Investment in biotechnology companies that are determined to be unconsolidated variable interest entities $ 38.0 $ 29.2
    Neurimmune    
    Variable Interest Entity [Line Items]    
    Remaining potential development milestone payments and royalties on commercial sales under the terms of collaboration agreement $ 275.0  
    Research and development cost in support of collaboration agreement 100.00%  
    Other Variable Interest Entities    
    Variable Interest Entity [Line Items]    
    Additional investments committed to if certain development milestones are achieved $ 8.0  
    XML 111 R77.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Collaborative and Other Relationships Collaborative and Other Relationships - Collaborations (Details) - USD ($)
    $ in Millions
    		 3 Months Ended 6 Months Ended
    Jun. 30, 2016
    Jun. 30, 2015
    Jun. 30, 2016
    Jun. 30, 2015
    Dec. 31, 2015
    Jan. 31, 2007
    Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
    Research and development $ 473.1 $ 490.7 $ 910.4 $ 951.3    
    Investments and other assets 1,153.0   $ 1,153.0   $ 1,107.6  
    Sobi rate to Biogen on net sales in the Sobi Territory            
    Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
    Reimbursement under the amended agreement method     Royalty      
    Base rate after first commercial sale     12.00%      
    Rate during the reimbursement period     Base Rate plus 5%      
    Biogen rate to Sobi on net sales in the Biogen North America Territory            
    Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
    Reimbursement under the amended agreement method     Royalty      
    Rate during the reimbursement period     Base Rate less 5%      
    Biogen rate to Sobi on net sales in the Biogen North America Territory | Sobi Territory            
    Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
    Base rate after first commercial sale     12.00%      
    Biogen rate to Sobi on net sales in the Biogen Direct Territory            
    Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
    Reimbursement under the amended agreement method     Royalty      
    Rate during the reimbursement period     Base Rate less 5%      
    Biogen rate to Sobi on net sales in the Biogen Direct Territory | Sobi Territory            
    Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
    Base rate after first commercial sale     17.00%      
    Biogen rate to Sobi on net revenue from the Biogen Distributor Territory            
    Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
    Reimbursement under the amended agreement method     Net Revenue Share      
    Rate during the reimbursement period     Base Rate less 15%      
    Biogen rate to Sobi on net revenue from the Biogen Distributor Territory | Sobi Territory            
    Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
    Base rate after first commercial sale     50.00%      
    Biogen Hemophilia            
    Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
    Percentage of stock acquired           100.00%
    University of Pennsylvania            
    Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
    Research and development 20.0          
    Investments and other assets 15.0   $ 15.0      
    Future research and development commitment 47.5   47.5      
    Potential future milestone payments $ 2,000.0   $ 2,000.0      
    Swedish Orphan Biovitrum            
    Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
    Reimbursement recognition period     10 years      
    Reimbursement cost achieving period     6 years      
    Time period for paying remaining balance due     90 days      
    Swedish Orphan Biovitrum | ELOCTATE            
    Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
    Research and development     $ 157.0      
    Swedish Orphan Biovitrum | ALPROLIX            
    Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]            
    Research and development     $ 130.0      
    XML 112 R78.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Collaborative and Other Relationships Collaborative and Other Relationships - Equity Method Investments (Details)
    $ in Millions, ₩ in Billions
    		 1 Months Ended 3 Months Ended 6 Months Ended
    Feb. 29, 2012
    USD ($)
    Jun. 30, 2016
    USD ($)
    Jun. 30, 2015
    USD ($)
    Dec. 31, 2013
    USD ($)
    Jun. 30, 2016
    USD ($)
    Jun. 30, 2015
    USD ($)
    Feb. 29, 2012
    KRW (₩)
    Schedule of Equity Method Investments [Line Items]              
    Recognized loss   $ 0.0 $ (4.9)   $ 0.0 $ (5.7)  
    Research and development   473.1 490.7   910.4 951.3  
    Revenue related to technical development and technology transfer services   $ 79.0 55.6   $ 166.9 107.6  
    Samsung Biosimilar Agreement [Member]              
    Schedule of Equity Method Investments [Line Items]              
    Contribution from Samsung to develop, manufacture and market biosimilar pharmaceuticals $ 250.0           ₩ 280.5
    Variable interest entity, qualitative or quantitative information, ownership percentage 85.00%            
    Contribution from Biogen to develop, manufacture and market biosimilar pharmaceuticals $ 45.0           ₩ 49.5
    Percentage of stake in entity minimum 15.00% 9.00%     9.00%   15.00%
    Percentage of stake in entity maximum 49.90%            
    Recognized loss     (4.9)     (5.7)  
    Research and development       $ 46.0      
    Expected profit share with Samsung Bioepis       50.00%      
    Revenue related to technical development and technology transfer services   $ 14.2 $ 17.2   $ 16.9 $ 36.1  
    Acquired and in-licensed rights and patents | Biosimilars              
    Schedule of Equity Method Investments [Line Items]              
    Increase in acquired and in-licensed rights and patents   $ 25.0     $ 50.0    
    XML 113 R79.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Litigation (Details)
    		 3 Months Ended
    Jun. 30, 2014
    Italy  
    Loss Contingencies [Line Items]  
    Reimbursement limit stated in the resolution 24 months
    XML 114 R80.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Commitments and Contingences (Details) - Fumapharm AG - USD ($)
    $ in Millions
    		 6 Months Ended 12 Months Ended
    Jun. 30, 2016
    Dec. 31, 2006
    Jun. 30, 2013
    Business Acquisition, Contingent Consideration [Line Items]      
    Cash portion of consideration $ 600.0 $ 220.0  
    TECFIDERA      
    Business Acquisition, Contingent Consideration [Line Items]      
    Maximum contingent consideration in the form of development and approval milestones     $ 15.0
    Seven billion      
    Business Acquisition, Contingent Consideration [Line Items]      
    Cumulative sales level 7,000.0    
    Eight billion      
    Business Acquisition, Contingent Consideration [Line Items]      
    Cumulative sales level 8,000.0    
    Nine billion      
    Business Acquisition, Contingent Consideration [Line Items]      
    Cash portion of consideration 300.0    
    Cumulative sales level 9,000.0    
    Each additional one billion up to twenty billion      
    Business Acquisition, Contingent Consideration [Line Items]      
    Cumulative sales level 20,000.0    
    One billion      
    Business Acquisition, Contingent Consideration [Line Items]      
    Cumulative sales level 1,000.0    
    Three billion      
    Business Acquisition, Contingent Consideration [Line Items]      
    Cumulative sales level $ 3,000.0    
    XML 115 R81.htm IDEA: XBRL DOCUMENT v3.5.0.2
    Commitments and Contingencies Commitments and Contingencies (Details 1)
    $ in Millions
    Jun. 30, 2016
    USD ($)
    Switzerland  
    Long-term Purchase Commitment [Line Items]  
    Contractual commitments for the construction of the facility $ 226.0
    EXCEL 116 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
    _TW47[[N]7:]^=Y0N6 M!UZ/CL"4!P9-,0*D#2&33"KD>,">VW]1][#!CN?\-4*+KS&_LNM4+]*BR?@ M,;\;T+ZMNT$%JOAN_?V]X&I8K;/UGC&E03=2HD]'I(K\976?SK?% M"8WPC_MFE2@&>*V3' F^%5].;\%!XMFIBI*X-HTQPOALZ;GY!>B B%6 MIU,X/6 '%R@-?JF]%9K>,MP1.2.3[\APR;-'BIV[T@%,"<3^N MH#ZZ;<@X83@0>1.TL_>^BO)D2!!'LI_TI_\70EJXGS_*9.EWNSO$NE9&2#*= M-?@=T$+K5X+XGX\N%RNP&-'S@+#(]8\H8&HT1GD11.]F5 O!7JCL-:@]0N.! MA&[K:0TE#R'9*%SF*+E/X#,#@UV>5@U0H_B<@ME,Z-"%JR-64P6HWC6 AS9- M@0UF@FP*_*L8"9UF'-4C>/-T"MI?GD[0M"4^ZPJ-?Y,2CCZQ9:(&5T%38%7 MIHJJ>&%9\$4GK$[?0:0ZXQ) 2A*]Z30T%>O!3Z"U]J;PC<.[A1]#<] M-SY1?YQ-476L:C*G$?L!>Q10W8S#';O M81H:!E955E:6X='[3)RS?: /=$BUG6U#>J2\F#)912*LMHW-OGXJZ&L3.2?& M=APR>1YIP+;[.92]1A=%@T0F/B!P?H6@!)#FN,&D =5KH_!!C1P$_5*"_A>/ M$MH-BA&*0[0$,WZ-/HK++T),>0FJD"WQYXUXY:0QF(Y4(U#&ZBY45]@RDJ!U MJQ&K:WB#&-DOHET=\D&GIATF'*/7&<+1\.@7+J5724QB7N+9R0:KC&U1<+D49\3JI?3GY&DY 2*8B/5*R.$B+M4@ MYKI%TB/UX!C/D(P5%O@;9*1VXV!ES,6AF4M_I+A4->+; E6OE'*B_ /OIMO M C5.G&-@ZLO0O D7)&UU%]EH&X3,)B?-*B]1^$P*]&CA+QF,,"0M<\*FJ[W(VCT<3!UL?/:U?20I@E M&O;@ME&L$W'#\E1@4AROOGIT=33HI#N$X\;8-IU]$'//6TJ; 9D68Y"@Q6<%3HDB':-"+SZG MI?C4K1@/%05H(_#_=)1/0=S+IZ#2$,$&U[[%W"0S,^F8Z;9+(US_AX48__*[ M46W:SRHI">-Y9+F#$$FI_%F*5V$>A]7TR/Y+W"Y 3X<3V[LSX1@->%CKJD!R MJ+.&9*-I*CF)^9M_$0@<7PN:U8X 1PIP=-0 JZ5/35B1N!=1=90 M@%::9V70_*1!-\CBI%-IA,HKWD0N^"W.)D'4:8IA_6, 2-U X;O=N8BQ1_5Y M(+">AU<W"8E:$%5G: 3('&9G1R=$GV>*_$X8(%!CHYQ3EN0+ M3YLZLU:T [?(%DY6"[N-4UEX6C,LQR4)5_$,!+>2Y!60\\\X-)E>P#L%@Q#P MD /. MFW)>FW>W@Z_46KKD3YEH>&(VC&ZB5N]HB:14KT)%0"8,1FQ!O)DXR'4-1K/1 MF3\2#UT/4W[M[7KUF:PKID_)#9R6\(?QC=^-L6*9GI!='9 M#Z2@2HX),9$3OI#DZ$+"KP5Z%U](5NB?4;%704D ;M(*FMZ.@-8E67]@( M236E?3>FK3:[4X'P'9ERT)+B;D@J;%KNNX0Z#ZQ!1?W-02W/))^B)-?N M]C0FVZ&F29WRWDS*FF.(DZ*J.&@X@:!):.O_ \TQJZIPY),R!DJY+\*P]%;6!Z3Z84^&UT M.JDHZ29 ;&/D_#";=8&&T*28*&-4.9&DEF=@R'))&)V$YYV5!>#O_1X<>_[$ M%>@R:#Z35.T/0W3E-SETU;AS+E:8<8DOO/MN]>YSF>4I[QTV;DB75 9%96M4 M5X YG>@\>(:H-QJ AT ^D)]VOU0F.%GMME)AWDI[!%HC0.<@S=E6BUD P3V0 MJ5@%SXA,!R%\]O0^-YMD]B%3G#K;OG6FHS5E(JTIN=+L88]:0K@$Q "?.T(J M>&4;*)ETS;A%M[L'$TWC7I;3WN<9 OB9WU[+Q)NO8B[_(!0U1,=_;4K+73&9 M2UUB#43,3ZH:Y"M-,2'!.\TXV"Y/)_C;VP648UA1RS\N($8!QL %^E8[62L1 M\E)@)\"(MRV+ H0;Y)CC5>+W#+_GC%J,UA"8.RRP:X1Q$G"&A.W!V )C;'% MGU1\Q#W$/M)&T/\^+N\6+QG@ G.6E]=DB81'=RM(BS3W3J9\S8Y;RA4GUOIZB=1)11VA( Z;6-T/4Y4%A#@X]#8:WAG$+:?.''(C M.;BJ.*IQS]"T8R134T,9_1UGQ&FS- M^FP[%+3!&!CR*(:2NE2[?,M2D*XXKFK5LK[$4PG:YAZAH(?NPNNPM.^@VKRN MTRP3G&S2X*>7[%@4F/+M^1@_;:H;TPU3:BZ"^,=-A;>6$VS2SOM&SO<1X=\C MS?K#O/8@5EO)!2\=M7)RY994AF=]WP%KK;U MFD 8P5-TN4O5!WP) A$\=W^@&LK@^J!O@YB7*-P*CF[AN,DDEZ^9*GN-Z)L@7TP4%:+7%N5;,,?0YX3OTA)P@=^/[:4L M(-/H.;CA&OBH<7H+T.F>6^41684/%P456LJ#4+LC@2[63NT55(SV?@H)+6K*:4='FBS$QEP^J<<(6JBT/8_;9WR;*?6J MD9W-E7(?F'XT$4Z5A2N39M4\S]GKGA0X?(;XS+#&KY,GC/!<'UIX]/( MVE&I+5@.#=QM#^L5!0&.:TY7 _)F\\M+B:D5!Z-D0L HP:0E L #JH1A@4@6 MQ01\ !?KQ_FMBIK3Y5@^ >9S/@7I"5+3&]Z[-4:NUZ41Y!AT>J;9A%UU:=;4 MMO7EJ%7&4!>^N&C5#8R[R[NWX1@6I'MWM=ML&:9RVT%693!5T)1'%XXSZ\<% M(RJT2TZUXZ30)[7'RR2:)HDUE'$/<=NC^>A!'(L8L4JV9%43&YI1X/$ T$%Y M(W@=G=[<'5DDWD0V-$I' F7(W)&4^GXOS01HF#*8VP6BYMZ#Q'BYOEH"@/-+ ML3V2\@43$56\ ]N2C+HA@I/$JW8K4G[4_!6=NMJ''GQW.@G/R^;PV=28$NC[R_?CI)G<(2)+KSG0R?CE.I8H/"W6ZKUKX[+RA3LZ-ZJZ@C:?:N2? M=BEJ"4:Z-4I 6Q2<>P@X!EA2D7)P1EH;E^>P#XM2%5!-*1U3@DRF7FA*&<\6 M2=W[X#V&2-Z#\NC;/?'8CONU$.A">Z*"FTRMO*-ZO0N2TR8C1.A\&G4!SDCD MWC-C[5%295G(J%+J1IB,QI5L@2W:XPKC/7HUT##<8P##<>A9X@9W=*0.M= 8 M7;S7 &-TY)H;>(SN*?3B2JK!I7(7!.[XL%[UW32R9TNS].!<"1;R2K$/#]OZ MUY,/;RY^^CCSOSYT/)]O%B_G]\"!0C/R[O3D3[,W)]8V/OYP?#X[M:[W 4@. M)1D/_EXZ^@QIKZ'X0Q.#<3#,I5RBGV=76V0UUNR9KS*0*CE7RT"H]H'*J3/8 MA<+'VU FCCMA\O9NT#*K1S]IQS+$/MGL^V1A!S''/FEYSEPHG#:/VMIRO2TY M.@$]?Q-DO%K>[>[\X(ZWRT^B<\F2E&Q[$?/2?6SZWC?_J^M]A:<5%V)HS#W^ MD>7C^#?Y^^NY>_;#V8?C/]D[+QK[\PF/^H=-J#K^OB6=(49AV@#JC=$6+M^M]K MM?'3Y>S-Q8F29W\;@K^[IX0P0.Y6SX:DG5#@GW>3!([O(%:K_^96'E_,Q R_V]W-[X4^?C>:_'[7.7^?5AUGL,$[ODQ?Z ,WON\B' M>?7@!3[,:_=?W#[198#8URGB&Y3^6@BS:0=!U]EP"TC7#UQ/#9_;T+4]/?"W MZ(.V=9E??$"V+K.)#ZD6L&F[]_K@: & MGNO#V\6$&8'KWX1O?IO=ENQW-LM MJ2*R'*4A+QVUY*40<2@T54OZ=,WX!PQT2MN,$,#6C+LYT/IP9,TGM!#H1P\YQ1\1QNXU M/<;O#;#,60LP$7/:_93F@85,G0B:T0^W439=C_5"2:9.5,L]FPH3N@N4,GX" M["?#HX] M4P#(XYZ/#S>'F(LHXFQ'SNR^T0;)M+[ZZV37?7T6\H.EO^A:(&R M[7G8I#(22(="N N59:]*^^S.7DWLBS/.[E4 LFW84'-!R3WJ<*QY?J@]/[BG M,&YBAW IR,(4'&(2/ZU%+P(&SR?)2UZ\T7Y_.IS- MW\+1BRDK+3BD?C3(;F/*14RY4!0#O;SCBN3R*2C'ZB.*J><'"$MM9R'XTS?, M*(#A8_!X'R\P% TRU'=6&CR.0.#*\,6,P MRL/9.Z 0GMWP+EA9/)(F#]R6AXSV(=W0:X++L\_+3DR=>;3]=7Z_Q\3(!(C? M[*0IV?<(5D91=:V815GQT^"DD'FTV#Q 5I=.BNS@NICV,XN\NI@N0WKMP7GY MC7)?H0/;5'7^R;.AL"8$) Z>6VU;( 2-\*]:#KI\MS'EGW1 #.?1 M[]^-$O&\)7.'WQTT7!HQB#>+^\WB>NET.U^N;P6#VFU6*8"1/_QML1$OLH1[ M,)ABG#]C]F+>@H-PW:V))3EU-'J*D2"L(M@K?G>U68J]DH[>6\%!%RKF\19C M,;3'VS$-BUO8)SW3(-%/AZ? Q,.BOHS"1?6AC;J8TB"04;^U^0FXHI9:W0,K MZAQMT-;=61F7:9L1#.(WWW>[VU>C?.J+;7GTAK9<[JZV8H%A2,>_]&[!W<.7 M->=ERZ011DS2JK'$?8!SE%+\*4U1Z\[GE"/DF9>EC$?J#6D[8N0G1&C@*9OK M+L)AKKME/6UTR(#/@K92;BPP5W#DNF39KP<(.W0?S^(P%T/+W0%&A(5H;6/_ MR@3P)1%7P8,?[I\1<#^B!88/7*A6C!YRZ M$'N[#1BWTI080H*@_#\*EK+\A'[?+C9IJ.6W$!4I/MO@I#KO*/2L&\+T?V.7 M#'##6""=NN<2KS.R#^'L4#<4:%S33Z8E(:]\W1[L3XP'[YH-HFD=- Y,2@=[ M'7P(:PC(@&CCQT7K/K0/V*,UU"#&HR7"]Z KVE[3/< 5;>/M$)Q)]],(SV1) M;KV 3FZ7;.@.-^+C8$^[ 25V9.*('+NA((_!/;,T[B[N MF<4CAFRWX RA'\C#*HS"!5MCQS.@W+#W&!J3^VUJ2,0>SGY=+3: 8H/BS"@Y MOCP[?X'9T$*ZVP$+"YW=02S".W(A>/J1-\UX='QY?N[AG,OM%JRKI#"Y[D,% MRO5#&VO.A^/11E?K_@JX:K;ST8!9LX;CNC][5;DN.N[T@K1U;T3,MNRY-1S$ M<'-=;]RW-Z^FCLOQF&_V^R'\RGX/.G%M4YV-R>+@]0G*-3M:M3A7NJ M"=\T?K?3H MRS_,/EK#73\LKZG.#3@HMLH9HV+)X+C\LKZE^FBB>5TM39RL!NJ:-$Q:(Y;G M"@"&"38.<"\\.BLO7$O!#N+ QX$7<][3GJA\:S! M!-#QW-)=/'('K9BJDJA0#AU9HQTT2._/'KFS@_BH"OUVH1\M4\5<4]]_/W%*!'])^OKQQ2STG@O LAM &Q@/(IP=2SFXDI)P@F36HTS8?+BI/O V7X>4]?T.4NAFV3IP[($*_^8;Y92\,")9J^ M6JX-E /@#//54#%N 2B:7@X8P):8J!/ZT>Z.I[0!XH4C M0MX]L.8!3=)^]J^]16FE^-7AG#D< M].A+\SXXB 93\G?SE13&;-&GW8G99@/<6),!1F_[;B&C]_R:^A4,4MP+-#/, M=S0-SL7?8(!1%#*Z0T!0]Y%K-8O DX0 SE'+&QLTU))_"R>>70="M(W6ZG:. MP.O_\]_AR6_N;W?;D9WXP\;68Q/*U7BL8=WA5GPA3>N#F>KN;3UP+ M'X&*&H6(ZE!\OF&Q]YM+3Q$H200K=>[]?+2$:GKU?;Q]A=QJEJMOB/(*!^0"W-[9_R0.B89 M=LH^(2WV]NM"J!]?1F>;>T@%$T/^90G126$&QEHK%3]QLH8\99RG 4#1IOBHP=D-!5BYS_@PAO/Z?IN$=X,#RL]][3: M^ 3^+F$ M^+YTZ-V7\[OM3M"9AJP:S=1Y_?-[1%&U.HO97,"(8(\@EY+-B'YQ;U*A(4AC M(2T])SM>Z3B$:NG8 3?[@EK,?T]%?P'G[0%0E=HWX$WZ@OY([/,@PZQRV7G?\8L-1KGZ,Z'^>;J<..ZV-.^.]F@ M:ES&3)73<;]9@\&/W$CH(#*(:'&_M 9Y*ICI9ZY8$@/O;>$985J*5IR7/=Z1 M(W6(D+2LG^QHG";&4WR*C6(:F1769HZBM+J%B- M^Y8V:ED'@X2BLDWPY-WQ M6L=8D()-@$[V#G-0B*-^J]DE,!M!Q#@!MJ$.XQ_0;8^"VRV\P"(63%+S-/$! MEL[SVS'4))MK57"M;QWM[I'O_2J&\NA[_LS?--5H\0W+2S.8;QO\U73'AIVP M_N#?4Y7L(7TTQDM[J%VGUEX;_92) ]=F6+$L>#*_[F#M?;O=/OS+?P-02P$" M% ,4 " #IB_5([OS=/48" "R+P $P @ $ 6T-O M;G1E;G1?5'EP97-=+GAM;%!+ 0(4 Q0 ( .F+]4A(=07NQ0 "L" + M " 7<" !?&UL4$L! A0#% @ Z8OU2*<] M)5D^ 0 :0, !$ ( !*@H &1O8U!R;W!S+V-O&UL M4$L! A0#% @ Z8OU2)E&PO!4RF@4 "<9 / " : 4 !X;"]W;W)K8F]O M:RYX;6Q02P$"% ,4 " #IB_5(@+RK>D(" ".!P & M@ %G&@ >&PO=V]R:W-H965T&UL4$L! A0#% @ Z8OU M2 2&PO=V]R:W-H M965T&UL4$L! A0#% @ Z8OU2&J;@FJU 0 1@0 !@ M ( !:"H 'AL+W=O&PO=V]R:W-H965T&UL M4$L! A0#% @ Z8OU2#L;AX>F 0 L0, !@ ( !J#( M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ Z8OU2$KB'4JD 0 L0, !D M ( !%3H 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ Z8OU2%?W,NFE 0 L0, !D ( !HS\ M 'AL+W=O_/ M+Z(! "Q P &0 @ %_00 >&PO=V]R:W-H965T:HHP$ +$# 9 M " 5A# !X;"]W;W)K&UL4$L! A0#% @ MZ8OU2-#D(HVD 0 L0, !D ( !,D4 'AL+W=O=J,! "Q P &0 @ &9 M3 >&PO=V]R:W-H965T&UL4$L! A0#% @ Z8OU2%[S"9.D 0 L0, !D M ( !3% 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ Z8OU2 -=B'/: 0 104 !D ( !X%4 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ Z8OU M2!L;7GJD 0 L0, !D ( !M5L 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ Z8OU2.")$DWKX! ![! &0 @ &$8P M>&PO=V]R:W-H965T&UL4$L! A0#% @ Z8OU2.#,]?NO 0 %@0 !D M ( !5F< 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ Z8OU2(%@IK>D 0 L0, !D ( !#FT 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ Z8OU2"TG M-$JW 0 %@0 !D ( !KG( 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ Z8OU2"/\]NPC P N X !D M ( !4WH 'AL+W=OE>? ! #1!0 &0 @ &M?0 >&PO M=V]R:W-H965T&UL4$L! A0#% @ Z8OU2!HVP[':0P& !V) &0 @ $GA >&PO=V]R:W-H965T&UL4$L! A0#% M @ Z8OU2&N3UW/6!0 .R< !D ( !)8T 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ Z8OU2$!A,BUL M @ D0D !D ( !5YD 'AL+W=O&PO=V]R:W-H965T !X;"]W;W)K&UL4$L! A0#% @ Z8OU2."@J ]+ @ G0< !D M ( !$Z, 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ Z8OU2*\J6@RI 0 \ , !D ( !(*H M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ MZ8OU2'N%!59\ @ JP@ !D ( !0K0 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ Z8OU2,7R_N.! P M?P\ !D ( !.[X 'AL+W=O<" "0# &0 @ 'S MP0 >&PO=V]R:W-H965T&UL4$L! A0#% @ Z8OU2)OO&R\Y P \@T !D M ( !@<@ 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ Z8OU2(R** _" @ !0P !D ( !FM 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ Z8OU M2'IF!3I_ @ X0@ !D ( !W]D 'AL+W=O&PO=V]R:W-H965T !X;"]W;W)K M&UL4$L! A0#% @ Z8OU2 Y2<^YM P S X M !D ( !/^, 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ Z8OU2%D"_>63 0 >@, !D M ( !K>L 'AL+W=O1 ""1P( % @ %W[0 >&PO:6YG XML 117 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 118 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 120 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 311 307 1 false 111 0 false 8 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.biogenidec.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Condensed Consolidated Statements of Income (Unaudited) Sheet http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfIncomeUnaudited Condensed Consolidated Statements of Income (Unaudited) Statements 2 false false R3.htm 1002000 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) Sheet http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited Condensed Consolidated Statements of Comprehensive Income (Unaudited) Statements 3 false false R4.htm 1003000 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://www.biogenidec.com/role/CondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 4 false false R5.htm 1003501 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://www.biogenidec.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 5 false false R6.htm 1004000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.biogenidec.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 2101100 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.biogenidec.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 2106100 - Disclosure - Restructuring Restructuring Sheet http://www.biogenidec.com/role/RestructuringRestructuring Restructuring Restructuring Notes 8 false false R9.htm 2107100 - Disclosure - Reserves for Discounts and Allowances Sheet http://www.biogenidec.com/role/ReservesForDiscountsAndAllowances Reserves for Discounts and Allowances Notes 9 false false R10.htm 2108100 - Disclosure - Inventory Sheet http://www.biogenidec.com/role/Inventory Inventory Notes 10 false false R11.htm 2109100 - Disclosure - Intangible Assets and Goodwill Sheet http://www.biogenidec.com/role/IntangibleAssetsAndGoodwill Intangible Assets and Goodwill Notes 11 false false R12.htm 2110100 - Disclosure - Fair Value Measurements Sheet http://www.biogenidec.com/role/FairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 2112100 - Disclosure - Financial Instruments Sheet http://www.biogenidec.com/role/FinancialInstruments Financial Instruments Notes 13 false false R14.htm 2114100 - Disclosure - Derivative Instruments Sheet http://www.biogenidec.com/role/DerivativeInstruments Derivative Instruments Notes 14 false false R15.htm 2116100 - Disclosure - Property, Plant and Equipment Property, Plant and Equipment Sheet http://www.biogenidec.com/role/PropertyPlantAndEquipmentPropertyPlantAndEquipment Property, Plant and Equipment Property, Plant and Equipment Notes 15 false false R16.htm 2118100 - Disclosure - Equity Sheet http://www.biogenidec.com/role/Equity Equity Notes 16 false false R17.htm 2119100 - Disclosure - Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) Sheet http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLoss Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) Notes 17 false false R18.htm 2120100 - Disclosure - Earnings per Share Sheet http://www.biogenidec.com/role/EarningsPerShare Earnings per Share Notes 18 false false R19.htm 2121100 - Disclosure - Share-based Payments Sheet http://www.biogenidec.com/role/ShareBasedPayments Share-based Payments Notes 19 false false R20.htm 2122100 - Disclosure - Income Taxes Sheet http://www.biogenidec.com/role/IncomeTaxes Income Taxes Notes 20 false false R21.htm 2123100 - Disclosure - Other Consolidated Financial Statement Detail Sheet http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetail Other Consolidated Financial Statement Detail Notes 21 false false R22.htm 2124100 - Disclosure - Investments in Variable Interest Entities Sheet http://www.biogenidec.com/role/InvestmentsInVariableInterestEntities Investments in Variable Interest Entities Notes 22 false false R23.htm 2125100 - Disclosure - Collaborative and Other Relationships Sheet http://www.biogenidec.com/role/CollaborativeAndOtherRelationships Collaborative and Other Relationships Notes 23 false false R24.htm 2126100 - Disclosure - Litigation Sheet http://www.biogenidec.com/role/Litigation Litigation Notes 24 false false R25.htm 2127100 - Disclosure - Commitments and Contingencies Sheet http://www.biogenidec.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 25 false false R26.htm 2128100 - Disclosure - Subsequent Events Subsequent Events Sheet http://www.biogenidec.com/role/SubsequentEventsSubsequentEvents Subsequent Events Subsequent Events Notes 26 false false R27.htm 2201201 - Disclosure - Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Policies) Sheet http://www.biogenidec.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Policies) Policies http://www.biogenidec.com/role/SummaryOfSignificantAccountingPolicies 27 false false R28.htm 2306301 - Disclosure - Restructuring Restructuring (Tables) Sheet http://www.biogenidec.com/role/RestructuringRestructuringTables Restructuring Restructuring (Tables) Tables http://www.biogenidec.com/role/RestructuringRestructuring 28 false false R29.htm 2307301 - Disclosure - Reserves for Discounts and Allowances (Tables) Sheet http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesTables Reserves for Discounts and Allowances (Tables) Tables http://www.biogenidec.com/role/ReservesForDiscountsAndAllowances 29 false false R30.htm 2308301 - Disclosure - Inventory (Tables) Sheet http://www.biogenidec.com/role/InventoryTables Inventory (Tables) Tables http://www.biogenidec.com/role/Inventory 30 false false R31.htm 2309301 - Disclosure - Intangible Assets and Goodwill (Tables) Sheet http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillTables Intangible Assets and Goodwill (Tables) Tables http://www.biogenidec.com/role/IntangibleAssetsAndGoodwill 31 false false R32.htm 2310301 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.biogenidec.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.biogenidec.com/role/FairValueMeasurements 32 false false R33.htm 2312301 - Disclosure - Financial Instruments (Tables) Sheet http://www.biogenidec.com/role/FinancialInstrumentsTables Financial Instruments (Tables) Tables http://www.biogenidec.com/role/FinancialInstruments 33 false false R34.htm 2314301 - Disclosure - Derivative Instruments (Tables) Sheet http://www.biogenidec.com/role/DerivativeInstrumentsTables Derivative Instruments (Tables) Tables http://www.biogenidec.com/role/DerivativeInstruments 34 false false R35.htm 2318301 - Disclosure - Equity (Tables) Sheet http://www.biogenidec.com/role/EquityTables Equity (Tables) Tables http://www.biogenidec.com/role/Equity 35 false false R36.htm 2319301 - Disclosure - Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Tables) Sheet http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossTables Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Tables) Tables http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLoss 36 false false R37.htm 2320301 - Disclosure - Earnings per Share (Tables) Sheet http://www.biogenidec.com/role/EarningsPerShareTables Earnings per Share (Tables) Tables http://www.biogenidec.com/role/EarningsPerShare 37 false false R38.htm 2321301 - Disclosure - Share-Based Payments (Tables) Sheet http://www.biogenidec.com/role/ShareBasedPaymentsTables Share-Based Payments (Tables) Tables 38 false false R39.htm 2322301 - Disclosure - Income Taxes (Tables) Sheet http://www.biogenidec.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.biogenidec.com/role/IncomeTaxes 39 false false R40.htm 2323301 - Disclosure - Other Consolidated Financial Statement Detail (Tables) Sheet http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailTables Other Consolidated Financial Statement Detail (Tables) Tables http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetail 40 false false R41.htm 2325301 - Disclosure - Collaborative and Other Relationships Collaborative and Other Relationships (Tables) Sheet http://www.biogenidec.com/role/CollaborativeAndOtherRelationshipsCollaborativeAndOtherRelationshipsTables Collaborative and Other Relationships Collaborative and Other Relationships (Tables) Tables 41 false false R42.htm 2401402 - Disclosure - Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Details) Sheet http://www.biogenidec.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Details) Details http://www.biogenidec.com/role/SummaryOfSignificantAccountingPoliciesSummaryOfSignificantAccountingPoliciesPolicies 42 false false R43.htm 2406402 - Disclosure - Restructuring Restructuring (Details) Sheet http://www.biogenidec.com/role/RestructuringRestructuringDetails Restructuring Restructuring (Details) Details http://www.biogenidec.com/role/RestructuringRestructuringTables 43 false false R44.htm 2406403 - Disclosure - Restructuring Restructuring (Details Textual) Sheet http://www.biogenidec.com/role/RestructuringRestructuringDetailsTextual Restructuring Restructuring (Details Textual) Details http://www.biogenidec.com/role/RestructuringRestructuringTables 44 false false R45.htm 2407402 - Disclosure - Reserves for Discounts and Allowances (Details) Sheet http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesDetails Reserves for Discounts and Allowances (Details) Details http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesTables 45 false false R46.htm 2407403 - Disclosure - Reserves for Discounts and Allowances (Details 1) Sheet http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesDetails1 Reserves for Discounts and Allowances (Details 1) Details http://www.biogenidec.com/role/ReservesForDiscountsAndAllowancesTables 46 false false R47.htm 2408402 - Disclosure - Inventory (Details) Sheet http://www.biogenidec.com/role/InventoryDetails Inventory (Details) Details http://www.biogenidec.com/role/InventoryTables 47 false false R48.htm 2408403 - Disclosure - Inventory Inventory (Details Textual) Sheet http://www.biogenidec.com/role/InventoryInventoryDetailsTextual Inventory Inventory (Details Textual) Details 48 false false R49.htm 2409402 - Disclosure - Intangible Assets and Goodwill (Details) Sheet http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillDetails Intangible Assets and Goodwill (Details) Details http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillTables 49 false false R50.htm 2409403 - Disclosure - Intangible Assets and Goodwill (Details 1) Sheet http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillDetails1 Intangible Assets and Goodwill (Details 1) Details http://www.biogenidec.com/role/IntangibleAssetsAndGoodwillTables 50 false false R51.htm 2410402 - Disclosure - Fair Value Measurements (Details) Sheet http://www.biogenidec.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://www.biogenidec.com/role/FairValueMeasurementsTables 51 false false R52.htm 2410403 - Disclosure - Fair Value Measurements (Details 1) Sheet http://www.biogenidec.com/role/FairValueMeasurementsDetails1 Fair Value Measurements (Details 1) Details http://www.biogenidec.com/role/FairValueMeasurementsTables 52 false false R53.htm 2410404 - Disclosure - Fair Value Measurements (Details 2) Sheet http://www.biogenidec.com/role/FairValueMeasurementsDetails2 Fair Value Measurements (Details 2) Details http://www.biogenidec.com/role/FairValueMeasurementsTables 53 false false R54.htm 2410405 - Disclosure - Fair Value Measurements (Details Textual) Sheet http://www.biogenidec.com/role/FairValueMeasurementsDetailsTextual Fair Value Measurements (Details Textual) Details http://www.biogenidec.com/role/FairValueMeasurementsTables 54 false false R55.htm 2412402 - Disclosure - Financial Instruments (Details) Sheet http://www.biogenidec.com/role/FinancialInstrumentsDetails Financial Instruments (Details) Details http://www.biogenidec.com/role/FinancialInstrumentsTables 55 false false R56.htm 2412403 - Disclosure - Financial Instruments (Details 1) Sheet http://www.biogenidec.com/role/FinancialInstrumentsDetails1 Financial Instruments (Details 1) Details http://www.biogenidec.com/role/FinancialInstrumentsTables 56 false false R57.htm 2412404 - Disclosure - Financial Instruments (Details 2) Sheet http://www.biogenidec.com/role/FinancialInstrumentsDetails2 Financial Instruments (Details 2) Details http://www.biogenidec.com/role/FinancialInstrumentsTables 57 false false R58.htm 2412405 - Disclosure - Financial Instruments (Details 3) Sheet http://www.biogenidec.com/role/FinancialInstrumentsDetails3 Financial Instruments (Details 3) Details http://www.biogenidec.com/role/FinancialInstrumentsTables 58 false false R59.htm 2412406 - Disclosure - Financial Instruments (Details Textual) Sheet http://www.biogenidec.com/role/FinancialInstrumentsDetailsTextual Financial Instruments (Details Textual) Details http://www.biogenidec.com/role/FinancialInstrumentsTables 59 false false R60.htm 2412407 - Disclosure - Financial Instruments Financial Instruments (Details Textual 2) Sheet http://www.biogenidec.com/role/FinancialInstrumentsFinancialInstrumentsDetailsTextual2 Financial Instruments Financial Instruments (Details Textual 2) Details 60 false false R61.htm 2414402 - Disclosure - Derivative Instruments (Details) Sheet http://www.biogenidec.com/role/DerivativeInstrumentsDetails Derivative Instruments (Details) Details http://www.biogenidec.com/role/DerivativeInstrumentsTables 61 false false R62.htm 2416401 - Disclosure - Property, Plant and Equipment Property, Plant and Equipment (Details) Sheet http://www.biogenidec.com/role/PropertyPlantAndEquipmentPropertyPlantAndEquipmentDetails Property, Plant and Equipment Property, Plant and Equipment (Details) Details http://www.biogenidec.com/role/PropertyPlantAndEquipmentPropertyPlantAndEquipment 62 false false R63.htm 2418402 - Disclosure - Equity (Details) Sheet http://www.biogenidec.com/role/EquityDetails Equity (Details) Details http://www.biogenidec.com/role/EquityTables 63 false false R64.htm 2418403 - Disclosure - Equity (Details Textual) Sheet http://www.biogenidec.com/role/EquityDetailsTextual Equity (Details Textual) Details http://www.biogenidec.com/role/EquityTables 64 false false R65.htm 2419402 - Disclosure - Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Details) Sheet http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Details) Details http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossTables 65 false false R66.htm 2419403 - Disclosure - Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Details 1) Sheet http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossDetails1 Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss) (Details 1) Details http://www.biogenidec.com/role/AccumulatedOtherComprehensiveIncomeLossAccumulatedOtherComprehensiveIncomeLossTables 66 false false R67.htm 2420402 - Disclosure - Earnings per Share (Details) Sheet http://www.biogenidec.com/role/EarningsPerShareDetails Earnings per Share (Details) Details http://www.biogenidec.com/role/EarningsPerShareTables 67 false false R68.htm 2421402 - Disclosure - Share-Based Payments (Details) Sheet http://www.biogenidec.com/role/ShareBasedPaymentsDetails Share-Based Payments (Details) Details http://www.biogenidec.com/role/ShareBasedPaymentsTables 68 false false R69.htm 2421403 - Disclosure - Share-Based Payments (Details 1) Sheet http://www.biogenidec.com/role/ShareBasedPaymentsDetails1 Share-Based Payments (Details 1) Details http://www.biogenidec.com/role/ShareBasedPaymentsTables 69 false false R70.htm 2421404 - Disclosure - Share-Based Payments (Details 2) Sheet http://www.biogenidec.com/role/ShareBasedPaymentsDetails2 Share-Based Payments (Details 2) Details http://www.biogenidec.com/role/ShareBasedPaymentsTables 70 false false R71.htm 2421405 - Disclosure - Share-Based Payments (Details Textual) Sheet http://www.biogenidec.com/role/ShareBasedPaymentsDetailsTextual Share-Based Payments (Details Textual) Details http://www.biogenidec.com/role/ShareBasedPaymentsTables 71 false false R72.htm 2422402 - Disclosure - Income Taxes (Details) Sheet http://www.biogenidec.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.biogenidec.com/role/IncomeTaxesTables 72 false false R73.htm 2422403 - Disclosure - Income Taxes (Details Textual) Sheet http://www.biogenidec.com/role/IncomeTaxesDetailsTextual Income Taxes (Details Textual) Details http://www.biogenidec.com/role/IncomeTaxesTables 73 false false R74.htm 2423402 - Disclosure - Other Consolidated Financial Statement Detail (Details) Sheet http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailDetails Other Consolidated Financial Statement Detail (Details) Details http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailTables 74 false false R75.htm 2423403 - Disclosure - Other Consolidated Financial Statement Detail Other Consolidated Financial Statement (Details Textual) Sheet http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailOtherConsolidatedFinancialStatementDetailsTextual Other Consolidated Financial Statement Detail Other Consolidated Financial Statement (Details Textual) Details 75 false false R76.htm 2424401 - Disclosure - Investments in Variable Interest Entities (Details) Sheet http://www.biogenidec.com/role/InvestmentsInVariableInterestEntitiesDetails Investments in Variable Interest Entities (Details) Details http://www.biogenidec.com/role/InvestmentsInVariableInterestEntities 76 false false R77.htm 2425402 - Disclosure - Collaborative and Other Relationships Collaborative and Other Relationships - Collaborations (Details) Sheet http://www.biogenidec.com/role/CollaborativeAndOtherRelationshipsCollaborativeAndOtherRelationshipsCollaborationsDetails Collaborative and Other Relationships Collaborative and Other Relationships - Collaborations (Details) Details http://www.biogenidec.com/role/CollaborativeAndOtherRelationshipsCollaborativeAndOtherRelationshipsTables 77 false false R78.htm 2425403 - Disclosure - Collaborative and Other Relationships Collaborative and Other Relationships - Equity Method Investments (Details) Sheet http://www.biogenidec.com/role/CollaborativeAndOtherRelationshipsCollaborativeAndOtherRelationshipsEquityMethodInvestmentsDetails Collaborative and Other Relationships Collaborative and Other Relationships - Equity Method Investments (Details) Details 78 false false R79.htm 2426401 - Disclosure - Litigation (Details) Sheet http://www.biogenidec.com/role/LitigationDetails Litigation (Details) Details http://www.biogenidec.com/role/Litigation 79 false false R80.htm 2427401 - Disclosure - Commitments and Contingences (Details) Sheet http://www.biogenidec.com/role/CommitmentsAndContingencesDetails Commitments and Contingences (Details) Details http://www.biogenidec.com/role/CommitmentsAndContingencies 80 false false R81.htm 2427402 - Disclosure - Commitments and Contingencies Commitments and Contingencies (Details 1) Sheet http://www.biogenidec.com/role/CommitmentsAndContingenciesCommitmentsAndContingenciesDetails1 Commitments and Contingencies Commitments and Contingencies (Details 1) Details 81 false false All Reports Book All Reports biib-20160630.xml biib-20160630.xsd biib-20160630_cal.xml biib-20160630_def.xml biib-20160630_lab.xml biib-20160630_pre.xml true true ZIP 122 0000875045-16-000065-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000875045-16-000065-xbrl.zip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�UH]-JZWI+ZVIM8_ Q78*0 ?0T$!?I'TM:-6]B=M_W;%FBOW)/^_8[Q^,& M=J%%&]<]5J[ Q/?K!][>.N[K3ZGSE3])T%=+I?/''72 I;?IQ-3"FN3RJF/. MQ]A-2?+Y2G'UO,GGU#A=3G!2=8_5R^W5- \A5TB-MYNXNF!G]RZ#QSL8-^V5 MRFOC\< -XY#S\<'ME_>/#YK%'6&K1_!R%MVNV@^ BH)@SC:4P N]K<#J!Q'#>Z!TMWKI^Z6[& \1=*LN07[!X&_G>,9F@%(F= MRK1)^H ]T&7>T;="9GI#-[I4@7@70T.&N&#YE)B%U/).Q>E%/F_0[JBCD[JP M!CD^JY7EX<4.E$UCXG3/ A72=Q1\1 M'OA.\GV(.'G$[ 1]OD>'_J)WF^UTPV"N;Y('#+!GR9F>W#O6[!?4+SI:6*6C MA8U,.A/G5>9PP,,N>$;4<19/Y&+&"1&&#L+Y6<1'N5S@K;Q/\^4[L/%1P?A, MGOO*N-RZ'>S.7[& 9D>S.#Z2<>NW* CQ<'R;YRT>+TNP9,EV'%&V2 MK",YUBS/(\DT%!'N;$PRS!X;AIC+ ML]^,#VT':1>N$YA&!5_P&J?:$&840G/"8'8WIM>9)SH)FNR20%\MT&>5Q0)7 MT/7"Y)C^"L5)C]6_[P34\;AA?+H/89H<!QDC[#GJ?/ M0-3NF.IJ_V.'&1$C1=FCU[5"K>A)1,QXINSLH3Y09=MC.K#)U(K!<7 M52\N^&5E19/JRK#^.D9A H4).PO4:"Z7&5,MTM+H'UG5FC%>612+//Q<3^DW M#7+P=Z BFNU>[]4NU9(C?B\QOY1>PE MYK<2JU+A+FJ9^2FC,GU#-Y3I3%T<3N*.JLF'9I1)Q\C_)O][K)=NIZNVM2K>^VBFNJBW[2G6>4ESED.+JP?Y& M":[*,BC53U)#":XHZJ<$5\0=E."*$EQ1NHP38>F2I\O8?@_G\5FEFKDTE.V2 MK:^.GYXJKU5>RIM5T/H8.0+D"%2*),D1($>@[CI^>JI\N"- !Y0H'5O:^*TEIGE5V?24I<^D3)I$;^5D=]*K$J%NZAEYJ>,RE : .*. M4G!'!7UOFE&NF(Z1_WW*_G=)"[%52_>(WTK,;R56)?*_R?_>9\)W?1JN;3-E M975%1\W()KW2N_!%82S:&O+D1WQH>J!9?K.TD_L>MY"+(&1?>2C8-5SC?]2[ Q?Q9,[J)/ MCZ[;J3Q\E$?PPJ>@X*E0/)>9@ @.[QEZ/H Y0._N0'\;'MNP. )$^[R)\&\ MR,?),+O70]E MQ!W&)^#CA2B:7!O]EVZOT]08W.^L.D&G\E4@$KATC/IO@_:#)CR(:2@F0PAD M]4Z#&9JA-=DC*L9[<.-PKR4"T&CXT6(\8&/@)!&@J%"K1MSVV3-WHAF>X'GR MESKI%^-AZ-O#*,Z#".J5Z>N"^(!-'FP$&4H@F K3'L'[X(()/,.U5BFX390\N=96I;E/+L[F6#"MB!3 MPR,L_(R'Z%RY[B^Q&(3P3]P>>;-LM&);5GK?Z<[SX2N774>^+USSE<$7+]RW M%MRH>/KN!M[ZS!$E]7.BN!-XL0&,S9\G>SQ*A&.FPADEPIDI98-%X!4X0"$2 M$U;D\]B)0B?!%6P"%XY1TQT1P,7H6MFA+6VG))2W+_#MX'=0P5@ H, CL^5KFBQU ($8F7" Q."^A,-,$RD2.7 4Y]H#1&0=O9QTO;!A M0]O[KBL2=]F+0D"Z:R6"6)3WG%U>@$_R]5TZG5[3*,1WD?8KW\[T#+T@1PR) M/F^_$G-.SN>E6AJZ=RN.ME=KC&[ N**[FNF8+CNV?+!/K>,,-G@:NU/.:U,F M4G-D0KC\PP.]W^S6!6%ZMRBVR-B;F#(SK"@V.5W>RJ6]!CI^#6EX0!. GJY=6.C1= V<)QQE+D?JP5Z\4^8V[$ "+?J ^%6L;RHQM66@B MCAJ2F4IKWEL91 ?1\#=0E@38,D+@OH\S'7$T+$.9.'".,"0"S0GM9)+0\F2H MX8U& 7#"_,DXLR+">)+&L?G0=FR\9T,(OA#6*-?(8P_&HXSP'">98Y=S7X%4 M0K@N>#NCA)*; HZAB3*&W$ETZ5!G@YWLL(-]=B+Y;3CV@E53DOB;/5\FN=A[ M+-9)-G//PH)M:8NK)#4"-$U=K92.DE(I;>VPL@>'WG]HU89^*:HVT):+=Y:5 M23X;Y;-]0K9\DPJ6+-G:-GD#[]#J_1.MWK;RICSDJM+>G=V[:4RR(4,_)7H] M3-)7B8?V(.?L]TC[6I6TIA5DH$OI,:>EAE;/KRBA(A!DJ;0_EVAG.0*7;UBQ M^^K]L((N(WX02%V=T*GP\_GA'G.*%Y3"9#3NF!.D S\D> MX#$*2.Q4P_WS-#M$C+_;/G$PDF&\9(*3]_%*.#$_,?_QF+_55%:0HQ1J5![J M/Z%(X*=D_?:5HH&]@RG3]"-AS5*-S0T$60:R#$>0F=YN]LDR4%! 04$1TT". MA_T2_B2[%XJ8GYC_"#++(7E"*;2I/ ;@E-?XEHX&T@H?K?#1"E_9T$LK?+3" M5P9!DD]7F>*,Y,O5W!S0-"]-\Y9&G&08U$SS:K3WH^[3O,FY. ,/P1T]1"59 MY1#.'R=J+X^L*@K,HRL8R:=2 "SX7(S\1&?Q-GLF=!:O=I(NSUF\$Z*6^)!= MFH:,K.13T%)1% M*YS1*-VYL;*+C2@Y\SQ#W:[@TV1D.LA%![EHD8@6B8X/4EHDHD4B\J6.&][2 MC"01-?V*O[__+@K.GSB?7LPCPLP& MPDO72K857F+103E-=6,'IN,%D2\>02)7CF?^_N.?__3][#FSGW\977L31+G< M@_LU+CYZ[05A\##FOKCB@;"^))7B9X^2-4GAPU_'FP_, MMN +;H;G-[V!=GG7ZK>-KMZYNKVYZAF=Z];-S77GJF7PH;*@% MMFK@WZ]"UU\\16,HUGIC?OZOT^OK@^Z:/;A2I.=#E"E+A?JN]FS=0>2$BA1^ MS,@@JWKL-C8V2N31G1ZQ#/H[50:#3.?-;.<32YN4!H1?WZ\W&(3P3[S+PQLE M]7ZI2& >10+UKIHJ@9WC5OD[]/Y*WU[MUE/GJ])Y6G$^<$*^=X3C7)4XO'7G M^;)"\>/8%X+]#->, [8N'KEUT8%(RZE5=^:#]+2R>OI@?\M'2^FX\[&/.RL[ M>TMU,-\.R2Z%+XFNB]/46BKD6A54MFV)5+ R9+G]*?OC*RXQ:775F)B4-D;N M,)O^5000-9ACN?YLB6?A>%.<]6;'Q/9:*JYJJI*R9OO,0YY'JP6H%Y DNC0* MF.612K[-MR*DM9,4D935T9295%98B+:L9%I;=^Y'Z5SOUJ&\T! MN5]$>16EO+(H%KE?>4JJTU,8(Y9%94I\!*:VTV8/PH$[GAKL2;C"YXZ[C#'>[0YG7ZSE[M341>LDM^@#FAUP%.,H"ZE+2*@ MY >44[-(W5:S31:)@$86:5^+U->;?;)(%&9MN3LA]",SC'P\ZV>.N?^T4Z*! M[HF'HA=RAR=;#V;^C ML.8"A9=D 7.=;%5UP*\X\]?NJ\OY>A*[80AB9,OVM66ZUB[@?!(AC9!6VY5# MO36@).6* [':QF'7?"J3I/X'78XZTX3IOA.F;87[9FC"E"9, MRV1A3V;"],Q0."&SI=#J E:"9UGA>7*V6/TI*++%9(NK ?8Z8#I&<:>I+ $; MV>(<0^P:KW7N4FM#KHK*B%L>EDP+7]'[ZO(R M$5 (**=ND08]=<4)R2(1T$[/(NFMEKK<%W5!"BUVKE:6>UF>D(7\&Q.CD3!# MFD8M8!I5-Q1FIZ%Y5)I'+9,A/9UY5%UEYDJ:2"5\E@*?)V>-C5YQ,"9K3&@O M%=KK .H8QJT!+6O2LF9UEC5=$>)G#+]Y&/KV, KYT(%8W&-7MO3,? MC6Z!1EM>A*\[A A*,<%:II3^FX1\2,[_,N?(7B'45DMYP9(]Y%J7^4MRB4I( M?R5FN8)YK>+TE1)63EO45PB,>(EXB=PR$$12O/8U\(]C-<,X[3"*URJFY=7"K\>^0*UM(:%).2GA:NIP_VMWRT="^* MS6,X\MIE4-A0G=V[#![F0 @1[++%:M:Q5IDV#&X8CN/C97%.=?60&)JN;"L2 MT;4Z3:VE0JY5066I>D@%*T.6JG*)$Y.2&A.3[LRD=,QT]7SZS]S_7>#3//-W M%KEVN$OV'N6@+L6R=)GV1YS.]@>51WW*H$6TN:&\FQMH[\(6PJDHM<1;$RCU M$W'&\3FC%(:(W)ECR,S0%1;B*H,:$3>58W[@9+)E&92_D68QMMT5:$_$^;,( M<%N?#__XMHE_[C>K01D@UQ\+5:5[Y01*7>@M$V#+)@9,$. M*5I&$17AA"(J5?:HKS"5+=DCPMGIV:-VLTT&B2*J;73E=C)UO%66LKZ\]I)*2ZTI*1L/0"[E#LZ*'&\:.1M.B M9/EH6G1_-FKWU2UT$U (**=ND72MK7#RDDP2(>WD3)+>&I!-4AQ.U3::NN93 M&X(I^-):7X?+](*<=D721.6"]3M3N,A^L&SG2KRK<,NEYRODO$M5"#*P--NY M&Z>>&<6M-]0-K 3/LL+SY&QQKP2[:.H&;[+%U0!['3 =H[BC,+4#V>+\(NP: M+UANJHUMNZ838*Y"A8.!9LQ&V?/7,G$LP; M,2_RF3>$D9;3=P'C0>"9-L>*-R]V.):_+Z5GEM-XYKL9G!D/Y=L$7 FO$=P< M,U],/5!=]PDOMST++@ +^C26,X)QD1WYN G(ISEGY.MH$CG0O&?!N/5;%(3X M>\!"#U\0B,7F^P)>8R(6K/BE?T3<#X6/E_MBY,![F#GF[I,(Y-3D>':@W[>A M[7)^,I$6-#P*36\BY8079CIY[@M'7F)ZKF7+=S>WM"%[:XS>S5]CYFY5:\B3 M'_&A%W)#E1E_LU0\^V_P$AB17Z&=/LM.#5]GIX:_./!:):+I'@M+CX@?SP$G M!+58L@\+HLF$^W!=(,$B_HCL\)4]Q2(!K1-)XHB@ 7HT B7S8_Q8-BAJZ,&G M2,H-;S8CWQ=N6D(;4TL$%WM+;)U ,OZV/FXWL M2HL>WZ\;!]Y_W-N+;?UN*W,4LRSI?*?-H)SZ[W08T.W40FBNF"%K)KZ^E!D MQ]9EGB,[1G:,[-AA65651FYU@0J9L37[,>R).'\6 >[$@6 L].UX&U')ISK+ MC,)5=FW0)L-&AHT,VT'E,WH4H+UOV:J\F[>\>S-G=:L>I%'\DM:MPMV8[.SV MX*&W$4IS?\8)""W6DZG/M"?)??T7-G>DW#9O6LV MY?4,^\_.9G]^:C+8PDS?I<^&*3OFOWY*7VX^#:U?=QM''=DSJ,+=W&XT&>+&T5$R%YWNYS:]R00>%GM!X9B'<.\K]&%6M,Q*MIR&V;XR.][H MM* )*@>JVS T;24'JGQ+<[D3U=JOG^X_RU5*@?TMU^7Z=KJD%CI<"4$\B)\ 3P01#.*0#[)T"'F>N%( M5J%7I P&_=Q%,%>A1!9+8IB3>')P9.K;@-57<# 2N<2'5.+#+$/GBEU'VV,37^*#)-::KE40KF$1CJR@&> M__'/?_H^?=0M]UW@L>"+\.4=LXOPM IRVEJ.KV^/NBN\Z$2@=*FV[P2Z!%?&IU&<*)1GIN*N MHA;'K"#/5$'\84;QB2<>)$=@Z&A*>C1%US1UAU%T-:=1VIWC'@8M+IJ3$Q*&PJWFQ"//V8W5,@W?(XFPN5*18I#^D M/T1,I%BE4ZQ3U!_RME9O/_@L0BP4A2E6>1CZ]C"*U^E#+[M34Q5*J2 !%20H M-@M00VL/J%04':PIBY]"-0D*D5Y%&2S>:6OTFJW")$;$1,1$KAFY9H4+U6AH MAE9@\952Z"(QX(DQ8(F)CERSW0^"-7J%AI-UH2::?=MVK?-&N-[$=FFULPP6 M@2PF+2J0_M!J)RE6^>1#Q)2?OZ77T>&2S_N7W+&'1ZA!!OPIF\ E3=F2Y'&) MPB#D+G9O'Z7<6%\FMUQV)0B55DWVZ(.FKBQLHIDXW#%:>;]Z:8PS:0*49%FHD^ M3DR>)B-G4X>[-*5P^)2"1I/<1/LTH; _92D$$.&$<$+VB.P1X8SL$=FCTDQO MUS?<4EH)DTP:F30R:632\C!I!IDTP@F%6&2/"&?5Q5D=X)0 B':U4HBUG:[\ MS/W?19A[2%5D7O:R83)G$[>O:.L";3*!Q>&T#G L&H"$,\(9V4.RAX33^N&T M#G!4/85Y*O:0#J6L5J6;]"C*U N%&]K<64P$0/:T"'N:4[I;LJ=D3\F>;F-/ MVV1/"6=EQ1G90[*'A-/RX[0.<$P J*R0[*G8PT/CRWY= \R'.)]<% B+P9T@ M S-R> B=B-,@P-<@V*GR@Z+BTL=,#I234[R+Z+<7 M8X6Y@VQT@2BO/9AC^+8Z1986(9022LD6YVF+BRN(1K:84$ZVF&QQF5&:B;:_ MD_6:5UU?6,,R0@/5$.=CF63]0C>TCPL:+?[& MT/3N/XQ_/]Y\8+8%7W S/->,N\[U3>^JJW<'G;9Q.[B^N^X;G>N^KNLWE]=W M'WY\,[K98<#3K@'[+%[85V_"U]/RULK17]0%0[$N&'/?HM/KZX-N_.-+W)RA MYUCQZU"H3$J5_2PXRG0"JOK^/H#= 9#AE:, XA%47Q)' %H-QI5-07>@!:"U M(\^?Q'C@0R\*F1?YC >!".,44H[-A[8C (0^9B\>V\+EOCE\1G?@; M?ATW+Q3FV+7_B 1BD 'R'.BCA97K+1$*?P(CP8+('&<>]WZ6T6V'L?W.(&6> ML6#=M3?4AY^S+W%1ZLZBMN ULP?+T6*F<)SDFA\^:!_D9[!A9OIY=Z"^V%8X MOA@,FGVMHW7[AM&%_O8['U-#"IAQ^#00%^D?2PH\;V)VXG=N7+LKO9+MYX[C M%K;UCYO-]TI'(K[_T-N-X[Z>.D^=KW_G=UM%RG%9,J]UIKY:@XZ/6^W&7 9H M,/\>@0UL:0V&[A\[NW<9O,#!=)"?]@EX-Z:U+7XDWI>^":96^,>0_Z,7G,BJ%+#J\M5K:VYBLY$+BT.Q!_Q,1@JP#J4 M1ECU-:ND<:1QI'&D<:1QIZ%QE$YQS2Z0:QZ,F?@CLI^YLW&32\Y!?BE.HAZ^ M5_DOA='@MH[]C"!59Q&FZ%*8$YYBB850K?;[BLL,E%WT)+U).M)UI. 2$"L(Q#) M%A($"8)D"RL&1#JJM/FH$B;K"5\I=E0*UI9!$Z]D+LE<$@()@83 TT0@.:P$ M1 (B ;&20*3(<4WD> ._/'-9DQK+0?O)]JP$:>SRPQ$KXO$'Z3J7 #""8] M-Q?4;BAV>6JH;G449FC>5[9U@3O9W2+L+B$X=[M,0"8@$Y#)%!.""<&$8#+% MU0VAV^VZAM"/7LB=?-2L!6IF>1'N!$[U;!_$ED(WRU1#99.03ZC(2K?1[W<4 M3NGO+=JZ\"0Y//L[/"6BQN1M>.NRL2?>5,^;>0B\%OO;]Q9Z:528Z);HECQ1 M\D0W>J(=0^%!=O)$B1J)&HD::T"-N<]GGB(]'IK)KH;SF?%'?,R%'<)KS?@- M/]E\:#M4++4L-FD<:5Q)!$<:1QI'&E=^P=$&\'R.#+^K@10&%T"%]8ER MC7:SG[O8ZA*]D@G-R?<@TB+2HM-XQ%W$7<1=->B1Z+&:]*AT[PSQ(O$B\2+Q8@UX,<=) MQU,DQLRLXWI\_7O_&ZK3ENNU17O-*\W ML7VU;DD_S6+S$EN1H>=8\?,O ^:-V(TPQ60H?-;2&\S0] X[NW<9O,3!K9Z? M=G!ZV:7$O9=GL7#+B%D-BI3,"9"1)?TA_2'](?\HI']*?_!RG&B?9 MX,&8B3\B^YD[X <-M(&ZLSEUV1%$9HI8@UCC'6'D M<'"%N(.X@[CC!+B#/ YB#6(-8@WR.,J1-:6^DR+Q;BAYA,$20WBL,",_OQ*+ MIS@A1W:+](?TA_2']*>T\B']R<]W,OIU]9VN/7_J^3Q<\$)X(=M"6"&LD&VIRFQQ?2.>OR%NW0G6 MJ:)H9RN)&8U^KT,6B2P2622R2(07P@O9%L(*885L2WGP0M'.NKTQGA\^\2?! MN&LQ#[.<,(YGK1FF>Q46A4#;B;$]:#=U AT9*3)29*0(+X07LBR$%$(*699R MX(6.!FP^&H!9$\)7"GBV$URK1X?WR"J152*@$% (*.2^$5X(+X27DN"%PITU M.G,#OSQS+&Q!6SD^#LP[FNWZQKW/7HA=_+1IA9H MD^5%N%%0&11+*$%EN<:WEEZ5DY%W&OU!1]T\[D:9U87 R&$H(34E#\4KCFLZ M*\];>4BRFAM6-TJS-$I'='=B=$>,5C-/K--K]L@3(VHB:B)J*A,UY3[156-Z M.C1M3PTGNN*/^)@+.X37FO$;?K+YT':HJ!45E2E4/J0_I#^D/Z0_I#\EE _M M#\WG&%R^&Z]+*"^J0)QYGMY6-\]4ESB-+!61!I$&G6(A[B#N(.X@AX-(@TB# M2(,$AL@_<\D6=#)G'CI:MZFI M@N.IG'8@4T](*X/Y([P1W@AOA#?"&^'MZ'@C3Y+.S=*YV?)(D+9$[\1>AD9G M-E*Y$X!XB7B)>(EXJ>2S434FILQTU'>R M!.FJZPMK6$9H,/KB?"PDM^F&]G%!1^7V!RE6VP7R"B]:^$4ALU308\'&_%FP MH1 N6^J.RI>Y7JZ/9Q,>PH_<8?9DRFU_ I(,F#=B7N2GF5;Z?^ M'KEB;BY;6H,9FM[-]95-=N\R!!/NI6G@N(%&O^#_5%J9S3%WGT3 X#;4RWC3 M4"C,L6O_$<'WG@\_32/0Z2BT';C9PJ]">%4P$GX < Y?$-$9S4Z4'W'!'/$L MG("4O7+*#HR=&5/);S_A6#(#]"$(_2BF/=,!QK-'DM[@$P_&LA@WW"1_QI&8 MS.MT6V(89JITQ_"Q!-#I!.R6!?KA>]'3&/ZU?8M-N1^^LJEOFZ@[T-AGVQ1! MD]V! G*X+3!]>QION[KVK O:#D>.=G+Q1,;^0VT/%'?,Q":HB': +B>\4./H C!((V.;SOTC2] M2&[X8U\\N!@S1[ ['*U_2@3^/$?@\JX_E7K20-F@Z''3H2>E#V(=V2YW3;20 M00A?Q)IBNZ83H=#A#7A'KNT"@"PGPE,*?U#""=.U\_]M+O=$B6^F=_/WS< ! M]_R+_S(ZO=:0K]!!^T58S5D/ M=57R5H;V&NP%'C]F'.A+LN*4]J MZX22N62!8_9Q_J@B9S9U$9\9K9@V/N-H7C)-?\\$'[(#]#]&:FGU<, MQZ,] 1E^%B_LJS?A2Y,E+[85CB\&@Z9F=%IM76]I7:UM##ZF821HI\.G@;A( M__CKVY!PWL3LGH!Y6-E=N0%D^VT%<0O;G8^; ]>547)\OW[@[8?>7^G;J]UZ MZGQ5.K_;!J.CS3^OGQ3KJS60\\<=M.NO=^"NOR$W?W^"H,"USA-GQ9+_Y;T= MT 1+*?Q\Q3OWOK@Y7.-K74H?!"- MC;PH\63HZMI#;3Q/?V[$::8#"$2;NE2 M![=.,KX7J^8A[ JQ[NJ!.+MW&3S,P8-\G_91\4U9MHX@];(J/E:+! M 0]:&0$.@(6NS/W H?_[J]1IQ"N[?DLGJNR<$<^]\WQG'KB;13]?2:) M-^91.]*.J6.%#IU!OVGD'CS4!;]@*&;L$N"3 M'[C&#]0;Z FJ2W-VZIX@!6,$PGU J/4H'",GDYS, [)U-MJ#7G/K8VZGXF82 M5@@KJ[#2[Q!6*"3;3EU:S:ZQ:H5L*23;95&'O,&UWJ &(9FZ!*^G[@U22$8@ MW!F$@X%!LR+D9)*3>8B3J>EM=?L\""N$E=IB!PU=UQ2>B=I;M'7A M20KB]W=6B!J)&LM#C=U&QV@K/"! U$CA6OD8L,1$5S"U59S!$L[JMCL%NG-$ M341-1$U$35M14T?KJCL,?3+4E)EX^R[$RDZKKB^L81FAP?B+\W%Q%/G/7UL0FW/]=A,P;PFN>Y1VV.XW"H '_FDZ$O69FY/O0,?@F%#X\@''7 M8B//!P&YR8_F*Q/?S#%WGP3SX?%!DRVV3I:4%MP8$W,$O MBR8P"!8+QQ W/(V3=C:R#<56F)[O>P 8V:, GFOBJ^_@<3ABH>VYW(%V0V.A MT_")^<*1UX)Q7<)R11#D]6KYHE0,IN?*N7TIFI'MT07!!"%](N23: +_" M"_".7)NULMJXTGZ#ADR8KIW_;U,Q)R0YYH M[0GT_K-X85^]"5_R\%]L*QS#G]"GQ-N MR&Z_RA>WJ=WYN-F[6NG*)7TZ\/9#[Z_T[=5N/76^*IW?;;W_:-,DZR.W'&H7 M*]B&TROW-IPCUGJ': 2=BL>Q+P3[&:X9!VQ=B'KKHI/]]\@5K*4U:))/V20? MZ>FV>OI@?\M'2_]F<^@--A1/MNOB]+LW8E.XQ;..B?"UA+P]E99+X+ENG#U@7VP>\CQ:P4NM M7T 2M])H(.U)*^^>M+TXKRR*5?;*])7E+/F\=E=O[E)B?!N/\/@Z0V14,S(J MO?DC!ZR$#EBW@*(FI=% XKR:<5Y9%(L@*ZZ*51F9;&%_ M?S\N)0#?RGN(C4#?T UE5H".-9.;<'J)C5L*O7 ""@&%#!,9)L(;&:;#(Z]> MFRI24W"UI;9+ U<]J/[)F"M-N:PG2_9,C(D)V<(3M36,IS61EVE4H) MN7N7(P\$+[)C^]DQ0V&V,;)C!+23LV,=*A5(X=B6NO*%O\KT*+E8+BJ,M MSEKJ_,N#95L7QW2%G,E-/8:;>BK57O)8-SB1BB^$-S*N9%S)N!+8R;B2<2U7 MB%O;"#=['EJXEOJ3T,66$2K-UN0RG=3)L\909;?%KSK*HW>:O>-+O30Z3,%. M><_Z4 &00J17Y0(@[8'"I8Z3*?]!Q%1"8BJ_K21_C_P]\O>(5BM%JR4F2/+W MR-^C-?6EJ[J:4YX"L^8- 9O=DJI#,-YHM@ M*LS0?H8Q:NQ4W$O.W:=U$U>5]HJ+%_IBY, +X$H>P-,F4^ C_!%?%0*),<=# M:A'^A#DV']J.'=KQ.:2D)< R@; 6:_(-N<-=4[!@+ 2^R ['LE8#O)G;,K%J M 26O'(\\_V9]CH5F_N%\%UH^$]E_QP Y^=>?E M'>^Q#"7\[+DFW"6'8/9\.5[PX:L8_?#A[@8YZQ_&OQ]O/C#;@B^X&9[?75W> M]&ZN.X-^I]=I&?#O]:7>;E_>7K' M*E$IO'6W5[NB&76>.E^!SE,I/"J%EX\4Y2859;/>>51;&H$DNNN_2H%!Z14?G)J/3FCQRP$CI@5 J/.*^ZG%<6Q2(' M+$])42D\2@^JZBR$1:7PJ.(0N0EE=A-.+\$UE<(CH%#)!3),A+=ZX*T.L(HC M+RJ%1\$5E<([MCVC4GADR,B042F\' 5$:= I+LO?CE$I/+)C9,>H%!Z%8P7H M"I7"*\ZR4;6>8N1,;NHQW%2JUI,;F.MBA0EO9%S)N))Q);"3<27C6JX0M[81 M+I7"*\58Y'I2ATJC4&F4LO$Q^3\EI-42$V3!E)B?L*@T"A$3$1/Y>^3OD;]7 M,ATF6CTQ6BTQ09*_1_Y>>4KA;5F 26%=I6S=IK]YGO5B.\ZE:]V[(7>?;+CY M,@A$&,Q+/NU2D:ESV^Y>]SN]FQO-Z%S?&8/^Y:UFM&ZUZUNC,] 'A59DTOO3 MA8I+AF)\&'/CW^GU]4$W_G$IN^9S(%8$]D;:TQ]Y^2&FW<^BT*0KDMK,&X+U@032;=+/.Y4PTUE#3>26@VD M5KI9MGES]8KN(2U+191+684X+;>VNEP]Z>GQ];0&ZOB> MX(4TR&PFS2ZH'8M_!?=25]/*6_#4)[@K-5VTXPE:+5/]FC7=+8D''8TCA0 M]:RM5?#:"T)205+!8SHL\[6&2K'W969=A"!$$#JB*GX61.*D@>1'D J>L J2 M'T$0(@@5Y4?0T>'5>ZI^B<)SQX8A#(3%ID!&NR7**AFJC[)E5V^=&RWV*KA? M8Y(A\=W.?%>2AO^UF%E> B=.-& M/ O'FPIK2UXIN'FA,,T,$$0.U![VH O9=N/ZF*,JC ;?PRJN7?/ MI[YGBB!@O@A N.98)JZVXEE[S%Q]L"H=79K%8>_>M<3(=NU0L,@-;0?:.)D( MW[2A(724E6+Z8F+Z[L"@"7*:("<('@^"_U\.U;<)B 1$ B+90IJSJP32Z@ H M^;Q>2U.WTDM((:34%BDY>'V$%\)+;?%"EJ6B4]5%*,>CSRTQX?[OP1Q-W"WK M-G)LK,LGHL)[H(\\8UY=P577DIS<;$!;W9G(DY\,H/DX0B!-C!,0"8A5!"*9 M0IJ]H-F+0T(7E0@BH!!0:@L4FA8GO!!>R+#0K/CANG%I_A'9OK#D+FW;G175 MF$-+MCTHYS3YPOP]E0'9BQS.]3Y5 :%9@J*RK;2U#F4SIJDZ N$1LZUTC2+* MPRRKTZ[B*]H0$L!,$F-'H:YJZ;$9U,48'3M;K1<_>%L8VCU[('6:[(7>? M[*$C& \"4>4I\-)Q$,GGD(@R+A"<]+XU_<8L+T(U38L$[R/ \IBUC6:O/(+?:2*B1KI/ MJUA$VQ557:+MXG?P#+J]9O?X[!72F096OIH*,[2?A?,*PQI@U:8IQY$,O?R'3*O/D/4*TK^W M0P9W(V].?1L8%,]&)R/(\0(VA>=X5M!D6Q0[0U!'+B#6=DTGL@# UF]1$.)/ M 1O!T^'_P6ZX3'PSQP!RP> E@HV1' M?.B%#?1EF_'[;F)I 3H>A3EVX9:G5R5=[J8]SK@S"W98*\@.SWL8SGJ(RC7A M/CP2=,>!,4=29U[DL\M__O+Y]O_@=\\")6BP%WC-F+UP5#(3W3PT"*"0KHL* M"Z;BQ0['4E\GPG\2/IJ.*]M[$FX#--1L2I6\O[F]9E_&W)]P4T32PPS8M>=/ M/3^V-_!(0]-:3?8(#W)%R(;0,?;,G4C@ Z&O06Q\D,_@B[J97RG@?/FL!>3< M+X3/FLL]J1=G+&0MN9]G+6%?9;(2^?67+=*!**.2HESZ=>E:F#_O>)('98EA M4H*1?F5@S]Q,QX$+)MQVH;?I<^#2QW\_7%Y]O6["WPQ=4QVAM]^ M(LK(CS*,1K?5:K8K31J%F5E40W"S?,$#_&,>/VV!%2OR4?MSCY8I1C[,3\]R MVL@!!RBX>%=KY301,X7C)#KZPP?M@_P<3+F9?DZ:MZ3&V?8^VA/PT3Z+%_;5 MFW#WKVR=2J\ZH?1B6^$X1L+&R;C%:<'M+][YD-0NTX)+D'_3^X6Y'5[-^1RLJB,= 5QXA@T>((/1W:>Q]6WSUR;^_7?N1MQ_E=PAK_N9QQ\68_+#YXB)"8@)*L<$1F%,L$0 M*?XOA\-_V@+A#[#U^53.'@3)U,)9_.NG3:S@BZ<(0A /@)XEB/]W__GJZ[\? M+U-2^+7Y($DAY0 YRTC()^2?(/*[S4XAR)^[\"MM^.5/7[[^ J;[K=V>F^D8 M^7:\RN';&&#AK,)AP<>QZ="$+T&7D0??\"$*8>3Y$YQH?7&%+Z ML3V-I_.7O.ZI(Z>X_"AERR#H2;_@CX!^YII M_O)\JU)@- M_0BBGTSL9-D0!7^=\I-IKR@1J5KD**&-8DZ7..7R%-Z1:[/ ]BQ7>E7:;U": M"=.U\__=3W]BSW@5< >^FZ$7=PFTVRZ()W.![N.I<;8*8.=^52I/EJ.D"@+W+'#3(N/!#^CSNO M@2V];FB/;=I3^6;''@E00&S*LW C(2]8;@T(%4W MV974Y212S0QD(PU"$@X:Q1RTPY;*4;)9U@5A@64".RF+8J"&();,1+V'> -< M[#C>RX:UI_?&+#-$N!_,'KVN'93,8Q9F6+0WE@ _9]_CHH_B+&J'EIV5V6E> M[+UIL#Z= VZF6Q+-]'_F ;B(OUC2457SYS-9F/:*[,U;C_Q%3>IW_NX MZ]3;POWZ@;O]NM^\V%[CRH,'R48+B#Q6M/Y#05TM=_=1_?HGQ,_0<*SGU M=N^FDRO!+L>S9AUK;4I95>7\(D,J%G^\@+":=6#TDE[,=1:O.;>#6 M!(8[$M9=L'*G@I+DHV4H'E78@3&Y:'LVWSP6V-^2#2A'/<58BD(&9Q2YIT N0Z0O1ZYK 1()8#< M18\(D.L V>TT=V$V N3LS^IF2=*[A6UL 5UK#?F*G2*KUQ[^YGG6B^TX2OK= MG1XI.=2CW,>,R]CRX*M<"\9MW[8E L8!"XZ#:^(OW+?BT]PBNQ,"]VP\)7)@ M0^[@CHC]5\-IZ7O)?-+2-RU]T](W+7U7:.E[J>[FWJ-2FFR6^QC6U#UHL*%X MLN.-;C!@<=8P55XLU8,I\9IY95/7KHJ]&MUNJ[G+RLM^8BV-#I9GKN2$ZAC? MIVE[0F\65M#,R>'H[>@T,J2#F":QN%;K, MDTV*.ENTH8RG5S.18FF6?"Q@WQ[9XAMZ>B6^F M$P5X$C?OY-%_Z7>*S+C)O[&A<,7(#H-/21;B.%_>8GJI8,Q],?8<*TDR=1=- M^!3S2['+O^'!],Q/<)?M)WF-FTERCR211I!=MEU9;>+]!#D9Y4L.52_GQ@K4 MM+PLR5*.F6IGC^Q&%;=0E[5,#B_S5HQYSA;)]?)52&Z:T22*"<">3+GM3^)< M#D$@%NQ2ZE9LR.>6_/W]=U%P_L3Y]"(-(R]=:YX?)DX/6@W;F][5QIO2NCU;[36KW+JT&_=S>X^O#C&_1D9;EA%\@JG_I] M\+U)XF,HQIJ12>+3Z^N#[IJEY5BF#(2Z@NDJM;OI4A;+ :YT[-B,#47X(L0\ MS>R<#D8";%%"J9%,48L&6I9A0OK'G4Y"9G5!3V3VDQVP()I@+OK_8(4!2@E2 M]+XHW5"R,:K=.7!GDG'FI]?GOBBI_++ET-Z5ES.P>N9>6\9%7$]K35 M7D-:9O915H+].9Z.63>==BNG:=)=:JHF34E/24^WUM,'^UL^6EH1BBUT6[$" MA2[5)H):;"'>90]P^?2WO-1[J*;64B'7JN!RYF52P:.K8,YDN?T:]?$5EYBT MNFI,3$J[V7:8+GZ8S?WBY*XJ0.>W>[4"NZ**V'A^ AM5YS3ZD>R,,CNC7#YE M1J=R/-8-=@2TXP"-["/91[*/E8/M7DF)2"KJB+&+*">:=V 3E:5K*I:JZJI2UQ<-[ 1 MO"C")%M86GB2+21;2+:PE+:0(LS5 OP2^>:88WY0>Y8UD7&9-I',J(I].%3_ MFRP@6<"]^4DA@ @GA!.R1V2/"&=DCPZP1\H6WNN"$PJM5JO*S]R-1MP,X_(X MEK BDU;JE,U.*DN61;.39 O)%NXU.VG07E!:J2L#O$[<%JHK]$NVD,!*MG"O M@Q&T%Y16ZO(48%R+<2K\"7>Q=)H=B@FMT2D@?JV 6+(N"4 $C9A$A=<$)!U3M!E3*V+;(B3IE1N-*HM8XNYKJ MF8Q>O@I4-S@F %268'.3_ AGA#.RAYOLH;KC=60/":=D#W>VAX4YI'7!V:%! M9+^N4>3M:"3,T'Z6!174%OY;4*T6J);E17A$+Q<;6MG:*BL,K-')R\+N,PHG M4:-EQ2A04:4C6_,5RGI2S!!S04O="N76XCT)R!/(2PIR\@O6^05=A:E3R2\@ MOZ VE'%2S!!S05OAUGGR"Q3X!9DIAN]"#N);=7UAWC MPN#I.%1O)2P_VRX00WC1P@N*$/F=Y[-P+-A2MU2^)!S[0LBNA9X[IUY@X\GK MH,$L$9B^/817#P58[H;48L[&@&OAP^,<+IL*0V#"$_G3[&EI+1^X#UO PQ > M$X7SH?NU^=!LS!^%'?@M\NW LN6I[^;R8![&- FSZ-W\F67NO[6&//D1'WIA MA\!W9OS-2]SBH>=8<0,N31,-K(=B1F4%X20R*,?#= *::*-R>ND0!_@3L+NM>8O0&OC1$6YQ1/ M*U5EK\:7VN&8C<0+M-(4TP0ZT (G0G'+MTY]#V %[;?L@#L )0[CRUX$?C:C M($CQ!=]@QUV/.9[[)*1,?@-"0-BL;CEV,9:.3&PNE><5X(>/Q/8B&;08?"G[ MT8#G@B^&G\&HGR\^,B.TS!.#58_4VLH1>FQ%O'?9S]PWQY(]Y4CXPA1 ;\AX M(Q"&(Q/]!8$DSQFGWG#7#L:(3':9:.(K.WOXW\O'3U)P(*L!/.F)^U(97D!7 MQ@!ZJ1BR AHJ%CXH!)(/4V).N1CP#]R*9L]]A2N@!SS6.OCEV7.>)0#2-O 1 MZ+Z-]D#2M.O)(U )(\]^##(C#GV^!*/B2..]V.>W/0Z2WNBZ?+K4JO>ZA5<' M-HP&]]?WHLD>L>=>B*^:(/\E;Q363'B--R^UP;\)0C"$B349YNR^_:7;;0X8 MW.ZLRD:BU@.8DX84&?0S,UBILYH=$VF"8SDL2$F.Y9B#;9YP"^B'O\;7PW6H MFK'(\3WYBDYO-;5"1">9W_30?L:>$?#J-$+/Z(W 4*N @!$5\%.0NH\Q#(&$ M;8&NUYB',6VGKM!,G"'_72 L):;&=A "X)%0$5SH[R![/X-HK2;+R84IC!!O MXDP\TM&VORW&%BO=?V!-O!@K;\1N+$J96[]%03C3OD57$TU-1L8B(&"IH4&.W /JVX.*"S4[?&>/M M'DT%OO]KW%/V(/QG&]S+L_NO#Y]B[UIZ K$_E_B,F62\8G2:.^"R0?97A5BC3A;/_@?X* M/[::1KO_5ZO!;H0+9N!WZ;W8+FBVO):S221A)$$@0P)XJPG= 0,1?@BA#L; M4FRY=.E&B7LXZYL.'P'93^/$C88N2:K)/-:+GR.)K1;Q(Z8<^!:?,W]'8L]@%A-S..AV)#$=P(>XWME8]"Q MFD=C*&/+%R_S<'.;%DEE">+9$)4N;3R''4VGGB\7&^3GJ1?".VVXWAQS]TFD M$RU!]E4\&0GQ#0DZAI=\-U\8G-3MB9N"$:AKXI/3!Z$9R Q\4MYM([^G?W__ M712/T*T/K[CW_^T_?SZ\"B@CQ>5UPGPPWX M\%6,?OAP=X-C]@_CWX\W'YAMP1?0D?.>=M6^N=8O;WN#F\YM]^:RI;4'[>O^ MX'K0:=UH5Q]^?&-^LG3W:$] F)]A\+]Z$[Y^N71KZ]5?-%:&8F-ES*<^.[V^ M/NBNF>B_G^0,Q'J:&N#B[W[ MO,7H+RQ(:V_D@I^S#W714W46%02OF3TX1K@)/EURS0\?M _R

    O=\?WZ@;G^E;R_V];OMT\_Q$$A>._G[:CD0 M'[>:VL_ @4F\^F"7_("SCK4^'"9UI=OX-@S'^T. ZZ'"SW<0%C>*K5E6E*9I MW78.Z6WB[-VZ"U8NZM..LX7=.L=0]%KJ\SX:?"-,,<%YD9;^KA8O[]V@U!\[ M^;M?^0O#R2$? C)E>13WVD-9AO.YAV_I_8LJ&6ZT>14]=KIJ,WJKHW W>AGT MB,YYEW<'>('GN MC<66L4W%RB>D$MR>H$DA=6(/\GS7[%#W_=YS:3B;7]W'Z MC4U.?VX)7DJ N!7FO-MI4^Y.,N;D%8'0,GG=7H]=1"J"U+(A*TY[63C M[@1AL2?/L\B"J:@/VQI0A5BR8&3!#J@0VZ8@3+D%JVWJL$=Y5,3>:@O)T0_[ MK^/SJIY2SW46^^#<('5,N[#*Y6AH1K_ / SEUV)R6L5 M30PO&=+X(SXF34\CWW#%'7FXZ&$L1,BN'1X$\I .GK9Y_Q!#/;CPZ)@N.?\= M73XEY[PJ\=S1E.H8X==VI\]H"RMM82ZD\%MH.1-N!:#M03?BNZO6ETJ2 MVAY;#PY:74J2F,:)7^UW)EW2O)NFATW%U+SPEU0FF0IVF*S#![@.'V32AN-5 M=H"7>"/VLG@V.:]LQT5)<9[Q)[>\P&G:H$P.>SW.89_K:QM)8NTE+Y.)'028^O?L]OI3U&WSUR;^_7?N1ICP&S/FR1?]S%^31,Y)7GK[ M63BOC5F]'UE.LQNSL[N8RT^<9CM*,TPN9M3%Q M^32PX_)A$\F@/S]DBU[AWVF;=L^7O#X/\MM\R8FE2_>,">OJ]1I>Y'-9&N!G M'D98(ND&M.@1/8I=\BE?M?5N]ZYK7.J]7N=*[PSZK8[1N[V[[=WU^C>=7J'Y ME$M300T1,Z^(-.*VG]3)D%6@0+=#B3W3"\*T=$:LQ3+#KR6&T!)A1DDM"/[, M0=WAEW/0H_. PR5#Z6ZD(XA9X.004IKCC6F.=4U3E]A8[RK);-SNG%)RWY+= M7NW64^>KTOG*;X'((;VL@E787IGR4Y^_VV:AG6:0,SJ_W-#'2^5=)M9=/1!'KQ10S+&04BC];1H;;AN5E:+5=QC'_A/C6+(0 MZBT$P6=[FY'.H%0*/M=>$!)P"#AD=\CN$'RJ")_ZVQU*Q[!F(MX2RUO M479V"F/*2T\E9B&UO%-Q>DD(13>TYM:+1:=R.)5X@WB#>&,#;QA4XX)F?[:? M_>&C4/CS":!P#([GTYB-[.?X&\K5HB)72\/H=)H#"A!H8J.X!1 "X1((VQW* MB$C>]A&P5@=()1YFIZ?0DA%6""MUQDJ_15BA:&S7:"SGX*ND)T>.MGICZ'EE MM=I!N'5!-X5N181N!.$E"*O;-D(0)F>V**36 9#R>7J_K6[!N:Y++/C*IK,N\P:(%4+M- :ZH7#% M9V_1UH5%*;C/:6<6E0&H-6]6-MOU:E+5]+P<4"H#0!%B^8FUQ!19,"E6W&>4 MSVLW^GU-X>:\33(C:B)J(FHB:MJ.F@:ZNB)U)T--6Q43V9R'?-_\XMD\Y3^) M)WEI*/S@TK7P?M!"X9JV"'9)2-[3^]?7M]>]]O55JZ/?WEYI_>O!3;?3Z5YW M;KL=H]"$Y#I.AV8>8B@&@#$//3J]OC[HQC\NI0#YR0[M)YG!_EW-V+9;&_.L M%U66Y%]"9CPW(]^']SI8O>/9]* !T<'L2EWEQ4,GBFBP">Q,T MDGH?\'=2P$ J(+-$8/KV$,N]"#"46!4 BX1@'O^DHD' 0D\F;N>F"4&7K#\P MA= *]55F_I??P#7;OCX*9 6&-&U\?(>9A4'H<)DON,4^>Z%@>F-I0!7) M-_Z(C[F0M2+,6.+L06:7?\6F/L#@ ]Q-#B^\G$OA2R*%O%H6MR.1_D)IGI'M MD6NS#U"%]S_)7^,'<-?U0H RX-L2#/44:R:X M_$GJ"!MCG83(ES6@,B#/H#.N-"*^@7/KB 8[LS\E-55B=,.5(VC7:X.]V YH M7^0_X]9$RPZ@93:6&6$33_+&%(VB;8J_PC/@(5E*@3Y#"[UAR&' K-D),WB( MB0[[J[SES3TQ#4D198^XXPL6!208,1G4*JO0,';2P= ?J%XZL*?C0=N0W MB7*#HB.198T*$ADTPHK,$,V"/14H3GQ&4G L!HJEXKUCX5A8<$362 MD.:! MS#L6RP9^!Y'Z5JH>\(F'*!+05A_!BX^T_?2A378IZP[! Z'546@BV+$4D9N^ M'K[/2AFL"[0"Z"%RPC03%];^\?P9"<253E! V/$Q!]!Q-.@PM%B1>#(%Y,%] M4G;#* !YQ5RQ8$+B-\B@%#D ME3MA[!\(-_X3;_\.DY0!U;@@RI%(%2 S1DW56$VPJ7?SQ^9\PKTUY"N+WWT"C#L"S:4=,OX$B Q"<,O3BEU?Q1.( M"O!_#0PBX7@3 =$ZEN>/&HEH7QG2[5,<3@ !/MY>W]W?W'Z]G/%@D ["KV', M"C][EG#8S>U\XLS0H,E:AVF&P73=F/_PJ\[.L"51 MF>U>.O)-]BN(R$^']_]G[TV76S>NM>'?R55TZ1Q_1ZZ2: "<%=M5U)2C'-O: MEN3DS4\0;(K(!@$&@[25J_]Z $A0(B62:H -\'%5LDD*X^JUGC7T&CS[^83; M;H]!F%Z1ZX@P&',2!GYV,\XI\K)NQ-45\^\2J=+2FS?(:\/XU=N=B!\FU.:7 M$Z:LF/''/* 71C.F$>;.;:9GA6[+E-B2ELV4]GPD:B3UJ)2+;+S>JV6['3.- M1*6Y\;SB69>X=9>'C2?!*VN W^J5#<;/688W^5SJ+5+=,'[PRY>[VU]N_M\" MUKG.YW24X33%*F[?Z/Z/S,P6GE$B1E%&DO&^C-FA(1]BR62=$\ 5 WH#QNO" MG9','=M?N668F4:,2_EA8AYC#HAZ)QVC>=+M=A<8=WSU;<9X6\R^9&QY+:=2 M_OU&3K%D"S"8VV\2JZ931BP^,Y//KOM>Q)(??A,ZA['DKPR_'.Z(D &W1U_J):DW M?NJ7\= *^7?"O [>0F?,-;AY0L[=@+TTD40A]W>_Y 2#.M3E/C3C%":F9!P& M4W&M#RE(COF__V$73 ^U"=!["08+??[/^\'YW4U:5CIU M1Z?7=!BFPV.-/K,TN*KA/CT#%W'^ M&;>(R)>0/_XE99>=,D=0*-P[RMS-1(Z3E7]?_/(]>62$%F/&7\23G[,?)/!AGF7_)\Z=@V,PR3BUR_RV_RI'-V>I'[-EX5#*UKAJ$R:68 M]R;](L%E\XG&G,'GU+>9!<7Y=K%X7/%&3"I7+J*04C'A5HA1[I',9B.]#_OK M&[D7^CQ3YH)EYBHD]S#9B&7&=6XPDC=;EM(L8IJ;^]RL6Y2<[T/Q!TOA+Q\+ M7I@]0J'*K:Q5>T;MXL:]KU%\MR*T?I$/M%W/PVGWV5X-QTG;]0K?-Y+112?@ M2Q>),HR-UF&DS)XF__,I\7;460[DX3OM/"0.0/Q81++V+>\?_;L M1;,==EMO$W#L"LS"8N?';"E\^K*T524BVW*K/(KE[@3[.)VQ M1V(,Q*-'W)@4R0'V5*C,-%)!Q97Y$P1,Z3X)1S"EF+S*\MIR"G._13HMOGRL M)W9A3I41=5SN%HIM#?A#F^+._6+&?5VAYQ]T"1723!6YH<0TM_"'>)B*08RP M@NB8L:0M\Q:XH<9^R^PEWVF0E10[2:&+H8O-+&9VG4G@C42W4C)('A.&9FD8 MO)T9VCLBD# KI13EA"Q#DCE*")\J@XA%?22'A(B!(7\T]BC\&2X:)'-BNG_I M]OYU/)1ADOR/\;$M?S2[Y*)QW;C+GV.UC(9I#$_;\N$\;N7(QW+'8Q)Q>Y ] M8#[4NPR=W*FP^28FDT3YRXE8++'+MC@@I#SRPU9.NDSI)=+3?!D7YV 7,5_3 MCM(_I#](O.'NF A!+T*["VR31V3P]C\"U*2CQ]66'(G;6;MP'V^Q1?9-3%S1-P2.-G;I>](MS"@(GF M=EG^9H/9S,L B$>C3?.'=K=STNN:[)IY]I!Z#*16[ 0Y$SI*O/1$CU^-8U_] M=W&$V+'U#+FQ>4>?7/I,OM#8722@+&2Q7G)WR[=*0F="+!G$[*2RQR6+<%_, MC1-NB)<5JIVHZ+Z:!GX:\)!]DAUP$[#'G0;'!F/W_B"?6 MD\LP>8S(W\DOOUS(/$EF!L4\O=/S-3*LL3$$+I9WL-@[^FAO9L+I>9.2UXE=/J )AT6?%$0O.T^B=- M2^BF$_:U;Q@G[6[W9"EED><$<*M:^#U)SE%@]&4O]!^F/(;D.(UT?R^-YK)U28CGR3.4.RE)1U=^Y7IXF0VWGFB1I#6C\U9AIY-;:& M#,S<&C*_F4<8GX*O5)IT\V-3^/<3N>U'S&:7M-G_4LN.?4HMNVPO2 ][+K>Q MU'GOY=-\+GN^G9?%SW@H/MMR$KD;69*2V.V9IUDO G=RCZM^_NG[HI52DUF) M0>HC2->T7@)UL[3SS5VR]W7S,$RC/7X6V\EVE=-$]GG>9BYR_W_LM4<\N2!( M)5'^\?_RH6N1,)<7STPC2?$TF>RTB6GE,X5R^]+YW79IPMF/XG'X3A273+Z) MY_%<(1']7&S\?I^*.[OR:W%?3HK,9,[,2L8<1ABF[=[<>*4*6SS'6VA(-P[D MZ^;2+7/[KE:SL7CO^USVJ(2_R)[2S R=+Y"S9#R]BF;Q[6[VZ__:CPGSKX-Y ML@,QTSB8# :^R??+UO.!H)NZ9Q.P ?IWT&OF=BKDEOJ#\ M!U9R9@;^7\9Y2V:SC!#Z^1LOCF(7]<16=;?!3)REFW!#8O6-TH>6EZF[(?$_ MW7;[ %+6?\UG!EK2'S'F65*_#N0&P+'<-6 LDVT+,-V9_35+8+=SP?E7TKZ4(#UDCV"_,/S[7Z:!XXG#MR\D-#LT$47U4?K(XC"& M9HQEDS&O"0]Y7@(/H_&\J'1;D-U#Y(:=7ST,[J_N;G\3O^=/X7^]^G\/@[_? M#!@07OUZ2>X92OG!27J;C2Y_=W5^<\U.3U-%Y9E.<#H_?'Z,./&WX(G7RD1O MWNPB"&?BGBOODCUFICE>^S'=DW:O=\+Y^CC'W7-X3XTXD3PMJX*SF*+8@(YM M:85-IXD?3(-1DNW-YKP?FSRY?/>%9SFX"S&S+XS6U:9"7+7A#%\YQV3H%Y0FLCY8T)WX[A_DZ01(QGW[+GVS(+ MH3$,]NH517)=*G;L9:GM3'(2MWC?C:3HM<"X?.=V7BC*C,2A MS7< $#D2R'S3:/Y7YI!@(\.L0>B40)MXWRF[4- MGH?*4&MAZ\+Q9'Y2:D-N;//ZAD6=['1M:^\^QL MD48D,B725(+'.1EXAE(23X(TL2"MN^8[WH]2_RW*M5YG-F45^-&B3'B>;BZ" MBJ("<#@+J&_SZJNTQ4B0E@-G.Z%!C0?@QIVJ1%K,;S)& "RX266:7/$P;VS-)V MDO2"PKRD61N+ 7L>7CS_:]X_$-4#0IDS]>/+(OS%.HM*$=L=B4TR''%V^ MA,%C:$]SKM&BO$Q8AK*; G]Z7M48I/6)P7XX1]\$F2^R%P7SS[-F!WR]9-J, MZ.R5V[VNG^[B#)-V^UBTGTK;RMYWI-NHHEV]!]QM]7K2Q^L)-ZH1I&0%0HJ?5B_S_;;K175QWVEVK MVVKW+HQV_]P<="X'UM7 Z#0'1KO7-TKM1O>AR%AE%;$(_<+>3B"IRXO&?/:6 M^4YJ2]27B"SCW6D*_:)\)-=Y[)Z9!2,[9!KL/.#)5L?7@_OS[SD[27F+TK^+ MUD7\A&$PRO>JL4?!+.;>=1H 3O>"V5TEHPH=R7B8E_I[@E'Y99_=:%Z^M$YZ M4H;9,:]-_[. M!421]\UC-_-F$2VY$\%Y(:/V2I[Y8R:V!XX']W]\+WM1L'-/C?X)WVBCO&F/ ML(NRSI:IT7*11#'#6P9UQP_!C#U>AACHYA>D'&!<&C M[Z:F$_.>0\GP^2#;E ?9&/78?<*7TWEZPF/BCK@1+$-+7'SFW)U>*4H#;1R@ MQ?:6N-=_Z/SNPL9BQC9['3\:\U=X#'@:!6.8U$03FU3._ U%@R;FPW/:23X- MZ=BCG!8B\Y@QE3M*V6O!]-DS\&"8(_>]4BLT#3SS[@YO[BQVD]/L]45"YM(B MWO^1+5/[E*_RULMT1BYYB"V4M:]BPWHN:[Q;:;:,(V;5OJ21NF4DR,Y;HK^X M_WS72AC?7?[6RS_UY,J)-Y*Q$6X.RUUMWLA*[IJYZ1I,@D#V*I 8)= IN]\" ML)@__.AR)_+K-:RBM9[NY'[\?CR#N\WPW'+W?\ M(EINB4E3;MY^XVW[SKO\Q5)2>"!_=Q59[FK!J^NZLV;>JPA M5KK&+QM1P-J) K_981@\G][S!G+D9BHJAA=NX!<95V$K=<4$?>0NG'[)U%Q# M>@'O;I.Z4U-&BG=>^T34>U-/%%1(_2VBA]-L\SS/)LQKX3CD2DO[1(02'#N: MO,*D;.-X49JWP%KI;Z.;%MORS&J4H?#EM>RN\Y"F0=Y5:-]'MV1_%$NLL?MC5?[J&^ M^<%;3Q7CU7\% 7V,;%@R1PS MVGQ7G@G+(Z\XB\@INU(P$O[+(C!TFN5P>:=_,("Z#\;Q,T>^X_MD& N]TVP; MIRV#J9Y,(_U/E+?=N?EXS>M_O_"X'E>LY,(+DA'39]-9(@.%H:ARVR!&OTE; M?(@L1+:N(LO3Z_@P!U]L!J>&7[/)I>^>VYRID2I#Z:)+81;7GY\%"8.$0<+6 M2QCSR\ZS&#=34<.T(]CH9[172]DKAY83O](OLA308_2M)9[ H$,'J&?&B M+4'F"\WW(A8.S\@5G>32T*F_>\A4S@%9VW]I[NN^>H"5@SO*+A7;?'#'F4#- M_!^6HO%%/3?F>I0ZUZ/$0'RN(=N'P4"4W#Z)O=&Y#2O1+GH> MX5H*YHMF*/-[N8M7>CU\*'>2#-R(?+J7-$DCERC!840T>,KZ2G*;:6R[(9_J MD-!(-/&0%.!9@[D_R?.=B2TZDLP<8%T/RY- M]OJ >#P\MIZ '/]CD91)V,D\;9DI$S>4/<.%'DY?-$?D8,AW-<2-9J'[,W#GO/,EOS321WH1ADSC=*Q,FG$D^\TTIF=;OGS M1Q.>.-^B">F$1YB?Q&@/GD$P;[C(JYKG(KY6PE@1P=*E MXQ;,O]C( 5MC-_HJ8MB9=CWA.>PR\"F33(-G\=II2U#V3FE<5(;>1F(G MA[^O_4VTHE^./MM/MNOQ%3AEKW7*X[WLC&&<[TXDV&MNE$GR2O*LN/8**1#1 MC6$^["OX/7H;&$RW?I9-%M&G,[V4*\5)[IC)%U"V[5M#_9+O-/JA@K%.R"_< M&%M8W2WK^_=V4>6&/%M;ON5/Q72W;"=5])%::!1OH4>R;7R>&R $P9/W3#LZ M#&TO969*X[SRH+Q/,KN$3,CC?_@W[R:<_; T^VD8)+'(I.;7%DIH$>SZ'(/V ME3.HS_.VWS#IB>AG*)XK.YQ/U%M)T8\W1M;M?N0?_/7>QZ&(R.:[O^R 2W:E M)\%PON!2#*2SFZV M$\Q3^D?>)VZ2#WEE\S94"('*]U(=!9/Y/ GX=.P>+O,](%$ M.\]I\+32W)+C2Z)HWK'!SE^.[Y7&4JO.-:*D,W#8ILWS15> MOAZ?\C W=E>P"N4-M7W!5RL= Y&Y(UJ-9<\LU8:0(\E5\]2493,[[68H[&F1 MO,FMO5 $)U(;S6/,+O)A@F>?AB([?\[J0@!YFDHZ+H<9?+X<_9+:ON)1ICQG M)^LCF+[_XDE/WIFQ%M)T^"&O Q&IJNR7,!"9KMQ@Y5J/48G.3HZ?B!U!YMY(R^F4W,<\?W?IQU2@NV:/)_ODLUO8.EPQ^0Y>&-_?\_:JI^>B M]NU+.ICO75&>FY'Y7+^YXRH<+>Y52/81BR:,3-D>R<6BT<*+$6?-0 M6%J$(3+/>8FBB))D&3.+8(6P59=#R:)7[*DLY,NF#(H,E;30]'6 (O>\W!$7 MG1X<4?&:3OYV%CTNY",SP:2N>))4,,5,PH65+!I6O#K9S[+;XGG\1J3RC)D' MJ$"O*I:X=7 6A/E@Y=([U#[Q=MX$Z*,\M.;Z8-^%-*;XQ,:\MN5Y:*^">\M' M,LJNO.0*QLDB-%EF=AK%D7/*QF*Z:)3W6G)^218,E%+FYF_SQSS E;_9R2*= MDS=G%A*XZL+<3\II'W:+U'%<2@M?#JDM!XFR*1CR2E)@7X6 4BW'CTB3>?,2 M,*2+C#>QDOK%Q/DCL3OJ58C7RZU%1)#V!&?;+(H1-@-.6!I?]0V;H] MU>19?_EEVHA*/_GX\R=WF+IC6E?FNW+Z_9U[\IHM0\ MO+9:YQ>6T;]J7@SZI=;&O"ZMLQ3#HY4K]>[VS'YG?2&=H/$)$526)?X9G

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end

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�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�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